{"data": [{"Element": "<div class=\"WordSection1\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleA\"><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"18\" id=\"Immagine 1\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image001.gif\" width=\"22\"/></span><span lang=\"EN-GB\">This medicinal product is subject to additional monitoring. This\nwill allow quick identification of new safety information. Healthcare\nprofessionals are asked to report any suspected adverse reactions. See section\u00a04.8\nfor how to report adverse reactions.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg\nhard capsules</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE\nCOMPOSITION</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg\nhard capsules</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each capsule\ncontains 2.3\u00a0mg of ixazomib (as 3.3\u00a0mg of ixazomib citrate)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each capsule contains 3\u00a0mg of ixazomib (as 4.3\u00a0mg of\nixazomib citrate) </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each capsule contains 4\u00a0mg of ixazomib (as 5.7\u00a0mg of\nixazomib citrate)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full\nlist of excipients, see section\u00a06.1.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hard capsule.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO\n2.3\u00a0mg hard capsules</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Light pink, size\n4 gelatin hard capsule, marked \u201cTakeda\u201d on the cap and\n\u201c2.3\u00a0mg\u201d on the body with black ink.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Light grey, size 4 gelatin hard capsule, marked \u201cTakeda\u201d\non the cap and \u201c3\u00a0mg\u201d on the body with black ink.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Light orange,\nsize 3 gelatin hard capsule, marked \u201cTakeda\u201d on the cap and\n\u201c4\u00a0mg\u201d on the body with black ink.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b><b><span lang=\"EN-GB\">CLINICAL PARTICULARS</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO in\ncombination with lenalidomide and dexamethasone is indicated for the treatment\nof adult patients with multiple myeloma who have received at least one prior\ntherapy.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Treatment must be initiated and\nmonitored under the supervision of a physician experienced in the management of\nmultiple myeloma. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The recommended starting dose of ixazomib\nis 4\u00a0mg administered orally once a week on Days 1, 8, and 15 of a 28\u2011day\ntreatment cycle. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The recommended starting dose of lenalidomide is 25\u00a0mg\nadministered daily on Days 1 to 21 of a 28\u2011day treatment cycle. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The recommended starting dose of dexamethasone is 40\u00a0mg\nadministered on Days 1, 8, 15, and 22 of a 28\u2011day treatment cycle.</span></p>\n<table align=\"left\" border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none;margin-left:6.75pt;margin-right:\n 6.75pt\">\n<tr style=\"height:13.4pt\">\n<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:13.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Dosing schedule: Ixazomib taken with\n  lenalidomide and dexamethasone</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:92.3pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 1</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 2</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 3</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.35pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 4</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 1</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">2 to 7</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 8</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">9 to 14</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 15</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">16 to 21</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 22</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days 23 to 28</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Ixazomib</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Lenalidomide</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Dexamethasone</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:Webdings\">a</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">=\u00a0intake of medicinal product</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">For additional information regarding lenalidomide </span><span lang=\"EN-GB\">and dexamethasone, refer to the Summary of Product Characteristics\n(SmPC) for these medicinal products.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">Prior to initiating a new cycle\nof therapy:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"IT\" style=\"font-family:Symbol\">\u00b7</span><span lang=\"IT\"> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Absolute\nneutrophil count should be \u2265\u00a01,000/mm<sup>3</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"IT\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"IT\">Platelet count should be \u2265\u00a075,000/mm<sup>3</sup></span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"IT\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"IT\">Non\u2011haematologic toxicities should, at the\nphysician\u2019s discretion, generally be recovered to patient\u2019s\nbaseline condition or \u2264\u00a0Grade\u00a01</span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Treatment\nshould be continued until disease progression or unacceptable toxicity.</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\"> </span><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">Treatment with ixazomib in combination with\nlenalidomide and dexamethasone for longer than 24\u00a0cycles should be based\non an individual benefit risk assessment, as the data on the tolerability and\ntoxicity beyond 24\u00a0cycles are limited (see section\u00a05.1).</span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Delayed or missed doses </span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">In the event that a ixazomib dose is delayed or missed, the dose\nshould be taken only if the next scheduled dose is \u2265\u00a072 hours away. </span><span lang=\"EN-GB\">A missed dose should not be taken within 72 hours of the next\nscheduled dose. A double dose should not be taken to make up for a missed dose.\n</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If a patient\nvomits after taking a dose, the patient should not repeat the dose but should\nresume dosing at the time of the next scheduled dose.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Dose modifications</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The ixazomib\ndose reduction steps are presented in Table 1 and the dose modification\nguidelines are provided in </span><span lang=\"EN-GB\">Table 2. <br/>\n<br/>\n</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"Table1\"><b><span lang=\"EN-GB\" style=\"position:relative;top:.5pt\">Table 1</span></b></a><b><span lang=\"EN-GB\" style=\"position:relative;top:.5pt\">: Ixazomib dose reduction steps</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:459.0pt;margin-left:5.4pt;border-collapse:collapse;border:none\" width=\"612\">\n<tr>\n<td style=\"width:145.05pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"193\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Recommended starting dose* </span></p>\n</td>\n<td style=\"width:116.35pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">First reduction to</span></p>\n</td>\n<td style=\"width:108.7pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"145\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Second reduction to</span></p>\n</td>\n<td rowspan=\"2\" style=\"width:88.9pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" width=\"119\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Discontinue</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:145.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"193\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">4\u00a0mg</span></p>\n</td>\n<td style=\"width:116.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">3\u00a0mg</span></p>\n</td>\n<td style=\"width:108.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"145\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.3\u00a0mg</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-left:11.5pt;text-indent:-.1in;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">*Recommended\nreduced dose of 3\u00a0mg in the presence of moderate or severe hepatic\nimpairment, severe renal impairment or end\u2011stage renal disease (ESRD)\nrequiring dialysis.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">An alternating dose modification approach is recommended for ixazomib\nand lenalidomide for overlapping toxicities of thrombocytopenia, neutropenia\nand rash. For these toxicities, the first dose modification step is to\nwithhold/reduce lenalidomide. </span><span lang=\"EN-GB\">Refer to the lenalidomide\nSmPC, section\u00a04.2 for the dose reduction steps for these toxicities.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:461.3pt;margin-left:7.6pt;border-collapse:collapse;border:none\" width=\"615\">\n<thead>\n<tr style=\"height:15.7pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:none;\n   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:\n   15.7pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"Table2\"><b><span lang=\"EN-GB\">Table 2</span></b></a><b><span lang=\"EN-GB\">:\n   Dose modifications guidelines for ixazomib in combination with lenalidomide\n   and dexamethasone </span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"height:15.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Haematological toxicities</span></b></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin:0in;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended\n  actions</span></b></p>\n</td>\n</tr>\n<tr style=\"height:15.8pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.8pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Thrombocytopenia (platelet count)</span></b></p>\n</td>\n</tr>\n<tr style=\"height:31.95pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:31.95pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Platelet count\n  <span style=\"position:relative;top:.5pt\">&lt;\u00a0<span style=\"letter-spacing:\n  .05pt\">30</span>,000/m<span style=\"letter-spacing:-.05pt\">m<sup>3</sup></span></span></span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:31.95pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC\n  and resume ixazomib at its most recent dose. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  platelet count falls to &lt;\u00a030,000/mm<sup>3</sup> again, withhold ixazomib\n  and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>\n</tr>\n<tr style=\"height:15.7pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Neutropenia\n  (absolute neutrophil count)</span></b></p>\n</td>\n</tr>\n<tr style=\"height:15.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"letter-spacing:.05pt\">Absolute neutrophil count</span><span lang=\"EN-GB\"> <span style=\"position:relative;top:.5pt\">&lt;\u00a0</span>500/mm<sup>3</sup></span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until absolute neutrophil count is \u2265\u00a0500/mm<sup>3</sup>.\n  Consider adding G\u2011CSF as per clinical guidelines.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its\n  prescribing information and resume ixazomib at its most recent dose. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  absolute neutrophil count falls to &lt;\u00a0500/mm<sup>3</sup> again,\n  withhold ixazomib and lenalidomide until absolute neutrophil count is \u2265\n  500/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>\n</tr>\n<tr style=\"height:15.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Non\u2011haematological\n  toxicities</span></b></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended actions</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rash</span></b></p>\n</td>\n</tr>\n<tr style=\"height:31.75pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:31.75pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade<sup>\u2020</sup>\n  2 or 3</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:31.75pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  lenalidomide until rash recovers to \u2264\u00a0Grade\u00a01.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  Grade 2 or 3 rash occurs again, withhold ixazomib and lenalidomide until rash\n  recovers to \u2264\u00a0Grade\u00a01.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>\n</tr>\n<tr style=\"height:17.05pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade 4</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Peripheral neuropathy</span></b></p>\n</td>\n</tr>\n<tr style=\"height:36.8pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:36.8pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Grade 1 peripheral neuropathy with pain or Grade 2 peripheral neuropathy</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:36.8pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib until peripheral neuropathy recovers to \u2264\u00a0Grade\u00a01\n  without pain or patient's baseline.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at its most recent dose.</span></p>\n</td>\n</tr>\n<tr style=\"height:36.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:36.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Grade 2 peripheral neuropathy with pain or Grade 3 peripheral neuropathy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:36.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or \u2264\u00a0Grade\u00a01\n  prior to resuming ixazomib.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose.</span></p>\n</td>\n</tr>\n<tr style=\"height:17.05pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade 4 peripheral\n  neuropathy</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span></p>\n</td>\n</tr>\n<tr style=\"height:17.05pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other non\u2011haematological toxicities</span></b></p>\n</td>\n</tr>\n<tr style=\"height:17.05pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Other Grade 3 or 4 non\u2011haematological toxicities</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or at most\u00a0Grade 1 prior\n  to resuming ixazomib.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  attributable to ixazomib, resume ixazomib at the next lower dose following\n  recovery.</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-left:4.3pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">*</span><span lang=\"EN-GB\" style=\"font-size:\n10.0pt\">For additional occurrences, alternate dose modification of lenalidomide\nand ixazomib</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:4.3pt;line-height:normal\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span></sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Grading based on </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">National Cancer Institute Common Terminology Criteria\n(CTCAE) Version 4.03</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><u><span lang=\"EN-GB\">Concomitant\nmedicinal products</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Antiviral\nprophylaxis should be considered in patients being treated with ixazomib to\ndecrease the risk of herpes zoster reactivation. Patients included in studies\nwith ixazomib who received antiviral prophylaxis had a lower incidence of\nherpes zoster infection compared to patients who did not receive prophylaxis.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Thromboprophylaxis\nis recommended in patients being treated with ixazomib in combination with\nlenalidomide and dexamethasone, and should be based on an assessment of the\npatient\u2019s underlying risks and clinical status. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For other\nconcomitant medicinal products that may be required, refer to the current\nlenalidomide and dexamethasone SmPC.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><a name=\"_Toc360524842\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Special patient populations</span></u></a></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-style:normal\">\u00a0</span></p>\n<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Elderly</span></i></p>\n<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span></i></p>\n<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style='font-size:\n11.0pt;font-family:\"Times New Roman\",serif;font-weight:normal;text-decoration:\nnone'>No dose adjustment of ixazomib is required for patients over 65\u00a0years\nof age. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Discontinuations in patients &gt;\u00a075\nyears of age were reported in 13 patients (28%) in the ixazomib regimen and 10\npatients (16%) in the placebo regimen. Cardiac arrhythmias in patients &gt;\u00a075\nyears of age were observed in 10 patients (21%) in the ixazomib regimen and 9\npatients (15%) in the placebo regimen. </p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Hepatic\nimpairment</span></i></p>\n<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment of ixazomib is required for patients with mild hepatic impairment\n(total bilirubin \u2264\u00a0upper limit of normal (ULN) and aspartate\naminotransferase\u00a0(AST) &gt;\u00a0ULN or total bilirubin &gt;\u00a01\u20111.5\u00a0x\u00a0ULN\nand any AST). The reduced dose of 3\u00a0mg is recommended in patients with moderate\n(total bilirubin &gt;\u00a01.5\u20113\u00a0x\u00a0ULN) or severe (total\nbilirubin &gt;\u00a03\u00a0x\u00a0ULN) hepatic impairment (see section\u00a05.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Renal\nimpairment</span></i></p>\n<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment of ixazomib is required for patients with mild or moderate renal\nimpairment (creatinine clearance \u2265\u00a0</span><span lang=\"EN-GB\">30\u00a0mL/min).\nThe reduced dose of 3\u00a0mg is recommended in patients with severe renal impairment\n(creatinine clearance &lt;\u00a030\u00a0mL/min) or end\u2011stage renal\ndisease (ESRD) requiring dialysis. Ixazomib is not dialyzable and, therefore,\ncan be administered without regard to the timing of dialysis (see section\u00a05.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Refer to the\nlenalidomide SmPC for dosing recommendations in patients with renal impairment.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Paediatric population</span></i></p>\n<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety and efficacy of ixazomib in children below 18\u00a0years\nof age have not been established. No data are available.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration </span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Ixazomib is for oral use.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Ixazomib should be taken at approximately the same time on days 1,\n8, and 15 of each treatment cycle at least 1 hour before or at least 2 hours\nafter food (see section\u00a05.2). The capsule should be swallowed whole with\nwater. It should not be crushed, chewed, or opened (see section\u00a06.6). </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Hypersensitivity to the active substance or to any of the excipients\nlisted in section\u00a06.1.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and\ndexamethasone, refer to the SmPC for these medicinal products for additional\ncontraindications.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and precautions for use</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and dexamethasone,\nrefer to the SmPC for these medicinal products for additional special warnings\nand precautions for use.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia</span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia\nhas been reported with </span><span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\">ixazomib</span><span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\"> (see section\u00a04.8) with platelet nadirs typically\noccurring between Days 14\u201121 of each 28\u2011day cycle and recovery to\nbaseline by the start of the next cycle (see section\u00a04.8). </span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Platelet\ncounts should be monitored at least monthly during ixazomib treatment. </span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">More frequent monitoring should\nbe considered during the first three cycles as per the lenalidomide SmPC. </span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia can be\nmanaged with dose modifications (see section\u00a04.2) and platelet\ntransfusions as per standard medical guidelines. </span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Gastrointestinal toxicities</span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Diarrhoea,\nconstipation, nausea and vomiting have been reported with ixazomib,\noccasionally requiring use of antiemetic and antidiarrhoeal medicinal products and\nsupportive care (see section\u00a04.8). The dose should be adjusted for severe\n(Grade 3\u20114) symptoms (see section\u00a04.2).</span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"> In case of severe gastrointestinal\nevents, monitoring of serum potassium level is recommended.</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Peripheral neuropathy</span></u></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNoSpacing\"><span style='font-family:\"Times New Roman\",serif'>Peripheral\nneuropathy has been reported with ixazomib (see section\u00a04.8).<i> </i></span><span style='font-family:\"Times New Roman\",serif'>The patient should be monitored for\nsymptoms of peripheral neuropathy. Patients experiencing new or worsening\nperipheral neuropathy may require dose modification </span><span style='font-family:\"Times New Roman\",serif'>(see section\u00a04.2)</span><span style='font-family:\"Times New Roman\",serif'>.</span></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Peripheral oedema</span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peripheral\noedema has been reported with ixazomib (see section\u00a04.8). The patient\nshould be e</span><span lang=\"EN-GB\">valuated for underlying causes and provide\nsupportive care, as necessary. The dose of dexamethasone should be adjusted per\nits prescribing information or ixazomib for Grade</span><span lang=\"EN-GB\">\u00a0</span><span lang=\"EN-GB\">3</span><span lang=\"EN-GB\">\u00a0</span><span lang=\"EN-GB\">or</span><span lang=\"EN-GB\">\u00a0</span><span lang=\"EN-GB\">4 symptoms </span><span lang=\"EN-GB\">(see\nsection\u00a04.2)</span><span lang=\"EN-GB\">.</span></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span style='font-family:\n\"Times New Roman\",serif'>Cutaneous reactions</span></u></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><span style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rash has been\nreported with ixazomib (see section\u00a04.8). </span><span class=\"MsoCommentReference\"><span lang=\"EN-GB\">Rash should be managed with supportive\ncare or with dose modification if Grade</span></span><span lang=\"EN-GB\">\u00a0</span><span class=\"MsoCommentReference\"><span lang=\"EN-GB\">2 or higher </span></span><span lang=\"EN-GB\">(see section\u00a04.2)</span><i><span lang=\"EN-GB\">.</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span style='font-family:\n\"Times New Roman\",serif'>Thrombotic microangiopathy</span></u></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cases of\nthrombotic microangiopathy (TMA), </span>including thrombotic thrombocytopenic\npurpura (TTP), <span lang=\"EN-GB\">have been reported in patients who received\nixazomib. Some of these events have been fatal. Signs and symptoms of TMA\nshould be monitored for. If the diagnosis is suspected, stop ixazomib and\nevaluate patients for possible TMA. If the diagnosis of TMA is excluded,\nixazomib can be restarted. The safety of reinitiating ixazomib therapy in\npatients previously experiencing TMA is not known.</span></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span style='font-family:\n\"Times New Roman\",serif'>Hepatotoxicity</span></u></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><span style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoCommentText\" style=\"line-height:normal\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">Drug\u2011induced liver injury, hepatocellular\ninjury, hepatic steatosis, hepatitis cholestatic and hepatotoxicity have been uncommonly\nreported with ixazomib (see section\u00a04.8). </span><span style=\"font-size:\n11.0pt\">Hepatic enzymes should be m</span><span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">onitored regularly and </span></span><span class=\"MsoCommentReference\"><span style=\"font-size:11.0pt\">the dose should be\nadjusted</span></span><span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\"> for Grade</span></span><span lang=\"X-NONE\" style=\"font-size:11.0pt\">\u00a0</span><span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">3</span></span><span lang=\"X-NONE\" style=\"font-size:11.0pt\">\u00a0</span><span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">or</span></span><span lang=\"X-NONE\" style=\"font-size:11.0pt\">\u00a0</span><span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">4 symptoms </span></span><span lang=\"X-NONE\" style=\"font-size:11.0pt\">(see section\u00a04.2)</span><i><span lang=\"X-NONE\" style=\"font-size:11.0pt\">.</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Women should\navoid becoming pregnant while being treated with ixazomib. </span><span lang=\"EN-GB\">If ixazomib is used during pregnancy or if the patient becomes\npregnant while taking ixazomib, the patient should be apprised of the potential\nhazard to the foetus. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Women of\nchildbearing potential must use highly effective contraception while taking ixazomib\nand for 90 days after stopping treatment (see sections\u00a04.5 and 4.6). Women\nusing hormonal contraceptives should additionally use a barrier method of\ncontraception<b>.</b></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posterior reversible encephalopathy syndrome</span></u><b><span lang=\"EN-GB\"> </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Posterior reversible encephalopathy syndrome (PRES) has occurred in\npatients receiving ixazomib. PRES is a rare, reversible, neurological disorder\nwhich can present with seizure, hypertension, headache, altered consciousness,\nand visual disturbances. Brain imaging, preferably Magnetic Resonance Imaging,\nis used to confirm the diagnosis. In patients developing PRES, discontinue ixazomib.\n</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Strong CYP3A inducers</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Strong inducers\nmay reduce the efficacy of ixazomib, therefore the concomitant use of strong\nCYP3A inducers such as carbamazepine, phenytoin, rifampicin and St.\nJohn\u2019s Wort (<i>Hypericum perforatum</i>), should be avoided (see sections\u00a04.5\nand 5.2). Closely monitor patients for disease control if co\u2011administration\nwith a strong CYP3A inducer cannot be avoided.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other medicinal\nproducts and other forms of interaction</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pharmacokinetic interactions</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">CYP inhibitors</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Co\u2011administration\nof ixazomib with clarithromycin, a strong CYP3A inhibitor, did not result in a\nclinically meaningful change in the systemic exposure of ixazomib. Ixazomib C<sub>max</sub>\nwas decreased by 4% and AUC was increased by 11%. Therefore, no dose\nmodification is required for ixazomib with co\u2011administration of strong\nCYP3A inhibitors.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Co\u2011administration\nof ixazomib with strong CYP1A2 inhibitors did not result in a clinically\nmeaningful change in the systemic exposure of ixazomib based on the results of\na population pharmacokinetic (PK) analysis. Therefore, no dose modification is\nrequired for ixazomib with co\u2011administration of strong CYP1A2 inhibitors.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">CYP inducers</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Co\u2011administration\nof ixazomib with rifampicin decreased ixazomib C<sub>max</sub> by 54% and AUC\nby 74%. Therefore, co\u2011administration of strong CYP3A inducers with\nixazomib is not recommended (see section\u00a04.4).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Effect of ixazomib on other medicinal products</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib is not\na reversible or a time\u2011dependent inhibitor of CYPs 1A2, 2B6, 2C8, 2C9,\n2C19, 2D6, or 3A4/5. Ixazomib did not induce CYP1A2, CYP2B6, and CYP3A4/5\nactivity or corresponding immunoreactive protein levels. Ixazomib is not\nexpected to produce drug\u2011drug interactions via CYP\u00a0inhibition or induction.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Transporter\u2011based interactions</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Ixazomib is a low affinity substrate of P\u2011gp. Ixazomib is not\na substrate of BCRP, MRP2 or hepatic OATPs. Ixazomib is not an inhibitor of P\u2011gp,\nBCRP, MRP2, OATP1B1, OATP1B3, OCT2, OAT1, OAT3, MATE1, or MATE2\u2011K. Ixazomib\nis not expected to cause transporter\u2011mediated drug\u2011drug\ninteractions. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Oral\ncontraceptives</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">When ixazomib is\nadministered together with dexamethasone, which is known to be a weak to\nmoderate inducer of CYP3A4 as well as other enzymes and transporters, the risk\nfor reduced efficacy of oral contraceptives needs to be considered. Women using\nhormonal contraceptives should additionally use a barrier method of\ncontraception.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy and lactation</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and\ndexamethasone, refer to the SmPC for these medicinal products for additional\ninformation on fertility, pregnancy and lactation.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Women of childbearing potential/Contraception in males and females</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Male and female\npatients who are able to have children must use effective contraceptive\nmeasures during and for 90\u00a0days following treatment. Ixazomib is not\nrecommended in women of childbearing potential not using contraception.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">When ixazomib is administered\ntogether with dexamethasone, which is known to be a weak to moderate inducer of\nCYP3A4 as well as other enzymes and transporters, the risk for reduced efficacy\nof oral contraceptives needs to be considered. Therefore, women using oral\nhormonal contraceptives should additionally use a barrier method of\ncontraception.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib is not\nrecommended during pregnancy as it can cause foetal harm when administered to a\npregnant woman. Therefore, women should avoid becoming pregnant while being\ntreated with ixazomib. </span></p>\n<h4 style=\"margin:0in;line-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-weight:normal'>\u00a0</span></h4>\n<h4 style=\"margin:0in;line-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-weight:normal'>There are no data for the use of ixazomib in pregnant\nwomen. Studies in animals have shown reproductive toxicity (see section\u00a05.3).</span></h4>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib is\ngiven in combination with lenalidomide. Lenalidomide is structurally related to\nthalidomide. Thalidomide is a known human teratogenic active substance that\ncauses severe life\u2011threatening birth defects. If lenalidomide is taken\nduring pregnancy, a teratogenic effect in humans is expected. The conditions of\nthe Pregnancy Prevention Programme for lenalidomide must be fulfilled for all\npatients unless there is reliable evidence that the patient does not have\nchildbearing potential. Please refer to the current lenalidomide SmPC.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast\u2011feeding</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown\nwhether ixazomib</span><span lang=\"EN-GB\"> or its metabolites</span><span lang=\"EN-GB\"> are excreted in human milk. No animal data are available. </span><span lang=\"EN-GB\">A risk to newborns/infants cannot be excluded and therefore </span><span lang=\"EN-GB\">breast\u2011feeding should be discontinued. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib will be\ngiven in combination with lenalidomide and breast\u2011feeding should be\nstopped because of the use of lenalidomide.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Fertility\nstudies have not been conducted with ixazomib (see section\u00a05.3).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to drive and use\nmachines</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib has\nminor influence on the ability to drive or use machines. Fatigue and dizziness\nhave been observed in clinical trials. Patients should be advised not to drive\nor operate machines if they experience any of these symptoms.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and\ndexamethasone, refer to the SmPC for these medicinal products for additional\nundesirable effects.</span></p>\n<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\">Summary of the safety profile</span></u></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety profile of NINLARO is based on available clinical trial\ndata and post\u2011marketing experience to date. Frequencies of adverse\nreactions described below and in Table\u00a03 have been determined based on\ndata generated from clinical studies.</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Unless\notherwise noted, the data presented below is </span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">the pooled safety data from the\npivotal, Phase 3, global C16010 study (n=720) and the double\u2011blind,\nplacebo\u2011controlled C16010 China Continuation Study (n=115). </span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">The most frequently\nreported adverse reactions (\u2265\u00a020%) across 417 patients treated within\nthe ixazomib regimen and 418 patients within the placebo regimen were diarrhoea\n(39% vs. 32%), thrombocytopenia (33% vs. 21%), neutropenia (33% vs. 30%), constipation\n(30% vs. 22%), peripheral neuropathy (25% vs. 20%), nausea (23% vs. 18%),\nperipheral oedema (23% vs. 17%), vomiting (20% vs. 10%) and upper respiratory\ntract infection (21% vs. 16%). Serious adverse reactions reported in \u2265\u00a02%\nof patients included thrombocytopenia (2%) and diarrhoea (2%). </span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Tabulated list of adverse reactions</span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">The following convention is used for\nthe classification of the frequency of an adverse drug reaction (ADR): very\ncommon (\u2265\u00a01/10); common (\u2265\u00a01/100 to &lt;\u00a01/10);\nuncommon (\u2265\u00a01/1,000 to &lt;\u00a01/100); rare (\u2265\u00a01/10,000\nto &lt;\u00a01/1,000); very rare (&lt;\u00a01/10,000); not known (cannot be\nestimated from the available data). Within each system organ class, the ADRs\nare ranked by frequency, with the most frequent reactions first.</span><span lang=\"EN-GB\" style=\"font-style:normal\"> </span><span lang=\"EN-GB\" style=\"color:\nwindowtext;font-style:normal\">Within each frequency grouping, adverse reactions\nare presented in order of decreasing seriousness.</span></p>\n<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"Table3\"><b><span lang=\"EN-GB\">Table 3</span></b></a><b><span lang=\"EN-GB\">:\nAdverse reactions in patients treated with ixazomib in combination with lenalidomide\nand dexamethasone (all grades, grade 3 and grade 4) </span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:455.95pt;border-collapse:collapse;border:none\" width=\"608\">\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">System organ class / Adverse reaction</span></b></p>\n</td>\n<td style=\"width:112.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Adverse reactions (all grades)</span></b></p>\n</td>\n<td style=\"width:115.15pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Grade 3 adverse reactions</span></b></p>\n</td>\n<td style=\"width:101.4pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Grade 4 adverse reactions</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Infections and infestations</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Upper respiratory tract infection</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Herpes zoster</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombocytopenia*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Neutropenia*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombotic microangiopathy</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombotic thrombocytopenic purpura</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Metabolism and nutrition disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Tumour lysis syndrome</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Nervous system disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peripheral\n  neuropathies*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Posterior\n  reversible encephalopathy disorders*</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Transverse\n  myelitis</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Gastrointestinal\n  disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Diarrhoea</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Nausea</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vomiting</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Constipation</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Skin and\n  subcutaneous tissue disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rash*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Stevens\u2011Johnson\n  syndrome</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Acute febrile </span><span lang=\"FR\">neutrophilic dermatosis</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Musculoskeletal\n  and connective tissue disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Back pain</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common </span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">General\n  disorders and administration site conditions</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oedema\n  peripheral</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Note: ADRs included as preferred terms are based on\nMedDRA version 16.0.</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">*Represents a pooling of preferred terms</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span></sup><span lang=\"EN-GB\" style=\"font-size:\n10.0pt\">Reported outside of the Phase<sup> </sup>3 studies</span></p>\n<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Description of selected adverse\nreactions</span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Discontinuations</span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">For\neach adverse reaction, one or more of the three medicinal products was\ndiscontinued in \u2264\u00a01% of patients in the ixazomib regimen.</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Thrombocytopenia</span></u></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Three\npercent of patients in the ixazomib regimen and 1% of patients in the placebo\nregimen had a platelet count \u2264\u00a010,000/mm<sup>3</sup></span><span lang=\"EN-GB\" style=\"color:windowtext\"> </span><span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\">during treatment</span><span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\">. Less than 1% of patients in both regimens had a platelet\ncount \u2264\u00a05,000/mm<sup>3</sup></span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"> during treatment</span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">. Thrombocytopenia\nresulted in discontinuation of one or more of the three medicinal products in\n&lt;\u00a01% of patients in the ixazomib regimen and 1% of patients in the\nplacebo regimen.</span><span lang=\"EN-GB\" style=\"color:windowtext\"> </span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia did not\nresult in an increase in haemorrhagic events or platelet transfusions.</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Gastrointestinal toxicities</span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Diarrhoea\nresulted in discontinuation of one or more of the three medicinal products in\n1% of patients in the ixazomib regimen and &lt;\u00a01% of patients in the\nplacebo regimen.</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext\">\u00a0</span></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Rash</span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rash occurred in\n18% of patients in the ixazomib regimen compared to 10% of patients in the\nplacebo regimen. The most common type of rash reported in both regimens was maculo\u2011papular\nand macular rash. Grade\u00a03 rash was reported in 2% of patients in the ixazomib\nregimen compared to 1%\u00a0of patients in the placebo regimen. Rash resulted\nin discontinuation of one or more of the three medicinal products in &lt;\u00a01%\nof patients in both regimens.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Peripheral neuropathy</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peripheral\nneuropathy occurred in 25% of patients in the ixazomib regimen compared to 20%\nof patients in the placebo regimen. Grade 3 adverse reactions of peripheral\nneuropathy were reported in 2% of patients in both regimens. The most commonly\nreported reaction was peripheral sensory neuropathy (16%\u00a0and 12% in the ixazomib\nand placebo regimen, respectively). Peripheral motor neuropathy was not\ncommonly reported in either regimen (&lt;\u00a01%). Peripheral neuropathy\nresulted in discontinuation of one or more of the three medicinal products in\n1% of patients in the ixazomib regimen compared to &lt;\u00a01% of patients in\nthe placebo regimen.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Eye disorders </span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Eye\ndisorders were reported with many different preferred terms but in aggregate,\nthe frequency was 24% in patients in the ixazomib regimen and 15% of patients\nin the placebo regimen. The most common adverse reactions were blurred vision (5%\nin the ixazomib regimen and 4% in the placebo regimen), dry eye (4% in the ixazomib\nregimen and 1% in the placebo regimen), conjunctivitis (5% in the ixazomib\nregimen and 1% in the placebo regimen) and cataract (4% in the ixazomib regimen\nand 5% in the placebo regimen). Grade 3 adverse reactions were reported in 2%\nof patients in both regimens.</span></p>\n<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Other adverse reactions</span></u></p>\n<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In the pooled\ndataset from the pivotal, Phase 3, global C16010 study (n=720) and the double\u2011blind,\nplacebo\u2011controlled, C16010 China Continuation Study (n=115), the\nfollowing adverse reactions occurred with a similar rate between the ixazomib\nand placebo regimens: fatigue (26% vs. 24%), decreased appetite (12% vs. 9%),\nhypotension (4% each), heart failure</span><sup>\u2020</sup><span lang=\"EN-GB\">\n(3% each), arrhythmia</span><sup>\u2020</sup><span lang=\"EN-GB\"> (12% vs. 11%),\nand liver impairment including enzyme changes</span><sup>\u2020</sup><span lang=\"EN-GB\"> (8% vs. 6%).</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\"><span style=\"color:windowtext;font-style:normal\">The\nfrequency of severe (Grade\u00a03\u20114) events of hypokalaemia was higher in\nthe ixazomib regimen (5%) than the placebo regimen (&lt;\u00a01%). </span></p>\n<p class=\"MsoBodyText\"><span style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoBodyText\"><span style=\"color:windowtext;font-style:normal\">Fungal\nand viral pneumonia resulting in fatal outcome were rarely reported in patients\ngiven the ixazomib, lenalidomide and dexamethasone combination.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><sup>\u2020 </sup><span lang=\"EN-GB\">Standardised MedDRA Queries (SMQs)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the\nmedicinal product is important. It allows continued monitoring of the\nbenefit/risk balance of the medicinal product. Healthcare professionals are\nasked to report any suspected adverse reactions via <span style=\"background:\nsilver\">the national reporting system listed in </span><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:silver\">Appendix V</span></a><span style=\"background:silver\">.</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Overdose has been reported in patients taking NINLARO. Symptoms of\noverdose are generally consistent with the known risks of NINLARO (see section\n4.8). Overdose of 12\u00a0mg (taken at one time) has resulted in serious\nadverse events, such as severe nausea, aspiration pneumonia, multiple organ\nfailure and death.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no\nknown specific antidote for ixazomib overdose. In the event of an overdose,\nmonitor the patient closely </span>for adverse reactions (section\u00a04.8) <span lang=\"EN-GB\">and provide appropriate supportive care. Ixazomib is not dialyzable\n(see section\u00a05.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Overdoses were\nmost common in patients starting treatment with NINLARO. The importance of\ncarefully following all dosage instructions should be discussed with patients\nstarting treatment. </span><span lang=\"EN-GB\">Instruct patients to take the\nrecommended dosage as directed because overdose has led to deaths.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL PROPERTIES</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1 \u00a0\u00a0\u00a0 Pharmacodynamic properties</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pharmacotherapeutic\ngroup: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX50</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Ixazomib citrate, a prodrug, is a substance that rapidly hydrolyses\nunder physiological conditions to its biologically active form, ixazomib. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib is an\noral, highly selective and reversible proteasome inhibitor. Ixazomib\npreferentially binds and inhibits the chymotrypsin\u2011like activity of the\nbeta 5 subunit of the 20S proteasome. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib induced\napoptosis of several tumour cell types <i>in\u00a0vitro</i>. Ixazomib\ndemonstrated <i>in\u00a0vitro</i> cytotoxicity against myeloma cells from\npatients who had relapsed after multiple prior therapies, including bortezomib,\nlenalidomide, and dexamethasone. The combination of ixazomib and lenalidomide\ndemonstrated synergistic cytotoxic effects in multiple myeloma cell lines. <i>In\u00a0vivo</i>,\nixazomib demonstrated antitumour activity in various tumour xenograft models,\nincluding models of multiple myeloma. <i>In\u00a0vitro</i>, ixazomib affected\ncell types found in the bone marrow microenvironment including vascular\nendothelial cells, osteoclasts and osteoblasts.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Cardiac electrophysiology</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib did not\nprolong the QTc interval at clinically relevant exposures based on the results\nof a pharmacokinetic\u2011pharmacodynamic analysis of data from 245 patients.\nAt the 4\u00a0mg dose, mean\u00a0change from baseline in QTcF was estimated to\nbe 0.07\u00a0msec (90% CI; \u20110.22, 0.36) from the model based analysis.\nThere was no discernible relationship between ixazomib concentration and the RR\ninterval suggesting no clinically meaningful effect of ixazomib on heart rate.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"CM36\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\nefficacy and safety of ixazomib in combination with lenalidomide and\ndexamethasone was evaluated in an international randomised, double\u2011blind,\nplacebo\u2011controlled, multicenter Phase 3 superiority study (C16010) in\npatients with relapsed and/or refractory multiple myeloma who had received at\nleast one prior therapy. A total of 722 patients (intent\u2011to-treat [ITT] population)\nwere randomised in a 1:1 ratio to receive either the combination of ixazomib,\nlenalidomide, and dexamethasone (N=360; ixazomib regimen) or placebo, lenalidomide\nand dexamethasone (N=362;</span><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>placebo\nregimen) until disease progression or unacceptable toxicity. Patients enrolled\nin the trial had multiple myeloma that was refractory, including primary\nrefractory, had relapsed after prior therapy, or had relapsed and was\nrefractory to any prior therapy. Patients that changed therapies prior to\ndisease progression were eligible for enrolment, as well as those with\ncontrolled cardiovascular conditions. </span><span style='font-size:11.0pt;\nfont-family:\"Times New Roman\",serif'>The Phase 3 study excluded patients who\nwere refractory to lenalidomide or proteasome inhibitors and patients who\nreceived more than three prior therapies. </span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>For the purposes\nof this study, refractory disease was defined as disease progression on\ntreatment or progression within 60 days after the last dose of lenalidomide or\na proteasome inhibitor. </span><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>As\ndata are l</span><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>imited\nin these patients, a careful risk\u2011benefit assessment is recommended\nbefore initiating the ixazomib regimen.</span></p>\n<p class=\"CM36\"><span style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"CM36\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Thromboprophylaxis\nwas recommended for all patients in both treatment groups according to the\nlenalidomide SmPC. Concomitant medicinal products, such as antiemetic,\nantiviral, and antihistamine medicinal products were given to patients at the\nphysician's discretion as prophylaxis and/or management of symptoms. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Patients received ixazomib 4\u00a0mg or placebo on Days 1, 8, and 15\nplus lenalidomide (25\u00a0mg) on Days\u00a01 through 21 and dexamethasone\n(40\u00a0mg) on Days 1, 8, 15, and 22 of a 28\u2011day cycle. Patients with\nrenal impairment received a starting dose of lenalidomide according to its\nSmPC. Treatment continued until disease progression or unacceptable toxicities.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"CM36\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\nbaseline demographics and disease characteristics were balanced and comparable\nbetween the study regimens. </span><span style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif'>The median age was 66\u00a0years, range 38\u201191\u00a0years;\n58% of patients were older than 65\u00a0years. Fifty seven percent of patients\nwere male. Eighty five percent of the population was White, 9% Asian and 2% Black.\nNinety three percent of patients had an ECOG performance status of 0\u20111\nand 12% had baseline ISS stage III disease (N=90). Twenty five percent of\npatients had a creatinine clearance of &lt;\u00a060\u00a0mL/min. Twenty three\npercent of patients had light chain disease and 12% of patients had measurable\ndisease by free light chain assay only. Nineteen percent had high\u2011risk\ncytogenetic abnormalities (del[17], t[4;14], t[14;16]) (N=137), 10% had del(17)\n(N=69) and 34% had 1q amplification (1q21) (N=247). Patients received one to\nthree prior therapies (median of 1) including prior treatment with bortezomib\n(69%), carfilzomib (&lt;\u00a01%), thalidomide (45%), lenalidomide (12%),\nmelphalan (81%). Fifty seven percent of patients had undergone prior stem cell\ntransplantation. Seventy seven percent of patients relapsed after prior therapies\nand 11% were refractory to prior therapies. Primary refractory, defined as best\nresponse of stable disease or disease progression on all prior therapies, was\ndocumented in 6% of patients.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The primary endpoint was progression\u2011free survival (PFS)\naccording to the 2011 International Myeloma Working Group (IMWG) Consensus\nUniform Response Criteria as assessed by a blinded independent review committee\n(IRC) based on central laboratory results. Response was assessed every 4\u00a0weeks\nuntil disease progression. At the primary analysis (median follow up of 14.7\nmonths and a median of 13 cycles), PFS was statistically significantly\ndifferent between the treatment arms. PFS results are summarised in Table 4 and\nFigure 1. The improvement in PFS in the ixazomib regimen was supported by\nimprovements in overall response rate.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table 4: Progression free survival and response Results in multiple myeloma\npatients treated with ixazomib or placebo in combination with lenalidomide and dexamethasone\n(intent\u2011to-treat population)</span></b></p>\n<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td colspan=\"3\" style=\"width:155.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Ixazomib + Lenalidomide and\n  Dexamethasone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(N = 360)</span></p>\n</td>\n<td style=\"width:155.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Placebo + Lenalidomide and\n  Dexamethasone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(N = 362)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Progression\u2011Free Survival</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Events, n (%)</span></p>\n</td>\n<td colspan=\"3\" style=\"width:155.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">129 (36)</span></p>\n</td>\n<td style=\"width:155.2pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">157 (43)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Median (months)</span></p>\n</td>\n<td colspan=\"3\" style=\"width:155.2pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">20.6</span></p>\n</td>\n<td style=\"width:155.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">14.7</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">p\u2011value*</span></p>\n</td>\n<td colspan=\"4\" style=\"width:310.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"414\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">0.012</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Hazard Ratio<sup>\u2020</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(95% CI)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:310.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"414\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">0.74</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(0.59, 0.94)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Overall Response Rate</span></b><sup><span lang=\"EN-GB\">\u2021</span></sup><b><span lang=\"EN-GB\">, n (%) </span></b></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">282 (78.3)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">259 (71.5)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Response Category, n (%)</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Complete Response </span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">42 (11.7)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">24 (6.6)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Very Good Partial Response </span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">131 (36.4)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">117 (32.3)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Partial Response </span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">109 (30.3)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">118 (32.6)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Time to Response, months</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Median</span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">1.1</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">1.9</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Duration of Response</span></b><sup><span lang=\"EN-GB\">\u00a7</span></sup><b><span lang=\"EN-GB\">, months</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Median</span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">20.5</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">15.0</span></p>\n</td>\n</tr>\n<tr height=\"0\">\n<td style=\"border:none\" width=\"206\"></td>\n<td style=\"border:none\" width=\"0\"></td>\n<td style=\"border:none\" width=\"206\"></td>\n<td style=\"border:none\" width=\"1\"></td>\n<td style=\"border:none\" width=\"207\"></td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"margin-left:4.3pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">*P\u2011value is based on the\nstratified log\u2011rank test.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:13.65pt;text-indent:-9.35pt;line-height:\nnormal;text-autospace:none\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span></sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Hazard ratio is based on a stratified\nCox\u2019s proportional hazard regression model. A hazard ratio less than 1\nindicates an advantage for the ixazomib regimen.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:13.65pt;text-indent:-9.35pt;line-height:\nnormal;text-autospace:none\"><a name=\"footnote-14\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2021</span></sup></a><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORR=CR+VGPR+PR</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:13.65pt;text-indent:-9.35pt;line-height:\nnormal;text-autospace:none\"><a name=\"footnote-15\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a7</span></sup></a><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Based on responders in the response\u2011evaluable\npopulation</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Figure 1: Kaplan\u2011Meier plot of progression\u2011free\nsurvival in the intent\u2011to-treat population</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"><img height=\"321\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image002.gif\" width=\"605\"/></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A planned\ninterim analysis for overall survival (OS) at a median follow up of 23\u00a0months\nwas conducted with 35% of the required number of deaths for final OS analysis\nin the ITT population; there were 81\u00a0deaths in the ixazomib regimen and\n90\u00a0deaths in the placebo regimen. Median overall survival was not reached\nin either regimen. At this analysis, estimated median PFS was 20\u00a0months in\nthe ixazomib regimen and 15.9\u00a0months in the placebo regimen (HR=0.82 [95%\nCI (0.67, 1.0)]) in the ITT population.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A randomised, double\u2011blind, placebo\u2011controlled Phase 3\nstudy was conducted in China (N=115) with a similar study design and\neligibility criteria. Many of the patients enrolled in the study had advanced\ndisease with Durie\u2011Salmon Stage III (69%) at initial diagnosis and a\ntreatment history of receiving at least 2 prior therapies (60%) and being\nthalidomide refractory (63%). At the primary analysis (median follow up of 8\nmonths and a median of 6 cycles), the median PFS was 6.7 months in the ixazomib\nregimen compared to 4 months in the placebo regimen (p\u2011value=0.035,\nHR=0.60). At the final analysis for OS at a median follow up of 19.8 months, </span><span lang=\"EN-GB\">OS was improved for patients treated in the ixazomib regimen\ncompared with placebo </span><span lang=\"EN-GB\">[p\u2011value=0.0014, HR=0.42,</span><span lang=\"EN-GB\"> 95% CI: 0.242, 0.726</span><span lang=\"EN-GB\"> ]).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">As multiple myeloma is a heterogeneous disease, benefit\nmay vary across subgroups in the Phase 3 study (C16010) (see Figure 2). </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Figure 2: Forest plot of progression\u2011free\nsurvival in subgroups</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"><img border=\"0\" height=\"522\" id=\"Picture 3\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image003.gif\" width=\"605\"/></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the Phase 3 study </span><span lang=\"EN-GB\">(C16010), 10\u00a0patients\n(5 in each treatment regimen) had severe renal impairment at baseline. Of the\n5\u00a0patients in the ixazomib regimen, one patient had a confirmed partial\nresponse and 3 confirmed stable disease (however 2 were unconfirmed partial\nresponse and 1 was an unconfirmed very good partial response). Of the\n5\u00a0patients in the placebo regimen, 2 had a confirmed very good partial\nresponse.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Quality of life as\nassessed by global health scores (EORTC QLQ\u2011C30 and MY\u201120) was\nmaintained during treatment and was similar in both treatment regimens in the\nPhase 3 study (C16010).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Paediatric population</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European\nMedicines Agency has waived the obligation to submit the results of studies\nwith ixazomib in all subsets of the paediatric population in multiple myeloma\n(see section\u00a04.2 for information on paediatric use).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Absorption</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">After oral\nadministration, peak plasma concentrations of ixazomib were achieved at\napproximately one hour after dosing. The mean absolute oral bioavailability is\n58%. Ixazomib AUC increases in a dose proportional manner over a dose range of\n0.2\u201110.6\u00a0mg.<i> </i></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Administration\nwith a high\u2011fat meal decreased ixazomib AUC by 28% compared with\nadministration after an overnight fast (see section\u00a04.2). </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Distribution</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">Ixazomib is 99% bound to plasma proteins and\ndistributes into red blood cells with a blood\u2011to\u2011plasma AUC ratio of\u00a010.\nThe steady\u2011state volume of distribution is 543\u00a0L. </span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Biotransformation</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">After oral administration of a radiolabeled dose,\n70% of total drug\u2011related material in plasma was accounted for by\nixazomib. Metabolism by multiple CYP enzymes and non\u2011CYP proteins is\nexpected to be the major clearance mechanism for ixazomib. At clinically\nrelevant ixazomib concentrations, <i>in\u00a0vitro</i> studies using human cDNA\u2011expressed\ncytochrome P450\u00a0isozymes</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">indicate that no\nspecific CYP\u00a0isozyme predominantly contributes to ixazomib metabolism and\nnon\u2011CYP proteins contribute to overall metabolism. At concentrations\nexceeding those observed clinically, ixazomib was metabolized by multiple CYP\nisoforms with estimated relative contributions of 3A4 (42.3%), 1A2 (26.1%),\n2B6\u00a0(16.0%), 2C8 (6.0%), 2D6 (4.8%), 2C19 (4.8%) and 2C9 (&lt;\u00a01%).</span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Elimination</span></u></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">Ixazomib exhibits a multi\u2011exponential\ndisposition profile. Based on a population PK analysis, systemic clearance (CL)\nwas approximately 1.86\u00a0L/hr with inter\u2011individual variability of\n44%. The terminal half\u2011life (t<sub>1/2</sub>) of ixazomib was 9.5 days.\nApproximately 2\u2011fold accumulation in AUC was observed with weekly oral\ndosing on Day 15.</span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Excretion</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">After administration of a single oral dose of <sup>14</sup>C\u2011ixazomib\nto 5 patients with advanced cancer, 62% of the administered radioactivity was\nexcreted in urine and 22% in the faeces. Unchanged ixazomib accounted for\n&lt;\u00a03.5% of the administered dose recovered in urine.</span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><a name=\"_Toc360524860\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Special populations</span></u></a></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Hepatic impairment</span></u></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The PK of ixazomib\nis similar in patients with normal hepatic function and in patients with mild\nhepatic impairment (total bilirubin \u2264\u00a0ULN and AST &gt;\u00a0ULN or\ntotal bilirubin &gt;\u00a01\u20111.5\u00a0x\u00a0ULN and any AST) based on the\nresults of a population PK analysis. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal;font-style:normal\">The PK of ixazomib was\ncharacterized in patients with normal hepatic function at 4\u00a0mg (N=12), moderate\nhepatic impairment at 2.3\u00a0mg (total bilirubin &gt;\u00a01.5\u20113\u00a0x\u00a0ULN,\nN=13) or severe hepatic impairment at 1.5\u00a0mg (total bilirubin\n&gt;\u00a03\u00a0x\u00a0ULN, N=18). Unbound dose\u2011normalized AUC was 27%</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal;font-style:normal\">higher in\npatients with moderate or severe hepatic impairment as compared to patients\nwith normal hepatic function (see section\u00a04.2).</span></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal;font-style:normal\">\u00a0</span></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Renal impairment</span></u></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The PK of ixazomib is similar in patients with normal renal function\nand in patients with mild or moderate renal impairment (creatinine clearance \u2265\u00a030\u00a0mL/min)\nbased on the results of a population PK analysis. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The PK of ixazomib was characterized at a dose of 3\u00a0mg in\npatients with normal renal function (creatinine clearance \u2265\u00a090\u00a0mL/min,\nN=18), severe renal impairment (creatinine clearance &lt;\u00a030\u00a0mL/min,\nN=14), or ESRD requiring dialysis (N=6). Unbound AUC was 38% higher in patients\nwith severe renal impairment or ESRD requiring dialysis as compared to patients\nwith normal renal function.\u00a0Pre\u2011 and post\u2011dialyzer\nconcentrations of ixazomib measured during the haemodialysis session were\nsimilar, suggesting that ixazomib is not dialyzable (see section\u00a04.2). </span></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Age, gender, race</span></u></p>\n<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There was no\nclinically meaningful effect of age (23\u201191 years), sex, body surface area\n(1.2\u20112.7\u00a0m<sup>2</sup>), or race on the clearance of ixazomib based\non the results of a population PK analysis. The mean AUC was 35% higher in\nAsian patients; however, there was overlap in the AUC of ixazomib across White\nand Asian patients.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></b></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Mutagenicity</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib was not\nmutagenic in a bacterial reverse mutation assay (Ames assay) or clastogenic in\na bone marrow micronucleus assay in mice. Ixazomib was positive in an <i>in\u00a0vitro</i>\nclastogenicity test in human peripheral blood lymphocytes. However, ixazomib\nwas negative in an <i>in\u00a0vivo</i> comet assay in mice, in which percent\ntail DNA was assessed in the stomach and liver. Therefore, the weight of\nevidence indicates that ixazomib is not considered to present a genotoxic risk.\n</span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Reproductive and embryo\u2011foetal development</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Ixazomib caused embryo\u2011foetal\ntoxicity in pregnant rats and rabbits only at maternally toxic doses and at\nexposures that were slightly higher than those observed in patients receiving\nthe recommended dose. <span lang=\"EN-GB\">Studies of fertility and early embryonic\ndevelopment and pre\u2011 and post\u2011natal toxicology were not conducted\nwith ixazomib, but evaluation of reproductive tissues was conducted in the\ngeneral toxicity studies. There were no effects due to ixazomib treatment on\nmale or female reproductive organs in studies up to 6\u2011months duration in\nrats and up to 9\u2011months duration in dogs.</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Animal toxicology and/or pharmacology</span></u></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">In multi\u2011cycle repeated\u2011dose toxicity\nstudies conducted in rats and dogs, the principal target organs included the\ngastrointestinal tract, lymphoid tissues, and the nervous system. In the 9\u2011month\nstudy (10\u00a0cycles) in dogs orally administered with a dosing schedule mimicking\nthe clinical regimen (28\u2011day</span><span lang=\"EN-GB\" style=\"font-size:\n11.0pt\">\u00a0</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">cycle),\nmicroscopic neuronal effects were generally minimal in nature and only observed\nat 0.2\u00a0mg/kg (4\u00a0mg/m<sup>2</sup>). The majority of target organ\nfindings demonstrated partial to full recovery following discontinuation of\ntreatment, with the exception of neuronal findings in the lumbar dorsal root\nganglion and dorsal column. </span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Following oral\nadministration, a tissue distribution study in rats revealed that the brain and\nspinal cord were amongst the tissues with the lowest levels, suggesting that the\npenetration of ixazomib through the blood\u2011brain barrier appears to be\nlimited. However, the relevance to humans is unknown.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Non\u2011clinical\nsafety pharmacology studies both <i>in\u00a0vitro</i> (on hERG channels) and <i>in\u00a0vivo</i>\n(in telemetered dogs following </span>single oral administration)<span lang=\"EN-GB\"> demonstrated no effects of ixazomib on cardiovascular or\nrespiratory functions at </span>AUC more than 8\u2011fold higher than the\nclinical value<span lang=\"EN-GB\">.</span></p>\n<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><u><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL PARTICULARS</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg hard capsules</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"IT\">Capsule contents</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"IT\">Microcrystalline cellulose</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"IT\">Magnesium stearate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IT\">Talc</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IT\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"IT\">Capsule shell</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IT\">Gelatin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IT\">Titanium dioxide (E171)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Red iron\noxide (E172)</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Printing ink</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">Shellac</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Propylene glycol</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Potassium hydroxide</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Black iron oxide\n(E172)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsules</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\">Capsule contents</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Microcrystalline cellulose</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Magnesium stearate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Talc</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\">Capsule shell</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gelatin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Titanium dioxide (E171)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Black iron oxide (E172)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\">Printing ink</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Shellac</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Propylene glycol</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Potassium hydroxide</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Black iron oxide (E172)</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span style=\"text-decoration:none\">\u00a0</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u>NINLARO 4\u00a0mg\nhard capsules</u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i>\u00a0</i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u>Capsule contents</u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Microcrystalline\ncellulose </p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Magnesium stearate</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Talc</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Capsule shell</span></u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gelatin</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span style=\"color:black\">Titanium dioxide (E171)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Yellow iron oxide (E172)</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Red iron oxide (E172) </p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u>Printing\nink</u></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Shellac</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Propylene\nglycol</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Potassium hydroxide</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span style=\"color:black\">Black iron oxide (E172)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Not applicable.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3 years.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store\nabove 30\u00a0\u00b0C. Do not freeze. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNoSpacing\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Store\nin the original package in order to protect from moisture. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">PVC\u2011Aluminium\n/Aluminium blister sealed inside a wallet pack containing one capsule.</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Three\nsingle blister wallet packs are packaged in one carton.</span></p>\n<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal and other handling</span></b></a></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib is\ncytotoxic. The capsule should not be removed until just prior to dosing. The capsules\nshould not be opened or crushed. Direct contact with the capsule contents\nshould be avoided. In case of capsule breakage, avoid raising dust during clean\u2011up.\nIf contact occurs, wash thoroughly with soap and water. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused\nmedicinal product or waste material should be disposed of in accordance with\nlocal requirements.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nHOLDER</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Takeda Pharma A/S</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\">Delta\nPark 45</span><span style=\"border:none windowtext 1.0pt;padding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Denmark</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nNUMBER(S) </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">EU/1/16/1094/001</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">EU/1/16/1094/002</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/16/1094/003</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Date of first authorisation: 21 November 2016</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Date of Last\nRenewal: 20\u00a0November\u00a02020</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\nwebsite of the European Medicines Agency <a href=\"http://www.ema.europa.eu/\">http://www.ema.europa.eu</a>.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX II</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER\nRESPONSIBLE FOR BATCH RELEASE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.9pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.45pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS\nOR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:77.95pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.45pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:77.9pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions or restrictions with regard to the\nsafe and effective use of the medicinal product</span></span></b></p>\n<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">E.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIFIC\nOBLIGATION TO COMPLETE POST\u2011AUTHORISATION MEASURES FOR THE CONDITIONAL\nMARKETING AUTHORISATION</span></b></p>\n<b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p class=\"TitleB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS RESPONSIBLE FOR\nBATCH RELEASE</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Name and\naddress of the manufacturers responsible for batch release</span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Ireland\nLimited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grange Castle\nBusiness Park</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dublin 22</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">D22 XR57</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Production Site\nSingen</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Robert Bosch\nStrasse 8</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">78224 Singen</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Germany</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dybendal Alle 10</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">2630 Taastrup</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The printed\npackage leaflet of the medicinal product must state the name and address of the\nmanufacturer responsible for the release of the concerned batch.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS\nREGARDING SUPPLY AND USE</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\nproduct subject to restricted medical prescription (see Annex I: Summary of\nProduct Characteristics, section 4.2).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"TitleB\">C. \u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS\nOF THE MARKETING AUTHORISATION </p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Periodic safety update reports (PSURs)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The requirements\nfor submission of PSURs for this medicinal product are set out in the list of\nUnion reference dates (EURD list) </span><span lang=\"EN-GB\">provided for under\nArticle 107c(7) of Directive 2001/83/EC and any subsequent updates published on\nthe European medicines web\u2011portal.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"TitleB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS\nWITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Risk management plan (RMP)</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The marketing\nauthorisation holder (MAH) shall perform the required pharmacovigilance\nactivities and interventions detailed in the agreed RMP presented in Module\n1.8.2 of the marketing authorisation and any agreed subsequent updates of the\nRMP.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">An updated RMP\nshould be submitted:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">At the request of the European Medicines Agency;</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Whenever the risk management system is modified,\nespecially as the result of new information being received that may lead to a\nsignificant change to the benefit/risk profile or as the result of an important\n(pharmacovigilance or risk minimisation) milestone being reached. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\npage-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Obligation to conduct post\u2011authorisation\nmeasures</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The MAH shall complete, within the stated timeframe, the below\nmeasure:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:1.2pt;border-collapse:collapse\" width=\"629\">\n<tr>\n<td style=\"width:410.15pt;border:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"547\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:61.65pt;border:solid black 1.0pt;\n  border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:410.15pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"547\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Post\u2011authorisation efficacy study (PAES) C16010: To\n  provide an interim report of overall survival at the time of the 3<sup>rd</sup>\n  interim analysis and to provide a final report for the final analysis of OS\n  from the phase 3, randomized, double\u2011blind study C16010 in adult\n  patients with relapsed and/or refractory multiple myeloma.</span></p>\n</td>\n<td style=\"width:61.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">June 2021</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"TitleB\">E.\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIFIC OBLIGATION TO\nCOMPLETE POST\u2011AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING\nAUTHORISATION </p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This being a\nconditional marketing authorisation and pursuant to Article 14a(4) of\nRegulation (EC) No\u00a0726/2004, the MAH shall complete, within the stated\ntimeframe, the following measures:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:1.2pt;border-collapse:collapse\" width=\"641\">\n<thead>\n<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n   background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:63.75pt;border:solid black 1.0pt;\n   border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>\n</td>\n</tr>\n</thead>\n<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">C16014: In order to further investigate the efficacy the\n  MAH should conduct a phase 3, randomized, double\u2011blind, multicenter\n  study comparing ixazomib plus lenalidomide and dexamethasone versus placebo\n  plus lenalidomide and dexamethasone in adult patients with newly diagnosed\n  multiple myeloma not eligible for stem cell transplantation (SCT) and provide\n  the final report for primary endpoint PFS.</span></p>\n</td>\n<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">December 2020</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">C16019: In order to further investigate the efficacy the\n  MAH should provide additional OS/PFS2 data when approximately 200 death\n  events have occurred from the Phase 3, randomized, placebo\u2011controlled,\n  double\u2011blind study of ixazomib in maintenance therapy in patients with\n  multiple myeloma following SCT. </span></p>\n</td>\n<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">December 2021</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">NSMM\u20115001: The MAH should conduct a global,\n  prospective, non\u2011interventional, observational study in multiple\n  myeloma patients and provide a report with the final analysis when at least\n  110 PFS events are expected to have occurred in subjects prospectively\n  exposed to ixazomib.</span></p>\n</td>\n<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">July 2022</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"TitleA\"><span lang=\"EN-GB\">A. LABELLING</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always;\nbackground:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3\u00a0mg\nhard capsules</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 2.3 mg of ixazomib (as 3.3 mg of ixazomib\ncitrate)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Hard capsule</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3 packs of 1\nhard capsule.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span></p>\n<p class=\"Default\"><span style=\"font-size:11.0pt\">Store in the original package\nin order to protect from moisture.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\">Delta\nPark 45</span><span style=\"border:none windowtext 1.0pt;padding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Denmark</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/001</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3\u00a0mg </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">2D barcode carrying the unique identifier included.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">PC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SN</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NN</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always;\nbackground:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg hard\ncapsules </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 2.3 mg of ixazomib (as 3.3 mg of ixazomib\ncitrate)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Store in the original package in\norder to protect from moisture.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/001</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">WALLET</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg hard\ncapsules </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Hard capsule </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Do not crush, open or chew the capsules. Take each NINLARO capsule\nwhole with water at the same time each week, at least one hour before or no\nsooner than two hours after any food.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The capsule should not be removed until just prior to dosing.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Takeda Pharma A/S </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b></p>\n</div>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg hard\ncapsules</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 3 mg of ixazomib (as 4.3 mg of ixazomib\ncitrate) </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Hard capsule</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3 packs of 1\nhard capsule.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Store in the original package in\norder to protect from moisture.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/002</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">2D barcode carrying the unique identifier included.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">PC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SN</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NN</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg hard\ncapsules </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 3 mg of ixazomib (as 4.3 mg of ixazomib\ncitrate) </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store above\n30\u00baC. Do not freeze. </span></p>\n<p class=\"Default\"><span style=\"font-size:11.0pt\">Store in the original package\nin order to protect from moisture.</span></p>\n<p class=\"Default\"><span style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"Default\"><span style=\"font-size:11.0pt\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/002</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">WALLET </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg hard\ncapsules </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Hard capsule </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Do not crush, open or chew the capsules. Take each NINLARO capsule\nwhole with water at the same time each week, at least one hour before or no\nsooner than two hours after any food.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The capsule should not be removed until just prior to dosing.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Takeda Pharma A/S </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b></p>\n</div>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO 3 mg</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg hard\ncapsules</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 4 mg of ixazomib (as 5.7 mg of ixazomib\ncitrate).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Hard capsule</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3 packs of 1\nhard capsule.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">Store in the original package in\norder to protect from moisture.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/003</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">2D barcode carrying the unique identifier included.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">PC</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SN</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NN</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always;\nbackground:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg hard\ncapsules </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 4 mg of ixazomib (as 5.7 mg of ixazomib\ncitrate).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Do not store above 30\u00baC. Do not freeze. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Store in\nthe original package in order to protect from moisture.</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/003</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">WALLET </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg hard\ncapsules </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Do not crush, open or chew the capsules. Take each NINLARO capsule\nwhole with water at the same time each week, at least one hour before or no\nsooner than two hours after any food.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The capsule should not be removed until just prior to dosing.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Takeda Pharma A/S </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b></p>\n</div>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</div>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\npage-break-before:always\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"TitleA\"><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\npage-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Package leaflet: Information for the patient</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg hard capsules</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsules</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">NINLARO 4\u00a0mg hard capsules</span></b></p>\n<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">ixazomib</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Immagine 3\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image001.gif\" width=\"22\"/></span><span lang=\"EN-GB\">This medicine is subject to additional monitoring. This will allow\nquick identification of new safety information. You can help by reporting any\nside effects you may get. See the end of section\u00a04 for how to report side\neffects.</span><span lang=\"EN-GB\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Read all of this leaflet carefully before you start taking this\nmedicine because it contains </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">important information for you.</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Keep this leaflet. You may need to read it\nagain. </span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you have any further questions, ask your\ndoctor, pharmacist or nurse.</span></p>\n<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This\nmedicine has been prescribed for you only. Do not pass it on to others. It may\nharm them, even if their signs of illness are the same as yours.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you get any side effects, talk to your doctor,\npharmacist or nurse. This includes any possible side effects not listed in this\nleaflet. See section\u00a04.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What is in this leaflet</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0 What\nNINLARO is and what it is used for</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0 What\nyou need to know before you take NINLARO</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0 How\nto take NINLARO</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0 Possible\nside effects</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0 How\nto store NINLARO</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0 Contents\nof the pack and other information</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What NINLARO is and what it\nis used for</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What NINLARO is</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO is a\ncancer medicine that contains ixazomib, a \u2018proteasome inhibitor\u2019.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO is used\nto treat a cancer of the bone marrow called multiple myeloma. Its active\nsubstance ixazomib works by blocking the action of proteasomes. These are\nstructures inside the cell that digest proteins and are important for cell\nsurvival. Because myeloma cells produce a lot of proteins, blocking the action\nof proteasomes can kill the cancerous cells.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What NINLARO is used for</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO is used\nto treat adults with multiple myeloma.</span><span lang=\"EN-GB\"> NINLARO will be\ngiven to you together with lenalidomide and dexamethasone, which are other\nmedicines used to treat multiple myeloma.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">What multiple myeloma is </span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Multiple\nmyeloma is a cancer of the blood</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> which affects a type of cell, called the plasma cell</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">. A plasma cell is a blood\ncell that normally produces proteins to fight infections. People with multiple\nmyeloma have cancerous plasma cells, also called </span><span lang=\"EN-GB\" style=\"font-size:11.0pt\"><a href=\"javascript:void(0);\" title=\"(my-uh-LOW-muh) Cancerous plasma cells.\"><span style=\"color:windowtext;\ntext-decoration:none\">myeloma cells</span></a></span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">, which can damage the bones. Protein\nproduced by myeloma cells can damage the kidneys. Treatment for multiple\nmyeloma involves killing myeloma cells and reducing the symptoms of the\ndisease. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before\nyou take NINLARO</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Do not take NINLARO</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 if you are\nallergic to ixazomib or to any of the other any of the other ingredients of\nthis medicine (listed in section\u00a06).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you are\nuncertain whether the condition above applies to you, talk to your doctor,\npharmacist or nurse before taking NINLARO.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Warnings and precautions</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Talk to your doctor, pharmacist or nurse before taking or during\ntreatment with NINLARO if:</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">you have a history of bleeding</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">you have persistent nausea, vomiting or diarrhoea</span></p>\n<p class=\"MsoListParagraph\" style=\"margin:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>you\nhave a history of nerve problems, to include tingling and numbness</span></p>\n<p class=\"MsoListParagraph\" style=\"margin:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>you\nhave a history of swelling</span></p>\n<p class=\"MsoListParagraph\" style=\"margin:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>you\nhave a persistent rash</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">you have or have had liver or kidney problems as\nyour dose may have to be adjusted</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-bottom:0in;text-indent:-.5in;\nline-height:normal;text-autospace:none\"><span style=\"font-family:Symbol;\ncolor:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span style='font-family:\"Times New Roman\",serif;color:black'>you\nhave or have had damage to the smallest blood vessels known as thrombotic\nmicroangiopathy or thrombotic thrombocytopenic purpura. Tell your doctor if you\ndevelop fatigue, fever, bruising, bleeding, decreased urination, swelling,\nconfusion, vision loss, and seizures.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Your doctor will\nexamine you and you will be monitored closely during treatment. Before starting\nNINLARO and during treatment, you will have blood tests to check that you have\nenough blood cells.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Children and adolescents</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO is not\nrecommended for use in children and adolescents aged under 18\u00a0years.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other medicines and NINLARO</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tell\nyour doctor, pharmacist or nurse if you are taking, have recently taken or\nmight take any other medicines. This includes any medicines obtained without a\nprescription, such as vitamins or herbal remedies. This is because other\nmedicines can affect the way NINLARO works. In particular, tell your doctor,\npharmacist or nurse if you are taking any of the following medicines:\ncarbamazepine, phenytoin, rifampicin and St. John\u2019s wort (<i>Hypericum </i><i>perforatum</i>).\nThese medicines should be avoided as they may reduce the effectiveness of\nNINLARO.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Pregnancy and breast\u2011feeding</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO is not\nrecommended during pregnancy as it may harm your unborn baby. Breast\u2011feeding\nshould be stopped when taking NINLARO.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Avoid becoming\npregnant or breast\u2011feeding while being treated with NINLARO. If you are\npregnant or breast\u2011feeding, think you may be pregnant or are planning to\nhave a baby, ask your doctor or pharmacist for advice before taking this\nmedicine. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">If you are a woman of childbearing potential or a man who can father\na child, you </span><span lang=\"EN-GB\">must use effective contraception during\nand for 90\u00a0days after treatment. </span><span lang=\"EN-GB\">Women using\nhormonal contraceptives should additionally use a barrier method of\ncontraception. </span><span lang=\"EN-GB\">Tell doctor right away if you or your\npartner becomes pregnant while receiving NINLARO.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">As NINLARO is given in combination with lenalidomide, </span><span lang=\"EN-GB\">you should adhere to the pregnancy prevention programme of\nlenalidomide</span><span lang=\"EN-GB\"> because lenalidomide can be harmful to the\nunborn child.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">See the package leaflets for lenalidomide and dexamethasone for additional\ninformation on pregnancy and breast\u2011feeding</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Driving and using machines</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO may\naffect your ability to drive or use machines. You may feel tired and dizzy while\ntaking NINLARO. Do not drive or operate machines if you have these side effects.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take NINLARO</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO must be\nprescribed to you by a doctor with experience of treating multiple myeloma.\nAlways take this medicine exactly as your doctor or pharmacist has told you. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO</span><span lang=\"EN-GB\"> is used with lenalidomide (a medicine which affects how your immune\nsystem works) and dexamethasone (an anti\u2011inflammatory medicine).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO,\nlenalidomide and dexamethasone are taken in 4\u2011week treatment cycles. NINLARO\nis taken once a week (on the same day of the week) for the first 3\u00a0weeks\nof this cycle. The recommended dose is one 4\u00a0mg capsule taken by mouth.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The recommended dose of lenalidomide is 25\u00a0mg taken every day\nfor the first 3\u00a0weeks of the cycle. The recommended dose of dexamethasone\nis 40\u00a0mg taken once a week on the same day for all 4\u00a0weeks of the\ncycle. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<table align=\"left\" border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none;margin-left:6.75pt;margin-right:\n 6.75pt\">\n<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Dosing schedule: NINLARO taken with lenalidomide\n  and dexamethasone</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:.5in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Take medicine</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:92.3pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 1</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 2</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 3</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.35pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 4</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 1</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">2 to 7</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 8</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">9 to 14</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 15</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">16 to 21</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 22</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days 23 to 28</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">NINLARO</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Lenalidomide</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Dexamethasone</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">You\nshould read the Package Leaflets of these other medicines for further\ninformation on their use and effects. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If\nyou have liver or kidney problems, your doctor may prescribe NINLARO capsules\ncontaining 3\u00a0mg. If you have side effects, your doctor may prescribe\nNINLARO capsules containing 3\u00a0mg or 2.3\u00a0mg. The doctor may also\nadjust the doses of the other medicines.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">How and when to take NINLARO </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Take NINLARO at least one hour before or at\nleast two hours after food. </span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Swallow the capsule whole with water. Do not crush,\nchew or open the capsule. </span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Do not let the contents of the capsule come into\ncontact with your skin. If the powder accidentally comes into contact with your\nskin, wash it off thoroughly with soap and water. If the capsule breaks, clean\nup the powder, taking care that it does not cause dust in the air. </span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you take more NINLARO than you\nshould </span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Accidental overdose\ncan cause serious side effects.</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you take more NINLARO\nthan you should, talk to a doctor immediately or go to a hospital straight\naway. Take the medicine pack with you.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Duration of the treatment with\nNINLARO </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">You should\ncontinue treatment until your doctor tells you to stop. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you forget to take NINLARO </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">If a dose is missed or delayed, you should take the dose\nas long as the next scheduled dose is more than 3 days or 72\u00a0hours away. </span><span lang=\"EN-GB\">Do not take a missed dose if it is within 3\u00a0days or 72\u00a0hours\nof your next scheduled dose.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">If you vomit after taking a dose, do not take an extra dose. Take\nthe next dose, as normal, when it is due. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If\nyou have any further questions on the use of this medicine, ask your doctor or\npharmacist.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Like all\nmedicines, this medicine can cause side effects, although not everybody gets\nthem.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Tell your doctor or pharmacist straight away if you\nnotice any of these following very common serious side effects which may affect\nmore than 1 in 10 people:</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">low platelet counts (thrombocytopenia) which may\nincrease the risk of nose bleeds and you may easily bruise </span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">nausea, vomiting and diarrhoea</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">numbness, tingling or burning of the hands or\nfeet (peripheral neuropathy)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">swelling of the legs or feet (peripheral oedema)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">skin rash that may be itchy and in a few areas\nor all over the body </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Additionally, tell a doctor immediately if you notice any of these\nfollowing </span></b><b><span lang=\"EN-GB\">rare side effects which may affect up\nto 1 in 1,000 people: </span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">severe skin rashes such as red to purple bumps\n(Sweet\u2019s syndrome) or rash with skin peeling and mouth sores (Stevens\u2011Johnson\nsyndrome)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">muscle weakness, loss of feelings of the toes\nand feet or loss of leg movement (transverse myelitis)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">changes in vision, changes in mental status, or\nseizures (posterior reversible encephalopathy syndrome)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">rapid death of cancer cells that may cause\ndizziness, decreased urination, confusion, vomiting, nausea, swelling,\nshortness of breath, or heart rhythm disturbances (tumour lysis syndrome)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">rare blood condition resulting from blood clots that\nmay cause fatigue, fever, bruising, bleeding e.g. nose bleeds, decreased\nurination, swelling, confusion, vision loss, and seizures (thrombotic\nmicroangiopathy, thrombotic thrombocytopenic purpura)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Other possible\nside effects </span></b></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><span style='font-family:\n\"Times New Roman\",serif'>Tell your doctor or pharmacist if any of the side\neffects below become severe. </span></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><span style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very common side effects may affect\nmore than 1 in 10 people:</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">constipation</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">back pain</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">cold\u2011like symptoms (upper respiratory\ntract infection)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">feeling tired or weak (fatigue)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">lowered white blood cells called neutrophils (neutropenia)\nthat may increase the risk of infection </span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">not feeling like eating (decreased appetite)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">irregular heart rate (arrhythmia)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">vision conditions including blurred vision, dry\neye and pink eye (conjunctivitis)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Common side effects may affect up to 1 in 10 people:</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">reactivation of the chicken pox virus (shingles)\nthat can cause a skin rash and pain (herpes zoster)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">lowered blood pressure (hypotension)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">shortness of breath or persistent coughing or\nwheezing (heart failure)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">yellow discoloration of eyes and skin (jaundice which\ncould be a symptom of liver  impairment)</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">low levels of potassium in the blood\n(hypokalaemia)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Reporting of side effects</span></b></p>\n<p class=\"BodytextAgency\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>If you\nget any side effects, talk to your doctor, pharmacist or nurse. This includes\nany possible side effects not listed in this leaflet. You can also report side\neffects directly via <span style=\"background:silver\">the national reporting\nsystem listed in </span><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:silver\">Appendix\u00a0V</span></a>. By reporting side effects\nyou can help provide more information on the safety of this medicine.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nNINLARO</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep this\nmedicine out of the sight and reach of children.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not use this\nmedicine after the expiry date which is stated on the blister, wallet and\ncarton after EXP. The expiry date refers to the last day of that month.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Do\nnot store above 30\u00a0\u00b0C. Do not freeze. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNoSpacing\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Store\nin the original package in order to protect from moisture.</span></p>\n<p class=\"MsoNoSpacing\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>\n<p class=\"MsoNoSpacing\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do\nnot remove the capsule until you need to take a dose.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not use this\nmedicine if you notice any damage or signs of tampering to medicine packaging.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not throw\naway any medicines via wastewater or household waste. Ask your pharmacist how\nto throw away medicines you no longer use. These measures will help protect the\nenvironment.</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and\nother information</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What NINLARO contains </span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO\n2.3\u00a0mg hard capsule: </span></p>\n<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The active substance is\nixazomib. Each capsule contains 2.3\u00a0mg of ixazomib (as 3.3\u00a0mg of\nixazomib citrate).</span></p>\n<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The other ingredients are:</span></p>\n<p class=\"Default\" style=\"margin-left:0in;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">In the capsule: microcrystalline\ncellulose, magnesium stearate and talc.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The capsule shell contains: gelatin, titanium\ndioxide (E171) and red iron oxide (E172) </span></p>\n<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The printing ink contains: shellac, propylene\nglycol, potassium hydroxide, and black iron  oxide (E172).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsule: </span></p>\n<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The active substance is\nixazomib. Each capsule contains 3\u00a0mg of ixazomib (as 4.3\u00a0mg of\nixazomib citrate). </span></p>\n<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The other ingredients are:</span></p>\n<p class=\"Default\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">In the capsule: microcrystalline\ncellulose, magnesium stearate and talc.</span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The capsule shell contains: gelatin, titanium\ndioxide (E171) and black iron oxide (E172) </span></p>\n<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The printing ink contains: shellac, propylene\nglycol, potassium hydroxide, and black iron oxide (E172).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO 4\u00a0mg hard capsule: </span></p>\n<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The active substance is\nixazomib. Each capsule contains 4\u00a0mg of ixazomib (as 5.7\u00a0mg of\nixazomib citrate). </span></p>\n<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The other ingredients are</span></p>\n<p class=\"Default\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">In the capsule: microcrystalline\ncellulose, magnesium stearate and talc.</span></p>\n<p class=\"Default\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The capsule shell\ncontains: gelatin, titanium dioxide (E171), yellow iron oxide (E172) and red\niron oxide (E172) </span></p>\n<p class=\"Default\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The printing ink\ncontains: shellac, propylene glycol, potassium hydroxide, and black iron oxide\n(E172).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What NINLARO looks like and contents of the pack</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO 2.3\u00a0mg hard capsule: Light\npink, size 4, marked \u201cTakeda\u201d on the cap and \u201c2.3\u00a0mg\u201d\non the body with black ink.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO\n3\u00a0mg hard capsule:</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Light\ngrey, size 4, marked \u201cTakeda\u201d on the cap and\n\u201c3\u00a0mg\u201d on the body with black ink.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO\n4\u00a0mg hard capsule:</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Light\norange, size 3, marked \u201cTakeda\u201d on the cap and\n\u201c4\u00a0mg\u201d on the body with black ink.</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each pack\ncontains 3\u00a0hard capsules (three single cartons, each containing a blister\nsealed inside a wallet. Each blister contains one capsule).</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Manufacturer</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Ireland\nLimited</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grange Castle\nBusiness Park</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dublin 22</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">D22 XR57</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Takeda Pharma A/S</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Dybendal Alle 10</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">2630 Taastrup</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Denmark</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Takeda GmbH</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\" style=\"background:\nsilver\">Takeda (Werk Singen)</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\" style=\"background:\nsilver\">Robert Bosch Stra\u00dfe 8</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">78224 Singen</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Germany</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For any\ninformation about this medicine, please contact the local representative of the\nMarketing Authorisation Holder:</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-1.7pt;border-collapse:collapse\" width=\"624\">\n<tr style=\"height:67.3pt\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.3pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">takeda-belgium@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.3pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"FI\">Lietuva</span></b></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda,\n  UAB </span></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +370 521 09 070 </span></p>\n<p class=\"Default\"><span lang=\"FI\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0430\u043a\u0435\u0434\u0430\n  \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0435\u043b.:\n  + 359 2 958 27 36</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">takeda-belgium@takeda.com\n  </span></p>\n</td>\n</tr>\n<tr style=\"height:67.75pt\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.75pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Czech\n  Republic s.r.o. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  + 420 234 722 722 </span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.75pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Kft. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +361\n  2707030 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma A/S </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +45 46 77 11 11 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FI\">Malta</span></b></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 06\n  502601 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +49 (0) 800 825 3325</span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt\">medinfoEMEA@takeda.com</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Nederland</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Nederland bv </span></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +31 23 56 68 777 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">nl.medical.info@takeda.com\n  </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"PT-BR\">Eesti</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda Pharma AS </span></p>\n<p class=\"Default\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +372 6177 669 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-NYN\">Norge</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  AS </span></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +47 6676 3030 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">infonorge@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">TAKEDA\n  </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395\u039b\u039b\u0391\u03a3</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0391</span><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">.</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">T\u03b7\u03bb</span><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">: +30 210 6387800</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">gr.info@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">\u00d6sterreich</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Ges.m.b.H. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +43 (0)\n  800-20 80 50 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Espa\u00f1a</span></b></p>\n<p class=\"Default\"><span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00e9utica Espa\u00f1a S.A </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +34 917 90 42 22</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">spain@takeda.com</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PL\">Polska</span></b></p>\n<p class=\"Default\"><span lang=\"PL\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma sp. z o.o</span></p>\n<p class=\"Default\"><span lang=\"PL\" style=\"font-size:11.0pt\">Tel.: + 48 22 608 13\n  00 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\">France</span></b></p>\n<p class=\"Default\"><span lang=\"FR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  France SAS</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">T\u00e9l:</span><span lang=\"FR\"> </span><span lang=\"FR\">+ 33 1 40 67 33 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">medinfoEMEA@takeda.com</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Portugal</span></b></p>\n<p class=\"Default\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00eauticos Portugal, Lda. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 351 21\n  120 1457 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Croatia d.o.o. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +385 1 377 88 96 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Products Ireland Limited </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +353 (0) 1 6420021 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals SRL </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +40 21\n  335 03 91 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-NYN\">Slovenija</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH Podru\u017enica Slovenija </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">Tel.+ 386 (0)\n  59 082 480 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vistor hf. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi</span><span lang=\"EN-GB\">: +354 535 7000 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">vistor@vistor.is\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Slovakia s.r.o. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +421 (2)\n  20 602 600 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Italia</span></b></p>\n<p class=\"Default\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 06\n  502601 </span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Suomi/Finland</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Oy</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Puh/Tel:</span><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\"> +358 20 746 5000 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"Default\"><span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">A. Potamitis Medicare\n  Ltd</span></p>\n<p class=\"Default\"><span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">T</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u03b7\u03bb</span><span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">: </span><span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">+357 22583333</span></p>\n<p class=\"Default\"><span lang=\"ES\" style=\"font-size:11.0pt\">info@potamitismedicare.com</span><span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Sverige</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma AB </span></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +46 8 731 28 00 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">infosweden@takeda.com\n  </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">Latvija</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda Latvia SIA </span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Tel: +371 67840082 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">United Kingdom</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda UK Ltd </span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel: +44 (0)1628 537 900 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n</table>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">This leaflet was last revised in </span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other sources of information</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed\ninformation on this medicine is available on the European Medicines Agency web\nsite: <a href=\"http://www.ema.europa.eu/\">http://www.ema.europa.eu</a>.<a name=\"_GoBack\"></a></span></p>\n</div>", "ID": "bac005d4-97c7-423a-a704-2189366a81b7", "Styles": "None", "Classes": "['WordSection1']", "Text": "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              ", "ParentId": "f83a8686-f8fa-4627-bbe7-2aad04c62df1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b6cd10f3-24ae-400f-b27a-7ec7a714457f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "458c2eff-c9a1-4baa-b458-df57c413ad03", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b6cd10f3-24ae-400f-b27a-7ec7a714457f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b15175b0-7831-4c35-b8ae-2e86485f0b4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "0a6c777c-a72b-4e74-bc13-4ca90c224fe2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b15175b0-7831-4c35-b8ae-2e86485f0b4e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aa35898e-a9c4-4286-bf03-69587da52b72", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0a6c777c-a72b-4e74-bc13-4ca90c224fe2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "f14e1eea-f0c2-4b1c-aa79-c34f6ad70199", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f60a0742-fffc-4216-89bc-dd3de0be326a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f14e1eea-f0c2-4b1c-aa79-c34f6ad70199"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "11e6450a-e62b-4048-9d6e-1f8655dd750e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f60a0742-fffc-4216-89bc-dd3de0be326a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "8668af7b-9953-42b6-85ad-1f196778925c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "fdb24503-6900-4c44-89c8-823cde2a3a4f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8668af7b-9953-42b6-85ad-1f196778925c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "75f3e190-9c73-412a-be1d-fcebb49465c2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fdb24503-6900-4c44-89c8-823cde2a3a4f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "4e2aefce-5954-4c67-8ee6-56d4a11c0154", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "50a447cd-0496-4f2e-9976-7ad9b9b03e7e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4e2aefce-5954-4c67-8ee6-56d4a11c0154"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e16f65ba-aafd-45ac-ac4d-e89a9eb3b495", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "50a447cd-0496-4f2e-9976-7ad9b9b03e7e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "16322c65-08ca-4028-9dd5-cbed297b9fd1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "ab46fcd1-2fe3-44a3-ba6b-5460f5a54cc3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16322c65-08ca-4028-9dd5-cbed297b9fd1"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0b0dd756-2860-4a5d-8b17-efe269c611bb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ab46fcd1-2fe3-44a3-ba6b-5460f5a54cc3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9e387f64-60ec-47b8-bfb3-b4364f4fc281", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "e712cf35-a265-4ff0-a2aa-2c4a2f68234f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9e387f64-60ec-47b8-bfb3-b4364f4fc281"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f25ad7ec-867f-4a6c-9fec-adf2aa010b73", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e712cf35-a265-4ff0-a2aa-2c4a2f68234f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "e17b580c-21c7-45cb-804c-cb8a53bbc11c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c5b67980-85d6-47be-a109-c0c926c8ec42", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e17b580c-21c7-45cb-804c-cb8a53bbc11c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f80b3827-fe15-4d2a-9a89-ba62a9461c43", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c5b67980-85d6-47be-a109-c0c926c8ec42"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "59138b74-38ef-48f8-b6ca-ccfb334d7c2a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "b12f87cf-13e2-46dd-8828-bccf5dca88de", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "59138b74-38ef-48f8-b6ca-ccfb334d7c2a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e6f6f140-8495-4707-95d6-1fc34ddd5bf9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b12f87cf-13e2-46dd-8828-bccf5dca88de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b0089d2f-a9ea-44e3-bfc6-c6a9380713c3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "6085a00c-2551-49c6-89fe-e7d93fbfdfa9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b0089d2f-a9ea-44e3-bfc6-c6a9380713c3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "410d84a8-dac9-4f76-9eb7-b333fac25c5a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6085a00c-2551-49c6-89fe-e7d93fbfdfa9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "2365e77f-cee7-45ad-b9ec-af093a45f0c9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9a835db5-29f3-4a13-a0c7-d89ca92021ed", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2365e77f-cee7-45ad-b9ec-af093a45f0c9"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0caef07f-426f-41f6-8602-53246c1fe7f2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9a835db5-29f3-4a13-a0c7-d89ca92021ed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5ab17263-5c7e-461b-948f-525644275cf0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "113f4776-16d8-44bd-bcc4-09b07432ccaf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5ab17263-5c7e-461b-948f-525644275cf0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3dbbcf1a-3639-4a95-a444-4f1dcd56ebfc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "113f4776-16d8-44bd-bcc4-09b07432ccaf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "e0af27df-7615-4e76-983e-606a1297b988", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "642b221b-7297-4853-ba47-29fc2c84666f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e0af27df-7615-4e76-983e-606a1297b988"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3663e8b3-4c18-4df5-8ddd-79e373e0daea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "642b221b-7297-4853-ba47-29fc2c84666f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "27d22db4-8987-4273-80bd-afe595f68398", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "7d4dd7f4-026e-48ea-99af-5a22e5feead3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "27d22db4-8987-4273-80bd-afe595f68398"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "594b0830-8cb6-41cd-beb1-541b7ab56ead", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7d4dd7f4-026e-48ea-99af-5a22e5feead3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5468df2a-4722-4df2-98c1-cac167691c2b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "aa424349-25a3-4e33-8ed2-781bd10915ac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5468df2a-4722-4df2-98c1-cac167691c2b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8848c0bf-daff-44e2-81f5-62538669e1af", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aa424349-25a3-4e33-8ed2-781bd10915ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9b226874-4612-44b9-84ea-f84f298e3a12", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "81ee7f16-c509-4296-9aee-0af72f6c0841", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9b226874-4612-44b9-84ea-f84f298e3a12"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "00fd4dc6-49e1-4d40-b131-16595c764c12", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "81ee7f16-c509-4296-9aee-0af72f6c0841"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "924a10d7-9e36-4257-a0b5-281f039d6337", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f7503815-65b9-491f-940b-89b92c7ac47f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "924a10d7-9e36-4257-a0b5-281f039d6337"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e5571de2-d1d1-4ea1-a686-bcbb26065f30", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f7503815-65b9-491f-940b-89b92c7ac47f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "2692de9e-1949-4b18-b229-d15715531473", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "232380b2-0324-4152-b2e1-41ae58f39d8f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2692de9e-1949-4b18-b229-d15715531473"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ddec7341-dddc-4ead-b609-9c50847c8c81", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "232380b2-0324-4152-b2e1-41ae58f39d8f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "c0488250-d439-480a-8aea-02e552c73632", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "4dd0fe6d-74e5-45f5-847c-874f85523bf3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c0488250-d439-480a-8aea-02e552c73632"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ce30a989-b67b-4566-b6b8-e50e39ba3c21", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4dd0fe6d-74e5-45f5-847c-874f85523bf3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "88f63a75-7862-4e49-9703-86ed53aa5b5e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "ed4f42c8-cf2b-4a8e-87d6-b7999f6a9004", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "88f63a75-7862-4e49-9703-86ed53aa5b5e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "408a97eb-3f3d-4982-92ed-36c947a02c49", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ed4f42c8-cf2b-4a8e-87d6-b7999f6a9004"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "25cd947a-c547-403d-931b-0d2c0aa85746", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "8852d39e-feea-4677-a02d-f1eb2aec0f51", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "25cd947a-c547-403d-931b-0d2c0aa85746"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1de66057-b150-4ebe-bc01-01dfae999b3e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8852d39e-feea-4677-a02d-f1eb2aec0f51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "d1fa20b3-e32e-49e2-8252-408816491b54", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "30ea26e2-7032-4cdd-9636-aa481c074e5c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d1fa20b3-e32e-49e2-8252-408816491b54"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e97d089b-b100-4437-af20-b1f498bb008e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "30ea26e2-7032-4cdd-9636-aa481c074e5c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "f30619f9-f6ac-428d-9380-61c2f2a94df9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "472a7ff9-32b1-4640-83c2-7c1eb983044e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f30619f9-f6ac-428d-9380-61c2f2a94df9"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9d8d50ea-945f-44b7-bd96-249d96126d9b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "472a7ff9-32b1-4640-83c2-7c1eb983044e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX I</span></b></p>", "ID": "2f8252aa-c2d8-4a96-aef2-b7da3c5a499b", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX I</span></b>", "ID": "6eb1f87e-d2a3-43d3-8f2a-7dc5a77b2caf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2f8252aa-c2d8-4a96-aef2-b7da3c5a499b"}, {"Element": "<span lang=\"EN-GB\">ANNEX I</span>", "ID": "5be9146f-0792-4b39-a650-1c1a749a27db", "Styles": "None", "Classes": "None", "Text": "ANNEX I", "ParentId": "6eb1f87e-d2a3-43d3-8f2a-7dc5a77b2caf"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8cd94545-892c-4621-9b26-fec1025d90f3", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ddabf9ce-e4fd-4cd1-9b88-19712a15c21c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8cd94545-892c-4621-9b26-fec1025d90f3"}, {"Element": "<p class=\"TitleA\"><span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span></p>", "ID": "03dfc8a8-df71-4490-9ee4-356cb552acfe", "Styles": "None", "Classes": "['TitleA']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">SUMMARY OF PRODUCT CHARACTERISTICS</span>", "ID": "1b2aadef-a195-4e35-9ccf-fec7ce59c0b2", "Styles": "None", "Classes": "None", "Text": "SUMMARY OF PRODUCT CHARACTERISTICS", "ParentId": "03dfc8a8-df71-4490-9ee4-356cb552acfe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"18\" id=\"Immagine 1\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image001.gif\" width=\"22\"/></span><span lang=\"EN-GB\">This medicinal product is subject to additional monitoring. This\nwill allow quick identification of new safety information. Healthcare\nprofessionals are asked to report any suspected adverse reactions. See section\u00a04.8\nfor how to report adverse reactions.</span></p>", "ID": "74824628-3bfc-4e92-af67-749fe945a4d7", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" height=\"18\" id=\"Immagine 1\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image001.gif\" width=\"22\"/></span>", "ID": "a1b03098-ca22-4f0f-8376-1d4417008ded", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "74824628-3bfc-4e92-af67-749fe945a4d7"}, {"Element": "<img alt=\"BT_1000x858px\" height=\"18\" id=\"Immagine 1\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image001.gif\" width=\"22\"/>", "ID": "c9f8356e-ef9f-4c81-ae7e-7d63aebffccd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a1b03098-ca22-4f0f-8376-1d4417008ded"}, {"Element": "<span lang=\"EN-GB\">This medicinal product is subject to additional monitoring. This\nwill allow quick identification of new safety information. Healthcare\nprofessionals are asked to report any suspected adverse reactions. See section\u00a04.8\nfor how to report adverse reactions.</span>", "ID": "ca0c5946-cda1-41e9-9f22-59ddf7bb7f21", "Styles": "None", "Classes": "None", "Text": "This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section\u00a04.8 for how to report adverse reactions.", "ParentId": "74824628-3bfc-4e92-af67-749fe945a4d7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fbdeea83-11d3-4bd1-9de4-433f028ba53f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "25cace83-1524-463c-9d97-4f6dfde68394", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fbdeea83-11d3-4bd1-9de4-433f028ba53f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4d432962-cb0b-4983-9c99-0c15feac7a0b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4b3efc9d-7da0-47b5-836d-1a8f865791c7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4d432962-cb0b-4983-9c99-0c15feac7a0b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "a0b13443-4417-45ee-8fac-17fe6cf921bf", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "ba892a3a-90d1-4c74-84fa-d4251068ba8a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a0b13443-4417-45ee-8fac-17fe6cf921bf"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "08ebc78c-f67d-42c3-8b39-c7eeb9379d44", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "ba892a3a-90d1-4c74-84fa-d4251068ba8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f2d63a3f-75a5-48bb-8cc8-9be74d165062", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2265e033-7045-4270-a2b4-4d54f8730294", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f2d63a3f-75a5-48bb-8cc8-9be74d165062"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg\nhard capsules</span></p>", "ID": "178889b7-f130-4f0f-9743-356a0d21c4ce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO 2.3\u00a0mg\nhard capsules</span>", "ID": "dc7632a3-ab2b-4fe3-892a-dc6120857447", "Styles": "None", "Classes": "None", "Text": "NINLARO 2.3\u00a0mg hard capsules", "ParentId": "178889b7-f130-4f0f-9743-356a0d21c4ce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span></p>", "ID": "2f58b958-d25d-4257-aa09-f8be6d0a13d6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span>", "ID": "9f4aa71b-50ba-459b-824f-f7704fd745a0", "Styles": "None", "Classes": "None", "Text": "NINLARO 3\u00a0mg hard capsules", "ParentId": "2f58b958-d25d-4257-aa09-f8be6d0a13d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span></p>", "ID": "3d1f7eac-10d8-4a50-a1ec-4b3cab82b695", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span>", "ID": "2bf76027-b73b-4e62-8e5f-cb76bc3eed1d", "Styles": "None", "Classes": "None", "Text": "NINLARO 4\u00a0mg hard capsules", "ParentId": "3d1f7eac-10d8-4a50-a1ec-4b3cab82b695"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "74fade01-20df-4fbe-b3e7-8f74cda185d7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "713b9be4-b286-47f7-a410-58ded8189793", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "74fade01-20df-4fbe-b3e7-8f74cda185d7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ce01ffdb-5d44-40e0-9d9a-30a39665cd9e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "15a75a3d-9e82-47cf-b1c3-a23a0c46ee07", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ce01ffdb-5d44-40e0-9d9a-30a39665cd9e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE\nCOMPOSITION</span></b></p>", "ID": "c6969cb3-6420-421c-8e5e-a575f601af0f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE\nCOMPOSITION</span></b>", "ID": "3a057e45-c4ab-4ad7-99f1-c5f7a99193be", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c6969cb3-6420-421c-8e5e-a575f601af0f"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE\nCOMPOSITION</span>", "ID": "39c5acd7-b030-4bc5-b0e6-33ec6251dace", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 QUALITATIVE AND QUANTITATIVE COMPOSITION", "ParentId": "3a057e45-c4ab-4ad7-99f1-c5f7a99193be"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3e30121a-68a5-485f-b873-434fe79f92ea", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "73cfe417-9323-4d35-b6e5-5e33e353363d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3e30121a-68a5-485f-b873-434fe79f92ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg\nhard capsules</span></u></p>", "ID": "1c4f08b0-41be-44b1-9f49-68eea41ae16f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg\nhard capsules</span></u>", "ID": "d9f38ec5-0acf-4d82-a8f3-4750a6e28d8b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1c4f08b0-41be-44b1-9f49-68eea41ae16f"}, {"Element": "<span lang=\"EN-GB\">NINLARO 2.3\u00a0mg\nhard capsules</span>", "ID": "afc5bd31-52eb-43df-8289-23f1f3393300", "Styles": "None", "Classes": "None", "Text": "NINLARO 2.3\u00a0mg hard capsules", "ParentId": "d9f38ec5-0acf-4d82-a8f3-4750a6e28d8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cc89ccad-e40a-401d-9fd1-572a083da90b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5705d1ab-1e1d-4522-9528-f05bdc7cda00", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cc89ccad-e40a-401d-9fd1-572a083da90b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each capsule\ncontains 2.3\u00a0mg of ixazomib (as 3.3\u00a0mg of ixazomib citrate)</span></p>", "ID": "9c2d4f27-679c-4fc8-943b-d0cff60d7253", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Each capsule\ncontains 2.3\u00a0mg of ixazomib (as 3.3\u00a0mg of ixazomib citrate)</span>", "ID": "ae81e38c-20a6-48b4-ba84-8d60e30ce02e", "Styles": "None", "Classes": "None", "Text": "Each capsule contains 2.3\u00a0mg of ixazomib (as 3.3\u00a0mg of ixazomib citrate)", "ParentId": "9c2d4f27-679c-4fc8-943b-d0cff60d7253"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1d70d75b-e421-4f61-b141-9b33c7a0e500", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "de46219b-2777-4fad-a0be-0c7931489166", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1d70d75b-e421-4f61-b141-9b33c7a0e500"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span></u></p>", "ID": "8f148652-2fdb-4553-937b-a0f98c34870f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span></u>", "ID": "239f6bb3-ca88-4e9e-aec2-54f03f54a1bc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8f148652-2fdb-4553-937b-a0f98c34870f"}, {"Element": "<span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span>", "ID": "9c267108-18f7-4ffe-9523-6dd92e73a536", "Styles": "None", "Classes": "None", "Text": "NINLARO 3\u00a0mg hard capsules", "ParentId": "239f6bb3-ca88-4e9e-aec2-54f03f54a1bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "84ab367b-bd72-4729-981b-966cd55b78f4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "01c7008d-4b07-46c6-b098-40c35b8cdce1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "84ab367b-bd72-4729-981b-966cd55b78f4"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "f963fbdb-d812-4d77-bde7-6b8396c51327", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "01c7008d-4b07-46c6-b098-40c35b8cdce1"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "3e307fd8-3a5e-417a-81ba-0fe5a7e66378", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "f963fbdb-d812-4d77-bde7-6b8396c51327"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each capsule contains 3\u00a0mg of ixazomib (as 4.3\u00a0mg of\nixazomib citrate) </span></p>", "ID": "60aa9444-57ec-4285-b1bf-74339149f5cd", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Each capsule contains 3\u00a0mg of ixazomib (as 4.3\u00a0mg of\nixazomib citrate) </span>", "ID": "1142d467-6709-41f7-b581-0b5acbdc94b1", "Styles": "None", "Classes": "None", "Text": "Each capsule contains 3\u00a0mg of ixazomib (as 4.3\u00a0mg of ixazomib citrate) ", "ParentId": "60aa9444-57ec-4285-b1bf-74339149f5cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "9d9993a3-281a-4727-a28a-611351a4abe6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "aa4da626-f034-4ce0-8ee7-4e4e1212a9c5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9d9993a3-281a-4727-a28a-611351a4abe6"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "d3abb26d-1bbe-4cac-b9fb-37d77a1a6a2b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa4da626-f034-4ce0-8ee7-4e4e1212a9c5"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "0718550d-0097-4ead-a955-c29239a5e4e6", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "d3abb26d-1bbe-4cac-b9fb-37d77a1a6a2b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span></u></p>", "ID": "870301db-4e60-41e4-b4be-14a39ca58fe2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span></u>", "ID": "34aa5f7d-3f81-441e-9310-9b0449370268", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "870301db-4e60-41e4-b4be-14a39ca58fe2"}, {"Element": "<span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span>", "ID": "423f4b1a-205f-4a75-bff3-772d7e3a0f32", "Styles": "None", "Classes": "None", "Text": "NINLARO 4\u00a0mg hard capsules", "ParentId": "34aa5f7d-3f81-441e-9310-9b0449370268"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "637a6e41-efc1-47cf-8e8b-25cef8f8a456", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "b9e10a7f-c899-4e80-a3ed-484f9d537366", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "637a6e41-efc1-47cf-8e8b-25cef8f8a456"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "26ebfcb1-f70a-4c3a-a889-83d69650177b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b9e10a7f-c899-4e80-a3ed-484f9d537366"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "e5213d4b-4a77-40d2-9268-8fefeb12fb36", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "26ebfcb1-f70a-4c3a-a889-83d69650177b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each capsule contains 4\u00a0mg of ixazomib (as 5.7\u00a0mg of\nixazomib citrate)</span></p>", "ID": "a21210a8-47e0-47be-8a85-caaeb80942c5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Each capsule contains 4\u00a0mg of ixazomib (as 5.7\u00a0mg of\nixazomib citrate)</span>", "ID": "24fcf4fb-1a4b-482b-9e74-5f800fd12f91", "Styles": "None", "Classes": "None", "Text": "Each capsule contains 4\u00a0mg of ixazomib (as 5.7\u00a0mg of ixazomib citrate)", "ParentId": "a21210a8-47e0-47be-8a85-caaeb80942c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0ee8c70b-5a32-4c0b-ba5f-10c1741ed291", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c2f879eb-e932-4269-b8d9-d8359c00f0c2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0ee8c70b-5a32-4c0b-ba5f-10c1741ed291"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For the full\nlist of excipients, see section\u00a06.1.</span></p>", "ID": "6575d95e-e73d-4557-b8bd-d722bfccfbff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">For the full\nlist of excipients, see section\u00a06.1.</span>", "ID": "d8c5f638-2908-4b71-9e44-d809f5cf417a", "Styles": "None", "Classes": "None", "Text": "For the full list of excipients, see section\u00a06.1.", "ParentId": "6575d95e-e73d-4557-b8bd-d722bfccfbff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "86a32fd2-d1e2-4be5-a606-c01a8d8408fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ac876f41-4c44-40e8-80b1-dad0f0c36157", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "86a32fd2-d1e2-4be5-a606-c01a8d8408fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2736f785-952c-4c98-b3f0-80661580ee70", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "834bccb0-c2cf-4d84-9c18-625349f2d6e2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2736f785-952c-4c98-b3f0-80661580ee70"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM</span></b></p>", "ID": "955e3068-bc0f-4a47-8abb-7c26de663112", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM</span></b>", "ID": "5f44699d-5898-4e1d-b548-904774af1cb6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "955e3068-bc0f-4a47-8abb-7c26de663112"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM</span>", "ID": "49da9ded-8458-405d-8a67-936cd5bf530f", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM", "ParentId": "5f44699d-5898-4e1d-b548-904774af1cb6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0c70a16f-68fa-4fee-b35e-4448f38b3eb0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5c25deb9-97f8-4c9f-a039-0b6732724e26", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0c70a16f-68fa-4fee-b35e-4448f38b3eb0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Hard capsule.</span></p>", "ID": "429cc7bd-2753-40d0-875a-8cb6869ed613", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Hard capsule.</span>", "ID": "bf3a3dca-469f-414a-8a43-c097c60e0d9f", "Styles": "None", "Classes": "None", "Text": "Hard capsule.", "ParentId": "429cc7bd-2753-40d0-875a-8cb6869ed613"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e4eaa6ce-c5d6-4f0a-92ca-4b84f315f14c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ab06085b-7447-4b41-96e3-3636fe446ca5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e4eaa6ce-c5d6-4f0a-92ca-4b84f315f14c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO\n2.3\u00a0mg hard capsules</span></u></p>", "ID": "5e6e9814-0c64-4706-afd1-3c990b78e5e3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">NINLARO\n2.3\u00a0mg hard capsules</span></u>", "ID": "25fc72f8-f25b-4e37-a8fa-77977cb0c874", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5e6e9814-0c64-4706-afd1-3c990b78e5e3"}, {"Element": "<span lang=\"EN-GB\">NINLARO\n2.3\u00a0mg hard capsules</span>", "ID": "ec9a621a-e604-46aa-801e-9ffffe684344", "Styles": "None", "Classes": "None", "Text": "NINLARO 2.3\u00a0mg hard capsules", "ParentId": "25fc72f8-f25b-4e37-a8fa-77977cb0c874"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "943d7fa0-5c72-4bf0-b1f1-e597f4c7378b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "0f53b31e-8be7-4ee8-b948-29543649479f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "943d7fa0-5c72-4bf0-b1f1-e597f4c7378b"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "2285785b-e649-4d1c-8dce-3f528cd852fa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0f53b31e-8be7-4ee8-b948-29543649479f"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "41da6d23-b656-4985-acf5-867d715f7d91", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "2285785b-e649-4d1c-8dce-3f528cd852fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Light pink, size\n4 gelatin hard capsule, marked \u201cTakeda\u201d on the cap and\n\u201c2.3\u00a0mg\u201d on the body with black ink.</span></p>", "ID": "3d70aa12-5cca-40ca-a0ec-4ee9169256b2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Light pink, size\n4 gelatin hard capsule, marked \u201cTakeda\u201d on the cap and\n\u201c2.3\u00a0mg\u201d on the body with black ink.</span>", "ID": "f82c645f-d2b7-4f4d-ab0b-f0786988806b", "Styles": "None", "Classes": "None", "Text": "Light pink, size 4 gelatin hard capsule, marked \u201cTakeda\u201d on the cap and \u201c2.3\u00a0mg\u201d on the body with black ink.", "ParentId": "3d70aa12-5cca-40ca-a0ec-4ee9169256b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "6f521b76-b933-4cf1-8138-5b4161903494", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "952dde81-87e0-4a9a-a490-27d64edb2ec4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6f521b76-b933-4cf1-8138-5b4161903494"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "757d81c1-fab0-47bc-af3a-4472a9351872", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "952dde81-87e0-4a9a-a490-27d64edb2ec4"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "6862bd72-8934-40e7-a207-af1524c7bd95", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "757d81c1-fab0-47bc-af3a-4472a9351872"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span></u></p>", "ID": "dc273f20-d18a-455d-9b42-7a58d8249976", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span></u>", "ID": "94298f0f-8f35-492d-9031-47992136d8e2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc273f20-d18a-455d-9b42-7a58d8249976"}, {"Element": "<span lang=\"EN-GB\">NINLARO\n3\u00a0mg hard capsules</span>", "ID": "eff397f2-c726-4ba3-874e-c88b12a17e38", "Styles": "None", "Classes": "None", "Text": "NINLARO 3\u00a0mg hard capsules", "ParentId": "94298f0f-8f35-492d-9031-47992136d8e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "51c815a9-0e17-4af9-a107-d4673bc1b55c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "04f266ed-f5c7-4fd2-bf02-83bfa0dec8c5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "51c815a9-0e17-4af9-a107-d4673bc1b55c"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "9e62b481-2c00-43c3-9548-e827dd2bf026", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "04f266ed-f5c7-4fd2-bf02-83bfa0dec8c5"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "4446871b-4df8-42f4-b880-e33b2e07af45", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "9e62b481-2c00-43c3-9548-e827dd2bf026"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Light grey, size 4 gelatin hard capsule, marked \u201cTakeda\u201d\non the cap and \u201c3\u00a0mg\u201d on the body with black ink.</span></p>", "ID": "16078389-8a84-4178-97b6-532e34b7de6b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Light grey, size 4 gelatin hard capsule, marked \u201cTakeda\u201d\non the cap and \u201c3\u00a0mg\u201d on the body with black ink.</span>", "ID": "be02dbf0-29cf-4898-a355-ddd04ee659cd", "Styles": "None", "Classes": "None", "Text": "Light grey, size 4 gelatin hard capsule, marked \u201cTakeda\u201d on the cap and \u201c3\u00a0mg\u201d on the body with black ink.", "ParentId": "16078389-8a84-4178-97b6-532e34b7de6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "e02f8de6-fe94-4dfa-b567-9cf00102af96", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "83d28f17-5d72-46bc-8e80-b1b3a3e24307", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e02f8de6-fe94-4dfa-b567-9cf00102af96"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "fa8b9260-cc10-489d-96f2-621ded6811c9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "83d28f17-5d72-46bc-8e80-b1b3a3e24307"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "2f5a8cee-3b4b-4a38-a1c6-99c876d10751", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "fa8b9260-cc10-489d-96f2-621ded6811c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span></u></p>", "ID": "de2097d8-6f80-41f9-8a2b-bb340acfb5ed", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span></u>", "ID": "4ccca591-4b7a-4fb1-8d1f-5cc4bb736b31", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "de2097d8-6f80-41f9-8a2b-bb340acfb5ed"}, {"Element": "<span lang=\"EN-GB\">NINLARO\n4\u00a0mg hard capsules</span>", "ID": "3ae72c0c-de73-46c6-aabf-563897137026", "Styles": "None", "Classes": "None", "Text": "NINLARO 4\u00a0mg hard capsules", "ParentId": "4ccca591-4b7a-4fb1-8d1f-5cc4bb736b31"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "5d47fa01-3d76-4c29-8992-0378d1d3f250", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "750798a2-0348-456c-a6de-a0a9c6d66f0e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5d47fa01-3d76-4c29-8992-0378d1d3f250"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "fcfcd7a6-5478-4fc8-9ecb-03c0aff7d2d0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "750798a2-0348-456c-a6de-a0a9c6d66f0e"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "51743c5d-87e0-4db3-b0ae-a021b2c21028", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "fcfcd7a6-5478-4fc8-9ecb-03c0aff7d2d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Light orange,\nsize 3 gelatin hard capsule, marked \u201cTakeda\u201d on the cap and\n\u201c4\u00a0mg\u201d on the body with black ink.</span></p>", "ID": "2c5c0440-3ac7-46a8-a137-ee12bd536650", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Light orange,\nsize 3 gelatin hard capsule, marked \u201cTakeda\u201d on the cap and\n\u201c4\u00a0mg\u201d on the body with black ink.</span>", "ID": "4945bed0-0cbe-448e-8767-79341ae2c765", "Styles": "None", "Classes": "None", "Text": "Light orange, size 3 gelatin hard capsule, marked \u201cTakeda\u201d on the cap and \u201c4\u00a0mg\u201d on the body with black ink.", "ParentId": "2c5c0440-3ac7-46a8-a137-ee12bd536650"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d29d6dd1-9c86-4b29-ac24-4c33db36c307", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "78a4b8e0-55d8-4099-ac17-d11ae8200066", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d29d6dd1-9c86-4b29-ac24-4c33db36c307"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "258d0b7e-0e32-4b86-b5f1-f7787b0df888", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fb237295-304a-48a1-9cdb-cfea416ccd14", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "258d0b7e-0e32-4b86-b5f1-f7787b0df888"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b><b><span lang=\"EN-GB\">CLINICAL PARTICULARS</span></b></p>", "ID": "8781b4f3-1df8-407a-ac17-9af519408d16", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span></b>", "ID": "60b58234-2f5d-457d-85f6-832923ab7d51", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8781b4f3-1df8-407a-ac17-9af519408d16"}, {"Element": "<span lang=\"EN-GB\" style=\"text-transform:uppercase\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 </span>", "ID": "01c9771c-2b32-4a38-a2b5-cda00f2675f1", "Styles": "text-transform:uppercase", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "60b58234-2f5d-457d-85f6-832923ab7d51"}, {"Element": "<b><span lang=\"EN-GB\">CLINICAL PARTICULARS</span></b>", "ID": "588b1f42-1e5f-4ffc-b69b-1b953953d83a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8781b4f3-1df8-407a-ac17-9af519408d16"}, {"Element": "<span lang=\"EN-GB\">CLINICAL PARTICULARS</span>", "ID": "638576e4-1dd4-4ec7-a74f-331dbc20d356", "Styles": "None", "Classes": "None", "Text": "CLINICAL PARTICULARS", "ParentId": "588b1f42-1e5f-4ffc-b69b-1b953953d83a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "67e5b8a4-411c-47c6-a582-cb1fa19f6bb1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cf72098c-7660-4282-9e49-c2c12e5f03cb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "67e5b8a4-411c-47c6-a582-cb1fa19f6bb1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span></b></p>", "ID": "9aef773c-8f3e-4ff1-bcd4-6123016e67a9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span></b>", "ID": "5741bb85-9659-47d0-9a61-1dae9b1d476b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9aef773c-8f3e-4ff1-bcd4-6123016e67a9"}, {"Element": "<span lang=\"EN-GB\">4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications</span>", "ID": "98ed5e16-b255-4926-9d7a-ca3d3462e2cf", "Styles": "None", "Classes": "None", "Text": "4.1\u00a0\u00a0\u00a0\u00a0 Therapeutic indications", "ParentId": "5741bb85-9659-47d0-9a61-1dae9b1d476b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8dcfde6b-4974-43a0-807a-ba8cad31a59a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "86794392-df5e-4986-ae7a-1251e3256b96", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8dcfde6b-4974-43a0-807a-ba8cad31a59a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO in\ncombination with lenalidomide and dexamethasone is indicated for the treatment\nof adult patients with multiple myeloma who have received at least one prior\ntherapy.</span></p>", "ID": "32bdfc8d-649e-4b35-83ba-a58d374b387b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO in\ncombination with lenalidomide and dexamethasone is indicated for the treatment\nof adult patients with multiple myeloma who have received at least one prior\ntherapy.</span>", "ID": "73ded9fa-ce81-4172-8fac-bae79af47c0c", "Styles": "None", "Classes": "None", "Text": "NINLARO in combination with lenalidomide and dexamethasone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.", "ParentId": "32bdfc8d-649e-4b35-83ba-a58d374b387b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d3fbf24f-1d14-454f-ab72-501508abcd62", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "900b72ae-ea46-42c3-91d2-e7f88f65cadb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d3fbf24f-1d14-454f-ab72-501508abcd62"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration</span></b></p>", "ID": "0b28974c-8e23-45a2-83d0-55c6a2d5c2b7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration</span></b>", "ID": "801f5c7b-8fa1-4b69-9046-88f23636ba72", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0b28974c-8e23-45a2-83d0-55c6a2d5c2b7"}, {"Element": "<span lang=\"EN-GB\">4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration</span>", "ID": "32e36a2d-3067-4c25-8075-70f2370fde94", "Styles": "None", "Classes": "None", "Text": "4.2\u00a0\u00a0\u00a0\u00a0 Posology and method of administration", "ParentId": "801f5c7b-8fa1-4b69-9046-88f23636ba72"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fa968f78-f06b-43f8-bc89-9698823ad32e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1395d8e8-3b4c-4d3c-93c7-eb2b0e9986d0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa968f78-f06b-43f8-bc89-9698823ad32e"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Treatment must be initiated and\nmonitored under the supervision of a physician experienced in the management of\nmultiple myeloma. </span></p>", "ID": "8a682daa-f1e5-41af-ab27-a471070649aa", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Treatment must be initiated and\nmonitored under the supervision of a physician experienced in the management of\nmultiple myeloma. </span>", "ID": "14086db2-379b-4058-b9dd-966d3b5fad0d", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Treatment must be initiated and monitored under the supervision of a physician experienced in the management of multiple myeloma. ", "ParentId": "8a682daa-f1e5-41af-ab27-a471070649aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0a84ed99-2b66-4f7b-9bdd-a0b563e5a046", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e9c942fe-a1d8-4b74-a659-89d1854f9e46", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0a84ed99-2b66-4f7b-9bdd-a0b563e5a046"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posology</span></u></p>", "ID": "2c9c35c0-448b-42fe-971d-4327766965d1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Posology</span></u>", "ID": "900f29a0-a47e-4878-b57d-da66c6e7ba5a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2c9c35c0-448b-42fe-971d-4327766965d1"}, {"Element": "<span lang=\"EN-GB\">Posology</span>", "ID": "a216f018-2737-4f98-a3f6-4087250696bc", "Styles": "None", "Classes": "None", "Text": "Posology", "ParentId": "900f29a0-a47e-4878-b57d-da66c6e7ba5a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "f280eec9-8adf-4997-a9fe-5a1f8845f165", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "40328f7b-bb61-4534-8d7c-6c80b848d26f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f280eec9-8adf-4997-a9fe-5a1f8845f165"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "71f00caa-6cc3-4786-9969-48084bc53078", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "40328f7b-bb61-4534-8d7c-6c80b848d26f"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "cbe1e617-36a2-4466-a313-f5a5e5e62aa5", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "71f00caa-6cc3-4786-9969-48084bc53078"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The recommended starting dose of ixazomib\nis 4\u00a0mg administered orally once a week on Days 1, 8, and 15 of a 28\u2011day\ntreatment cycle. </span></p>", "ID": "e4b4644d-456e-4b26-a57d-2fb41c23ca3b", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">The recommended starting dose of ixazomib\nis 4\u00a0mg administered orally once a week on Days 1, 8, and 15 of a 28\u2011day\ntreatment cycle. </span>", "ID": "95af799c-be93-407a-8793-f2f81f4e2141", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "The recommended starting dose of ixazomib is 4\u00a0mg administered orally once a week on Days 1, 8, and 15 of a 28\u2011day treatment cycle. ", "ParentId": "e4b4644d-456e-4b26-a57d-2fb41c23ca3b"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "740609b7-a6e5-4b44-9a72-b043505b3d9d", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "da91db6a-108c-4d33-bcad-6ccb3d301107", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "740609b7-a6e5-4b44-9a72-b043505b3d9d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The recommended starting dose of lenalidomide is 25\u00a0mg\nadministered daily on Days 1 to 21 of a 28\u2011day treatment cycle. </span></p>", "ID": "e8b2f702-d81f-4743-b421-155c524a6674", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The recommended starting dose of lenalidomide is 25\u00a0mg\nadministered daily on Days 1 to 21 of a 28\u2011day treatment cycle. </span>", "ID": "759dabef-0dd0-474d-8583-a1a8c4636c5b", "Styles": "None", "Classes": "None", "Text": "The recommended starting dose of lenalidomide is 25\u00a0mg administered daily on Days 1 to 21 of a 28\u2011day treatment cycle. ", "ParentId": "e8b2f702-d81f-4743-b421-155c524a6674"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0271aa8e-186e-435c-add5-60c37c32f6ae", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "90e19b23-ebdd-45db-a8a5-bb02b4ef9d7f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0271aa8e-186e-435c-add5-60c37c32f6ae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The recommended starting dose of dexamethasone is 40\u00a0mg\nadministered on Days 1, 8, 15, and 22 of a 28\u2011day treatment cycle.</span></p>", "ID": "a4ec9316-db39-47ac-ab27-8caf1112962d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The recommended starting dose of dexamethasone is 40\u00a0mg\nadministered on Days 1, 8, 15, and 22 of a 28\u2011day treatment cycle.</span>", "ID": "1625f1ad-4d1c-4652-a453-eb2807974528", "Styles": "None", "Classes": "None", "Text": "The recommended starting dose of dexamethasone is 40\u00a0mg administered on Days 1, 8, 15, and 22 of a 28\u2011day treatment cycle.", "ParentId": "a4ec9316-db39-47ac-ab27-8caf1112962d"}, {"Element": "<table align=\"left\" border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none;margin-left:6.75pt;margin-right:\n 6.75pt\">\n<tr style=\"height:13.4pt\">\n<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:13.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Dosing schedule: Ixazomib taken with\n  lenalidomide and dexamethasone</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:92.3pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 1</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 2</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 3</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.35pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 4</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 1</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">2 to 7</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 8</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">9 to 14</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 15</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">16 to 21</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 22</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days 23 to 28</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Ixazomib</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Lenalidomide</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Dexamethasone</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:Webdings\">a</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">=\u00a0intake of medicinal product</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n</table>", "ID": "36d1ade7-6994-46ce-b552-2caf13571b7e", "Styles": "border-collapse:collapse;border:none;margin-left:6.75pt;margin-right:\n 6.75pt", "Classes": "['MsoNormalTable']", "Text": "         ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<tr style=\"height:13.4pt\">\n<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:13.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Dosing schedule: Ixazomib taken with\n  lenalidomide and dexamethasone</span></b></p>\n</td>\n</tr>", "ID": "74ad43c8-78d6-4c52-9613-2ada6b877d3b", "Styles": "height:13.4pt", "Classes": "None", "Text": "  ", "ParentId": "36d1ade7-6994-46ce-b552-2caf13571b7e"}, {"Element": "<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:13.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Dosing schedule: Ixazomib taken with\n  lenalidomide and dexamethasone</span></b></p>\n</td>", "ID": "9d516a63-24a4-44e1-bb79-9520d399f47a", "Styles": "width:466.1pt;border:none;\n  border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:13.4pt", "Classes": "None", "Text": "  ", "ParentId": "74ad43c8-78d6-4c52-9613-2ada6b877d3b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Dosing schedule: Ixazomib taken with\n  lenalidomide and dexamethasone</span></b></p>", "ID": "ecd54c08-8c45-4d7b-8526-fbde191ac0db", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9d516a63-24a4-44e1-bb79-9520d399f47a"}, {"Element": "<b><span lang=\"EN-GB\">Dosing schedule: Ixazomib taken with\n  lenalidomide and dexamethasone</span></b>", "ID": "41f83594-b0b3-4b4c-a11f-583e8ade6f51", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ecd54c08-8c45-4d7b-8526-fbde191ac0db"}, {"Element": "<span lang=\"EN-GB\">Dosing schedule: Ixazomib taken with\n  lenalidomide and dexamethasone</span>", "ID": "900aee68-7e3a-4c14-9485-dcf6ea26854f", "Styles": "None", "Classes": "None", "Text": "Dosing schedule: Ixazomib taken with   lenalidomide and dexamethasone", "ParentId": "41f83594-b0b3-4b4c-a11f-583e8ade6f51"}, {"Element": "<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b></p>\n</td>\n</tr>", "ID": "e4b79984-9713-4501-9d1d-739a749b0124", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "36d1ade7-6994-46ce-b552-2caf13571b7e"}, {"Element": "<td colspan=\"9\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b></p>\n</td>", "ID": "14ff55ae-a306-43b2-bb65-d0c0962800f7", "Styles": "width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e4b79984-9713-4501-9d1d-739a749b0124"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b></p>", "ID": "28d9396e-d1a2-4b60-94d9-296b8d9ada44", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "14ff55ae-a306-43b2-bb65-d0c0962800f7"}, {"Element": "<b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b>", "ID": "f54c21a2-9664-42b9-8c45-489d24c4f89a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "28d9396e-d1a2-4b60-94d9-296b8d9ada44"}, {"Element": "<span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span>", "ID": "48049ceb-9227-47fe-9fad-dc0c98044210", "Styles": "None", "Classes": "None", "Text": "28\u2011day cycle (a 4\u2011week cycle)", "ParentId": "f54c21a2-9664-42b9-8c45-489d24c4f89a"}, {"Element": "<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:92.3pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 1</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 2</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 3</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.35pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 4</span></b></p>\n</td>\n</tr>", "ID": "48e8e9ba-b060-435f-b79c-18b0ebcd9bc2", "Styles": "None", "Classes": "None", "Text": "      ", "ParentId": "36d1ade7-6994-46ce-b552-2caf13571b7e"}, {"Element": "<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "a7f480f8-422e-4e8b-8d89-43f748dbbbff", "Styles": "width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "48e8e9ba-b060-435f-b79c-18b0ebcd9bc2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "74429fc9-c47f-4020-9ad4-6c49eea7950d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a7f480f8-422e-4e8b-8d89-43f748dbbbff"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4def0eb3-8d8f-414f-a49f-7dc0b984e53f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "74429fc9-c47f-4020-9ad4-6c49eea7950d"}, {"Element": "<td colspan=\"2\" style=\"width:92.3pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 1</span></b></p>\n</td>", "ID": "ad7992fc-aa2d-43a9-be83-92e6a5b5606b", "Styles": "width:92.3pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "48e8e9ba-b060-435f-b79c-18b0ebcd9bc2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 1</span></b></p>", "ID": "e7e1ad19-4144-474d-8b7b-b0da7cf69e3f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ad7992fc-aa2d-43a9-be83-92e6a5b5606b"}, {"Element": "<b><span lang=\"EN-GB\">Week 1</span></b>", "ID": "a7f184b4-31d8-48f6-aacf-790bd454080e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e7e1ad19-4144-474d-8b7b-b0da7cf69e3f"}, {"Element": "<span lang=\"EN-GB\">Week 1</span>", "ID": "73118d5c-b4b7-49b7-af3e-4064e5554313", "Styles": "None", "Classes": "None", "Text": "Week 1", "ParentId": "a7f184b4-31d8-48f6-aacf-790bd454080e"}, {"Element": "<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 2</span></b></p>\n</td>", "ID": "fe381abc-3ee7-4bc8-aa4c-2c9de52b5be9", "Styles": "width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "48e8e9ba-b060-435f-b79c-18b0ebcd9bc2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 2</span></b></p>", "ID": "0c2f396c-0a1b-4db8-bb5c-5ef5c8858d03", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fe381abc-3ee7-4bc8-aa4c-2c9de52b5be9"}, {"Element": "<b><span lang=\"EN-GB\">Week 2</span></b>", "ID": "a387a013-4b88-4e85-a1ee-3c9750c84694", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0c2f396c-0a1b-4db8-bb5c-5ef5c8858d03"}, {"Element": "<span lang=\"EN-GB\">Week 2</span>", "ID": "695f2cae-5923-46b9-9c22-b1ac158c901f", "Styles": "None", "Classes": "None", "Text": "Week 2", "ParentId": "a387a013-4b88-4e85-a1ee-3c9750c84694"}, {"Element": "<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 3</span></b></p>\n</td>", "ID": "2514f62a-8bb6-4537-9651-0dc219aaafc6", "Styles": "width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "48e8e9ba-b060-435f-b79c-18b0ebcd9bc2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 3</span></b></p>", "ID": "0e449cb1-42c2-4bfe-8546-5acefd66098b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2514f62a-8bb6-4537-9651-0dc219aaafc6"}, {"Element": "<b><span lang=\"EN-GB\">Week 3</span></b>", "ID": "580cd613-e9dc-4946-831e-1e3212905e59", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0e449cb1-42c2-4bfe-8546-5acefd66098b"}, {"Element": "<span lang=\"EN-GB\">Week 3</span>", "ID": "9a3ec07a-9886-4cc5-940b-d3f65999dd02", "Styles": "None", "Classes": "None", "Text": "Week 3", "ParentId": "580cd613-e9dc-4946-831e-1e3212905e59"}, {"Element": "<td colspan=\"2\" style=\"width:92.35pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 4</span></b></p>\n</td>", "ID": "3dc12112-42e1-482e-af55-23c5a6b896dc", "Styles": "width:92.35pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "48e8e9ba-b060-435f-b79c-18b0ebcd9bc2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 4</span></b></p>", "ID": "4c5017d8-0fe3-4c46-ba79-24c9fa801749", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3dc12112-42e1-482e-af55-23c5a6b896dc"}, {"Element": "<b><span lang=\"EN-GB\">Week 4</span></b>", "ID": "e58e5542-608b-417e-bf4d-73cda47da5fb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4c5017d8-0fe3-4c46-ba79-24c9fa801749"}, {"Element": "<span lang=\"EN-GB\">Week 4</span>", "ID": "243807bb-4bd4-44d2-a720-d9427b205f88", "Styles": "None", "Classes": "None", "Text": "Week 4", "ParentId": "e58e5542-608b-417e-bf4d-73cda47da5fb"}, {"Element": "<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 1</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">2 to 7</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 8</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">9 to 14</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 15</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">16 to 21</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 22</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days 23 to 28</span></p>\n</td>\n</tr>", "ID": "a9d9f4e7-a6af-4ce0-9e01-956791907cac", "Styles": "None", "Classes": "None", "Text": "          ", "ParentId": "36d1ade7-6994-46ce-b552-2caf13571b7e"}, {"Element": "<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "353e2b60-02e1-4ea6-b191-b8ff949ae7e5", "Styles": "width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a9d9f4e7-a6af-4ce0-9e01-956791907cac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6cc927c1-919e-4d3e-a0df-ccc25debb0c4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "353e2b60-02e1-4ea6-b191-b8ff949ae7e5"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a7ddf398-32fd-4db1-abb6-8c79dc7d1b36", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6cc927c1-919e-4d3e-a0df-ccc25debb0c4"}, {"Element": "<td style=\"width:40.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 1</span></p>\n</td>", "ID": "d325262b-e8bf-432b-843b-8ec66fb0f4fe", "Styles": "width:40.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a9d9f4e7-a6af-4ce0-9e01-956791907cac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 1</span></p>", "ID": "446c2209-b4c8-41c2-8802-0a70272551ab", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d325262b-e8bf-432b-843b-8ec66fb0f4fe"}, {"Element": "<span lang=\"EN-GB\">Day 1</span>", "ID": "6ea2183a-b3a9-43a5-b8ca-1e719c2f20ab", "Styles": "None", "Classes": "None", "Text": "Day 1", "ParentId": "446c2209-b4c8-41c2-8802-0a70272551ab"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">2 to 7</span></p>\n</td>", "ID": "9b1372c2-2696-4b25-aec9-fdc7441439be", "Styles": "width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "a9d9f4e7-a6af-4ce0-9e01-956791907cac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>", "ID": "0a17ccff-a05f-4709-b8b9-93ef7feef4ba", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9b1372c2-2696-4b25-aec9-fdc7441439be"}, {"Element": "<span lang=\"EN-GB\">Days </span>", "ID": "bf5356d6-dc72-4b1b-80d8-4b293dceb01b", "Styles": "None", "Classes": "None", "Text": "Days ", "ParentId": "0a17ccff-a05f-4709-b8b9-93ef7feef4ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">2 to 7</span></p>", "ID": "7284b932-587b-414f-b5e1-1d4f813914de", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9b1372c2-2696-4b25-aec9-fdc7441439be"}, {"Element": "<span lang=\"EN-GB\">2 to 7</span>", "ID": "3f3a4243-9dad-45fe-87b4-cab0bc0f79f2", "Styles": "None", "Classes": "None", "Text": "2 to 7", "ParentId": "7284b932-587b-414f-b5e1-1d4f813914de"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 8</span></p>\n</td>", "ID": "7a79a72d-e8bc-4283-91a1-cc4e85b0f751", "Styles": "width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a9d9f4e7-a6af-4ce0-9e01-956791907cac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 8</span></p>", "ID": "42a604e1-75c9-4841-ae08-ffe2366f175f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7a79a72d-e8bc-4283-91a1-cc4e85b0f751"}, {"Element": "<span lang=\"EN-GB\">Day 8</span>", "ID": "df1e2d82-be67-4a1f-bb1d-109aea309d72", "Styles": "None", "Classes": "None", "Text": "Day 8", "ParentId": "42a604e1-75c9-4841-ae08-ffe2366f175f"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">9 to 14</span></p>\n</td>", "ID": "27de55d3-2ef7-4f38-a55c-4de20f3db827", "Styles": "width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "a9d9f4e7-a6af-4ce0-9e01-956791907cac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>", "ID": "debd9b70-022b-4a00-865a-3cf4f590f6cb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "27de55d3-2ef7-4f38-a55c-4de20f3db827"}, {"Element": "<span lang=\"EN-GB\">Days </span>", "ID": "b999e02c-c985-443b-99a7-56adc5776034", "Styles": "None", "Classes": "None", "Text": "Days ", "ParentId": "debd9b70-022b-4a00-865a-3cf4f590f6cb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">9 to 14</span></p>", "ID": "92cf364f-6db2-49b2-a5dc-e7fc6481a016", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "27de55d3-2ef7-4f38-a55c-4de20f3db827"}, {"Element": "<span lang=\"EN-GB\">9 to 14</span>", "ID": "7c30719e-aeb7-4bd2-b8ba-936be03f03c7", "Styles": "None", "Classes": "None", "Text": "9 to 14", "ParentId": "92cf364f-6db2-49b2-a5dc-e7fc6481a016"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 15</span></p>\n</td>", "ID": "b8de9c29-eb7f-47ae-a0b1-ab0d5aa02463", "Styles": "width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a9d9f4e7-a6af-4ce0-9e01-956791907cac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 15</span></p>", "ID": "2cdc7623-ce14-4aa3-86ea-51e4cb963c48", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b8de9c29-eb7f-47ae-a0b1-ab0d5aa02463"}, {"Element": "<span lang=\"EN-GB\">Day 15</span>", "ID": "7da97037-d19c-4bde-84d9-c425f3207dac", "Styles": "None", "Classes": "None", "Text": "Day 15", "ParentId": "2cdc7623-ce14-4aa3-86ea-51e4cb963c48"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">16 to 21</span></p>\n</td>", "ID": "5b7ae49e-deb4-4b81-82d1-372d1ae4efd2", "Styles": "width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "a9d9f4e7-a6af-4ce0-9e01-956791907cac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>", "ID": "21e7cdf1-e80f-4286-b0a1-75c36249dcd4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5b7ae49e-deb4-4b81-82d1-372d1ae4efd2"}, {"Element": "<span lang=\"EN-GB\">Days </span>", "ID": "9496c149-4cee-4a68-8748-08035e910b3b", "Styles": "None", "Classes": "None", "Text": "Days ", "ParentId": "21e7cdf1-e80f-4286-b0a1-75c36249dcd4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">16 to 21</span></p>", "ID": "02010a9d-3a97-4b33-8ca5-20d4311fda0a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5b7ae49e-deb4-4b81-82d1-372d1ae4efd2"}, {"Element": "<span lang=\"EN-GB\">16 to 21</span>", "ID": "c58f55dc-807d-4b25-b013-c5690eb4d6ae", "Styles": "None", "Classes": "None", "Text": "16 to 21", "ParentId": "02010a9d-3a97-4b33-8ca5-20d4311fda0a"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 22</span></p>\n</td>", "ID": "d580eb0f-72a4-48d6-a8c4-8bcbbdabdc5a", "Styles": "width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a9d9f4e7-a6af-4ce0-9e01-956791907cac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 22</span></p>", "ID": "6e2681bc-6c55-4b26-b5ce-2388a559805c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d580eb0f-72a4-48d6-a8c4-8bcbbdabdc5a"}, {"Element": "<span lang=\"EN-GB\">Day 22</span>", "ID": "6d8f3261-3fa5-404e-9e74-d62464c2fef6", "Styles": "None", "Classes": "None", "Text": "Day 22", "ParentId": "6e2681bc-6c55-4b26-b5ce-2388a559805c"}, {"Element": "<td style=\"width:51.9pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days 23 to 28</span></p>\n</td>", "ID": "6a22774d-6067-47e7-92af-850e3eb79cc3", "Styles": "width:51.9pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a9d9f4e7-a6af-4ce0-9e01-956791907cac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days 23 to 28</span></p>", "ID": "91bc6c66-fdb5-4e59-aae3-fd51279b3f48", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6a22774d-6067-47e7-92af-850e3eb79cc3"}, {"Element": "<span lang=\"EN-GB\">Days 23 to 28</span>", "ID": "942c8f5c-4a40-42a7-827a-fb8d5bd232f6", "Styles": "None", "Classes": "None", "Text": "Days 23 to 28", "ParentId": "91bc6c66-fdb5-4e59-aae3-fd51279b3f48"}, {"Element": "<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Ixazomib</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "1c1f131d-aa16-4207-9b43-6d8b2b5ede10", "Styles": "None", "Classes": "None", "Text": "          ", "ParentId": "36d1ade7-6994-46ce-b552-2caf13571b7e"}, {"Element": "<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Ixazomib</span></p>\n</td>", "ID": "a047b682-9da5-477b-a4fc-e270523ca096", "Styles": "width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c1f131d-aa16-4207-9b43-6d8b2b5ede10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Ixazomib</span></p>", "ID": "cb4265b0-a66e-425b-922c-72d13575bd49", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a047b682-9da5-477b-a4fc-e270523ca096"}, {"Element": "<span lang=\"EN-GB\">Ixazomib</span>", "ID": "959e1e62-ab4f-4dba-9c52-66f78be153ab", "Styles": "None", "Classes": "None", "Text": "Ixazomib", "ParentId": "cb4265b0-a66e-425b-922c-72d13575bd49"}, {"Element": "<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "d35b88c7-2eb7-456d-9403-fa90468ace64", "Styles": "width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c1f131d-aa16-4207-9b43-6d8b2b5ede10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "fdf298e0-4cc0-4eb6-8c3c-41dabbd74379", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d35b88c7-2eb7-456d-9403-fa90468ace64"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "43caf08d-809c-4201-9e09-0151037bc416", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "fdf298e0-4cc0-4eb6-8c3c-41dabbd74379"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "8deccfb2-771d-40d4-949b-150d549b2cb5", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c1f131d-aa16-4207-9b43-6d8b2b5ede10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "96516bc4-cf06-4704-8af8-5693aca1c626", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8deccfb2-771d-40d4-949b-150d549b2cb5"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "729d427f-becd-4696-9224-c8d8319b6c3b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "96516bc4-cf06-4704-8af8-5693aca1c626"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "7749f90b-2d37-4ed3-b46f-2d74099c9764", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c1f131d-aa16-4207-9b43-6d8b2b5ede10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "905cdc1f-e122-4988-a9a4-798278ce58d3", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7749f90b-2d37-4ed3-b46f-2d74099c9764"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "de3c6ac5-e9ec-496f-8486-344af7dccf89", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "905cdc1f-e122-4988-a9a4-798278ce58d3"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "57e96fb0-7fc3-4127-bcdd-3e2d773b67d6", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c1f131d-aa16-4207-9b43-6d8b2b5ede10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "265b3756-c251-46ef-ba6c-8dbb28306939", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "57e96fb0-7fc3-4127-bcdd-3e2d773b67d6"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "45f720c7-a063-4a61-8d98-fca7e1706073", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "265b3756-c251-46ef-ba6c-8dbb28306939"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "c9a2b26d-15a5-429b-b439-9004478618ed", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c1f131d-aa16-4207-9b43-6d8b2b5ede10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "a04612e7-6ead-4625-bf00-f03dc3cf2f56", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c9a2b26d-15a5-429b-b439-9004478618ed"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "f1842553-4c22-43e9-b11f-c29440e657ce", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "a04612e7-6ead-4625-bf00-f03dc3cf2f56"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "325bd4ad-98f4-46df-9cfc-549ce80e6528", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c1f131d-aa16-4207-9b43-6d8b2b5ede10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ad2dd432-8e64-4979-bc00-f0a998526c8e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "325bd4ad-98f4-46df-9cfc-549ce80e6528"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "decba742-0100-4c4e-9ce5-78943c12450e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ad2dd432-8e64-4979-bc00-f0a998526c8e"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "ab871b1f-dfb4-4b35-a445-2dfd8682eed0", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c1f131d-aa16-4207-9b43-6d8b2b5ede10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "33946faa-4ba3-4dee-9edf-75f064e1214c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab871b1f-dfb4-4b35-a445-2dfd8682eed0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "58fd4b04-12b7-4c5b-b7e8-077fcd7f1019", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "33946faa-4ba3-4dee-9edf-75f064e1214c"}, {"Element": "<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "7a97869d-3f21-4e50-96d3-a088494b27b7", "Styles": "width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c1f131d-aa16-4207-9b43-6d8b2b5ede10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "05ffc64f-fdeb-4fc5-ad7d-fba655607b3a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7a97869d-3f21-4e50-96d3-a088494b27b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3dbf180b-b4e4-4db8-8a7b-21ed8db1e1b8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "05ffc64f-fdeb-4fc5-ad7d-fba655607b3a"}, {"Element": "<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Lenalidomide</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "16a65c98-1788-4967-9e5f-d9f7f79ef483", "Styles": "None", "Classes": "None", "Text": "          ", "ParentId": "36d1ade7-6994-46ce-b552-2caf13571b7e"}, {"Element": "<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Lenalidomide</span></p>\n</td>", "ID": "01d05411-be26-49b6-a876-21fd1389dc6c", "Styles": "width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "16a65c98-1788-4967-9e5f-d9f7f79ef483"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Lenalidomide</span></p>", "ID": "7d5f89d4-b36e-4da6-80fe-5d7cc545e93b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "01d05411-be26-49b6-a876-21fd1389dc6c"}, {"Element": "<span lang=\"EN-GB\">Lenalidomide</span>", "ID": "b1b70db4-0d3c-4444-a099-fe1924c04cb5", "Styles": "None", "Classes": "None", "Text": "Lenalidomide", "ParentId": "7d5f89d4-b36e-4da6-80fe-5d7cc545e93b"}, {"Element": "<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "394a1603-65d7-4a48-8f59-a8fa3a27d793", "Styles": "width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "16a65c98-1788-4967-9e5f-d9f7f79ef483"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "68874a26-a937-44a1-943d-29844fd2573d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "394a1603-65d7-4a48-8f59-a8fa3a27d793"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "8a9927db-2bfa-4f1e-8a30-b40f56c56968", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "68874a26-a937-44a1-943d-29844fd2573d"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>", "ID": "a4c3cc2c-0a0c-4faf-be74-340164e2e57f", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "16a65c98-1788-4967-9e5f-d9f7f79ef483"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>", "ID": "cbe05902-71f0-4047-9300-85d4476f49f2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a4c3cc2c-0a0c-4faf-be74-340164e2e57f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "81fb0f3d-3621-4c42-9769-0fbad37467a4", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "cbe05902-71f0-4047-9300-85d4476f49f2"}, {"Element": "<span lang=\"EN-GB\">Daily</span>", "ID": "a7c3373f-109b-4345-b9d0-d495b24cbca7", "Styles": "None", "Classes": "None", "Text": "Daily", "ParentId": "cbe05902-71f0-4047-9300-85d4476f49f2"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "9749f59a-39a9-42d8-bd1a-368f942efc63", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "16a65c98-1788-4967-9e5f-d9f7f79ef483"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "e8238826-0bb4-4ce7-8000-5e1b179f5f43", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9749f59a-39a9-42d8-bd1a-368f942efc63"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "b19ea135-2115-4d3d-9dad-67e8e814cb32", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "e8238826-0bb4-4ce7-8000-5e1b179f5f43"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>", "ID": "eed6403c-cca1-4b88-bcc9-60a07482edfe", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "16a65c98-1788-4967-9e5f-d9f7f79ef483"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>", "ID": "656d8424-fef1-4d26-8a43-b83988e1a5c4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eed6403c-cca1-4b88-bcc9-60a07482edfe"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "0d252012-4ec6-4ffd-a07d-20c041ad279a", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "656d8424-fef1-4d26-8a43-b83988e1a5c4"}, {"Element": "<span lang=\"EN-GB\">Daily</span>", "ID": "c77c55ce-eedd-4273-9ecb-6ee0993a05f6", "Styles": "None", "Classes": "None", "Text": "Daily", "ParentId": "656d8424-fef1-4d26-8a43-b83988e1a5c4"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "c21157e6-1ce8-44bb-b5a9-3e6022bfd009", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "16a65c98-1788-4967-9e5f-d9f7f79ef483"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "2f134ad9-09bd-40f5-a245-7c3883c79cdb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c21157e6-1ce8-44bb-b5a9-3e6022bfd009"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "4a1df4e2-be82-4455-8880-64eadfd6c1e3", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "2f134ad9-09bd-40f5-a245-7c3883c79cdb"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>", "ID": "e817fe4b-ea23-4b2e-8dc2-bc8515a99120", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "16a65c98-1788-4967-9e5f-d9f7f79ef483"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>", "ID": "b759aa2d-c062-4d22-bf9e-f69928e41faf", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e817fe4b-ea23-4b2e-8dc2-bc8515a99120"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "926eb45d-f1f6-4bf2-9e41-86937d46f89e", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "b759aa2d-c062-4d22-bf9e-f69928e41faf"}, {"Element": "<span lang=\"EN-GB\">Daily</span>", "ID": "6c6076d1-8b64-4963-bf13-148a742b222e", "Styles": "None", "Classes": "None", "Text": "Daily", "ParentId": "b759aa2d-c062-4d22-bf9e-f69928e41faf"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "d486cca2-8fbf-4c13-815c-e1fd1a6485f9", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "16a65c98-1788-4967-9e5f-d9f7f79ef483"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "070aa77a-3d05-4e67-b33d-c416c619cf44", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d486cca2-8fbf-4c13-815c-e1fd1a6485f9"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c20e421e-17c5-4efc-8b9f-7c93d20c980e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "070aa77a-3d05-4e67-b33d-c416c619cf44"}, {"Element": "<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "0f99b398-3555-4daf-80a6-33c04b3e1a2b", "Styles": "width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "16a65c98-1788-4967-9e5f-d9f7f79ef483"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "14db8cfe-2e33-48fa-8f18-33871c734516", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0f99b398-3555-4daf-80a6-33c04b3e1a2b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0f837ed2-2584-412c-a199-26057c72f745", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "14db8cfe-2e33-48fa-8f18-33871c734516"}, {"Element": "<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Dexamethasone</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "fd93dcf7-1ca3-4c4e-a002-02c28fd9e4e6", "Styles": "None", "Classes": "None", "Text": "          ", "ParentId": "36d1ade7-6994-46ce-b552-2caf13571b7e"}, {"Element": "<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Dexamethasone</span></p>\n</td>", "ID": "81ff853f-5997-4d6a-942e-21db31642a2f", "Styles": "width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fd93dcf7-1ca3-4c4e-a002-02c28fd9e4e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Dexamethasone</span></p>", "ID": "5dd38386-8f98-4af2-a4a9-23c15dc0f3c4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81ff853f-5997-4d6a-942e-21db31642a2f"}, {"Element": "<span lang=\"EN-GB\">Dexamethasone</span>", "ID": "9caeaa1e-d7ef-43fe-96ee-c80c68455b64", "Styles": "None", "Classes": "None", "Text": "Dexamethasone", "ParentId": "5dd38386-8f98-4af2-a4a9-23c15dc0f3c4"}, {"Element": "<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "81b6f140-0a66-483b-968c-7a74b5fabde3", "Styles": "width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fd93dcf7-1ca3-4c4e-a002-02c28fd9e4e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "f9ca3e6c-75fa-45fc-ae8f-2c454f705136", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81b6f140-0a66-483b-968c-7a74b5fabde3"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "854ae6cf-1e33-4142-9b1f-9027f56cd6a2", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "f9ca3e6c-75fa-45fc-ae8f-2c454f705136"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "62f8d697-f711-4551-9d56-a4127157f6b6", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fd93dcf7-1ca3-4c4e-a002-02c28fd9e4e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "50c68c4d-edf6-488e-8a6f-ab100f0292a9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "62f8d697-f711-4551-9d56-a4127157f6b6"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "abe1e37e-d02a-498a-97f5-2d0fb6886174", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "50c68c4d-edf6-488e-8a6f-ab100f0292a9"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "33675094-59cb-4336-bef5-1e2e31bd2d74", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fd93dcf7-1ca3-4c4e-a002-02c28fd9e4e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "4541dfdb-e03d-49e4-b560-068e2d4597be", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "33675094-59cb-4336-bef5-1e2e31bd2d74"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "ba163745-bbcb-4914-81ea-3cdbca25963d", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "4541dfdb-e03d-49e4-b560-068e2d4597be"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "1fb6fa0e-8665-4148-aed2-64018ac0c648", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fd93dcf7-1ca3-4c4e-a002-02c28fd9e4e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3405ac82-e35b-49cf-a830-4fda076ef0c8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1fb6fa0e-8665-4148-aed2-64018ac0c648"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "17fc5bf8-b313-4911-b4fa-c6c55050311e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3405ac82-e35b-49cf-a830-4fda076ef0c8"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "596bd087-0d18-4731-a1cf-725ae6b88b01", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fd93dcf7-1ca3-4c4e-a002-02c28fd9e4e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "527666d1-804a-48c8-965d-c8d15b1d1d88", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "596bd087-0d18-4731-a1cf-725ae6b88b01"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "27d8e755-f4ae-4d13-be6b-113284007bfa", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "527666d1-804a-48c8-965d-c8d15b1d1d88"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "de24a29e-1a64-465f-bc22-1be33ba5625e", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fd93dcf7-1ca3-4c4e-a002-02c28fd9e4e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ffc6330f-02e9-4438-a156-3d7259790af1", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "de24a29e-1a64-465f-bc22-1be33ba5625e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f2b21d13-58a6-422f-84f4-705f4ed4f2f2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ffc6330f-02e9-4438-a156-3d7259790af1"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "4260fd3c-93dc-4bcd-9961-bb77ebd69111", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fd93dcf7-1ca3-4c4e-a002-02c28fd9e4e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "34cbe0a5-29da-422b-90fc-a4d52f22a772", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4260fd3c-93dc-4bcd-9961-bb77ebd69111"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "19f6ece6-4406-40af-8f8e-c8c68a69dc2a", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "34cbe0a5-29da-422b-90fc-a4d52f22a772"}, {"Element": "<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "4cf38fdc-c19c-429d-8693-5847d1f0333e", "Styles": "width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "fd93dcf7-1ca3-4c4e-a002-02c28fd9e4e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e63d2e4f-c501-4746-9b27-298f1accd77b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4cf38fdc-c19c-429d-8693-5847d1f0333e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e6b5449a-8444-48e6-84af-095c42abe3a2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e63d2e4f-c501-4746-9b27-298f1accd77b"}, {"Element": "<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:Webdings\">a</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">=\u00a0intake of medicinal product</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "a8a2e0f0-aa8c-4a46-b054-04adfd87ca42", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "36d1ade7-6994-46ce-b552-2caf13571b7e"}, {"Element": "<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:Webdings\">a</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">=\u00a0intake of medicinal product</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "1bc8aaa6-75a0-4cb1-913d-46d38d0de767", "Styles": "width:466.1pt;border:none;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "a8a2e0f0-aa8c-4a46-b054-04adfd87ca42"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:Webdings\">a</span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">=\u00a0intake of medicinal product</span></p>", "ID": "1d0cc1b5-a388-496a-a63b-484b2635a7ec", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1bc8aaa6-75a0-4cb1-913d-46d38d0de767"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt;font-family:Webdings\">a</span>", "ID": "a46f3184-99ba-4e4f-bc97-5854d93e8593", "Styles": "font-size:10.0pt;font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "1d0cc1b5-a388-496a-a63b-484b2635a7ec"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">=\u00a0intake of medicinal product</span>", "ID": "07934c59-7d79-4033-8576-d1acd2610440", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "=\u00a0intake of medicinal product", "ParentId": "1d0cc1b5-a388-496a-a63b-484b2635a7ec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a09a648b-7a87-4968-b1d8-2ef320402b0d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1bc8aaa6-75a0-4cb1-913d-46d38d0de767"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "55e09b26-0a0d-427f-a5c1-a39a5e66ad35", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a09a648b-7a87-4968-b1d8-2ef320402b0d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">For additional information regarding lenalidomide </span><span lang=\"EN-GB\">and dexamethasone, refer to the Summary of Product Characteristics\n(SmPC) for these medicinal products.</span></p>", "ID": "faed5320-7bd2-4f97-be1c-61c8a1c8e1cc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">For additional information regarding lenalidomide </span>", "ID": "a4be866c-067a-4084-86f9-f6357faf2bbc", "Styles": "color:black", "Classes": "None", "Text": "For additional information regarding lenalidomide ", "ParentId": "faed5320-7bd2-4f97-be1c-61c8a1c8e1cc"}, {"Element": "<span lang=\"EN-GB\">and dexamethasone, refer to the Summary of Product Characteristics\n(SmPC) for these medicinal products.</span>", "ID": "d57ca6c8-5511-465f-9673-d2d343c5ceea", "Styles": "None", "Classes": "None", "Text": "and dexamethasone, refer to the Summary of Product Characteristics (SmPC) for these medicinal products.", "ParentId": "faed5320-7bd2-4f97-be1c-61c8a1c8e1cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "513b11ac-23e4-45cb-85d9-d504d1e005a3", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92028161-8441-4284-a26e-3d526b2858cf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "513b11ac-23e4-45cb-85d9-d504d1e005a3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\">Prior to initiating a new cycle\nof therapy:</span></p>", "ID": "5834fbd5-d68b-4629-80f4-3b0aa5991fca", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Prior to initiating a new cycle\nof therapy:</span>", "ID": "09161248-41fa-4cf0-b3c2-a17c92b556c3", "Styles": "None", "Classes": "None", "Text": "Prior to initiating a new cycle of therapy:", "ParentId": "5834fbd5-d68b-4629-80f4-3b0aa5991fca"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"IT\" style=\"font-family:Symbol\">\u00b7</span><span lang=\"IT\"> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Absolute\nneutrophil count should be \u2265\u00a01,000/mm<sup>3</sup></span></p>", "ID": "d01768e3-8d00-47ed-a9c3-2d63a28a7472", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"IT\" style=\"font-family:Symbol\">\u00b7</span>", "ID": "b7f3e741-4f0b-452e-a6c2-48c9b6aa86ca", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "d01768e3-8d00-47ed-a9c3-2d63a28a7472"}, {"Element": "<span lang=\"IT\"> \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Absolute\nneutrophil count should be \u2265\u00a01,000/mm<sup>3</sup></span>", "ID": "2f71ff6d-1728-4fe2-9d48-7d9d0f8eab02", "Styles": "None", "Classes": "None", "Text": " \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Absolute neutrophil count should be \u2265\u00a01,000/mm", "ParentId": "d01768e3-8d00-47ed-a9c3-2d63a28a7472"}, {"Element": "<sup>3</sup>", "ID": "a66ad0c4-a0d9-4406-835d-b9800c6e7974", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "2f71ff6d-1728-4fe2-9d48-7d9d0f8eab02"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"IT\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"IT\">Platelet count should be \u2265\u00a075,000/mm<sup>3</sup></span></p>", "ID": "8df3901b-93af-46aa-9db6-17dda387e0c9", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"IT\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "85c7926a-81c3-42a2-9d01-318f8cc8c626", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "8df3901b-93af-46aa-9db6-17dda387e0c9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ca550035-4531-4aa9-af60-b0a5f0f8a95b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "85c7926a-81c3-42a2-9d01-318f8cc8c626"}, {"Element": "<span lang=\"IT\">Platelet count should be \u2265\u00a075,000/mm<sup>3</sup></span>", "ID": "5f3ef68d-796a-461f-a137-5891ff864c5a", "Styles": "None", "Classes": "None", "Text": "Platelet count should be \u2265\u00a075,000/mm", "ParentId": "8df3901b-93af-46aa-9db6-17dda387e0c9"}, {"Element": "<sup>3</sup>", "ID": "051b6bbc-7b3e-4664-91bc-6f2a13d96cb0", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "5f3ef68d-796a-461f-a137-5891ff864c5a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"IT\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"IT\">Non\u2011haematologic toxicities should, at the\nphysician\u2019s discretion, generally be recovered to patient\u2019s\nbaseline condition or \u2264\u00a0Grade\u00a01</span></p>", "ID": "78e07aa2-8949-4a27-b6da-b9a8129054ae", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"IT\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e9151111-6dc1-4bca-98d5-e3efd569f004", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "78e07aa2-8949-4a27-b6da-b9a8129054ae"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a4069ee9-04ed-4402-a24d-bd04eb3c4b33", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e9151111-6dc1-4bca-98d5-e3efd569f004"}, {"Element": "<span lang=\"IT\">Non\u2011haematologic toxicities should, at the\nphysician\u2019s discretion, generally be recovered to patient\u2019s\nbaseline condition or \u2264\u00a0Grade\u00a01</span>", "ID": "e218254c-8f68-4ab8-992a-b6b233d652fe", "Styles": "None", "Classes": "None", "Text": "Non\u2011haematologic toxicities should, at the physician\u2019s discretion, generally be recovered to patient\u2019s baseline condition or \u2264\u00a0Grade\u00a01", "ParentId": "78e07aa2-8949-4a27-b6da-b9a8129054ae"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>", "ID": "ca31c223-2323-447b-beb2-729778c24e6e", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span>", "ID": "de2e9d02-7189-4525-b1f5-50c95d74b73f", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "ca31c223-2323-447b-beb2-729778c24e6e"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Treatment\nshould be continued until disease progression or unacceptable toxicity.</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\"> </span><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">Treatment with ixazomib in combination with\nlenalidomide and dexamethasone for longer than 24\u00a0cycles should be based\non an individual benefit risk assessment, as the data on the tolerability and\ntoxicity beyond 24\u00a0cycles are limited (see section\u00a05.1).</span></p>", "ID": "f919ba13-ebcf-420c-ba09-010e5c4f3e05", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Treatment\nshould be continued until disease progression or unacceptable toxicity.</span>", "ID": "801730e2-beb1-4026-9ca5-16b925844675", "Styles": "font-size:11.0pt;font-weight:normal", "Classes": "None", "Text": "Treatment should be continued until disease progression or unacceptable toxicity.", "ParentId": "f919ba13-ebcf-420c-ba09-010e5c4f3e05"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\"> </span>", "ID": "84e5eed1-9cb0-4691-8e8e-1b3ca394a454", "Styles": "font-size:11.0pt", "Classes": "None", "Text": " ", "ParentId": "f919ba13-ebcf-420c-ba09-010e5c4f3e05"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">Treatment with ixazomib in combination with\nlenalidomide and dexamethasone for longer than 24\u00a0cycles should be based\non an individual benefit risk assessment, as the data on the tolerability and\ntoxicity beyond 24\u00a0cycles are limited (see section\u00a05.1).</span>", "ID": "ac3d4008-4f15-4fef-a4b7-b7c2897f893e", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "Treatment with ixazomib in combination with lenalidomide and dexamethasone for longer than 24\u00a0cycles should be based on an individual benefit risk assessment, as the data on the tolerability and toxicity beyond 24\u00a0cycles are limited (see section\u00a05.1).", "ParentId": "f919ba13-ebcf-420c-ba09-010e5c4f3e05"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span></p>", "ID": "c7d78227-f8ed-494f-8ecd-1b628ebd22e1", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span>", "ID": "8c3f8a33-5f1b-4b66-9526-bf7f5df8bf61", "Styles": "font-size:11.0pt;font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "c7d78227-f8ed-494f-8ecd-1b628ebd22e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Delayed or missed doses </span></u></i></p>", "ID": "c6ddf166-c60d-49d3-854b-51b0987572f1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Delayed or missed doses </span></u></i>", "ID": "65cf3379-fceb-4a95-adeb-5d0d0cc2d274", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c6ddf166-c60d-49d3-854b-51b0987572f1"}, {"Element": "<u><span lang=\"EN-GB\">Delayed or missed doses </span></u>", "ID": "fdbceb11-0719-4239-8e09-810e6fa6ad01", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65cf3379-fceb-4a95-adeb-5d0d0cc2d274"}, {"Element": "<span lang=\"EN-GB\">Delayed or missed doses </span>", "ID": "bf2b7772-2a30-4b34-8385-277c73afab2b", "Styles": "None", "Classes": "None", "Text": "Delayed or missed doses ", "ParentId": "fdbceb11-0719-4239-8e09-810e6fa6ad01"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "9094379c-41ba-46ef-8cc6-f5c8d4dde201", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "278ca1c7-bcb1-484a-bda8-8d3bcd88f193", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9094379c-41ba-46ef-8cc6-f5c8d4dde201"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "532fd683-0ef8-4e47-9c3b-e6f59ca274ab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "278ca1c7-bcb1-484a-bda8-8d3bcd88f193"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">In the event that a ixazomib dose is delayed or missed, the dose\nshould be taken only if the next scheduled dose is \u2265\u00a072 hours away. </span><span lang=\"EN-GB\">A missed dose should not be taken within 72 hours of the next\nscheduled dose. A double dose should not be taken to make up for a missed dose.\n</span></p>", "ID": "da376cea-82b5-4da1-a196-b8d99c54d36c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">In the event that a ixazomib dose is delayed or missed, the dose\nshould be taken only if the next scheduled dose is \u2265\u00a072 hours away. </span>", "ID": "ba922f9a-487f-45df-9fa4-b36cf089dcac", "Styles": "None", "Classes": "None", "Text": "In the event that a ixazomib dose is delayed or missed, the dose should be taken only if the next scheduled dose is \u2265\u00a072 hours away. ", "ParentId": "da376cea-82b5-4da1-a196-b8d99c54d36c"}, {"Element": "<span lang=\"EN-GB\">A missed dose should not be taken within 72 hours of the next\nscheduled dose. A double dose should not be taken to make up for a missed dose.\n</span>", "ID": "bbb250da-2f3d-48e7-b992-2ca1f9eb6102", "Styles": "None", "Classes": "None", "Text": "A missed dose should not be taken within 72 hours of the next scheduled dose. A double dose should not be taken to make up for a missed dose. ", "ParentId": "da376cea-82b5-4da1-a196-b8d99c54d36c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "28615c05-2980-4395-9f73-55f040e08fcf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "813f3435-a965-4ffb-b2f3-e9c971a6d3a4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "28615c05-2980-4395-9f73-55f040e08fcf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If a patient\nvomits after taking a dose, the patient should not repeat the dose but should\nresume dosing at the time of the next scheduled dose.</span></p>", "ID": "0fe19cc4-52c1-476b-84af-e27875df4c05", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">If a patient\nvomits after taking a dose, the patient should not repeat the dose but should\nresume dosing at the time of the next scheduled dose.</span>", "ID": "9809facb-c657-4961-b87e-6ef6ae1dea3f", "Styles": "None", "Classes": "None", "Text": "If a patient vomits after taking a dose, the patient should not repeat the dose but should resume dosing at the time of the next scheduled dose.", "ParentId": "0fe19cc4-52c1-476b-84af-e27875df4c05"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6489418b-ad28-4d30-af8a-d2df8041e650", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "05b4a5dd-766e-4168-9156-aaff61bbd757", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6489418b-ad28-4d30-af8a-d2df8041e650"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Dose modifications</span></u></i></p>", "ID": "ebcc460c-0c79-4db7-ad9f-b3ef9ba76f22", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Dose modifications</span></u></i>", "ID": "4ff806be-8c13-48a0-978f-90cb353cdf6a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ebcc460c-0c79-4db7-ad9f-b3ef9ba76f22"}, {"Element": "<u><span lang=\"EN-GB\">Dose modifications</span></u>", "ID": "2b086414-31b6-42c4-937e-4c9786df599f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4ff806be-8c13-48a0-978f-90cb353cdf6a"}, {"Element": "<span lang=\"EN-GB\">Dose modifications</span>", "ID": "53f8d616-ae0d-4b2d-855f-4a61a65ac347", "Styles": "None", "Classes": "None", "Text": "Dose modifications", "ParentId": "2b086414-31b6-42c4-937e-4c9786df599f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "18a36e0c-2774-4a0c-933d-31bd2b9b7bb3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "11bebf23-da9b-4fa2-9d8a-eca46cd7ff83", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "18a36e0c-2774-4a0c-933d-31bd2b9b7bb3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7a6541bb-683a-4fd8-9d25-f6359e74be57", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "11bebf23-da9b-4fa2-9d8a-eca46cd7ff83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The ixazomib\ndose reduction steps are presented in Table 1 and the dose modification\nguidelines are provided in </span><span lang=\"EN-GB\">Table 2. <br/>\n<br/>\n</span></p>", "ID": "2811e2c4-bd8c-406f-8801-a0db1780bab5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The ixazomib\ndose reduction steps are presented in Table 1 and the dose modification\nguidelines are provided in </span>", "ID": "89d6721e-37c0-4053-a4cf-a49bb68a357a", "Styles": "None", "Classes": "None", "Text": "The ixazomib dose reduction steps are presented in Table 1 and the dose modification guidelines are provided in ", "ParentId": "2811e2c4-bd8c-406f-8801-a0db1780bab5"}, {"Element": "<span lang=\"EN-GB\">Table 2. <br/>\n<br/>\n</span>", "ID": "88fdb34a-c10d-427f-bd9f-028b2ae4ee66", "Styles": "None", "Classes": "None", "Text": "Table 2.   ", "ParentId": "2811e2c4-bd8c-406f-8801-a0db1780bab5"}, {"Element": "<br/>", "ID": "f61ecc99-bf1f-4e61-9f0e-8346ff2501b4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "88fdb34a-c10d-427f-bd9f-028b2ae4ee66"}, {"Element": "<br/>", "ID": "406fb575-35b7-46c6-b1b0-066c9e86a201", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "88fdb34a-c10d-427f-bd9f-028b2ae4ee66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"Table1\"><b><span lang=\"EN-GB\" style=\"position:relative;top:.5pt\">Table 1</span></b></a><b><span lang=\"EN-GB\" style=\"position:relative;top:.5pt\">: Ixazomib dose reduction steps</span></b></p>", "ID": "0272f63b-1c6a-4eea-aa60-5cf9b0f60cc8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<a name=\"Table1\"><b><span lang=\"EN-GB\" style=\"position:relative;top:.5pt\">Table 1</span></b></a>", "ID": "57f53153-382d-4d0b-a51e-9fb74fc19dff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0272f63b-1c6a-4eea-aa60-5cf9b0f60cc8"}, {"Element": "<b><span lang=\"EN-GB\" style=\"position:relative;top:.5pt\">Table 1</span></b>", "ID": "2d2232a1-c55c-4691-920a-6dc79b74e7ae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "57f53153-382d-4d0b-a51e-9fb74fc19dff"}, {"Element": "<span lang=\"EN-GB\" style=\"position:relative;top:.5pt\">Table 1</span>", "ID": "2ae999e8-3a65-415c-bf52-5665531ea51a", "Styles": "position:relative;top:.5pt", "Classes": "None", "Text": "Table 1", "ParentId": "2d2232a1-c55c-4691-920a-6dc79b74e7ae"}, {"Element": "<b><span lang=\"EN-GB\" style=\"position:relative;top:.5pt\">: Ixazomib dose reduction steps</span></b>", "ID": "b84e43f4-c5df-434a-94a4-d07272c23e52", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0272f63b-1c6a-4eea-aa60-5cf9b0f60cc8"}, {"Element": "<span lang=\"EN-GB\" style=\"position:relative;top:.5pt\">: Ixazomib dose reduction steps</span>", "ID": "1ef6f6dc-3967-46a8-a5c7-a0bf7b5a1510", "Styles": "position:relative;top:.5pt", "Classes": "None", "Text": ": Ixazomib dose reduction steps", "ParentId": "b84e43f4-c5df-434a-94a4-d07272c23e52"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:459.0pt;margin-left:5.4pt;border-collapse:collapse;border:none\" width=\"612\">\n<tr>\n<td style=\"width:145.05pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"193\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Recommended starting dose* </span></p>\n</td>\n<td style=\"width:116.35pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">First reduction to</span></p>\n</td>\n<td style=\"width:108.7pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"145\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Second reduction to</span></p>\n</td>\n<td rowspan=\"2\" style=\"width:88.9pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" width=\"119\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Discontinue</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:145.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"193\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">4\u00a0mg</span></p>\n</td>\n<td style=\"width:116.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">3\u00a0mg</span></p>\n</td>\n<td style=\"width:108.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"145\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.3\u00a0mg</span></p>\n</td>\n</tr>\n</table>", "ID": "3c1403f8-137d-40d2-8994-69137b5ed3db", "Styles": "width:459.0pt;margin-left:5.4pt;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "   ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<tr>\n<td style=\"width:145.05pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"193\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Recommended starting dose* </span></p>\n</td>\n<td style=\"width:116.35pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">First reduction to</span></p>\n</td>\n<td style=\"width:108.7pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"145\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Second reduction to</span></p>\n</td>\n<td rowspan=\"2\" style=\"width:88.9pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" width=\"119\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Discontinue</span></p>\n</td>\n</tr>", "ID": "ac97f1fa-3a01-4d84-b1bc-0cbc239698c2", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "3c1403f8-137d-40d2-8994-69137b5ed3db"}, {"Element": "<td style=\"width:145.05pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"193\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Recommended starting dose* </span></p>\n</td>", "ID": "0d5135c4-06ac-453a-9112-3b529aefc61e", "Styles": "width:145.05pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ac97f1fa-3a01-4d84-b1bc-0cbc239698c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Recommended starting dose* </span></p>", "ID": "b1355b9f-4b3a-4fa0-b8ac-cd215f5ca89a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0d5135c4-06ac-453a-9112-3b529aefc61e"}, {"Element": "<span lang=\"EN-GB\">Recommended starting dose* </span>", "ID": "b40b164e-f5a4-45c2-ac4e-3483ff294a94", "Styles": "None", "Classes": "None", "Text": "Recommended starting dose* ", "ParentId": "b1355b9f-4b3a-4fa0-b8ac-cd215f5ca89a"}, {"Element": "<td style=\"width:116.35pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">First reduction to</span></p>\n</td>", "ID": "68d21cf2-efc2-452a-ab6c-c06416394869", "Styles": "width:116.35pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ac97f1fa-3a01-4d84-b1bc-0cbc239698c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">First reduction to</span></p>", "ID": "0fabaeb8-cffd-4f27-8ef2-efb6996b2a32", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "68d21cf2-efc2-452a-ab6c-c06416394869"}, {"Element": "<span lang=\"EN-GB\">First reduction to</span>", "ID": "87bd5e73-d6e5-4f2d-bf30-8ff878bce768", "Styles": "None", "Classes": "None", "Text": "First reduction to", "ParentId": "0fabaeb8-cffd-4f27-8ef2-efb6996b2a32"}, {"Element": "<td style=\"width:108.7pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"145\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Second reduction to</span></p>\n</td>", "ID": "27bc3f54-cf00-4381-8bb3-fa914a7d1d00", "Styles": "width:108.7pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ac97f1fa-3a01-4d84-b1bc-0cbc239698c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Second reduction to</span></p>", "ID": "0a3f86d4-89d9-4535-81a0-73bcd0aa8ce4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "27bc3f54-cf00-4381-8bb3-fa914a7d1d00"}, {"Element": "<span lang=\"EN-GB\">Second reduction to</span>", "ID": "b99bb155-5fb1-4629-9fc3-12c64bdf72f4", "Styles": "None", "Classes": "None", "Text": "Second reduction to", "ParentId": "0a3f86d4-89d9-4535-81a0-73bcd0aa8ce4"}, {"Element": "<td rowspan=\"2\" style=\"width:88.9pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" width=\"119\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Discontinue</span></p>\n</td>", "ID": "2260fb62-e572-45d9-86ec-9b4b10bb8421", "Styles": "width:88.9pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ac97f1fa-3a01-4d84-b1bc-0cbc239698c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Discontinue</span></p>", "ID": "b6b49ba5-9ec0-4faf-8f1c-0f5dbb8de04e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2260fb62-e572-45d9-86ec-9b4b10bb8421"}, {"Element": "<span lang=\"EN-GB\">Discontinue</span>", "ID": "ca846b2e-78a9-407d-84ee-331e83f994b1", "Styles": "None", "Classes": "None", "Text": "Discontinue", "ParentId": "b6b49ba5-9ec0-4faf-8f1c-0f5dbb8de04e"}, {"Element": "<tr>\n<td style=\"width:145.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"193\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">4\u00a0mg</span></p>\n</td>\n<td style=\"width:116.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">3\u00a0mg</span></p>\n</td>\n<td style=\"width:108.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"145\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.3\u00a0mg</span></p>\n</td>\n</tr>", "ID": "6b6c8e93-0366-4c70-8681-4f25e208e987", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "3c1403f8-137d-40d2-8994-69137b5ed3db"}, {"Element": "<td style=\"width:145.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"193\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">4\u00a0mg</span></p>\n</td>", "ID": "4c2d27d6-308a-4075-bdbc-1eb80ea8e134", "Styles": "width:145.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "6b6c8e93-0366-4c70-8681-4f25e208e987"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">4\u00a0mg</span></p>", "ID": "d01a1f3b-3604-47a7-9162-18c1ab89b2d8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4c2d27d6-308a-4075-bdbc-1eb80ea8e134"}, {"Element": "<span lang=\"EN-GB\">4\u00a0mg</span>", "ID": "96a72573-ef9b-4a02-b47c-c0c5992f1d1b", "Styles": "None", "Classes": "None", "Text": "4\u00a0mg", "ParentId": "d01a1f3b-3604-47a7-9162-18c1ab89b2d8"}, {"Element": "<td style=\"width:116.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"155\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">3\u00a0mg</span></p>\n</td>", "ID": "4e9324e5-f163-4d1a-9155-47bdf3ab36ef", "Styles": "width:116.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "6b6c8e93-0366-4c70-8681-4f25e208e987"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">3\u00a0mg</span></p>", "ID": "6dac5dcb-8fca-4cce-8198-7dc1825db648", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4e9324e5-f163-4d1a-9155-47bdf3ab36ef"}, {"Element": "<span lang=\"EN-GB\">3\u00a0mg</span>", "ID": "2fea3123-7ba0-49ed-8e3c-a7808871e4cb", "Styles": "None", "Classes": "None", "Text": "3\u00a0mg", "ParentId": "6dac5dcb-8fca-4cce-8198-7dc1825db648"}, {"Element": "<td style=\"width:108.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"145\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.3\u00a0mg</span></p>\n</td>", "ID": "26d53111-98e3-4d93-b902-46ec677a360f", "Styles": "width:108.7pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "6b6c8e93-0366-4c70-8681-4f25e208e987"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">2.3\u00a0mg</span></p>", "ID": "8cd1fe30-7c8a-4cd8-971c-4e22ced0dda0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "26d53111-98e3-4d93-b902-46ec677a360f"}, {"Element": "<span lang=\"EN-GB\">2.3\u00a0mg</span>", "ID": "71ac4eda-b7a9-478e-90c4-f2c4faf7fa31", "Styles": "None", "Classes": "None", "Text": "2.3\u00a0mg", "ParentId": "8cd1fe30-7c8a-4cd8-971c-4e22ced0dda0"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:11.5pt;text-indent:-.1in;line-height:\nnormal;page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">*Recommended\nreduced dose of 3\u00a0mg in the presence of moderate or severe hepatic\nimpairment, severe renal impairment or end\u2011stage renal disease (ESRD)\nrequiring dialysis.</span></p>", "ID": "8d9ff26f-e068-41e3-bdb1-a3e2611e8491", "Styles": "margin-left:11.5pt;text-indent:-.1in;line-height:\nnormal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">*Recommended\nreduced dose of 3\u00a0mg in the presence of moderate or severe hepatic\nimpairment, severe renal impairment or end\u2011stage renal disease (ESRD)\nrequiring dialysis.</span>", "ID": "c9cbe2ad-ba10-4f00-8639-5e8714e5d147", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "*Recommended reduced dose of 3\u00a0mg in the presence of moderate or severe hepatic impairment, severe renal impairment or end\u2011stage renal disease (ESRD) requiring dialysis.", "ParentId": "8d9ff26f-e068-41e3-bdb1-a3e2611e8491"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ca043992-964b-4e6e-adcc-dfbef8f91334", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d340c3a1-8297-4b07-9a1b-7e859f135cb7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ca043992-964b-4e6e-adcc-dfbef8f91334"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">An alternating dose modification approach is recommended for ixazomib\nand lenalidomide for overlapping toxicities of thrombocytopenia, neutropenia\nand rash. For these toxicities, the first dose modification step is to\nwithhold/reduce lenalidomide. </span><span lang=\"EN-GB\">Refer to the lenalidomide\nSmPC, section\u00a04.2 for the dose reduction steps for these toxicities.</span></p>", "ID": "914265c9-6f5a-4eab-86bd-c05275b20e5e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">An alternating dose modification approach is recommended for ixazomib\nand lenalidomide for overlapping toxicities of thrombocytopenia, neutropenia\nand rash. For these toxicities, the first dose modification step is to\nwithhold/reduce lenalidomide. </span>", "ID": "b274539e-9d29-4c2a-9570-a7a28eb4faf6", "Styles": "None", "Classes": "None", "Text": "An alternating dose modification approach is recommended for ixazomib and lenalidomide for overlapping toxicities of thrombocytopenia, neutropenia and rash. For these toxicities, the first dose modification step is to withhold/reduce lenalidomide. ", "ParentId": "914265c9-6f5a-4eab-86bd-c05275b20e5e"}, {"Element": "<span lang=\"EN-GB\">Refer to the lenalidomide\nSmPC, section\u00a04.2 for the dose reduction steps for these toxicities.</span>", "ID": "f6946d61-9193-4a85-be28-537cf33438b2", "Styles": "None", "Classes": "None", "Text": "Refer to the lenalidomide SmPC, section\u00a04.2 for the dose reduction steps for these toxicities.", "ParentId": "914265c9-6f5a-4eab-86bd-c05275b20e5e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "84af2e54-9c9e-4e53-be42-f804ec38d62a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e821116d-3353-48db-ad5e-bfb0c1338987", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "84af2e54-9c9e-4e53-be42-f804ec38d62a"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:461.3pt;margin-left:7.6pt;border-collapse:collapse;border:none\" width=\"615\">\n<thead>\n<tr style=\"height:15.7pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:none;\n   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:\n   15.7pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"Table2\"><b><span lang=\"EN-GB\">Table 2</span></b></a><b><span lang=\"EN-GB\">:\n   Dose modifications guidelines for ixazomib in combination with lenalidomide\n   and dexamethasone </span></b></p>\n</td>\n</tr>\n</thead>\n<tr style=\"height:15.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Haematological toxicities</span></b></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin:0in;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended\n  actions</span></b></p>\n</td>\n</tr>\n<tr style=\"height:15.8pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.8pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Thrombocytopenia (platelet count)</span></b></p>\n</td>\n</tr>\n<tr style=\"height:31.95pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:31.95pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Platelet count\n  <span style=\"position:relative;top:.5pt\">&lt;\u00a0<span style=\"letter-spacing:\n  .05pt\">30</span>,000/m<span style=\"letter-spacing:-.05pt\">m<sup>3</sup></span></span></span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:31.95pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC\n  and resume ixazomib at its most recent dose. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  platelet count falls to &lt;\u00a030,000/mm<sup>3</sup> again, withhold ixazomib\n  and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>\n</tr>\n<tr style=\"height:15.7pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Neutropenia\n  (absolute neutrophil count)</span></b></p>\n</td>\n</tr>\n<tr style=\"height:15.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"letter-spacing:.05pt\">Absolute neutrophil count</span><span lang=\"EN-GB\"> <span style=\"position:relative;top:.5pt\">&lt;\u00a0</span>500/mm<sup>3</sup></span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until absolute neutrophil count is \u2265\u00a0500/mm<sup>3</sup>.\n  Consider adding G\u2011CSF as per clinical guidelines.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its\n  prescribing information and resume ixazomib at its most recent dose. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  absolute neutrophil count falls to &lt;\u00a0500/mm<sup>3</sup> again,\n  withhold ixazomib and lenalidomide until absolute neutrophil count is \u2265\n  500/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>\n</tr>\n<tr style=\"height:15.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Non\u2011haematological\n  toxicities</span></b></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended actions</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rash</span></b></p>\n</td>\n</tr>\n<tr style=\"height:31.75pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:31.75pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade<sup>\u2020</sup>\n  2 or 3</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:31.75pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  lenalidomide until rash recovers to \u2264\u00a0Grade\u00a01.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  Grade 2 or 3 rash occurs again, withhold ixazomib and lenalidomide until rash\n  recovers to \u2264\u00a0Grade\u00a01.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>\n</tr>\n<tr style=\"height:17.05pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade 4</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Peripheral neuropathy</span></b></p>\n</td>\n</tr>\n<tr style=\"height:36.8pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:36.8pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Grade 1 peripheral neuropathy with pain or Grade 2 peripheral neuropathy</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:36.8pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib until peripheral neuropathy recovers to \u2264\u00a0Grade\u00a01\n  without pain or patient's baseline.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at its most recent dose.</span></p>\n</td>\n</tr>\n<tr style=\"height:36.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:36.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Grade 2 peripheral neuropathy with pain or Grade 3 peripheral neuropathy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:36.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or \u2264\u00a0Grade\u00a01\n  prior to resuming ixazomib.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose.</span></p>\n</td>\n</tr>\n<tr style=\"height:17.05pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade 4 peripheral\n  neuropathy</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span></p>\n</td>\n</tr>\n<tr style=\"height:17.05pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other non\u2011haematological toxicities</span></b></p>\n</td>\n</tr>\n<tr style=\"height:17.05pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Other Grade 3 or 4 non\u2011haematological toxicities</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or at most\u00a0Grade 1 prior\n  to resuming ixazomib.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  attributable to ixazomib, resume ixazomib at the next lower dose following\n  recovery.</span></p>\n</td>\n</tr>\n</table>", "ID": "d4180105-6074-4bbc-836e-d75adf6b2976", "Styles": "width:461.3pt;margin-left:7.6pt;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "                 ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<thead>\n<tr style=\"height:15.7pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:none;\n   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:\n   15.7pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"Table2\"><b><span lang=\"EN-GB\">Table 2</span></b></a><b><span lang=\"EN-GB\">:\n   Dose modifications guidelines for ixazomib in combination with lenalidomide\n   and dexamethasone </span></b></p>\n</td>\n</tr>\n</thead>", "ID": "2e262186-ed90-49c3-9bb1-f3678103b34d", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<tr style=\"height:15.7pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:none;\n   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:\n   15.7pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"Table2\"><b><span lang=\"EN-GB\">Table 2</span></b></a><b><span lang=\"EN-GB\">:\n   Dose modifications guidelines for ixazomib in combination with lenalidomide\n   and dexamethasone </span></b></p>\n</td>\n</tr>", "ID": "60c28965-7042-4621-872d-d1b882f3be75", "Styles": "height:15.7pt", "Classes": "None", "Text": "  ", "ParentId": "2e262186-ed90-49c3-9bb1-f3678103b34d"}, {"Element": "<td colspan=\"2\" style=\"width:461.3pt;border:none;\n   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:\n   15.7pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"Table2\"><b><span lang=\"EN-GB\">Table 2</span></b></a><b><span lang=\"EN-GB\">:\n   Dose modifications guidelines for ixazomib in combination with lenalidomide\n   and dexamethasone </span></b></p>\n</td>", "ID": "bca88daf-cd13-4baf-b1e2-b859f1107696", "Styles": "width:461.3pt;border:none;\n   border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt;height:\n   15.7pt", "Classes": "None", "Text": "  ", "ParentId": "60c28965-7042-4621-872d-d1b882f3be75"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"Table2\"><b><span lang=\"EN-GB\">Table 2</span></b></a><b><span lang=\"EN-GB\">:\n   Dose modifications guidelines for ixazomib in combination with lenalidomide\n   and dexamethasone </span></b></p>", "ID": "c63a72ad-0f69-41df-a80b-f953c627d933", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bca88daf-cd13-4baf-b1e2-b859f1107696"}, {"Element": "<a name=\"Table2\"><b><span lang=\"EN-GB\">Table 2</span></b></a>", "ID": "0532a4ff-3d02-403e-b59c-25c862c0ee68", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c63a72ad-0f69-41df-a80b-f953c627d933"}, {"Element": "<b><span lang=\"EN-GB\">Table 2</span></b>", "ID": "8222fb10-452f-47c2-a2e2-d066a06ec36e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0532a4ff-3d02-403e-b59c-25c862c0ee68"}, {"Element": "<span lang=\"EN-GB\">Table 2</span>", "ID": "a7687a68-2241-4f44-8852-baa92d6b257d", "Styles": "None", "Classes": "None", "Text": "Table 2", "ParentId": "8222fb10-452f-47c2-a2e2-d066a06ec36e"}, {"Element": "<b><span lang=\"EN-GB\">:\n   Dose modifications guidelines for ixazomib in combination with lenalidomide\n   and dexamethasone </span></b>", "ID": "65f0f51a-5aa4-4c6d-9dd1-5bea22f3ecf2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c63a72ad-0f69-41df-a80b-f953c627d933"}, {"Element": "<span lang=\"EN-GB\">:\n   Dose modifications guidelines for ixazomib in combination with lenalidomide\n   and dexamethasone </span>", "ID": "1a69d996-0f12-4be4-ae9c-03c155baf369", "Styles": "None", "Classes": "None", "Text": ":    Dose modifications guidelines for ixazomib in combination with lenalidomide    and dexamethasone ", "ParentId": "65f0f51a-5aa4-4c6d-9dd1-5bea22f3ecf2"}, {"Element": "<tr style=\"height:15.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Haematological toxicities</span></b></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin:0in;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended\n  actions</span></b></p>\n</td>\n</tr>", "ID": "5a360342-da39-4558-a603-7b07e9a3d15d", "Styles": "height:15.7pt", "Classes": "None", "Text": "   ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Haematological toxicities</span></b></p>\n</td>", "ID": "3869e694-2920-4f6d-9f31-78d1ce048927", "Styles": "width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt", "Classes": "None", "Text": "  ", "ParentId": "5a360342-da39-4558-a603-7b07e9a3d15d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Haematological toxicities</span></b></p>", "ID": "92900b04-d9e1-40b7-9963-ef4454882544", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3869e694-2920-4f6d-9f31-78d1ce048927"}, {"Element": "<b><span lang=\"EN-GB\">Haematological toxicities</span></b>", "ID": "e48d577b-628a-4a4a-9bf5-de9b8030ed36", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "92900b04-d9e1-40b7-9963-ef4454882544"}, {"Element": "<span lang=\"EN-GB\">Haematological toxicities</span>", "ID": "22ccf0ef-2571-4f1a-ac53-5cb73d13e70c", "Styles": "None", "Classes": "None", "Text": "Haematological toxicities", "ParentId": "e48d577b-628a-4a4a-9bf5-de9b8030ed36"}, {"Element": "<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin:0in;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended\n  actions</span></b></p>\n</td>", "ID": "47bfcd5d-05e7-4b03-80a7-fc9e4586a6a7", "Styles": "width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt", "Classes": "None", "Text": "  ", "ParentId": "5a360342-da39-4558-a603-7b07e9a3d15d"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin:0in;line-height:normal;page-break-after:\n  avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended\n  actions</span></b></p>", "ID": "e79bd9fa-d75b-4c62-bf99-13a0b06d021d", "Styles": "margin:0in;line-height:normal;page-break-after:\n  avoid", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "47bfcd5d-05e7-4b03-80a7-fc9e4586a6a7"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended\n  actions</span></b>", "ID": "2b4cbbdc-7b2b-43bf-8c0b-1f3504fd6cf4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e79bd9fa-d75b-4c62-bf99-13a0b06d021d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended\n  actions</span>", "ID": "1ca21eae-e717-4256-bbb7-a1cca4fb8836", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Recommended   actions", "ParentId": "2b4cbbdc-7b2b-43bf-8c0b-1f3504fd6cf4"}, {"Element": "<tr style=\"height:15.8pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.8pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Thrombocytopenia (platelet count)</span></b></p>\n</td>\n</tr>", "ID": "7e957468-1f94-415f-b063-7ea908904f55", "Styles": "height:15.8pt", "Classes": "None", "Text": "  ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.8pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Thrombocytopenia (platelet count)</span></b></p>\n</td>", "ID": "6c784961-737a-4b1e-8524-fc03f72b0640", "Styles": "width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.8pt", "Classes": "None", "Text": "  ", "ParentId": "7e957468-1f94-415f-b063-7ea908904f55"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Thrombocytopenia (platelet count)</span></b></p>", "ID": "f49a2068-afc5-4439-8297-42c7deab588a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6c784961-737a-4b1e-8524-fc03f72b0640"}, {"Element": "<b><span lang=\"EN-GB\">Thrombocytopenia (platelet count)</span></b>", "ID": "ce5d3595-c8f6-4766-9c65-2322ee0c3455", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f49a2068-afc5-4439-8297-42c7deab588a"}, {"Element": "<span lang=\"EN-GB\">Thrombocytopenia (platelet count)</span>", "ID": "509592e4-b76c-4a3d-9f74-3fa849b3270b", "Styles": "None", "Classes": "None", "Text": "Thrombocytopenia (platelet count)", "ParentId": "ce5d3595-c8f6-4766-9c65-2322ee0c3455"}, {"Element": "<tr style=\"height:31.95pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:31.95pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Platelet count\n  <span style=\"position:relative;top:.5pt\">&lt;\u00a0<span style=\"letter-spacing:\n  .05pt\">30</span>,000/m<span style=\"letter-spacing:-.05pt\">m<sup>3</sup></span></span></span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:31.95pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC\n  and resume ixazomib at its most recent dose. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  platelet count falls to &lt;\u00a030,000/mm<sup>3</sup> again, withhold ixazomib\n  and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>\n</tr>", "ID": "cb4c7938-478e-4f4a-ac3c-dac3473742e8", "Styles": "height:31.95pt", "Classes": "None", "Text": "   ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:31.95pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Platelet count\n  <span style=\"position:relative;top:.5pt\">&lt;\u00a0<span style=\"letter-spacing:\n  .05pt\">30</span>,000/m<span style=\"letter-spacing:-.05pt\">m<sup>3</sup></span></span></span></p>\n</td>", "ID": "9fc7c4be-a288-48c0-a6c3-7fae55125d07", "Styles": "width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:31.95pt", "Classes": "None", "Text": "  ", "ParentId": "cb4c7938-478e-4f4a-ac3c-dac3473742e8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Platelet count\n  <span style=\"position:relative;top:.5pt\">&lt;\u00a0<span style=\"letter-spacing:\n  .05pt\">30</span>,000/m<span style=\"letter-spacing:-.05pt\">m<sup>3</sup></span></span></span></p>", "ID": "fd9f6a60-48b1-4993-974d-4079922bd7f9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9fc7c4be-a288-48c0-a6c3-7fae55125d07"}, {"Element": "<span lang=\"EN-GB\">Platelet count\n  <span style=\"position:relative;top:.5pt\">&lt;\u00a0<span style=\"letter-spacing:\n  .05pt\">30</span>,000/m<span style=\"letter-spacing:-.05pt\">m<sup>3</sup></span></span></span>", "ID": "614f9510-dda4-45d2-8fe9-517489545de7", "Styles": "None", "Classes": "None", "Text": "Platelet count   ", "ParentId": "fd9f6a60-48b1-4993-974d-4079922bd7f9"}, {"Element": "<span style=\"position:relative;top:.5pt\">&lt;\u00a0<span style=\"letter-spacing:\n  .05pt\">30</span>,000/m<span style=\"letter-spacing:-.05pt\">m<sup>3</sup></span></span>", "ID": "9e601d2b-b028-40fc-b3fc-4e8995df2ac5", "Styles": "position:relative;top:.5pt", "Classes": "None", "Text": "<\u00a0,000/m", "ParentId": "614f9510-dda4-45d2-8fe9-517489545de7"}, {"Element": "<span style=\"letter-spacing:\n  .05pt\">30</span>", "ID": "3bcf10c7-38ea-4bde-b53a-f1b21982042c", "Styles": "letter-spacing:\n  .05pt", "Classes": "None", "Text": "30", "ParentId": "9e601d2b-b028-40fc-b3fc-4e8995df2ac5"}, {"Element": "<span style=\"letter-spacing:-.05pt\">m<sup>3</sup></span>", "ID": "a8f74428-a087-4b70-aefc-6a8306aebdb3", "Styles": "letter-spacing:-.05pt", "Classes": "None", "Text": "m", "ParentId": "9e601d2b-b028-40fc-b3fc-4e8995df2ac5"}, {"Element": "<sup>3</sup>", "ID": "5ec4b7b1-73ac-4dde-9abb-2340386eaefc", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "a8f74428-a087-4b70-aefc-6a8306aebdb3"}, {"Element": "<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:31.95pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC\n  and resume ixazomib at its most recent dose. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  platelet count falls to &lt;\u00a030,000/mm<sup>3</sup> again, withhold ixazomib\n  and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>", "ID": "bafb16cc-5700-466c-a916-a7be25a4f6a5", "Styles": "width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:31.95pt", "Classes": "None", "Text": "     ", "ParentId": "cb4c7938-478e-4f4a-ac3c-dac3473742e8"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span></p>", "ID": "180f645f-ea2d-40f0-a231-4cbcd900c046", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "bafb16cc-5700-466c-a916-a7be25a4f6a5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "e4df174e-5f93-4bd7-9a4d-8fd84dd3397b", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "180f645f-ea2d-40f0-a231-4cbcd900c046"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "ee0acb5a-70e4-43cc-ab5c-6b6574cb8810", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "e4df174e-5f93-4bd7-9a4d-8fd84dd3397b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span>", "ID": "468d64e8-e56f-419e-a425-b76f9e4737ae", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Withhold   ixazomib and lenalidomide until platelet count \u2265\u00a030,000/mm.", "ParentId": "180f645f-ea2d-40f0-a231-4cbcd900c046"}, {"Element": "<sup>3</sup>", "ID": "444a6706-e32f-4257-808c-752707d65281", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "468d64e8-e56f-419e-a425-b76f9e4737ae"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC\n  and resume ixazomib at its most recent dose. </span></p>", "ID": "41fde48c-71a1-4a9f-b586-7b41c03d485e", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "bafb16cc-5700-466c-a916-a7be25a4f6a5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "633ef69c-7341-47ea-8efc-7ca517320a37", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "41fde48c-71a1-4a9f-b586-7b41c03d485e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "fb495cd7-b8d3-4a04-acec-1bfae558d5f5", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "633ef69c-7341-47ea-8efc-7ca517320a37"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC\n  and resume ixazomib at its most recent dose. </span>", "ID": "faf83c47-59ef-4789-b03e-eba905d77d3f", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following   recovery, resume lenalidomide at the next lower dose according to its SmPC   and resume ixazomib at its most recent dose. ", "ParentId": "41fde48c-71a1-4a9f-b586-7b41c03d485e"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  platelet count falls to &lt;\u00a030,000/mm<sup>3</sup> again, withhold ixazomib\n  and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span></p>", "ID": "f17b4173-9627-4c16-be12-2a7d379ce37c", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "bafb16cc-5700-466c-a916-a7be25a4f6a5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "8409f734-f121-492c-b057-5e9ec4105579", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f17b4173-9627-4c16-be12-2a7d379ce37c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "885fc620-beda-466f-be83-e2166411cf1f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "8409f734-f121-492c-b057-5e9ec4105579"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  platelet count falls to &lt;\u00a030,000/mm<sup>3</sup> again, withhold ixazomib\n  and lenalidomide until platelet count \u2265\u00a030,000/mm<sup>3</sup>.</span>", "ID": "664c2ec7-4615-4110-b796-c90348ade542", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If   platelet count falls to <\u00a030,000/mm again, withhold ixazomib   and lenalidomide until platelet count \u2265\u00a030,000/mm.", "ParentId": "f17b4173-9627-4c16-be12-2a7d379ce37c"}, {"Element": "<sup>3</sup>", "ID": "2ec6cca7-b64e-4230-abd3-b5afefabac96", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "664c2ec7-4615-4110-b796-c90348ade542"}, {"Element": "<sup>3</sup>", "ID": "5685c6ab-0237-447a-b57c-d1bfdf4b5e6e", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "664c2ec7-4615-4110-b796-c90348ade542"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>", "ID": "8a91e188-d003-475c-a872-ffa19df2adb3", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "bafb16cc-5700-466c-a916-a7be25a4f6a5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "67c4dabf-da41-4c09-a318-30e5078f9c38", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "8a91e188-d003-475c-a872-ffa19df2adb3"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "ee13a1fb-1c6e-4e73-879e-694f9c1f0f22", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "67c4dabf-da41-4c09-a318-30e5078f9c38"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span>", "ID": "9a4f122a-1c39-445b-90a1-3fae569d1821", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following   recovery, resume ixazomib at the next lower dose and resume lenalidomide at   its most recent dose.*", "ParentId": "8a91e188-d003-475c-a872-ffa19df2adb3"}, {"Element": "<tr style=\"height:15.7pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Neutropenia\n  (absolute neutrophil count)</span></b></p>\n</td>\n</tr>", "ID": "8dbfff6f-9157-43c3-992a-cccdc2f18062", "Styles": "height:15.7pt", "Classes": "None", "Text": "  ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Neutropenia\n  (absolute neutrophil count)</span></b></p>\n</td>", "ID": "d6f064b9-179a-40e9-beda-5ae15ac2cdd9", "Styles": "width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt", "Classes": "None", "Text": "  ", "ParentId": "8dbfff6f-9157-43c3-992a-cccdc2f18062"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Neutropenia\n  (absolute neutrophil count)</span></b></p>", "ID": "91cf6286-f450-4e10-9538-6bdfd37690b4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d6f064b9-179a-40e9-beda-5ae15ac2cdd9"}, {"Element": "<b><span lang=\"EN-GB\">Neutropenia\n  (absolute neutrophil count)</span></b>", "ID": "dfabffe4-83b2-4fe6-8896-ac5e8b9c43d6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "91cf6286-f450-4e10-9538-6bdfd37690b4"}, {"Element": "<span lang=\"EN-GB\">Neutropenia\n  (absolute neutrophil count)</span>", "ID": "06ad0fc4-d837-4751-a0bd-c6347af144af", "Styles": "None", "Classes": "None", "Text": "Neutropenia   (absolute neutrophil count)", "ParentId": "dfabffe4-83b2-4fe6-8896-ac5e8b9c43d6"}, {"Element": "<tr style=\"height:15.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"letter-spacing:.05pt\">Absolute neutrophil count</span><span lang=\"EN-GB\"> <span style=\"position:relative;top:.5pt\">&lt;\u00a0</span>500/mm<sup>3</sup></span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until absolute neutrophil count is \u2265\u00a0500/mm<sup>3</sup>.\n  Consider adding G\u2011CSF as per clinical guidelines.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its\n  prescribing information and resume ixazomib at its most recent dose. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  absolute neutrophil count falls to &lt;\u00a0500/mm<sup>3</sup> again,\n  withhold ixazomib and lenalidomide until absolute neutrophil count is \u2265\n  500/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>\n</tr>", "ID": "9b0eb127-b76b-4c72-a5a8-2062f4f37335", "Styles": "height:15.7pt", "Classes": "None", "Text": "   ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"letter-spacing:.05pt\">Absolute neutrophil count</span><span lang=\"EN-GB\"> <span style=\"position:relative;top:.5pt\">&lt;\u00a0</span>500/mm<sup>3</sup></span></p>\n</td>", "ID": "2bff1df3-5dd4-429a-9a08-3db51cb4e102", "Styles": "width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt", "Classes": "None", "Text": "  ", "ParentId": "9b0eb127-b76b-4c72-a5a8-2062f4f37335"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"letter-spacing:.05pt\">Absolute neutrophil count</span><span lang=\"EN-GB\"> <span style=\"position:relative;top:.5pt\">&lt;\u00a0</span>500/mm<sup>3</sup></span></p>", "ID": "6e40f16e-8bb7-4337-88c2-dab853e68c70", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2bff1df3-5dd4-429a-9a08-3db51cb4e102"}, {"Element": "<span lang=\"EN-GB\" style=\"letter-spacing:.05pt\">Absolute neutrophil count</span>", "ID": "98459ca8-9c10-4609-b955-38f7e4b1aed5", "Styles": "letter-spacing:.05pt", "Classes": "None", "Text": "Absolute neutrophil count", "ParentId": "6e40f16e-8bb7-4337-88c2-dab853e68c70"}, {"Element": "<span lang=\"EN-GB\"> <span style=\"position:relative;top:.5pt\">&lt;\u00a0</span>500/mm<sup>3</sup></span>", "ID": "008eef93-56be-4d87-b64d-2f434f01905f", "Styles": "None", "Classes": "None", "Text": " 500/mm", "ParentId": "6e40f16e-8bb7-4337-88c2-dab853e68c70"}, {"Element": "<span style=\"position:relative;top:.5pt\">&lt;\u00a0</span>", "ID": "041f6252-4216-40ce-ac5f-c35093e9cb14", "Styles": "position:relative;top:.5pt", "Classes": "None", "Text": "<\u00a0", "ParentId": "008eef93-56be-4d87-b64d-2f434f01905f"}, {"Element": "<sup>3</sup>", "ID": "b5ec4f76-b91a-462d-bcda-1b8e117be0af", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "008eef93-56be-4d87-b64d-2f434f01905f"}, {"Element": "<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until absolute neutrophil count is \u2265\u00a0500/mm<sup>3</sup>.\n  Consider adding G\u2011CSF as per clinical guidelines.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its\n  prescribing information and resume ixazomib at its most recent dose. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  absolute neutrophil count falls to &lt;\u00a0500/mm<sup>3</sup> again,\n  withhold ixazomib and lenalidomide until absolute neutrophil count is \u2265\n  500/mm<sup>3</sup>.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>", "ID": "3bce1837-2c21-4246-b833-9c20df0f2929", "Styles": "width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt", "Classes": "None", "Text": "     ", "ParentId": "9b0eb127-b76b-4c72-a5a8-2062f4f37335"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until absolute neutrophil count is \u2265\u00a0500/mm<sup>3</sup>.\n  Consider adding G\u2011CSF as per clinical guidelines.</span></p>", "ID": "77cd08a8-2d86-491b-a975-d368b9d74c0d", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "3bce1837-2c21-4246-b833-9c20df0f2929"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "6492ecbe-1a02-4b15-b1c5-2392c338a83d", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "77cd08a8-2d86-491b-a975-d368b9d74c0d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "2f20d692-5c23-45a8-a22f-587c03914956", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "6492ecbe-1a02-4b15-b1c5-2392c338a83d"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib and lenalidomide until absolute neutrophil count is \u2265\u00a0500/mm<sup>3</sup>.\n  Consider adding G\u2011CSF as per clinical guidelines.</span>", "ID": "250c00cb-c861-46bb-bd0b-4a25cb18ab18", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Withhold   ixazomib and lenalidomide until absolute neutrophil count is \u2265\u00a0500/mm.   Consider adding G\u2011CSF as per clinical guidelines.", "ParentId": "77cd08a8-2d86-491b-a975-d368b9d74c0d"}, {"Element": "<sup>3</sup>", "ID": "20ba5ffc-bdb0-48a0-ab12-0b0b7e2b6049", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "250c00cb-c861-46bb-bd0b-4a25cb18ab18"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its\n  prescribing information and resume ixazomib at its most recent dose. </span></p>", "ID": "e81aaee9-e5a3-4106-8f09-c8ecb6371427", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "3bce1837-2c21-4246-b833-9c20df0f2929"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "1d3bc386-cf3e-4fe8-93b6-8ba422e60daf", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e81aaee9-e5a3-4106-8f09-c8ecb6371427"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "5c592087-f265-4117-bec7-3574870007a0", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "1d3bc386-cf3e-4fe8-93b6-8ba422e60daf"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its\n  prescribing information and resume ixazomib at its most recent dose. </span>", "ID": "2b6d1a3b-b047-4e86-96c0-79c9181ee79c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following   recovery, resume lenalidomide at the next lower dose according to its   prescribing information and resume ixazomib at its most recent dose. ", "ParentId": "e81aaee9-e5a3-4106-8f09-c8ecb6371427"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  absolute neutrophil count falls to &lt;\u00a0500/mm<sup>3</sup> again,\n  withhold ixazomib and lenalidomide until absolute neutrophil count is \u2265\n  500/mm<sup>3</sup>.</span></p>", "ID": "b7765baf-d907-489b-83fb-9b0d58337119", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "3bce1837-2c21-4246-b833-9c20df0f2929"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "616f69e0-5624-4221-8197-70d42ca033ab", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b7765baf-d907-489b-83fb-9b0d58337119"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "23453278-0ece-4383-83f5-cf13bf2e5cfb", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "616f69e0-5624-4221-8197-70d42ca033ab"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  absolute neutrophil count falls to &lt;\u00a0500/mm<sup>3</sup> again,\n  withhold ixazomib and lenalidomide until absolute neutrophil count is \u2265\n  500/mm<sup>3</sup>.</span>", "ID": "d98f82a7-366d-40ad-a36b-ba9dd5885cdc", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If   absolute neutrophil count falls to <\u00a0500/mm again,   withhold ixazomib and lenalidomide until absolute neutrophil count is \u2265   500/mm.", "ParentId": "b7765baf-d907-489b-83fb-9b0d58337119"}, {"Element": "<sup>3</sup>", "ID": "c11cf886-b091-488c-97ff-60dd779bbd4e", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "d98f82a7-366d-40ad-a36b-ba9dd5885cdc"}, {"Element": "<sup>3</sup>", "ID": "5472e0ac-ef91-46f1-b307-77a8e123905b", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "d98f82a7-366d-40ad-a36b-ba9dd5885cdc"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>", "ID": "7c8fdf2f-b039-4363-bbc3-5f8f4087ffe9", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "3bce1837-2c21-4246-b833-9c20df0f2929"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "1857c25e-716d-4ee9-836e-dffd06d1354f", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7c8fdf2f-b039-4363-bbc3-5f8f4087ffe9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "8aaea764-3132-4657-90cb-b84bec95255d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "1857c25e-716d-4ee9-836e-dffd06d1354f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span>", "ID": "fb4639a9-43e0-494f-8b2e-4df1545f8ded", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following   recovery, resume ixazomib at the next lower dose and resume lenalidomide at   its most recent dose.*", "ParentId": "7c8fdf2f-b039-4363-bbc3-5f8f4087ffe9"}, {"Element": "<tr style=\"height:15.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Non\u2011haematological\n  toxicities</span></b></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended actions</span></b></p>\n</td>\n</tr>", "ID": "298f65a9-feb8-4d25-a3b7-5475ecd14d54", "Styles": "height:15.7pt", "Classes": "None", "Text": "   ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Non\u2011haematological\n  toxicities</span></b></p>\n</td>", "ID": "8713d738-6d8d-4896-b46d-9f816c0e65e5", "Styles": "width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:15.7pt", "Classes": "None", "Text": "  ", "ParentId": "298f65a9-feb8-4d25-a3b7-5475ecd14d54"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Non\u2011haematological\n  toxicities</span></b></p>", "ID": "82d01614-a8a4-4ddd-a745-6739d7628ace", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8713d738-6d8d-4896-b46d-9f816c0e65e5"}, {"Element": "<b><span lang=\"EN-GB\">Non\u2011haematological\n  toxicities</span></b>", "ID": "76770faa-6aea-4fee-84ef-d60c5e08cfc1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "82d01614-a8a4-4ddd-a745-6739d7628ace"}, {"Element": "<span lang=\"EN-GB\">Non\u2011haematological\n  toxicities</span>", "ID": "d565affb-3703-4a2e-9544-37db222ffdfe", "Styles": "None", "Classes": "None", "Text": "Non\u2011haematological   toxicities", "ParentId": "76770faa-6aea-4fee-84ef-d60c5e08cfc1"}, {"Element": "<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended actions</span></b></p>\n</td>", "ID": "3cc546bb-1043-4720-a777-daea016ece84", "Styles": "width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:15.7pt", "Classes": "None", "Text": "  ", "ParentId": "298f65a9-feb8-4d25-a3b7-5475ecd14d54"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin:0in;line-height:normal\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended actions</span></b></p>", "ID": "7c18abf6-0d34-4cac-936e-c0bfcee1f54c", "Styles": "margin:0in;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "3cc546bb-1043-4720-a777-daea016ece84"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended actions</span></b>", "ID": "2760d626-fdd6-42e3-82e2-e7c434238d66", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7c18abf6-0d34-4cac-936e-c0bfcee1f54c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Recommended actions</span>", "ID": "855085fb-451d-4ad2-b38b-b21191a81ea1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Recommended actions", "ParentId": "2760d626-fdd6-42e3-82e2-e7c434238d66"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rash</span></b></p>\n</td>\n</tr>", "ID": "ddb3e7cd-8333-45b9-a9ed-5e227dd43a23", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rash</span></b></p>\n</td>", "ID": "3c5a4553-e94e-426f-8019-a1009475f951", "Styles": "width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ddb3e7cd-8333-45b9-a9ed-5e227dd43a23"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rash</span></b></p>", "ID": "711ff168-dda2-40dc-9710-d64152728475", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c5a4553-e94e-426f-8019-a1009475f951"}, {"Element": "<b><span lang=\"EN-GB\">Rash</span></b>", "ID": "97b54a23-6da0-457f-8ce8-9ea3901b2777", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "711ff168-dda2-40dc-9710-d64152728475"}, {"Element": "<span lang=\"EN-GB\">Rash</span>", "ID": "720e3506-7cae-43b3-bb9c-bd847f0b65f7", "Styles": "None", "Classes": "None", "Text": "Rash", "ParentId": "97b54a23-6da0-457f-8ce8-9ea3901b2777"}, {"Element": "<tr style=\"height:31.75pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:31.75pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade<sup>\u2020</sup>\n  2 or 3</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:31.75pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  lenalidomide until rash recovers to \u2264\u00a0Grade\u00a01.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  Grade 2 or 3 rash occurs again, withhold ixazomib and lenalidomide until rash\n  recovers to \u2264\u00a0Grade\u00a01.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>\n</tr>", "ID": "262493cf-69be-454b-a3d9-1820fe190324", "Styles": "height:31.75pt", "Classes": "None", "Text": "   ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:31.75pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade<sup>\u2020</sup>\n  2 or 3</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "3b0d92ae-cfd3-417a-bc9a-afff00c36ce7", "Styles": "width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:31.75pt", "Classes": "None", "Text": "   ", "ParentId": "262493cf-69be-454b-a3d9-1820fe190324"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade<sup>\u2020</sup>\n  2 or 3</span></p>", "ID": "e91927b6-ccac-4aab-a231-8c21c1ac4c58", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3b0d92ae-cfd3-417a-bc9a-afff00c36ce7"}, {"Element": "<span lang=\"EN-GB\">Grade<sup>\u2020</sup>\n  2 or 3</span>", "ID": "c693336c-59b0-45ae-99b0-f74d5096c442", "Styles": "None", "Classes": "None", "Text": "Grade   2 or 3", "ParentId": "e91927b6-ccac-4aab-a231-8c21c1ac4c58"}, {"Element": "<sup>\u2020</sup>", "ID": "4c007ca8-a111-407e-8b05-3f6cbade394a", "Styles": "None", "Classes": "None", "Text": "\u2020", "ParentId": "c693336c-59b0-45ae-99b0-f74d5096c442"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e7733aac-8d8d-466f-a1bd-8382cd829308", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3b0d92ae-cfd3-417a-bc9a-afff00c36ce7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f292fc9e-6671-491e-90ae-fa8ce63a61d2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e7733aac-8d8d-466f-a1bd-8382cd829308"}, {"Element": "<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:31.75pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  lenalidomide until rash recovers to \u2264\u00a0Grade\u00a01.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC. </span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  Grade 2 or 3 rash occurs again, withhold ixazomib and lenalidomide until rash\n  recovers to \u2264\u00a0Grade\u00a01.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>\n</td>", "ID": "eb041842-343b-4f6c-96c0-0ba9abc75697", "Styles": "width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:31.75pt", "Classes": "None", "Text": "     ", "ParentId": "262493cf-69be-454b-a3d9-1820fe190324"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  lenalidomide until rash recovers to \u2264\u00a0Grade\u00a01.</span></p>", "ID": "80a1995e-e66d-4bfd-948d-7dc4a4bfc4c6", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "eb041842-343b-4f6c-96c0-0ba9abc75697"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "5489d17a-5aaf-432c-93ef-4f6a204589b0", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "80a1995e-e66d-4bfd-948d-7dc4a4bfc4c6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "3fb58db7-d27f-406e-8b0a-43559fa881a8", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "5489d17a-5aaf-432c-93ef-4f6a204589b0"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  lenalidomide until rash recovers to \u2264\u00a0Grade\u00a01.</span>", "ID": "39e7a2e4-1f9d-4b41-bcdc-ac8cb0bc7e8c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Withhold   lenalidomide until rash recovers to \u2264\u00a0Grade\u00a01.", "ParentId": "80a1995e-e66d-4bfd-948d-7dc4a4bfc4c6"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC. </span></p>", "ID": "f9295efa-e0dc-41b8-9e2b-abc1880041af", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "eb041842-343b-4f6c-96c0-0ba9abc75697"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "1accdf24-1559-44e6-b688-2e093108b9a4", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f9295efa-e0dc-41b8-9e2b-abc1880041af"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "3154b896-57ce-4af6-97aa-02ea15be864a", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "1accdf24-1559-44e6-b688-2e093108b9a4"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume lenalidomide at the next lower dose according to its SmPC. </span>", "ID": "551f519c-717d-47a6-8abd-800c55104532", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following   recovery, resume lenalidomide at the next lower dose according to its SmPC. ", "ParentId": "f9295efa-e0dc-41b8-9e2b-abc1880041af"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  Grade 2 or 3 rash occurs again, withhold ixazomib and lenalidomide until rash\n  recovers to \u2264\u00a0Grade\u00a01.</span></p>", "ID": "aaa87bb9-9b9b-40af-9d44-af2b9404a836", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "eb041842-343b-4f6c-96c0-0ba9abc75697"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "257d2a27-2149-4339-8537-ece065e7ee56", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "aaa87bb9-9b9b-40af-9d44-af2b9404a836"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "5f07d2eb-36da-4e27-aae8-953d62e9d0f7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "257d2a27-2149-4339-8537-ece065e7ee56"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  Grade 2 or 3 rash occurs again, withhold ixazomib and lenalidomide until rash\n  recovers to \u2264\u00a0Grade\u00a01.</span>", "ID": "992dde28-0356-4fca-b5bd-55898e67753d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If   Grade 2 or 3 rash occurs again, withhold ixazomib and lenalidomide until rash   recovers to \u2264\u00a0Grade\u00a01.", "ParentId": "aaa87bb9-9b9b-40af-9d44-af2b9404a836"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span></p>", "ID": "b33d6ae7-aa8c-495f-9179-ab50188d890c", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "eb041842-343b-4f6c-96c0-0ba9abc75697"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "544269e2-6e2e-493e-a4c9-6b9ba10829af", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b33d6ae7-aa8c-495f-9179-ab50188d890c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "51db1029-1a25-4ac0-9571-c66327a77c89", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "544269e2-6e2e-493e-a4c9-6b9ba10829af"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose and resume lenalidomide at\n  its most recent dose.*</span>", "ID": "f7a46144-451e-4a6b-b802-882adc8f4f56", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following   recovery, resume ixazomib at the next lower dose and resume lenalidomide at   its most recent dose.*", "ParentId": "b33d6ae7-aa8c-495f-9179-ab50188d890c"}, {"Element": "<tr style=\"height:17.05pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade 4</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span></p>\n</td>\n</tr>", "ID": "e9c4b0ff-7375-474f-b1e4-356cb46a91ab", "Styles": "height:17.05pt", "Classes": "None", "Text": "   ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade 4</span></p>\n</td>", "ID": "f67194e7-db66-483f-8ab8-4a587f7d759a", "Styles": "width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt", "Classes": "None", "Text": "  ", "ParentId": "e9c4b0ff-7375-474f-b1e4-356cb46a91ab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade 4</span></p>", "ID": "4b123631-ccc0-406b-ba9f-f386efc83202", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f67194e7-db66-483f-8ab8-4a587f7d759a"}, {"Element": "<span lang=\"EN-GB\">Grade 4</span>", "ID": "b9217d8e-422a-4e54-89e7-181f131efcc7", "Styles": "None", "Classes": "None", "Text": "Grade 4", "ParentId": "4b123631-ccc0-406b-ba9f-f386efc83202"}, {"Element": "<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span></p>\n</td>", "ID": "407f6746-1210-4650-8ed3-d6da250e1b7d", "Styles": "width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt", "Classes": "None", "Text": "  ", "ParentId": "e9c4b0ff-7375-474f-b1e4-356cb46a91ab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span></p>", "ID": "6d907054-cdaa-4160-96b1-cbafc6007c39", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "407f6746-1210-4650-8ed3-d6da250e1b7d"}, {"Element": "<span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span>", "ID": "f9c9e8ad-db41-46ec-9037-f2072f098ae5", "Styles": "None", "Classes": "None", "Text": "Discontinue   treatment regimen.", "ParentId": "6d907054-cdaa-4160-96b1-cbafc6007c39"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Peripheral neuropathy</span></b></p>\n</td>\n</tr>", "ID": "4c6f8e05-e855-4627-b744-b0ca71deec9a", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Peripheral neuropathy</span></b></p>\n</td>", "ID": "0b98f186-f619-4dbb-a2d3-4c84a933c12d", "Styles": "width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "4c6f8e05-e855-4627-b744-b0ca71deec9a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Peripheral neuropathy</span></b></p>", "ID": "43388eff-0b90-4afc-ac49-03c4632d3c89", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0b98f186-f619-4dbb-a2d3-4c84a933c12d"}, {"Element": "<b><span lang=\"EN-GB\">Peripheral neuropathy</span></b>", "ID": "88f1b6cc-3a4f-4c84-9e11-194ef442f81b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "43388eff-0b90-4afc-ac49-03c4632d3c89"}, {"Element": "<span lang=\"EN-GB\">Peripheral neuropathy</span>", "ID": "554f9ac7-b67a-45b9-8174-2e8a105d93bf", "Styles": "None", "Classes": "None", "Text": "Peripheral neuropathy", "ParentId": "88f1b6cc-3a4f-4c84-9e11-194ef442f81b"}, {"Element": "<tr style=\"height:36.8pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:36.8pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Grade 1 peripheral neuropathy with pain or Grade 2 peripheral neuropathy</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:36.8pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib until peripheral neuropathy recovers to \u2264\u00a0Grade\u00a01\n  without pain or patient's baseline.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at its most recent dose.</span></p>\n</td>\n</tr>", "ID": "bc860854-3184-4efb-9a1c-324f6e156b13", "Styles": "height:36.8pt", "Classes": "None", "Text": "   ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:36.8pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Grade 1 peripheral neuropathy with pain or Grade 2 peripheral neuropathy</span></p>\n</td>", "ID": "473b6529-2a40-448e-957f-059497998a69", "Styles": "width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:36.8pt", "Classes": "None", "Text": "  ", "ParentId": "bc860854-3184-4efb-9a1c-324f6e156b13"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Grade 1 peripheral neuropathy with pain or Grade 2 peripheral neuropathy</span></p>", "ID": "4cc7a2d8-3374-4674-8171-c9bcd080d676", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "473b6529-2a40-448e-957f-059497998a69"}, {"Element": "<span lang=\"EN-GB\">Grade 1 peripheral neuropathy with pain or Grade 2 peripheral neuropathy</span>", "ID": "db00963b-4799-4097-8082-12e2f43a51ac", "Styles": "None", "Classes": "None", "Text": "Grade 1 peripheral neuropathy with pain or Grade 2 peripheral neuropathy", "ParentId": "4cc7a2d8-3374-4674-8171-c9bcd080d676"}, {"Element": "<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:36.8pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib until peripheral neuropathy recovers to \u2264\u00a0Grade\u00a01\n  without pain or patient's baseline.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at its most recent dose.</span></p>\n</td>", "ID": "49be4c53-6bf7-4ee4-a4c7-a04157a05a7f", "Styles": "width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:36.8pt", "Classes": "None", "Text": "   ", "ParentId": "bc860854-3184-4efb-9a1c-324f6e156b13"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib until peripheral neuropathy recovers to \u2264\u00a0Grade\u00a01\n  without pain or patient's baseline.</span></p>", "ID": "dc9133ba-e027-40c2-a5ae-696be8a03e5c", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "49be4c53-6bf7-4ee4-a4c7-a04157a05a7f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "5059ca85-4cf8-480f-ab3b-d90953912899", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "dc9133ba-e027-40c2-a5ae-696be8a03e5c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "57ea14a6-5105-4039-a0af-6529421b22ae", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "5059ca85-4cf8-480f-ab3b-d90953912899"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib until peripheral neuropathy recovers to \u2264\u00a0Grade\u00a01\n  without pain or patient's baseline.</span>", "ID": "7b16fb1e-29ee-4518-b176-89ff26d666fa", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Withhold   ixazomib until peripheral neuropathy recovers to \u2264\u00a0Grade\u00a01   without pain or patient's baseline.", "ParentId": "dc9133ba-e027-40c2-a5ae-696be8a03e5c"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at its most recent dose.</span></p>", "ID": "df8c26c2-d05c-4c51-ae1c-28f8b51d5ebc", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "49be4c53-6bf7-4ee4-a4c7-a04157a05a7f"}, {"Element": "<span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "96c12aab-ae6b-40c8-909e-27ea9b7a6dda", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "df8c26c2-d05c-4c51-ae1c-28f8b51d5ebc"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "457c9ed3-c010-4982-b465-178bf3335aed", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "96c12aab-ae6b-40c8-909e-27ea9b7a6dda"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at its most recent dose.</span>", "ID": "49de8128-b2ba-4776-851b-b533a8ccdd4b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following   recovery, resume ixazomib at its most recent dose.", "ParentId": "df8c26c2-d05c-4c51-ae1c-28f8b51d5ebc"}, {"Element": "<tr style=\"height:36.7pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:36.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Grade 2 peripheral neuropathy with pain or Grade 3 peripheral neuropathy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:36.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or \u2264\u00a0Grade\u00a01\n  prior to resuming ixazomib.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose.</span></p>\n</td>\n</tr>", "ID": "9ed70a68-ca7c-43bb-9d14-1d9dba6d6d89", "Styles": "height:36.7pt", "Classes": "None", "Text": "   ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:36.7pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Grade 2 peripheral neuropathy with pain or Grade 3 peripheral neuropathy</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "27624385-570c-4f7d-a025-a42a81cb2d5b", "Styles": "width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:36.7pt", "Classes": "None", "Text": "    ", "ParentId": "9ed70a68-ca7c-43bb-9d14-1d9dba6d6d89"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Grade 2 peripheral neuropathy with pain or Grade 3 peripheral neuropathy</span></p>", "ID": "781b6860-08a0-454a-933f-78e7f3c1d084", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "27624385-570c-4f7d-a025-a42a81cb2d5b"}, {"Element": "<span lang=\"EN-GB\">Grade 2 peripheral neuropathy with pain or Grade 3 peripheral neuropathy</span>", "ID": "8f6fedeb-7286-43a3-8195-bceede2decae", "Styles": "None", "Classes": "None", "Text": "Grade 2 peripheral neuropathy with pain or Grade 3 peripheral neuropathy", "ParentId": "781b6860-08a0-454a-933f-78e7f3c1d084"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2fa01047-8926-4161-8372-b372da40bd89", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "27624385-570c-4f7d-a025-a42a81cb2d5b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1e66347f-7bf9-4fbd-9191-850118336631", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2fa01047-8926-4161-8372-b372da40bd89"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a049a11f-26f3-4229-839e-2b66dbf6f47d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "27624385-570c-4f7d-a025-a42a81cb2d5b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3d4226d1-9bbd-476d-87a8-e3d921628c60", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a049a11f-26f3-4229-839e-2b66dbf6f47d"}, {"Element": "<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:36.7pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or \u2264\u00a0Grade\u00a01\n  prior to resuming ixazomib.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose.</span></p>\n</td>", "ID": "68803b68-1cbc-4d62-9ed1-ad1aeacb09fd", "Styles": "width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:36.7pt", "Classes": "None", "Text": "   ", "ParentId": "9ed70a68-ca7c-43bb-9d14-1d9dba6d6d89"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or \u2264\u00a0Grade\u00a01\n  prior to resuming ixazomib.</span></p>", "ID": "13611bb4-f522-4dbd-8ff2-1793b6628c47", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "68803b68-1cbc-4d62-9ed1-ad1aeacb09fd"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "3d293750-12c3-4c42-b326-c743505b3568", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "13611bb4-f522-4dbd-8ff2-1793b6628c47"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "a4155e28-280a-4157-a542-e7278760cc1d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "3d293750-12c3-4c42-b326-c743505b3568"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or \u2264\u00a0Grade\u00a01\n  prior to resuming ixazomib.</span>", "ID": "03897c4f-6aaf-4934-9e17-f3fbd87dc2ee", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Withhold   ixazomib. Toxicities should, at the physician\u2019s discretion, generally   recover to patient\u2019s baseline condition or \u2264\u00a0Grade\u00a01   prior to resuming ixazomib.", "ParentId": "13611bb4-f522-4dbd-8ff2-1793b6628c47"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose.</span></p>", "ID": "b6509eb8-7ee4-497d-b5dc-8addfacba3b0", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "68803b68-1cbc-4d62-9ed1-ad1aeacb09fd"}, {"Element": "<span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "94ebb618-196c-406d-8c5f-744cacd040bc", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b6509eb8-7ee4-497d-b5dc-8addfacba3b0"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "ab70e7cd-4e76-437d-bb7e-52414c241335", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "94ebb618-196c-406d-8c5f-744cacd040bc"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Following\n  recovery, resume ixazomib at the next lower dose.</span>", "ID": "1922c58f-17de-4e95-b66f-2df397fb1bcf", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Following   recovery, resume ixazomib at the next lower dose.", "ParentId": "b6509eb8-7ee4-497d-b5dc-8addfacba3b0"}, {"Element": "<tr style=\"height:17.05pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade 4 peripheral\n  neuropathy</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span></p>\n</td>\n</tr>", "ID": "3fbfc21d-70df-4df0-a718-17c67004b987", "Styles": "height:17.05pt", "Classes": "None", "Text": "   ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade 4 peripheral\n  neuropathy</span></p>\n</td>", "ID": "7eda3821-c176-4629-a382-9b9d05c39620", "Styles": "width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt", "Classes": "None", "Text": "  ", "ParentId": "3fbfc21d-70df-4df0-a718-17c67004b987"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grade 4 peripheral\n  neuropathy</span></p>", "ID": "672be4c0-3081-4d53-b672-8fea7704f3f6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7eda3821-c176-4629-a382-9b9d05c39620"}, {"Element": "<span lang=\"EN-GB\">Grade 4 peripheral\n  neuropathy</span>", "ID": "fe6f6ce3-49b9-4f00-aafb-f37d7c539b9d", "Styles": "None", "Classes": "None", "Text": "Grade 4 peripheral   neuropathy", "ParentId": "672be4c0-3081-4d53-b672-8fea7704f3f6"}, {"Element": "<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span></p>\n</td>", "ID": "404f4f9a-6859-4277-aab9-722cf98cb419", "Styles": "width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt", "Classes": "None", "Text": "  ", "ParentId": "3fbfc21d-70df-4df0-a718-17c67004b987"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span></p>", "ID": "836f56ca-e2c5-4a7f-a3c7-ac38449a02df", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "404f4f9a-6859-4277-aab9-722cf98cb419"}, {"Element": "<span lang=\"EN-GB\">Discontinue\n  treatment regimen.</span>", "ID": "e7a5c13d-5efe-4290-bc89-7cbfe0eec25b", "Styles": "None", "Classes": "None", "Text": "Discontinue   treatment regimen.", "ParentId": "836f56ca-e2c5-4a7f-a3c7-ac38449a02df"}, {"Element": "<tr style=\"height:17.05pt\">\n<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other non\u2011haematological toxicities</span></b></p>\n</td>\n</tr>", "ID": "79227685-8115-4c94-8830-1492fef6a780", "Styles": "height:17.05pt", "Classes": "None", "Text": "  ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td colspan=\"2\" style=\"width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"615\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other non\u2011haematological toxicities</span></b></p>\n</td>", "ID": "6751e45d-79bc-483e-9ee0-7ee0d99adfb3", "Styles": "width:461.3pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt", "Classes": "None", "Text": "  ", "ParentId": "79227685-8115-4c94-8830-1492fef6a780"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other non\u2011haematological toxicities</span></b></p>", "ID": "87301345-7df2-4ba1-8bb7-8d0efa378701", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6751e45d-79bc-483e-9ee0-7ee0d99adfb3"}, {"Element": "<b><span lang=\"EN-GB\">Other non\u2011haematological toxicities</span></b>", "ID": "abedd799-8753-4f8b-b1f9-8479c9e11671", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "87301345-7df2-4ba1-8bb7-8d0efa378701"}, {"Element": "<span lang=\"EN-GB\">Other non\u2011haematological toxicities</span>", "ID": "e241c02f-4636-4264-bd8d-5b1e06003410", "Styles": "None", "Classes": "None", "Text": "Other non\u2011haematological toxicities", "ParentId": "abedd799-8753-4f8b-b1f9-8479c9e11671"}, {"Element": "<tr style=\"height:17.05pt\">\n<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Other Grade 3 or 4 non\u2011haematological toxicities</span></p>\n</td>\n<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or at most\u00a0Grade 1 prior\n  to resuming ixazomib.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  attributable to ixazomib, resume ixazomib at the next lower dose following\n  recovery.</span></p>\n</td>\n</tr>", "ID": "827d551f-594b-4f2b-bb76-853d36adfbac", "Styles": "height:17.05pt", "Classes": "None", "Text": "   ", "ParentId": "d4180105-6074-4bbc-836e-d75adf6b2976"}, {"Element": "<td style=\"width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"225\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Other Grade 3 or 4 non\u2011haematological toxicities</span></p>\n</td>", "ID": "c149c987-8377-4de5-b2bb-bf18aeed6376", "Styles": "width:168.8pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt;height:17.05pt", "Classes": "None", "Text": "  ", "ParentId": "827d551f-594b-4f2b-bb76-853d36adfbac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Other Grade 3 or 4 non\u2011haematological toxicities</span></p>", "ID": "a729959a-c25d-4f5f-ab7f-b10fd5a99784", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c149c987-8377-4de5-b2bb-bf18aeed6376"}, {"Element": "<span lang=\"EN-GB\">Other Grade 3 or 4 non\u2011haematological toxicities</span>", "ID": "437d2f16-8963-4f81-a267-86ad01d4e34c", "Styles": "None", "Classes": "None", "Text": "Other Grade 3 or 4 non\u2011haematological toxicities", "ParentId": "a729959a-c25d-4f5f-ab7f-b10fd5a99784"}, {"Element": "<td style=\"width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt\" valign=\"top\" width=\"390\">\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or at most\u00a0Grade 1 prior\n  to resuming ixazomib.</span></p>\n<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  attributable to ixazomib, resume ixazomib at the next lower dose following\n  recovery.</span></p>\n</td>", "ID": "4e65d823-dcf3-4d4d-948e-89415b5aa38d", "Styles": "width:292.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt;height:17.05pt", "Classes": "None", "Text": "   ", "ParentId": "827d551f-594b-4f2b-bb76-853d36adfbac"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or at most\u00a0Grade 1 prior\n  to resuming ixazomib.</span></p>", "ID": "e17cccd8-fcf8-4e68-8228-ce6547d38748", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "4e65d823-dcf3-4d4d-948e-89415b5aa38d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "c072a649-3bf1-4560-847e-1ee6b8b0420a", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e17cccd8-fcf8-4e68-8228-ce6547d38748"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "ca5f6589-30c8-479c-9d88-c51458b3e1ec", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "c072a649-3bf1-4560-847e-1ee6b8b0420a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Withhold\n  ixazomib. Toxicities should, at the physician\u2019s discretion, generally\n  recover to patient\u2019s baseline condition or at most\u00a0Grade 1 prior\n  to resuming ixazomib.</span>", "ID": "d9209708-a0c3-48d8-b802-5da3203eb890", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Withhold   ixazomib. Toxicities should, at the physician\u2019s discretion, generally   recover to patient\u2019s baseline condition or at most\u00a0Grade 1 prior   to resuming ixazomib.", "ParentId": "e17cccd8-fcf8-4e68-8228-ce6547d38748"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal\"><span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  attributable to ixazomib, resume ixazomib at the next lower dose following\n  recovery.</span></p>", "ID": "0fbfea4b-5841-4e75-aa3b-c8a0a6a9f4b9", "Styles": "margin-top:0in;margin-right:0in;margin-bottom:\n  0in;margin-left:15.0pt;text-indent:-15.0pt;line-height:normal", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "4e65d823-dcf3-4d4d-948e-89415b5aa38d"}, {"Element": "<span style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span></span>", "ID": "05857b82-2300-485c-88fa-2787a93c9816", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0fbfea4b-5841-4e75-aa3b-c8a0a6a9f4b9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n  </span>", "ID": "2fd76045-5970-4c53-8387-dafd0b2fc4de", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0   ", "ParentId": "05857b82-2300-485c-88fa-2787a93c9816"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>If\n  attributable to ixazomib, resume ixazomib at the next lower dose following\n  recovery.</span>", "ID": "b6ee7adc-fdfe-4bba-b05f-fa95715af434", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If   attributable to ixazomib, resume ixazomib at the next lower dose following   recovery.", "ParentId": "0fbfea4b-5841-4e75-aa3b-c8a0a6a9f4b9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:4.3pt;line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">*</span><span lang=\"EN-GB\" style=\"font-size:\n10.0pt\">For additional occurrences, alternate dose modification of lenalidomide\nand ixazomib</span></p>", "ID": "6e0a7c07-7487-40f4-b2aa-13b3bb596d43", "Styles": "margin-left:4.3pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">*</span>", "ID": "65e7dfcc-f28b-46fd-a341-7a9d99f99ef1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "*", "ParentId": "6e0a7c07-7487-40f4-b2aa-13b3bb596d43"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n10.0pt\">For additional occurrences, alternate dose modification of lenalidomide\nand ixazomib</span>", "ID": "bede0d28-d817-42d4-94af-9f6e79836cd8", "Styles": "font-size:\n10.0pt", "Classes": "None", "Text": "For additional occurrences, alternate dose modification of lenalidomide and ixazomib", "ParentId": "6e0a7c07-7487-40f4-b2aa-13b3bb596d43"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:4.3pt;line-height:normal\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span></sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Grading based on </span><span lang=\"EN-GB\" style=\"font-size:10.0pt\">National Cancer Institute Common Terminology Criteria\n(CTCAE) Version 4.03</span></p>", "ID": "1a4ed358-2304-4c7a-b522-8d992289210b", "Styles": "margin-left:4.3pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span></sup>", "ID": "5056c076-eedb-47af-b8f5-631c592e2254", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1a4ed358-2304-4c7a-b522-8d992289210b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span>", "ID": "cfba11fc-898b-48f2-b2a0-3a9eee49783c", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2020", "ParentId": "5056c076-eedb-47af-b8f5-631c592e2254"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Grading based on </span>", "ID": "d02676b1-16d6-4a76-8c96-f50fc306126a", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Grading based on ", "ParentId": "1a4ed358-2304-4c7a-b522-8d992289210b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">National Cancer Institute Common Terminology Criteria\n(CTCAE) Version 4.03</span>", "ID": "7d5a1286-78ac-43d7-bf3f-4c3d36b0b924", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "National Cancer Institute Common Terminology Criteria (CTCAE) Version 4.03", "ParentId": "1a4ed358-2304-4c7a-b522-8d992289210b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3f0d39de-89a2-42f9-8253-3a92d06b0514", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9b70b569-bb44-4cec-af2f-622b512e9b5e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3f0d39de-89a2-42f9-8253-3a92d06b0514"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><u><span lang=\"EN-GB\">Concomitant\nmedicinal products</span></u></i></p>", "ID": "ec1f2432-8981-4314-a634-dd9a62344e81", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Concomitant\nmedicinal products</span></u></i>", "ID": "3888dc12-88a5-4096-9900-7e288eef0bc6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ec1f2432-8981-4314-a634-dd9a62344e81"}, {"Element": "<u><span lang=\"EN-GB\">Concomitant\nmedicinal products</span></u>", "ID": "ee432df6-0f5e-4de5-91c7-6f6d51b71ea2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3888dc12-88a5-4096-9900-7e288eef0bc6"}, {"Element": "<span lang=\"EN-GB\">Concomitant\nmedicinal products</span>", "ID": "d65e3be6-9cd0-4118-a0d1-0891d5a32148", "Styles": "None", "Classes": "None", "Text": "Concomitant medicinal products", "ParentId": "ee432df6-0f5e-4de5-91c7-6f6d51b71ea2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "20b09aab-25f3-45fd-9a20-d54f89aa8baf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "963f7a26-30a9-45a9-9892-284a305e193e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "20b09aab-25f3-45fd-9a20-d54f89aa8baf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Antiviral\nprophylaxis should be considered in patients being treated with ixazomib to\ndecrease the risk of herpes zoster reactivation. Patients included in studies\nwith ixazomib who received antiviral prophylaxis had a lower incidence of\nherpes zoster infection compared to patients who did not receive prophylaxis.</span></p>", "ID": "89949472-ec35-41dd-8367-d99b377ce09c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Antiviral\nprophylaxis should be considered in patients being treated with ixazomib to\ndecrease the risk of herpes zoster reactivation. Patients included in studies\nwith ixazomib who received antiviral prophylaxis had a lower incidence of\nherpes zoster infection compared to patients who did not receive prophylaxis.</span>", "ID": "205dc773-8de1-4d18-92c8-e848be854cd2", "Styles": "None", "Classes": "None", "Text": "Antiviral prophylaxis should be considered in patients being treated with ixazomib to decrease the risk of herpes zoster reactivation. Patients included in studies with ixazomib who received antiviral prophylaxis had a lower incidence of herpes zoster infection compared to patients who did not receive prophylaxis.", "ParentId": "89949472-ec35-41dd-8367-d99b377ce09c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d47a33f9-38a5-4928-a454-7fd5fe02d5f7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c7ebe21b-b54a-44b2-a2a1-8519edd2b5fc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d47a33f9-38a5-4928-a454-7fd5fe02d5f7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Thromboprophylaxis\nis recommended in patients being treated with ixazomib in combination with\nlenalidomide and dexamethasone, and should be based on an assessment of the\npatient\u2019s underlying risks and clinical status. </span></p>", "ID": "6a0bd130-70ae-4a66-9859-45c5d0877da4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Thromboprophylaxis\nis recommended in patients being treated with ixazomib in combination with\nlenalidomide and dexamethasone, and should be based on an assessment of the\npatient\u2019s underlying risks and clinical status. </span>", "ID": "18a48c5c-57c6-439f-83b5-1dee667df672", "Styles": "None", "Classes": "None", "Text": "Thromboprophylaxis is recommended in patients being treated with ixazomib in combination with lenalidomide and dexamethasone, and should be based on an assessment of the patient\u2019s underlying risks and clinical status. ", "ParentId": "6a0bd130-70ae-4a66-9859-45c5d0877da4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "67e1e969-520b-405b-8185-d6b885b440d1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2544f62c-77ce-49ab-8aeb-0a6fcc146afe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "67e1e969-520b-405b-8185-d6b885b440d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For other\nconcomitant medicinal products that may be required, refer to the current\nlenalidomide and dexamethasone SmPC.</span></p>", "ID": "fb707358-cd22-4feb-8bac-f596b37916da", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">For other\nconcomitant medicinal products that may be required, refer to the current\nlenalidomide and dexamethasone SmPC.</span>", "ID": "f4e2115a-71cb-480a-8f05-52b07df2b05b", "Styles": "None", "Classes": "None", "Text": "For other concomitant medicinal products that may be required, refer to the current lenalidomide and dexamethasone SmPC.", "ParentId": "fb707358-cd22-4feb-8bac-f596b37916da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e0d5e327-9861-4372-a73d-05192e58286a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "31311d80-89a3-49fa-91c5-3fa516fa5c5c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e0d5e327-9861-4372-a73d-05192e58286a"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><a name=\"_Toc360524842\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Special patient populations</span></u></a></p>", "ID": "25d614ed-4476-423d-a810-9b390446f2ec", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<a name=\"_Toc360524842\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Special patient populations</span></u></a>", "ID": "259c4912-2f53-464e-8f05-939c3a94e985", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "25d614ed-4476-423d-a810-9b390446f2ec"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Special patient populations</span></u>", "ID": "bd031089-6296-4cf5-a201-e3a864f6c494", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "259c4912-2f53-464e-8f05-939c3a94e985"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Special patient populations</span>", "ID": "9899cc7d-5009-4e78-9637-6948e91e2d17", "Styles": "font-size:11.0pt;font-weight:normal", "Classes": "None", "Text": "Special patient populations", "ParentId": "bd031089-6296-4cf5-a201-e3a864f6c494"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-style:normal\">\u00a0</span></p>", "ID": "a556bb05-7cd3-45fc-995b-bcb826c3a1ba", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-style:normal\">\u00a0</span>", "ID": "e497bdf9-a2fe-444c-9809-31ebe2a2ce55", "Styles": "font-size:11.0pt;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "a556bb05-7cd3-45fc-995b-bcb826c3a1ba"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Elderly</span></i></p>", "ID": "bf8e32a0-7d90-4ae9-9aa6-6a906b0055bd", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading2']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Elderly</span></i>", "ID": "1ea44a67-29e0-48ab-89ab-34362f052829", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bf8e32a0-7d90-4ae9-9aa6-6a906b0055bd"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Elderly</span>", "ID": "f6721bd0-641a-4f37-9441-5bb08f5e7eb4", "Styles": "font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none", "Classes": "None", "Text": "Elderly", "ParentId": "1ea44a67-29e0-48ab-89ab-34362f052829"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span></i></p>", "ID": "9edaf0c5-4698-4ff0-9386-68f030f38719", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading2']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span></i>", "ID": "e4eb309a-56d7-4c95-80b3-fe591e46601b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9edaf0c5-4698-4ff0-9386-68f030f38719"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span>", "ID": "60635ddf-1af0-49d9-bcfd-901d8a18c3ba", "Styles": "font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "e4eb309a-56d7-4c95-80b3-fe591e46601b"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style='font-size:\n11.0pt;font-family:\"Times New Roman\",serif;font-weight:normal;text-decoration:\nnone'>No dose adjustment of ixazomib is required for patients over 65\u00a0years\nof age. </span></p>", "ID": "557e14fd-a12f-411f-acc6-862a41873123", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorSubheading2']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:\n11.0pt;font-family:\"Times New Roman\",serif;font-weight:normal;text-decoration:\nnone'>No dose adjustment of ixazomib is required for patients over 65\u00a0years\nof age. </span>", "ID": "8624ac4b-36ef-4c4a-b72c-ea9cc947bc75", "Styles": "font-size:\n11.0pt;font-family:\"Times New Roman\",serif;font-weight:normal;text-decoration:\nnone", "Classes": "None", "Text": "No dose adjustment of ixazomib is required for patients over 65\u00a0years of age. ", "ParentId": "557e14fd-a12f-411f-acc6-862a41873123"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8f0501bb-a7cb-44a7-8d7a-9faae09f2df1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f0e6e97e-730a-4484-8a54-52165e01e29c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8f0501bb-a7cb-44a7-8d7a-9faae09f2df1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Discontinuations in patients &gt;\u00a075\nyears of age were reported in 13 patients (28%) in the ixazomib regimen and 10\npatients (16%) in the placebo regimen. Cardiac arrhythmias in patients &gt;\u00a075\nyears of age were observed in 10 patients (21%) in the ixazomib regimen and 9\npatients (15%) in the placebo regimen. </p>", "ID": "512cdcfa-3c9a-4b87-962b-c6fcab1ebe87", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Discontinuations in patients >\u00a075 years of age were reported in 13 patients (28%) in the ixazomib regimen and 10 patients (16%) in the placebo regimen. Cardiac arrhythmias in patients >\u00a075 years of age were observed in 10 patients (21%) in the ixazomib regimen and 9 patients (15%) in the placebo regimen. ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "2a445b8c-fef4-415a-a958-b6472de2552d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Hepatic\nimpairment</span></i></p>", "ID": "033cf07c-7e44-4d35-b8ad-b9680c6d9037", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading2']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Hepatic\nimpairment</span></i>", "ID": "f5df75c3-918d-4fb3-ac7b-248968fba600", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "033cf07c-7e44-4d35-b8ad-b9680c6d9037"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Hepatic\nimpairment</span>", "ID": "5c9cc2f2-17f9-433f-94bf-04d7c527a6e1", "Styles": "font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none", "Classes": "None", "Text": "Hepatic impairment", "ParentId": "f5df75c3-918d-4fb3-ac7b-248968fba600"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></p>", "ID": "158a451f-786c-4c49-a18a-cd96b6ddd7c4", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading2']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "4f4435c3-1445-4993-ac43-2faa903ffbd4", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "158a451f-786c-4c49-a18a-cd96b6ddd7c4"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "f4d66815-5b07-4770-bcb0-bf1c7ef2f9e1", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "4f4435c3-1445-4993-ac43-2faa903ffbd4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment of ixazomib is required for patients with mild hepatic impairment\n(total bilirubin \u2264\u00a0upper limit of normal (ULN) and aspartate\naminotransferase\u00a0(AST) &gt;\u00a0ULN or total bilirubin &gt;\u00a01\u20111.5\u00a0x\u00a0ULN\nand any AST). The reduced dose of 3\u00a0mg is recommended in patients with moderate\n(total bilirubin &gt;\u00a01.5\u20113\u00a0x\u00a0ULN) or severe (total\nbilirubin &gt;\u00a03\u00a0x\u00a0ULN) hepatic impairment (see section\u00a05.2).</span></p>", "ID": "73f62a36-78e9-4980-b3d3-25f2e73c6d36", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">No dose\nadjustment of ixazomib is required for patients with mild hepatic impairment\n(total bilirubin \u2264\u00a0upper limit of normal (ULN) and aspartate\naminotransferase\u00a0(AST) &gt;\u00a0ULN or total bilirubin &gt;\u00a01\u20111.5\u00a0x\u00a0ULN\nand any AST). The reduced dose of 3\u00a0mg is recommended in patients with moderate\n(total bilirubin &gt;\u00a01.5\u20113\u00a0x\u00a0ULN) or severe (total\nbilirubin &gt;\u00a03\u00a0x\u00a0ULN) hepatic impairment (see section\u00a05.2).</span>", "ID": "a9205bc6-4a76-435f-a00c-34d8443e56d9", "Styles": "None", "Classes": "None", "Text": "No dose adjustment of ixazomib is required for patients with mild hepatic impairment (total bilirubin \u2264\u00a0upper limit of normal (ULN) and aspartate aminotransferase\u00a0(AST) >\u00a0ULN or total bilirubin >\u00a01\u20111.5\u00a0x\u00a0ULN and any AST). The reduced dose of 3\u00a0mg is recommended in patients with moderate (total bilirubin >\u00a01.5\u20113\u00a0x\u00a0ULN) or severe (total bilirubin >\u00a03\u00a0x\u00a0ULN) hepatic impairment (see section\u00a05.2).", "ParentId": "73f62a36-78e9-4980-b3d3-25f2e73c6d36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "749df921-ed34-4b5f-b64c-eecf0a8c8849", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "4e665157-34b5-4bec-bd8e-d9bd58b77e67", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "749df921-ed34-4b5f-b64c-eecf0a8c8849"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "2e2df58b-7e77-4f9f-8b82-10e245ed00a7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4e665157-34b5-4bec-bd8e-d9bd58b77e67"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "9b5ddc71-55f8-4c60-b8d6-f8326b4d32a8", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "2e2df58b-7e77-4f9f-8b82-10e245ed00a7"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Renal\nimpairment</span></i></p>", "ID": "5d293124-7a5f-4dce-8850-98f070dce47e", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading2']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Renal\nimpairment</span></i>", "ID": "9d9c3dcd-6a5d-4525-a69d-012dfcb864a0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5d293124-7a5f-4dce-8850-98f070dce47e"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Renal\nimpairment</span>", "ID": "cd0352fd-ddf0-444f-82a6-502895233140", "Styles": "font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none", "Classes": "None", "Text": "Renal impairment", "ParentId": "9d9c3dcd-6a5d-4525-a69d-012dfcb864a0"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span></i></p>", "ID": "713859f0-c938-4783-96c8-37e015999db9", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading2']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span></i>", "ID": "3cae9317-4bde-4a65-8643-fa6657c98b49", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "713859f0-c938-4783-96c8-37e015999db9"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span>", "ID": "dc63d63a-59f6-49cc-aec7-b2d09bf4a264", "Styles": "font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "3cae9317-4bde-4a65-8643-fa6657c98b49"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">No dose\nadjustment of ixazomib is required for patients with mild or moderate renal\nimpairment (creatinine clearance \u2265\u00a0</span><span lang=\"EN-GB\">30\u00a0mL/min).\nThe reduced dose of 3\u00a0mg is recommended in patients with severe renal impairment\n(creatinine clearance &lt;\u00a030\u00a0mL/min) or end\u2011stage renal\ndisease (ESRD) requiring dialysis. Ixazomib is not dialyzable and, therefore,\ncan be administered without regard to the timing of dialysis (see section\u00a05.2).</span></p>", "ID": "18a045db-3fe7-43eb-8df4-cdb40346ca56", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">No dose\nadjustment of ixazomib is required for patients with mild or moderate renal\nimpairment (creatinine clearance \u2265\u00a0</span>", "ID": "ff33ffd9-1202-42ef-ac24-ea29b4561dee", "Styles": "None", "Classes": "None", "Text": "No dose adjustment of ixazomib is required for patients with mild or moderate renal impairment (creatinine clearance \u2265\u00a0", "ParentId": "18a045db-3fe7-43eb-8df4-cdb40346ca56"}, {"Element": "<span lang=\"EN-GB\">30\u00a0mL/min).\nThe reduced dose of 3\u00a0mg is recommended in patients with severe renal impairment\n(creatinine clearance &lt;\u00a030\u00a0mL/min) or end\u2011stage renal\ndisease (ESRD) requiring dialysis. Ixazomib is not dialyzable and, therefore,\ncan be administered without regard to the timing of dialysis (see section\u00a05.2).</span>", "ID": "e72d0395-ddce-408f-829f-dd806c956fe9", "Styles": "None", "Classes": "None", "Text": "30\u00a0mL/min). The reduced dose of 3\u00a0mg is recommended in patients with severe renal impairment (creatinine clearance <\u00a030\u00a0mL/min) or end\u2011stage renal disease (ESRD) requiring dialysis. Ixazomib is not dialyzable and, therefore, can be administered without regard to the timing of dialysis (see section\u00a05.2).", "ParentId": "18a045db-3fe7-43eb-8df4-cdb40346ca56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e10d55cd-1b8b-4517-bd07-745f12dd512d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "60d25747-6ed6-4ae2-ac23-d0c7576aa8b7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e10d55cd-1b8b-4517-bd07-745f12dd512d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Refer to the\nlenalidomide SmPC for dosing recommendations in patients with renal impairment.</span></p>", "ID": "940e18c1-7c6a-4ba2-93f2-f2c9c339a727", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Refer to the\nlenalidomide SmPC for dosing recommendations in patients with renal impairment.</span>", "ID": "a0e4a1a2-1173-4a4a-a14c-2c2b4415e333", "Styles": "None", "Classes": "None", "Text": "Refer to the lenalidomide SmPC for dosing recommendations in patients with renal impairment.", "ParentId": "940e18c1-7c6a-4ba2-93f2-f2c9c339a727"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "24b0e0db-2da7-41f7-a32e-b2c1654c105e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "71ab2f4d-b6e8-4890-95ef-a1ee7d5d244a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "24b0e0db-2da7-41f7-a32e-b2c1654c105e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a48734d3-41c9-4313-8eeb-d3888187f83c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "71ab2f4d-b6e8-4890-95ef-a1ee7d5d244a"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Paediatric population</span></i></p>", "ID": "ee445868-3eef-4e95-a9dd-7314bb371460", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading2']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Paediatric population</span></i>", "ID": "16e71f21-406f-492d-b3be-e075e4360ed9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ee445868-3eef-4e95-a9dd-7314bb371460"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>Paediatric population</span>", "ID": "718d43be-d9d4-4948-860b-382c76b264e9", "Styles": "font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none", "Classes": "None", "Text": "Paediatric population", "ParentId": "16e71f21-406f-492d-b3be-e075e4360ed9"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading2\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span></i></p>", "ID": "cad6de81-d856-4ece-9f25-0c3de4658406", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading2']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span></i>", "ID": "38009345-bcb9-43c6-99f9-f7a6102d46fd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cad6de81-d856-4ece-9f25-0c3de4658406"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none'>\u00a0</span>", "ID": "cc84dabe-cf5f-452d-99da-67ae5615447b", "Styles": "font-size:11.0pt;font-family:\n\"Times New Roman\",serif;font-weight:normal;text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "38009345-bcb9-43c6-99f9-f7a6102d46fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety and efficacy of ixazomib in children below 18\u00a0years\nof age have not been established. No data are available.</span></p>", "ID": "18d1223f-3331-4813-8465-66e4804c7051", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The safety and efficacy of ixazomib in children below 18\u00a0years\nof age have not been established. No data are available.</span>", "ID": "71a78420-3d06-4491-a68a-c714b74f82ff", "Styles": "None", "Classes": "None", "Text": "The safety and efficacy of ixazomib in children below 18\u00a0years of age have not been established. No data are available.", "ParentId": "18d1223f-3331-4813-8465-66e4804c7051"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "87e2b93c-c918-42f0-bf7b-90d848f1a5b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "2ef3721f-0f76-4d1c-b5a9-818b808917ff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "87e2b93c-c918-42f0-bf7b-90d848f1a5b5"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "1bb3d4a6-599c-4740-9e5f-48177bd694db", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2ef3721f-0f76-4d1c-b5a9-818b808917ff"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "cb6b8d78-3556-4c13-b767-6d5c98277220", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "1bb3d4a6-599c-4740-9e5f-48177bd694db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Method of administration </span></u></p>", "ID": "0fea9293-7b7f-48f2-989a-f1c459a8b9e4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Method of administration </span></u>", "ID": "25ed95bb-bf5c-497c-ab01-674462f33a45", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0fea9293-7b7f-48f2-989a-f1c459a8b9e4"}, {"Element": "<span lang=\"EN-GB\">Method of administration </span>", "ID": "55baf047-667d-450e-9fe3-4e86d7428fdb", "Styles": "None", "Classes": "None", "Text": "Method of administration ", "ParentId": "25ed95bb-bf5c-497c-ab01-674462f33a45"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "8f900bf6-4bba-4953-8b7c-b07055a33b8e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "75365c36-a89d-474f-84ec-7c3f0d25f6ef", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8f900bf6-4bba-4953-8b7c-b07055a33b8e"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "373a8f52-946d-4e1a-8258-1b87e198611d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "75365c36-a89d-474f-84ec-7c3f0d25f6ef"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "8f77d53f-229d-4a14-8643-d61224356d2c", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "373a8f52-946d-4e1a-8258-1b87e198611d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Ixazomib is for oral use.</span></p>", "ID": "23d8c470-b932-4860-8c1f-98a22237aee3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib is for oral use.</span>", "ID": "3354a562-3c2d-448b-9292-15ceeb45fa5a", "Styles": "None", "Classes": "None", "Text": "Ixazomib is for oral use.", "ParentId": "23d8c470-b932-4860-8c1f-98a22237aee3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>", "ID": "fa07d953-55c6-49b7-a99e-f1920ac817b2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i>", "ID": "bcbcee13-87cb-4b47-a852-abbac7946e9c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fa07d953-55c6-49b7-a99e-f1920ac817b2"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "91bd46e7-b223-483e-9699-48aa7e3915d8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bcbcee13-87cb-4b47-a852-abbac7946e9c"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "2b26fcff-c803-4117-890c-d15435b9d2b7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "91bd46e7-b223-483e-9699-48aa7e3915d8"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "a07a39bb-48c0-4f55-8a38-387adf38f658", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "2b26fcff-c803-4117-890c-d15435b9d2b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Ixazomib should be taken at approximately the same time on days 1,\n8, and 15 of each treatment cycle at least 1 hour before or at least 2 hours\nafter food (see section\u00a05.2). The capsule should be swallowed whole with\nwater. It should not be crushed, chewed, or opened (see section\u00a06.6). </span></p>", "ID": "9ec8c7ec-9286-4ac9-b3e0-ec760bfd6024", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib should be taken at approximately the same time on days 1,\n8, and 15 of each treatment cycle at least 1 hour before or at least 2 hours\nafter food (see section\u00a05.2). The capsule should be swallowed whole with\nwater. It should not be crushed, chewed, or opened (see section\u00a06.6). </span>", "ID": "897ae4e8-bd21-4a8a-b8c4-652161f056e4", "Styles": "None", "Classes": "None", "Text": "Ixazomib should be taken at approximately the same time on days 1, 8, and 15 of each treatment cycle at least 1 hour before or at least 2 hours after food (see section\u00a05.2). The capsule should be swallowed whole with water. It should not be crushed, chewed, or opened (see section\u00a06.6). ", "ParentId": "9ec8c7ec-9286-4ac9-b3e0-ec760bfd6024"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4892682e-4856-4826-ba4e-edcfba0a31e1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8daa8141-5fda-4699-9da2-f4a47f467d50", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4892682e-4856-4826-ba4e-edcfba0a31e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></b></p>", "ID": "e6e8bf6d-3670-4bfb-a4fc-6346e8542f2a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span></b>", "ID": "19e0f56a-e4f7-4af3-a623-71f5b1adb078", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e6e8bf6d-3670-4bfb-a4fc-6346e8542f2a"}, {"Element": "<span lang=\"EN-GB\">4.3\u00a0\u00a0\u00a0\u00a0 Contraindications</span>", "ID": "a8428c4d-5c4d-4bf5-98c0-d71ce7cd3cb0", "Styles": "None", "Classes": "None", "Text": "4.3\u00a0\u00a0\u00a0\u00a0 Contraindications", "ParentId": "19e0f56a-e4f7-4af3-a623-71f5b1adb078"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "347df14a-1fb7-4492-8153-099eed7d0f0d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a6be0b50-cae9-45b4-992e-474716e56e72", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "347df14a-1fb7-4492-8153-099eed7d0f0d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Hypersensitivity to the active substance or to any of the excipients\nlisted in section\u00a06.1.</span></p>", "ID": "9e14ad07-fd7d-476e-858c-db5e70e7703c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Hypersensitivity to the active substance or to any of the excipients\nlisted in section\u00a06.1.</span>", "ID": "dd10df9c-9ff1-4421-9a12-2941f1a9495a", "Styles": "None", "Classes": "None", "Text": "Hypersensitivity to the active substance or to any of the excipients listed in section\u00a06.1.", "ParentId": "9e14ad07-fd7d-476e-858c-db5e70e7703c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a5aebfc1-5c35-4c97-90e9-28d90bdb0309", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4df81e3f-0d21-44d1-a5b9-80b65aaf771d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a5aebfc1-5c35-4c97-90e9-28d90bdb0309"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and\ndexamethasone, refer to the SmPC for these medicinal products for additional\ncontraindications.</span></p>", "ID": "26dcc187-e5a3-44ba-9629-94989dff13d7", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and\ndexamethasone, refer to the SmPC for these medicinal products for additional\ncontraindications.</span>", "ID": "29437416-c03c-4964-a3fd-739fe6a879a9", "Styles": "None", "Classes": "None", "Text": "As ixazomib is administered in combination with lenalidomide and dexamethasone, refer to the SmPC for these medicinal products for additional contraindications.", "ParentId": "26dcc187-e5a3-44ba-9629-94989dff13d7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "69440e94-5e95-4efe-8efc-e6e84047111a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "b8f5d191-2bf4-4673-98f9-a9f786a9750b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "69440e94-5e95-4efe-8efc-e6e84047111a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f8040ad4-6f78-4b02-b13e-2ac9b7417889", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b8f5d191-2bf4-4673-98f9-a9f786a9750b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and precautions for use</span></b></p>", "ID": "37ec0913-beb5-4621-bdb7-3f9b208a8366", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and precautions for use</span></b>", "ID": "4d21d5af-b8b1-4fb2-a755-8cbf326baae9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "37ec0913-beb5-4621-bdb7-3f9b208a8366"}, {"Element": "<span lang=\"EN-GB\">4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and precautions for use</span>", "ID": "3b7e180c-b54d-4473-a7c9-21a9e3f4f538", "Styles": "None", "Classes": "None", "Text": "4.4\u00a0\u00a0\u00a0\u00a0 Special warnings and precautions for use", "ParentId": "4d21d5af-b8b1-4fb2-a755-8cbf326baae9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5ae6a19a-eae4-4dc8-af2b-59d9737fb9df", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "4e37faa5-9a8d-4a75-ab4e-a83c2bf0010c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5ae6a19a-eae4-4dc8-af2b-59d9737fb9df"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "979c34e2-081d-41b2-afea-99a515dd609b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4e37faa5-9a8d-4a75-ab4e-a83c2bf0010c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and dexamethasone,\nrefer to the SmPC for these medicinal products for additional special warnings\nand precautions for use.</span></p>", "ID": "aad4eda8-0d11-4607-aa11-0b18fa9c4a5a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and dexamethasone,\nrefer to the SmPC for these medicinal products for additional special warnings\nand precautions for use.</span>", "ID": "8d0c14cc-fb4a-4323-8040-1f571479549c", "Styles": "None", "Classes": "None", "Text": "As ixazomib is administered in combination with lenalidomide and dexamethasone, refer to the SmPC for these medicinal products for additional special warnings and precautions for use.", "ParentId": "aad4eda8-0d11-4607-aa11-0b18fa9c4a5a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "de322822-b002-4e63-8431-171f961c8429", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "a0fc1a50-8825-4316-a4ea-36378b790061", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "de322822-b002-4e63-8431-171f961c8429"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e4066cb9-8a99-4fff-b3d5-376619f083f6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a0fc1a50-8825-4316-a4ea-36378b790061"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia</span></u></p>", "ID": "550b7c29-840e-43ad-a2e5-38b6241c76a4", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia</span></u>", "ID": "227010ec-e58c-4b81-b409-228cc4473511", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "550b7c29-840e-43ad-a2e5-38b6241c76a4"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia</span>", "ID": "bb72201f-121d-472e-ac6a-cbac43b26227", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Thrombocytopenia", "ParentId": "227010ec-e58c-4b81-b409-228cc4473511"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "33f38f57-7844-431a-ae23-f50e8ee35934", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "e0f96e3b-1086-4ddd-a2e8-356d39e7a798", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "33f38f57-7844-431a-ae23-f50e8ee35934"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "18698839-8023-4c4f-ba91-3a4fe441e82f", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "", "ParentId": "e0f96e3b-1086-4ddd-a2e8-356d39e7a798"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "46e59886-add7-4624-8304-96f41fd33b86", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "18698839-8023-4c4f-ba91-3a4fe441e82f"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia\nhas been reported with </span><span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\">ixazomib</span><span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\"> (see section\u00a04.8) with platelet nadirs typically\noccurring between Days 14\u201121 of each 28\u2011day cycle and recovery to\nbaseline by the start of the next cycle (see section\u00a04.8). </span></p>", "ID": "87ae9c9d-e644-42d9-a449-9ee6a605eb07", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia\nhas been reported with </span>", "ID": "32c4302a-7420-4beb-b48f-1308bd85e89c", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Thrombocytopenia has been reported with ", "ParentId": "87ae9c9d-e644-42d9-a449-9ee6a605eb07"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\">ixazomib</span>", "ID": "683460ed-37c4-48d8-8221-59bc221cb601", "Styles": "color:windowtext;\nfont-style:normal", "Classes": "None", "Text": "ixazomib", "ParentId": "87ae9c9d-e644-42d9-a449-9ee6a605eb07"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\"> (see section\u00a04.8) with platelet nadirs typically\noccurring between Days 14\u201121 of each 28\u2011day cycle and recovery to\nbaseline by the start of the next cycle (see section\u00a04.8). </span>", "ID": "a9ac918e-e588-45ab-a447-6e82f2135f5d", "Styles": "color:windowtext;\nfont-style:normal", "Classes": "None", "Text": " (see section\u00a04.8) with platelet nadirs typically occurring between Days 14\u201121 of each 28\u2011day cycle and recovery to baseline by the start of the next cycle (see section\u00a04.8). ", "ParentId": "87ae9c9d-e644-42d9-a449-9ee6a605eb07"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "28cbb8d4-5b81-436c-b802-0e8965a82582", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "487ac709-3734-43f5-ac22-71d7019a864f", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "28cbb8d4-5b81-436c-b802-0e8965a82582"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Platelet\ncounts should be monitored at least monthly during ixazomib treatment. </span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">More frequent monitoring should\nbe considered during the first three cycles as per the lenalidomide SmPC. </span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia can be\nmanaged with dose modifications (see section\u00a04.2) and platelet\ntransfusions as per standard medical guidelines. </span></p>", "ID": "e8818fa6-5fe0-47f5-ae63-424b8b82345c", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Platelet\ncounts should be monitored at least monthly during ixazomib treatment. </span>", "ID": "99213039-de28-4024-a2bd-6b825db9f32a", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Platelet counts should be monitored at least monthly during ixazomib treatment. ", "ParentId": "e8818fa6-5fe0-47f5-ae63-424b8b82345c"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">More frequent monitoring should\nbe considered during the first three cycles as per the lenalidomide SmPC. </span>", "ID": "45d32b72-09d1-413d-83df-9ad46ccefef5", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "More frequent monitoring should be considered during the first three cycles as per the lenalidomide SmPC. ", "ParentId": "e8818fa6-5fe0-47f5-ae63-424b8b82345c"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia can be\nmanaged with dose modifications (see section\u00a04.2) and platelet\ntransfusions as per standard medical guidelines. </span>", "ID": "11bbb25a-11bd-4919-a2e0-01c86473cdb7", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Thrombocytopenia can be managed with dose modifications (see section\u00a04.2) and platelet transfusions as per standard medical guidelines. ", "ParentId": "e8818fa6-5fe0-47f5-ae63-424b8b82345c"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "ab916246-1ff4-4110-9f28-8b550b721ae4", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "118bcdea-6acf-4b42-83e0-51abf976c0fc", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "ab916246-1ff4-4110-9f28-8b550b721ae4"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Gastrointestinal toxicities</span></u></p>", "ID": "93c3b9ba-b411-416c-a7b4-b7cca04a5076", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Gastrointestinal toxicities</span></u>", "ID": "f514b511-77e3-45de-9aa2-6d3b21075785", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "93c3b9ba-b411-416c-a7b4-b7cca04a5076"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Gastrointestinal toxicities</span>", "ID": "61c39833-814a-4402-81a3-0c2544196016", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Gastrointestinal toxicities", "ParentId": "f514b511-77e3-45de-9aa2-6d3b21075785"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "dc5200a0-4323-406d-a3c6-404510755e8f", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "38eb79e4-2a71-458e-b212-aa2a70ce02bd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc5200a0-4323-406d-a3c6-404510755e8f"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "15ed18b9-ec59-40f3-83af-de01dbaab6dd", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "", "ParentId": "38eb79e4-2a71-458e-b212-aa2a70ce02bd"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "78ca0c56-5c27-4f0a-9f2a-adc8aa030078", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "15ed18b9-ec59-40f3-83af-de01dbaab6dd"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Diarrhoea,\nconstipation, nausea and vomiting have been reported with ixazomib,\noccasionally requiring use of antiemetic and antidiarrhoeal medicinal products and\nsupportive care (see section\u00a04.8). The dose should be adjusted for severe\n(Grade 3\u20114) symptoms (see section\u00a04.2).</span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"> In case of severe gastrointestinal\nevents, monitoring of serum potassium level is recommended.</span></p>", "ID": "17017808-99f3-44fd-b642-f1ba38be55ab", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Diarrhoea,\nconstipation, nausea and vomiting have been reported with ixazomib,\noccasionally requiring use of antiemetic and antidiarrhoeal medicinal products and\nsupportive care (see section\u00a04.8). The dose should be adjusted for severe\n(Grade 3\u20114) symptoms (see section\u00a04.2).</span>", "ID": "cc21a683-082f-40d6-9cc3-9907a758642a", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Diarrhoea, constipation, nausea and vomiting have been reported with ixazomib, occasionally requiring use of antiemetic and antidiarrhoeal medicinal products and supportive care (see section\u00a04.8). The dose should be adjusted for severe (Grade 3\u20114) symptoms (see section\u00a04.2).", "ParentId": "17017808-99f3-44fd-b642-f1ba38be55ab"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"> In case of severe gastrointestinal\nevents, monitoring of serum potassium level is recommended.</span>", "ID": "3d0ac5e2-ecb7-46e6-8def-5d5249203037", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": " In case of severe gastrointestinal events, monitoring of serum potassium level is recommended.", "ParentId": "17017808-99f3-44fd-b642-f1ba38be55ab"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "4161c9d9-25e4-4589-bcf4-038f2ef4490d", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "9afc6e76-ea8b-406d-b400-25d9ce9b6718", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "4161c9d9-25e4-4589-bcf4-038f2ef4490d"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Peripheral neuropathy</span></u></p>", "ID": "f6cd3f5c-83bc-4549-ab6b-3cba17021f0a", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Peripheral neuropathy</span></u>", "ID": "7e5d2c8a-238f-4582-bddb-485516a2c110", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f6cd3f5c-83bc-4549-ab6b-3cba17021f0a"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Peripheral neuropathy</span>", "ID": "1f20c4bb-3053-43f3-a0c5-3c58ea3fea74", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Peripheral neuropathy", "ParentId": "7e5d2c8a-238f-4582-bddb-485516a2c110"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "73b31d1d-8e66-4401-9a81-8b3e73c8a1a8", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "ed1bcb61-6302-402d-bce1-e9e38402d932", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "73b31d1d-8e66-4401-9a81-8b3e73c8a1a8"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "2f7aa4a4-467b-4204-8b4f-fe5ea7183f6d", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "ed1bcb61-6302-402d-bce1-e9e38402d932"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "55249c56-613a-41a4-8641-cdeaf3aa9c9f", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "2f7aa4a4-467b-4204-8b4f-fe5ea7183f6d"}, {"Element": "<p class=\"MsoNoSpacing\"><span style='font-family:\"Times New Roman\",serif'>Peripheral\nneuropathy has been reported with ixazomib (see section\u00a04.8).<i> </i></span><span style='font-family:\"Times New Roman\",serif'>The patient should be monitored for\nsymptoms of peripheral neuropathy. Patients experiencing new or worsening\nperipheral neuropathy may require dose modification </span><span style='font-family:\"Times New Roman\",serif'>(see section\u00a04.2)</span><span style='font-family:\"Times New Roman\",serif'>.</span></p>", "ID": "db280030-cc1d-4cb3-87a9-c78cc636b438", "Styles": "None", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style='font-family:\"Times New Roman\",serif'>Peripheral\nneuropathy has been reported with ixazomib (see section\u00a04.8).<i> </i></span>", "ID": "c54ba919-fc3c-47a5-a361-e254a47a1665", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Peripheral neuropathy has been reported with ixazomib (see section\u00a04.8).", "ParentId": "db280030-cc1d-4cb3-87a9-c78cc636b438"}, {"Element": "<i> </i>", "ID": "70e6a015-82c6-4d24-a928-4cdbb70a9ee3", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "c54ba919-fc3c-47a5-a361-e254a47a1665"}, {"Element": "<span style='font-family:\"Times New Roman\",serif'>The patient should be monitored for\nsymptoms of peripheral neuropathy. Patients experiencing new or worsening\nperipheral neuropathy may require dose modification </span>", "ID": "e998e73a-bf8b-4186-89a3-c4acb683ae25", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The patient should be monitored for symptoms of peripheral neuropathy. Patients experiencing new or worsening peripheral neuropathy may require dose modification ", "ParentId": "db280030-cc1d-4cb3-87a9-c78cc636b438"}, {"Element": "<span style='font-family:\"Times New Roman\",serif'>(see section\u00a04.2)</span>", "ID": "373c18dd-fc5b-4bb5-9212-f75a9746bfef", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "(see section\u00a04.2)", "ParentId": "db280030-cc1d-4cb3-87a9-c78cc636b438"}, {"Element": "<span style='font-family:\"Times New Roman\",serif'>.</span>", "ID": "7247111f-d0ce-46b1-b780-4c053d0ac789", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": ".", "ParentId": "db280030-cc1d-4cb3-87a9-c78cc636b438"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "bc7a9a72-90a2-4e3e-88a7-9807eeb1a39c", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "6764e491-a517-4d5a-8eee-9fe2bf4cc09f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc7a9a72-90a2-4e3e-88a7-9807eeb1a39c"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "0a49350d-29fb-4f5f-96aa-1e4e2d8ba678", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "6764e491-a517-4d5a-8eee-9fe2bf4cc09f"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "085d0077-dcad-4be9-acb9-15a1c38d7e2c", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "0a49350d-29fb-4f5f-96aa-1e4e2d8ba678"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Peripheral oedema</span></u></p>", "ID": "9c98d58d-a6bc-4f44-81d9-51d2e86f553b", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Peripheral oedema</span></u>", "ID": "4f1c048a-33b9-4baf-ba6d-1bfa71d9cf18", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9c98d58d-a6bc-4f44-81d9-51d2e86f553b"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Peripheral oedema</span>", "ID": "84bbdbdd-f2df-43f2-a516-8fc550b5370d", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Peripheral oedema", "ParentId": "4f1c048a-33b9-4baf-ba6d-1bfa71d9cf18"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "5dc836ee-b569-4a85-99e3-202d753fbfcd", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "5f76a921-a3ae-4bcb-b5e4-d5ff6c78687c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5dc836ee-b569-4a85-99e3-202d753fbfcd"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "352e6af3-b6e5-48c4-a880-341c81df2407", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "", "ParentId": "5f76a921-a3ae-4bcb-b5e4-d5ff6c78687c"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "98c58ec4-26ff-43da-80a8-25c372d9df12", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "352e6af3-b6e5-48c4-a880-341c81df2407"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peripheral\noedema has been reported with ixazomib (see section\u00a04.8). The patient\nshould be e</span><span lang=\"EN-GB\">valuated for underlying causes and provide\nsupportive care, as necessary. The dose of dexamethasone should be adjusted per\nits prescribing information or ixazomib for Grade</span><span lang=\"EN-GB\">\u00a0</span><span lang=\"EN-GB\">3</span><span lang=\"EN-GB\">\u00a0</span><span lang=\"EN-GB\">or</span><span lang=\"EN-GB\">\u00a0</span><span lang=\"EN-GB\">4 symptoms </span><span lang=\"EN-GB\">(see\nsection\u00a04.2)</span><span lang=\"EN-GB\">.</span></p>", "ID": "03ea8a4f-905c-496c-9297-7980bf3bf243", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Peripheral\noedema has been reported with ixazomib (see section\u00a04.8). The patient\nshould be e</span>", "ID": "ea4b2ff1-7f4c-444c-b3a6-ea96008d6aff", "Styles": "None", "Classes": "None", "Text": "Peripheral oedema has been reported with ixazomib (see section\u00a04.8). The patient should be e", "ParentId": "03ea8a4f-905c-496c-9297-7980bf3bf243"}, {"Element": "<span lang=\"EN-GB\">valuated for underlying causes and provide\nsupportive care, as necessary. The dose of dexamethasone should be adjusted per\nits prescribing information or ixazomib for Grade</span>", "ID": "7d13ba75-9d09-4a62-9546-87702742da5d", "Styles": "None", "Classes": "None", "Text": "valuated for underlying causes and provide supportive care, as necessary. The dose of dexamethasone should be adjusted per its prescribing information or ixazomib for Grade", "ParentId": "03ea8a4f-905c-496c-9297-7980bf3bf243"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7e54af26-2cd6-48eb-81d5-2530cf64e3bc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "03ea8a4f-905c-496c-9297-7980bf3bf243"}, {"Element": "<span lang=\"EN-GB\">3</span>", "ID": "feb99b3d-d35e-42fc-b835-b6d75c12864c", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "03ea8a4f-905c-496c-9297-7980bf3bf243"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6720e434-46ea-4ef4-8336-973ad7c6ebde", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "03ea8a4f-905c-496c-9297-7980bf3bf243"}, {"Element": "<span lang=\"EN-GB\">or</span>", "ID": "df3871b9-732a-4936-be63-59c43e9abfe2", "Styles": "None", "Classes": "None", "Text": "or", "ParentId": "03ea8a4f-905c-496c-9297-7980bf3bf243"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5bf0feeb-784f-41d5-93cb-63da56ccf15d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "03ea8a4f-905c-496c-9297-7980bf3bf243"}, {"Element": "<span lang=\"EN-GB\">4 symptoms </span>", "ID": "d8c844bb-cdef-41f5-b12d-bc1122e8af23", "Styles": "None", "Classes": "None", "Text": "4 symptoms ", "ParentId": "03ea8a4f-905c-496c-9297-7980bf3bf243"}, {"Element": "<span lang=\"EN-GB\">(see\nsection\u00a04.2)</span>", "ID": "0efc2d32-1b51-4a9b-bbca-531a48f857ed", "Styles": "None", "Classes": "None", "Text": "(see section\u00a04.2)", "ParentId": "03ea8a4f-905c-496c-9297-7980bf3bf243"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "dcae091e-9f0c-44fd-b15a-31d7d3264bee", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "03ea8a4f-905c-496c-9297-7980bf3bf243"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "4392deee-6488-42e2-b75f-2447bba8644b", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "a8a60cb6-d66b-43ea-b1e2-df1f2bedc7fc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4392deee-6488-42e2-b75f-2447bba8644b"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "f8ca6ae7-7cac-4a17-94bc-3605eb5906c3", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "a8a60cb6-d66b-43ea-b1e2-df1f2bedc7fc"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "a6e3eb15-9336-4e1a-a759-7df21e60dbea", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "f8ca6ae7-7cac-4a17-94bc-3605eb5906c3"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span style='font-family:\n\"Times New Roman\",serif'>Cutaneous reactions</span></u></p>", "ID": "4f5bba39-fe4b-4ca9-92d4-83035349a6e0", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span style='font-family:\n\"Times New Roman\",serif'>Cutaneous reactions</span></u>", "ID": "79883af1-9ef6-4815-a354-16eb91463bf1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4f5bba39-fe4b-4ca9-92d4-83035349a6e0"}, {"Element": "<span style='font-family:\n\"Times New Roman\",serif'>Cutaneous reactions</span>", "ID": "1c3dd71c-0c4e-4f4d-ad49-128a2ec3a983", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Cutaneous reactions", "ParentId": "79883af1-9ef6-4815-a354-16eb91463bf1"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><span style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a23f1a81-bd18-4dda-9b84-9eced8eef595", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "2db78468-441b-40cb-bf09-2a15a84c04ae", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a23f1a81-bd18-4dda-9b84-9eced8eef595"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rash has been\nreported with ixazomib (see section\u00a04.8). </span><span class=\"MsoCommentReference\"><span lang=\"EN-GB\">Rash should be managed with supportive\ncare or with dose modification if Grade</span></span><span lang=\"EN-GB\">\u00a0</span><span class=\"MsoCommentReference\"><span lang=\"EN-GB\">2 or higher </span></span><span lang=\"EN-GB\">(see section\u00a04.2)</span><i><span lang=\"EN-GB\">.</span></i></p>", "ID": "352fd069-2cd0-4d25-9008-b265ee59d507", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Rash has been\nreported with ixazomib (see section\u00a04.8). </span>", "ID": "6d52b606-3176-4d21-82fb-99fcbdc61f85", "Styles": "None", "Classes": "None", "Text": "Rash has been reported with ixazomib (see section\u00a04.8). ", "ParentId": "352fd069-2cd0-4d25-9008-b265ee59d507"}, {"Element": "<span class=\"MsoCommentReference\"><span lang=\"EN-GB\">Rash should be managed with supportive\ncare or with dose modification if Grade</span></span>", "ID": "1c96ef08-6358-487f-8a87-13e8b4fb3f6c", "Styles": "None", "Classes": "['MsoCommentReference']", "Text": "", "ParentId": "352fd069-2cd0-4d25-9008-b265ee59d507"}, {"Element": "<span lang=\"EN-GB\">Rash should be managed with supportive\ncare or with dose modification if Grade</span>", "ID": "c7fd57ca-d402-4140-b345-9c69ec1a1aca", "Styles": "None", "Classes": "None", "Text": "Rash should be managed with supportive care or with dose modification if Grade", "ParentId": "1c96ef08-6358-487f-8a87-13e8b4fb3f6c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f774cb8a-c40c-4481-b9f1-9c0eae4ca324", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "352fd069-2cd0-4d25-9008-b265ee59d507"}, {"Element": "<span class=\"MsoCommentReference\"><span lang=\"EN-GB\">2 or higher </span></span>", "ID": "c102313f-f775-4f94-b582-c62348cba33b", "Styles": "None", "Classes": "['MsoCommentReference']", "Text": "", "ParentId": "352fd069-2cd0-4d25-9008-b265ee59d507"}, {"Element": "<span lang=\"EN-GB\">2 or higher </span>", "ID": "84118106-dae0-4e33-a453-6d356184043f", "Styles": "None", "Classes": "None", "Text": "2 or higher ", "ParentId": "c102313f-f775-4f94-b582-c62348cba33b"}, {"Element": "<span lang=\"EN-GB\">(see section\u00a04.2)</span>", "ID": "0537f27f-85db-4009-8d24-63f34f72d329", "Styles": "None", "Classes": "None", "Text": "(see section\u00a04.2)", "ParentId": "352fd069-2cd0-4d25-9008-b265ee59d507"}, {"Element": "<i><span lang=\"EN-GB\">.</span></i>", "ID": "3f99916f-f25c-47ac-851e-89ec91578cf8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "352fd069-2cd0-4d25-9008-b265ee59d507"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "db57b499-0921-46e2-ac43-29f6a87bf4fd", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "3f99916f-f25c-47ac-851e-89ec91578cf8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "803884d8-c526-4e9e-8103-c1182d436205", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0666659d-afb4-4d43-815a-408153349200", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "803884d8-c526-4e9e-8103-c1182d436205"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span style='font-family:\n\"Times New Roman\",serif'>Thrombotic microangiopathy</span></u></p>", "ID": "f6f6aa02-0658-4c25-b3dd-300ffe0dfb50", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span style='font-family:\n\"Times New Roman\",serif'>Thrombotic microangiopathy</span></u>", "ID": "1ce044ce-9673-41a0-95a6-b0b8a9a515ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f6f6aa02-0658-4c25-b3dd-300ffe0dfb50"}, {"Element": "<span style='font-family:\n\"Times New Roman\",serif'>Thrombotic microangiopathy</span>", "ID": "2709141c-379c-4706-bff7-a69797caf209", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Thrombotic microangiopathy", "ParentId": "1ce044ce-9673-41a0-95a6-b0b8a9a515ad"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "65a21cff-951f-4b8b-904c-2e957e3edf3f", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "5955a23d-9fc9-43e8-ba92-72ca929997ee", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65a21cff-951f-4b8b-904c-2e957e3edf3f"}, {"Element": "<span style='font-family:\n\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "5b6a2450-5b80-47a7-83d8-2fc3267219ff", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "5955a23d-9fc9-43e8-ba92-72ca929997ee"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "e722f6d9-9611-4a58-a182-0e14323e394c", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "5b6a2450-5b80-47a7-83d8-2fc3267219ff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cases of\nthrombotic microangiopathy (TMA), </span>including thrombotic thrombocytopenic\npurpura (TTP), <span lang=\"EN-GB\">have been reported in patients who received\nixazomib. Some of these events have been fatal. Signs and symptoms of TMA\nshould be monitored for. If the diagnosis is suspected, stop ixazomib and\nevaluate patients for possible TMA. If the diagnosis of TMA is excluded,\nixazomib can be restarted. The safety of reinitiating ixazomib therapy in\npatients previously experiencing TMA is not known.</span></p>", "ID": "54b580f7-ba18-48a2-bf82-80a43fec0642", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "including thrombotic thrombocytopenic purpura (TTP), ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Cases of\nthrombotic microangiopathy (TMA), </span>", "ID": "1dded43b-3119-41fd-a37a-a623b26e86d6", "Styles": "None", "Classes": "None", "Text": "Cases of thrombotic microangiopathy (TMA), ", "ParentId": "54b580f7-ba18-48a2-bf82-80a43fec0642"}, {"Element": "<span lang=\"EN-GB\">have been reported in patients who received\nixazomib. Some of these events have been fatal. Signs and symptoms of TMA\nshould be monitored for. If the diagnosis is suspected, stop ixazomib and\nevaluate patients for possible TMA. If the diagnosis of TMA is excluded,\nixazomib can be restarted. The safety of reinitiating ixazomib therapy in\npatients previously experiencing TMA is not known.</span>", "ID": "fe4654fa-4317-4dad-8eb3-710c5c04768a", "Styles": "None", "Classes": "None", "Text": "have been reported in patients who received ixazomib. Some of these events have been fatal. Signs and symptoms of TMA should be monitored for. If the diagnosis is suspected, stop ixazomib and evaluate patients for possible TMA. If the diagnosis of TMA is excluded, ixazomib can be restarted. The safety of reinitiating ixazomib therapy in patients previously experiencing TMA is not known.", "ParentId": "54b580f7-ba18-48a2-bf82-80a43fec0642"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "9c5b3071-b43c-4937-b596-022a8eaf93f3", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "4a57f670-85fa-4a17-9bd5-b93c702a0f95", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9c5b3071-b43c-4937-b596-022a8eaf93f3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "32394cf9-d707-45f1-9dc6-86dc71babc5c", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "", "ParentId": "4a57f670-85fa-4a17-9bd5-b93c702a0f95"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "7a32c13f-df2d-484f-b0fc-384fd854302b", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "32394cf9-d707-45f1-9dc6-86dc71babc5c"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><u><span style='font-family:\n\"Times New Roman\",serif'>Hepatotoxicity</span></u></p>", "ID": "907887e2-405a-467a-8f39-85a4df2ad53f", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span style='font-family:\n\"Times New Roman\",serif'>Hepatotoxicity</span></u>", "ID": "32303413-393e-4da0-a320-3583ef2a0a32", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "907887e2-405a-467a-8f39-85a4df2ad53f"}, {"Element": "<span style='font-family:\n\"Times New Roman\",serif'>Hepatotoxicity</span>", "ID": "4f884ab2-55ed-4a6a-ad3e-b342b99efc0a", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Hepatotoxicity", "ParentId": "32303413-393e-4da0-a320-3583ef2a0a32"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><span style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "04fb16ba-32cc-4105-be78-067b9e6dc7de", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "08dae45b-daa2-47b5-92e5-14e05e218c90", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "04fb16ba-32cc-4105-be78-067b9e6dc7de"}, {"Element": "<p class=\"MsoCommentText\" style=\"line-height:normal\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">Drug\u2011induced liver injury, hepatocellular\ninjury, hepatic steatosis, hepatitis cholestatic and hepatotoxicity have been uncommonly\nreported with ixazomib (see section\u00a04.8). </span><span style=\"font-size:\n11.0pt\">Hepatic enzymes should be m</span><span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">onitored regularly and </span></span><span class=\"MsoCommentReference\"><span style=\"font-size:11.0pt\">the dose should be\nadjusted</span></span><span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\"> for Grade</span></span><span lang=\"X-NONE\" style=\"font-size:11.0pt\">\u00a0</span><span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">3</span></span><span lang=\"X-NONE\" style=\"font-size:11.0pt\">\u00a0</span><span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">or</span></span><span lang=\"X-NONE\" style=\"font-size:11.0pt\">\u00a0</span><span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">4 symptoms </span></span><span lang=\"X-NONE\" style=\"font-size:11.0pt\">(see section\u00a04.2)</span><i><span lang=\"X-NONE\" style=\"font-size:11.0pt\">.</span></i></p>", "ID": "22d641bd-c0b7-4546-9543-882fa215047c", "Styles": "line-height:normal", "Classes": "['MsoCommentText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\">Drug\u2011induced liver injury, hepatocellular\ninjury, hepatic steatosis, hepatitis cholestatic and hepatotoxicity have been uncommonly\nreported with ixazomib (see section\u00a04.8). </span>", "ID": "3a26ffc3-fcac-4d37-a973-729a9ac49acf", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Drug\u2011induced liver injury, hepatocellular injury, hepatic steatosis, hepatitis cholestatic and hepatotoxicity have been uncommonly reported with ixazomib (see section\u00a04.8). ", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span style=\"font-size:\n11.0pt\">Hepatic enzymes should be m</span>", "ID": "ba5d0b37-6e6b-43c4-8ea2-f64813099e9e", "Styles": "font-size:\n11.0pt", "Classes": "None", "Text": "Hepatic enzymes should be m", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">onitored regularly and </span></span>", "ID": "e0ffe857-6710-4871-85c9-b0499dd5d655", "Styles": "None", "Classes": "['MsoCommentReference']", "Text": "", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\">onitored regularly and </span>", "ID": "05711848-88a2-4d69-8c3b-5a7682745e42", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "onitored regularly and ", "ParentId": "e0ffe857-6710-4871-85c9-b0499dd5d655"}, {"Element": "<span class=\"MsoCommentReference\"><span style=\"font-size:11.0pt\">the dose should be\nadjusted</span></span>", "ID": "eb49100c-b727-49c9-898e-243990ab552e", "Styles": "None", "Classes": "['MsoCommentReference']", "Text": "", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span style=\"font-size:11.0pt\">the dose should be\nadjusted</span>", "ID": "29f69654-18d7-4539-bb27-701acc58227a", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "the dose should be adjusted", "ParentId": "eb49100c-b727-49c9-898e-243990ab552e"}, {"Element": "<span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\"> for Grade</span></span>", "ID": "7bca2f5d-7170-4fc5-836c-b8713109dd66", "Styles": "None", "Classes": "['MsoCommentReference']", "Text": "", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\"> for Grade</span>", "ID": "c3ae736f-36d6-4510-a235-0824c998c09d", "Styles": "font-size:11.0pt", "Classes": "None", "Text": " for Grade", "ParentId": "7bca2f5d-7170-4fc5-836c-b8713109dd66"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "a10a6575-08a4-45b8-a664-b2dcb7f1080e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">3</span></span>", "ID": "57f183ec-0ff0-42b5-8084-01cd7668404a", "Styles": "None", "Classes": "['MsoCommentReference']", "Text": "", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\">3</span>", "ID": "e29359e2-2176-4b16-8281-b6c2d8ad9fc2", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "3", "ParentId": "57f183ec-0ff0-42b5-8084-01cd7668404a"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "584d56f3-dcc9-4f12-9adf-7fffcb908bec", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">or</span></span>", "ID": "81ec79dc-5f03-4be0-a255-5179f2980430", "Styles": "None", "Classes": "['MsoCommentReference']", "Text": "", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\">or</span>", "ID": "409accab-cf72-41fc-af38-873c704f2c3c", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "or", "ParentId": "81ec79dc-5f03-4be0-a255-5179f2980430"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "a31e0683-4618-432d-87a1-442fb522416d", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span class=\"MsoCommentReference\"><span lang=\"X-NONE\" style=\"font-size:11.0pt\">4 symptoms </span></span>", "ID": "e4c31021-97b1-4502-a735-b5fecdecc898", "Styles": "None", "Classes": "['MsoCommentReference']", "Text": "", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\">4 symptoms </span>", "ID": "f622a298-52d5-4f6d-9090-045a284e82f3", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "4 symptoms ", "ParentId": "e4c31021-97b1-4502-a735-b5fecdecc898"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\">(see section\u00a04.2)</span>", "ID": "db93d982-70e5-4d9b-85cb-04d1e136a3b9", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "(see section\u00a04.2)", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<i><span lang=\"X-NONE\" style=\"font-size:11.0pt\">.</span></i>", "ID": "45b94986-e963-411d-9956-13198c85aeca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "22d641bd-c0b7-4546-9543-882fa215047c"}, {"Element": "<span lang=\"X-NONE\" style=\"font-size:11.0pt\">.</span>", "ID": "c302343b-b7aa-4049-a5f3-1cc6782cf91b", "Styles": "font-size:11.0pt", "Classes": "None", "Text": ".", "ParentId": "45b94986-e963-411d-9956-13198c85aeca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "d8be4b73-91ae-4638-838f-f8c448eba09f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "e6e204f7-732d-4e3e-b5b0-6b994bfababf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d8be4b73-91ae-4638-838f-f8c448eba09f"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "10e12da0-7f29-4069-989d-013b5ef7a5e4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e6e204f7-732d-4e3e-b5b0-6b994bfababf"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "2eeae6b1-a96a-408f-b24b-af68c228cb59", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "10e12da0-7f29-4069-989d-013b5ef7a5e4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>", "ID": "bfc9d9f1-a4ba-44c8-92a7-117c9f64982b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Pregnancy</span></u>", "ID": "14d66204-201c-4494-ac37-483d9562d6e4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bfc9d9f1-a4ba-44c8-92a7-117c9f64982b"}, {"Element": "<span lang=\"EN-GB\">Pregnancy</span>", "ID": "8794d6a3-2430-46b1-80fd-95240c078b5d", "Styles": "None", "Classes": "None", "Text": "Pregnancy", "ParentId": "14d66204-201c-4494-ac37-483d9562d6e4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "f7916346-7b5f-4e4e-96d6-b086a83879a5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "f5032a83-f874-40e2-9335-288eaaca2f4e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f7916346-7b5f-4e4e-96d6-b086a83879a5"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "31148927-cee1-4b57-a4af-ad7014335983", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f5032a83-f874-40e2-9335-288eaaca2f4e"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "8e11d0fc-dc7a-43b5-9e43-da22de403f40", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "31148927-cee1-4b57-a4af-ad7014335983"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Women should\navoid becoming pregnant while being treated with ixazomib. </span><span lang=\"EN-GB\">If ixazomib is used during pregnancy or if the patient becomes\npregnant while taking ixazomib, the patient should be apprised of the potential\nhazard to the foetus. </span></p>", "ID": "deb7a305-f848-445b-8f04-813758544103", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Women should\navoid becoming pregnant while being treated with ixazomib. </span>", "ID": "b01b0df5-9f0f-4539-930a-b57548e96def", "Styles": "None", "Classes": "None", "Text": "Women should avoid becoming pregnant while being treated with ixazomib. ", "ParentId": "deb7a305-f848-445b-8f04-813758544103"}, {"Element": "<span lang=\"EN-GB\">If ixazomib is used during pregnancy or if the patient becomes\npregnant while taking ixazomib, the patient should be apprised of the potential\nhazard to the foetus. </span>", "ID": "f77e0d7b-71d4-484f-963f-edcd6e77c478", "Styles": "None", "Classes": "None", "Text": "If ixazomib is used during pregnancy or if the patient becomes pregnant while taking ixazomib, the patient should be apprised of the potential hazard to the foetus. ", "ParentId": "deb7a305-f848-445b-8f04-813758544103"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "f3b744dd-ee66-4737-8b21-00f1dc5cec49", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c256f887-0f4a-4ecd-824a-f14a7e82a899", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f3b744dd-ee66-4737-8b21-00f1dc5cec49"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9bc5cb26-da59-4efc-b5da-3d00d7ca295c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c256f887-0f4a-4ecd-824a-f14a7e82a899"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Women of\nchildbearing potential must use highly effective contraception while taking ixazomib\nand for 90 days after stopping treatment (see sections\u00a04.5 and 4.6). Women\nusing hormonal contraceptives should additionally use a barrier method of\ncontraception<b>.</b></span></p>", "ID": "93c1e126-a4ba-4d89-ba32-da506bbb7a66", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Women of\nchildbearing potential must use highly effective contraception while taking ixazomib\nand for 90 days after stopping treatment (see sections\u00a04.5 and 4.6). Women\nusing hormonal contraceptives should additionally use a barrier method of\ncontraception<b>.</b></span>", "ID": "b035ee3f-e3af-40a2-8086-1349a474b0d4", "Styles": "None", "Classes": "None", "Text": "Women of childbearing potential must use highly effective contraception while taking ixazomib and for 90 days after stopping treatment (see sections\u00a04.5 and 4.6). Women using hormonal contraceptives should additionally use a barrier method of contraception", "ParentId": "93c1e126-a4ba-4d89-ba32-da506bbb7a66"}, {"Element": "<b>.</b>", "ID": "71469867-86c8-48d9-a565-62200614f590", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "b035ee3f-e3af-40a2-8086-1349a474b0d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9f7a43a4-a6a3-4036-8ace-66e2fab95eb4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "71936f0b-b4e6-474c-b7d5-372ce821e855", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9f7a43a4-a6a3-4036-8ace-66e2fab95eb4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Posterior reversible encephalopathy syndrome</span></u><b><span lang=\"EN-GB\"> </span></b></p>", "ID": "a76b5777-a32f-4c43-b807-5016a1fca4e8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Posterior reversible encephalopathy syndrome</span></u>", "ID": "e97583a7-1b7c-4d8b-b588-7ad5a3d34909", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a76b5777-a32f-4c43-b807-5016a1fca4e8"}, {"Element": "<span lang=\"EN-GB\">Posterior reversible encephalopathy syndrome</span>", "ID": "5d85e43e-2a90-468b-8ca1-4468dfdfa247", "Styles": "None", "Classes": "None", "Text": "Posterior reversible encephalopathy syndrome", "ParentId": "e97583a7-1b7c-4d8b-b588-7ad5a3d34909"}, {"Element": "<b><span lang=\"EN-GB\"> </span></b>", "ID": "f5b429e1-9a14-4200-acfb-c686080dbc92", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a76b5777-a32f-4c43-b807-5016a1fca4e8"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "90ae2baa-18a3-4831-86b5-1b736a868ad7", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "f5b429e1-9a14-4200-acfb-c686080dbc92"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "a68e913d-643f-429d-a432-7829b12a59a1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "8274b339-e5c7-4253-a14f-8706632b951a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a68e913d-643f-429d-a432-7829b12a59a1"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2a15dbbf-1225-45e7-ab1d-4bc9d5c6a569", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8274b339-e5c7-4253-a14f-8706632b951a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Posterior reversible encephalopathy syndrome (PRES) has occurred in\npatients receiving ixazomib. PRES is a rare, reversible, neurological disorder\nwhich can present with seizure, hypertension, headache, altered consciousness,\nand visual disturbances. Brain imaging, preferably Magnetic Resonance Imaging,\nis used to confirm the diagnosis. In patients developing PRES, discontinue ixazomib.\n</span></p>", "ID": "b86685d1-724d-4dcb-b099-f6e66e03b621", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Posterior reversible encephalopathy syndrome (PRES) has occurred in\npatients receiving ixazomib. PRES is a rare, reversible, neurological disorder\nwhich can present with seizure, hypertension, headache, altered consciousness,\nand visual disturbances. Brain imaging, preferably Magnetic Resonance Imaging,\nis used to confirm the diagnosis. In patients developing PRES, discontinue ixazomib.\n</span>", "ID": "c2cf86fc-158a-48fd-bfcd-e4deb8b5ac44", "Styles": "None", "Classes": "None", "Text": "Posterior reversible encephalopathy syndrome (PRES) has occurred in patients receiving ixazomib. PRES is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, altered consciousness, and visual disturbances. Brain imaging, preferably Magnetic Resonance Imaging, is used to confirm the diagnosis. In patients developing PRES, discontinue ixazomib. ", "ParentId": "b86685d1-724d-4dcb-b099-f6e66e03b621"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "072f9a7d-07bc-4210-a1d8-25385a32e571", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "ce4925b5-68ee-4cec-a742-282cc2fb26e3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "072f9a7d-07bc-4210-a1d8-25385a32e571"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "fcd1908d-a388-4417-8bc4-da3dfb58b7b0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ce4925b5-68ee-4cec-a742-282cc2fb26e3"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "af388702-1008-4b76-bc03-ff4552d22aa7", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "fcd1908d-a388-4417-8bc4-da3dfb58b7b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Strong CYP3A inducers</span></u></p>", "ID": "62d86f37-c2d6-4ddf-86ec-50d8257e5056", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Strong CYP3A inducers</span></u>", "ID": "29e9c715-7aad-45aa-a4a2-5c1730fefc1f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "62d86f37-c2d6-4ddf-86ec-50d8257e5056"}, {"Element": "<span lang=\"EN-GB\">Strong CYP3A inducers</span>", "ID": "a82118cb-7ce9-40c0-bcf9-5e114c688cad", "Styles": "None", "Classes": "None", "Text": "Strong CYP3A inducers", "ParentId": "29e9c715-7aad-45aa-a4a2-5c1730fefc1f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "a4574bc0-37c9-471a-8dfe-73d5db978bfb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "6cf70b54-b209-490c-9eeb-448c0c5a1410", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a4574bc0-37c9-471a-8dfe-73d5db978bfb"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "01b2bae7-73ba-44dc-95d9-0ea5748a2bb4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6cf70b54-b209-490c-9eeb-448c0c5a1410"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "891ee49f-7004-495f-b0b6-34a9911d065b", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "01b2bae7-73ba-44dc-95d9-0ea5748a2bb4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Strong inducers\nmay reduce the efficacy of ixazomib, therefore the concomitant use of strong\nCYP3A inducers such as carbamazepine, phenytoin, rifampicin and St.\nJohn\u2019s Wort (<i>Hypericum perforatum</i>), should be avoided (see sections\u00a04.5\nand 5.2). Closely monitor patients for disease control if co\u2011administration\nwith a strong CYP3A inducer cannot be avoided.</span></p>", "ID": "6d56f745-f658-4ecc-a200-39be1a5e8078", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Strong inducers\nmay reduce the efficacy of ixazomib, therefore the concomitant use of strong\nCYP3A inducers such as carbamazepine, phenytoin, rifampicin and St.\nJohn\u2019s Wort (<i>Hypericum perforatum</i>), should be avoided (see sections\u00a04.5\nand 5.2). Closely monitor patients for disease control if co\u2011administration\nwith a strong CYP3A inducer cannot be avoided.</span>", "ID": "3a85e9af-9820-4527-bc8f-be6b055f4af6", "Styles": "None", "Classes": "None", "Text": "Strong inducers may reduce the efficacy of ixazomib, therefore the concomitant use of strong CYP3A inducers such as carbamazepine, phenytoin, rifampicin and St. John\u2019s Wort (), should be avoided (see sections\u00a04.5 and 5.2). Closely monitor patients for disease control if co\u2011administration with a strong CYP3A inducer cannot be avoided.", "ParentId": "6d56f745-f658-4ecc-a200-39be1a5e8078"}, {"Element": "<i>Hypericum perforatum</i>", "ID": "9a5b03ed-bf2b-4280-905c-53b89c2093af", "Styles": "None", "Classes": "None", "Text": "Hypericum perforatum", "ParentId": "3a85e9af-9820-4527-bc8f-be6b055f4af6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7c78af15-f7a2-42dd-8eaf-4a646afa9677", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7748f44-9bcd-4edf-b483-da972a259cd9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7c78af15-f7a2-42dd-8eaf-4a646afa9677"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other medicinal\nproducts and other forms of interaction</span></b></p>", "ID": "717c8717-b482-4eed-81d1-3f3dc8621587", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other medicinal\nproducts and other forms of interaction</span></b>", "ID": "b7274d7b-786a-4f54-ae35-46a7fb6036df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "717c8717-b482-4eed-81d1-3f3dc8621587"}, {"Element": "<span lang=\"EN-GB\">4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other medicinal\nproducts and other forms of interaction</span>", "ID": "57b2ea56-84b2-4be9-8177-1095cba67677", "Styles": "None", "Classes": "None", "Text": "4.5\u00a0\u00a0\u00a0\u00a0 Interaction with other medicinal products and other forms of interaction", "ParentId": "b7274d7b-786a-4f54-ae35-46a7fb6036df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cec7f9cd-b35b-4f70-bc4d-c826841d7e91", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "73e6a374-045b-4110-9623-afba8000488d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cec7f9cd-b35b-4f70-bc4d-c826841d7e91"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pharmacokinetic interactions</span></u></p>", "ID": "3822164f-aef7-4a99-95cd-b2536afa697f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Pharmacokinetic interactions</span></u>", "ID": "d22defed-0c42-4031-b828-ce59df067431", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3822164f-aef7-4a99-95cd-b2536afa697f"}, {"Element": "<span lang=\"EN-GB\">Pharmacokinetic interactions</span>", "ID": "f79d5d1f-1604-4565-bc79-fc8435f338f6", "Styles": "None", "Classes": "None", "Text": "Pharmacokinetic interactions", "ParentId": "d22defed-0c42-4031-b828-ce59df067431"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "1d91f99b-7369-457a-8b5f-01aeb4ac1f29", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "516d16e7-1453-4c13-851e-b6f3a82dd498", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1d91f99b-7369-457a-8b5f-01aeb4ac1f29"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "5cbaae91-8293-49d1-b993-39c63471b64f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "516d16e7-1453-4c13-851e-b6f3a82dd498"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "376633f3-ff5c-4682-bf0c-7ac0062e2f51", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "5cbaae91-8293-49d1-b993-39c63471b64f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">CYP inhibitors</span></u></i></p>", "ID": "754489de-be3d-4971-bf09-a3a357c09848", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">CYP inhibitors</span></u></i>", "ID": "e5678871-a5cb-4d72-96f2-645adc910819", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "754489de-be3d-4971-bf09-a3a357c09848"}, {"Element": "<u><span lang=\"EN-GB\">CYP inhibitors</span></u>", "ID": "d1770130-325f-4667-b8d6-36e13584aaa6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e5678871-a5cb-4d72-96f2-645adc910819"}, {"Element": "<span lang=\"EN-GB\">CYP inhibitors</span>", "ID": "10ed408a-70a8-4bae-b050-d344252ff3af", "Styles": "None", "Classes": "None", "Text": "CYP inhibitors", "ParentId": "d1770130-325f-4667-b8d6-36e13584aaa6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ec5c8ca4-e621-4ea2-9cf4-700995e633f4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fcdab6eb-5edc-4a25-8d7a-8846d6649987", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ec5c8ca4-e621-4ea2-9cf4-700995e633f4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Co\u2011administration\nof ixazomib with clarithromycin, a strong CYP3A inhibitor, did not result in a\nclinically meaningful change in the systemic exposure of ixazomib. Ixazomib C<sub>max</sub>\nwas decreased by 4% and AUC was increased by 11%. Therefore, no dose\nmodification is required for ixazomib with co\u2011administration of strong\nCYP3A inhibitors.</span></p>", "ID": "03d3553c-ca2d-4bbf-a79d-798aeac22670", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Co\u2011administration\nof ixazomib with clarithromycin, a strong CYP3A inhibitor, did not result in a\nclinically meaningful change in the systemic exposure of ixazomib. Ixazomib C<sub>max</sub>\nwas decreased by 4% and AUC was increased by 11%. Therefore, no dose\nmodification is required for ixazomib with co\u2011administration of strong\nCYP3A inhibitors.</span>", "ID": "644676d6-2fef-412b-aeb7-033da0555ad4", "Styles": "None", "Classes": "None", "Text": "Co\u2011administration of ixazomib with clarithromycin, a strong CYP3A inhibitor, did not result in a clinically meaningful change in the systemic exposure of ixazomib. Ixazomib C was decreased by 4% and AUC was increased by 11%. Therefore, no dose modification is required for ixazomib with co\u2011administration of strong CYP3A inhibitors.", "ParentId": "03d3553c-ca2d-4bbf-a79d-798aeac22670"}, {"Element": "<sub>max</sub>", "ID": "5da39d96-1927-47d3-89e9-0289374a2fe2", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "644676d6-2fef-412b-aeb7-033da0555ad4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "334d0004-f94b-4798-aa14-cbdf91250e27", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ad4743bd-f348-401e-ba39-823a250ffeac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "334d0004-f94b-4798-aa14-cbdf91250e27"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Co\u2011administration\nof ixazomib with strong CYP1A2 inhibitors did not result in a clinically\nmeaningful change in the systemic exposure of ixazomib based on the results of\na population pharmacokinetic (PK) analysis. Therefore, no dose modification is\nrequired for ixazomib with co\u2011administration of strong CYP1A2 inhibitors.</span></p>", "ID": "743af537-6cf5-425a-b06e-9232d2f9bdf9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Co\u2011administration\nof ixazomib with strong CYP1A2 inhibitors did not result in a clinically\nmeaningful change in the systemic exposure of ixazomib based on the results of\na population pharmacokinetic (PK) analysis. Therefore, no dose modification is\nrequired for ixazomib with co\u2011administration of strong CYP1A2 inhibitors.</span>", "ID": "a7ba2e18-74a5-454d-bc42-5f6ba070f314", "Styles": "None", "Classes": "None", "Text": "Co\u2011administration of ixazomib with strong CYP1A2 inhibitors did not result in a clinically meaningful change in the systemic exposure of ixazomib based on the results of a population pharmacokinetic (PK) analysis. Therefore, no dose modification is required for ixazomib with co\u2011administration of strong CYP1A2 inhibitors.", "ParentId": "743af537-6cf5-425a-b06e-9232d2f9bdf9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "606f784f-0b6a-42d2-9b79-a495f7cb9c1e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "06df2031-256a-4756-8b89-460fa664dab9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "606f784f-0b6a-42d2-9b79-a495f7cb9c1e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">CYP inducers</span></u></i></p>", "ID": "f3c2315e-9db5-4660-9bb0-1d22e83eb0f9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">CYP inducers</span></u></i>", "ID": "f5add569-8a32-4e84-b092-1c4ba47106c7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f3c2315e-9db5-4660-9bb0-1d22e83eb0f9"}, {"Element": "<u><span lang=\"EN-GB\">CYP inducers</span></u>", "ID": "d98ac46b-15fa-43b9-a59f-5cfac337fd7e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f5add569-8a32-4e84-b092-1c4ba47106c7"}, {"Element": "<span lang=\"EN-GB\">CYP inducers</span>", "ID": "08e8f741-ce93-4603-9db1-560a38eb88a2", "Styles": "None", "Classes": "None", "Text": "CYP inducers", "ParentId": "d98ac46b-15fa-43b9-a59f-5cfac337fd7e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>", "ID": "ba04c8e9-0f9d-411a-890b-83d0e925f536", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i>", "ID": "ff108d14-edba-43ef-a652-f3b31d42ac37", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ba04c8e9-0f9d-411a-890b-83d0e925f536"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "8894b488-b3a0-4682-b4da-43f1ecf30057", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ff108d14-edba-43ef-a652-f3b31d42ac37"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "e2b0a3f0-b10d-46a9-b593-9b51bfb9567a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8894b488-b3a0-4682-b4da-43f1ecf30057"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "3e33cf57-5d41-48fb-bf19-91d8ebba2958", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "e2b0a3f0-b10d-46a9-b593-9b51bfb9567a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Co\u2011administration\nof ixazomib with rifampicin decreased ixazomib C<sub>max</sub> by 54% and AUC\nby 74%. Therefore, co\u2011administration of strong CYP3A inducers with\nixazomib is not recommended (see section\u00a04.4).</span></p>", "ID": "22e58670-0517-471b-9e12-17b5b0b00798", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Co\u2011administration\nof ixazomib with rifampicin decreased ixazomib C<sub>max</sub> by 54% and AUC\nby 74%. Therefore, co\u2011administration of strong CYP3A inducers with\nixazomib is not recommended (see section\u00a04.4).</span>", "ID": "4692b451-b123-46b9-a934-05ebeacaeb3f", "Styles": "None", "Classes": "None", "Text": "Co\u2011administration of ixazomib with rifampicin decreased ixazomib C by 54% and AUC by 74%. Therefore, co\u2011administration of strong CYP3A inducers with ixazomib is not recommended (see section\u00a04.4).", "ParentId": "22e58670-0517-471b-9e12-17b5b0b00798"}, {"Element": "<sub>max</sub>", "ID": "0ba80521-0302-422d-91f0-b625dea26cb0", "Styles": "None", "Classes": "None", "Text": "max", "ParentId": "4692b451-b123-46b9-a934-05ebeacaeb3f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9ec635b9-82a9-40bd-98c9-257cc4f6cfe9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1a150c94-6df1-480a-a55e-220824393614", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9ec635b9-82a9-40bd-98c9-257cc4f6cfe9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Effect of ixazomib on other medicinal products</span></u></i></p>", "ID": "22abf718-2d89-4648-a393-c7bc7a1edcc6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Effect of ixazomib on other medicinal products</span></u></i>", "ID": "3d75e964-77c8-4aba-9fcd-00dc1423a123", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "22abf718-2d89-4648-a393-c7bc7a1edcc6"}, {"Element": "<u><span lang=\"EN-GB\">Effect of ixazomib on other medicinal products</span></u>", "ID": "b8e01a54-ace0-4bb2-a6b8-79166b3d4261", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d75e964-77c8-4aba-9fcd-00dc1423a123"}, {"Element": "<span lang=\"EN-GB\">Effect of ixazomib on other medicinal products</span>", "ID": "01ce49a3-19ef-464b-804e-9599861c9855", "Styles": "None", "Classes": "None", "Text": "Effect of ixazomib on other medicinal products", "ParentId": "b8e01a54-ace0-4bb2-a6b8-79166b3d4261"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "80046251-7904-4778-89ae-52ff940ea562", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c8f27dc-d360-4721-9c38-171cab1d6a1b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "80046251-7904-4778-89ae-52ff940ea562"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib is not\na reversible or a time\u2011dependent inhibitor of CYPs 1A2, 2B6, 2C8, 2C9,\n2C19, 2D6, or 3A4/5. Ixazomib did not induce CYP1A2, CYP2B6, and CYP3A4/5\nactivity or corresponding immunoreactive protein levels. Ixazomib is not\nexpected to produce drug\u2011drug interactions via CYP\u00a0inhibition or induction.</span></p>", "ID": "9f035ac8-e23e-43ef-8cbd-39cdcfee5270", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib is not\na reversible or a time\u2011dependent inhibitor of CYPs 1A2, 2B6, 2C8, 2C9,\n2C19, 2D6, or 3A4/5. Ixazomib did not induce CYP1A2, CYP2B6, and CYP3A4/5\nactivity or corresponding immunoreactive protein levels. Ixazomib is not\nexpected to produce drug\u2011drug interactions via CYP\u00a0inhibition or induction.</span>", "ID": "c2e6296e-79c3-4232-ae3b-10c9a676126f", "Styles": "None", "Classes": "None", "Text": "Ixazomib is not a reversible or a time\u2011dependent inhibitor of CYPs 1A2, 2B6, 2C8, 2C9, 2C19, 2D6, or 3A4/5. Ixazomib did not induce CYP1A2, CYP2B6, and CYP3A4/5 activity or corresponding immunoreactive protein levels. Ixazomib is not expected to produce drug\u2011drug interactions via CYP\u00a0inhibition or induction.", "ParentId": "9f035ac8-e23e-43ef-8cbd-39cdcfee5270"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "5963f4c9-21e7-46f0-a17a-7fd01b87da58", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "e53276fa-23e1-4115-9ba8-9d246223b410", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5963f4c9-21e7-46f0-a17a-7fd01b87da58"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "0228150e-2dce-4ffc-9042-78b8188a2101", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e53276fa-23e1-4115-9ba8-9d246223b410"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "46c90a26-88a7-4b91-87ee-23b23cb686ea", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "0228150e-2dce-4ffc-9042-78b8188a2101"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Transporter\u2011based interactions</span></u></i></p>", "ID": "15f2f150-42a1-4857-96aa-6fe9318cbf7a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Transporter\u2011based interactions</span></u></i>", "ID": "d3ed0604-3338-4c6a-b09a-3afc909dda11", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "15f2f150-42a1-4857-96aa-6fe9318cbf7a"}, {"Element": "<u><span lang=\"EN-GB\">Transporter\u2011based interactions</span></u>", "ID": "ad69a471-9948-48ae-a9bb-017665aa5dae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d3ed0604-3338-4c6a-b09a-3afc909dda11"}, {"Element": "<span lang=\"EN-GB\">Transporter\u2011based interactions</span>", "ID": "8328ad99-a9a5-46b4-ab7a-8e7f5011f8a3", "Styles": "None", "Classes": "None", "Text": "Transporter\u2011based interactions", "ParentId": "ad69a471-9948-48ae-a9bb-017665aa5dae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "779a601b-e85e-4272-8a46-5cc975f87f8c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cf706d87-d66e-4da7-a4ce-e804b28d4dd5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "779a601b-e85e-4272-8a46-5cc975f87f8c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Ixazomib is a low affinity substrate of P\u2011gp. Ixazomib is not\na substrate of BCRP, MRP2 or hepatic OATPs. Ixazomib is not an inhibitor of P\u2011gp,\nBCRP, MRP2, OATP1B1, OATP1B3, OCT2, OAT1, OAT3, MATE1, or MATE2\u2011K. Ixazomib\nis not expected to cause transporter\u2011mediated drug\u2011drug\ninteractions. </span></p>", "ID": "11506d83-023f-4480-9679-97dc38ef7993", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib is a low affinity substrate of P\u2011gp. Ixazomib is not\na substrate of BCRP, MRP2 or hepatic OATPs. Ixazomib is not an inhibitor of P\u2011gp,\nBCRP, MRP2, OATP1B1, OATP1B3, OCT2, OAT1, OAT3, MATE1, or MATE2\u2011K. Ixazomib\nis not expected to cause transporter\u2011mediated drug\u2011drug\ninteractions. </span>", "ID": "b7cf79b2-f835-44a6-a912-40f7bc1cef51", "Styles": "None", "Classes": "None", "Text": "Ixazomib is a low affinity substrate of P\u2011gp. Ixazomib is not a substrate of BCRP, MRP2 or hepatic OATPs. Ixazomib is not an inhibitor of P\u2011gp, BCRP, MRP2, OATP1B1, OATP1B3, OCT2, OAT1, OAT3, MATE1, or MATE2\u2011K. Ixazomib is not expected to cause transporter\u2011mediated drug\u2011drug interactions. ", "ParentId": "11506d83-023f-4480-9679-97dc38ef7993"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "2077fa4c-ecf8-4575-b64f-81c9b1b1b17d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "dc394b2b-9ead-4b61-a3f2-bfbd38309597", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2077fa4c-ecf8-4575-b64f-81c9b1b1b17d"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "44d5f447-e88c-4556-b0e5-19a85a1912ef", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc394b2b-9ead-4b61-a3f2-bfbd38309597"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "838edb28-fa4e-442f-abbc-2e6e6c018120", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "44d5f447-e88c-4556-b0e5-19a85a1912ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Oral\ncontraceptives</span></u></p>", "ID": "5b3e543f-e2e1-46d8-a4c2-9d793f56f827", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Oral\ncontraceptives</span></u>", "ID": "2949f354-77e8-4e2d-a79d-ee13c8ba81d8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5b3e543f-e2e1-46d8-a4c2-9d793f56f827"}, {"Element": "<span lang=\"EN-GB\">Oral\ncontraceptives</span>", "ID": "1b3d167b-b9e3-47b8-bddf-8152c8484cbb", "Styles": "None", "Classes": "None", "Text": "Oral contraceptives", "ParentId": "2949f354-77e8-4e2d-a79d-ee13c8ba81d8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "2322732c-bf30-4814-b690-07066010b0ac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "02331093-ce33-45e0-8d8f-6673757b5af0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2322732c-bf30-4814-b690-07066010b0ac"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "1824664e-c447-4308-9334-d4cb95c906a7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "02331093-ce33-45e0-8d8f-6673757b5af0"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "b5d815f1-6047-4557-86c7-a7dc36f804f8", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "1824664e-c447-4308-9334-d4cb95c906a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">When ixazomib is\nadministered together with dexamethasone, which is known to be a weak to\nmoderate inducer of CYP3A4 as well as other enzymes and transporters, the risk\nfor reduced efficacy of oral contraceptives needs to be considered. Women using\nhormonal contraceptives should additionally use a barrier method of\ncontraception.</span></p>", "ID": "35990d8c-82fa-436d-9a05-f76b80265d91", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">When ixazomib is\nadministered together with dexamethasone, which is known to be a weak to\nmoderate inducer of CYP3A4 as well as other enzymes and transporters, the risk\nfor reduced efficacy of oral contraceptives needs to be considered. Women using\nhormonal contraceptives should additionally use a barrier method of\ncontraception.</span>", "ID": "f3cdbdcf-ec44-49a0-9035-da262ef8ad45", "Styles": "None", "Classes": "None", "Text": "When ixazomib is administered together with dexamethasone, which is known to be a weak to moderate inducer of CYP3A4 as well as other enzymes and transporters, the risk for reduced efficacy of oral contraceptives needs to be considered. Women using hormonal contraceptives should additionally use a barrier method of contraception.", "ParentId": "35990d8c-82fa-436d-9a05-f76b80265d91"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "4423ae73-a117-40ba-8700-ca11bd2a0f8a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "ea4d9330-ee08-4be8-ac8c-31c5a7384b54", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4423ae73-a117-40ba-8700-ca11bd2a0f8a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1687b61a-f9d7-4e83-a4ed-5210482ef22f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ea4d9330-ee08-4be8-ac8c-31c5a7384b54"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy and lactation</span></b></p>", "ID": "f87267ff-6d34-467f-9a4a-ec9f0f2a5aa4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy and lactation</span></b>", "ID": "083730b9-cdc3-44c2-ad55-d9f18650e6ff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f87267ff-6d34-467f-9a4a-ec9f0f2a5aa4"}, {"Element": "<span lang=\"EN-GB\">4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy and lactation</span>", "ID": "a8216fcd-ba74-4655-8d31-2b5cfdfbc72c", "Styles": "None", "Classes": "None", "Text": "4.6\u00a0\u00a0\u00a0\u00a0 Fertility, pregnancy and lactation", "ParentId": "083730b9-cdc3-44c2-ad55-d9f18650e6ff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "2459ba20-903b-4a60-9854-a2cd8d4b24e0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "f73d90a8-e394-4d0d-8677-dcebed0f7b9e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2459ba20-903b-4a60-9854-a2cd8d4b24e0"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "320704ab-83ff-4523-b751-ef7d9711264c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f73d90a8-e394-4d0d-8677-dcebed0f7b9e"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "39c4bbac-2ab0-4864-9938-94e631cdd772", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "320704ab-83ff-4523-b751-ef7d9711264c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and\ndexamethasone, refer to the SmPC for these medicinal products for additional\ninformation on fertility, pregnancy and lactation.</span></p>", "ID": "92c959ec-c92b-4995-bef4-bf5c02f6e561", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and\ndexamethasone, refer to the SmPC for these medicinal products for additional\ninformation on fertility, pregnancy and lactation.</span>", "ID": "ccd20195-516f-4d2b-99b3-86e8265eb882", "Styles": "None", "Classes": "None", "Text": "As ixazomib is administered in combination with lenalidomide and dexamethasone, refer to the SmPC for these medicinal products for additional information on fertility, pregnancy and lactation.", "ParentId": "92c959ec-c92b-4995-bef4-bf5c02f6e561"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "f01cec1b-19b2-4336-86c0-3c9bc4d19ad3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "cd4c1a34-f090-4a25-b57e-447b25b35da7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f01cec1b-19b2-4336-86c0-3c9bc4d19ad3"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "1da7685c-12e4-490a-b7f0-89669c178e56", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd4c1a34-f090-4a25-b57e-447b25b35da7"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "404f1a23-fb67-4480-b7e1-d60e4f7f6d6b", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "1da7685c-12e4-490a-b7f0-89669c178e56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Women of childbearing potential/Contraception in males and females</span></u></p>", "ID": "5295dff0-6076-43c1-9036-c4f138750bdc", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Women of childbearing potential/Contraception in males and females</span></u>", "ID": "b1f548c8-a07f-4a56-8ca7-8fc6e6226c99", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5295dff0-6076-43c1-9036-c4f138750bdc"}, {"Element": "<span lang=\"EN-GB\">Women of childbearing potential/Contraception in males and females</span>", "ID": "fc908af3-7130-4db9-b9e5-61484e22b664", "Styles": "None", "Classes": "None", "Text": "Women of childbearing potential/Contraception in males and females", "ParentId": "b1f548c8-a07f-4a56-8ca7-8fc6e6226c99"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "b021f6c3-0778-4277-9c50-639ea69c7a69", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "2ee626b4-cf74-4522-a3c5-4d2d03f8cc6a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b021f6c3-0778-4277-9c50-639ea69c7a69"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "377db1d0-726d-46d8-a300-606333005896", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2ee626b4-cf74-4522-a3c5-4d2d03f8cc6a"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "d9c2d773-c932-4a9e-bae5-b1ab6925455b", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "377db1d0-726d-46d8-a300-606333005896"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Male and female\npatients who are able to have children must use effective contraceptive\nmeasures during and for 90\u00a0days following treatment. Ixazomib is not\nrecommended in women of childbearing potential not using contraception.</span></p>", "ID": "72791e90-2128-4afc-804e-b07b1cf5e62b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Male and female\npatients who are able to have children must use effective contraceptive\nmeasures during and for 90\u00a0days following treatment. Ixazomib is not\nrecommended in women of childbearing potential not using contraception.</span>", "ID": "0876c312-6f79-4de7-a706-0ffb7ac19f45", "Styles": "None", "Classes": "None", "Text": "Male and female patients who are able to have children must use effective contraceptive measures during and for 90\u00a0days following treatment. Ixazomib is not recommended in women of childbearing potential not using contraception.", "ParentId": "72791e90-2128-4afc-804e-b07b1cf5e62b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a5068e88-134e-4259-8e58-8d8d1ec301bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a56afafb-77fd-4625-94d5-6224e74c3a7b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a5068e88-134e-4259-8e58-8d8d1ec301bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">When ixazomib is administered\ntogether with dexamethasone, which is known to be a weak to moderate inducer of\nCYP3A4 as well as other enzymes and transporters, the risk for reduced efficacy\nof oral contraceptives needs to be considered. Therefore, women using oral\nhormonal contraceptives should additionally use a barrier method of\ncontraception.</p>", "ID": "59608cb2-5a69-4d5e-a2f0-1825215ec9e2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "When ixazomib is administered together with dexamethasone, which is known to be a weak to moderate inducer of CYP3A4 as well as other enzymes and transporters, the risk for reduced efficacy of oral contraceptives needs to be considered. Therefore, women using oral hormonal contraceptives should additionally use a barrier method of contraception.", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "22ffec1c-46a9-45a9-9470-5d3d272d3ed4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Pregnancy</span></u></p>", "ID": "f4021e19-b02f-4627-8354-e56a89b73b08", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Pregnancy</span></u>", "ID": "66f24de1-cb54-46ef-b5b1-4d333db26361", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f4021e19-b02f-4627-8354-e56a89b73b08"}, {"Element": "<span lang=\"EN-GB\">Pregnancy</span>", "ID": "8465f763-c8a2-4916-963e-7eeac6d5d7ab", "Styles": "None", "Classes": "None", "Text": "Pregnancy", "ParentId": "66f24de1-cb54-46ef-b5b1-4d333db26361"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "858d2573-73a6-4e54-b3ac-720255f5ec7a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9c50b192-a524-4fe8-89df-cbe74eca4d42", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "858d2573-73a6-4e54-b3ac-720255f5ec7a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib is not\nrecommended during pregnancy as it can cause foetal harm when administered to a\npregnant woman. Therefore, women should avoid becoming pregnant while being\ntreated with ixazomib. </span></p>", "ID": "7f8a7b67-71d3-4d12-bf75-8e1a48b8f384", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib is not\nrecommended during pregnancy as it can cause foetal harm when administered to a\npregnant woman. Therefore, women should avoid becoming pregnant while being\ntreated with ixazomib. </span>", "ID": "575883d1-f24e-4df1-a4d9-47a28a0f4262", "Styles": "None", "Classes": "None", "Text": "Ixazomib is not recommended during pregnancy as it can cause foetal harm when administered to a pregnant woman. Therefore, women should avoid becoming pregnant while being treated with ixazomib. ", "ParentId": "7f8a7b67-71d3-4d12-bf75-8e1a48b8f384"}, {"Element": "<h4 style=\"margin:0in;line-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-weight:normal'>\u00a0</span></h4>", "ID": "aee48f89-55ba-4c4c-a667-8c26f6ff82d1", "Styles": "margin:0in;line-height:normal;page-break-after:auto", "Classes": "None", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-weight:normal'>\u00a0</span>", "ID": "4745d356-cc44-4146-8063-ec8c5dfee983", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "aee48f89-55ba-4c4c-a667-8c26f6ff82d1"}, {"Element": "<h4 style=\"margin:0in;line-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-weight:normal'>There are no data for the use of ixazomib in pregnant\nwomen. Studies in animals have shown reproductive toxicity (see section\u00a05.3).</span></h4>", "ID": "b28cdadc-c7cf-4e0a-a7ab-0f622006599a", "Styles": "margin:0in;line-height:normal;page-break-after:auto", "Classes": "None", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-weight:normal'>There are no data for the use of ixazomib in pregnant\nwomen. Studies in animals have shown reproductive toxicity (see section\u00a05.3).</span>", "ID": "96bbd1eb-819b-479e-867d-214d87d271cb", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\nfont-weight:normal", "Classes": "None", "Text": "There are no data for the use of ixazomib in pregnant women. Studies in animals have shown reproductive toxicity (see section\u00a05.3).", "ParentId": "b28cdadc-c7cf-4e0a-a7ab-0f622006599a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib is\ngiven in combination with lenalidomide. Lenalidomide is structurally related to\nthalidomide. Thalidomide is a known human teratogenic active substance that\ncauses severe life\u2011threatening birth defects. If lenalidomide is taken\nduring pregnancy, a teratogenic effect in humans is expected. The conditions of\nthe Pregnancy Prevention Programme for lenalidomide must be fulfilled for all\npatients unless there is reliable evidence that the patient does not have\nchildbearing potential. Please refer to the current lenalidomide SmPC.</span></p>", "ID": "ecc755d4-7901-4d6e-a9da-326493a5b112", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib is\ngiven in combination with lenalidomide. Lenalidomide is structurally related to\nthalidomide. Thalidomide is a known human teratogenic active substance that\ncauses severe life\u2011threatening birth defects. If lenalidomide is taken\nduring pregnancy, a teratogenic effect in humans is expected. The conditions of\nthe Pregnancy Prevention Programme for lenalidomide must be fulfilled for all\npatients unless there is reliable evidence that the patient does not have\nchildbearing potential. Please refer to the current lenalidomide SmPC.</span>", "ID": "d0fdb02a-cb3a-4f16-bf1b-350c23d058cd", "Styles": "None", "Classes": "None", "Text": "Ixazomib is given in combination with lenalidomide. Lenalidomide is structurally related to thalidomide. Thalidomide is a known human teratogenic active substance that causes severe life\u2011threatening birth defects. If lenalidomide is taken during pregnancy, a teratogenic effect in humans is expected. The conditions of the Pregnancy Prevention Programme for lenalidomide must be fulfilled for all patients unless there is reliable evidence that the patient does not have childbearing potential. Please refer to the current lenalidomide SmPC.", "ParentId": "ecc755d4-7901-4d6e-a9da-326493a5b112"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9d06acb9-b976-43f9-b517-1fb84ab1253b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "38a614c6-5177-472e-8fbb-b6c7da4b245c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9d06acb9-b976-43f9-b517-1fb84ab1253b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Breast\u2011feeding</span></u></p>", "ID": "1acfb3fe-593a-4953-af27-e8f93152f546", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Breast\u2011feeding</span></u>", "ID": "28700939-5850-4670-8307-d0270ed5751e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1acfb3fe-593a-4953-af27-e8f93152f546"}, {"Element": "<span lang=\"EN-GB\">Breast\u2011feeding</span>", "ID": "635b84e5-12ef-424c-8bf7-ba0cdf4cad4b", "Styles": "None", "Classes": "None", "Text": "Breast\u2011feeding", "ParentId": "28700939-5850-4670-8307-d0270ed5751e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "ea9f703d-eb9c-4a27-9e76-95bfa2c6f14d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "1fc2ea8b-b5b5-4082-bc56-c223cb3a2d41", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ea9f703d-eb9c-4a27-9e76-95bfa2c6f14d"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "a3fea232-cdf9-43ec-ae61-9bc478d55af0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1fc2ea8b-b5b5-4082-bc56-c223cb3a2d41"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "ba03917b-aeb1-400c-a1f4-d632b5801dc0", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "a3fea232-cdf9-43ec-ae61-9bc478d55af0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">It is unknown\nwhether ixazomib</span><span lang=\"EN-GB\"> or its metabolites</span><span lang=\"EN-GB\"> are excreted in human milk. No animal data are available. </span><span lang=\"EN-GB\">A risk to newborns/infants cannot be excluded and therefore </span><span lang=\"EN-GB\">breast\u2011feeding should be discontinued. </span></p>", "ID": "2188043f-ff34-4e35-995e-741ec8c0640a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">It is unknown\nwhether ixazomib</span>", "ID": "3cfcab9e-571f-4fa8-a679-15aebbea265d", "Styles": "None", "Classes": "None", "Text": "It is unknown whether ixazomib", "ParentId": "2188043f-ff34-4e35-995e-741ec8c0640a"}, {"Element": "<span lang=\"EN-GB\"> or its metabolites</span>", "ID": "1a053882-85eb-47ed-8938-272a53ce68d4", "Styles": "None", "Classes": "None", "Text": " or its metabolites", "ParentId": "2188043f-ff34-4e35-995e-741ec8c0640a"}, {"Element": "<span lang=\"EN-GB\"> are excreted in human milk. No animal data are available. </span>", "ID": "77219380-4f77-436a-b86c-85c2e0cb88a1", "Styles": "None", "Classes": "None", "Text": " are excreted in human milk. No animal data are available. ", "ParentId": "2188043f-ff34-4e35-995e-741ec8c0640a"}, {"Element": "<span lang=\"EN-GB\">A risk to newborns/infants cannot be excluded and therefore </span>", "ID": "ee644634-72f5-4b87-910d-4270e2f7f450", "Styles": "None", "Classes": "None", "Text": "A risk to newborns/infants cannot be excluded and therefore ", "ParentId": "2188043f-ff34-4e35-995e-741ec8c0640a"}, {"Element": "<span lang=\"EN-GB\">breast\u2011feeding should be discontinued. </span>", "ID": "0f48d810-6e8b-4aa2-9e6f-468f3e9a1ad2", "Styles": "None", "Classes": "None", "Text": "breast\u2011feeding should be discontinued. ", "ParentId": "2188043f-ff34-4e35-995e-741ec8c0640a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b79cdedf-8a83-455d-9139-7f3579b57bd5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8ef35046-9ba8-4869-b1f3-6337d6fee556", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b79cdedf-8a83-455d-9139-7f3579b57bd5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib will be\ngiven in combination with lenalidomide and breast\u2011feeding should be\nstopped because of the use of lenalidomide.</span></p>", "ID": "a1391b4f-ae31-4411-b099-089ddd3937c5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib will be\ngiven in combination with lenalidomide and breast\u2011feeding should be\nstopped because of the use of lenalidomide.</span>", "ID": "cb8b5ce3-f269-448b-9c53-f2be8d4c5824", "Styles": "None", "Classes": "None", "Text": "Ixazomib will be given in combination with lenalidomide and breast\u2011feeding should be stopped because of the use of lenalidomide.", "ParentId": "a1391b4f-ae31-4411-b099-089ddd3937c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3ecf39e1-bb73-4368-b3bc-504e8af8c436", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4462b87-ff18-47c9-ae30-615833c2fb0b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3ecf39e1-bb73-4368-b3bc-504e8af8c436"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Fertility</span></u></p>", "ID": "b04fa4a6-a839-43ae-8b45-20f03d44fbd5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Fertility</span></u>", "ID": "9eacfdd1-3fcf-4b60-b7ee-716df344b9aa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b04fa4a6-a839-43ae-8b45-20f03d44fbd5"}, {"Element": "<span lang=\"EN-GB\">Fertility</span>", "ID": "df8a1a70-9b7a-4afb-bde7-166272cd5d83", "Styles": "None", "Classes": "None", "Text": "Fertility", "ParentId": "9eacfdd1-3fcf-4b60-b7ee-716df344b9aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "8474536f-f567-4cd8-a8d1-b1ae00628bc7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "294cc02f-aa72-4657-8e79-2783a096a056", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8474536f-f567-4cd8-a8d1-b1ae00628bc7"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "2313fde1-a124-4b92-9e76-7cff5a7cfda5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "294cc02f-aa72-4657-8e79-2783a096a056"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "1791d4cf-6426-4a97-bda4-22e96c7c3590", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "2313fde1-a124-4b92-9e76-7cff5a7cfda5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Fertility\nstudies have not been conducted with ixazomib (see section\u00a05.3).</span></p>", "ID": "2556716c-6ec6-465b-9574-9d6d8410f8b9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Fertility\nstudies have not been conducted with ixazomib (see section\u00a05.3).</span>", "ID": "3ed89041-9226-4dcf-87f7-6139c07483a4", "Styles": "None", "Classes": "None", "Text": "Fertility studies have not been conducted with ixazomib (see section\u00a05.3).", "ParentId": "2556716c-6ec6-465b-9574-9d6d8410f8b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "624df460-793e-4880-b35b-9c59f4328cdb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "380ad878-b65f-407f-8a44-f7d50cd9bf6f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "624df460-793e-4880-b35b-9c59f4328cdb"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "061b75c7-6fa9-4dc5-97b9-bec6c9cd56eb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "380ad878-b65f-407f-8a44-f7d50cd9bf6f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to drive and use\nmachines</span></b></p>", "ID": "aa8ae105-94e5-49eb-9ef3-03f405f6623e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to drive and use\nmachines</span></b>", "ID": "de0bd61a-5d7c-4cc4-9f29-b1de9c3171a2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa8ae105-94e5-49eb-9ef3-03f405f6623e"}, {"Element": "<span lang=\"EN-GB\">4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to drive and use\nmachines</span>", "ID": "89f6c889-58b9-4b40-9b3a-8167cc2ea981", "Styles": "None", "Classes": "None", "Text": "4.7\u00a0\u00a0\u00a0\u00a0 Effects on ability to drive and use machines", "ParentId": "de0bd61a-5d7c-4cc4-9f29-b1de9c3171a2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e750b593-4258-4239-8bdb-adc7679dcf3c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fe1ca4d4-50c0-4c45-9cba-fd0b1b28b575", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e750b593-4258-4239-8bdb-adc7679dcf3c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib has\nminor influence on the ability to drive or use machines. Fatigue and dizziness\nhave been observed in clinical trials. Patients should be advised not to drive\nor operate machines if they experience any of these symptoms.</span></p>", "ID": "6c988f02-3cd7-4350-b948-4fe3caa5b52f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib has\nminor influence on the ability to drive or use machines. Fatigue and dizziness\nhave been observed in clinical trials. Patients should be advised not to drive\nor operate machines if they experience any of these symptoms.</span>", "ID": "01359249-8545-4117-97d9-b105b44a21c8", "Styles": "None", "Classes": "None", "Text": "Ixazomib has minor influence on the ability to drive or use machines. Fatigue and dizziness have been observed in clinical trials. Patients should be advised not to drive or operate machines if they experience any of these symptoms.", "ParentId": "6c988f02-3cd7-4350-b948-4fe3caa5b52f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "bbb9a37d-70ff-4d94-9d1b-c3880f28e3c8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "87e8ade1-a1fa-4159-a5b2-66fcabcd9c9a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bbb9a37d-70ff-4d94-9d1b-c3880f28e3c8"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d8aeabfb-fefd-41de-b758-7d52b4eb9a68", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "87e8ade1-a1fa-4159-a5b2-66fcabcd9c9a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span></b></p>", "ID": "ebd6ac1e-0f15-422c-852c-559a1374a105", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span></b>", "ID": "64aa6efb-f9fc-41a8-b65a-770e8560c798", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ebd6ac1e-0f15-422c-852c-559a1374a105"}, {"Element": "<span lang=\"EN-GB\">4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects</span>", "ID": "27be7b68-40c3-4ac4-b7bc-497af94a981d", "Styles": "None", "Classes": "None", "Text": "4.8\u00a0\u00a0\u00a0\u00a0 Undesirable effects", "ParentId": "64aa6efb-f9fc-41a8-b65a-770e8560c798"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "aed3914f-d32b-42ba-860f-082afa0d6f04", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4ed25706-5ba1-4f39-a5cb-f4d30782eb02", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aed3914f-d32b-42ba-860f-082afa0d6f04"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and\ndexamethasone, refer to the SmPC for these medicinal products for additional\nundesirable effects.</span></p>", "ID": "ccd40ebe-d372-44ef-be38-2da629171ee1", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">As ixazomib is administered in combination with lenalidomide and\ndexamethasone, refer to the SmPC for these medicinal products for additional\nundesirable effects.</span>", "ID": "fd096af5-ac0b-4121-82be-40463d3863a5", "Styles": "None", "Classes": "None", "Text": "As ixazomib is administered in combination with lenalidomide and dexamethasone, refer to the SmPC for these medicinal products for additional undesirable effects.", "ParentId": "ccd40ebe-d372-44ef-be38-2da629171ee1"}, {"Element": "<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "56f021ec-a967-4acf-89b9-1e56451577c9", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "4a907851-b8dc-4a96-afc6-89c8cf6c51df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "56f021ec-a967-4acf-89b9-1e56451577c9"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "59c1f4f1-a5e1-4107-9cd6-b8a9cd74a225", "Styles": "color:windowtext;font-style:\nnormal", "Classes": "None", "Text": "", "ParentId": "4a907851-b8dc-4a96-afc6-89c8cf6c51df"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "10464a27-671c-48f6-a455-0394412a5763", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "59c1f4f1-a5e1-4107-9cd6-b8a9cd74a225"}, {"Element": "<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\">Summary of the safety profile</span></u></p>", "ID": "7c921932-fa3d-44ba-9bdb-19625117a54b", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\">Summary of the safety profile</span></u>", "ID": "8a754220-8275-4357-b48b-42624e52b1f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7c921932-fa3d-44ba-9bdb-19625117a54b"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\">Summary of the safety profile</span>", "ID": "36dbe94a-c49a-4a0a-a38f-27e03896b950", "Styles": "color:windowtext;font-style:\nnormal", "Classes": "None", "Text": "Summary of the safety profile", "ParentId": "8a754220-8275-4357-b48b-42624e52b1f8"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "6758bdb0-8fc4-4233-a04a-d510e6e56d4d", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "dad5be5f-91fb-4dc4-bb55-72057b05c34a", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "6758bdb0-8fc4-4233-a04a-d510e6e56d4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The safety profile of NINLARO is based on available clinical trial\ndata and post\u2011marketing experience to date. Frequencies of adverse\nreactions described below and in Table\u00a03 have been determined based on\ndata generated from clinical studies.</span></p>", "ID": "a371045e-c37d-452b-9c9a-598d0fe6ff49", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The safety profile of NINLARO is based on available clinical trial\ndata and post\u2011marketing experience to date. Frequencies of adverse\nreactions described below and in Table\u00a03 have been determined based on\ndata generated from clinical studies.</span>", "ID": "28469fc1-3ace-44dd-8e0b-550ed027c080", "Styles": "None", "Classes": "None", "Text": "The safety profile of NINLARO is based on available clinical trial data and post\u2011marketing experience to date. Frequencies of adverse reactions described below and in Table\u00a03 have been determined based on data generated from clinical studies.", "ParentId": "a371045e-c37d-452b-9c9a-598d0fe6ff49"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "8e3f7860-7107-402d-8142-2a2fe6c1d50c", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "74fdde00-9be2-4dd1-8e78-3fc2471b0550", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "8e3f7860-7107-402d-8142-2a2fe6c1d50c"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Unless\notherwise noted, the data presented below is </span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">the pooled safety data from the\npivotal, Phase 3, global C16010 study (n=720) and the double\u2011blind,\nplacebo\u2011controlled C16010 China Continuation Study (n=115). </span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">The most frequently\nreported adverse reactions (\u2265\u00a020%) across 417 patients treated within\nthe ixazomib regimen and 418 patients within the placebo regimen were diarrhoea\n(39% vs. 32%), thrombocytopenia (33% vs. 21%), neutropenia (33% vs. 30%), constipation\n(30% vs. 22%), peripheral neuropathy (25% vs. 20%), nausea (23% vs. 18%),\nperipheral oedema (23% vs. 17%), vomiting (20% vs. 10%) and upper respiratory\ntract infection (21% vs. 16%). Serious adverse reactions reported in \u2265\u00a02%\nof patients included thrombocytopenia (2%) and diarrhoea (2%). </span></p>", "ID": "cc29985c-1b37-47bf-9762-d18fa3215dd9", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Unless\notherwise noted, the data presented below is </span>", "ID": "3c94d4a7-a0e4-40bb-8323-bbd242b69c8a", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Unless otherwise noted, the data presented below is ", "ParentId": "cc29985c-1b37-47bf-9762-d18fa3215dd9"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">the pooled safety data from the\npivotal, Phase 3, global C16010 study (n=720) and the double\u2011blind,\nplacebo\u2011controlled C16010 China Continuation Study (n=115). </span>", "ID": "d7944d28-e3a5-4ea5-8237-b27d617e17f9", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "the pooled safety data from the pivotal, Phase 3, global C16010 study (n=720) and the double\u2011blind, placebo\u2011controlled C16010 China Continuation Study (n=115). ", "ParentId": "cc29985c-1b37-47bf-9762-d18fa3215dd9"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">The most frequently\nreported adverse reactions (\u2265\u00a020%) across 417 patients treated within\nthe ixazomib regimen and 418 patients within the placebo regimen were diarrhoea\n(39% vs. 32%), thrombocytopenia (33% vs. 21%), neutropenia (33% vs. 30%), constipation\n(30% vs. 22%), peripheral neuropathy (25% vs. 20%), nausea (23% vs. 18%),\nperipheral oedema (23% vs. 17%), vomiting (20% vs. 10%) and upper respiratory\ntract infection (21% vs. 16%). Serious adverse reactions reported in \u2265\u00a02%\nof patients included thrombocytopenia (2%) and diarrhoea (2%). </span>", "ID": "eb613397-60cb-41d6-910b-cfe886498de3", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "The most frequently reported adverse reactions (\u2265\u00a020%) across 417 patients treated within the ixazomib regimen and 418 patients within the placebo regimen were diarrhoea (39% vs. 32%), thrombocytopenia (33% vs. 21%), neutropenia (33% vs. 30%), constipation (30% vs. 22%), peripheral neuropathy (25% vs. 20%), nausea (23% vs. 18%), peripheral oedema (23% vs. 17%), vomiting (20% vs. 10%) and upper respiratory tract infection (21% vs. 16%). Serious adverse reactions reported in \u2265\u00a02% of patients included thrombocytopenia (2%) and diarrhoea (2%). ", "ParentId": "cc29985c-1b37-47bf-9762-d18fa3215dd9"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "bf921a2c-728e-4058-b54d-260025d109f7", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "bbb79b38-8e04-4c25-88e6-4d1b3863962a", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "bf921a2c-728e-4058-b54d-260025d109f7"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Tabulated list of adverse reactions</span></u></p>", "ID": "419cb590-b7ce-439d-aaaf-10b3bcf88d1c", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Tabulated list of adverse reactions</span></u>", "ID": "9627d287-80a8-4007-ac64-3648686cb3bb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "419cb590-b7ce-439d-aaaf-10b3bcf88d1c"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Tabulated list of adverse reactions</span>", "ID": "a9594abf-12d3-4cd3-8d84-9f79f99fb9f7", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Tabulated list of adverse reactions", "ParentId": "9627d287-80a8-4007-ac64-3648686cb3bb"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "931320a6-268e-4fd6-a9f2-716f3ee287fa", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "474397cc-d12b-442c-9eb0-f310311895d6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "931320a6-268e-4fd6-a9f2-716f3ee287fa"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "8d1f7cd0-951b-42ca-a9eb-09fdd8ac9fcd", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "", "ParentId": "474397cc-d12b-442c-9eb0-f310311895d6"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "bcc79cc2-7504-45d7-84db-e8029c21e35f", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "8d1f7cd0-951b-42ca-a9eb-09fdd8ac9fcd"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">The following convention is used for\nthe classification of the frequency of an adverse drug reaction (ADR): very\ncommon (\u2265\u00a01/10); common (\u2265\u00a01/100 to &lt;\u00a01/10);\nuncommon (\u2265\u00a01/1,000 to &lt;\u00a01/100); rare (\u2265\u00a01/10,000\nto &lt;\u00a01/1,000); very rare (&lt;\u00a01/10,000); not known (cannot be\nestimated from the available data). Within each system organ class, the ADRs\nare ranked by frequency, with the most frequent reactions first.</span><span lang=\"EN-GB\" style=\"font-style:normal\"> </span><span lang=\"EN-GB\" style=\"color:\nwindowtext;font-style:normal\">Within each frequency grouping, adverse reactions\nare presented in order of decreasing seriousness.</span></p>", "ID": "ebfb1042-d5d6-4462-99f4-77d29d68708b", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">The following convention is used for\nthe classification of the frequency of an adverse drug reaction (ADR): very\ncommon (\u2265\u00a01/10); common (\u2265\u00a01/100 to &lt;\u00a01/10);\nuncommon (\u2265\u00a01/1,000 to &lt;\u00a01/100); rare (\u2265\u00a01/10,000\nto &lt;\u00a01/1,000); very rare (&lt;\u00a01/10,000); not known (cannot be\nestimated from the available data). Within each system organ class, the ADRs\nare ranked by frequency, with the most frequent reactions first.</span>", "ID": "e9ba564a-3318-4f8a-a45e-caef3563984b", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "The following convention is used for the classification of the frequency of an adverse drug reaction (ADR): very common (\u2265\u00a01/10); common (\u2265\u00a01/100 to <\u00a01/10); uncommon (\u2265\u00a01/1,000 to <\u00a01/100); rare (\u2265\u00a01/10,000 to <\u00a01/1,000); very rare (<\u00a01/10,000); not known (cannot be estimated from the available data). Within each system organ class, the ADRs are ranked by frequency, with the most frequent reactions first.", "ParentId": "ebfb1042-d5d6-4462-99f4-77d29d68708b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-style:normal\"> </span>", "ID": "29d4cf34-2871-448c-83aa-34a16504dd76", "Styles": "font-style:normal", "Classes": "None", "Text": " ", "ParentId": "ebfb1042-d5d6-4462-99f4-77d29d68708b"}, {"Element": "<span lang=\"EN-GB\" style=\"color:\nwindowtext;font-style:normal\">Within each frequency grouping, adverse reactions\nare presented in order of decreasing seriousness.</span>", "ID": "9e8ea1f5-af36-4856-a83d-808a4c07f274", "Styles": "color:\nwindowtext;font-style:normal", "Classes": "None", "Text": "Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.", "ParentId": "ebfb1042-d5d6-4462-99f4-77d29d68708b"}, {"Element": "<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "9a2cf02c-5ef8-48d0-8d15-5d05e2f284c1", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "6aeb5126-450f-4a7b-b92d-59769d545368", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a2cf02c-5ef8-48d0-8d15-5d05e2f284c1"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "de1f8b47-c18d-4ca9-b11b-cfed6f3df7ef", "Styles": "color:windowtext;font-style:\nnormal", "Classes": "None", "Text": "", "ParentId": "6aeb5126-450f-4a7b-b92d-59769d545368"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "bbf23a93-caef-4d47-baa9-de80a3bebf45", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "de1f8b47-c18d-4ca9-b11b-cfed6f3df7ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"Table3\"><b><span lang=\"EN-GB\">Table 3</span></b></a><b><span lang=\"EN-GB\">:\nAdverse reactions in patients treated with ixazomib in combination with lenalidomide\nand dexamethasone (all grades, grade 3 and grade 4) </span></b></p>", "ID": "ab244cad-4d06-47dd-b073-e77a619bbb60", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<a name=\"Table3\"><b><span lang=\"EN-GB\">Table 3</span></b></a>", "ID": "e4007206-a1f2-40be-8a92-9c7d4a145cdb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ab244cad-4d06-47dd-b073-e77a619bbb60"}, {"Element": "<b><span lang=\"EN-GB\">Table 3</span></b>", "ID": "12c860f0-f9a3-4cc0-bfa4-87a603ad29e2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e4007206-a1f2-40be-8a92-9c7d4a145cdb"}, {"Element": "<span lang=\"EN-GB\">Table 3</span>", "ID": "f3a11a8a-99b0-4bad-8c67-a44669e8ddca", "Styles": "None", "Classes": "None", "Text": "Table 3", "ParentId": "12c860f0-f9a3-4cc0-bfa4-87a603ad29e2"}, {"Element": "<b><span lang=\"EN-GB\">:\nAdverse reactions in patients treated with ixazomib in combination with lenalidomide\nand dexamethasone (all grades, grade 3 and grade 4) </span></b>", "ID": "924a8b0e-5c42-47b7-aac7-6a0c47fdb69c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ab244cad-4d06-47dd-b073-e77a619bbb60"}, {"Element": "<span lang=\"EN-GB\">:\nAdverse reactions in patients treated with ixazomib in combination with lenalidomide\nand dexamethasone (all grades, grade 3 and grade 4) </span>", "ID": "ede41427-f9de-467a-bdc5-4d0c9da3ff75", "Styles": "None", "Classes": "None", "Text": ": Adverse reactions in patients treated with ixazomib in combination with lenalidomide and dexamethasone (all grades, grade 3 and grade 4) ", "ParentId": "924a8b0e-5c42-47b7-aac7-6a0c47fdb69c"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"width:455.95pt;border-collapse:collapse;border:none\" width=\"608\">\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">System organ class / Adverse reaction</span></b></p>\n</td>\n<td style=\"width:112.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Adverse reactions (all grades)</span></b></p>\n</td>\n<td style=\"width:115.15pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Grade 3 adverse reactions</span></b></p>\n</td>\n<td style=\"width:101.4pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Grade 4 adverse reactions</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Infections and infestations</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Upper respiratory tract infection</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Herpes zoster</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombocytopenia*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Neutropenia*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombotic microangiopathy</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombotic thrombocytopenic purpura</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Metabolism and nutrition disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Tumour lysis syndrome</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Nervous system disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peripheral\n  neuropathies*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Posterior\n  reversible encephalopathy disorders*</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Transverse\n  myelitis</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Gastrointestinal\n  disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Diarrhoea</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Nausea</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vomiting</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Constipation</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Skin and\n  subcutaneous tissue disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rash*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Stevens\u2011Johnson\n  syndrome</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Acute febrile </span><span lang=\"FR\">neutrophilic dermatosis</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Musculoskeletal\n  and connective tissue disorders</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Back pain</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common </span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">General\n  disorders and administration site conditions</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oedema\n  peripheral</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>\n</table>", "ID": "e2e25528-fc76-4b24-a72e-05ce1f782342", "Styles": "width:455.95pt;border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "                             ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">System organ class / Adverse reaction</span></b></p>\n</td>\n<td style=\"width:112.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Adverse reactions (all grades)</span></b></p>\n</td>\n<td style=\"width:115.15pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Grade 3 adverse reactions</span></b></p>\n</td>\n<td style=\"width:101.4pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Grade 4 adverse reactions</span></b></p>\n</td>\n</tr>", "ID": "3c4dba5d-fae7-4e35-8d9a-867899306720", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">System organ class / Adverse reaction</span></b></p>\n</td>", "ID": "4a3016d8-b7a0-417d-89ff-f289cd69eabf", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3c4dba5d-fae7-4e35-8d9a-867899306720"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">System organ class / Adverse reaction</span></b></p>", "ID": "f0c86a56-f7d9-45d6-bf41-a1a79f1d2d24", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4a3016d8-b7a0-417d-89ff-f289cd69eabf"}, {"Element": "<b><span lang=\"EN-GB\">System organ class / Adverse reaction</span></b>", "ID": "27420d7a-2625-4218-9329-5824ac1ef210", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f0c86a56-f7d9-45d6-bf41-a1a79f1d2d24"}, {"Element": "<span lang=\"EN-GB\">System organ class / Adverse reaction</span>", "ID": "b231ab83-816a-4b6a-a065-b5eab9cc6e49", "Styles": "None", "Classes": "None", "Text": "System organ class / Adverse reaction", "ParentId": "27420d7a-2625-4218-9329-5824ac1ef210"}, {"Element": "<td style=\"width:112.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Adverse reactions (all grades)</span></b></p>\n</td>", "ID": "4d291167-27b3-436d-b439-d3bfac5d641d", "Styles": "width:112.5pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3c4dba5d-fae7-4e35-8d9a-867899306720"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Adverse reactions (all grades)</span></b></p>", "ID": "bcd0f15c-706e-4274-b4eb-33a92ffb0a80", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4d291167-27b3-436d-b439-d3bfac5d641d"}, {"Element": "<b><span lang=\"EN-GB\">Adverse reactions (all grades)</span></b>", "ID": "a1bcb16e-d0f9-4ab2-ba7d-0476ca799b49", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bcd0f15c-706e-4274-b4eb-33a92ffb0a80"}, {"Element": "<span lang=\"EN-GB\">Adverse reactions (all grades)</span>", "ID": "0753c3fc-b029-4fc5-b3c3-055f3f1641fd", "Styles": "None", "Classes": "None", "Text": "Adverse reactions (all grades)", "ParentId": "a1bcb16e-d0f9-4ab2-ba7d-0476ca799b49"}, {"Element": "<td style=\"width:115.15pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Grade 3 adverse reactions</span></b></p>\n</td>", "ID": "4320a93a-e1b3-4309-8f5b-bff00af160b0", "Styles": "width:115.15pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3c4dba5d-fae7-4e35-8d9a-867899306720"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Grade 3 adverse reactions</span></b></p>", "ID": "7f510b5d-de87-4bf2-b8b2-68a7af6b58c9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4320a93a-e1b3-4309-8f5b-bff00af160b0"}, {"Element": "<b><span lang=\"EN-GB\">Grade 3 adverse reactions</span></b>", "ID": "1d380c92-f2a2-4b88-9627-a1e310c016e0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7f510b5d-de87-4bf2-b8b2-68a7af6b58c9"}, {"Element": "<span lang=\"EN-GB\">Grade 3 adverse reactions</span>", "ID": "cd7bdf66-39fe-4056-bf35-e4fd86324aab", "Styles": "None", "Classes": "None", "Text": "Grade 3 adverse reactions", "ParentId": "1d380c92-f2a2-4b88-9627-a1e310c016e0"}, {"Element": "<td style=\"width:101.4pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Grade 4 adverse reactions</span></b></p>\n</td>", "ID": "82abbe3f-d0ab-48f7-b108-42ec50881499", "Styles": "width:101.4pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3c4dba5d-fae7-4e35-8d9a-867899306720"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Grade 4 adverse reactions</span></b></p>", "ID": "cf96e63a-b23a-4c4a-83d5-9272ea341e50", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "82abbe3f-d0ab-48f7-b108-42ec50881499"}, {"Element": "<b><span lang=\"EN-GB\">Grade 4 adverse reactions</span></b>", "ID": "feaac55b-f0b3-4fb3-a517-f098d60e4e9f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cf96e63a-b23a-4c4a-83d5-9272ea341e50"}, {"Element": "<span lang=\"EN-GB\">Grade 4 adverse reactions</span>", "ID": "bdb3d2c7-517e-4e55-868c-9ff0f9abfe25", "Styles": "None", "Classes": "None", "Text": "Grade 4 adverse reactions", "ParentId": "feaac55b-f0b3-4fb3-a517-f098d60e4e9f"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Infections and infestations</span></b></p>\n</td>\n</tr>", "ID": "09facbcc-ef32-47ae-89dd-5db0e9b64206", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Infections and infestations</span></b></p>\n</td>", "ID": "dc643e32-d69f-471e-9a11-3da78139084c", "Styles": "width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "09facbcc-ef32-47ae-89dd-5db0e9b64206"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Infections and infestations</span></b></p>", "ID": "ec5a4503-949b-44aa-9720-adba6c87df19", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dc643e32-d69f-471e-9a11-3da78139084c"}, {"Element": "<b><span lang=\"EN-GB\">Infections and infestations</span></b>", "ID": "5fd5a6a2-fb67-4dc4-b547-fa0a69106592", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ec5a4503-949b-44aa-9720-adba6c87df19"}, {"Element": "<span lang=\"EN-GB\">Infections and infestations</span>", "ID": "d6a924ba-bad1-409b-8500-398a7c0ba798", "Styles": "None", "Classes": "None", "Text": "Infections and infestations", "ParentId": "5fd5a6a2-fb67-4dc4-b547-fa0a69106592"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Upper respiratory tract infection</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "9fac6f82-00cc-4da5-b353-60d8fb099043", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Upper respiratory tract infection</span></p>\n</td>", "ID": "076be4b1-037a-4025-9b72-82646bac5499", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9fac6f82-00cc-4da5-b353-60d8fb099043"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Upper respiratory tract infection</span></p>", "ID": "51ee1ead-d818-48a0-a9b3-72387d1b572a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "076be4b1-037a-4025-9b72-82646bac5499"}, {"Element": "<span lang=\"EN-GB\">Upper respiratory tract infection</span>", "ID": "67d4f9a2-3e54-4c4a-8290-0a13aeb721b2", "Styles": "None", "Classes": "None", "Text": "Upper respiratory tract infection", "ParentId": "51ee1ead-d818-48a0-a9b3-72387d1b572a"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "afceafb9-98ac-4bdf-8bbc-2ca891ef30d5", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9fac6f82-00cc-4da5-b353-60d8fb099043"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "80e57ebb-4d88-43e6-b42b-0a0ed4c24f52", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "afceafb9-98ac-4bdf-8bbc-2ca891ef30d5"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "3d1f10cc-12d4-4125-855e-30a0002131a2", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "80e57ebb-4d88-43e6-b42b-0a0ed4c24f52"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>", "ID": "cc313323-f943-4451-a044-7d36b59b4830", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9fac6f82-00cc-4da5-b353-60d8fb099043"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Uncommon</span></p>", "ID": "896d50ea-7a7a-4e9c-83d7-ca136d266542", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cc313323-f943-4451-a044-7d36b59b4830"}, {"Element": "<span lang=\"EN-GB\">Uncommon</span>", "ID": "07bde161-e699-4117-b412-88f86de91766", "Styles": "None", "Classes": "None", "Text": "Uncommon", "ParentId": "896d50ea-7a7a-4e9c-83d7-ca136d266542"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "3be2808a-d394-4ebc-9d9d-dd7fc2a9382d", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9fac6f82-00cc-4da5-b353-60d8fb099043"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "712f46ff-faaa-4dfc-ae26-4415d9fed2f5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3be2808a-d394-4ebc-9d9d-dd7fc2a9382d"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "eab5a715-6198-400a-90a5-d92efd5c87df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "712f46ff-faaa-4dfc-ae26-4415d9fed2f5"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9334fe3c-e482-4392-92cd-826ee3a02296", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eab5a715-6198-400a-90a5-d92efd5c87df"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Herpes zoster</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "ca16f871-eb58-4bba-9553-84de0a5e228b", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Herpes zoster</span></p>\n</td>", "ID": "b10020a8-ed95-409d-8032-695db31e3a15", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca16f871-eb58-4bba-9553-84de0a5e228b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Herpes zoster</span></p>", "ID": "a78c17c7-f56d-4b66-97c1-b8d77836aea1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b10020a8-ed95-409d-8032-695db31e3a15"}, {"Element": "<span lang=\"EN-GB\">Herpes zoster</span>", "ID": "f0a17aa1-0833-492a-92ed-4c9584c2923e", "Styles": "None", "Classes": "None", "Text": "Herpes zoster", "ParentId": "a78c17c7-f56d-4b66-97c1-b8d77836aea1"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>", "ID": "adbf4667-e0ad-4bd9-8898-0c09ec40d431", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca16f871-eb58-4bba-9553-84de0a5e228b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>", "ID": "29fe696d-2c15-4c95-8f64-40ab17f07584", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "adbf4667-e0ad-4bd9-8898-0c09ec40d431"}, {"Element": "<span lang=\"EN-GB\">Common</span>", "ID": "21acf529-a3b3-4b5a-8ce8-9f463dad1057", "Styles": "None", "Classes": "None", "Text": "Common", "ParentId": "29fe696d-2c15-4c95-8f64-40ab17f07584"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>", "ID": "db2711c6-1bc1-4c8f-ab5e-86d6545cbd41", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca16f871-eb58-4bba-9553-84de0a5e228b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>", "ID": "0647025f-0d03-4434-b0fb-a00fbda937aa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db2711c6-1bc1-4c8f-ab5e-86d6545cbd41"}, {"Element": "<span lang=\"EN-GB\">Common</span>", "ID": "5ee15c1c-dd48-4630-8415-2093f4a935b0", "Styles": "None", "Classes": "None", "Text": "Common", "ParentId": "0647025f-0d03-4434-b0fb-a00fbda937aa"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "7851a618-3f07-42fa-bdff-b829b91db05f", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca16f871-eb58-4bba-9553-84de0a5e228b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9c3034ae-3fd9-4e51-a277-d6dc00f3516b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7851a618-3f07-42fa-bdff-b829b91db05f"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d071c7d7-2926-4514-9264-32f5f8a7ba3b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9c3034ae-3fd9-4e51-a277-d6dc00f3516b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fcba0c53-c2e1-44df-8d1b-e8fe672ef2f6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d071c7d7-2926-4514-9264-32f5f8a7ba3b"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b></p>\n</td>\n</tr>", "ID": "0237f7ed-ebe7-4fad-8837-2de6b5f2c53a", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b></p>\n</td>", "ID": "03096009-a792-4574-ac68-bd973e3aff66", "Styles": "width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "0237f7ed-ebe7-4fad-8837-2de6b5f2c53a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b></p>", "ID": "f3b722da-de20-4aae-8ab0-cd0fa3660cb4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "03096009-a792-4574-ac68-bd973e3aff66"}, {"Element": "<b><span lang=\"EN-GB\">Blood and lymphatic system disorders</span></b>", "ID": "33162c9d-f6a1-4885-a8af-9fdebcd0551b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f3b722da-de20-4aae-8ab0-cd0fa3660cb4"}, {"Element": "<span lang=\"EN-GB\">Blood and lymphatic system disorders</span>", "ID": "6614d662-9072-4a44-989a-ad42097198ba", "Styles": "None", "Classes": "None", "Text": "Blood and lymphatic system disorders", "ParentId": "33162c9d-f6a1-4885-a8af-9fdebcd0551b"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombocytopenia*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n</tr>", "ID": "bab115ae-c814-477e-b9f8-4d8f212aae42", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombocytopenia*</span></p>\n</td>", "ID": "50bedbe3-46d1-480e-9c4e-65538a1a6777", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bab115ae-c814-477e-b9f8-4d8f212aae42"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombocytopenia*</span></p>", "ID": "a060e4d5-2811-46b1-8731-266661c1b5d0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "50bedbe3-46d1-480e-9c4e-65538a1a6777"}, {"Element": "<span lang=\"EN-GB\">Thrombocytopenia*</span>", "ID": "bc06189d-f042-470e-bd99-a4081550e74f", "Styles": "None", "Classes": "None", "Text": "Thrombocytopenia*", "ParentId": "a060e4d5-2811-46b1-8731-266661c1b5d0"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "f45fd878-0335-4109-8ad0-303bae4c49bf", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bab115ae-c814-477e-b9f8-4d8f212aae42"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "75b781be-05a5-4f8c-bb00-56235e069319", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f45fd878-0335-4109-8ad0-303bae4c49bf"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "c2f8bc89-bb0c-4447-898e-c13daa5198f7", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "75b781be-05a5-4f8c-bb00-56235e069319"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "86c6f2f9-0082-4ee5-80fd-26df26039c90", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bab115ae-c814-477e-b9f8-4d8f212aae42"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "e97f919d-b16b-4ca5-aaba-2d19307ed9d4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "86c6f2f9-0082-4ee5-80fd-26df26039c90"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "e9f49d37-dc22-4cd1-a7cf-04628b778355", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "e97f919d-b16b-4ca5-aaba-2d19307ed9d4"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>", "ID": "5e7d9c45-32ff-421c-8bd4-1e59f58e8ba7", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "bab115ae-c814-477e-b9f8-4d8f212aae42"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>", "ID": "a6757275-2770-430e-89ae-60b74076c709", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5e7d9c45-32ff-421c-8bd4-1e59f58e8ba7"}, {"Element": "<span lang=\"EN-GB\">Common</span>", "ID": "028fc405-877b-4a5e-a70b-389a56a63c89", "Styles": "None", "Classes": "None", "Text": "Common", "ParentId": "a6757275-2770-430e-89ae-60b74076c709"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Neutropenia*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n</tr>", "ID": "62a7f45f-610a-4d37-b33e-fef9fbfc2c8a", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Neutropenia*</span></p>\n</td>", "ID": "01dcd83a-be4d-43a2-8a35-e6ceb4819d43", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "62a7f45f-610a-4d37-b33e-fef9fbfc2c8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Neutropenia*</span></p>", "ID": "81e30de9-53c1-4ea7-ac02-0eb89565230d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "01dcd83a-be4d-43a2-8a35-e6ceb4819d43"}, {"Element": "<span lang=\"EN-GB\">Neutropenia*</span>", "ID": "daf67bdf-585e-4a84-8cbb-15d67616373f", "Styles": "None", "Classes": "None", "Text": "Neutropenia*", "ParentId": "81e30de9-53c1-4ea7-ac02-0eb89565230d"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "659bb2c1-d680-4fe6-8769-d1b6a1f6a7f9", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "62a7f45f-610a-4d37-b33e-fef9fbfc2c8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "0b0351f0-351c-4b6c-887d-324315289996", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "659bb2c1-d680-4fe6-8769-d1b6a1f6a7f9"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "846d815a-7b40-420b-b91c-d4f415c00123", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "0b0351f0-351c-4b6c-887d-324315289996"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "cbad1aa5-ceac-4b23-8ec1-c66738c44f84", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "62a7f45f-610a-4d37-b33e-fef9fbfc2c8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "5661a596-5111-44fd-b832-44bc4e51fa94", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cbad1aa5-ceac-4b23-8ec1-c66738c44f84"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "7a42fbe6-d991-43e7-9076-ae176e959d90", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "5661a596-5111-44fd-b832-44bc4e51fa94"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>\n</td>", "ID": "d2411340-7620-4943-b0f6-b39831a95bed", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "62a7f45f-610a-4d37-b33e-fef9fbfc2c8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Common</span></p>", "ID": "ef12f69e-f027-41a0-8576-e7e54805b950", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d2411340-7620-4943-b0f6-b39831a95bed"}, {"Element": "<span lang=\"EN-GB\">Common</span>", "ID": "a28e3e68-63af-4311-ae36-077cfd5bd93d", "Styles": "None", "Classes": "None", "Text": "Common", "ParentId": "ef12f69e-f027-41a0-8576-e7e54805b950"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombotic microangiopathy</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>", "ID": "269a7f5c-b897-46cb-8cc2-e6c07217301d", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombotic microangiopathy</span></p>\n</td>", "ID": "aeec382e-f4f6-4754-ac08-84ae25330ec4", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "269a7f5c-b897-46cb-8cc2-e6c07217301d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombotic microangiopathy</span></p>", "ID": "1f4494ba-38ca-42a0-9ba2-0f2bb86f6194", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aeec382e-f4f6-4754-ac08-84ae25330ec4"}, {"Element": "<span lang=\"EN-GB\">Thrombotic microangiopathy</span>", "ID": "e9afa07c-f63b-415d-8b84-3fc2d16235ef", "Styles": "None", "Classes": "None", "Text": "Thrombotic microangiopathy", "ParentId": "1f4494ba-38ca-42a0-9ba2-0f2bb86f6194"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "7be9a58d-b812-454a-b48f-71ddaf6ea9e2", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "269a7f5c-b897-46cb-8cc2-e6c07217301d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "ac2eb1c7-33e6-48c5-824c-07a8e8001cb9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7be9a58d-b812-454a-b48f-71ddaf6ea9e2"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "feec8351-0d9c-4e87-9c21-dfc87d566a67", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "ac2eb1c7-33e6-48c5-824c-07a8e8001cb9"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "7d676cf3-79f4-487c-b50b-a4197d749767", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "269a7f5c-b897-46cb-8cc2-e6c07217301d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "52cf6330-f994-442e-94d6-b5613b9b43fa", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7d676cf3-79f4-487c-b50b-a4197d749767"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "627a0d15-4338-4c6f-a63d-234d9044ea54", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "52cf6330-f994-442e-94d6-b5613b9b43fa"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "74fa7913-dad6-4e79-b2d5-cf54ded5849d", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "269a7f5c-b897-46cb-8cc2-e6c07217301d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "829f248f-56e4-4734-a963-2596374054c8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "74fa7913-dad6-4e79-b2d5-cf54ded5849d"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "61af710b-cbdd-42d3-9407-f6f6bba723ad", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "829f248f-56e4-4734-a963-2596374054c8"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombotic thrombocytopenic purpura</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>", "ID": "d0a8f1d0-cd27-4ef2-8b81-cda1600cfccf", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombotic thrombocytopenic purpura</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>", "ID": "8512820c-58a0-42cf-a70f-904a20f67a83", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d0a8f1d0-cd27-4ef2-8b81-cda1600cfccf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Thrombotic thrombocytopenic purpura</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>", "ID": "73a09ba6-b48f-467e-9781-2252d47fdd3c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8512820c-58a0-42cf-a70f-904a20f67a83"}, {"Element": "<span lang=\"EN-GB\">Thrombotic thrombocytopenic purpura</span>", "ID": "e2b1a92d-63ec-43db-9a97-f9bbb1da065c", "Styles": "None", "Classes": "None", "Text": "Thrombotic thrombocytopenic purpura", "ParentId": "73a09ba6-b48f-467e-9781-2252d47fdd3c"}, {"Element": "<sup><span lang=\"EN-GB\">\u2020</span></sup>", "ID": "14c1df94-7af0-4aee-8cbe-b280ff163b3b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "73a09ba6-b48f-467e-9781-2252d47fdd3c"}, {"Element": "<span lang=\"EN-GB\">\u2020</span>", "ID": "15720421-e8cd-42dc-94f4-d33b935027ce", "Styles": "None", "Classes": "None", "Text": "\u2020", "ParentId": "14c1df94-7af0-4aee-8cbe-b280ff163b3b"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "ea0f2c7f-65d2-455f-88f5-0ea1387ab1dc", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d0a8f1d0-cd27-4ef2-8b81-cda1600cfccf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "20828c9b-3a31-4ea4-ae0e-eb2127107b8a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ea0f2c7f-65d2-455f-88f5-0ea1387ab1dc"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "6c5b57dd-ac46-4a02-b434-71e47a1794fb", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "20828c9b-3a31-4ea4-ae0e-eb2127107b8a"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "756967c4-7567-4f7e-a5da-433d9bdac6cc", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d0a8f1d0-cd27-4ef2-8b81-cda1600cfccf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "09e0e7c3-06aa-4daa-86d5-a6f1435d8701", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "756967c4-7567-4f7e-a5da-433d9bdac6cc"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "b924bc09-621a-4674-a822-8f6b466efc3d", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "09e0e7c3-06aa-4daa-86d5-a6f1435d8701"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "e05867e0-4234-44ec-9671-1b96d092fd58", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d0a8f1d0-cd27-4ef2-8b81-cda1600cfccf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "f7297c78-9b32-48d4-b711-8b71b0c52f76", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e05867e0-4234-44ec-9671-1b96d092fd58"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "e7a086c5-4609-4497-abc5-c598c52bf84e", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "f7297c78-9b32-48d4-b711-8b71b0c52f76"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Metabolism and nutrition disorders</span></b></p>\n</td>\n</tr>", "ID": "b96aced5-d8b0-475e-99a2-9845c49607a1", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Metabolism and nutrition disorders</span></b></p>\n</td>", "ID": "05f185f1-4d6e-4ad6-9305-095e5a3be4d5", "Styles": "width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b96aced5-d8b0-475e-99a2-9845c49607a1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Metabolism and nutrition disorders</span></b></p>", "ID": "fb9a564b-13a4-47a9-9c57-904c6502cab6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "05f185f1-4d6e-4ad6-9305-095e5a3be4d5"}, {"Element": "<b><span lang=\"EN-GB\">Metabolism and nutrition disorders</span></b>", "ID": "7f611ec7-1d59-4f13-8830-bc0db3d1a060", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fb9a564b-13a4-47a9-9c57-904c6502cab6"}, {"Element": "<span lang=\"EN-GB\">Metabolism and nutrition disorders</span>", "ID": "31b52d71-1898-47f1-9c4e-e1118ce9e773", "Styles": "None", "Classes": "None", "Text": "Metabolism and nutrition disorders", "ParentId": "7f611ec7-1d59-4f13-8830-bc0db3d1a060"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Tumour lysis syndrome</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>", "ID": "a04749de-79ec-4492-8558-715ccad65d07", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Tumour lysis syndrome</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>", "ID": "f57285fa-dfa3-4f9a-9f54-45431a40a27d", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a04749de-79ec-4492-8558-715ccad65d07"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Tumour lysis syndrome</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>", "ID": "bcd302ff-8fa5-4eab-baba-055998aa2f0d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f57285fa-dfa3-4f9a-9f54-45431a40a27d"}, {"Element": "<span lang=\"EN-GB\">Tumour lysis syndrome</span>", "ID": "8d617d34-c83c-4078-a2e6-fda2161c16b0", "Styles": "None", "Classes": "None", "Text": "Tumour lysis syndrome", "ParentId": "bcd302ff-8fa5-4eab-baba-055998aa2f0d"}, {"Element": "<sup><span lang=\"EN-GB\">\u2020</span></sup>", "ID": "63d67b0d-5b4d-49e1-bf49-c8b33be35a19", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bcd302ff-8fa5-4eab-baba-055998aa2f0d"}, {"Element": "<span lang=\"EN-GB\">\u2020</span>", "ID": "13f2f0f7-c37e-4e26-a30b-fe1c8e3fca97", "Styles": "None", "Classes": "None", "Text": "\u2020", "ParentId": "63d67b0d-5b4d-49e1-bf49-c8b33be35a19"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "cf84d3f6-ca7a-4457-ac86-78ee5970fd99", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a04749de-79ec-4492-8558-715ccad65d07"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "1b23dbe1-c51f-431d-868d-352f7a052bb8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cf84d3f6-ca7a-4457-ac86-78ee5970fd99"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "20de74f0-a8f0-41d4-a791-1e5408e8e756", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "1b23dbe1-c51f-431d-868d-352f7a052bb8"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "2e058e41-b7e3-485f-87cb-e1331cfc8c72", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a04749de-79ec-4492-8558-715ccad65d07"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "df14a594-de7b-4458-bb96-d12a402c81ec", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2e058e41-b7e3-485f-87cb-e1331cfc8c72"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "93001162-7986-4d31-9aef-2ba2e7c82452", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "df14a594-de7b-4458-bb96-d12a402c81ec"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "6a9b106d-4f1a-4b58-aa37-69d7d4cc4bc9", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a04749de-79ec-4492-8558-715ccad65d07"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "237b3c00-bae3-4a37-b4cb-93d8e8d660c5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6a9b106d-4f1a-4b58-aa37-69d7d4cc4bc9"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "f40ee552-4541-4280-a1d0-d8cc9c01a5c2", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "237b3c00-bae3-4a37-b4cb-93d8e8d660c5"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Nervous system disorders</span></b></p>\n</td>\n</tr>", "ID": "4d0e2aee-2e2b-4194-876a-62dbfc0cc4bd", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Nervous system disorders</span></b></p>\n</td>", "ID": "05263e08-f5ec-4d1a-8ec2-dd7c76763def", "Styles": "width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "4d0e2aee-2e2b-4194-876a-62dbfc0cc4bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Nervous system disorders</span></b></p>", "ID": "10b2f4ec-ec7d-47d2-9a9c-6d4e5baa70d4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "05263e08-f5ec-4d1a-8ec2-dd7c76763def"}, {"Element": "<b><span lang=\"EN-GB\">Nervous system disorders</span></b>", "ID": "89500ade-cff5-4267-aa49-860dff305ae5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "10b2f4ec-ec7d-47d2-9a9c-6d4e5baa70d4"}, {"Element": "<span lang=\"EN-GB\">Nervous system disorders</span>", "ID": "a98fc067-9ddb-4a83-b1ea-2d664b041619", "Styles": "None", "Classes": "None", "Text": "Nervous system disorders", "ParentId": "89500ade-cff5-4267-aa49-860dff305ae5"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peripheral\n  neuropathies*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "a15445ac-e0fd-4b02-b5fc-08d7dbdf5bf5", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peripheral\n  neuropathies*</span></p>\n</td>", "ID": "7ad38097-311f-460f-b2e1-054cbe1afb42", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a15445ac-e0fd-4b02-b5fc-08d7dbdf5bf5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peripheral\n  neuropathies*</span></p>", "ID": "d55b29fb-086a-4f89-a400-fb07765e2c27", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7ad38097-311f-460f-b2e1-054cbe1afb42"}, {"Element": "<span lang=\"EN-GB\">Peripheral\n  neuropathies*</span>", "ID": "afa1f28c-e481-4354-b551-c837a5786cff", "Styles": "None", "Classes": "None", "Text": "Peripheral   neuropathies*", "ParentId": "d55b29fb-086a-4f89-a400-fb07765e2c27"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "4363ec49-1004-4d82-b172-0ff79417a1bd", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a15445ac-e0fd-4b02-b5fc-08d7dbdf5bf5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "e1698b7f-ada5-42be-818e-3ccb3b59b731", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4363ec49-1004-4d82-b172-0ff79417a1bd"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "afa68432-618f-4e04-909a-4cc57329f4e5", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "e1698b7f-ada5-42be-818e-3ccb3b59b731"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>", "ID": "af37bf73-7e8e-45b4-99cf-0a97dc727d8a", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a15445ac-e0fd-4b02-b5fc-08d7dbdf5bf5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>", "ID": "68c4e46f-980f-4ddf-9e01-ed4d92836aa8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "af37bf73-7e8e-45b4-99cf-0a97dc727d8a"}, {"Element": "<span lang=\"EN-GB\">Common</span>", "ID": "3be7926c-1b07-4964-aebc-cb9f2c9b180d", "Styles": "None", "Classes": "None", "Text": "Common", "ParentId": "68c4e46f-980f-4ddf-9e01-ed4d92836aa8"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "7c259851-e0ae-4dd0-bc65-91f4e7131b87", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a15445ac-e0fd-4b02-b5fc-08d7dbdf5bf5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "03095a0d-8560-4632-a2d8-662c6d88e78f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7c259851-e0ae-4dd0-bc65-91f4e7131b87"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "21746710-0ede-4179-a892-c95705c9fee1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "03095a0d-8560-4632-a2d8-662c6d88e78f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7cc65d07-8c01-4f0d-b206-ff2109e7b489", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "21746710-0ede-4179-a892-c95705c9fee1"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Posterior\n  reversible encephalopathy disorders*</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n</tr>", "ID": "ca039b0f-a0d3-41bb-a419-8050d10afb1d", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Posterior\n  reversible encephalopathy disorders*</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>", "ID": "d20e3083-2bb1-4820-832d-3f9ce0027bf8", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca039b0f-a0d3-41bb-a419-8050d10afb1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Posterior\n  reversible encephalopathy disorders*</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>", "ID": "132b3722-7a20-4700-b876-0489387f5b14", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d20e3083-2bb1-4820-832d-3f9ce0027bf8"}, {"Element": "<span lang=\"EN-GB\">Posterior\n  reversible encephalopathy disorders*</span>", "ID": "7c50c5da-0bda-44d0-a9e0-619662c09e7e", "Styles": "None", "Classes": "None", "Text": "Posterior   reversible encephalopathy disorders*", "ParentId": "132b3722-7a20-4700-b876-0489387f5b14"}, {"Element": "<sup><span lang=\"EN-GB\">\u2020</span></sup>", "ID": "7658030a-614e-4157-b8e6-80e4b9c1412d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "132b3722-7a20-4700-b876-0489387f5b14"}, {"Element": "<span lang=\"EN-GB\">\u2020</span>", "ID": "ec83ad9e-6b58-4773-9e2e-daac66c92f9c", "Styles": "None", "Classes": "None", "Text": "\u2020", "ParentId": "7658030a-614e-4157-b8e6-80e4b9c1412d"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "5864c4c4-10b7-413a-a1e9-05dbc972a185", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca039b0f-a0d3-41bb-a419-8050d10afb1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "0f647ef3-c144-4c13-9d0d-7c50dfc63288", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5864c4c4-10b7-413a-a1e9-05dbc972a185"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "379d72d8-f680-4b2c-8e59-34d4556e22db", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "0f647ef3-c144-4c13-9d0d-7c50dfc63288"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "a551f9a0-5d00-490c-b28f-8743377f82f6", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca039b0f-a0d3-41bb-a419-8050d10afb1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "1f57f406-c8ec-4dbc-ae50-170f8b625bbb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a551f9a0-5d00-490c-b28f-8743377f82f6"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "67bf8c9a-4447-43c3-bab5-df9e1a0c28c2", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "1f57f406-c8ec-4dbc-ae50-170f8b625bbb"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "1809ede8-c798-4cd6-b956-18d645876a71", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ca039b0f-a0d3-41bb-a419-8050d10afb1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "f5e7a2f3-1da6-4d31-94a7-73db7a6bfc9d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1809ede8-c798-4cd6-b956-18d645876a71"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "a9ec86a8-ebf9-4446-a5c1-6d45b54f8a09", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "f5e7a2f3-1da6-4d31-94a7-73db7a6bfc9d"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Transverse\n  myelitis</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "c31a1141-460b-48ee-a1c6-c544d63437c9", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Transverse\n  myelitis</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>", "ID": "224edf3b-98cc-424a-86b4-5835fcf28b17", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c31a1141-460b-48ee-a1c6-c544d63437c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Transverse\n  myelitis</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>", "ID": "3fdd8b92-aa8e-4470-b48c-744dba99ae69", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "224edf3b-98cc-424a-86b4-5835fcf28b17"}, {"Element": "<span lang=\"EN-GB\">Transverse\n  myelitis</span>", "ID": "78182506-cee8-4fe6-ae45-ebd143e6c9d3", "Styles": "None", "Classes": "None", "Text": "Transverse   myelitis", "ParentId": "3fdd8b92-aa8e-4470-b48c-744dba99ae69"}, {"Element": "<sup><span lang=\"EN-GB\">\u2020</span></sup>", "ID": "6a67a00a-981f-4c3e-ba5b-b2454c191e7c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3fdd8b92-aa8e-4470-b48c-744dba99ae69"}, {"Element": "<span lang=\"EN-GB\">\u2020</span>", "ID": "e63ad5de-d2b6-4708-adb5-f42a10625925", "Styles": "None", "Classes": "None", "Text": "\u2020", "ParentId": "6a67a00a-981f-4c3e-ba5b-b2454c191e7c"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "f3ddd616-15ec-40f3-9f6f-5cafc1853924", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c31a1141-460b-48ee-a1c6-c544d63437c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "cb940120-6eeb-4a25-98e0-0f6bdbae4b09", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f3ddd616-15ec-40f3-9f6f-5cafc1853924"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "a4bf2e2d-576c-4ce0-8c09-b9e333e1cf11", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "cb940120-6eeb-4a25-98e0-0f6bdbae4b09"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "8d147202-ac22-47c2-82b7-d1d0bc01a549", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c31a1141-460b-48ee-a1c6-c544d63437c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "94f8cb52-44e8-4c7d-a017-94a2388c7c65", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8d147202-ac22-47c2-82b7-d1d0bc01a549"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "5e6cedb6-47d6-4897-81af-bd0cf4613589", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "94f8cb52-44e8-4c7d-a017-94a2388c7c65"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "e9a1f465-2d77-4215-9ffc-f0db15c176fc", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c31a1141-460b-48ee-a1c6-c544d63437c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9fe102a7-49cd-492f-ac5d-d8544358b848", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9a1f465-2d77-4215-9ffc-f0db15c176fc"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d8177620-3caa-41b1-914d-2e9a9ee39729", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9fe102a7-49cd-492f-ac5d-d8544358b848"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "442c726c-fac1-4aa6-95b2-bf1930ccf25f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d8177620-3caa-41b1-914d-2e9a9ee39729"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Gastrointestinal\n  disorders</span></b></p>\n</td>\n</tr>", "ID": "c5619ddc-275a-4756-8ae8-d610a05c0338", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Gastrointestinal\n  disorders</span></b></p>\n</td>", "ID": "0aa9c38a-aaf3-4198-9a5e-6ae67bf85a11", "Styles": "width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c5619ddc-275a-4756-8ae8-d610a05c0338"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Gastrointestinal\n  disorders</span></b></p>", "ID": "e90cec3f-1b12-4199-8402-671fbd47ce33", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0aa9c38a-aaf3-4198-9a5e-6ae67bf85a11"}, {"Element": "<b><span lang=\"EN-GB\">Gastrointestinal\n  disorders</span></b>", "ID": "75ff2344-5514-4add-8ce7-9e11b3109f73", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e90cec3f-1b12-4199-8402-671fbd47ce33"}, {"Element": "<span lang=\"EN-GB\">Gastrointestinal\n  disorders</span>", "ID": "a4b8bf64-832f-4801-a0bf-11c35244ea53", "Styles": "None", "Classes": "None", "Text": "Gastrointestinal   disorders", "ParentId": "75ff2344-5514-4add-8ce7-9e11b3109f73"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Diarrhoea</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "a7b7a585-9b83-49b2-8fa5-a7f9f8c7ab6b", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Diarrhoea</span></p>\n</td>", "ID": "9afc9eba-1745-4eb7-b0ab-0b933a26c2be", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a7b7a585-9b83-49b2-8fa5-a7f9f8c7ab6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Diarrhoea</span></p>", "ID": "230afc48-cb03-4e50-9a13-9497c1c603a0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9afc9eba-1745-4eb7-b0ab-0b933a26c2be"}, {"Element": "<span lang=\"EN-GB\">Diarrhoea</span>", "ID": "15bfc0f8-a8e4-4878-9209-3189c64273a7", "Styles": "None", "Classes": "None", "Text": "Diarrhoea", "ParentId": "230afc48-cb03-4e50-9a13-9497c1c603a0"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "4c44d793-e062-4b63-8a96-a007f35ea10d", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a7b7a585-9b83-49b2-8fa5-a7f9f8c7ab6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "c092bace-991c-41b5-9680-60e395193e1a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4c44d793-e062-4b63-8a96-a007f35ea10d"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "3ae6d5c9-fc3e-4e41-b50a-bd5bccdbe22f", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "c092bace-991c-41b5-9680-60e395193e1a"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>", "ID": "e272708a-9e18-4477-bdd6-bc97eeafe411", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a7b7a585-9b83-49b2-8fa5-a7f9f8c7ab6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>", "ID": "0c458ee9-8666-46fa-8adb-8d5aca606a95", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e272708a-9e18-4477-bdd6-bc97eeafe411"}, {"Element": "<span lang=\"EN-GB\">Common</span>", "ID": "41d4b9ff-f63c-46c0-be19-8a1442dce61e", "Styles": "None", "Classes": "None", "Text": "Common", "ParentId": "0c458ee9-8666-46fa-8adb-8d5aca606a95"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "c02cce96-993f-4589-9705-bea705b209a9", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "a7b7a585-9b83-49b2-8fa5-a7f9f8c7ab6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "c108320a-3870-4d62-87df-a1d6b806c5ce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c02cce96-993f-4589-9705-bea705b209a9"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "65e6e13e-bdad-4d6a-ad69-bfe2319c090e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c108320a-3870-4d62-87df-a1d6b806c5ce"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "22c2d0bf-d6d5-4044-9133-7a88dc28c268", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "65e6e13e-bdad-4d6a-ad69-bfe2319c090e"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Nausea</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "b81e1f06-075e-4fa8-9867-deefaadaaae8", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Nausea</span></p>\n</td>", "ID": "0ed8056c-8ddd-499f-acb3-b31c6c04813b", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b81e1f06-075e-4fa8-9867-deefaadaaae8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Nausea</span></p>", "ID": "448cab01-2a8d-4577-9d14-bf3da83e3714", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0ed8056c-8ddd-499f-acb3-b31c6c04813b"}, {"Element": "<span lang=\"EN-GB\">Nausea</span>", "ID": "5399b68b-517e-4df0-b8a3-0ee12ed248e3", "Styles": "None", "Classes": "None", "Text": "Nausea", "ParentId": "448cab01-2a8d-4577-9d14-bf3da83e3714"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "ad54283b-c1b8-451e-b34d-f19debb31acd", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b81e1f06-075e-4fa8-9867-deefaadaaae8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "d853b884-5533-4d80-9ce2-126d0d175ced", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ad54283b-c1b8-451e-b34d-f19debb31acd"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "0f7ae034-70b0-4705-995a-87db60f0b558", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "d853b884-5533-4d80-9ce2-126d0d175ced"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>", "ID": "bdda9c14-0e26-4c68-82b8-28288547ae11", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b81e1f06-075e-4fa8-9867-deefaadaaae8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>", "ID": "65b01843-08f9-49ee-9e93-c066ef805a2b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bdda9c14-0e26-4c68-82b8-28288547ae11"}, {"Element": "<span lang=\"EN-GB\">Common</span>", "ID": "e63bb14a-023b-4d07-bc8f-32b5a1f04a9c", "Styles": "None", "Classes": "None", "Text": "Common", "ParentId": "65b01843-08f9-49ee-9e93-c066ef805a2b"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "b10c1170-07bc-43ff-94d5-29fec34c962e", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b81e1f06-075e-4fa8-9867-deefaadaaae8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0ee63ac7-a384-41a3-b1a1-19d1e1a5cd8f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b10c1170-07bc-43ff-94d5-29fec34c962e"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c386a312-0ddd-48e6-9349-e385b073dae9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0ee63ac7-a384-41a3-b1a1-19d1e1a5cd8f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3b37c4cb-902b-457c-b14a-3d961361763d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c386a312-0ddd-48e6-9349-e385b073dae9"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vomiting</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "aac1003a-fcd3-4a62-8324-b6236217cbf3", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vomiting</span></p>\n</td>", "ID": "e9ce07a6-b36a-43e1-b4da-936fa21a6d38", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "aac1003a-fcd3-4a62-8324-b6236217cbf3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vomiting</span></p>", "ID": "9ece157b-5fec-4991-9a31-cdd0197533ab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e9ce07a6-b36a-43e1-b4da-936fa21a6d38"}, {"Element": "<span lang=\"EN-GB\">Vomiting</span>", "ID": "f802104a-05dd-44d6-934a-a7c7cf8708a9", "Styles": "None", "Classes": "None", "Text": "Vomiting", "ParentId": "9ece157b-5fec-4991-9a31-cdd0197533ab"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "c5c2ab24-e79e-4d3b-afc9-a76f8fcf5c4c", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "aac1003a-fcd3-4a62-8324-b6236217cbf3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "81a8d39a-0dcd-4097-96aa-f8181b55dfee", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c5c2ab24-e79e-4d3b-afc9-a76f8fcf5c4c"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "46693768-ef04-453c-80be-4ef7eef6742f", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "81a8d39a-0dcd-4097-96aa-f8181b55dfee"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>", "ID": "071274a8-1e81-458c-95b3-76f05867dbf2", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "aac1003a-fcd3-4a62-8324-b6236217cbf3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>", "ID": "47f306a1-4d89-4337-8f4c-24cb76f98853", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "071274a8-1e81-458c-95b3-76f05867dbf2"}, {"Element": "<span lang=\"EN-GB\">Uncommon</span>", "ID": "b3b5e617-bfe2-4d8e-84bd-cddc035b459b", "Styles": "None", "Classes": "None", "Text": "Uncommon", "ParentId": "47f306a1-4d89-4337-8f4c-24cb76f98853"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "a3501b41-0e36-4541-b4ae-34f20e30a646", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "aac1003a-fcd3-4a62-8324-b6236217cbf3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "a886bdee-bd34-449d-b0bc-0b7c4467e4d8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a3501b41-0e36-4541-b4ae-34f20e30a646"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d0237455-1c87-4c92-8e55-5523227663ce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a886bdee-bd34-449d-b0bc-0b7c4467e4d8"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fdfabfc8-8631-4d21-bb9b-c5971b4b7ed4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d0237455-1c87-4c92-8e55-5523227663ce"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Constipation</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "39599db1-6954-44e5-9b42-15579955984e", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Constipation</span></p>\n</td>", "ID": "92f4281b-33da-49dd-9fd5-166c36537459", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "39599db1-6954-44e5-9b42-15579955984e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Constipation</span></p>", "ID": "53ee8826-d541-4f25-bd92-b6c9e07ca713", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "92f4281b-33da-49dd-9fd5-166c36537459"}, {"Element": "<span lang=\"EN-GB\">Constipation</span>", "ID": "b72c823c-9245-454b-86d1-f775aa9b839f", "Styles": "None", "Classes": "None", "Text": "Constipation", "ParentId": "53ee8826-d541-4f25-bd92-b6c9e07ca713"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "a66134c7-7296-4af9-b903-69c224822b9f", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "39599db1-6954-44e5-9b42-15579955984e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "a531dbc7-7f17-4649-a33a-accfd10e4cb8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a66134c7-7296-4af9-b903-69c224822b9f"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "3187e5e3-4dd1-462e-9d87-05e192ddfac7", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "a531dbc7-7f17-4649-a33a-accfd10e4cb8"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>", "ID": "3d71fd7f-5002-47a0-b708-563d1e52dfd9", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "39599db1-6954-44e5-9b42-15579955984e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>", "ID": "2a67a5f8-0222-40fd-b793-4bea66a1495f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3d71fd7f-5002-47a0-b708-563d1e52dfd9"}, {"Element": "<span lang=\"EN-GB\">Uncommon</span>", "ID": "4bd926fc-e4e5-4958-82bd-c34ea051694a", "Styles": "None", "Classes": "None", "Text": "Uncommon", "ParentId": "2a67a5f8-0222-40fd-b793-4bea66a1495f"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "5c0b7565-729a-4b8e-bdd1-8b6c1d0e130b", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "39599db1-6954-44e5-9b42-15579955984e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "75e05c03-bbd9-487f-85b3-91f71bfae0af", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5c0b7565-729a-4b8e-bdd1-8b6c1d0e130b"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "39ae976c-5bd8-406e-a7a8-4274da0385b7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "75e05c03-bbd9-487f-85b3-91f71bfae0af"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a50749d6-c67a-4672-a52b-f395c7930abc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "39ae976c-5bd8-406e-a7a8-4274da0385b7"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Skin and\n  subcutaneous tissue disorders</span></b></p>\n</td>\n</tr>", "ID": "9d94b2d2-808a-4fea-82be-92eb9d0b041b", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Skin and\n  subcutaneous tissue disorders</span></b></p>\n</td>", "ID": "cc23317a-4b9c-4aac-bbec-4a5e2e054e66", "Styles": "width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9d94b2d2-808a-4fea-82be-92eb9d0b041b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Skin and\n  subcutaneous tissue disorders</span></b></p>", "ID": "d05efc96-cd8b-432d-8467-50ec625dc193", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cc23317a-4b9c-4aac-bbec-4a5e2e054e66"}, {"Element": "<b><span lang=\"EN-GB\">Skin and\n  subcutaneous tissue disorders</span></b>", "ID": "a25075e2-ba74-4663-8ef4-c0c122720a2a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d05efc96-cd8b-432d-8467-50ec625dc193"}, {"Element": "<span lang=\"EN-GB\">Skin and\n  subcutaneous tissue disorders</span>", "ID": "f5e37941-3ab3-4676-971d-3dab5a610214", "Styles": "None", "Classes": "None", "Text": "Skin and   subcutaneous tissue disorders", "ParentId": "a25075e2-ba74-4663-8ef4-c0c122720a2a"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rash*</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "607dbc83-73d5-4c6f-9b21-42b9a06ecffc", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rash*</span></p>\n</td>", "ID": "0bfeee2f-ed9d-4236-aa24-6936d67a4349", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "607dbc83-73d5-4c6f-9b21-42b9a06ecffc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rash*</span></p>", "ID": "754698ec-ccc6-4038-9ae7-a2494955b07f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0bfeee2f-ed9d-4236-aa24-6936d67a4349"}, {"Element": "<span lang=\"EN-GB\">Rash*</span>", "ID": "40688d75-7963-4139-bff2-29157ed19a12", "Styles": "None", "Classes": "None", "Text": "Rash*", "ParentId": "754698ec-ccc6-4038-9ae7-a2494955b07f"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "713de3f5-a7e3-4a3c-8213-d9c3c3c2f90e", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "607dbc83-73d5-4c6f-9b21-42b9a06ecffc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "d1307ac4-0dcd-4c78-8155-646326dc7296", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "713de3f5-a7e3-4a3c-8213-d9c3c3c2f90e"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "570eeb17-8952-485a-bfcb-3e5ec5a05933", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "d1307ac4-0dcd-4c78-8155-646326dc7296"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>", "ID": "dc9f7fa1-86f3-4536-8742-bc7b5cabf1d9", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "607dbc83-73d5-4c6f-9b21-42b9a06ecffc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>", "ID": "a0ab0ffe-e8db-47ea-bac5-3ca16100f7f7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dc9f7fa1-86f3-4536-8742-bc7b5cabf1d9"}, {"Element": "<span lang=\"EN-GB\">Common</span>", "ID": "7d2e74d4-1375-491e-b32c-ad41f7da3901", "Styles": "None", "Classes": "None", "Text": "Common", "ParentId": "a0ab0ffe-e8db-47ea-bac5-3ca16100f7f7"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "8a690fa7-46ae-4e0c-8a66-9f5f778975c0", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "607dbc83-73d5-4c6f-9b21-42b9a06ecffc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "dde72266-689e-4263-bf68-ef6620d03027", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8a690fa7-46ae-4e0c-8a66-9f5f778975c0"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "48dea264-0da8-488d-9e98-a02b2d157d42", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dde72266-689e-4263-bf68-ef6620d03027"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "045cbbba-af1c-4320-8d1a-85a4baec855a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "48dea264-0da8-488d-9e98-a02b2d157d42"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Stevens\u2011Johnson\n  syndrome</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "be105679-bec6-4f5c-82bb-91350e1b1eb9", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Stevens\u2011Johnson\n  syndrome</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>\n</td>", "ID": "5f81c051-caaa-4e55-b84c-8eae61a9eeb5", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "be105679-bec6-4f5c-82bb-91350e1b1eb9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Stevens\u2011Johnson\n  syndrome</span><sup><span lang=\"EN-GB\">\u2020</span></sup></p>", "ID": "630f4ad4-d876-4e2b-a254-186a3a9dd48c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5f81c051-caaa-4e55-b84c-8eae61a9eeb5"}, {"Element": "<span lang=\"EN-GB\">Stevens\u2011Johnson\n  syndrome</span>", "ID": "863af0c4-7e00-4d78-9e62-d64e23587080", "Styles": "None", "Classes": "None", "Text": "Stevens\u2011Johnson   syndrome", "ParentId": "630f4ad4-d876-4e2b-a254-186a3a9dd48c"}, {"Element": "<sup><span lang=\"EN-GB\">\u2020</span></sup>", "ID": "b30eb913-5c7c-49d2-a8d4-4220fae6cf6f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "630f4ad4-d876-4e2b-a254-186a3a9dd48c"}, {"Element": "<span lang=\"EN-GB\">\u2020</span>", "ID": "3809a20b-b1e9-409a-afae-833e40fc1348", "Styles": "None", "Classes": "None", "Text": "\u2020", "ParentId": "b30eb913-5c7c-49d2-a8d4-4220fae6cf6f"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "8c06c5d8-bb73-4241-91d7-c62049a5a813", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "be105679-bec6-4f5c-82bb-91350e1b1eb9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "a358d211-f6d1-482a-85f8-41f26ec46fb5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8c06c5d8-bb73-4241-91d7-c62049a5a813"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "8db1a0d2-08c3-44b6-81d1-f48ddd3e19a4", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "a358d211-f6d1-482a-85f8-41f26ec46fb5"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "a5c2e397-3773-4573-b93d-4cb34f2e6a77", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "be105679-bec6-4f5c-82bb-91350e1b1eb9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "c9b2ae38-31a6-4e19-9003-6d935f66e1bd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a5c2e397-3773-4573-b93d-4cb34f2e6a77"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "3ae6afd5-237f-4738-8366-0e3840c57a38", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "c9b2ae38-31a6-4e19-9003-6d935f66e1bd"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "17833e8a-1789-4e6d-bb13-e01c0090c0e5", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "be105679-bec6-4f5c-82bb-91350e1b1eb9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "a4624112-48a3-41c5-9b54-58e794384889", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "17833e8a-1789-4e6d-bb13-e01c0090c0e5"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "e3c1fedf-d0c0-4e1b-a82a-6d8ef1876080", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a4624112-48a3-41c5-9b54-58e794384889"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "12643509-b53d-451a-9e99-74ad9f27fb34", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e3c1fedf-d0c0-4e1b-a82a-6d8ef1876080"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Acute febrile </span><span lang=\"FR\">neutrophilic dermatosis</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "d1a1af4f-fc3a-4d66-a1bb-7083256dc647", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Acute febrile </span><span lang=\"FR\">neutrophilic dermatosis</span></p>\n</td>", "ID": "ce9dd180-85cb-4a7b-93d3-715aec47abad", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d1a1af4f-fc3a-4d66-a1bb-7083256dc647"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">Acute febrile </span><span lang=\"FR\">neutrophilic dermatosis</span></p>", "ID": "ea1817f7-f9bf-45b3-99ae-7350ab35c636", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ce9dd180-85cb-4a7b-93d3-715aec47abad"}, {"Element": "<span lang=\"FR\">Acute febrile </span>", "ID": "c012c037-9f28-4211-9699-70d1df35d5f1", "Styles": "None", "Classes": "None", "Text": "Acute febrile ", "ParentId": "ea1817f7-f9bf-45b3-99ae-7350ab35c636"}, {"Element": "<span lang=\"FR\">neutrophilic dermatosis</span>", "ID": "72d551bd-c353-4ad8-908b-1f5074ac48e0", "Styles": "None", "Classes": "None", "Text": "neutrophilic dermatosis", "ParentId": "ea1817f7-f9bf-45b3-99ae-7350ab35c636"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "0fec3102-f13e-4746-9f74-0023eac8c597", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d1a1af4f-fc3a-4d66-a1bb-7083256dc647"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "4f7a64bf-8188-41c9-ad45-00a51daaa5dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0fec3102-f13e-4746-9f74-0023eac8c597"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "98317e45-02e1-4e1c-88e4-541fc9c32bc8", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "4f7a64bf-8188-41c9-ad45-00a51daaa5dc"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>\n</td>", "ID": "824c2612-a189-47eb-851d-7bbf1c97a077", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d1a1af4f-fc3a-4d66-a1bb-7083256dc647"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rare</span></p>", "ID": "63070deb-db89-4999-a651-f5aff683230a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "824c2612-a189-47eb-851d-7bbf1c97a077"}, {"Element": "<span lang=\"EN-GB\">Rare</span>", "ID": "a2801360-d69f-4e6e-9ead-35840552c352", "Styles": "None", "Classes": "None", "Text": "Rare", "ParentId": "63070deb-db89-4999-a651-f5aff683230a"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "81f690a5-c86a-44a5-b14f-f58a1594717c", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d1a1af4f-fc3a-4d66-a1bb-7083256dc647"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0edc54db-ca47-4b4c-b11e-d0cd46079a3f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81f690a5-c86a-44a5-b14f-f58a1594717c"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "dcc62dc2-6d10-4897-849b-bfed7cb7bc0f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0edc54db-ca47-4b4c-b11e-d0cd46079a3f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fc9fe4b6-6a34-4a21-a1b3-8bdc421c7884", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dcc62dc2-6d10-4897-849b-bfed7cb7bc0f"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Musculoskeletal\n  and connective tissue disorders</span></b></p>\n</td>\n</tr>", "ID": "b7b90902-33e4-4e20-8aa5-65634bc276d3", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Musculoskeletal\n  and connective tissue disorders</span></b></p>\n</td>", "ID": "0fbf3c51-a518-4281-9909-d485f2ae9820", "Styles": "width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b7b90902-33e4-4e20-8aa5-65634bc276d3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Musculoskeletal\n  and connective tissue disorders</span></b></p>", "ID": "b241b9f6-fefd-4943-a69b-0a9db762d34f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0fbf3c51-a518-4281-9909-d485f2ae9820"}, {"Element": "<b><span lang=\"EN-GB\">Musculoskeletal\n  and connective tissue disorders</span></b>", "ID": "82937f62-6883-4987-876d-75561b86fba8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b241b9f6-fefd-4943-a69b-0a9db762d34f"}, {"Element": "<span lang=\"EN-GB\">Musculoskeletal\n  and connective tissue disorders</span>", "ID": "8e91cc48-0fd1-43c3-85c4-768db7cfc408", "Styles": "None", "Classes": "None", "Text": "Musculoskeletal   and connective tissue disorders", "ParentId": "82937f62-6883-4987-876d-75561b86fba8"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Back pain</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common </span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "c6e56106-487f-4a9b-a8c5-19839e6d36bc", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Back pain</span></p>\n</td>", "ID": "85b65fb8-d684-4171-b4ca-85e291f5570d", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c6e56106-487f-4a9b-a8c5-19839e6d36bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Back pain</span></p>", "ID": "cc9025cc-58e6-422f-9a18-4c5609440f3f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "85b65fb8-d684-4171-b4ca-85e291f5570d"}, {"Element": "<span lang=\"EN-GB\">Back pain</span>", "ID": "18fec75e-70d7-4d03-bad3-9a550d21cc31", "Styles": "None", "Classes": "None", "Text": "Back pain", "ParentId": "cc9025cc-58e6-422f-9a18-4c5609440f3f"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common </span></p>\n</td>", "ID": "b9d535a1-249b-455e-ab77-6f03576fb1a8", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c6e56106-487f-4a9b-a8c5-19839e6d36bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common </span></p>", "ID": "49e6ea19-1051-4d7e-82c6-ec585822a2df", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b9d535a1-249b-455e-ab77-6f03576fb1a8"}, {"Element": "<span lang=\"EN-GB\">Very common </span>", "ID": "f5f72390-7c7e-405b-97ce-ac2ac9e42421", "Styles": "None", "Classes": "None", "Text": "Very common ", "ParentId": "49e6ea19-1051-4d7e-82c6-ec585822a2df"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>\n</td>", "ID": "49cd44ca-d2ba-478b-94cd-fa572da5b50a", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c6e56106-487f-4a9b-a8c5-19839e6d36bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Uncommon</span></p>", "ID": "54c7da74-661e-4fa0-8091-cb6f7c38c29c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "49cd44ca-d2ba-478b-94cd-fa572da5b50a"}, {"Element": "<span lang=\"EN-GB\">Uncommon</span>", "ID": "d2bd6663-4ac2-4586-b3e6-cab250a42fae", "Styles": "None", "Classes": "None", "Text": "Uncommon", "ParentId": "54c7da74-661e-4fa0-8091-cb6f7c38c29c"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "e6265748-60bb-4656-b1db-d3151705b911", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c6e56106-487f-4a9b-a8c5-19839e6d36bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "dbc8bd0f-06ed-4fb0-a577-7548dc7c991b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e6265748-60bb-4656-b1db-d3151705b911"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9fa46f9b-956e-4baa-97d9-e47b04f0c04f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dbc8bd0f-06ed-4fb0-a577-7548dc7c991b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "06cb6fe8-1bf7-48e6-8e64-ad6eb510e562", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9fa46f9b-956e-4baa-97d9-e47b04f0c04f"}, {"Element": "<tr>\n<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">General\n  disorders and administration site conditions</span></b></p>\n</td>\n</tr>", "ID": "d7a9291d-0141-4b80-8e5e-92218983302a", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td colspan=\"4\" style=\"width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"608\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">General\n  disorders and administration site conditions</span></b></p>\n</td>", "ID": "284ab7f3-a5f0-4947-87da-4158368ec2cd", "Styles": "width:455.95pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "d7a9291d-0141-4b80-8e5e-92218983302a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">General\n  disorders and administration site conditions</span></b></p>", "ID": "1b076645-c91e-4e33-97ba-c3b0c7b548a8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "284ab7f3-a5f0-4947-87da-4158368ec2cd"}, {"Element": "<b><span lang=\"EN-GB\">General\n  disorders and administration site conditions</span></b>", "ID": "6824e12b-c711-420b-b3db-a1b7bacaa0af", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1b076645-c91e-4e33-97ba-c3b0c7b548a8"}, {"Element": "<span lang=\"EN-GB\">General\n  disorders and administration site conditions</span>", "ID": "ebb47def-9bc2-4958-ba58-dc1e3d13a23a", "Styles": "None", "Classes": "None", "Text": "General   disorders and administration site conditions", "ParentId": "6824e12b-c711-420b-b3db-a1b7bacaa0af"}, {"Element": "<tr>\n<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oedema\n  peripheral</span></p>\n</td>\n<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>\n<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>\n<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>\n</tr>", "ID": "8c077e38-16f9-477d-bb9a-6d36f65c8fc4", "Styles": "None", "Classes": "None", "Text": "     ", "ParentId": "e2e25528-fc76-4b24-a72e-05ce1f782342"}, {"Element": "<td style=\"width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"169\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oedema\n  peripheral</span></p>\n</td>", "ID": "d7615f94-820d-43cf-8f73-c27263d78703", "Styles": "width:126.9pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8c077e38-16f9-477d-bb9a-6d36f65c8fc4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oedema\n  peripheral</span></p>", "ID": "833e4dd4-b6eb-4e74-ad08-54c1c11aacb4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d7615f94-820d-43cf-8f73-c27263d78703"}, {"Element": "<span lang=\"EN-GB\">Oedema\n  peripheral</span>", "ID": "712317c9-5758-4cf7-9818-747cfdace6e7", "Styles": "None", "Classes": "None", "Text": "Oedema   peripheral", "ParentId": "833e4dd4-b6eb-4e74-ad08-54c1c11aacb4"}, {"Element": "<td style=\"width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"150\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>\n</td>", "ID": "b8dd35d8-df86-4c8f-bfae-b6eba0c544c2", "Styles": "width:112.5pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8c077e38-16f9-477d-bb9a-6d36f65c8fc4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Very common</span></p>", "ID": "3de9a88c-c6af-4c6d-bf89-e25efa58d96b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b8dd35d8-df86-4c8f-bfae-b6eba0c544c2"}, {"Element": "<span lang=\"EN-GB\">Very common</span>", "ID": "89dbbf9a-cb4e-4f2f-b77e-15679fc480dd", "Styles": "None", "Classes": "None", "Text": "Very common", "ParentId": "3de9a88c-c6af-4c6d-bf89-e25efa58d96b"}, {"Element": "<td style=\"width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"154\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>\n</td>", "ID": "aab779db-54b0-4158-9e75-6f7413554de8", "Styles": "width:115.15pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8c077e38-16f9-477d-bb9a-6d36f65c8fc4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Common</span></p>", "ID": "e2851283-a9c7-4365-b77e-363c147c9109", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aab779db-54b0-4158-9e75-6f7413554de8"}, {"Element": "<span lang=\"EN-GB\">Common</span>", "ID": "bcc4cf2d-19ee-4fc4-b6f3-8011268a31e5", "Styles": "None", "Classes": "None", "Text": "Common", "ParentId": "e2851283-a9c7-4365-b77e-363c147c9109"}, {"Element": "<td style=\"width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"135\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n</td>", "ID": "1a0c86d4-499f-4bc6-a346-30fe15b809ee", "Styles": "width:101.4pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8c077e38-16f9-477d-bb9a-6d36f65c8fc4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "90e64edc-0650-4703-8483-3a5abbf08f10", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1a0c86d4-499f-4bc6-a346-30fe15b809ee"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "dd034b67-59c6-4d5c-9095-85c3348bcc3e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "90e64edc-0650-4703-8483-3a5abbf08f10"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "22d4e576-b57d-402a-a852-451c9cfb2ebd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dd034b67-59c6-4d5c-9095-85c3348bcc3e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Note: ADRs included as preferred terms are based on\nMedDRA version 16.0.</span></b></p>", "ID": "c8feb811-134b-40ab-8e2d-ccdd65293f39", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Note: ADRs included as preferred terms are based on\nMedDRA version 16.0.</span></b>", "ID": "5993a86d-7a80-4e69-bb9d-dee5bad120ac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c8feb811-134b-40ab-8e2d-ccdd65293f39"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Note: ADRs included as preferred terms are based on\nMedDRA version 16.0.</span>", "ID": "e28c64d4-539a-4405-b48c-5c05cd4bf456", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Note: ADRs included as preferred terms are based on MedDRA version 16.0.", "ParentId": "5993a86d-7a80-4e69-bb9d-dee5bad120ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">*Represents a pooling of preferred terms</span></p>", "ID": "364529b0-4d58-4dc6-ac6f-1abfebd0cb22", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">*Represents a pooling of preferred terms</span>", "ID": "2277e2fa-2f11-4a2b-9bb1-021b2377bea1", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "*Represents a pooling of preferred terms", "ParentId": "364529b0-4d58-4dc6-ac6f-1abfebd0cb22"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span></sup><span lang=\"EN-GB\" style=\"font-size:\n10.0pt\">Reported outside of the Phase<sup> </sup>3 studies</span></p>", "ID": "2da6b1c4-177c-457a-8349-b05b3addd287", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span></sup>", "ID": "fd84a483-f733-49c3-ab44-bfee917975ba", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2da6b1c4-177c-457a-8349-b05b3addd287"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span>", "ID": "a8d65e5d-e4f7-45dc-986d-6f6dd7921f87", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2020", "ParentId": "fd84a483-f733-49c3-ab44-bfee917975ba"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n10.0pt\">Reported outside of the Phase<sup> </sup>3 studies</span>", "ID": "f3dcbe31-aa1b-4913-bc4b-3023642e2ac6", "Styles": "font-size:\n10.0pt", "Classes": "None", "Text": "Reported outside of the Phase3 studies", "ParentId": "2da6b1c4-177c-457a-8349-b05b3addd287"}, {"Element": "<sup> </sup>", "ID": "7ac7d469-0846-46c4-8492-b43cfa2852e5", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "f3dcbe31-aa1b-4913-bc4b-3023642e2ac6"}, {"Element": "<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "81c5fa1c-c481-4488-b6a4-0cb11a00f1aa", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "2abcf76a-bd86-413a-a2cd-f16a72e1cb0d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "81c5fa1c-c481-4488-b6a4-0cb11a00f1aa"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "96b8bb1f-a8c3-4484-ae40-bcd2c752581b", "Styles": "color:windowtext;font-style:\nnormal", "Classes": "None", "Text": "", "ParentId": "2abcf76a-bd86-413a-a2cd-f16a72e1cb0d"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "be555e0f-31d2-40e6-b9ff-d26ddac4b2cf", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "96b8bb1f-a8c3-4484-ae40-bcd2c752581b"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Description of selected adverse\nreactions</span></u></p>", "ID": "c360f5f5-9f51-4040-bae9-a342f3aeb056", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Description of selected adverse\nreactions</span></u>", "ID": "7cfac33e-3c4c-41e4-b2dc-48f4730adf60", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c360f5f5-9f51-4040-bae9-a342f3aeb056"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Description of selected adverse\nreactions</span>", "ID": "21f55dee-e5fc-4402-b366-28f209d12393", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Description of selected adverse reactions", "ParentId": "7cfac33e-3c4c-41e4-b2dc-48f4730adf60"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "00e2e313-3c9b-470f-a0ae-24a6ef4dcde5", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "bc3b1f4f-77ef-4bdf-997f-c6acdc28df8a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "00e2e313-3c9b-470f-a0ae-24a6ef4dcde5"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "81050408-85d4-44c3-9bf4-13cafc4e69fe", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "", "ParentId": "bc3b1f4f-77ef-4bdf-997f-c6acdc28df8a"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "a2d554bb-1458-4a2b-b1fa-3ee564bf6a8c", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "81050408-85d4-44c3-9bf4-13cafc4e69fe"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Discontinuations</span></u></p>", "ID": "6c7c703a-569a-4857-891c-a7b3c37340e2", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext\">Discontinuations</span></u>", "ID": "ef0e628f-ef32-471c-8873-dc0961a6b0b4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6c7c703a-569a-4857-891c-a7b3c37340e2"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\">Discontinuations</span>", "ID": "aa6422ee-e260-4b6d-b6f0-367adc46fe26", "Styles": "color:windowtext", "Classes": "None", "Text": "Discontinuations", "ParentId": "ef0e628f-ef32-471c-8873-dc0961a6b0b4"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "f0c98992-8c62-4e67-9d18-6224d5f8c027", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "4cc9cab9-db7d-48a4-9b02-2d63b427c5e9", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "f0c98992-8c62-4e67-9d18-6224d5f8c027"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">For\neach adverse reaction, one or more of the three medicinal products was\ndiscontinued in \u2264\u00a01% of patients in the ixazomib regimen.</span></p>", "ID": "f2e3103a-f525-4b0a-af15-798bc0283fe0", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">For\neach adverse reaction, one or more of the three medicinal products was\ndiscontinued in \u2264\u00a01% of patients in the ixazomib regimen.</span>", "ID": "760b85c3-a5a5-45fc-ba4c-dbebc3aa605d", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "For each adverse reaction, one or more of the three medicinal products was discontinued in \u2264\u00a01% of patients in the ixazomib regimen.", "ParentId": "f2e3103a-f525-4b0a-af15-798bc0283fe0"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "3d945952-43dc-4815-b4dd-ba7350766d22", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "49d7cf7a-1f15-41bb-90c9-4a1f282985cc", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "3d945952-43dc-4815-b4dd-ba7350766d22"}, {"Element": "<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Thrombocytopenia</span></u></p>", "ID": "5eb02339-5c0b-4130-b074-3edba89e6726", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext\">Thrombocytopenia</span></u>", "ID": "1141a53d-5371-43eb-8f58-abc2ad53592d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5eb02339-5c0b-4130-b074-3edba89e6726"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\">Thrombocytopenia</span>", "ID": "b178b7b4-5b60-4fe5-909f-285939ac4925", "Styles": "color:windowtext", "Classes": "None", "Text": "Thrombocytopenia", "ParentId": "1141a53d-5371-43eb-8f58-abc2ad53592d"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "df6a5519-3868-4188-976e-7c78f003fc02", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "5137867f-f7ba-4642-b50e-2318a020aca6", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "df6a5519-3868-4188-976e-7c78f003fc02"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Three\npercent of patients in the ixazomib regimen and 1% of patients in the placebo\nregimen had a platelet count \u2264\u00a010,000/mm<sup>3</sup></span><span lang=\"EN-GB\" style=\"color:windowtext\"> </span><span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\">during treatment</span><span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\">. Less than 1% of patients in both regimens had a platelet\ncount \u2264\u00a05,000/mm<sup>3</sup></span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"> during treatment</span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">. Thrombocytopenia\nresulted in discontinuation of one or more of the three medicinal products in\n&lt;\u00a01% of patients in the ixazomib regimen and 1% of patients in the\nplacebo regimen.</span><span lang=\"EN-GB\" style=\"color:windowtext\"> </span><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia did not\nresult in an increase in haemorrhagic events or platelet transfusions.</span></p>", "ID": "73f1e6a6-4b02-474a-a353-712c6046e532", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Three\npercent of patients in the ixazomib regimen and 1% of patients in the placebo\nregimen had a platelet count \u2264\u00a010,000/mm<sup>3</sup></span>", "ID": "2771772a-52e6-4abe-9413-074c7aaf2e30", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Three percent of patients in the ixazomib regimen and 1% of patients in the placebo regimen had a platelet count \u2264\u00a010,000/mm", "ParentId": "73f1e6a6-4b02-474a-a353-712c6046e532"}, {"Element": "<sup>3</sup>", "ID": "543cf9a3-0728-441f-bcf9-e5e09dae1820", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "2771772a-52e6-4abe-9413-074c7aaf2e30"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\"> </span>", "ID": "8e875707-4833-473b-9d9b-f6f16b34b7f2", "Styles": "color:windowtext", "Classes": "None", "Text": " ", "ParentId": "73f1e6a6-4b02-474a-a353-712c6046e532"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\">during treatment</span>", "ID": "bb514c14-3608-4ada-92f9-e903469e4987", "Styles": "color:windowtext;\nfont-style:normal", "Classes": "None", "Text": "during treatment", "ParentId": "73f1e6a6-4b02-474a-a353-712c6046e532"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;\nfont-style:normal\">. Less than 1% of patients in both regimens had a platelet\ncount \u2264\u00a05,000/mm<sup>3</sup></span>", "ID": "159825c9-cc1b-40cf-af72-c6ee53d4b18a", "Styles": "color:windowtext;\nfont-style:normal", "Classes": "None", "Text": ". Less than 1% of patients in both regimens had a platelet count \u2264\u00a05,000/mm", "ParentId": "73f1e6a6-4b02-474a-a353-712c6046e532"}, {"Element": "<sup>3</sup>", "ID": "91f9d817-58f7-4a4c-9a37-dcac6987add9", "Styles": "None", "Classes": "None", "Text": "3", "ParentId": "159825c9-cc1b-40cf-af72-c6ee53d4b18a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\"> during treatment</span>", "ID": "2ef8aad3-7648-41e4-a2f9-df816baa1c80", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": " during treatment", "ParentId": "73f1e6a6-4b02-474a-a353-712c6046e532"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">. Thrombocytopenia\nresulted in discontinuation of one or more of the three medicinal products in\n&lt;\u00a01% of patients in the ixazomib regimen and 1% of patients in the\nplacebo regimen.</span>", "ID": "fc350656-86e4-4d36-acd6-fb4c39c7552f", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": ". Thrombocytopenia resulted in discontinuation of one or more of the three medicinal products in <\u00a01% of patients in the ixazomib regimen and 1% of patients in the placebo regimen.", "ParentId": "73f1e6a6-4b02-474a-a353-712c6046e532"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\"> </span>", "ID": "6d3c40d7-f9c5-47b0-8447-147511d303e9", "Styles": "color:windowtext", "Classes": "None", "Text": " ", "ParentId": "73f1e6a6-4b02-474a-a353-712c6046e532"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Thrombocytopenia did not\nresult in an increase in haemorrhagic events or platelet transfusions.</span>", "ID": "51f53d5e-45be-4d91-a8bb-4b9fd559efa8", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Thrombocytopenia did not result in an increase in haemorrhagic events or platelet transfusions.", "ParentId": "73f1e6a6-4b02-474a-a353-712c6046e532"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "a41a952d-8e70-44f2-952f-6432b096df62", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "ca80e02a-a9d0-4130-b079-63e9b139752c", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "a41a952d-8e70-44f2-952f-6432b096df62"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Gastrointestinal toxicities</span></u></p>", "ID": "46c71082-2cbf-4954-ae94-2b5fd4726133", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext\">Gastrointestinal toxicities</span></u>", "ID": "c55fe6ed-782d-480d-b77c-30da51d2956a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "46c71082-2cbf-4954-ae94-2b5fd4726133"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\">Gastrointestinal toxicities</span>", "ID": "57b4f54e-5a4a-4eae-a0bb-2396dd9de740", "Styles": "color:windowtext", "Classes": "None", "Text": "Gastrointestinal toxicities", "ParentId": "c55fe6ed-782d-480d-b77c-30da51d2956a"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "b2c981f8-f9a1-4e59-ac77-7a641cedde08", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "fa3ea83c-612d-4c7b-8caa-96538ff3cd5c", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "b2c981f8-f9a1-4e59-ac77-7a641cedde08"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Diarrhoea\nresulted in discontinuation of one or more of the three medicinal products in\n1% of patients in the ixazomib regimen and &lt;\u00a01% of patients in the\nplacebo regimen.</span></p>", "ID": "eae14b74-fa8c-4973-9da2-b9096fc1605e", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Diarrhoea\nresulted in discontinuation of one or more of the three medicinal products in\n1% of patients in the ixazomib regimen and &lt;\u00a01% of patients in the\nplacebo regimen.</span>", "ID": "d69f018d-e91d-49cf-b6d6-26cda5dc44fe", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Diarrhoea resulted in discontinuation of one or more of the three medicinal products in 1% of patients in the ixazomib regimen and <\u00a01% of patients in the placebo regimen.", "ParentId": "eae14b74-fa8c-4973-9da2-b9096fc1605e"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext\">\u00a0</span></p>", "ID": "f70500bd-d60a-4137-bd9a-e3f4cdab83ce", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\">\u00a0</span>", "ID": "ccd271df-f64e-44a8-bcc8-808673087510", "Styles": "color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "f70500bd-d60a-4137-bd9a-e3f4cdab83ce"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Rash</span></u></p>", "ID": "2bb44eb2-e955-43b4-a625-56df71e6fcc6", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext\">Rash</span></u>", "ID": "bd1a6928-d43c-4c58-a5d9-47c063888766", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2bb44eb2-e955-43b4-a625-56df71e6fcc6"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\">Rash</span>", "ID": "e0b25552-fa7e-4686-8d9b-2a445e7d9e50", "Styles": "color:windowtext", "Classes": "None", "Text": "Rash", "ParentId": "bd1a6928-d43c-4c58-a5d9-47c063888766"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "298b8aca-7911-48a7-9db4-e97265120f82", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "cb36c5b4-e027-40a7-9852-2f39cf2de6af", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "298b8aca-7911-48a7-9db4-e97265120f82"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Rash occurred in\n18% of patients in the ixazomib regimen compared to 10% of patients in the\nplacebo regimen. The most common type of rash reported in both regimens was maculo\u2011papular\nand macular rash. Grade\u00a03 rash was reported in 2% of patients in the ixazomib\nregimen compared to 1%\u00a0of patients in the placebo regimen. Rash resulted\nin discontinuation of one or more of the three medicinal products in &lt;\u00a01%\nof patients in both regimens.</span></p>", "ID": "c354f5d9-48a7-46ef-880d-070df589f784", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Rash occurred in\n18% of patients in the ixazomib regimen compared to 10% of patients in the\nplacebo regimen. The most common type of rash reported in both regimens was maculo\u2011papular\nand macular rash. Grade\u00a03 rash was reported in 2% of patients in the ixazomib\nregimen compared to 1%\u00a0of patients in the placebo regimen. Rash resulted\nin discontinuation of one or more of the three medicinal products in &lt;\u00a01%\nof patients in both regimens.</span>", "ID": "b9fef3f1-d895-4d31-be75-f9ecad92cbfd", "Styles": "None", "Classes": "None", "Text": "Rash occurred in 18% of patients in the ixazomib regimen compared to 10% of patients in the placebo regimen. The most common type of rash reported in both regimens was maculo\u2011papular and macular rash. Grade\u00a03 rash was reported in 2% of patients in the ixazomib regimen compared to 1%\u00a0of patients in the placebo regimen. Rash resulted in discontinuation of one or more of the three medicinal products in <\u00a01% of patients in both regimens.", "ParentId": "c354f5d9-48a7-46ef-880d-070df589f784"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7d9ca0a0-d0a2-44f0-a5e1-e067bb94b44c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bbe2b413-a975-4e17-9703-39c9c3fa1ad3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7d9ca0a0-d0a2-44f0-a5e1-e067bb94b44c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Peripheral neuropathy</span></u></i></p>", "ID": "652fbfb6-0dc3-494a-b282-3a899afa1da3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Peripheral neuropathy</span></u></i>", "ID": "24ee9ae1-d55b-4bb4-83b6-7a3a95990fcb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "652fbfb6-0dc3-494a-b282-3a899afa1da3"}, {"Element": "<u><span lang=\"EN-GB\">Peripheral neuropathy</span></u>", "ID": "87618c01-7905-46e1-a5e0-88c0ecdae819", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "24ee9ae1-d55b-4bb4-83b6-7a3a95990fcb"}, {"Element": "<span lang=\"EN-GB\">Peripheral neuropathy</span>", "ID": "ecebba1b-d43d-48aa-84e1-705d5b20fe78", "Styles": "None", "Classes": "None", "Text": "Peripheral neuropathy", "ParentId": "87618c01-7905-46e1-a5e0-88c0ecdae819"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "5c89759f-e1e8-454b-9c0d-3fb75196f4d8", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "70c91670-8ec9-4e5b-b30e-ba8714b36b04", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5c89759f-e1e8-454b-9c0d-3fb75196f4d8"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "451f3b3f-d202-42fa-ba8f-b2c8823eade1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "70c91670-8ec9-4e5b-b30e-ba8714b36b04"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Peripheral\nneuropathy occurred in 25% of patients in the ixazomib regimen compared to 20%\nof patients in the placebo regimen. Grade 3 adverse reactions of peripheral\nneuropathy were reported in 2% of patients in both regimens. The most commonly\nreported reaction was peripheral sensory neuropathy (16%\u00a0and 12% in the ixazomib\nand placebo regimen, respectively). Peripheral motor neuropathy was not\ncommonly reported in either regimen (&lt;\u00a01%). Peripheral neuropathy\nresulted in discontinuation of one or more of the three medicinal products in\n1% of patients in the ixazomib regimen compared to &lt;\u00a01% of patients in\nthe placebo regimen.</span></p>", "ID": "80d9bee7-e0e0-4c7e-b023-3bf57c340598", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Peripheral\nneuropathy occurred in 25% of patients in the ixazomib regimen compared to 20%\nof patients in the placebo regimen. Grade 3 adverse reactions of peripheral\nneuropathy were reported in 2% of patients in both regimens. The most commonly\nreported reaction was peripheral sensory neuropathy (16%\u00a0and 12% in the ixazomib\nand placebo regimen, respectively). Peripheral motor neuropathy was not\ncommonly reported in either regimen (&lt;\u00a01%). Peripheral neuropathy\nresulted in discontinuation of one or more of the three medicinal products in\n1% of patients in the ixazomib regimen compared to &lt;\u00a01% of patients in\nthe placebo regimen.</span>", "ID": "a421726d-5116-4a57-b9b2-20f0adffc9e2", "Styles": "None", "Classes": "None", "Text": "Peripheral neuropathy occurred in 25% of patients in the ixazomib regimen compared to 20% of patients in the placebo regimen. Grade 3 adverse reactions of peripheral neuropathy were reported in 2% of patients in both regimens. The most commonly reported reaction was peripheral sensory neuropathy (16%\u00a0and 12% in the ixazomib and placebo regimen, respectively). Peripheral motor neuropathy was not commonly reported in either regimen (<\u00a01%). Peripheral neuropathy resulted in discontinuation of one or more of the three medicinal products in 1% of patients in the ixazomib regimen compared to <\u00a01% of patients in the placebo regimen.", "ParentId": "80d9bee7-e0e0-4c7e-b023-3bf57c340598"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8e531fb4-6818-4a09-bc8f-c7444b4569fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9e255630-4e81-498a-a39e-00e90a55c9da", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8e531fb4-6818-4a09-bc8f-c7444b4569fe"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Eye disorders </span></u></p>", "ID": "2a6240bc-867f-4725-afe4-25146ad1bde9", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext\">Eye disorders </span></u>", "ID": "c5030be0-27b1-4b97-b873-d9a7af85a535", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2a6240bc-867f-4725-afe4-25146ad1bde9"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\">Eye disorders </span>", "ID": "f73b3435-19b5-45c2-93a0-963e970bf3a6", "Styles": "color:windowtext", "Classes": "None", "Text": "Eye disorders ", "ParentId": "c5030be0-27b1-4b97-b873-d9a7af85a535"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "807e11ee-12b8-466b-9355-f9004440b643", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "4f519e2f-f656-4242-a0d5-27198ac4fc74", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "807e11ee-12b8-466b-9355-f9004440b643"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "bfe7b175-bdc0-4dfe-aed8-d111f9134443", "Styles": "color:windowtext", "Classes": "None", "Text": "", "ParentId": "4f519e2f-f656-4242-a0d5-27198ac4fc74"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "9be61f0a-ed2b-419c-9d7c-b740004deeb9", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "bfe7b175-bdc0-4dfe-aed8-d111f9134443"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Eye\ndisorders were reported with many different preferred terms but in aggregate,\nthe frequency was 24% in patients in the ixazomib regimen and 15% of patients\nin the placebo regimen. The most common adverse reactions were blurred vision (5%\nin the ixazomib regimen and 4% in the placebo regimen), dry eye (4% in the ixazomib\nregimen and 1% in the placebo regimen), conjunctivitis (5% in the ixazomib\nregimen and 1% in the placebo regimen) and cataract (4% in the ixazomib regimen\nand 5% in the placebo regimen). Grade 3 adverse reactions were reported in 2%\nof patients in both regimens.</span></p>", "ID": "7a32e925-98cf-45bb-beb1-bd455ab9e451", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Eye\ndisorders were reported with many different preferred terms but in aggregate,\nthe frequency was 24% in patients in the ixazomib regimen and 15% of patients\nin the placebo regimen. The most common adverse reactions were blurred vision (5%\nin the ixazomib regimen and 4% in the placebo regimen), dry eye (4% in the ixazomib\nregimen and 1% in the placebo regimen), conjunctivitis (5% in the ixazomib\nregimen and 1% in the placebo regimen) and cataract (4% in the ixazomib regimen\nand 5% in the placebo regimen). Grade 3 adverse reactions were reported in 2%\nof patients in both regimens.</span>", "ID": "854c09b7-72b9-4f5c-80b4-a280facc8da8", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Eye disorders were reported with many different preferred terms but in aggregate, the frequency was 24% in patients in the ixazomib regimen and 15% of patients in the placebo regimen. The most common adverse reactions were blurred vision (5% in the ixazomib regimen and 4% in the placebo regimen), dry eye (4% in the ixazomib regimen and 1% in the placebo regimen), conjunctivitis (5% in the ixazomib regimen and 1% in the placebo regimen) and cataract (4% in the ixazomib regimen and 5% in the placebo regimen). Grade 3 adverse reactions were reported in 2% of patients in both regimens.", "ParentId": "7a32e925-98cf-45bb-beb1-bd455ab9e451"}, {"Element": "<p class=\"MsoBodyText\"><u><span lang=\"EN-GB\" style=\"color:windowtext\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "e29b0b4a-51b8-4fe5-a8d1-6689cf73ecf4", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "6ccc483b-7cd9-4327-a2bb-08687d185c85", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e29b0b4a-51b8-4fe5-a8d1-6689cf73ecf4"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "bdf9ee39-fa15-4dad-8232-0f168227dd69", "Styles": "color:windowtext", "Classes": "None", "Text": "", "ParentId": "6ccc483b-7cd9-4327-a2bb-08687d185c85"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "1e7dc2b7-ee77-4f9e-809c-c7ca172e06b0", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "bdf9ee39-fa15-4dad-8232-0f168227dd69"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><u><span lang=\"EN-GB\" style=\"color:windowtext\">Other adverse reactions</span></u></p>", "ID": "af697582-fe0c-4309-afa8-4ad6b56878ac", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"color:windowtext\">Other adverse reactions</span></u>", "ID": "e48d2134-d933-4e65-93c3-12c787323abd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "af697582-fe0c-4309-afa8-4ad6b56878ac"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext\">Other adverse reactions</span>", "ID": "9fc32b91-030a-4961-9d37-b70b957f0ce1", "Styles": "color:windowtext", "Classes": "None", "Text": "Other adverse reactions", "ParentId": "e48d2134-d933-4e65-93c3-12c787323abd"}, {"Element": "<p class=\"MsoBodyText\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "49a64acf-e3e8-4542-b950-bf714c996e7b", "Styles": "page-break-after:avoid", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "28bdaeae-c8da-4abf-8381-bb53e90d82dd", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "49a64acf-e3e8-4542-b950-bf714c996e7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">In the pooled\ndataset from the pivotal, Phase 3, global C16010 study (n=720) and the double\u2011blind,\nplacebo\u2011controlled, C16010 China Continuation Study (n=115), the\nfollowing adverse reactions occurred with a similar rate between the ixazomib\nand placebo regimens: fatigue (26% vs. 24%), decreased appetite (12% vs. 9%),\nhypotension (4% each), heart failure</span><sup>\u2020</sup><span lang=\"EN-GB\">\n(3% each), arrhythmia</span><sup>\u2020</sup><span lang=\"EN-GB\"> (12% vs. 11%),\nand liver impairment including enzyme changes</span><sup>\u2020</sup><span lang=\"EN-GB\"> (8% vs. 6%).</span></p>", "ID": "01872f51-0967-4e1e-aa3d-d4bc5ea210a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">In the pooled\ndataset from the pivotal, Phase 3, global C16010 study (n=720) and the double\u2011blind,\nplacebo\u2011controlled, C16010 China Continuation Study (n=115), the\nfollowing adverse reactions occurred with a similar rate between the ixazomib\nand placebo regimens: fatigue (26% vs. 24%), decreased appetite (12% vs. 9%),\nhypotension (4% each), heart failure</span>", "ID": "dcccdb34-b119-4ed1-bf66-877809e077e3", "Styles": "None", "Classes": "None", "Text": "In the pooled dataset from the pivotal, Phase 3, global C16010 study (n=720) and the double\u2011blind, placebo\u2011controlled, C16010 China Continuation Study (n=115), the following adverse reactions occurred with a similar rate between the ixazomib and placebo regimens: fatigue (26% vs. 24%), decreased appetite (12% vs. 9%), hypotension (4% each), heart failure", "ParentId": "01872f51-0967-4e1e-aa3d-d4bc5ea210a9"}, {"Element": "<sup>\u2020</sup>", "ID": "0fd76ec6-87ab-4d1d-9c98-f14b55844c91", "Styles": "None", "Classes": "None", "Text": "\u2020", "ParentId": "01872f51-0967-4e1e-aa3d-d4bc5ea210a9"}, {"Element": "<span lang=\"EN-GB\">\n(3% each), arrhythmia</span>", "ID": "253a784d-8941-4520-b24f-a79779775342", "Styles": "None", "Classes": "None", "Text": " (3% each), arrhythmia", "ParentId": "01872f51-0967-4e1e-aa3d-d4bc5ea210a9"}, {"Element": "<sup>\u2020</sup>", "ID": "59dab8fc-4a99-4bfd-b867-26427f6c2008", "Styles": "None", "Classes": "None", "Text": "\u2020", "ParentId": "01872f51-0967-4e1e-aa3d-d4bc5ea210a9"}, {"Element": "<span lang=\"EN-GB\"> (12% vs. 11%),\nand liver impairment including enzyme changes</span>", "ID": "92b46bbe-6564-46b9-ae8d-719ae61c30a5", "Styles": "None", "Classes": "None", "Text": " (12% vs. 11%), and liver impairment including enzyme changes", "ParentId": "01872f51-0967-4e1e-aa3d-d4bc5ea210a9"}, {"Element": "<sup>\u2020</sup>", "ID": "7efa7163-e3c3-4571-b4fb-5204ad80fcdb", "Styles": "None", "Classes": "None", "Text": "\u2020", "ParentId": "01872f51-0967-4e1e-aa3d-d4bc5ea210a9"}, {"Element": "<span lang=\"EN-GB\"> (8% vs. 6%).</span>", "ID": "a10ecc20-1f69-40a6-88ba-ea1aa3d58892", "Styles": "None", "Classes": "None", "Text": " (8% vs. 6%).", "ParentId": "01872f51-0967-4e1e-aa3d-d4bc5ea210a9"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "64dde71f-2c77-4343-bab4-f0974069b4ea", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "82da9e7d-7590-4a29-801f-286b2ed69a6b", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "64dde71f-2c77-4343-bab4-f0974069b4ea"}, {"Element": "<p class=\"MsoBodyText\"><span style=\"color:windowtext;font-style:normal\">The\nfrequency of severe (Grade\u00a03\u20114) events of hypokalaemia was higher in\nthe ixazomib regimen (5%) than the placebo regimen (&lt;\u00a01%). </span></p>", "ID": "f1e77b74-5a59-495e-84b0-b03933f0f337", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"color:windowtext;font-style:normal\">The\nfrequency of severe (Grade\u00a03\u20114) events of hypokalaemia was higher in\nthe ixazomib regimen (5%) than the placebo regimen (&lt;\u00a01%). </span>", "ID": "00fec5e0-e510-4966-a599-e4b53d44c7bb", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "The frequency of severe (Grade\u00a03\u20114) events of hypokalaemia was higher in the ixazomib regimen (5%) than the placebo regimen (<\u00a01%). ", "ParentId": "f1e77b74-5a59-495e-84b0-b03933f0f337"}, {"Element": "<p class=\"MsoBodyText\"><span style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "90bf326d-f4ef-405c-ad1d-c3aa5c5f4482", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "c0f36beb-3868-4c29-b3ea-c05dd5d8cc7d", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "90bf326d-f4ef-405c-ad1d-c3aa5c5f4482"}, {"Element": "<p class=\"MsoBodyText\"><span style=\"color:windowtext;font-style:normal\">Fungal\nand viral pneumonia resulting in fatal outcome were rarely reported in patients\ngiven the ixazomib, lenalidomide and dexamethasone combination.</span></p>", "ID": "ea278538-77c0-4f30-8c15-2b3c362c9c6c", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"color:windowtext;font-style:normal\">Fungal\nand viral pneumonia resulting in fatal outcome were rarely reported in patients\ngiven the ixazomib, lenalidomide and dexamethasone combination.</span>", "ID": "6053c33a-7a14-4e85-88d8-399e4f2a01aa", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Fungal and viral pneumonia resulting in fatal outcome were rarely reported in patients given the ixazomib, lenalidomide and dexamethasone combination.", "ParentId": "ea278538-77c0-4f30-8c15-2b3c362c9c6c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "f221cb07-9e74-4730-baea-3022d7ce2337", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "85d3ef15-7780-46c9-94bc-0511360077bc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f221cb07-9e74-4730-baea-3022d7ce2337"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "341b6fb5-a011-4183-898d-8770555b99f2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "85d3ef15-7780-46c9-94bc-0511360077bc"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "abe41564-e0e1-4120-89d4-b66b47ae0d2c", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "341b6fb5-a011-4183-898d-8770555b99f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><sup>\u2020 </sup><span lang=\"EN-GB\">Standardised MedDRA Queries (SMQs)</span></p>", "ID": "5fbd2c9b-951d-4405-88a2-8ddc4bee3e65", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<sup>\u2020 </sup>", "ID": "6660a400-54a1-4d67-8319-11822901d69d", "Styles": "None", "Classes": "None", "Text": "\u2020 ", "ParentId": "5fbd2c9b-951d-4405-88a2-8ddc4bee3e65"}, {"Element": "<span lang=\"EN-GB\">Standardised MedDRA Queries (SMQs)</span>", "ID": "88db8c58-2189-47b3-932a-99e69766b683", "Styles": "None", "Classes": "None", "Text": "Standardised MedDRA Queries (SMQs)", "ParentId": "5fbd2c9b-951d-4405-88a2-8ddc4bee3e65"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "be1eb801-57b9-4051-bf6d-f672c91cad74", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "37be6ed2-53a1-4bad-88ed-7b4ead61f6d8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "be1eb801-57b9-4051-bf6d-f672c91cad74"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "de681d35-5ebb-4f96-b583-16e7e4891c71", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "37be6ed2-53a1-4bad-88ed-7b4ead61f6d8"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "2fa03f11-14eb-4abc-aba2-f3166e73f43d", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "de681d35-5ebb-4f96-b583-16e7e4891c71"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u></p>", "ID": "c6d0e928-f685-4e2d-86e3-4f37750d63dd", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Reporting of suspected adverse reactions</span></u>", "ID": "f6212b14-bc03-4a43-90a4-71ea7d581759", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c6d0e928-f685-4e2d-86e3-4f37750d63dd"}, {"Element": "<span lang=\"EN-GB\">Reporting of suspected adverse reactions</span>", "ID": "d6d3c4d0-bb6b-4144-830d-c88826981a80", "Styles": "None", "Classes": "None", "Text": "Reporting of suspected adverse reactions", "ParentId": "f6212b14-bc03-4a43-90a4-71ea7d581759"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "e36b2a6a-ba6d-4dd1-bd50-dbc631345c45", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "4384b6e4-0426-4c6e-99a8-884e158dde83", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e36b2a6a-ba6d-4dd1-bd50-dbc631345c45"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "19aa80cf-5ef7-440d-951e-43e1ade84eb3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4384b6e4-0426-4c6e-99a8-884e158dde83"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "ddb9d2b5-a58f-4053-8d5e-7a30ae354cf1", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "19aa80cf-5ef7-440d-951e-43e1ade84eb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the\nmedicinal product is important. It allows continued monitoring of the\nbenefit/risk balance of the medicinal product. Healthcare professionals are\nasked to report any suspected adverse reactions via <span style=\"background:\nsilver\">the national reporting system listed in </span><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:silver\">Appendix V</span></a><span style=\"background:silver\">.</span></span></p>", "ID": "408905c7-9c42-472f-ad1e-2076d8814374", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Reporting suspected adverse reactions after authorisation of the\nmedicinal product is important. It allows continued monitoring of the\nbenefit/risk balance of the medicinal product. Healthcare professionals are\nasked to report any suspected adverse reactions via <span style=\"background:\nsilver\">the national reporting system listed in </span><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:silver\">Appendix V</span></a><span style=\"background:silver\">.</span></span>", "ID": "30554da8-a6d0-432a-bef9-89b253e65258", "Styles": "None", "Classes": "None", "Text": "Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via ", "ParentId": "408905c7-9c42-472f-ad1e-2076d8814374"}, {"Element": "<span style=\"background:\nsilver\">the national reporting system listed in </span>", "ID": "ee295a35-7c22-40d2-905d-aef53998cc16", "Styles": "background:\nsilver", "Classes": "None", "Text": "the national reporting system listed in ", "ParentId": "30554da8-a6d0-432a-bef9-89b253e65258"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:silver\">Appendix V</span></a>", "ID": "d86eda0b-21a6-49ed-8176-21bff2838df6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "30554da8-a6d0-432a-bef9-89b253e65258"}, {"Element": "<span style=\"background:silver\">Appendix V</span>", "ID": "af3746a0-631b-4174-9951-97223f381f93", "Styles": "background:silver", "Classes": "None", "Text": "Appendix V", "ParentId": "d86eda0b-21a6-49ed-8176-21bff2838df6"}, {"Element": "<span style=\"background:silver\">.</span>", "ID": "16d02a5e-fd3a-4522-a8a8-356adffd1e22", "Styles": "background:silver", "Classes": "None", "Text": ".", "ParentId": "30554da8-a6d0-432a-bef9-89b253e65258"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "a9710227-08df-4c1f-b020-bfb0be83838b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "bd5d033e-c40a-4731-baf1-6e771cc40186", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a9710227-08df-4c1f-b020-bfb0be83838b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a6866f69-5c07-4c8b-8193-57f1dd9dfbba", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bd5d033e-c40a-4731-baf1-6e771cc40186"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b></p>", "ID": "97ea62f3-ce8c-46c4-b47e-b881af992614", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span></b>", "ID": "71a138d7-c255-49f3-91ac-a3b027e0f5ff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "97ea62f3-ce8c-46c4-b47e-b881af992614"}, {"Element": "<span lang=\"EN-GB\">4.9\u00a0\u00a0\u00a0\u00a0 Overdose</span>", "ID": "3b4b9b38-af9a-4ec9-bd7d-a74838fa7fdc", "Styles": "None", "Classes": "None", "Text": "4.9\u00a0\u00a0\u00a0\u00a0 Overdose", "ParentId": "71a138d7-c255-49f3-91ac-a3b027e0f5ff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "773351d1-9639-4375-b7b8-7d1f942ca5a5", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ce6006ed-76cf-4030-b265-607397bf4d5d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "773351d1-9639-4375-b7b8-7d1f942ca5a5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Overdose has been reported in patients taking NINLARO. Symptoms of\noverdose are generally consistent with the known risks of NINLARO (see section\n4.8). Overdose of 12\u00a0mg (taken at one time) has resulted in serious\nadverse events, such as severe nausea, aspiration pneumonia, multiple organ\nfailure and death.</span></p>", "ID": "8b8acd7c-17d3-431a-8240-2603c949d7be", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Overdose has been reported in patients taking NINLARO. Symptoms of\noverdose are generally consistent with the known risks of NINLARO (see section\n4.8). Overdose of 12\u00a0mg (taken at one time) has resulted in serious\nadverse events, such as severe nausea, aspiration pneumonia, multiple organ\nfailure and death.</span>", "ID": "ca8788fc-c6f0-438f-b6b6-b9310c0fbd29", "Styles": "None", "Classes": "None", "Text": "Overdose has been reported in patients taking NINLARO. Symptoms of overdose are generally consistent with the known risks of NINLARO (see section 4.8). Overdose of 12\u00a0mg (taken at one time) has resulted in serious adverse events, such as severe nausea, aspiration pneumonia, multiple organ failure and death.", "ParentId": "8b8acd7c-17d3-431a-8240-2603c949d7be"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "23562afb-616e-4fae-8774-c7e20ac2a3a5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5b0d42a2-d0a0-43f0-a8de-837dfc0cb3a1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "23562afb-616e-4fae-8774-c7e20ac2a3a5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There is no\nknown specific antidote for ixazomib overdose. In the event of an overdose,\nmonitor the patient closely </span>for adverse reactions (section\u00a04.8) <span lang=\"EN-GB\">and provide appropriate supportive care. Ixazomib is not dialyzable\n(see section\u00a05.2).</span></p>", "ID": "70108801-1b37-4808-a0a1-d2681c1f05fb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "for adverse reactions (section\u00a04.8) ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">There is no\nknown specific antidote for ixazomib overdose. In the event of an overdose,\nmonitor the patient closely </span>", "ID": "951058b5-c1b9-4472-ab53-0694620c071f", "Styles": "None", "Classes": "None", "Text": "There is no known specific antidote for ixazomib overdose. In the event of an overdose, monitor the patient closely ", "ParentId": "70108801-1b37-4808-a0a1-d2681c1f05fb"}, {"Element": "<span lang=\"EN-GB\">and provide appropriate supportive care. Ixazomib is not dialyzable\n(see section\u00a05.2).</span>", "ID": "6dfa0344-7c5a-474c-84b3-4787b16afe8d", "Styles": "None", "Classes": "None", "Text": "and provide appropriate supportive care. Ixazomib is not dialyzable (see section\u00a05.2).", "ParentId": "70108801-1b37-4808-a0a1-d2681c1f05fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f16f1643-df79-4b6c-8d45-3f4cedc7923d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aca22a84-0060-4191-99f5-89374ddfa3c0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f16f1643-df79-4b6c-8d45-3f4cedc7923d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Overdoses were\nmost common in patients starting treatment with NINLARO. The importance of\ncarefully following all dosage instructions should be discussed with patients\nstarting treatment. </span><span lang=\"EN-GB\">Instruct patients to take the\nrecommended dosage as directed because overdose has led to deaths.</span></p>", "ID": "e20f6964-3448-4db5-9182-e10328d3c058", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Overdoses were\nmost common in patients starting treatment with NINLARO. The importance of\ncarefully following all dosage instructions should be discussed with patients\nstarting treatment. </span>", "ID": "f7b65ed4-c05d-4eba-a250-9d391fadce84", "Styles": "None", "Classes": "None", "Text": "Overdoses were most common in patients starting treatment with NINLARO. The importance of carefully following all dosage instructions should be discussed with patients starting treatment. ", "ParentId": "e20f6964-3448-4db5-9182-e10328d3c058"}, {"Element": "<span lang=\"EN-GB\">Instruct patients to take the\nrecommended dosage as directed because overdose has led to deaths.</span>", "ID": "c41d9b11-5668-4ab3-8979-5a9771e315e6", "Styles": "None", "Classes": "None", "Text": "Instruct patients to take the recommended dosage as directed because overdose has led to deaths.", "ParentId": "e20f6964-3448-4db5-9182-e10328d3c058"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0255a406-17a7-4132-84dd-80f6d123648f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b1f4dc4e-8430-4696-bf83-d12968561ab0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0255a406-17a7-4132-84dd-80f6d123648f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3bea28e7-b0ae-4e5d-9f12-815048027c95", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7d0eeeb-5b09-4a82-83d5-46addeb02c8e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3bea28e7-b0ae-4e5d-9f12-815048027c95"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL PROPERTIES</span></b></p>", "ID": "8fa354d4-5112-47dd-aca9-ab38e14564eb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL PROPERTIES</span></b>", "ID": "478bdae4-46d2-4f84-bbc0-2bee32fe3046", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8fa354d4-5112-47dd-aca9-ab38e14564eb"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL PROPERTIES</span>", "ID": "2f2b124b-70df-4c42-a0ad-609894627b02", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACOLOGICAL PROPERTIES", "ParentId": "478bdae4-46d2-4f84-bbc0-2bee32fe3046"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0836e0cb-2de0-4825-bf6c-7b5861bef703", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7a711f58-d3c5-4b42-87b8-01a63cd38168", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0836e0cb-2de0-4825-bf6c-7b5861bef703"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.1 \u00a0\u00a0\u00a0 Pharmacodynamic properties</span></b></p>", "ID": "4e41ae51-fe10-4e17-9420-de7f8d2e7fde", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">5.1 \u00a0\u00a0\u00a0 Pharmacodynamic properties</span></b>", "ID": "4b6cb1b2-3cfe-4b1f-95fe-a16e65ea0b87", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4e41ae51-fe10-4e17-9420-de7f8d2e7fde"}, {"Element": "<span lang=\"EN-GB\">5.1 \u00a0\u00a0\u00a0 Pharmacodynamic properties</span>", "ID": "72bfed92-dceb-432f-8449-224661c3b62e", "Styles": "None", "Classes": "None", "Text": "5.1 \u00a0\u00a0\u00a0 Pharmacodynamic properties", "ParentId": "4b6cb1b2-3cfe-4b1f-95fe-a16e65ea0b87"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "a9366eab-9637-4187-9025-4a8319bea813", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "a8536819-7011-4690-91b3-d5a826337bd9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a9366eab-9637-4187-9025-4a8319bea813"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ce47f420-341d-4b2b-abe3-d15161f6d8b4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a8536819-7011-4690-91b3-d5a826337bd9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Pharmacotherapeutic\ngroup: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX50</span></p>", "ID": "7570c505-0ea7-40b9-bb80-764141baaad5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Pharmacotherapeutic\ngroup: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX50</span>", "ID": "18438e49-c29f-444c-9807-24c38b627ba8", "Styles": "None", "Classes": "None", "Text": "Pharmacotherapeutic group: Antineoplastic agents, other antineoplastic agents, ATC code: L01XX50", "ParentId": "7570c505-0ea7-40b9-bb80-764141baaad5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "05304372-3c27-4ec4-9bcd-6e9667baa088", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "df424ba2-0eeb-4c35-acc7-3e343b28d9a7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "05304372-3c27-4ec4-9bcd-6e9667baa088"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b99d4bdf-4366-4d1f-adf0-b96a279ce7e4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "df424ba2-0eeb-4c35-acc7-3e343b28d9a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Mechanism of action</span></u></p>", "ID": "24d94203-8c5a-4d0e-87ec-de107fe61786", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Mechanism of action</span></u>", "ID": "44d7a869-9b1a-468f-b1da-16c1058ae593", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "24d94203-8c5a-4d0e-87ec-de107fe61786"}, {"Element": "<span lang=\"EN-GB\">Mechanism of action</span>", "ID": "d29e4a51-5d50-42b9-bcfc-8fee4a193f62", "Styles": "None", "Classes": "None", "Text": "Mechanism of action", "ParentId": "44d7a869-9b1a-468f-b1da-16c1058ae593"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "2a08733f-9229-4411-b2c8-55886220b3bd", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "b0cfa53d-3b69-4ac8-a28c-91e162df070e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2a08733f-9229-4411-b2c8-55886220b3bd"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "40c8ef25-7cba-4308-8b36-abaa1fa20860", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b0cfa53d-3b69-4ac8-a28c-91e162df070e"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "9343b5d5-7935-4a85-96a8-dfade74933d4", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "40c8ef25-7cba-4308-8b36-abaa1fa20860"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Ixazomib citrate, a prodrug, is a substance that rapidly hydrolyses\nunder physiological conditions to its biologically active form, ixazomib. </span></p>", "ID": "a08d3dd0-b9ea-499f-9ee8-adb693da7c39", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib citrate, a prodrug, is a substance that rapidly hydrolyses\nunder physiological conditions to its biologically active form, ixazomib. </span>", "ID": "3169e90d-f766-430f-b0d7-fd642916dd45", "Styles": "None", "Classes": "None", "Text": "Ixazomib citrate, a prodrug, is a substance that rapidly hydrolyses under physiological conditions to its biologically active form, ixazomib. ", "ParentId": "a08d3dd0-b9ea-499f-9ee8-adb693da7c39"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fccaf2d2-fcf6-4d91-97bd-2dff40cb2f33", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "37a7e5ae-41cd-4bdb-a949-af6a99a6096f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fccaf2d2-fcf6-4d91-97bd-2dff40cb2f33"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib is an\noral, highly selective and reversible proteasome inhibitor. Ixazomib\npreferentially binds and inhibits the chymotrypsin\u2011like activity of the\nbeta 5 subunit of the 20S proteasome. </span></p>", "ID": "191bafa3-fb5e-423c-986f-2fe18a6e027a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib is an\noral, highly selective and reversible proteasome inhibitor. Ixazomib\npreferentially binds and inhibits the chymotrypsin\u2011like activity of the\nbeta 5 subunit of the 20S proteasome. </span>", "ID": "ae2f86d5-e3ff-464a-9422-b8b9c81c98b5", "Styles": "None", "Classes": "None", "Text": "Ixazomib is an oral, highly selective and reversible proteasome inhibitor. Ixazomib preferentially binds and inhibits the chymotrypsin\u2011like activity of the beta 5 subunit of the 20S proteasome. ", "ParentId": "191bafa3-fb5e-423c-986f-2fe18a6e027a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "58b9caaf-c4e6-484a-8c6e-485e3d1b7909", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "da4151c1-1ed1-4880-8240-b676356da023", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "58b9caaf-c4e6-484a-8c6e-485e3d1b7909"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib induced\napoptosis of several tumour cell types <i>in\u00a0vitro</i>. Ixazomib\ndemonstrated <i>in\u00a0vitro</i> cytotoxicity against myeloma cells from\npatients who had relapsed after multiple prior therapies, including bortezomib,\nlenalidomide, and dexamethasone. The combination of ixazomib and lenalidomide\ndemonstrated synergistic cytotoxic effects in multiple myeloma cell lines. <i>In\u00a0vivo</i>,\nixazomib demonstrated antitumour activity in various tumour xenograft models,\nincluding models of multiple myeloma. <i>In\u00a0vitro</i>, ixazomib affected\ncell types found in the bone marrow microenvironment including vascular\nendothelial cells, osteoclasts and osteoblasts.</span></p>", "ID": "d772261f-b725-438e-9a69-45e153d28a3b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib induced\napoptosis of several tumour cell types <i>in\u00a0vitro</i>. Ixazomib\ndemonstrated <i>in\u00a0vitro</i> cytotoxicity against myeloma cells from\npatients who had relapsed after multiple prior therapies, including bortezomib,\nlenalidomide, and dexamethasone. The combination of ixazomib and lenalidomide\ndemonstrated synergistic cytotoxic effects in multiple myeloma cell lines. <i>In\u00a0vivo</i>,\nixazomib demonstrated antitumour activity in various tumour xenograft models,\nincluding models of multiple myeloma. <i>In\u00a0vitro</i>, ixazomib affected\ncell types found in the bone marrow microenvironment including vascular\nendothelial cells, osteoclasts and osteoblasts.</span>", "ID": "86a4a4d5-9483-4d40-98c6-da0036d761df", "Styles": "None", "Classes": "None", "Text": "Ixazomib induced apoptosis of several tumour cell types . Ixazomib demonstrated  cytotoxicity against myeloma cells from patients who had relapsed after multiple prior therapies, including bortezomib, lenalidomide, and dexamethasone. The combination of ixazomib and lenalidomide demonstrated synergistic cytotoxic effects in multiple myeloma cell lines. , ixazomib demonstrated antitumour activity in various tumour xenograft models, including models of multiple myeloma. , ixazomib affected cell types found in the bone marrow microenvironment including vascular endothelial cells, osteoclasts and osteoblasts.", "ParentId": "d772261f-b725-438e-9a69-45e153d28a3b"}, {"Element": "<i>in\u00a0vitro</i>", "ID": "0c5dc454-ad55-485c-87cc-bbaf2dac8ff2", "Styles": "None", "Classes": "None", "Text": "in\u00a0vitro", "ParentId": "86a4a4d5-9483-4d40-98c6-da0036d761df"}, {"Element": "<i>in\u00a0vitro</i>", "ID": "58c3da4d-d504-49bf-bd22-4f4a8bb3e270", "Styles": "None", "Classes": "None", "Text": "in\u00a0vitro", "ParentId": "86a4a4d5-9483-4d40-98c6-da0036d761df"}, {"Element": "<i>In\u00a0vivo</i>", "ID": "6ea95627-5e2b-4add-8bbb-8987bbc613f2", "Styles": "None", "Classes": "None", "Text": "In\u00a0vivo", "ParentId": "86a4a4d5-9483-4d40-98c6-da0036d761df"}, {"Element": "<i>In\u00a0vitro</i>", "ID": "861a2b00-3744-419f-9861-eeeea118fd73", "Styles": "None", "Classes": "None", "Text": "In\u00a0vitro", "ParentId": "86a4a4d5-9483-4d40-98c6-da0036d761df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8a1fa5ad-1646-4041-b045-961134c32aa8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "737ebd4d-88bd-44f5-ab9c-6c4050bd9200", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8a1fa5ad-1646-4041-b045-961134c32aa8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Cardiac electrophysiology</span></u></p>", "ID": "c6a2aa5c-f57f-44c6-be25-2a0d3262d75d", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Cardiac electrophysiology</span></u>", "ID": "ac333cc1-41af-4893-8c68-dcf436fbbdb4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c6a2aa5c-f57f-44c6-be25-2a0d3262d75d"}, {"Element": "<span lang=\"EN-GB\">Cardiac electrophysiology</span>", "ID": "8dbd2f23-fd4d-492a-bfd4-a5227937b851", "Styles": "None", "Classes": "None", "Text": "Cardiac electrophysiology", "ParentId": "ac333cc1-41af-4893-8c68-dcf436fbbdb4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "dc00a9eb-cee9-42af-9927-734af0e1f634", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "bfa583ff-e563-4c8c-8741-7802469da467", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dc00a9eb-cee9-42af-9927-734af0e1f634"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "66d37b55-6f4a-4f97-8a7c-58d2a0987468", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bfa583ff-e563-4c8c-8741-7802469da467"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib did not\nprolong the QTc interval at clinically relevant exposures based on the results\nof a pharmacokinetic\u2011pharmacodynamic analysis of data from 245 patients.\nAt the 4\u00a0mg dose, mean\u00a0change from baseline in QTcF was estimated to\nbe 0.07\u00a0msec (90% CI; \u20110.22, 0.36) from the model based analysis.\nThere was no discernible relationship between ixazomib concentration and the RR\ninterval suggesting no clinically meaningful effect of ixazomib on heart rate.</span></p>", "ID": "6888c3aa-269b-454e-aa7e-0da80b82569a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib did not\nprolong the QTc interval at clinically relevant exposures based on the results\nof a pharmacokinetic\u2011pharmacodynamic analysis of data from 245 patients.\nAt the 4\u00a0mg dose, mean\u00a0change from baseline in QTcF was estimated to\nbe 0.07\u00a0msec (90% CI; \u20110.22, 0.36) from the model based analysis.\nThere was no discernible relationship between ixazomib concentration and the RR\ninterval suggesting no clinically meaningful effect of ixazomib on heart rate.</span>", "ID": "3d88374f-35ae-46e1-98a5-8c5d2627f1ac", "Styles": "None", "Classes": "None", "Text": "Ixazomib did not prolong the QTc interval at clinically relevant exposures based on the results of a pharmacokinetic\u2011pharmacodynamic analysis of data from 245 patients. At the 4\u00a0mg dose, mean\u00a0change from baseline in QTcF was estimated to be 0.07\u00a0msec (90% CI; \u20110.22, 0.36) from the model based analysis. There was no discernible relationship between ixazomib concentration and the RR interval suggesting no clinically meaningful effect of ixazomib on heart rate.", "ParentId": "6888c3aa-269b-454e-aa7e-0da80b82569a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "3283167b-ce7a-4f96-b441-0cbc78d9d67c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "fa8a47e5-695d-47f9-ad18-41f8695a715b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3283167b-ce7a-4f96-b441-0cbc78d9d67c"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "66ee7008-b870-44f8-b88c-b7446a5eea24", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fa8a47e5-695d-47f9-ad18-41f8695a715b"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "58735a35-176c-4ded-ad99-f6845e04d7e6", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "66ee7008-b870-44f8-b88c-b7446a5eea24"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u></p>", "ID": "0d6a41e6-8ec5-4e6b-ba9a-d1d66443922e", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Clinical efficacy and safety</span></u>", "ID": "31587abd-4510-4581-be80-766de0f8fa51", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0d6a41e6-8ec5-4e6b-ba9a-d1d66443922e"}, {"Element": "<span lang=\"EN-GB\">Clinical efficacy and safety</span>", "ID": "d8baf2d9-d839-42bf-8e2b-89b734778e41", "Styles": "None", "Classes": "None", "Text": "Clinical efficacy and safety", "ParentId": "31587abd-4510-4581-be80-766de0f8fa51"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5236cafb-f24d-4e84-adca-2c62be290553", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5aa244dc-50d0-41c1-9a85-eb2c6e5b92ae", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5236cafb-f24d-4e84-adca-2c62be290553"}, {"Element": "<p class=\"CM36\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\nefficacy and safety of ixazomib in combination with lenalidomide and\ndexamethasone was evaluated in an international randomised, double\u2011blind,\nplacebo\u2011controlled, multicenter Phase 3 superiority study (C16010) in\npatients with relapsed and/or refractory multiple myeloma who had received at\nleast one prior therapy. A total of 722 patients (intent\u2011to-treat [ITT] population)\nwere randomised in a 1:1 ratio to receive either the combination of ixazomib,\nlenalidomide, and dexamethasone (N=360; ixazomib regimen) or placebo, lenalidomide\nand dexamethasone (N=362;</span><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>placebo\nregimen) until disease progression or unacceptable toxicity. Patients enrolled\nin the trial had multiple myeloma that was refractory, including primary\nrefractory, had relapsed after prior therapy, or had relapsed and was\nrefractory to any prior therapy. Patients that changed therapies prior to\ndisease progression were eligible for enrolment, as well as those with\ncontrolled cardiovascular conditions. </span><span style='font-size:11.0pt;\nfont-family:\"Times New Roman\",serif'>The Phase 3 study excluded patients who\nwere refractory to lenalidomide or proteasome inhibitors and patients who\nreceived more than three prior therapies. </span><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>For the purposes\nof this study, refractory disease was defined as disease progression on\ntreatment or progression within 60 days after the last dose of lenalidomide or\na proteasome inhibitor. </span><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>As\ndata are l</span><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>imited\nin these patients, a careful risk\u2011benefit assessment is recommended\nbefore initiating the ixazomib regimen.</span></p>", "ID": "ed31cb71-3da0-4ede-a00e-dfaeee1f6190", "Styles": "None", "Classes": "['CM36']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\nefficacy and safety of ixazomib in combination with lenalidomide and\ndexamethasone was evaluated in an international randomised, double\u2011blind,\nplacebo\u2011controlled, multicenter Phase 3 superiority study (C16010) in\npatients with relapsed and/or refractory multiple myeloma who had received at\nleast one prior therapy. A total of 722 patients (intent\u2011to-treat [ITT] population)\nwere randomised in a 1:1 ratio to receive either the combination of ixazomib,\nlenalidomide, and dexamethasone (N=360; ixazomib regimen) or placebo, lenalidomide\nand dexamethasone (N=362;</span>", "ID": "5e903c29-cd40-423d-8473-cc2f44350a76", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The efficacy and safety of ixazomib in combination with lenalidomide and dexamethasone was evaluated in an international randomised, double\u2011blind, placebo\u2011controlled, multicenter Phase 3 superiority study (C16010) in patients with relapsed and/or refractory multiple myeloma who had received at least one prior therapy. A total of 722 patients (intent\u2011to-treat [ITT] population) were randomised in a 1:1 ratio to receive either the combination of ixazomib, lenalidomide, and dexamethasone (N=360; ixazomib regimen) or placebo, lenalidomide and dexamethasone (N=362;", "ParentId": "ed31cb71-3da0-4ede-a00e-dfaeee1f6190"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "ecc24646-07c9-402d-876c-b768d4a67b8a", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "ed31cb71-3da0-4ede-a00e-dfaeee1f6190"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>placebo\nregimen) until disease progression or unacceptable toxicity. Patients enrolled\nin the trial had multiple myeloma that was refractory, including primary\nrefractory, had relapsed after prior therapy, or had relapsed and was\nrefractory to any prior therapy. Patients that changed therapies prior to\ndisease progression were eligible for enrolment, as well as those with\ncontrolled cardiovascular conditions. </span>", "ID": "03de8b2b-b65d-477e-9366-d95403923b7e", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "placebo regimen) until disease progression or unacceptable toxicity. Patients enrolled in the trial had multiple myeloma that was refractory, including primary refractory, had relapsed after prior therapy, or had relapsed and was refractory to any prior therapy. Patients that changed therapies prior to disease progression were eligible for enrolment, as well as those with controlled cardiovascular conditions. ", "ParentId": "ed31cb71-3da0-4ede-a00e-dfaeee1f6190"}, {"Element": "<span style='font-size:11.0pt;\nfont-family:\"Times New Roman\",serif'>The Phase 3 study excluded patients who\nwere refractory to lenalidomide or proteasome inhibitors and patients who\nreceived more than three prior therapies. </span>", "ID": "3e844b8a-38bc-4a91-b234-d2083dea03f2", "Styles": "font-size:11.0pt;\nfont-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The Phase 3 study excluded patients who were refractory to lenalidomide or proteasome inhibitors and patients who received more than three prior therapies. ", "ParentId": "ed31cb71-3da0-4ede-a00e-dfaeee1f6190"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>For the purposes\nof this study, refractory disease was defined as disease progression on\ntreatment or progression within 60 days after the last dose of lenalidomide or\na proteasome inhibitor. </span>", "ID": "db45eb4c-2a3d-447d-8437-5deb5778b7ea", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "For the purposes of this study, refractory disease was defined as disease progression on treatment or progression within 60 days after the last dose of lenalidomide or a proteasome inhibitor. ", "ParentId": "ed31cb71-3da0-4ede-a00e-dfaeee1f6190"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>As\ndata are l</span>", "ID": "5c9b7074-319e-450c-940b-31e5d5c011dd", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "As data are l", "ParentId": "ed31cb71-3da0-4ede-a00e-dfaeee1f6190"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>imited\nin these patients, a careful risk\u2011benefit assessment is recommended\nbefore initiating the ixazomib regimen.</span>", "ID": "d9946333-acf2-483e-83e5-c4039b644030", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "imited in these patients, a careful risk\u2011benefit assessment is recommended before initiating the ixazomib regimen.", "ParentId": "ed31cb71-3da0-4ede-a00e-dfaeee1f6190"}, {"Element": "<p class=\"CM36\"><span style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "221a490c-60ca-4a70-8e44-7773f6fc4913", "Styles": "None", "Classes": "['CM36']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"font-size:11.0pt\">\u00a0</span>", "ID": "1cd18a42-f46c-4178-b993-30ca7f620fe0", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "221a490c-60ca-4a70-8e44-7773f6fc4913"}, {"Element": "<p class=\"CM36\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Thromboprophylaxis\nwas recommended for all patients in both treatment groups according to the\nlenalidomide SmPC. Concomitant medicinal products, such as antiemetic,\nantiviral, and antihistamine medicinal products were given to patients at the\nphysician's discretion as prophylaxis and/or management of symptoms. </span></p>", "ID": "cdcc9b46-92e2-4f59-8d67-048df9501271", "Styles": "None", "Classes": "['CM36']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>Thromboprophylaxis\nwas recommended for all patients in both treatment groups according to the\nlenalidomide SmPC. Concomitant medicinal products, such as antiemetic,\nantiviral, and antihistamine medicinal products were given to patients at the\nphysician's discretion as prophylaxis and/or management of symptoms. </span>", "ID": "355386b1-055d-4367-9350-0b6208c891ef", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Thromboprophylaxis was recommended for all patients in both treatment groups according to the lenalidomide SmPC. Concomitant medicinal products, such as antiemetic, antiviral, and antihistamine medicinal products were given to patients at the physician's discretion as prophylaxis and/or management of symptoms. ", "ParentId": "cdcc9b46-92e2-4f59-8d67-048df9501271"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c2052f31-5ceb-4f70-bc5a-5338cb730e7a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ce876274-42bf-4037-8aab-7cf5876bcccb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c2052f31-5ceb-4f70-bc5a-5338cb730e7a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Patients received ixazomib 4\u00a0mg or placebo on Days 1, 8, and 15\nplus lenalidomide (25\u00a0mg) on Days\u00a01 through 21 and dexamethasone\n(40\u00a0mg) on Days 1, 8, 15, and 22 of a 28\u2011day cycle. Patients with\nrenal impairment received a starting dose of lenalidomide according to its\nSmPC. Treatment continued until disease progression or unacceptable toxicities.</span></p>", "ID": "63bf6bb6-a2eb-48b1-b28d-b642de30fc36", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Patients received ixazomib 4\u00a0mg or placebo on Days 1, 8, and 15\nplus lenalidomide (25\u00a0mg) on Days\u00a01 through 21 and dexamethasone\n(40\u00a0mg) on Days 1, 8, 15, and 22 of a 28\u2011day cycle. Patients with\nrenal impairment received a starting dose of lenalidomide according to its\nSmPC. Treatment continued until disease progression or unacceptable toxicities.</span>", "ID": "f959365d-f761-47c4-ae75-2af20a948310", "Styles": "None", "Classes": "None", "Text": "Patients received ixazomib 4\u00a0mg or placebo on Days 1, 8, and 15 plus lenalidomide (25\u00a0mg) on Days\u00a01 through 21 and dexamethasone (40\u00a0mg) on Days 1, 8, 15, and 22 of a 28\u2011day cycle. Patients with renal impairment received a starting dose of lenalidomide according to its SmPC. Treatment continued until disease progression or unacceptable toxicities.", "ParentId": "63bf6bb6-a2eb-48b1-b28d-b642de30fc36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "32f81129-ff2e-49f1-8246-365b30ec1fea", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3f2e629f-e458-43b0-b199-ba562fedc000", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "32f81129-ff2e-49f1-8246-365b30ec1fea"}, {"Element": "<p class=\"CM36\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\nbaseline demographics and disease characteristics were balanced and comparable\nbetween the study regimens. </span><span style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif'>The median age was 66\u00a0years, range 38\u201191\u00a0years;\n58% of patients were older than 65\u00a0years. Fifty seven percent of patients\nwere male. Eighty five percent of the population was White, 9% Asian and 2% Black.\nNinety three percent of patients had an ECOG performance status of 0\u20111\nand 12% had baseline ISS stage III disease (N=90). Twenty five percent of\npatients had a creatinine clearance of &lt;\u00a060\u00a0mL/min. Twenty three\npercent of patients had light chain disease and 12% of patients had measurable\ndisease by free light chain assay only. Nineteen percent had high\u2011risk\ncytogenetic abnormalities (del[17], t[4;14], t[14;16]) (N=137), 10% had del(17)\n(N=69) and 34% had 1q amplification (1q21) (N=247). Patients received one to\nthree prior therapies (median of 1) including prior treatment with bortezomib\n(69%), carfilzomib (&lt;\u00a01%), thalidomide (45%), lenalidomide (12%),\nmelphalan (81%). Fifty seven percent of patients had undergone prior stem cell\ntransplantation. Seventy seven percent of patients relapsed after prior therapies\nand 11% were refractory to prior therapies. Primary refractory, defined as best\nresponse of stable disease or disease progression on all prior therapies, was\ndocumented in 6% of patients.</span></p>", "ID": "26561811-e515-454e-bf40-0b2b7a687dc8", "Styles": "None", "Classes": "['CM36']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>The\nbaseline demographics and disease characteristics were balanced and comparable\nbetween the study regimens. </span>", "ID": "66145923-84a5-444c-a7f4-dd95a0f821b8", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "The baseline demographics and disease characteristics were balanced and comparable between the study regimens. ", "ParentId": "26561811-e515-454e-bf40-0b2b7a687dc8"}, {"Element": "<span style='font-size:11.0pt;font-family:\n\"Times New Roman\",serif'>The median age was 66\u00a0years, range 38\u201191\u00a0years;\n58% of patients were older than 65\u00a0years. Fifty seven percent of patients\nwere male. Eighty five percent of the population was White, 9% Asian and 2% Black.\nNinety three percent of patients had an ECOG performance status of 0\u20111\nand 12% had baseline ISS stage III disease (N=90). Twenty five percent of\npatients had a creatinine clearance of &lt;\u00a060\u00a0mL/min. Twenty three\npercent of patients had light chain disease and 12% of patients had measurable\ndisease by free light chain assay only. Nineteen percent had high\u2011risk\ncytogenetic abnormalities (del[17], t[4;14], t[14;16]) (N=137), 10% had del(17)\n(N=69) and 34% had 1q amplification (1q21) (N=247). Patients received one to\nthree prior therapies (median of 1) including prior treatment with bortezomib\n(69%), carfilzomib (&lt;\u00a01%), thalidomide (45%), lenalidomide (12%),\nmelphalan (81%). Fifty seven percent of patients had undergone prior stem cell\ntransplantation. Seventy seven percent of patients relapsed after prior therapies\nand 11% were refractory to prior therapies. Primary refractory, defined as best\nresponse of stable disease or disease progression on all prior therapies, was\ndocumented in 6% of patients.</span>", "ID": "6bf0ea92-9152-435a-afb4-92ec6359df7d", "Styles": "font-size:11.0pt;font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "The median age was 66\u00a0years, range 38\u201191\u00a0years; 58% of patients were older than 65\u00a0years. Fifty seven percent of patients were male. Eighty five percent of the population was White, 9% Asian and 2% Black. Ninety three percent of patients had an ECOG performance status of 0\u20111 and 12% had baseline ISS stage III disease (N=90). Twenty five percent of patients had a creatinine clearance of <\u00a060\u00a0mL/min. Twenty three percent of patients had light chain disease and 12% of patients had measurable disease by free light chain assay only. Nineteen percent had high\u2011risk cytogenetic abnormalities (del[17], t[4;14], t[14;16]) (N=137), 10% had del(17) (N=69) and 34% had 1q amplification (1q21) (N=247). Patients received one to three prior therapies (median of 1) including prior treatment with bortezomib (69%), carfilzomib (<\u00a01%), thalidomide (45%), lenalidomide (12%), melphalan (81%). Fifty seven percent of patients had undergone prior stem cell transplantation. Seventy seven percent of patients relapsed after prior therapies and 11% were refractory to prior therapies. Primary refractory, defined as best response of stable disease or disease progression on all prior therapies, was documented in 6% of patients.", "ParentId": "26561811-e515-454e-bf40-0b2b7a687dc8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c075bd82-4a9d-40cf-b645-fe7318d0c85e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ff00bdca-8f80-440b-a1cb-f1b9524d5b9f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c075bd82-4a9d-40cf-b645-fe7318d0c85e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The primary endpoint was progression\u2011free survival (PFS)\naccording to the 2011 International Myeloma Working Group (IMWG) Consensus\nUniform Response Criteria as assessed by a blinded independent review committee\n(IRC) based on central laboratory results. Response was assessed every 4\u00a0weeks\nuntil disease progression. At the primary analysis (median follow up of 14.7\nmonths and a median of 13 cycles), PFS was statistically significantly\ndifferent between the treatment arms. PFS results are summarised in Table 4 and\nFigure 1. The improvement in PFS in the ixazomib regimen was supported by\nimprovements in overall response rate.</span></p>", "ID": "af9f1d5f-f7e6-4079-8bb3-243fde6c70bc", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The primary endpoint was progression\u2011free survival (PFS)\naccording to the 2011 International Myeloma Working Group (IMWG) Consensus\nUniform Response Criteria as assessed by a blinded independent review committee\n(IRC) based on central laboratory results. Response was assessed every 4\u00a0weeks\nuntil disease progression. At the primary analysis (median follow up of 14.7\nmonths and a median of 13 cycles), PFS was statistically significantly\ndifferent between the treatment arms. PFS results are summarised in Table 4 and\nFigure 1. The improvement in PFS in the ixazomib regimen was supported by\nimprovements in overall response rate.</span>", "ID": "817c469f-34f5-4aa5-b860-c9ac07e0c044", "Styles": "None", "Classes": "None", "Text": "The primary endpoint was progression\u2011free survival (PFS) according to the 2011 International Myeloma Working Group (IMWG) Consensus Uniform Response Criteria as assessed by a blinded independent review committee (IRC) based on central laboratory results. Response was assessed every 4\u00a0weeks until disease progression. At the primary analysis (median follow up of 14.7 months and a median of 13 cycles), PFS was statistically significantly different between the treatment arms. PFS results are summarised in Table 4 and Figure 1. The improvement in PFS in the ixazomib regimen was supported by improvements in overall response rate.", "ParentId": "af9f1d5f-f7e6-4079-8bb3-243fde6c70bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "89215233-a63c-4eb5-9395-764f319a8a99", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f723dd62-9c81-4f08-a6aa-cb70b9ea12ce", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "89215233-a63c-4eb5-9395-764f319a8a99"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Table 4: Progression free survival and response Results in multiple myeloma\npatients treated with ixazomib or placebo in combination with lenalidomide and dexamethasone\n(intent\u2011to-treat population)</span></b></p>", "ID": "23b9643a-037c-4cad-851c-8c780d74fb04", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Table 4: Progression free survival and response Results in multiple myeloma\npatients treated with ixazomib or placebo in combination with lenalidomide and dexamethasone\n(intent\u2011to-treat population)</span></b>", "ID": "3774d6fa-d61a-42e3-b634-4e6a62b4f6ff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "23b9643a-037c-4cad-851c-8c780d74fb04"}, {"Element": "<span lang=\"EN-GB\">Table 4: Progression free survival and response Results in multiple myeloma\npatients treated with ixazomib or placebo in combination with lenalidomide and dexamethasone\n(intent\u2011to-treat population)</span>", "ID": "839d05fc-3e77-4ed7-9ed8-b13469b90fcc", "Styles": "None", "Classes": "None", "Text": "Table 4: Progression free survival and response Results in multiple myeloma patients treated with ixazomib or placebo in combination with lenalidomide and dexamethasone (intent\u2011to-treat population)", "ParentId": "3774d6fa-d61a-42e3-b634-4e6a62b4f6ff"}, {"Element": "<table border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none\">\n<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td colspan=\"3\" style=\"width:155.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Ixazomib + Lenalidomide and\n  Dexamethasone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(N = 360)</span></p>\n</td>\n<td style=\"width:155.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Placebo + Lenalidomide and\n  Dexamethasone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(N = 362)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Progression\u2011Free Survival</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Events, n (%)</span></p>\n</td>\n<td colspan=\"3\" style=\"width:155.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">129 (36)</span></p>\n</td>\n<td style=\"width:155.2pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">157 (43)</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Median (months)</span></p>\n</td>\n<td colspan=\"3\" style=\"width:155.2pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">20.6</span></p>\n</td>\n<td style=\"width:155.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">14.7</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">p\u2011value*</span></p>\n</td>\n<td colspan=\"4\" style=\"width:310.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"414\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">0.012</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Hazard Ratio<sup>\u2020</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(95% CI)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:310.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"414\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">0.74</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(0.59, 0.94)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Overall Response Rate</span></b><sup><span lang=\"EN-GB\">\u2021</span></sup><b><span lang=\"EN-GB\">, n (%) </span></b></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">282 (78.3)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">259 (71.5)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Response Category, n (%)</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Complete Response </span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">42 (11.7)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">24 (6.6)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Very Good Partial Response </span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">131 (36.4)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">117 (32.3)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Partial Response </span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">109 (30.3)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">118 (32.6)</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Time to Response, months</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Median</span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">1.1</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">1.9</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Duration of Response</span></b><sup><span lang=\"EN-GB\">\u00a7</span></sup><b><span lang=\"EN-GB\">, months</span></b></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Median</span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">20.5</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">15.0</span></p>\n</td>\n</tr>\n<tr height=\"0\">\n<td style=\"border:none\" width=\"206\"></td>\n<td style=\"border:none\" width=\"0\"></td>\n<td style=\"border:none\" width=\"206\"></td>\n<td style=\"border:none\" width=\"1\"></td>\n<td style=\"border:none\" width=\"207\"></td>\n</tr>\n</table>", "ID": "6adf16e0-6589-451a-aeb7-c98976ee7bff", "Styles": "border-collapse:collapse;border:none", "Classes": "['MsoNormalTable']", "Text": "                 ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td colspan=\"3\" style=\"width:155.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Ixazomib + Lenalidomide and\n  Dexamethasone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(N = 360)</span></p>\n</td>\n<td style=\"width:155.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Placebo + Lenalidomide and\n  Dexamethasone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(N = 362)</span></p>\n</td>\n</tr>", "ID": "59f9b8b0-2ffe-4140-861d-07f5493a26bb", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "0e05d979-be20-4511-9be7-d2c6a2727352", "Styles": "width:154.65pt;border:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "59f9b8b0-2ffe-4140-861d-07f5493a26bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60fcc891-bc1a-4b83-81a3-4b9938b95cef", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0e05d979-be20-4511-9be7-d2c6a2727352"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8a24f854-104c-4bd3-ba5e-35e3ccfed512", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60fcc891-bc1a-4b83-81a3-4b9938b95cef"}, {"Element": "<td colspan=\"3\" style=\"width:155.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Ixazomib + Lenalidomide and\n  Dexamethasone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(N = 360)</span></p>\n</td>", "ID": "d6e37800-9889-4dc6-89fc-b85da60bc076", "Styles": "width:155.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "59f9b8b0-2ffe-4140-861d-07f5493a26bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Ixazomib + Lenalidomide and\n  Dexamethasone</span></p>", "ID": "ac5762fa-277d-4dca-aadc-5297d97ca20c", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d6e37800-9889-4dc6-89fc-b85da60bc076"}, {"Element": "<span lang=\"EN-GB\">Ixazomib + Lenalidomide and\n  Dexamethasone</span>", "ID": "74f8ac64-0521-4ea7-bc96-149d9959f243", "Styles": "None", "Classes": "None", "Text": "Ixazomib + Lenalidomide and   Dexamethasone", "ParentId": "ac5762fa-277d-4dca-aadc-5297d97ca20c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(N = 360)</span></p>", "ID": "dcfc4472-5e41-4f9a-81f3-224f8018dccb", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d6e37800-9889-4dc6-89fc-b85da60bc076"}, {"Element": "<span lang=\"EN-GB\">(N = 360)</span>", "ID": "6922e0de-a8c2-45d3-b5b9-c79fdee4cc58", "Styles": "None", "Classes": "None", "Text": "(N = 360)", "ParentId": "dcfc4472-5e41-4f9a-81f3-224f8018dccb"}, {"Element": "<td style=\"width:155.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Placebo + Lenalidomide and\n  Dexamethasone</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(N = 362)</span></p>\n</td>", "ID": "1ad14263-b2b8-4207-b3dd-cefbf90563c7", "Styles": "width:155.2pt;border:solid windowtext 1.0pt;\n  border-left:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "59f9b8b0-2ffe-4140-861d-07f5493a26bb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Placebo + Lenalidomide and\n  Dexamethasone</span></p>", "ID": "0a27a027-40bb-401e-b94b-cb6e4b59c63c", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ad14263-b2b8-4207-b3dd-cefbf90563c7"}, {"Element": "<span lang=\"EN-GB\">Placebo + Lenalidomide and\n  Dexamethasone</span>", "ID": "f0ee30b9-a8f8-41f2-b0d1-88defada6743", "Styles": "None", "Classes": "None", "Text": "Placebo + Lenalidomide and   Dexamethasone", "ParentId": "0a27a027-40bb-401e-b94b-cb6e4b59c63c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(N = 362)</span></p>", "ID": "80d0c9d3-4ece-487d-bcd5-e71df28d9e0e", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ad14263-b2b8-4207-b3dd-cefbf90563c7"}, {"Element": "<span lang=\"EN-GB\">(N = 362)</span>", "ID": "c1c89f21-d754-403e-82be-6acc0c1b8854", "Styles": "None", "Classes": "None", "Text": "(N = 362)", "ParentId": "80d0c9d3-4ece-487d-bcd5-e71df28d9e0e"}, {"Element": "<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Progression\u2011Free Survival</span></b></p>\n</td>\n</tr>", "ID": "c7e7ef3d-d73a-42e6-aac5-988c11a451d5", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Progression\u2011Free Survival</span></b></p>\n</td>", "ID": "4f865b9e-0bf1-4213-96eb-bdac768df357", "Styles": "width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c7e7ef3d-d73a-42e6-aac5-988c11a451d5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Progression\u2011Free Survival</span></b></p>", "ID": "851ab274-b710-4ae0-a949-706171aa6166", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4f865b9e-0bf1-4213-96eb-bdac768df357"}, {"Element": "<b><span lang=\"EN-GB\">Progression\u2011Free Survival</span></b>", "ID": "c19ff08a-e7d4-4689-a57b-6ce4f5488421", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "851ab274-b710-4ae0-a949-706171aa6166"}, {"Element": "<span lang=\"EN-GB\">Progression\u2011Free Survival</span>", "ID": "16561eaa-d70a-4394-9fe8-ae6c30155a4f", "Styles": "None", "Classes": "None", "Text": "Progression\u2011Free Survival", "ParentId": "c19ff08a-e7d4-4689-a57b-6ce4f5488421"}, {"Element": "<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Events, n (%)</span></p>\n</td>\n<td colspan=\"3\" style=\"width:155.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">129 (36)</span></p>\n</td>\n<td style=\"width:155.2pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">157 (43)</span></p>\n</td>\n</tr>", "ID": "8606b441-3a41-4fdf-ada0-4ef7117f52fa", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Events, n (%)</span></p>\n</td>", "ID": "be4e3fc7-e9b7-4e18-ad79-8f28db6afb09", "Styles": "width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8606b441-3a41-4fdf-ada0-4ef7117f52fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Events, n (%)</span></p>", "ID": "74f136d6-4441-4c6a-a4d8-8f331c41fea7", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "be4e3fc7-e9b7-4e18-ad79-8f28db6afb09"}, {"Element": "<span lang=\"EN-GB\">Events, n (%)</span>", "ID": "0577e149-587b-48e0-9e43-6395a38a3a0d", "Styles": "None", "Classes": "None", "Text": "Events, n (%)", "ParentId": "74f136d6-4441-4c6a-a4d8-8f331c41fea7"}, {"Element": "<td colspan=\"3\" style=\"width:155.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">129 (36)</span></p>\n</td>", "ID": "75d0b2e9-6c9b-4536-bc24-279b90e0b850", "Styles": "width:155.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8606b441-3a41-4fdf-ada0-4ef7117f52fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">129 (36)</span></p>", "ID": "818de77e-e6f3-43fb-8615-b591626f04a3", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "75d0b2e9-6c9b-4536-bc24-279b90e0b850"}, {"Element": "<span lang=\"EN-GB\">129 (36)</span>", "ID": "583ffa91-41a5-49b5-bdd3-7568a60a566f", "Styles": "None", "Classes": "None", "Text": "129 (36)", "ParentId": "818de77e-e6f3-43fb-8615-b591626f04a3"}, {"Element": "<td style=\"width:155.2pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">157 (43)</span></p>\n</td>", "ID": "43ff3323-6107-4caf-a792-f2208944ef7c", "Styles": "width:155.2pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8606b441-3a41-4fdf-ada0-4ef7117f52fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">157 (43)</span></p>", "ID": "dbf75dc9-5c67-4c91-beac-824659f10cb5", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "43ff3323-6107-4caf-a792-f2208944ef7c"}, {"Element": "<span lang=\"EN-GB\">157 (43)</span>", "ID": "fafa1ee6-9aa1-41d5-acf1-d04b1dc02804", "Styles": "None", "Classes": "None", "Text": "157 (43)", "ParentId": "dbf75dc9-5c67-4c91-beac-824659f10cb5"}, {"Element": "<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Median (months)</span></p>\n</td>\n<td colspan=\"3\" style=\"width:155.2pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">20.6</span></p>\n</td>\n<td style=\"width:155.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">14.7</span></p>\n</td>\n</tr>", "ID": "511e33eb-13e5-4293-8596-ad0480fc0fb3", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Median (months)</span></p>\n</td>", "ID": "82b308a4-6cb0-4c73-8a07-a91ec557d123", "Styles": "width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "511e33eb-13e5-4293-8596-ad0480fc0fb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Median (months)</span></p>", "ID": "e6f3630d-388b-472e-b88c-f2792bb081d9", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "82b308a4-6cb0-4c73-8a07-a91ec557d123"}, {"Element": "<span lang=\"EN-GB\">Median (months)</span>", "ID": "3224e887-265b-4b4f-8426-5a3a4aab7f87", "Styles": "None", "Classes": "None", "Text": "Median (months)", "ParentId": "e6f3630d-388b-472e-b88c-f2792bb081d9"}, {"Element": "<td colspan=\"3\" style=\"width:155.2pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">20.6</span></p>\n</td>", "ID": "9bc82677-69b2-45ea-9e4b-dd7f5b1f1020", "Styles": "width:155.2pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "511e33eb-13e5-4293-8596-ad0480fc0fb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">20.6</span></p>", "ID": "86c4faf7-4924-481e-a220-21e284e322fc", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9bc82677-69b2-45ea-9e4b-dd7f5b1f1020"}, {"Element": "<span lang=\"EN-GB\">20.6</span>", "ID": "29e1f5a0-9692-4d9e-ac47-e5b02b1e7945", "Styles": "None", "Classes": "None", "Text": "20.6", "ParentId": "86c4faf7-4924-481e-a220-21e284e322fc"}, {"Element": "<td style=\"width:155.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">14.7</span></p>\n</td>", "ID": "e395aae5-f2d7-4763-8c63-bf5fa0121973", "Styles": "width:155.2pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "511e33eb-13e5-4293-8596-ad0480fc0fb3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">14.7</span></p>", "ID": "b7efe45c-8116-4207-b26c-c63a681e4a7b", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e395aae5-f2d7-4763-8c63-bf5fa0121973"}, {"Element": "<span lang=\"EN-GB\">14.7</span>", "ID": "e1550ab5-64ea-4699-ad7d-c5d24bf104a9", "Styles": "None", "Classes": "None", "Text": "14.7", "ParentId": "b7efe45c-8116-4207-b26c-c63a681e4a7b"}, {"Element": "<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">p\u2011value*</span></p>\n</td>\n<td colspan=\"4\" style=\"width:310.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"414\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">0.012</span></p>\n</td>\n</tr>", "ID": "cdde2781-8e7e-46da-9938-359e0efd4eaa", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">p\u2011value*</span></p>\n</td>", "ID": "8b9ebee3-9d01-43d4-833b-5364aba38060", "Styles": "width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "cdde2781-8e7e-46da-9938-359e0efd4eaa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">p\u2011value*</span></p>", "ID": "0efe88a8-a9fd-4b89-a400-03899d6d270a", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8b9ebee3-9d01-43d4-833b-5364aba38060"}, {"Element": "<span lang=\"EN-GB\">p\u2011value*</span>", "ID": "4d5419ed-011f-4cf2-b07c-6f937777376c", "Styles": "None", "Classes": "None", "Text": "p\u2011value*", "ParentId": "0efe88a8-a9fd-4b89-a400-03899d6d270a"}, {"Element": "<td colspan=\"4\" style=\"width:310.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"414\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">0.012</span></p>\n</td>", "ID": "541dae1f-b6f6-4063-a7ce-74675fb631ed", "Styles": "width:310.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "cdde2781-8e7e-46da-9938-359e0efd4eaa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">0.012</span></p>", "ID": "f9549db4-6013-4994-bfda-c135bb3bf97e", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "541dae1f-b6f6-4063-a7ce-74675fb631ed"}, {"Element": "<span lang=\"EN-GB\">0.012</span>", "ID": "f17f73d8-13ed-4694-b9d2-0dcb2d7b42fa", "Styles": "None", "Classes": "None", "Text": "0.012", "ParentId": "f9549db4-6013-4994-bfda-c135bb3bf97e"}, {"Element": "<tr>\n<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Hazard Ratio<sup>\u2020</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(95% CI)</span></p>\n</td>\n<td colspan=\"4\" style=\"width:310.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"414\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">0.74</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(0.59, 0.94)</span></p>\n</td>\n</tr>", "ID": "370f669d-8bfa-4589-a3ab-22f2723a02c2", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td style=\"width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Hazard Ratio<sup>\u2020</sup></span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(95% CI)</span></p>\n</td>", "ID": "ea7103f5-d38c-418c-99ba-024ef9a626c2", "Styles": "width:154.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "370f669d-8bfa-4589-a3ab-22f2723a02c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">Hazard Ratio<sup>\u2020</sup></span></p>", "ID": "de86d983-857d-45c2-9937-02579ffb13a2", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ea7103f5-d38c-418c-99ba-024ef9a626c2"}, {"Element": "<span lang=\"EN-GB\">Hazard Ratio<sup>\u2020</sup></span>", "ID": "859cf373-a1dc-42cf-99bf-eca661800878", "Styles": "None", "Classes": "None", "Text": "Hazard Ratio", "ParentId": "de86d983-857d-45c2-9937-02579ffb13a2"}, {"Element": "<sup>\u2020</sup>", "ID": "eabd01f6-9a50-4ea0-8819-1ba6c321c075", "Styles": "None", "Classes": "None", "Text": "\u2020", "ParentId": "859cf373-a1dc-42cf-99bf-eca661800878"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(95% CI)</span></p>", "ID": "bf522ff1-c735-4af6-b815-2b6fbd10a378", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ea7103f5-d38c-418c-99ba-024ef9a626c2"}, {"Element": "<span lang=\"EN-GB\">(95% CI)</span>", "ID": "60d4ad2c-e82b-41ed-9607-bfaa98720fc7", "Styles": "None", "Classes": "None", "Text": "(95% CI)", "ParentId": "bf522ff1-c735-4af6-b815-2b6fbd10a378"}, {"Element": "<td colspan=\"4\" style=\"width:310.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"414\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">0.74</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(0.59, 0.94)</span></p>\n</td>", "ID": "84a92418-c974-479a-bdde-5052c4df0f44", "Styles": "width:310.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "370f669d-8bfa-4589-a3ab-22f2723a02c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">0.74</span></p>", "ID": "159f7b70-04cc-4551-ab48-c77c534eb4d6", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84a92418-c974-479a-bdde-5052c4df0f44"}, {"Element": "<span lang=\"EN-GB\">0.74</span>", "ID": "20a337a1-fae9-45e6-bf71-71c16130350c", "Styles": "None", "Classes": "None", "Text": "0.74", "ParentId": "159f7b70-04cc-4551-ab48-c77c534eb4d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><span lang=\"EN-GB\">(0.59, 0.94)</span></p>", "ID": "f73a04c7-9dbf-41a4-9bfc-d94b57fb36a2", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "84a92418-c974-479a-bdde-5052c4df0f44"}, {"Element": "<span lang=\"EN-GB\">(0.59, 0.94)</span>", "ID": "054ff2bf-00c8-4bf9-b011-0f2bcb989e90", "Styles": "None", "Classes": "None", "Text": "(0.59, 0.94)", "ParentId": "f73a04c7-9dbf-41a4-9bfc-d94b57fb36a2"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Overall Response Rate</span></b><sup><span lang=\"EN-GB\">\u2021</span></sup><b><span lang=\"EN-GB\">, n (%) </span></b></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">282 (78.3)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">259 (71.5)</span></p>\n</td>\n</tr>", "ID": "7008a340-7b7f-4936-b290-77d8fb08a161", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Overall Response Rate</span></b><sup><span lang=\"EN-GB\">\u2021</span></sup><b><span lang=\"EN-GB\">, n (%) </span></b></p>\n</td>", "ID": "9dd1d89e-be89-4154-9443-c5a443f1a341", "Styles": "width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7008a340-7b7f-4936-b290-77d8fb08a161"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Overall Response Rate</span></b><sup><span lang=\"EN-GB\">\u2021</span></sup><b><span lang=\"EN-GB\">, n (%) </span></b></p>", "ID": "c55a4af2-3bf2-4fb9-a40e-ac84e5366b97", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9dd1d89e-be89-4154-9443-c5a443f1a341"}, {"Element": "<b><span lang=\"EN-GB\">Overall Response Rate</span></b>", "ID": "ddf208de-e8f1-466d-bc96-a330f34ffec8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c55a4af2-3bf2-4fb9-a40e-ac84e5366b97"}, {"Element": "<span lang=\"EN-GB\">Overall Response Rate</span>", "ID": "4d904fd6-ba65-445c-8d33-43e5572c50c9", "Styles": "None", "Classes": "None", "Text": "Overall Response Rate", "ParentId": "ddf208de-e8f1-466d-bc96-a330f34ffec8"}, {"Element": "<sup><span lang=\"EN-GB\">\u2021</span></sup>", "ID": "1ccdc7f9-7279-4160-a31c-864adb430c31", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c55a4af2-3bf2-4fb9-a40e-ac84e5366b97"}, {"Element": "<span lang=\"EN-GB\">\u2021</span>", "ID": "185e2e7b-54a2-4b0d-a269-2fbbd929b8ab", "Styles": "None", "Classes": "None", "Text": "\u2021", "ParentId": "1ccdc7f9-7279-4160-a31c-864adb430c31"}, {"Element": "<b><span lang=\"EN-GB\">, n (%) </span></b>", "ID": "d21d865b-f9c4-4418-804b-4a28c205783d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c55a4af2-3bf2-4fb9-a40e-ac84e5366b97"}, {"Element": "<span lang=\"EN-GB\">, n (%) </span>", "ID": "88e5a31c-5c59-4bdd-bef9-2552eb4d6b02", "Styles": "None", "Classes": "None", "Text": ", n (%) ", "ParentId": "d21d865b-f9c4-4418-804b-4a28c205783d"}, {"Element": "<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">282 (78.3)</span></p>\n</td>", "ID": "67e312d4-3f39-4284-90eb-0013a6a780c8", "Styles": "width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7008a340-7b7f-4936-b290-77d8fb08a161"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">282 (78.3)</span></p>", "ID": "06d34e70-dc56-4226-b55e-11328c6f9f91", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "67e312d4-3f39-4284-90eb-0013a6a780c8"}, {"Element": "<span lang=\"EN-GB\">282 (78.3)</span>", "ID": "b027969e-f005-410a-b601-7716200a22dc", "Styles": "None", "Classes": "None", "Text": "282 (78.3)", "ParentId": "06d34e70-dc56-4226-b55e-11328c6f9f91"}, {"Element": "<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">259 (71.5)</span></p>\n</td>", "ID": "82fe72ff-f77e-4fce-b434-bef48616a034", "Styles": "width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "7008a340-7b7f-4936-b290-77d8fb08a161"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">259 (71.5)</span></p>", "ID": "d31ee381-4d50-4a72-a046-799154d33726", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "82fe72ff-f77e-4fce-b434-bef48616a034"}, {"Element": "<span lang=\"EN-GB\">259 (71.5)</span>", "ID": "99cf5b56-0373-4600-a079-e5ef09a12bca", "Styles": "None", "Classes": "None", "Text": "259 (71.5)", "ParentId": "d31ee381-4d50-4a72-a046-799154d33726"}, {"Element": "<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Response Category, n (%)</span></b></p>\n</td>\n</tr>", "ID": "1c04981d-2b73-4cae-bbf8-af6b2bc32783", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Response Category, n (%)</span></b></p>\n</td>", "ID": "59712d09-7279-4344-b333-1180931c93d0", "Styles": "width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "1c04981d-2b73-4cae-bbf8-af6b2bc32783"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Response Category, n (%)</span></b></p>", "ID": "8137a4b1-3e5b-4e56-afb7-3f102ce96c09", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "59712d09-7279-4344-b333-1180931c93d0"}, {"Element": "<b><span lang=\"EN-GB\">Response Category, n (%)</span></b>", "ID": "dbafcffc-f380-4d29-addd-0ac450f842f4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8137a4b1-3e5b-4e56-afb7-3f102ce96c09"}, {"Element": "<span lang=\"EN-GB\">Response Category, n (%)</span>", "ID": "bbb31be3-c3de-4458-aafa-d591b2571888", "Styles": "None", "Classes": "None", "Text": "Response Category, n (%)", "ParentId": "dbafcffc-f380-4d29-addd-0ac450f842f4"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Complete Response </span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">42 (11.7)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">24 (6.6)</span></p>\n</td>\n</tr>", "ID": "f92ca298-c575-4559-83f8-cdddbffe0d55", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Complete Response </span></p>\n</td>", "ID": "c30f46b8-ffa7-403c-ba3f-eefe6fcb97fa", "Styles": "width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f92ca298-c575-4559-83f8-cdddbffe0d55"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Complete Response </span></p>", "ID": "c993e81c-54cb-4e26-a752-239b31ba73bf", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c30f46b8-ffa7-403c-ba3f-eefe6fcb97fa"}, {"Element": "<span lang=\"EN-GB\">Complete Response </span>", "ID": "c2b66f8e-52e2-44a7-bfe0-6dc8ed0fb8dd", "Styles": "None", "Classes": "None", "Text": "Complete Response ", "ParentId": "c993e81c-54cb-4e26-a752-239b31ba73bf"}, {"Element": "<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">42 (11.7)</span></p>\n</td>", "ID": "7d8b4a48-af0e-40a4-9033-c866dbc181b5", "Styles": "width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f92ca298-c575-4559-83f8-cdddbffe0d55"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">42 (11.7)</span></p>", "ID": "38aaf177-1604-4956-8c35-c54ebba1ffd6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7d8b4a48-af0e-40a4-9033-c866dbc181b5"}, {"Element": "<span lang=\"EN-GB\">42 (11.7)</span>", "ID": "a699d2be-caff-494e-a03c-608900b2599a", "Styles": "None", "Classes": "None", "Text": "42 (11.7)", "ParentId": "38aaf177-1604-4956-8c35-c54ebba1ffd6"}, {"Element": "<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">24 (6.6)</span></p>\n</td>", "ID": "72d56f8a-8731-45f0-a44a-73f3f08a877b", "Styles": "width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f92ca298-c575-4559-83f8-cdddbffe0d55"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">24 (6.6)</span></p>", "ID": "d0062504-6245-4bfd-91a3-ca14f96e5780", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "72d56f8a-8731-45f0-a44a-73f3f08a877b"}, {"Element": "<span lang=\"EN-GB\">24 (6.6)</span>", "ID": "18ac7f3c-144a-4351-913d-3226f14ed7dd", "Styles": "None", "Classes": "None", "Text": "24 (6.6)", "ParentId": "d0062504-6245-4bfd-91a3-ca14f96e5780"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Very Good Partial Response </span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">131 (36.4)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">117 (32.3)</span></p>\n</td>\n</tr>", "ID": "3bfa00de-8119-4883-8ccb-03baf5746ee6", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Very Good Partial Response </span></p>\n</td>", "ID": "cddaf2be-82fa-4d85-93a1-73249151b0dd", "Styles": "width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3bfa00de-8119-4883-8ccb-03baf5746ee6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Very Good Partial Response </span></p>", "ID": "f817b426-cf3b-42bb-b915-9e25f7cdacfc", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cddaf2be-82fa-4d85-93a1-73249151b0dd"}, {"Element": "<span lang=\"EN-GB\">Very Good Partial Response </span>", "ID": "1d6cd313-4c8d-4429-81af-0b331c3210a2", "Styles": "None", "Classes": "None", "Text": "Very Good Partial Response ", "ParentId": "f817b426-cf3b-42bb-b915-9e25f7cdacfc"}, {"Element": "<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">131 (36.4)</span></p>\n</td>", "ID": "ba719800-203d-4bc8-8bac-d3a5d5aeffa8", "Styles": "width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3bfa00de-8119-4883-8ccb-03baf5746ee6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">131 (36.4)</span></p>", "ID": "b5cdb3a3-6c6d-4359-83ca-cb9cc0b00448", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ba719800-203d-4bc8-8bac-d3a5d5aeffa8"}, {"Element": "<span lang=\"EN-GB\">131 (36.4)</span>", "ID": "8fab3373-30cf-48d8-bbbb-41e5b3981bd9", "Styles": "None", "Classes": "None", "Text": "131 (36.4)", "ParentId": "b5cdb3a3-6c6d-4359-83ca-cb9cc0b00448"}, {"Element": "<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">117 (32.3)</span></p>\n</td>", "ID": "5cf52c81-6206-42eb-95dd-b02454393e32", "Styles": "width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "3bfa00de-8119-4883-8ccb-03baf5746ee6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">117 (32.3)</span></p>", "ID": "19eb55a2-be47-4737-8f34-7925062369e2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5cf52c81-6206-42eb-95dd-b02454393e32"}, {"Element": "<span lang=\"EN-GB\">117 (32.3)</span>", "ID": "b64a28a7-4203-4349-82c8-14b5317ca063", "Styles": "None", "Classes": "None", "Text": "117 (32.3)", "ParentId": "19eb55a2-be47-4737-8f34-7925062369e2"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Partial Response </span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">109 (30.3)</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">118 (32.6)</span></p>\n</td>\n</tr>", "ID": "f51e6193-d570-45fe-993a-b97d59a1b833", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Partial Response </span></p>\n</td>", "ID": "e4708f3d-8fce-4fe9-b8cc-7a1da3b14440", "Styles": "width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f51e6193-d570-45fe-993a-b97d59a1b833"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Partial Response </span></p>", "ID": "2754ab56-35e2-4421-ace9-e7df5bb90afd", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e4708f3d-8fce-4fe9-b8cc-7a1da3b14440"}, {"Element": "<span lang=\"EN-GB\">Partial Response </span>", "ID": "b39f4fa6-2909-4f80-976b-5a1f5663c7e4", "Styles": "None", "Classes": "None", "Text": "Partial Response ", "ParentId": "2754ab56-35e2-4421-ace9-e7df5bb90afd"}, {"Element": "<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">109 (30.3)</span></p>\n</td>", "ID": "137fcaa3-845d-4a19-bc7b-fc5238c3528a", "Styles": "width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f51e6193-d570-45fe-993a-b97d59a1b833"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">109 (30.3)</span></p>", "ID": "436779d8-3658-46a5-82b9-9796c0f9fb7c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "137fcaa3-845d-4a19-bc7b-fc5238c3528a"}, {"Element": "<span lang=\"EN-GB\">109 (30.3)</span>", "ID": "7bc26760-996e-40fa-bef4-b1c3f608b175", "Styles": "None", "Classes": "None", "Text": "109 (30.3)", "ParentId": "436779d8-3658-46a5-82b9-9796c0f9fb7c"}, {"Element": "<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">118 (32.6)</span></p>\n</td>", "ID": "d4b6a8c3-2b78-45fd-a8f2-08ad8aefa327", "Styles": "width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "f51e6193-d570-45fe-993a-b97d59a1b833"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">118 (32.6)</span></p>", "ID": "07c6da69-7225-4eca-929a-d54cc4b72125", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d4b6a8c3-2b78-45fd-a8f2-08ad8aefa327"}, {"Element": "<span lang=\"EN-GB\">118 (32.6)</span>", "ID": "4613f930-79fe-40e7-b614-11f31420ea0f", "Styles": "None", "Classes": "None", "Text": "118 (32.6)", "ParentId": "07c6da69-7225-4eca-929a-d54cc4b72125"}, {"Element": "<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Time to Response, months</span></b></p>\n</td>\n</tr>", "ID": "17ce34a7-006d-46da-9343-a8c6496a894e", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Time to Response, months</span></b></p>\n</td>", "ID": "2a1183ce-d384-4158-84e3-bf5187765df4", "Styles": "width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "17ce34a7-006d-46da-9343-a8c6496a894e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Time to Response, months</span></b></p>", "ID": "2ea065a4-c60b-4123-ac03-f31af76e1829", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2a1183ce-d384-4158-84e3-bf5187765df4"}, {"Element": "<b><span lang=\"EN-GB\">Time to Response, months</span></b>", "ID": "9a3ab3f7-5808-48db-b4ba-844bc5be7e00", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2ea065a4-c60b-4123-ac03-f31af76e1829"}, {"Element": "<span lang=\"EN-GB\">Time to Response, months</span>", "ID": "8a0f15df-8bd4-4209-916a-caa40d869642", "Styles": "None", "Classes": "None", "Text": "Time to Response, months", "ParentId": "9a3ab3f7-5808-48db-b4ba-844bc5be7e00"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Median</span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">1.1</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">1.9</span></p>\n</td>\n</tr>", "ID": "ce57a26c-52a0-471a-aafd-6cac307da1bc", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Median</span></p>\n</td>", "ID": "b6a55640-85c2-4ad0-ae83-68f1f5beaa0e", "Styles": "width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ce57a26c-52a0-471a-aafd-6cac307da1bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Median</span></p>", "ID": "c63aad79-9937-4054-80bc-154cc14ce06d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b6a55640-85c2-4ad0-ae83-68f1f5beaa0e"}, {"Element": "<span lang=\"EN-GB\">Median</span>", "ID": "fe446b70-5f46-498e-9d44-7990b767f5b8", "Styles": "None", "Classes": "None", "Text": "Median", "ParentId": "c63aad79-9937-4054-80bc-154cc14ce06d"}, {"Element": "<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">1.1</span></p>\n</td>", "ID": "61d95417-92d0-4deb-9ff0-9b20950a83fc", "Styles": "width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ce57a26c-52a0-471a-aafd-6cac307da1bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">1.1</span></p>", "ID": "35db495d-fd92-43e7-977f-acc250a81c03", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "61d95417-92d0-4deb-9ff0-9b20950a83fc"}, {"Element": "<span lang=\"EN-GB\">1.1</span>", "ID": "fc787a3c-dccd-4efe-8959-e7115e861e65", "Styles": "None", "Classes": "None", "Text": "1.1", "ParentId": "35db495d-fd92-43e7-977f-acc250a81c03"}, {"Element": "<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">1.9</span></p>\n</td>", "ID": "9a1a9fea-d0dc-4ee3-a444-ed5d91814672", "Styles": "width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "ce57a26c-52a0-471a-aafd-6cac307da1bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">1.9</span></p>", "ID": "470cf1e9-5b95-4cf2-8ce0-f26e1ec5bf8b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9a1a9fea-d0dc-4ee3-a444-ed5d91814672"}, {"Element": "<span lang=\"EN-GB\">1.9</span>", "ID": "203bd38a-4fe3-44f9-bd45-f0876ea6bb5d", "Styles": "None", "Classes": "None", "Text": "1.9", "ParentId": "470cf1e9-5b95-4cf2-8ce0-f26e1ec5bf8b"}, {"Element": "<tr>\n<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Duration of Response</span></b><sup><span lang=\"EN-GB\">\u00a7</span></sup><b><span lang=\"EN-GB\">, months</span></b></p>\n</td>\n</tr>", "ID": "942690ec-c0a0-446e-aeae-188be464b3e9", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td colspan=\"5\" style=\"width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"620\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Duration of Response</span></b><sup><span lang=\"EN-GB\">\u00a7</span></sup><b><span lang=\"EN-GB\">, months</span></b></p>\n</td>", "ID": "5cfe9e67-9854-443b-939b-42723c549163", "Styles": "width:465.05pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "942690ec-c0a0-446e-aeae-188be464b3e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Duration of Response</span></b><sup><span lang=\"EN-GB\">\u00a7</span></sup><b><span lang=\"EN-GB\">, months</span></b></p>", "ID": "795c3802-b3d0-4424-92e2-da9b50bc357d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5cfe9e67-9854-443b-939b-42723c549163"}, {"Element": "<b><span lang=\"EN-GB\">Duration of Response</span></b>", "ID": "21720b56-4449-47e4-94e4-3584dedcb7fc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "795c3802-b3d0-4424-92e2-da9b50bc357d"}, {"Element": "<span lang=\"EN-GB\">Duration of Response</span>", "ID": "49328b13-f747-4b64-a01a-025f04d6b9f6", "Styles": "None", "Classes": "None", "Text": "Duration of Response", "ParentId": "21720b56-4449-47e4-94e4-3584dedcb7fc"}, {"Element": "<sup><span lang=\"EN-GB\">\u00a7</span></sup>", "ID": "5250e9fc-66fb-4c60-9d98-6649670ddd8f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "795c3802-b3d0-4424-92e2-da9b50bc357d"}, {"Element": "<span lang=\"EN-GB\">\u00a7</span>", "ID": "31f16068-1ee1-4483-a691-4f1c72197389", "Styles": "None", "Classes": "None", "Text": "\u00a7", "ParentId": "5250e9fc-66fb-4c60-9d98-6649670ddd8f"}, {"Element": "<b><span lang=\"EN-GB\">, months</span></b>", "ID": "39930798-b633-419b-8192-b81448720430", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "795c3802-b3d0-4424-92e2-da9b50bc357d"}, {"Element": "<span lang=\"EN-GB\">, months</span>", "ID": "75d696bc-b83b-4353-94a8-eed02fbc51c8", "Styles": "None", "Classes": "None", "Text": ", months", "ParentId": "39930798-b633-419b-8192-b81448720430"}, {"Element": "<tr>\n<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Median</span></p>\n</td>\n<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">20.5</span></p>\n</td>\n<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">15.0</span></p>\n</td>\n</tr>", "ID": "78f16e11-cd16-4982-ab55-806656774922", "Styles": "None", "Classes": "None", "Text": "    ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td colspan=\"2\" style=\"width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Median</span></p>\n</td>", "ID": "a80bf2e5-0563-49e6-bf76-f291b9606c62", "Styles": "width:155.0pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "78f16e11-cd16-4982-ab55-806656774922"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Median</span></p>", "ID": "f1fe0e75-0d23-4045-b4b0-24454bd3a52f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a80bf2e5-0563-49e6-bf76-f291b9606c62"}, {"Element": "<span lang=\"EN-GB\">Median</span>", "ID": "e7c89455-4c45-4e99-aab5-189aeee2fec0", "Styles": "None", "Classes": "None", "Text": "Median", "ParentId": "f1fe0e75-0d23-4045-b4b0-24454bd3a52f"}, {"Element": "<td style=\"width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"206\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">20.5</span></p>\n</td>", "ID": "9984a2f2-d3ea-43bc-b666-620ba8bd216d", "Styles": "width:154.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "78f16e11-cd16-4982-ab55-806656774922"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">20.5</span></p>", "ID": "c4a69bf6-244b-4885-8a26-a17cdd5b9ee5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9984a2f2-d3ea-43bc-b666-620ba8bd216d"}, {"Element": "<span lang=\"EN-GB\">20.5</span>", "ID": "e9dc5e41-b23c-4153-8934-fd390788aa62", "Styles": "None", "Classes": "None", "Text": "20.5", "ParentId": "c4a69bf6-244b-4885-8a26-a17cdd5b9ee5"}, {"Element": "<td colspan=\"2\" style=\"width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"207\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">15.0</span></p>\n</td>", "ID": "819850a4-7bc5-49f7-a171-b1983d80e944", "Styles": "width:155.6pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "78f16e11-cd16-4982-ab55-806656774922"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">15.0</span></p>", "ID": "0ede4393-c188-4023-a5d9-ebd4787a8ba2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "819850a4-7bc5-49f7-a171-b1983d80e944"}, {"Element": "<span lang=\"EN-GB\">15.0</span>", "ID": "d471fc44-64a0-437b-8e0a-d7243cd7978f", "Styles": "None", "Classes": "None", "Text": "15.0", "ParentId": "0ede4393-c188-4023-a5d9-ebd4787a8ba2"}, {"Element": "<tr height=\"0\">\n<td style=\"border:none\" width=\"206\"></td>\n<td style=\"border:none\" width=\"0\"></td>\n<td style=\"border:none\" width=\"206\"></td>\n<td style=\"border:none\" width=\"1\"></td>\n<td style=\"border:none\" width=\"207\"></td>\n</tr>", "ID": "d84e812a-8c3a-4e84-9273-47a00d8094a9", "Styles": "None", "Classes": "None", "Text": "      ", "ParentId": "6adf16e0-6589-451a-aeb7-c98976ee7bff"}, {"Element": "<td style=\"border:none\" width=\"206\"></td>", "ID": "c9b92b96-cfdd-4289-aa7c-f34c541e53f4", "Styles": "border:none", "Classes": "None", "Text": "", "ParentId": "d84e812a-8c3a-4e84-9273-47a00d8094a9"}, {"Element": "<td style=\"border:none\" width=\"0\"></td>", "ID": "12f40e9e-6c23-4638-ba4b-8d1ae61869ca", "Styles": "border:none", "Classes": "None", "Text": "", "ParentId": "d84e812a-8c3a-4e84-9273-47a00d8094a9"}, {"Element": "<td style=\"border:none\" width=\"206\"></td>", "ID": "d6564e68-ffb2-4425-8807-7e01751a6b07", "Styles": "border:none", "Classes": "None", "Text": "", "ParentId": "d84e812a-8c3a-4e84-9273-47a00d8094a9"}, {"Element": "<td style=\"border:none\" width=\"1\"></td>", "ID": "323326ec-9cdb-4af9-bf44-fe5a043a88a0", "Styles": "border:none", "Classes": "None", "Text": "", "ParentId": "d84e812a-8c3a-4e84-9273-47a00d8094a9"}, {"Element": "<td style=\"border:none\" width=\"207\"></td>", "ID": "1fdbfda2-f25d-44dd-93d2-dc3e27af4f8f", "Styles": "border:none", "Classes": "None", "Text": "", "ParentId": "d84e812a-8c3a-4e84-9273-47a00d8094a9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:4.3pt;line-height:normal;text-autospace:\nnone\"><span lang=\"EN-GB\" style=\"font-size:10.0pt\">*P\u2011value is based on the\nstratified log\u2011rank test.</span></p>", "ID": "657b330d-463c-4c6c-b256-532679b1cd52", "Styles": "margin-left:4.3pt;line-height:normal;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">*P\u2011value is based on the\nstratified log\u2011rank test.</span>", "ID": "1963d090-7168-4cb6-a895-0e2dac301fe9", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "*P\u2011value is based on the stratified log\u2011rank test.", "ParentId": "657b330d-463c-4c6c-b256-532679b1cd52"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:13.65pt;text-indent:-9.35pt;line-height:\nnormal;text-autospace:none\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span></sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Hazard ratio is based on a stratified\nCox\u2019s proportional hazard regression model. A hazard ratio less than 1\nindicates an advantage for the ixazomib regimen.</span></p>", "ID": "d5e7a835-8363-4ef9-adcb-5d8c27ba9b0d", "Styles": "margin-left:13.65pt;text-indent:-9.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span></sup>", "ID": "466ebc3e-e3c6-437f-a808-808ff7b08193", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d5e7a835-8363-4ef9-adcb-5d8c27ba9b0d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2020</span>", "ID": "7bcab934-0adf-40f4-86f6-5e91a28195a7", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2020", "ParentId": "466ebc3e-e3c6-437f-a808-808ff7b08193"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Hazard ratio is based on a stratified\nCox\u2019s proportional hazard regression model. A hazard ratio less than 1\nindicates an advantage for the ixazomib regimen.</span>", "ID": "2150bea3-90a7-4d65-9e00-5f19171914fe", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Hazard ratio is based on a stratified Cox\u2019s proportional hazard regression model. A hazard ratio less than 1 indicates an advantage for the ixazomib regimen.", "ParentId": "d5e7a835-8363-4ef9-adcb-5d8c27ba9b0d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:13.65pt;text-indent:-9.35pt;line-height:\nnormal;text-autospace:none\"><a name=\"footnote-14\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2021</span></sup></a><span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORR=CR+VGPR+PR</span></p>", "ID": "4df45ddf-0cac-41bc-9f0c-c01fcbb14d82", "Styles": "margin-left:13.65pt;text-indent:-9.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<a name=\"footnote-14\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2021</span></sup></a>", "ID": "e1a7e536-16dd-4a8a-9f1b-7617358478c5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4df45ddf-0cac-41bc-9f0c-c01fcbb14d82"}, {"Element": "<sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2021</span></sup>", "ID": "8caeaf87-3092-4490-80b6-e586bb153bff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e1a7e536-16dd-4a8a-9f1b-7617358478c5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u2021</span>", "ID": "fcc11956-018c-4bbd-bc99-7ea56ea3f365", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u2021", "ParentId": "8caeaf87-3092-4490-80b6-e586bb153bff"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">ORR=CR+VGPR+PR</span>", "ID": "e0b26d55-a379-4e3a-97a6-1d5995307cc3", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "ORR=CR+VGPR+PR", "ParentId": "4df45ddf-0cac-41bc-9f0c-c01fcbb14d82"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:13.65pt;text-indent:-9.35pt;line-height:\nnormal;text-autospace:none\"><a name=\"footnote-15\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a7</span></sup></a><span lang=\"EN-GB\" style=\"font-size:10.0pt\">Based on responders in the response\u2011evaluable\npopulation</span></p>", "ID": "8b1593e1-c01b-4468-9f86-23aacd5c3148", "Styles": "margin-left:13.65pt;text-indent:-9.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<a name=\"footnote-15\"><sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a7</span></sup></a>", "ID": "b45a8841-2ebf-4219-a7af-1d96aa6c0612", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8b1593e1-c01b-4468-9f86-23aacd5c3148"}, {"Element": "<sup><span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a7</span></sup>", "ID": "c5e62941-acc2-4b2c-aed7-dd8a5b287ced", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b45a8841-2ebf-4219-a7af-1d96aa6c0612"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">\u00a7</span>", "ID": "1983e934-769c-4d8b-9dfa-b8994e776d60", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "\u00a7", "ParentId": "c5e62941-acc2-4b2c-aed7-dd8a5b287ced"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:10.0pt\">Based on responders in the response\u2011evaluable\npopulation</span>", "ID": "3fabac2e-8bcb-4bc2-9ca8-05e81cb5fd74", "Styles": "font-size:10.0pt", "Classes": "None", "Text": "Based on responders in the response\u2011evaluable population", "ParentId": "8b1593e1-c01b-4468-9f86-23aacd5c3148"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c212e1b4-d909-4d2a-aa43-99923ddca225", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1a20bc34-0f7f-452b-a4c6-25d4a8c0ca3d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c212e1b4-d909-4d2a-aa43-99923ddca225"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Figure 1: Kaplan\u2011Meier plot of progression\u2011free\nsurvival in the intent\u2011to-treat population</span></b></p>", "ID": "2428391d-ad43-4c68-b7d9-a3a58df1f953", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Figure 1: Kaplan\u2011Meier plot of progression\u2011free\nsurvival in the intent\u2011to-treat population</span></b>", "ID": "e7dd3f91-0039-4291-9928-cffff85d978d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2428391d-ad43-4c68-b7d9-a3a58df1f953"}, {"Element": "<span lang=\"EN-GB\">Figure 1: Kaplan\u2011Meier plot of progression\u2011free\nsurvival in the intent\u2011to-treat population</span>", "ID": "cfe60f52-a14b-46b4-b291-56f464da6389", "Styles": "None", "Classes": "None", "Text": "Figure 1: Kaplan\u2011Meier plot of progression\u2011free survival in the intent\u2011to-treat population", "ParentId": "e7dd3f91-0039-4291-9928-cffff85d978d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"><img height=\"321\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image002.gif\" width=\"605\"/></span></p>", "ID": "2c201a24-442c-4283-a46a-9fcbe307e083", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\"><img height=\"321\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image002.gif\" width=\"605\"/></span>", "ID": "d560c87d-47af-4f85-8a90-0f6dfa1274d4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2c201a24-442c-4283-a46a-9fcbe307e083"}, {"Element": "<img height=\"321\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image002.gif\" width=\"605\"/>", "ID": "d97b2933-49be-47c8-ad79-dd4ae643e378", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d560c87d-47af-4f85-8a90-0f6dfa1274d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "34053031-7397-45ee-a3be-602ab94ffd8b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d6dd76dc-22e0-41ba-896a-b291c63dd15c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "34053031-7397-45ee-a3be-602ab94ffd8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">A planned\ninterim analysis for overall survival (OS) at a median follow up of 23\u00a0months\nwas conducted with 35% of the required number of deaths for final OS analysis\nin the ITT population; there were 81\u00a0deaths in the ixazomib regimen and\n90\u00a0deaths in the placebo regimen. Median overall survival was not reached\nin either regimen. At this analysis, estimated median PFS was 20\u00a0months in\nthe ixazomib regimen and 15.9\u00a0months in the placebo regimen (HR=0.82 [95%\nCI (0.67, 1.0)]) in the ITT population.</span></p>", "ID": "6fac1a06-6429-45b4-a86d-51ef0648471e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">A planned\ninterim analysis for overall survival (OS) at a median follow up of 23\u00a0months\nwas conducted with 35% of the required number of deaths for final OS analysis\nin the ITT population; there were 81\u00a0deaths in the ixazomib regimen and\n90\u00a0deaths in the placebo regimen. Median overall survival was not reached\nin either regimen. At this analysis, estimated median PFS was 20\u00a0months in\nthe ixazomib regimen and 15.9\u00a0months in the placebo regimen (HR=0.82 [95%\nCI (0.67, 1.0)]) in the ITT population.</span>", "ID": "0f26adfa-1dba-4f25-9105-d8de30d81abb", "Styles": "None", "Classes": "None", "Text": "A planned interim analysis for overall survival (OS) at a median follow up of 23\u00a0months was conducted with 35% of the required number of deaths for final OS analysis in the ITT population; there were 81\u00a0deaths in the ixazomib regimen and 90\u00a0deaths in the placebo regimen. Median overall survival was not reached in either regimen. At this analysis, estimated median PFS was 20\u00a0months in the ixazomib regimen and 15.9\u00a0months in the placebo regimen (HR=0.82 [95% CI (0.67, 1.0)]) in the ITT population.", "ParentId": "6fac1a06-6429-45b4-a86d-51ef0648471e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c3d0bf01-eea1-47e4-b5ce-28c512efe74c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2bf19440-7f70-4435-a29b-69863c431818", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c3d0bf01-eea1-47e4-b5ce-28c512efe74c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">A randomised, double\u2011blind, placebo\u2011controlled Phase 3\nstudy was conducted in China (N=115) with a similar study design and\neligibility criteria. Many of the patients enrolled in the study had advanced\ndisease with Durie\u2011Salmon Stage III (69%) at initial diagnosis and a\ntreatment history of receiving at least 2 prior therapies (60%) and being\nthalidomide refractory (63%). At the primary analysis (median follow up of 8\nmonths and a median of 6 cycles), the median PFS was 6.7 months in the ixazomib\nregimen compared to 4 months in the placebo regimen (p\u2011value=0.035,\nHR=0.60). At the final analysis for OS at a median follow up of 19.8 months, </span><span lang=\"EN-GB\">OS was improved for patients treated in the ixazomib regimen\ncompared with placebo </span><span lang=\"EN-GB\">[p\u2011value=0.0014, HR=0.42,</span><span lang=\"EN-GB\"> 95% CI: 0.242, 0.726</span><span lang=\"EN-GB\"> ]).</span></p>", "ID": "a5164620-bfe8-4c50-a29c-e40c01c68ac1", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">A randomised, double\u2011blind, placebo\u2011controlled Phase 3\nstudy was conducted in China (N=115) with a similar study design and\neligibility criteria. Many of the patients enrolled in the study had advanced\ndisease with Durie\u2011Salmon Stage III (69%) at initial diagnosis and a\ntreatment history of receiving at least 2 prior therapies (60%) and being\nthalidomide refractory (63%). At the primary analysis (median follow up of 8\nmonths and a median of 6 cycles), the median PFS was 6.7 months in the ixazomib\nregimen compared to 4 months in the placebo regimen (p\u2011value=0.035,\nHR=0.60). At the final analysis for OS at a median follow up of 19.8 months, </span>", "ID": "e309817a-e7a3-44da-b577-e9001aff973d", "Styles": "None", "Classes": "None", "Text": "A randomised, double\u2011blind, placebo\u2011controlled Phase 3 study was conducted in China (N=115) with a similar study design and eligibility criteria. Many of the patients enrolled in the study had advanced disease with Durie\u2011Salmon Stage III (69%) at initial diagnosis and a treatment history of receiving at least 2 prior therapies (60%) and being thalidomide refractory (63%). At the primary analysis (median follow up of 8 months and a median of 6 cycles), the median PFS was 6.7 months in the ixazomib regimen compared to 4 months in the placebo regimen (p\u2011value=0.035, HR=0.60). At the final analysis for OS at a median follow up of 19.8 months, ", "ParentId": "a5164620-bfe8-4c50-a29c-e40c01c68ac1"}, {"Element": "<span lang=\"EN-GB\">OS was improved for patients treated in the ixazomib regimen\ncompared with placebo </span>", "ID": "dc1173cf-ac3d-43ae-8f3f-11891581a51a", "Styles": "None", "Classes": "None", "Text": "OS was improved for patients treated in the ixazomib regimen compared with placebo ", "ParentId": "a5164620-bfe8-4c50-a29c-e40c01c68ac1"}, {"Element": "<span lang=\"EN-GB\">[p\u2011value=0.0014, HR=0.42,</span>", "ID": "0d48d0d2-df6d-41f7-bd97-d55259d96406", "Styles": "None", "Classes": "None", "Text": "[p\u2011value=0.0014, HR=0.42,", "ParentId": "a5164620-bfe8-4c50-a29c-e40c01c68ac1"}, {"Element": "<span lang=\"EN-GB\"> 95% CI: 0.242, 0.726</span>", "ID": "9cf10e3b-1890-4208-a3a2-149fd8b32bc0", "Styles": "None", "Classes": "None", "Text": " 95% CI: 0.242, 0.726", "ParentId": "a5164620-bfe8-4c50-a29c-e40c01c68ac1"}, {"Element": "<span lang=\"EN-GB\"> ]).</span>", "ID": "0a9d86d7-f24c-42bb-a8f0-138389c384cf", "Styles": "None", "Classes": "None", "Text": " ]).", "ParentId": "a5164620-bfe8-4c50-a29c-e40c01c68ac1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b1dc7a50-ff98-442c-9adc-a22e42c332fb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "65508530-ac27-4207-90f0-78ee82e752c6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b1dc7a50-ff98-442c-9adc-a22e42c332fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">As multiple myeloma is a heterogeneous disease, benefit\nmay vary across subgroups in the Phase 3 study (C16010) (see Figure 2). </span></p>", "ID": "6feced76-8efb-4ebc-9949-dd3fc6023cb2", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">As multiple myeloma is a heterogeneous disease, benefit\nmay vary across subgroups in the Phase 3 study (C16010) (see Figure 2). </span>", "ID": "ae591964-b9af-415f-8005-711f884da226", "Styles": "None", "Classes": "None", "Text": "As multiple myeloma is a heterogeneous disease, benefit may vary across subgroups in the Phase 3 study (C16010) (see Figure 2). ", "ParentId": "6feced76-8efb-4ebc-9949-dd3fc6023cb2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d0ae2a93-202a-4dec-b4a7-5a94c37a30e9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "031356df-a921-4436-a60e-7536f31c063e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d0ae2a93-202a-4dec-b4a7-5a94c37a30e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Figure 2: Forest plot of progression\u2011free\nsurvival in subgroups</span></b></p>", "ID": "619cb5ec-60ce-4dd6-8b95-afda682a7f9d", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Figure 2: Forest plot of progression\u2011free\nsurvival in subgroups</span></b>", "ID": "fa6e5036-c67e-4755-935f-025cf2ce8be3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "619cb5ec-60ce-4dd6-8b95-afda682a7f9d"}, {"Element": "<span lang=\"EN-GB\">Figure 2: Forest plot of progression\u2011free\nsurvival in subgroups</span>", "ID": "4375510f-95e8-4d57-96b4-01a104e92444", "Styles": "None", "Classes": "None", "Text": "Figure 2: Forest plot of progression\u2011free survival in subgroups", "ParentId": "fa6e5036-c67e-4755-935f-025cf2ce8be3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\"><img border=\"0\" height=\"522\" id=\"Picture 3\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image003.gif\" width=\"605\"/></span></p>", "ID": "27a2506e-d169-483e-a970-85828b78960a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\"><img border=\"0\" height=\"522\" id=\"Picture 3\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image003.gif\" width=\"605\"/></span>", "ID": "f4e8faa3-4f20-45db-a6a7-554257dec730", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "27a2506e-d169-483e-a970-85828b78960a"}, {"Element": "<img border=\"0\" height=\"522\" id=\"Picture 3\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image003.gif\" width=\"605\"/>", "ID": "ec631709-6306-4fee-bf2d-54a9b24d476d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f4e8faa3-4f20-45db-a6a7-554257dec730"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "635edd27-c99d-4af3-a8fc-97cff4860b4a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b8b2ce54-f4e5-4cc8-877b-059197eaa29d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "635edd27-c99d-4af3-a8fc-97cff4860b4a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">In the Phase 3 study </span><span lang=\"EN-GB\">(C16010), 10\u00a0patients\n(5 in each treatment regimen) had severe renal impairment at baseline. Of the\n5\u00a0patients in the ixazomib regimen, one patient had a confirmed partial\nresponse and 3 confirmed stable disease (however 2 were unconfirmed partial\nresponse and 1 was an unconfirmed very good partial response). Of the\n5\u00a0patients in the placebo regimen, 2 had a confirmed very good partial\nresponse.</span></p>", "ID": "67e4bbec-0338-46e3-952c-40270a5d12fa", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">In the Phase 3 study </span>", "ID": "6ee88329-6cb7-43d7-afa9-f13bc901e2eb", "Styles": "None", "Classes": "None", "Text": "In the Phase 3 study ", "ParentId": "67e4bbec-0338-46e3-952c-40270a5d12fa"}, {"Element": "<span lang=\"EN-GB\">(C16010), 10\u00a0patients\n(5 in each treatment regimen) had severe renal impairment at baseline. Of the\n5\u00a0patients in the ixazomib regimen, one patient had a confirmed partial\nresponse and 3 confirmed stable disease (however 2 were unconfirmed partial\nresponse and 1 was an unconfirmed very good partial response). Of the\n5\u00a0patients in the placebo regimen, 2 had a confirmed very good partial\nresponse.</span>", "ID": "607b0596-bfbe-43a4-855e-c3fe9adc8b79", "Styles": "None", "Classes": "None", "Text": "(C16010), 10\u00a0patients (5 in each treatment regimen) had severe renal impairment at baseline. Of the 5\u00a0patients in the ixazomib regimen, one patient had a confirmed partial response and 3 confirmed stable disease (however 2 were unconfirmed partial response and 1 was an unconfirmed very good partial response). Of the 5\u00a0patients in the placebo regimen, 2 had a confirmed very good partial response.", "ParentId": "67e4bbec-0338-46e3-952c-40270a5d12fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>", "ID": "0c7a424e-03d7-4460-8b07-ce8a831406c5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i>", "ID": "f71fb1b4-2214-41e9-a62d-e3f401415491", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0c7a424e-03d7-4460-8b07-ce8a831406c5"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "ffad2426-3496-486c-82fb-7e4324d05ef8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f71fb1b4-2214-41e9-a62d-e3f401415491"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "f24e0b9d-d3ea-4a9b-955f-17d72967283a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ffad2426-3496-486c-82fb-7e4324d05ef8"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "25fe543a-7fe7-47b1-aa03-0be532043974", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "f24e0b9d-d3ea-4a9b-955f-17d72967283a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Quality of life as\nassessed by global health scores (EORTC QLQ\u2011C30 and MY\u201120) was\nmaintained during treatment and was similar in both treatment regimens in the\nPhase 3 study (C16010).</span></p>", "ID": "74248312-7ec6-4f93-bbe6-2d1b7c993e02", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Quality of life as\nassessed by global health scores (EORTC QLQ\u2011C30 and MY\u201120) was\nmaintained during treatment and was similar in both treatment regimens in the\nPhase 3 study (C16010).</span>", "ID": "17baa34e-b5c2-4824-a941-e4d8e0bdddcc", "Styles": "None", "Classes": "None", "Text": "Quality of life as assessed by global health scores (EORTC QLQ\u2011C30 and MY\u201120) was maintained during treatment and was similar in both treatment regimens in the Phase 3 study (C16010).", "ParentId": "74248312-7ec6-4f93-bbe6-2d1b7c993e02"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9cec296b-4303-4776-8edb-6f228e22eeff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6124fc34-7751-4cfb-973f-50edbac9c1c3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9cec296b-4303-4776-8edb-6f228e22eeff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Paediatric population</span></u></p>", "ID": "efab983a-651a-4ae8-b19b-5fd340975aab", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Paediatric population</span></u>", "ID": "9b088395-7ac2-488f-8425-02d28b49dab9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "efab983a-651a-4ae8-b19b-5fd340975aab"}, {"Element": "<span lang=\"EN-GB\">Paediatric population</span>", "ID": "c07374c7-3baf-4d8e-a810-21c35c03a739", "Styles": "None", "Classes": "None", "Text": "Paediatric population", "ParentId": "9b088395-7ac2-488f-8425-02d28b49dab9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b391f248-ffaf-4908-a6ee-54e6349fa4ae", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "535601e1-4e80-4a87-856a-d05577c5e440", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b391f248-ffaf-4908-a6ee-54e6349fa4ae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The European\nMedicines Agency has waived the obligation to submit the results of studies\nwith ixazomib in all subsets of the paediatric population in multiple myeloma\n(see section\u00a04.2 for information on paediatric use).</span></p>", "ID": "675a6574-3cc7-429f-9ae4-e58989ccf393", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The European\nMedicines Agency has waived the obligation to submit the results of studies\nwith ixazomib in all subsets of the paediatric population in multiple myeloma\n(see section\u00a04.2 for information on paediatric use).</span>", "ID": "8b553bde-2449-4891-afab-66654067039b", "Styles": "None", "Classes": "None", "Text": "The European Medicines Agency has waived the obligation to submit the results of studies with ixazomib in all subsets of the paediatric population in multiple myeloma (see section\u00a04.2 for information on paediatric use).", "ParentId": "675a6574-3cc7-429f-9ae4-e58989ccf393"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a2fe22c2-c7d8-4b1f-a0c0-9d6a4be630df", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "265aa81b-6198-45ea-bd46-512507a035d9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a2fe22c2-c7d8-4b1f-a0c0-9d6a4be630df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties</span></b></p>", "ID": "27c7b5a2-1c54-465a-885b-b16b24ec6d3d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties</span></b>", "ID": "ba71fcfc-fa8f-4ac0-adb1-7e0c47457d08", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "27c7b5a2-1c54-465a-885b-b16b24ec6d3d"}, {"Element": "<span lang=\"EN-GB\">5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties</span>", "ID": "76b935d4-0cef-4bbb-b284-3cddeb42fe6d", "Styles": "None", "Classes": "None", "Text": "5.2\u00a0\u00a0\u00a0\u00a0 Pharmacokinetic properties", "ParentId": "ba71fcfc-fa8f-4ac0-adb1-7e0c47457d08"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "c05338c3-5362-43cc-b2e6-4ba21e0afa73", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "00414d06-5553-49a4-952c-4fbd4746eaa6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c05338c3-5362-43cc-b2e6-4ba21e0afa73"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "33b184a7-f1c1-41fb-bf70-856344957a72", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "00414d06-5553-49a4-952c-4fbd4746eaa6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Absorption</span></u></p>", "ID": "20d00620-344c-423c-b5b3-4a599cbc30bd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Absorption</span></u>", "ID": "31867e59-b336-45cf-bafd-72ccdd18aef0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "20d00620-344c-423c-b5b3-4a599cbc30bd"}, {"Element": "<span lang=\"EN-GB\">Absorption</span>", "ID": "957f3d60-a9c6-4a12-82df-8ec5dcdb1dfe", "Styles": "None", "Classes": "None", "Text": "Absorption", "ParentId": "31867e59-b336-45cf-bafd-72ccdd18aef0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "a856f534-6c17-4ab7-9edb-6e2695651cca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "af4827ee-bc07-4eb3-a0d6-e2c16ddce3e2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a856f534-6c17-4ab7-9edb-6e2695651cca"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "a6b2f4d1-1c99-4ffd-bc9f-9079bd796845", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "af4827ee-bc07-4eb3-a0d6-e2c16ddce3e2"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "c23c313c-fdc6-40c7-b8a5-4630306c89c5", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "a6b2f4d1-1c99-4ffd-bc9f-9079bd796845"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">After oral\nadministration, peak plasma concentrations of ixazomib were achieved at\napproximately one hour after dosing. The mean absolute oral bioavailability is\n58%. Ixazomib AUC increases in a dose proportional manner over a dose range of\n0.2\u201110.6\u00a0mg.<i> </i></span></p>", "ID": "c158faf5-c76a-4958-b969-1e2a85e081f7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">After oral\nadministration, peak plasma concentrations of ixazomib were achieved at\napproximately one hour after dosing. The mean absolute oral bioavailability is\n58%. Ixazomib AUC increases in a dose proportional manner over a dose range of\n0.2\u201110.6\u00a0mg.<i> </i></span>", "ID": "29b8510e-34e4-4f62-9aed-cd319174768b", "Styles": "None", "Classes": "None", "Text": "After oral administration, peak plasma concentrations of ixazomib were achieved at approximately one hour after dosing. The mean absolute oral bioavailability is 58%. Ixazomib AUC increases in a dose proportional manner over a dose range of 0.2\u201110.6\u00a0mg.", "ParentId": "c158faf5-c76a-4958-b969-1e2a85e081f7"}, {"Element": "<i> </i>", "ID": "1dc39911-0d18-40e3-91ff-3ac0074b4f3e", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "29b8510e-34e4-4f62-9aed-cd319174768b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "9456f486-8597-4883-940d-b3b67182ee4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "a37814ec-7406-4756-adc7-52a503d30cbb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9456f486-8597-4883-940d-b3b67182ee4e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3f7d0591-41e3-4352-b4a5-1adf0f392e84", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a37814ec-7406-4756-adc7-52a503d30cbb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Administration\nwith a high\u2011fat meal decreased ixazomib AUC by 28% compared with\nadministration after an overnight fast (see section\u00a04.2). </span></p>", "ID": "63c8cc5f-6d99-4835-8377-e4a3ac868c47", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Administration\nwith a high\u2011fat meal decreased ixazomib AUC by 28% compared with\nadministration after an overnight fast (see section\u00a04.2). </span>", "ID": "a072d249-2a56-4843-949b-e9ee6f56e41d", "Styles": "None", "Classes": "None", "Text": "Administration with a high\u2011fat meal decreased ixazomib AUC by 28% compared with administration after an overnight fast (see section\u00a04.2). ", "ParentId": "63c8cc5f-6d99-4835-8377-e4a3ac868c47"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7393be11-82e2-4555-a90f-feda76ad7d71", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0993c938-1044-4bc1-9c34-b9ee17b689f7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7393be11-82e2-4555-a90f-feda76ad7d71"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Distribution</span></u></p>", "ID": "6dd8178f-be74-40b8-b48b-f27eae422463", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Distribution</span></u>", "ID": "4879eb2d-144d-4dd6-a1a3-32906f3cc11a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6dd8178f-be74-40b8-b48b-f27eae422463"}, {"Element": "<span lang=\"EN-GB\">Distribution</span>", "ID": "667f5e3b-2851-4ba8-8321-63104a532b8a", "Styles": "None", "Classes": "None", "Text": "Distribution", "ParentId": "4879eb2d-144d-4dd6-a1a3-32906f3cc11a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "4c0facdd-7c8c-45ae-a34c-2ec3aef2445b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "14d9b926-a71c-48d7-a02d-b7bfcaa0ff32", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4c0facdd-7c8c-45ae-a34c-2ec3aef2445b"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "c2d49ca6-9bb5-40c3-8908-83fb815909f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "14d9b926-a71c-48d7-a02d-b7bfcaa0ff32"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "200d7779-7ff3-4d2b-8433-7faa169e1b41", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "c2d49ca6-9bb5-40c3-8908-83fb815909f8"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">Ixazomib is 99% bound to plasma proteins and\ndistributes into red blood cells with a blood\u2011to\u2011plasma AUC ratio of\u00a010.\nThe steady\u2011state volume of distribution is 543\u00a0L. </span></p>", "ID": "537c15e9-f121-4a03-ab68-2b6b8677f6fc", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">Ixazomib is 99% bound to plasma proteins and\ndistributes into red blood cells with a blood\u2011to\u2011plasma AUC ratio of\u00a010.\nThe steady\u2011state volume of distribution is 543\u00a0L. </span>", "ID": "24fe4b4a-3f5f-45ba-b791-99c9ef2bca8d", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "Ixazomib is 99% bound to plasma proteins and distributes into red blood cells with a blood\u2011to\u2011plasma AUC ratio of\u00a010. The steady\u2011state volume of distribution is 543\u00a0L. ", "ParentId": "537c15e9-f121-4a03-ab68-2b6b8677f6fc"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>", "ID": "0781c35f-782c-44bb-b54d-0c0d6204d797", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span>", "ID": "dfb0337e-a675-4597-bcd0-f1e98bc03a5e", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "0781c35f-782c-44bb-b54d-0c0d6204d797"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Biotransformation</span></u></p>", "ID": "aa629616-f246-46fc-814c-6dd4b32ac487", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Biotransformation</span></u>", "ID": "b86504e3-d7f6-416a-8ba8-424a72ab5576", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa629616-f246-46fc-814c-6dd4b32ac487"}, {"Element": "<span lang=\"EN-GB\">Biotransformation</span>", "ID": "fdc01af9-d34f-4954-b126-256215aad988", "Styles": "None", "Classes": "None", "Text": "Biotransformation", "ParentId": "b86504e3-d7f6-416a-8ba8-424a72ab5576"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "ff8e9375-724c-4b4d-b75e-9d61b938f270", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "2be6fb43-1570-47af-adad-91227e22a61c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ff8e9375-724c-4b4d-b75e-9d61b938f270"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "e0d946d7-e102-4a5f-9d30-e774558f1a42", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2be6fb43-1570-47af-adad-91227e22a61c"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "a28b9b07-f9b5-40e5-b444-29cd2bfa1287", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "e0d946d7-e102-4a5f-9d30-e774558f1a42"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">After oral administration of a radiolabeled dose,\n70% of total drug\u2011related material in plasma was accounted for by\nixazomib. Metabolism by multiple CYP enzymes and non\u2011CYP proteins is\nexpected to be the major clearance mechanism for ixazomib. At clinically\nrelevant ixazomib concentrations, <i>in\u00a0vitro</i> studies using human cDNA\u2011expressed\ncytochrome P450\u00a0isozymes</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">indicate that no\nspecific CYP\u00a0isozyme predominantly contributes to ixazomib metabolism and\nnon\u2011CYP proteins contribute to overall metabolism. At concentrations\nexceeding those observed clinically, ixazomib was metabolized by multiple CYP\nisoforms with estimated relative contributions of 3A4 (42.3%), 1A2 (26.1%),\n2B6\u00a0(16.0%), 2C8 (6.0%), 2D6 (4.8%), 2C19 (4.8%) and 2C9 (&lt;\u00a01%).</span></p>", "ID": "6c271c26-fa21-48b2-b923-d672dabd283c", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">After oral administration of a radiolabeled dose,\n70% of total drug\u2011related material in plasma was accounted for by\nixazomib. Metabolism by multiple CYP enzymes and non\u2011CYP proteins is\nexpected to be the major clearance mechanism for ixazomib. At clinically\nrelevant ixazomib concentrations, <i>in\u00a0vitro</i> studies using human cDNA\u2011expressed\ncytochrome P450\u00a0isozymes</span>", "ID": "66ab9bdb-b387-4205-8db5-2375f379968a", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "After oral administration of a radiolabeled dose, 70% of total drug\u2011related material in plasma was accounted for by ixazomib. Metabolism by multiple CYP enzymes and non\u2011CYP proteins is expected to be the major clearance mechanism for ixazomib. At clinically relevant ixazomib concentrations,  studies using human cDNA\u2011expressed cytochrome P450\u00a0isozymes", "ParentId": "6c271c26-fa21-48b2-b923-d672dabd283c"}, {"Element": "<i>in\u00a0vitro</i>", "ID": "e6a2c05f-4aeb-4c4e-87db-f13fadf013f7", "Styles": "None", "Classes": "None", "Text": "in\u00a0vitro", "ParentId": "66ab9bdb-b387-4205-8db5-2375f379968a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\"> </span>", "ID": "a805807d-123a-451b-ad12-0fd77c699ce7", "Styles": "font-size:11.0pt", "Classes": "None", "Text": " ", "ParentId": "6c271c26-fa21-48b2-b923-d672dabd283c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">indicate that no\nspecific CYP\u00a0isozyme predominantly contributes to ixazomib metabolism and\nnon\u2011CYP proteins contribute to overall metabolism. At concentrations\nexceeding those observed clinically, ixazomib was metabolized by multiple CYP\nisoforms with estimated relative contributions of 3A4 (42.3%), 1A2 (26.1%),\n2B6\u00a0(16.0%), 2C8 (6.0%), 2D6 (4.8%), 2C19 (4.8%) and 2C9 (&lt;\u00a01%).</span>", "ID": "0b71617d-2b9f-4979-aa52-18d9e2fd949b", "Styles": "font-size:11.0pt;font-weight:normal", "Classes": "None", "Text": "indicate that no specific CYP\u00a0isozyme predominantly contributes to ixazomib metabolism and non\u2011CYP proteins contribute to overall metabolism. At concentrations exceeding those observed clinically, ixazomib was metabolized by multiple CYP isoforms with estimated relative contributions of 3A4 (42.3%), 1A2 (26.1%), 2B6\u00a0(16.0%), 2C8 (6.0%), 2D6 (4.8%), 2C19 (4.8%) and 2C9 (<\u00a01%).", "ParentId": "6c271c26-fa21-48b2-b923-d672dabd283c"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "09d1c256-0807-49d3-a15e-2850ed05c844", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "70b150d0-3a42-4d72-bb06-e272de2551f9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "09d1c256-0807-49d3-a15e-2850ed05c844"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "19ea93b8-d237-4ea3-b89b-84534fbfd2a3", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "", "ParentId": "70b150d0-3a42-4d72-bb06-e272de2551f9"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "ae168b0d-97f4-46ba-828a-00a97a2bb11d", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "19ea93b8-d237-4ea3-b89b-84534fbfd2a3"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Elimination</span></u></p>", "ID": "32556712-1c09-4b45-9c3e-8fa29db38d96", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Elimination</span></u>", "ID": "95d42446-0233-486b-845e-898c77d6e11e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "32556712-1c09-4b45-9c3e-8fa29db38d96"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Elimination</span>", "ID": "c52e28d1-6d6d-47f9-85a2-0fad70a6ce5d", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "Elimination", "ParentId": "95d42446-0233-486b-845e-898c77d6e11e"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "015bcb2e-57c1-47b4-8d94-9b02bfa8e313", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "a1287640-bd3c-46ef-90b4-bb6616da2f31", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "015bcb2e-57c1-47b4-8d94-9b02bfa8e313"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "9009bca0-7e1e-4d61-99ad-1d3ce229030a", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "", "ParentId": "a1287640-bd3c-46ef-90b4-bb6616da2f31"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "ff5f4143-b658-4734-8391-d41acd3baa78", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "9009bca0-7e1e-4d61-99ad-1d3ce229030a"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">Ixazomib exhibits a multi\u2011exponential\ndisposition profile. Based on a population PK analysis, systemic clearance (CL)\nwas approximately 1.86\u00a0L/hr with inter\u2011individual variability of\n44%. The terminal half\u2011life (t<sub>1/2</sub>) of ixazomib was 9.5 days.\nApproximately 2\u2011fold accumulation in AUC was observed with weekly oral\ndosing on Day 15.</span></p>", "ID": "4527724a-d751-42b1-8bf4-aa0fd7e18db2", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">Ixazomib exhibits a multi\u2011exponential\ndisposition profile. Based on a population PK analysis, systemic clearance (CL)\nwas approximately 1.86\u00a0L/hr with inter\u2011individual variability of\n44%. The terminal half\u2011life (t<sub>1/2</sub>) of ixazomib was 9.5 days.\nApproximately 2\u2011fold accumulation in AUC was observed with weekly oral\ndosing on Day 15.</span>", "ID": "90ee870f-738a-45f2-8667-fb5c056e5b31", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "Ixazomib exhibits a multi\u2011exponential disposition profile. Based on a population PK analysis, systemic clearance (CL) was approximately 1.86\u00a0L/hr with inter\u2011individual variability of 44%. The terminal half\u2011life (t) of ixazomib was 9.5 days. Approximately 2\u2011fold accumulation in AUC was observed with weekly oral dosing on Day 15.", "ParentId": "4527724a-d751-42b1-8bf4-aa0fd7e18db2"}, {"Element": "<sub>1/2</sub>", "ID": "33f22919-db71-4e9a-b7d0-5a2a246279f8", "Styles": "None", "Classes": "None", "Text": "1/2", "ParentId": "90ee870f-738a-45f2-8667-fb5c056e5b31"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>", "ID": "762b39a4-55e6-4c09-a3d6-444c8b1634e6", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span>", "ID": "8d2944f5-4e12-4bb8-81d1-c43ae5cbef35", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "762b39a4-55e6-4c09-a3d6-444c8b1634e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\">Excretion</span></u></i></p>", "ID": "ec777a7a-8f46-4a5e-9fba-3267409001b6", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Excretion</span></u></i>", "ID": "e74ae75c-0c45-485c-bd83-9a8818cec93e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ec777a7a-8f46-4a5e-9fba-3267409001b6"}, {"Element": "<u><span lang=\"EN-GB\">Excretion</span></u>", "ID": "be58f2f7-f837-4ff8-89c1-fb46421e6a9e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e74ae75c-0c45-485c-bd83-9a8818cec93e"}, {"Element": "<span lang=\"EN-GB\">Excretion</span>", "ID": "66531f37-c243-4026-8208-a583396c983e", "Styles": "None", "Classes": "None", "Text": "Excretion", "ParentId": "be58f2f7-f837-4ff8-89c1-fb46421e6a9e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i></p>", "ID": "e6b5e9d4-5171-42af-96ee-91c5928e2745", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></i>", "ID": "61a96d4d-717a-4811-9876-d63028a88db7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e6b5e9d4-5171-42af-96ee-91c5928e2745"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "52231155-b53f-433d-91e2-a306218c56ba", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "61a96d4d-717a-4811-9876-d63028a88db7"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "eb5f1dad-e61a-4798-a34d-c3921bf324ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "52231155-b53f-433d-91e2-a306218c56ba"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "24fc0943-0a05-4a24-a220-7b3ed8af430f", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "eb5f1dad-e61a-4798-a34d-c3921bf324ad"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">After administration of a single oral dose of <sup>14</sup>C\u2011ixazomib\nto 5 patients with advanced cancer, 62% of the administered radioactivity was\nexcreted in urine and 22% in the faeces. Unchanged ixazomib accounted for\n&lt;\u00a03.5% of the administered dose recovered in urine.</span></p>", "ID": "2bf673ff-423c-4e24-a065-754516122ea4", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">After administration of a single oral dose of <sup>14</sup>C\u2011ixazomib\nto 5 patients with advanced cancer, 62% of the administered radioactivity was\nexcreted in urine and 22% in the faeces. Unchanged ixazomib accounted for\n&lt;\u00a03.5% of the administered dose recovered in urine.</span>", "ID": "802937a0-7d94-4669-84a0-5613c2bfcb03", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "After administration of a single oral dose of C\u2011ixazomib to 5 patients with advanced cancer, 62% of the administered radioactivity was excreted in urine and 22% in the faeces. Unchanged ixazomib accounted for <\u00a03.5% of the administered dose recovered in urine.", "ParentId": "2bf673ff-423c-4e24-a065-754516122ea4"}, {"Element": "<sup>14</sup>", "ID": "8233ea14-08bf-46ad-b339-411c92c5d7d4", "Styles": "None", "Classes": "None", "Text": "14", "ParentId": "802937a0-7d94-4669-84a0-5613c2bfcb03"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>", "ID": "fc549ff7-35fb-4ae4-9683-43e4bdeaa54d", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span>", "ID": "6884cdeb-e167-4a11-a6ac-dabc83b60f26", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "fc549ff7-35fb-4ae4-9683-43e4bdeaa54d"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><a name=\"_Toc360524860\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Special populations</span></u></a></p>", "ID": "da7d26f2-ee26-4dda-92f5-8c2be4d12339", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<a name=\"_Toc360524860\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Special populations</span></u></a>", "ID": "2bfb61f9-ebea-4f0e-99af-73e0040d38ca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "da7d26f2-ee26-4dda-92f5-8c2be4d12339"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Special populations</span></u>", "ID": "205203ea-f975-402a-b2d8-6278b0bc5512", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2bfb61f9-ebea-4f0e-99af-73e0040d38ca"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">Special populations</span>", "ID": "a72975da-a56a-4e28-b874-d529e0cd8a8f", "Styles": "font-size:11.0pt;font-weight:normal", "Classes": "None", "Text": "Special populations", "ParentId": "205203ea-f975-402a-b2d8-6278b0bc5512"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "1c6f43dd-f611-4ad1-a574-ac055ee62d41", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "e398689f-108b-48b5-ace6-e8793364dad2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1c6f43dd-f611-4ad1-a574-ac055ee62d41"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "65a76c27-8b5b-4927-abf5-127d39d7e10a", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "", "ParentId": "e398689f-108b-48b5-ace6-e8793364dad2"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "1ad8c95e-5c4c-44be-ae0b-610fb85a1137", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "65a76c27-8b5b-4927-abf5-127d39d7e10a"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Hepatic impairment</span></u></p>", "ID": "25ced99e-8c01-45e5-a1ae-ec66768f52f5", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Hepatic impairment</span></u>", "ID": "534a4ac1-0d09-4604-bcd3-1ba23c2bc2e9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "25ced99e-8c01-45e5-a1ae-ec66768f52f5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Hepatic impairment</span>", "ID": "7af84013-ef03-4665-8ada-466fe2759e37", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "Hepatic impairment", "ParentId": "534a4ac1-0d09-4604-bcd3-1ba23c2bc2e9"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span></p>", "ID": "a46d3936-8656-41d6-acc3-8f68aa0697d6", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span>", "ID": "65f91c2c-051f-4f5c-82c5-e928bf37c444", "Styles": "font-size:11.0pt;font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "a46d3936-8656-41d6-acc3-8f68aa0697d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The PK of ixazomib\nis similar in patients with normal hepatic function and in patients with mild\nhepatic impairment (total bilirubin \u2264\u00a0ULN and AST &gt;\u00a0ULN or\ntotal bilirubin &gt;\u00a01\u20111.5\u00a0x\u00a0ULN and any AST) based on the\nresults of a population PK analysis. </span></p>", "ID": "f850543a-c133-487e-9b11-62739143a62c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The PK of ixazomib\nis similar in patients with normal hepatic function and in patients with mild\nhepatic impairment (total bilirubin \u2264\u00a0ULN and AST &gt;\u00a0ULN or\ntotal bilirubin &gt;\u00a01\u20111.5\u00a0x\u00a0ULN and any AST) based on the\nresults of a population PK analysis. </span>", "ID": "a09df847-8394-4b7f-976c-6e76eff132f3", "Styles": "None", "Classes": "None", "Text": "The PK of ixazomib is similar in patients with normal hepatic function and in patients with mild hepatic impairment (total bilirubin \u2264\u00a0ULN and AST >\u00a0ULN or total bilirubin >\u00a01\u20111.5\u00a0x\u00a0ULN and any AST) based on the results of a population PK analysis. ", "ParentId": "f850543a-c133-487e-9b11-62739143a62c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "75bec295-cc2f-45bb-bae9-af570000fb64", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "db973563-ffda-4075-b01c-795b3539374d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "75bec295-cc2f-45bb-bae9-af570000fb64"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal;font-style:normal\">The PK of ixazomib was\ncharacterized in patients with normal hepatic function at 4\u00a0mg (N=12), moderate\nhepatic impairment at 2.3\u00a0mg (total bilirubin &gt;\u00a01.5\u20113\u00a0x\u00a0ULN,\nN=13) or severe hepatic impairment at 1.5\u00a0mg (total bilirubin\n&gt;\u00a03\u00a0x\u00a0ULN, N=18). Unbound dose\u2011normalized AUC was 27%</span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal;font-style:normal\">higher in\npatients with moderate or severe hepatic impairment as compared to patients\nwith normal hepatic function (see section\u00a04.2).</span></p>", "ID": "bf696be2-5654-49e7-9a26-7dc283102ad1", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal;font-style:normal\">The PK of ixazomib was\ncharacterized in patients with normal hepatic function at 4\u00a0mg (N=12), moderate\nhepatic impairment at 2.3\u00a0mg (total bilirubin &gt;\u00a01.5\u20113\u00a0x\u00a0ULN,\nN=13) or severe hepatic impairment at 1.5\u00a0mg (total bilirubin\n&gt;\u00a03\u00a0x\u00a0ULN, N=18). Unbound dose\u2011normalized AUC was 27%</span>", "ID": "24118740-dcdc-466a-8bd9-341f72ec5b0f", "Styles": "font-size:\n11.0pt;font-weight:normal;font-style:normal", "Classes": "None", "Text": "The PK of ixazomib was characterized in patients with normal hepatic function at 4\u00a0mg (N=12), moderate hepatic impairment at 2.3\u00a0mg (total bilirubin >\u00a01.5\u20113\u00a0x\u00a0ULN, N=13) or severe hepatic impairment at 1.5\u00a0mg (total bilirubin >\u00a03\u00a0x\u00a0ULN, N=18). Unbound dose\u2011normalized AUC was 27%", "ParentId": "bf696be2-5654-49e7-9a26-7dc283102ad1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "2492a569-0743-4329-a3c0-09f118fdf344", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "bf696be2-5654-49e7-9a26-7dc283102ad1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal;font-style:normal\">higher in\npatients with moderate or severe hepatic impairment as compared to patients\nwith normal hepatic function (see section\u00a04.2).</span>", "ID": "64240146-1922-4e54-ae70-aec9a4e2cd9c", "Styles": "font-size:11.0pt;font-weight:normal;font-style:normal", "Classes": "None", "Text": "higher in patients with moderate or severe hepatic impairment as compared to patients with normal hepatic function (see section\u00a04.2).", "ParentId": "bf696be2-5654-49e7-9a26-7dc283102ad1"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal;font-style:normal\">\u00a0</span></p>", "ID": "5f24eef1-61b6-4e86-8db5-766b264dabb6", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal;font-style:normal\">\u00a0</span>", "ID": "949f0a40-2b27-411f-9498-68d0d1c1b537", "Styles": "font-size:\n11.0pt;font-weight:normal;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "5f24eef1-61b6-4e86-8db5-766b264dabb6"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Renal impairment</span></u></p>", "ID": "23ca31bf-b185-44cc-a2ce-da95e3f3e76c", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Renal impairment</span></u>", "ID": "c2e4236a-c5ae-4fd6-a0e9-9efeeec90464", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "23ca31bf-b185-44cc-a2ce-da95e3f3e76c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Renal impairment</span>", "ID": "11895a78-277a-428c-b716-ac6008399db3", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "Renal impairment", "ParentId": "c2e4236a-c5ae-4fd6-a0e9-9efeeec90464"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span></p>", "ID": "a76d590b-1e3f-4935-9e7c-615ba245a03e", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span>", "ID": "3fc38f0a-599d-4a0e-a41c-8479a76aa4bd", "Styles": "font-size:11.0pt;font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "a76d590b-1e3f-4935-9e7c-615ba245a03e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The PK of ixazomib is similar in patients with normal renal function\nand in patients with mild or moderate renal impairment (creatinine clearance \u2265\u00a030\u00a0mL/min)\nbased on the results of a population PK analysis. </span></p>", "ID": "7dca5d0f-48a0-4bc0-9965-a2cda9708557", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The PK of ixazomib is similar in patients with normal renal function\nand in patients with mild or moderate renal impairment (creatinine clearance \u2265\u00a030\u00a0mL/min)\nbased on the results of a population PK analysis. </span>", "ID": "81e2bb94-221b-4d41-a04a-b936107534e9", "Styles": "None", "Classes": "None", "Text": "The PK of ixazomib is similar in patients with normal renal function and in patients with mild or moderate renal impairment (creatinine clearance \u2265\u00a030\u00a0mL/min) based on the results of a population PK analysis. ", "ParentId": "7dca5d0f-48a0-4bc0-9965-a2cda9708557"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7236aa2d-c43f-4e1d-bb37-a2529d798a3b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c5494321-dd56-408a-96a2-78dd98de602c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7236aa2d-c43f-4e1d-bb37-a2529d798a3b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The PK of ixazomib was characterized at a dose of 3\u00a0mg in\npatients with normal renal function (creatinine clearance \u2265\u00a090\u00a0mL/min,\nN=18), severe renal impairment (creatinine clearance &lt;\u00a030\u00a0mL/min,\nN=14), or ESRD requiring dialysis (N=6). Unbound AUC was 38% higher in patients\nwith severe renal impairment or ESRD requiring dialysis as compared to patients\nwith normal renal function.\u00a0Pre\u2011 and post\u2011dialyzer\nconcentrations of ixazomib measured during the haemodialysis session were\nsimilar, suggesting that ixazomib is not dialyzable (see section\u00a04.2). </span></p>", "ID": "b7c60370-0fe2-4fce-b589-95e4a43d5696", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The PK of ixazomib was characterized at a dose of 3\u00a0mg in\npatients with normal renal function (creatinine clearance \u2265\u00a090\u00a0mL/min,\nN=18), severe renal impairment (creatinine clearance &lt;\u00a030\u00a0mL/min,\nN=14), or ESRD requiring dialysis (N=6). Unbound AUC was 38% higher in patients\nwith severe renal impairment or ESRD requiring dialysis as compared to patients\nwith normal renal function.\u00a0Pre\u2011 and post\u2011dialyzer\nconcentrations of ixazomib measured during the haemodialysis session were\nsimilar, suggesting that ixazomib is not dialyzable (see section\u00a04.2). </span>", "ID": "72ed2bab-e36c-4d01-a970-0b5fcecc9d6b", "Styles": "None", "Classes": "None", "Text": "The PK of ixazomib was characterized at a dose of 3\u00a0mg in patients with normal renal function (creatinine clearance \u2265\u00a090\u00a0mL/min, N=18), severe renal impairment (creatinine clearance <\u00a030\u00a0mL/min, N=14), or ESRD requiring dialysis (N=6). Unbound AUC was 38% higher in patients with severe renal impairment or ESRD requiring dialysis as compared to patients with normal renal function.\u00a0Pre\u2011 and post\u2011dialyzer concentrations of ixazomib measured during the haemodialysis session were similar, suggesting that ixazomib is not dialyzable (see section\u00a04.2). ", "ParentId": "b7c60370-0fe2-4fce-b589-95e4a43d5696"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>", "ID": "ec4845aa-f195-4586-96ae-83f30e62f8c5", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span>", "ID": "1581fe05-0129-4083-bb98-a9a3d0c1adc1", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "ec4845aa-f195-4586-96ae-83f30e62f8c5"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Age, gender, race</span></u></p>", "ID": "eb27b12f-89d8-41f1-8aa4-06f737c0916b", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Age, gender, race</span></u>", "ID": "516660d4-babf-408a-be5e-cff543f7ebb6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eb27b12f-89d8-41f1-8aa4-06f737c0916b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Age, gender, race</span>", "ID": "f57c3e75-b889-454e-b93b-98fbdb17df9a", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "Age, gender, race", "ParentId": "516660d4-babf-408a-be5e-cff543f7ebb6"}, {"Element": "<p align=\"left\" class=\"CCDSMinorSubheading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span></p>", "ID": "834563a4-d192-4a3b-9b10-9aae9e7554b8", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorSubheading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">\u00a0</span>", "ID": "fda17f9b-72fc-4c20-a10a-d6da0d355e7d", "Styles": "font-size:11.0pt;font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "834563a4-d192-4a3b-9b10-9aae9e7554b8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">There was no\nclinically meaningful effect of age (23\u201191 years), sex, body surface area\n(1.2\u20112.7\u00a0m<sup>2</sup>), or race on the clearance of ixazomib based\non the results of a population PK analysis. The mean AUC was 35% higher in\nAsian patients; however, there was overlap in the AUC of ixazomib across White\nand Asian patients.</span></p>", "ID": "6c64bf98-1934-48a6-adcc-a026175eb14e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">There was no\nclinically meaningful effect of age (23\u201191 years), sex, body surface area\n(1.2\u20112.7\u00a0m<sup>2</sup>), or race on the clearance of ixazomib based\non the results of a population PK analysis. The mean AUC was 35% higher in\nAsian patients; however, there was overlap in the AUC of ixazomib across White\nand Asian patients.</span>", "ID": "45718221-042b-4440-9f3a-85b91668d42e", "Styles": "None", "Classes": "None", "Text": "There was no clinically meaningful effect of age (23\u201191 years), sex, body surface area (1.2\u20112.7\u00a0m), or race on the clearance of ixazomib based on the results of a population PK analysis. The mean AUC was 35% higher in Asian patients; however, there was overlap in the AUC of ixazomib across White and Asian patients.", "ParentId": "6c64bf98-1934-48a6-adcc-a026175eb14e"}, {"Element": "<sup>2</sup>", "ID": "b1557596-6933-4ef2-97bb-7b0ac8248815", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "45718221-042b-4440-9f3a-85b91668d42e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "099719f8-277a-46eb-9c03-f618bffc2427", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "7bb30115-bd22-4975-b5f1-aab64264e64a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "099719f8-277a-46eb-9c03-f618bffc2427"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7a911cac-08d4-4873-b62b-4798f61c3c9a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7bb30115-bd22-4975-b5f1-aab64264e64a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></b></p>", "ID": "9d39d372-a955-47a2-a4eb-355658e0b4bd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span></b>", "ID": "9b246eb5-8ae2-4dc3-b43e-c69e76301dc7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9d39d372-a955-47a2-a4eb-355658e0b4bd"}, {"Element": "<span lang=\"EN-GB\">5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data</span>", "ID": "0e40c2fa-2827-49c5-b8bc-18d874dcc380", "Styles": "None", "Classes": "None", "Text": "5.3\u00a0\u00a0\u00a0\u00a0 Preclinical safety data", "ParentId": "9b246eb5-8ae2-4dc3-b43e-c69e76301dc7"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "0140534d-2013-49f5-8bee-a7ee9582211e", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "abb96940-ea29-4cba-b4b9-07ca92e502e7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0140534d-2013-49f5-8bee-a7ee9582211e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "74186d6e-ca06-457d-9b07-a200fec3ab9b", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "", "ParentId": "abb96940-ea29-4cba-b4b9-07ca92e502e7"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "439b3d05-f734-4bb9-83fa-833940ef0870", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "74186d6e-ca06-457d-9b07-a200fec3ab9b"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Mutagenicity</span></u></p>", "ID": "4b6ab7e1-0a3a-4707-a20b-dde634e5b0b9", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Mutagenicity</span></u>", "ID": "e63aa3b1-ff73-41ad-822f-b5288a53c758", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4b6ab7e1-0a3a-4707-a20b-dde634e5b0b9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Mutagenicity</span>", "ID": "fec4be13-5edc-4e88-a3cc-10dcb031d374", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "Mutagenicity", "ParentId": "e63aa3b1-ff73-41ad-822f-b5288a53c758"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "16f8eb4d-2f8a-46f1-8d4e-6af488770b66", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8525570b-420f-4f8e-81e2-8d720f57b34f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "16f8eb4d-2f8a-46f1-8d4e-6af488770b66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib was not\nmutagenic in a bacterial reverse mutation assay (Ames assay) or clastogenic in\na bone marrow micronucleus assay in mice. Ixazomib was positive in an <i>in\u00a0vitro</i>\nclastogenicity test in human peripheral blood lymphocytes. However, ixazomib\nwas negative in an <i>in\u00a0vivo</i> comet assay in mice, in which percent\ntail DNA was assessed in the stomach and liver. Therefore, the weight of\nevidence indicates that ixazomib is not considered to present a genotoxic risk.\n</span></p>", "ID": "c2f160b6-7b05-4475-b9a3-47b43438b3e9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib was not\nmutagenic in a bacterial reverse mutation assay (Ames assay) or clastogenic in\na bone marrow micronucleus assay in mice. Ixazomib was positive in an <i>in\u00a0vitro</i>\nclastogenicity test in human peripheral blood lymphocytes. However, ixazomib\nwas negative in an <i>in\u00a0vivo</i> comet assay in mice, in which percent\ntail DNA was assessed in the stomach and liver. Therefore, the weight of\nevidence indicates that ixazomib is not considered to present a genotoxic risk.\n</span>", "ID": "44367740-e1ee-4525-a27c-4969ab8f65c5", "Styles": "None", "Classes": "None", "Text": "Ixazomib was not mutagenic in a bacterial reverse mutation assay (Ames assay) or clastogenic in a bone marrow micronucleus assay in mice. Ixazomib was positive in an  clastogenicity test in human peripheral blood lymphocytes. However, ixazomib was negative in an  comet assay in mice, in which percent tail DNA was assessed in the stomach and liver. Therefore, the weight of evidence indicates that ixazomib is not considered to present a genotoxic risk. ", "ParentId": "c2f160b6-7b05-4475-b9a3-47b43438b3e9"}, {"Element": "<i>in\u00a0vitro</i>", "ID": "b6132fa9-6322-4f71-88b0-05fb17c49967", "Styles": "None", "Classes": "None", "Text": "in\u00a0vitro", "ParentId": "44367740-e1ee-4525-a27c-4969ab8f65c5"}, {"Element": "<i>in\u00a0vivo</i>", "ID": "62890251-4bc5-4c28-9f22-e9032a7ba5de", "Styles": "None", "Classes": "None", "Text": "in\u00a0vivo", "ParentId": "44367740-e1ee-4525-a27c-4969ab8f65c5"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "fcfc6501-967c-48e6-83d5-afded871197e", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "7e4d539f-640d-495b-a501-c2358601a327", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fcfc6501-967c-48e6-83d5-afded871197e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "e61e7f4b-a0ff-4696-b6c1-58d66b2d0094", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "", "ParentId": "7e4d539f-640d-495b-a501-c2358601a327"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "71016fd7-572f-4891-aaf3-4105008a2cdf", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "e61e7f4b-a0ff-4696-b6c1-58d66b2d0094"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><u><span lang=\"EN-GB\">Reproductive and embryo\u2011foetal development</span></u></p>", "ID": "b51068b5-9beb-43bc-b7c0-4e5579b97b2c", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Reproductive and embryo\u2011foetal development</span></u>", "ID": "5bc56ecb-c3f6-4000-9a85-ecaa4bab46a3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b51068b5-9beb-43bc-b7c0-4e5579b97b2c"}, {"Element": "<span lang=\"EN-GB\">Reproductive and embryo\u2011foetal development</span>", "ID": "e1924fbb-d25a-4905-81e6-8230b2ead32a", "Styles": "None", "Classes": "None", "Text": "Reproductive and embryo\u2011foetal development", "ParentId": "5bc56ecb-c3f6-4000-9a85-ecaa4bab46a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ddb166c7-8f8b-44da-b878-55ca2d84902d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d329c882-0f5b-4797-91b5-85b770c7dec9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ddb166c7-8f8b-44da-b878-55ca2d84902d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Ixazomib caused embryo\u2011foetal\ntoxicity in pregnant rats and rabbits only at maternally toxic doses and at\nexposures that were slightly higher than those observed in patients receiving\nthe recommended dose. <span lang=\"EN-GB\">Studies of fertility and early embryonic\ndevelopment and pre\u2011 and post\u2011natal toxicology were not conducted\nwith ixazomib, but evaluation of reproductive tissues was conducted in the\ngeneral toxicity studies. There were no effects due to ixazomib treatment on\nmale or female reproductive organs in studies up to 6\u2011months duration in\nrats and up to 9\u2011months duration in dogs.</span><span lang=\"EN-GB\"> </span></p>", "ID": "e4407f5c-29a6-4610-a5db-cdf4c21afb6e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Ixazomib caused embryo\u2011foetal toxicity in pregnant rats and rabbits only at maternally toxic doses and at exposures that were slightly higher than those observed in patients receiving the recommended dose. ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Studies of fertility and early embryonic\ndevelopment and pre\u2011 and post\u2011natal toxicology were not conducted\nwith ixazomib, but evaluation of reproductive tissues was conducted in the\ngeneral toxicity studies. There were no effects due to ixazomib treatment on\nmale or female reproductive organs in studies up to 6\u2011months duration in\nrats and up to 9\u2011months duration in dogs.</span>", "ID": "9af006e1-475a-4aca-ad07-dd6b252759a0", "Styles": "None", "Classes": "None", "Text": "Studies of fertility and early embryonic development and pre\u2011 and post\u2011natal toxicology were not conducted with ixazomib, but evaluation of reproductive tissues was conducted in the general toxicity studies. There were no effects due to ixazomib treatment on male or female reproductive organs in studies up to 6\u2011months duration in rats and up to 9\u2011months duration in dogs.", "ParentId": "e4407f5c-29a6-4610-a5db-cdf4c21afb6e"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "dd8a4b36-7abd-4e6b-8064-b66b905759de", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "e4407f5c-29a6-4610-a5db-cdf4c21afb6e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "405a7735-08da-48ae-9c92-c5cdfe870abb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d8a6965f-3970-4fd0-9832-ca27a852a995", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "405a7735-08da-48ae-9c92-c5cdfe870abb"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Animal toxicology and/or pharmacology</span></u></p>", "ID": "8619ab60-f2e0-4400-b637-5827a75eee23", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Animal toxicology and/or pharmacology</span></u>", "ID": "8e66393b-306c-4622-b882-09e505599726", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8619ab60-f2e0-4400-b637-5827a75eee23"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\">Animal toxicology and/or pharmacology</span>", "ID": "9a0c2801-2d89-41f3-bf7d-2508dfc5f64a", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "Animal toxicology and/or pharmacology", "ParentId": "8e66393b-306c-4622-b882-09e505599726"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal\"><u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "d88f1513-0e39-4a9f-906b-244407adc7ec", "Styles": "margin-top:0in;text-align:left;\nline-height:normal", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "26225539-dfc7-4097-8a7e-56a09c7f903b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d88f1513-0e39-4a9f-906b-244407adc7ec"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:\nnormal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "7d8cd65f-e88b-46ab-ada6-5a3a565865af", "Styles": "font-size:11.0pt;font-weight:\nnormal", "Classes": "None", "Text": "", "ParentId": "26225539-dfc7-4097-8a7e-56a09c7f903b"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "4002fbec-863a-4a1d-9df0-0588605f7739", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "7d8cd65f-e88b-46ab-ada6-5a3a565865af"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">In multi\u2011cycle repeated\u2011dose toxicity\nstudies conducted in rats and dogs, the principal target organs included the\ngastrointestinal tract, lymphoid tissues, and the nervous system. In the 9\u2011month\nstudy (10\u00a0cycles) in dogs orally administered with a dosing schedule mimicking\nthe clinical regimen (28\u2011day</span><span lang=\"EN-GB\" style=\"font-size:\n11.0pt\">\u00a0</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">cycle),\nmicroscopic neuronal effects were generally minimal in nature and only observed\nat 0.2\u00a0mg/kg (4\u00a0mg/m<sup>2</sup>). The majority of target organ\nfindings demonstrated partial to full recovery following discontinuation of\ntreatment, with the exception of neuronal findings in the lumbar dorsal root\nganglion and dorsal column. </span></p>", "ID": "27562c02-d1ba-483e-bf31-74b7f98fbbc7", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">In multi\u2011cycle repeated\u2011dose toxicity\nstudies conducted in rats and dogs, the principal target organs included the\ngastrointestinal tract, lymphoid tissues, and the nervous system. In the 9\u2011month\nstudy (10\u00a0cycles) in dogs orally administered with a dosing schedule mimicking\nthe clinical regimen (28\u2011day</span>", "ID": "6482b570-ff5b-4b44-a5b2-1794fff31244", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "In multi\u2011cycle repeated\u2011dose toxicity studies conducted in rats and dogs, the principal target organs included the gastrointestinal tract, lymphoid tissues, and the nervous system. In the 9\u2011month study (10\u00a0cycles) in dogs orally administered with a dosing schedule mimicking the clinical regimen (28\u2011day", "ParentId": "27562c02-d1ba-483e-bf31-74b7f98fbbc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt\">\u00a0</span>", "ID": "71767234-b3bc-40ec-badb-43244cd52f72", "Styles": "font-size:\n11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "27562c02-d1ba-483e-bf31-74b7f98fbbc7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-weight:normal\">cycle),\nmicroscopic neuronal effects were generally minimal in nature and only observed\nat 0.2\u00a0mg/kg (4\u00a0mg/m<sup>2</sup>). The majority of target organ\nfindings demonstrated partial to full recovery following discontinuation of\ntreatment, with the exception of neuronal findings in the lumbar dorsal root\nganglion and dorsal column. </span>", "ID": "e0f104e8-cd1a-4eed-bfb5-3ee4578a05e2", "Styles": "font-size:11.0pt;font-weight:normal", "Classes": "None", "Text": "cycle), microscopic neuronal effects were generally minimal in nature and only observed at 0.2\u00a0mg/kg (4\u00a0mg/m). The majority of target organ findings demonstrated partial to full recovery following discontinuation of treatment, with the exception of neuronal findings in the lumbar dorsal root ganglion and dorsal column. ", "ParentId": "27562c02-d1ba-483e-bf31-74b7f98fbbc7"}, {"Element": "<sup>2</sup>", "ID": "59d70a4f-44f4-42a8-abfb-47729dd74cba", "Styles": "None", "Classes": "None", "Text": "2", "ParentId": "e0f104e8-cd1a-4eed-bfb5-3ee4578a05e2"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span></p>", "ID": "9dd90265-f257-4134-8a40-e8a168023629", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\">\u00a0</span>", "ID": "de129d09-c50e-4f03-877c-b8ea32dce25b", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "9dd90265-f257-4134-8a40-e8a168023629"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Following oral\nadministration, a tissue distribution study in rats revealed that the brain and\nspinal cord were amongst the tissues with the lowest levels, suggesting that the\npenetration of ixazomib through the blood\u2011brain barrier appears to be\nlimited. However, the relevance to humans is unknown.</span></p>", "ID": "286a36e7-8fdc-478f-8b4b-85b3f0762766", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Following oral\nadministration, a tissue distribution study in rats revealed that the brain and\nspinal cord were amongst the tissues with the lowest levels, suggesting that the\npenetration of ixazomib through the blood\u2011brain barrier appears to be\nlimited. However, the relevance to humans is unknown.</span>", "ID": "37ebf987-8cc3-4ad2-b8a9-dd96360b649f", "Styles": "None", "Classes": "None", "Text": "Following oral administration, a tissue distribution study in rats revealed that the brain and spinal cord were amongst the tissues with the lowest levels, suggesting that the penetration of ixazomib through the blood\u2011brain barrier appears to be limited. However, the relevance to humans is unknown.", "ParentId": "286a36e7-8fdc-478f-8b4b-85b3f0762766"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b069813b-a732-46d5-a061-33d5b5dc51ad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c80cc0fd-d7a1-4017-8567-dc54c791c315", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b069813b-a732-46d5-a061-33d5b5dc51ad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Non\u2011clinical\nsafety pharmacology studies both <i>in\u00a0vitro</i> (on hERG channels) and <i>in\u00a0vivo</i>\n(in telemetered dogs following </span>single oral administration)<span lang=\"EN-GB\"> demonstrated no effects of ixazomib on cardiovascular or\nrespiratory functions at </span>AUC more than 8\u2011fold higher than the\nclinical value<span lang=\"EN-GB\">.</span></p>", "ID": "ac810aa7-44bc-4f1a-af07-27a63beaf8f8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "single oral administration)AUC more than 8\u2011fold higher than the clinical value", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Non\u2011clinical\nsafety pharmacology studies both <i>in\u00a0vitro</i> (on hERG channels) and <i>in\u00a0vivo</i>\n(in telemetered dogs following </span>", "ID": "7fcfc408-565f-47ce-a6e4-1cade0d88100", "Styles": "None", "Classes": "None", "Text": "Non\u2011clinical safety pharmacology studies both  (on hERG channels) and  (in telemetered dogs following ", "ParentId": "ac810aa7-44bc-4f1a-af07-27a63beaf8f8"}, {"Element": "<i>in\u00a0vitro</i>", "ID": "829c65ba-b55f-45ee-aca1-c5591af84bba", "Styles": "None", "Classes": "None", "Text": "in\u00a0vitro", "ParentId": "7fcfc408-565f-47ce-a6e4-1cade0d88100"}, {"Element": "<i>in\u00a0vivo</i>", "ID": "fb408cd8-1228-4718-ad71-40d4d8e8c21a", "Styles": "None", "Classes": "None", "Text": "in\u00a0vivo", "ParentId": "7fcfc408-565f-47ce-a6e4-1cade0d88100"}, {"Element": "<span lang=\"EN-GB\"> demonstrated no effects of ixazomib on cardiovascular or\nrespiratory functions at </span>", "ID": "33e7a4f5-378c-4475-88ba-3f50e454f6d5", "Styles": "None", "Classes": "None", "Text": " demonstrated no effects of ixazomib on cardiovascular or respiratory functions at ", "ParentId": "ac810aa7-44bc-4f1a-af07-27a63beaf8f8"}, {"Element": "<span lang=\"EN-GB\">.</span>", "ID": "6c9cd911-429a-452b-87d0-77caad7c0907", "Styles": "None", "Classes": "None", "Text": ".", "ParentId": "ac810aa7-44bc-4f1a-af07-27a63beaf8f8"}, {"Element": "<p align=\"left\" class=\"CCDSMinorHeading1\" style=\"margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto\"><u><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "b4800c50-996f-48df-a918-120a0ea25d15", "Styles": "margin-top:0in;text-align:left;\nline-height:normal;page-break-after:auto", "Classes": "['CCDSMinorHeading1']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "381896e6-3df0-4899-b93f-238f42f1be2b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b4800c50-996f-48df-a918-120a0ea25d15"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:\n11.0pt;font-weight:normal\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "cd7553eb-73dc-45a1-9faf-807a042c14f7", "Styles": "font-size:\n11.0pt;font-weight:normal", "Classes": "None", "Text": "", "ParentId": "381896e6-3df0-4899-b93f-238f42f1be2b"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "c9f68cdb-c487-443f-8623-12695b08fd5b", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "cd7553eb-73dc-45a1-9faf-807a042c14f7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9c4e1562-3e25-4e45-8079-c85a4e5b284f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "af2b4aac-c717-442f-84bc-74d4deb08751", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9c4e1562-3e25-4e45-8079-c85a4e5b284f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL PARTICULARS</span></b></p>", "ID": "f7d677d8-5900-4f8e-8fc8-59081cbe95f4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL PARTICULARS</span></b>", "ID": "42288f4f-cd9e-4518-9c41-4553489c7ac7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f7d677d8-5900-4f8e-8fc8-59081cbe95f4"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL PARTICULARS</span>", "ID": "9095d31f-2420-4990-8997-f9bf534a25cc", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL PARTICULARS", "ParentId": "42288f4f-cd9e-4518-9c41-4553489c7ac7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "34673141-9c30-488d-8512-a70bd699284a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "47e2f207-b95e-48f1-910d-e13ba298d35e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "34673141-9c30-488d-8512-a70bd699284a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b></p>", "ID": "3d9420b5-0b2c-4eae-b004-679237b39ddb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span></b>", "ID": "9f4991aa-3ab6-4e8e-84db-f15c1e57069c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d9420b5-0b2c-4eae-b004-679237b39ddb"}, {"Element": "<span lang=\"EN-GB\">6.1\u00a0\u00a0\u00a0\u00a0 List of excipients</span>", "ID": "a3898539-f594-4b4f-984c-37b1bbafde94", "Styles": "None", "Classes": "None", "Text": "6.1\u00a0\u00a0\u00a0\u00a0 List of excipients", "ParentId": "9f4991aa-3ab6-4e8e-84db-f15c1e57069c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "bc0aeb3b-792e-45cf-b325-e53ed62dda94", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "b87e6113-c4cc-4f31-b8aa-e2f4cf88236c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc0aeb3b-792e-45cf-b325-e53ed62dda94"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d37f0715-c4e5-4e02-aec2-3faf9cc16c09", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b87e6113-c4cc-4f31-b8aa-e2f4cf88236c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><u><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg hard capsules</span></u></p>", "ID": "ad572a90-1852-43e7-8304-0ea12e8089b5", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg hard capsules</span></u>", "ID": "199b4592-f268-4757-9789-d41461717091", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad572a90-1852-43e7-8304-0ea12e8089b5"}, {"Element": "<span lang=\"EN-GB\">NINLARO 2.3\u00a0mg hard capsules</span>", "ID": "09e4dfc9-79c9-48d9-8b30-22cfb47c9963", "Styles": "None", "Classes": "None", "Text": "NINLARO 2.3\u00a0mg hard capsules", "ParentId": "199b4592-f268-4757-9789-d41461717091"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "3e9c6868-c594-462c-847b-1f4b7411ffcb", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "22594c6a-e014-4847-954b-5ace0d6319d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3e9c6868-c594-462c-847b-1f4b7411ffcb"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e9ed4be4-cde7-4497-96ae-e323bad08d67", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "22594c6a-e014-4847-954b-5ace0d6319d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"IT\">Capsule contents</span></u></i></p>", "ID": "9a3fb51e-c34a-4f3e-82d6-efd724e503a9", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"IT\">Capsule contents</span></u></i>", "ID": "f8d51c3d-dbf0-4cbe-af2e-eb7cf4c58730", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a3fb51e-c34a-4f3e-82d6-efd724e503a9"}, {"Element": "<u><span lang=\"IT\">Capsule contents</span></u>", "ID": "04f970f1-0218-4429-851b-fc2014f8e9f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f8d51c3d-dbf0-4cbe-af2e-eb7cf4c58730"}, {"Element": "<span lang=\"IT\">Capsule contents</span>", "ID": "0450d9a3-bb17-4494-95c4-cbdf33f1010c", "Styles": "None", "Classes": "None", "Text": "Capsule contents", "ParentId": "04f970f1-0218-4429-851b-fc2014f8e9f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"IT\">Microcrystalline cellulose</span></p>", "ID": "a3245a4d-5f44-45a6-b7c9-099b64fc9f98", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"IT\">Microcrystalline cellulose</span>", "ID": "bf7fef24-8274-4365-877b-68cd559f30f4", "Styles": "None", "Classes": "None", "Text": "Microcrystalline cellulose", "ParentId": "a3245a4d-5f44-45a6-b7c9-099b64fc9f98"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"IT\">Magnesium stearate</span></p>", "ID": "6bdb887f-95c3-4e1e-9a55-4465f0cb741a", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"IT\">Magnesium stearate</span>", "ID": "df8594ef-7ca0-4702-b39c-d134492ef20f", "Styles": "None", "Classes": "None", "Text": "Magnesium stearate", "ParentId": "6bdb887f-95c3-4e1e-9a55-4465f0cb741a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IT\">Talc</span></p>", "ID": "1c53d04a-9be6-482b-af7d-d37c2b9923fb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"IT\">Talc</span>", "ID": "660f3953-d216-47d5-a091-e6fe8ca77f0c", "Styles": "None", "Classes": "None", "Text": "Talc", "ParentId": "1c53d04a-9be6-482b-af7d-d37c2b9923fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IT\">\u00a0</span></p>", "ID": "5549c2a2-0013-4527-9834-ed5527fc1556", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"IT\">\u00a0</span>", "ID": "ae25bad5-de60-4ae7-bb70-401c505c09e4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5549c2a2-0013-4527-9834-ed5527fc1556"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"IT\">Capsule shell</span></u></i></p>", "ID": "f2d9b592-6613-466e-995e-e5dc54b16f19", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"IT\">Capsule shell</span></u></i>", "ID": "fc1ca59d-d7c4-4dae-9f6b-001a39ed226a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f2d9b592-6613-466e-995e-e5dc54b16f19"}, {"Element": "<u><span lang=\"IT\">Capsule shell</span></u>", "ID": "c64d11ac-d6a3-4e8b-9fd6-8b9d56d68081", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fc1ca59d-d7c4-4dae-9f6b-001a39ed226a"}, {"Element": "<span lang=\"IT\">Capsule shell</span>", "ID": "3f325ae1-7ea4-4592-b3b8-536fcc560db2", "Styles": "None", "Classes": "None", "Text": "Capsule shell", "ParentId": "c64d11ac-d6a3-4e8b-9fd6-8b9d56d68081"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IT\">Gelatin</span></p>", "ID": "9e55e52a-5b35-4a17-9951-abf8f7fad171", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"IT\">Gelatin</span>", "ID": "6f510e1b-a381-4992-ad4c-7f3017833a0f", "Styles": "None", "Classes": "None", "Text": "Gelatin", "ParentId": "9e55e52a-5b35-4a17-9951-abf8f7fad171"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"IT\">Titanium dioxide (E171)</span></p>", "ID": "bb98a9c0-feec-4774-8653-bd5e63019c7e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"IT\">Titanium dioxide (E171)</span>", "ID": "6651069d-9e0c-49fb-ae6b-64ab834c5949", "Styles": "None", "Classes": "None", "Text": "Titanium dioxide (E171)", "ParentId": "bb98a9c0-feec-4774-8653-bd5e63019c7e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Red iron\noxide (E172)</p>", "ID": "1ce345e9-69d5-47f1-9e20-dc4d39e968e3", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "Red iron oxide (E172)", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">\u00a0</p>", "ID": "413506d3-9612-43eb-ba7d-b387dc9509c1", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Printing ink</span></u></i></p>", "ID": "558b5a3e-39c0-45c1-90ca-beb4fe5f9e5d", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Printing ink</span></u></i>", "ID": "3a44c92e-e557-4e9f-81e4-4d8e38fd6fca", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "558b5a3e-39c0-45c1-90ca-beb4fe5f9e5d"}, {"Element": "<u><span lang=\"EN-GB\">Printing ink</span></u>", "ID": "0cd6dcf5-4958-4d35-af30-4409634936e2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3a44c92e-e557-4e9f-81e4-4d8e38fd6fca"}, {"Element": "<span lang=\"EN-GB\">Printing ink</span>", "ID": "d6eacb0c-2f13-44d9-bd41-c29e57bd3923", "Styles": "None", "Classes": "None", "Text": "Printing ink", "ParentId": "0cd6dcf5-4958-4d35-af30-4409634936e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">Shellac</span></p>", "ID": "0021ceb3-fb56-425c-a801-0b35eceac897", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Shellac</span>", "ID": "a008b407-187c-46aa-b798-9c6c474fb7ec", "Styles": "None", "Classes": "None", "Text": "Shellac", "ParentId": "0021ceb3-fb56-425c-a801-0b35eceac897"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Propylene glycol</span></p>", "ID": "fd237c87-4184-4011-83ba-7543f5def1e8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Propylene glycol</span>", "ID": "3531a39f-25f3-4735-8f06-ed919745011f", "Styles": "None", "Classes": "None", "Text": "Propylene glycol", "ParentId": "fd237c87-4184-4011-83ba-7543f5def1e8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Potassium hydroxide</span></p>", "ID": "e6c1c750-c4e2-4294-b9b5-dcd200ef28c0", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Potassium hydroxide</span>", "ID": "cae51f90-6a3c-4c12-bd46-16cec2d07807", "Styles": "None", "Classes": "None", "Text": "Potassium hydroxide", "ParentId": "e6c1c750-c4e2-4294-b9b5-dcd200ef28c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Black iron oxide\n(E172)</span></p>", "ID": "2910c9e4-4a59-4426-a5cc-84646a3b6b6d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Black iron oxide\n(E172)</span>", "ID": "8de18667-097a-4950-92a8-40a507057391", "Styles": "None", "Classes": "None", "Text": "Black iron oxide (E172)", "ParentId": "2910c9e4-4a59-4426-a5cc-84646a3b6b6d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "76b6d8f1-f490-4575-a139-72ec702bebd8", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b8cab5ff-2e35-4947-a5f1-0304a1521910", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "76b6d8f1-f490-4575-a139-72ec702bebd8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsules</span></u></p>", "ID": "d07b0025-ec9d-4b9c-b386-661d2b96759b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsules</span></u>", "ID": "9010d871-2709-4a90-b3da-639c420e60b8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d07b0025-ec9d-4b9c-b386-661d2b96759b"}, {"Element": "<span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsules</span>", "ID": "4dba0b16-e1d0-4e2c-9d2f-aa24952a92e6", "Styles": "None", "Classes": "None", "Text": "NINLARO 3\u00a0mg hard capsules", "ParentId": "9010d871-2709-4a90-b3da-639c420e60b8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "84351b66-c518-4148-828d-91e88ddd382c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "6de0a8fe-537a-444d-8a26-46d912cfae85", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "84351b66-c518-4148-828d-91e88ddd382c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cc86af8e-6a8d-4642-86d7-4bd23b7203d6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6de0a8fe-537a-444d-8a26-46d912cfae85"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\">Capsule contents</span></u></i></p>", "ID": "44ad709e-c746-44ff-a88b-64b854c8332d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Capsule contents</span></u></i>", "ID": "e813a413-de7e-400c-a7f2-0d7e3bcafe3b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "44ad709e-c746-44ff-a88b-64b854c8332d"}, {"Element": "<u><span lang=\"EN-GB\">Capsule contents</span></u>", "ID": "80fdab80-4351-4386-b395-92085dd8f13d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e813a413-de7e-400c-a7f2-0d7e3bcafe3b"}, {"Element": "<span lang=\"EN-GB\">Capsule contents</span>", "ID": "58546e5b-35c4-4dae-a687-af4b659b0e51", "Styles": "None", "Classes": "None", "Text": "Capsule contents", "ParentId": "80fdab80-4351-4386-b395-92085dd8f13d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Microcrystalline cellulose</span></p>", "ID": "262f3606-f140-4117-9c24-edf078add972", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Microcrystalline cellulose</span>", "ID": "96693ae5-e254-4dd2-a075-ea4d8ee9e86a", "Styles": "None", "Classes": "None", "Text": "Microcrystalline cellulose", "ParentId": "262f3606-f140-4117-9c24-edf078add972"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Magnesium stearate</span></p>", "ID": "62b065ad-3298-4868-8e5c-5d3825963384", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Magnesium stearate</span>", "ID": "2d4ffe29-2e6b-4839-b709-62d52195f6ad", "Styles": "None", "Classes": "None", "Text": "Magnesium stearate", "ParentId": "62b065ad-3298-4868-8e5c-5d3825963384"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Talc</span></p>", "ID": "c647bab3-9ffd-4391-b427-c5d85dad92a8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Talc</span>", "ID": "1df3ca79-6cab-41ec-8a14-89a7544cdde9", "Styles": "None", "Classes": "None", "Text": "Talc", "ParentId": "c647bab3-9ffd-4391-b427-c5d85dad92a8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5e4f9181-e6d3-4bdc-9a72-cc10f14c8e90", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f9be2a01-84b5-425c-983b-fd45b0205ef1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5e4f9181-e6d3-4bdc-9a72-cc10f14c8e90"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\">Capsule shell</span></u></i></p>", "ID": "9459bc1b-1e54-4a7c-aa6f-4e59469bd063", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Capsule shell</span></u></i>", "ID": "6c246f51-ce7a-49d3-a0b6-33cd91675e4d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9459bc1b-1e54-4a7c-aa6f-4e59469bd063"}, {"Element": "<u><span lang=\"EN-GB\">Capsule shell</span></u>", "ID": "d2d4801e-d508-4d4e-9f06-ff9907200f2c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6c246f51-ce7a-49d3-a0b6-33cd91675e4d"}, {"Element": "<span lang=\"EN-GB\">Capsule shell</span>", "ID": "3692ef86-d31e-46c0-91b7-0c4201d1ea51", "Styles": "None", "Classes": "None", "Text": "Capsule shell", "ParentId": "d2d4801e-d508-4d4e-9f06-ff9907200f2c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Gelatin</span></p>", "ID": "10a060ae-3882-467e-ab9d-d0533f88fd38", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Gelatin</span>", "ID": "d64b8c44-049e-4334-ba39-e88da5d34bb5", "Styles": "None", "Classes": "None", "Text": "Gelatin", "ParentId": "10a060ae-3882-467e-ab9d-d0533f88fd38"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Titanium dioxide (E171)</span></p>", "ID": "d3e4bb47-5c6b-40d4-96ee-a4cc54b2091d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Titanium dioxide (E171)</span>", "ID": "b622de09-f64a-4d49-bcdc-b17ef57dcf4e", "Styles": "None", "Classes": "None", "Text": "Titanium dioxide (E171)", "ParentId": "d3e4bb47-5c6b-40d4-96ee-a4cc54b2091d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Black iron oxide (E172)</span></p>", "ID": "7951c238-914d-419b-80d2-08b0c6df62c3", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Black iron oxide (E172)</span>", "ID": "ac4f02f6-c841-42f8-a80e-b16733c48ff4", "Styles": "None", "Classes": "None", "Text": "Black iron oxide (E172)", "ParentId": "7951c238-914d-419b-80d2-08b0c6df62c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ba68e28f-c977-4cbc-81b1-8bb01033de55", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ee26dcfc-f365-4bbb-8e35-b1542e5f4717", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ba68e28f-c977-4cbc-81b1-8bb01033de55"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><i><u><span lang=\"EN-GB\">Printing ink</span></u></i></p>", "ID": "0832fc2a-f7d6-4b66-8ac8-6dcfcc23b605", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Printing ink</span></u></i>", "ID": "a5d39e12-ec6c-4499-99e5-b383fb878435", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0832fc2a-f7d6-4b66-8ac8-6dcfcc23b605"}, {"Element": "<u><span lang=\"EN-GB\">Printing ink</span></u>", "ID": "6963a40b-62a4-4e01-9ef1-bdc6edc6559f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a5d39e12-ec6c-4499-99e5-b383fb878435"}, {"Element": "<span lang=\"EN-GB\">Printing ink</span>", "ID": "1022662b-8743-458b-9afe-2807a135039d", "Styles": "None", "Classes": "None", "Text": "Printing ink", "ParentId": "6963a40b-62a4-4e01-9ef1-bdc6edc6559f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Shellac</span></p>", "ID": "3c0d0e65-154c-49b7-a056-1460a359e1c5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Shellac</span>", "ID": "ef876e37-27a1-42f0-8b20-7e4cd97e0554", "Styles": "None", "Classes": "None", "Text": "Shellac", "ParentId": "3c0d0e65-154c-49b7-a056-1460a359e1c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Propylene glycol</span></p>", "ID": "1f6e5437-fc85-4094-9638-69b0df346bb6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Propylene glycol</span>", "ID": "6417ad02-9d39-4dc8-8d0a-5e83353a5e8d", "Styles": "None", "Classes": "None", "Text": "Propylene glycol", "ParentId": "1f6e5437-fc85-4094-9638-69b0df346bb6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Potassium hydroxide</span></p>", "ID": "6a2fdfd6-30e0-4615-8c1c-00c258874b3e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Potassium hydroxide</span>", "ID": "c1e6e4d0-dc1b-4b14-b970-3b4b70543cca", "Styles": "None", "Classes": "None", "Text": "Potassium hydroxide", "ParentId": "6a2fdfd6-30e0-4615-8c1c-00c258874b3e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Black iron oxide (E172)</p>", "ID": "27a72e2a-8320-4e96-98f2-79e48f45b18c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Black iron oxide (E172)", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span style=\"text-decoration:none\">\u00a0</span></u></p>", "ID": "d5eae4c3-9cec-477b-bb49-288c3a8a2782", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span style=\"text-decoration:none\">\u00a0</span></u>", "ID": "e05f403a-b21b-45ab-9b3d-a5ca6b4e394b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d5eae4c3-9cec-477b-bb49-288c3a8a2782"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "c5f8c2e6-6a73-42ca-bd73-2d6633bea111", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "e05f403a-b21b-45ab-9b3d-a5ca6b4e394b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u>NINLARO 4\u00a0mg\nhard capsules</u></p>", "ID": "55dfba1b-744b-4b3e-a5ca-2fe69175dc11", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u>NINLARO 4\u00a0mg\nhard capsules</u>", "ID": "d59628d0-8b9d-4717-b66c-566b8dfa8d09", "Styles": "None", "Classes": "None", "Text": "NINLARO 4\u00a0mg hard capsules", "ParentId": "55dfba1b-744b-4b3e-a5ca-2fe69175dc11"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i>\u00a0</i></p>", "ID": "aaec8e88-0e6f-433e-9639-1b69567e62ac", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i>\u00a0</i>", "ID": "7b3cdd9c-f6dd-41d2-8c57-d616fa6e7465", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aaec8e88-0e6f-433e-9639-1b69567e62ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u>Capsule contents</u></i></p>", "ID": "4159cd9e-7469-448b-b4d3-972fc343c681", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u>Capsule contents</u></i>", "ID": "6e3cf8a2-b934-47b5-9af3-352d9da6dea3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4159cd9e-7469-448b-b4d3-972fc343c681"}, {"Element": "<u>Capsule contents</u>", "ID": "726235c2-5c24-4864-b45b-94daf01ee4db", "Styles": "None", "Classes": "None", "Text": "Capsule contents", "ParentId": "6e3cf8a2-b934-47b5-9af3-352d9da6dea3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\">Microcrystalline\ncellulose </p>", "ID": "12ed752c-f132-4d00-ae93-84efeb59dde8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "Microcrystalline cellulose ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Magnesium stearate</span></p>", "ID": "c10eb732-b910-406f-85a8-f879bb6af5e8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Magnesium stearate</span>", "ID": "e84e7aab-30ba-4f94-9c5b-7717f0077752", "Styles": "None", "Classes": "None", "Text": "Magnesium stearate", "ParentId": "c10eb732-b910-406f-85a8-f879bb6af5e8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Talc</span></p>", "ID": "d4cbfa53-02b0-48d9-8c25-5ba640176db8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Talc</span>", "ID": "5ec0ffbe-02f9-4d22-a259-1d0186e371ad", "Styles": "None", "Classes": "None", "Text": "Talc", "ParentId": "d4cbfa53-02b0-48d9-8c25-5ba640176db8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "c074011c-276d-4e58-bc88-82d9b9fec4f6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "ac32ef70-6a08-459a-b351-d0d6f4e19a61", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c074011c-276d-4e58-bc88-82d9b9fec4f6"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "2c056ded-bb0e-4301-83f8-dea3aa474352", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ac32ef70-6a08-459a-b351-d0d6f4e19a61"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "fa626207-9f8e-4181-8b0a-854603f58afa", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "2c056ded-bb0e-4301-83f8-dea3aa474352"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><i><u><span lang=\"EN-GB\">Capsule shell</span></u></i></p>", "ID": "04cee0f0-0b91-42b6-abfa-f49f3a089163", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u><span lang=\"EN-GB\">Capsule shell</span></u></i>", "ID": "e68ac5e9-6a8f-425c-a61a-1616d67f6305", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "04cee0f0-0b91-42b6-abfa-f49f3a089163"}, {"Element": "<u><span lang=\"EN-GB\">Capsule shell</span></u>", "ID": "3cd9dd6d-e91a-4236-bb99-1b0df59e6a25", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e68ac5e9-6a8f-425c-a61a-1616d67f6305"}, {"Element": "<span lang=\"EN-GB\">Capsule shell</span>", "ID": "193d6f92-aea5-47e1-8dcc-896da9d2a064", "Styles": "None", "Classes": "None", "Text": "Capsule shell", "ParentId": "3cd9dd6d-e91a-4236-bb99-1b0df59e6a25"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Gelatin</span></p>", "ID": "0e771ba2-4087-49f6-aa4e-33b8d33d20a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Gelatin</span>", "ID": "fbe1a974-3773-4a0e-bc14-2dcfa732672d", "Styles": "None", "Classes": "None", "Text": "Gelatin", "ParentId": "0e771ba2-4087-49f6-aa4e-33b8d33d20a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span style=\"color:black\">Titanium dioxide (E171)</span></p>", "ID": "583ffed9-943e-427f-ae18-f1d2fb98cf83", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"color:black\">Titanium dioxide (E171)</span>", "ID": "cd5df509-cd37-4789-bd3d-5cd08eae9c8b", "Styles": "color:black", "Classes": "None", "Text": "Titanium dioxide (E171)", "ParentId": "583ffed9-943e-427f-ae18-f1d2fb98cf83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Yellow iron oxide (E172)</p>", "ID": "cb42886c-3e8e-4841-991c-64d9471605bb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Yellow iron oxide (E172)", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Red iron oxide (E172) </p>", "ID": "3b4c606b-b718-462a-939a-0a5ddbfc8096", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Red iron oxide (E172) ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "757204a9-b8ad-4201-9e23-99eb4753058d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><u>Printing\nink</u></i></p>", "ID": "c2735902-e0b3-4e11-936a-64fe813571fd", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><u>Printing\nink</u></i>", "ID": "31913f4d-06d4-42b4-8fe1-046f75379a2b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c2735902-e0b3-4e11-936a-64fe813571fd"}, {"Element": "<u>Printing\nink</u>", "ID": "949ac91d-ce87-4af8-9ef0-1e71aa3278c2", "Styles": "None", "Classes": "None", "Text": "Printing ink", "ParentId": "31913f4d-06d4-42b4-8fe1-046f75379a2b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Shellac</p>", "ID": "73bacce7-9c34-4ff0-8030-e99168b00621", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "Shellac", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Propylene\nglycol</p>", "ID": "3aa8f0de-510e-449f-9669-2800a42dd763", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "Propylene glycol", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Potassium hydroxide</p>", "ID": "077c697d-f3d6-419e-988c-d1ec411d35ad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Potassium hydroxide", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span style=\"color:black\">Black iron oxide (E172)</span></p>", "ID": "9d798b61-41d4-4ce5-8dc3-9f6b6754ce69", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"color:black\">Black iron oxide (E172)</span>", "ID": "cf08a0ab-715d-406d-8b1f-b118ac1328c9", "Styles": "color:black", "Classes": "None", "Text": "Black iron oxide (E172)", "ParentId": "9d798b61-41d4-4ce5-8dc3-9f6b6754ce69"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "0ed3e43b-3fac-4fdc-a245-7fb655885439", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b></p>", "ID": "b676cba0-d4a6-4b81-b5ef-0299d2f65fe4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span></b>", "ID": "a0a78306-e175-4801-91ca-d93d8eb85f62", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b676cba0-d4a6-4b81-b5ef-0299d2f65fe4"}, {"Element": "<span lang=\"EN-GB\">6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities</span>", "ID": "86d38ea0-203a-4cf9-8032-6621e3320286", "Styles": "None", "Classes": "None", "Text": "6.2\u00a0\u00a0\u00a0\u00a0 Incompatibilities", "ParentId": "a0a78306-e175-4801-91ca-d93d8eb85f62"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "33fafc7e-f9a2-401f-beec-2d9fe4cde6f0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e01b10f2-1e04-46b0-aa36-61ee27dda584", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "33fafc7e-f9a2-401f-beec-2d9fe4cde6f0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Not applicable.</span></p>", "ID": "a4639eba-0f8a-4dd7-9ba6-8165ae406d36", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Not applicable.</span>", "ID": "94ea81ef-a7c8-4d4d-b9b4-61fd56ec0159", "Styles": "None", "Classes": "None", "Text": "Not applicable.", "ParentId": "a4639eba-0f8a-4dd7-9ba6-8165ae406d36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6dc1c4b0-4f2b-42e5-a287-2e01616491ec", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0fc58b6b-4d8e-49b6-81b4-eae6e75c8693", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6dc1c4b0-4f2b-42e5-a287-2e01616491ec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b></p>", "ID": "2520df8b-4324-49f9-bf0b-cbb14701754d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span></b>", "ID": "bde875a3-1a93-4238-9fa1-f36cd0a30e93", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2520df8b-4324-49f9-bf0b-cbb14701754d"}, {"Element": "<span lang=\"EN-GB\">6.3\u00a0\u00a0\u00a0\u00a0 Shelf life</span>", "ID": "70b1e8f2-52ec-414a-b5ea-527771a8d893", "Styles": "None", "Classes": "None", "Text": "6.3\u00a0\u00a0\u00a0\u00a0 Shelf life", "ParentId": "bde875a3-1a93-4238-9fa1-f36cd0a30e93"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "70c9175c-96c8-4fd6-a186-c26df00aedd5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e63d939c-27ec-45a1-afec-cb3d8a6ace98", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "70c9175c-96c8-4fd6-a186-c26df00aedd5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3 years.</span></p>", "ID": "3946c9e1-cee7-499d-b3eb-3950faef58b2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">3 years.</span>", "ID": "7fb5cd73-307d-4dfc-9bd9-024b7778facb", "Styles": "None", "Classes": "None", "Text": "3 years.", "ParentId": "3946c9e1-cee7-499d-b3eb-3950faef58b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b53e7081-2784-4fd6-a7b6-1149fb52d671", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "358fcf60-1b51-41fb-a00b-cbb8ea688289", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b53e7081-2784-4fd6-a7b6-1149fb52d671"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage</span></b></p>", "ID": "4cf979d7-8fe3-416b-b24c-5994addcf8e0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage</span></b>", "ID": "3f6fe697-cc1a-4696-ad3f-5bff037c3dd6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4cf979d7-8fe3-416b-b24c-5994addcf8e0"}, {"Element": "<span lang=\"EN-GB\">6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage</span>", "ID": "f8ae7641-6e3b-4a8e-b0e4-c1f5f96a14cf", "Styles": "None", "Classes": "None", "Text": "6.4\u00a0\u00a0\u00a0\u00a0 Special precautions for storage", "ParentId": "3f6fe697-cc1a-4696-ad3f-5bff037c3dd6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a6a156f0-01e9-459b-96d5-5f2e0fe412d3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4ee2c371-e65f-43e6-bed0-0187caee132e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a6a156f0-01e9-459b-96d5-5f2e0fe412d3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store\nabove 30\u00a0\u00b0C. Do not freeze. </span></p>", "ID": "c61f0ce3-e43a-4a1e-8292-03a105f482f2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not store\nabove 30\u00a0\u00b0C. Do not freeze. </span>", "ID": "e9094030-2adf-4c92-83d3-b7a22e0964c6", "Styles": "None", "Classes": "None", "Text": "Do not store above 30\u00a0\u00b0C. Do not freeze. ", "ParentId": "c61f0ce3-e43a-4a1e-8292-03a105f482f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e17730a3-a6ff-4dca-918b-a9f69dc582ec", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7e0deba3-5898-4013-b03c-c6664ff7aa65", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e17730a3-a6ff-4dca-918b-a9f69dc582ec"}, {"Element": "<p class=\"MsoNoSpacing\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Store\nin the original package in order to protect from moisture. </span></p>", "ID": "e19e7b97-bff8-449b-91aa-f988649cac7b", "Styles": "None", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Store\nin the original package in order to protect from moisture. </span>", "ID": "eb9fba22-e109-4448-9563-56908728f7b6", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Store in the original package in order to protect from moisture. ", "ParentId": "e19e7b97-bff8-449b-91aa-f988649cac7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5a16a16e-a54b-4d94-bed4-f215b9a896e3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "137491e5-a7e2-4d96-bbd4-0d98ac50f921", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5a16a16e-a54b-4d94-bed4-f215b9a896e3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container </span></b></p>", "ID": "15db2c46-9be4-44fa-b090-dbf8ba39589d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container </span></b>", "ID": "b94b4f0b-ba95-4c7e-8d95-c2f8389b9a4d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "15db2c46-9be4-44fa-b090-dbf8ba39589d"}, {"Element": "<span lang=\"EN-GB\">6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container </span>", "ID": "d484169b-8aa9-4198-8557-7f0e6b2573ee", "Styles": "None", "Classes": "None", "Text": "6.5\u00a0\u00a0\u00a0\u00a0 Nature and contents of container ", "ParentId": "b94b4f0b-ba95-4c7e-8d95-c2f8389b9a4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "6b4d0358-37f8-43ea-aa08-b3ae829da64f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "4cab5300-9077-4f95-ba74-ee2e59298554", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b4d0358-37f8-43ea-aa08-b3ae829da64f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0a87ddf0-c727-44eb-9052-97d06dc76ef8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4cab5300-9077-4f95-ba74-ee2e59298554"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">PVC\u2011Aluminium\n/Aluminium blister sealed inside a wallet pack containing one capsule.</span></p>", "ID": "af05c9b8-9b04-4ec1-b5a2-36c442c41738", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">PVC\u2011Aluminium\n/Aluminium blister sealed inside a wallet pack containing one capsule.</span>", "ID": "000868f6-594b-47a8-aeca-280e16816af9", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "PVC\u2011Aluminium /Aluminium blister sealed inside a wallet pack containing one capsule.", "ParentId": "af05c9b8-9b04-4ec1-b5a2-36c442c41738"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Three\nsingle blister wallet packs are packaged in one carton.</span></p>", "ID": "eab6d73a-45e2-4c29-a961-67200c169a21", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">Three\nsingle blister wallet packs are packaged in one carton.</span>", "ID": "eb4f2499-a73e-4978-b406-47bb2b6c7b5b", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "Three single blister wallet packs are packaged in one carton.", "ParentId": "eab6d73a-45e2-4c29-a961-67200c169a21"}, {"Element": "<p class=\"MsoBodyText\"><span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span></p>", "ID": "f28e5809-1c8f-42fc-9044-ea1971685f8f", "Styles": "None", "Classes": "['MsoBodyText']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:windowtext;font-style:normal\">\u00a0</span>", "ID": "6918c7cf-546d-4cf5-8cc4-72102d12a032", "Styles": "color:windowtext;font-style:normal", "Classes": "None", "Text": "\u00a0", "ParentId": "f28e5809-1c8f-42fc-9044-ea1971685f8f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal and other handling</span></b></a></p>", "ID": "27110b40-5328-48cb-a05d-b8b9fde2ed41", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<a name=\"OLE_LINK1\"><b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal and other handling</span></b></a>", "ID": "197fd6e4-e1f0-4354-a3e9-fcc314aa16dd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "27110b40-5328-48cb-a05d-b8b9fde2ed41"}, {"Element": "<b><span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal and other handling</span></b>", "ID": "a238e3bb-f206-443e-b14d-d8a34fac43bc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "197fd6e4-e1f0-4354-a3e9-fcc314aa16dd"}, {"Element": "<span lang=\"EN-GB\">6.6\u00a0\u00a0\u00a0\u00a0 Special\nprecautions for disposal and other handling</span>", "ID": "411b37de-ea52-4b34-9afd-4b26e08c7587", "Styles": "None", "Classes": "None", "Text": "6.6\u00a0\u00a0\u00a0\u00a0 Special precautions for disposal and other handling", "ParentId": "a238e3bb-f206-443e-b14d-d8a34fac43bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "422deb0b-0842-48d9-979e-d502bc08833a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6034103c-0a4c-4fb3-9d5a-580438b25832", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "422deb0b-0842-48d9-979e-d502bc08833a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ixazomib is\ncytotoxic. The capsule should not be removed until just prior to dosing. The capsules\nshould not be opened or crushed. Direct contact with the capsule contents\nshould be avoided. In case of capsule breakage, avoid raising dust during clean\u2011up.\nIf contact occurs, wash thoroughly with soap and water. </span></p>", "ID": "57477ed9-5173-46cc-bab2-061f7b0e93df", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ixazomib is\ncytotoxic. The capsule should not be removed until just prior to dosing. The capsules\nshould not be opened or crushed. Direct contact with the capsule contents\nshould be avoided. In case of capsule breakage, avoid raising dust during clean\u2011up.\nIf contact occurs, wash thoroughly with soap and water. </span>", "ID": "a1d71df3-4c5c-49c5-8aac-878927123e7d", "Styles": "None", "Classes": "None", "Text": "Ixazomib is cytotoxic. The capsule should not be removed until just prior to dosing. The capsules should not be opened or crushed. Direct contact with the capsule contents should be avoided. In case of capsule breakage, avoid raising dust during clean\u2011up. If contact occurs, wash thoroughly with soap and water. ", "ParentId": "57477ed9-5173-46cc-bab2-061f7b0e93df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "40122691-ff61-4940-8572-22f9a81d11d6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2950983a-0bbe-4161-85fd-8b3c3b2dc014", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "40122691-ff61-4940-8572-22f9a81d11d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Any unused\nmedicinal product or waste material should be disposed of in accordance with\nlocal requirements.</span></p>", "ID": "f35d2605-53c2-4200-aa0b-eec075039f86", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Any unused\nmedicinal product or waste material should be disposed of in accordance with\nlocal requirements.</span>", "ID": "5998fdc8-8db3-4bdd-86d7-8d195e3df99b", "Styles": "None", "Classes": "None", "Text": "Any unused medicinal product or waste material should be disposed of in accordance with local requirements.", "ParentId": "f35d2605-53c2-4200-aa0b-eec075039f86"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "47cb0270-4824-4590-af89-a9640b7297fb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a87a1287-5828-471d-b8c2-18789597c380", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "47cb0270-4824-4590-af89-a9640b7297fb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9fbb0b9b-c33c-4795-9ccb-ff66d137624c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f093cc79-9669-49c6-8689-0c80a393e303", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9fbb0b9b-c33c-4795-9ccb-ff66d137624c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nHOLDER</span></b></p>", "ID": "c41d0b0d-1963-4fff-b349-35cb02a02aa4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nHOLDER</span></b>", "ID": "a048bb6e-de47-400a-964c-171bc115ec65", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c41d0b0d-1963-4fff-b349-35cb02a02aa4"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nHOLDER</span>", "ID": "2bfc2b42-94a2-4c9b-947d-6a1977b4d75b", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION HOLDER", "ParentId": "a048bb6e-de47-400a-964c-171bc115ec65"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6ff8a882-0d52-43a0-94fa-9ea763e4987e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2a40cfcd-3e8a-4469-af4d-2437d7bc6f8e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6ff8a882-0d52-43a0-94fa-9ea763e4987e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Takeda Pharma A/S</span></p>", "ID": "e7989271-e6c3-4525-8bed-5b7e11957131", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma A/S</span>", "ID": "e95a0f84-95fd-40ef-8af1-958cb3d49a07", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S", "ParentId": "e7989271-e6c3-4525-8bed-5b7e11957131"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\">Delta\nPark 45</span><span style=\"border:none windowtext 1.0pt;padding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>", "ID": "82180562-209a-412c-91f7-ccd12427b52d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span class=\"readonlyfield1\">Delta\nPark 45</span>", "ID": "15807f77-eca9-4103-902d-a14d28fcec7d", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "Delta Park 45", "ParentId": "82180562-209a-412c-91f7-ccd12427b52d"}, {"Element": "<span style=\"border:none windowtext 1.0pt;padding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span>", "ID": "16e61541-8d62-4618-a9e1-ad5c5f0c6109", "Styles": "border:none windowtext 1.0pt;padding:0in", "Classes": "None", "Text": " ", "ParentId": "82180562-209a-412c-91f7-ccd12427b52d"}, {"Element": "<br/>", "ID": "ebf0cfa5-9271-401c-9ea5-56c311fd2c3b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "16e61541-8d62-4618-a9e1-ad5c5f0c6109"}, {"Element": "<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span>", "ID": "ff490a04-15ac-4159-8d69-6dfd830e70a6", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "2665 Vallensbaek Strand", "ParentId": "16e61541-8d62-4618-a9e1-ad5c5f0c6109"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Denmark</p>", "ID": "e700dbd7-fec2-483e-951e-704041385086", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Denmark", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "0864a779-9180-49e3-846a-a21177436911", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "da6f292a-38d4-42a5-9ee2-8907521bece9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nNUMBER(S) </span></b></p>", "ID": "6fd3fb8c-7fa2-471d-b0ff-6a80e05441d1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nNUMBER(S) </span></b>", "ID": "96b83b4b-5bed-41dd-a82b-8a7fd8da3984", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6fd3fb8c-7fa2-471d-b0ff-6a80e05441d1"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION\nNUMBER(S) </span>", "ID": "6df590ad-57d6-4f83-8166-9c0e89e31513", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "96b83b4b-5bed-41dd-a82b-8a7fd8da3984"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e35ee9cf-5fda-493a-9dc7-7dc96b5b9738", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7947c64e-0000-47e4-abd5-a4d975879b03", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e35ee9cf-5fda-493a-9dc7-7dc96b5b9738"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">EU/1/16/1094/001</span></p>", "ID": "46b286eb-2fc7-4c3c-b59b-698db13b0fe1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EU/1/16/1094/001</span>", "ID": "269be602-ceb8-489e-b7fb-2bca42b39c11", "Styles": "None", "Classes": "None", "Text": "EU/1/16/1094/001", "ParentId": "46b286eb-2fc7-4c3c-b59b-698db13b0fe1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">EU/1/16/1094/002</span></p>", "ID": "2b960068-704a-42ad-890b-910a2c31f8d9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EU/1/16/1094/002</span>", "ID": "eb65eaae-6d52-4972-af7d-842a325e42ee", "Styles": "None", "Classes": "None", "Text": "EU/1/16/1094/002", "ParentId": "2b960068-704a-42ad-890b-910a2c31f8d9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EU/1/16/1094/003</span></p>", "ID": "e7597aa8-56ae-4b31-9866-680fcb7ca83f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EU/1/16/1094/003</span>", "ID": "f062bcf5-7f4d-430e-abc8-4922a58706e0", "Styles": "None", "Classes": "None", "Text": "EU/1/16/1094/003", "ParentId": "e7597aa8-56ae-4b31-9866-680fcb7ca83f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "05c671cf-326e-4c1c-bb1f-c5a8f6053740", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0456a5de-9621-41df-aad4-77b20c7378a1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "05c671cf-326e-4c1c-bb1f-c5a8f6053740"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "704e4ea9-4eb4-4578-b0aa-dcd910a65f26", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "83a7a169-fbb8-4e3c-b9c7-45080c1b5147", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "704e4ea9-4eb4-4578-b0aa-dcd910a65f26"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b></p>", "ID": "ffe0b48b-c641-4069-a650-fa9e7860ad45", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b>", "ID": "d9bca06c-7c13-4cf3-9c3d-7e1f1aebf4f3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ffe0b48b-c641-4069-a650-fa9e7860ad45"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST\nAUTHORISATION/RENEWAL OF THE AUTHORISATION</span>", "ID": "8ea44480-c219-4daf-aea0-a39db03745cb", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION", "ParentId": "d9bca06c-7c13-4cf3-9c3d-7e1f1aebf4f3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "2c861b1e-0971-4b0f-8e5b-b5e924c0b26b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f98837fa-cb80-40ce-aad2-7c3f1b061536", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2c861b1e-0971-4b0f-8e5b-b5e924c0b26b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4abd75f-7497-413f-a85b-cb068d4b7dd7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f98837fa-cb80-40ce-aad2-7c3f1b061536"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Date of first authorisation: 21 November 2016</span></p>", "ID": "95053493-0c21-4208-adae-bee43ac87005", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Date of first authorisation: 21 November 2016</span>", "ID": "65a2f975-beaa-4530-8ce6-ca775d5b9170", "Styles": "None", "Classes": "None", "Text": "Date of first authorisation: 21 November 2016", "ParentId": "95053493-0c21-4208-adae-bee43ac87005"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Date of Last\nRenewal: 20\u00a0November\u00a02020</span></p>", "ID": "64a53a56-b182-45b0-b351-9a90e313e63a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Date of Last\nRenewal: 20\u00a0November\u00a02020</span>", "ID": "4bfdc688-fcc7-41aa-87f6-5a593c322530", "Styles": "None", "Classes": "None", "Text": "Date of Last Renewal: 20\u00a0November\u00a02020", "ParentId": "64a53a56-b182-45b0-b351-9a90e313e63a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "af013d14-cff5-4c48-a551-7d906660f984", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ac65ba91-f3a5-413e-9252-a7148e71616b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "af013d14-cff5-4c48-a551-7d906660f984"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d61d066b-d94a-4d4b-89a4-af2b16f9e7b9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f2fa1432-65d1-466f-bb63-df9078879b0a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d61d066b-d94a-4d4b-89a4-af2b16f9e7b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT</span></b></p>", "ID": "4c315948-15d0-45f7-9f60-1331d1c7fbdb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT</span></b>", "ID": "cad7a98f-7e58-46c7-b4fb-fbb4b4811a50", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4c315948-15d0-45f7-9f60-1331d1c7fbdb"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT</span>", "ID": "c2564903-444c-49ef-a9e1-42fccd974306", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 DATE OF REVISION OF THE TEXT", "ParentId": "cad7a98f-7e58-46c7-b4fb-fbb4b4811a50"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d516340e-7e51-4abf-994c-ebff7a7ecc1e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6128e152-3606-4b95-96ff-6f5a89373ac5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d516340e-7e51-4abf-994c-ebff7a7ecc1e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "17f7efc7-f8d9-47d6-8b18-dbdf399d92cc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bdabc416-65a6-4472-9cb6-0f639536bcb8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "17f7efc7-f8d9-47d6-8b18-dbdf399d92cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ed252d88-74fb-4d9c-b80a-c7777373067c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d871777b-4ec5-41b3-952b-3dfbfd107228", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ed252d88-74fb-4d9c-b80a-c7777373067c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\nwebsite of the European Medicines Agency <a href=\"http://www.ema.europa.eu/\">http://www.ema.europa.eu</a>.</span></p>", "ID": "e6aeae70-35a2-49b3-8fa2-97b3de48929e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Detailed information on this medicinal product is available on the\nwebsite of the European Medicines Agency <a href=\"http://www.ema.europa.eu/\">http://www.ema.europa.eu</a>.</span>", "ID": "65913e01-eb9c-433f-818d-3cf33912714c", "Styles": "None", "Classes": "None", "Text": "Detailed information on this medicinal product is available on the website of the European Medicines Agency .", "ParentId": "e6aeae70-35a2-49b3-8fa2-97b3de48929e"}, {"Element": "<a href=\"http://www.ema.europa.eu/\">http://www.ema.europa.eu</a>", "ID": "5896faa8-53fe-44cd-ba35-91405d9f1544", "Styles": "None", "Classes": "None", "Text": "http://www.ema.europa.eu", "ParentId": "65913e01-eb9c-433f-818d-3cf33912714c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "75fff56e-0f8a-42a7-913f-43c7555f6e16", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4f3c5f5-a893-4435-93cd-0d6e202bdc7c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "75fff56e-0f8a-42a7-913f-43c7555f6e16"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "37715e89-282d-4ff3-b3b0-a77496c94f4e", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "3de3f64f-6419-483f-bae1-aa37fc5b25f3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "37715e89-282d-4ff3-b3b0-a77496c94f4e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6e4d8fd7-df3c-43a7-906c-cc263dd5a2f2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3de3f64f-6419-483f-bae1-aa37fc5b25f3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "918b974e-7de7-4806-b590-e9d6de7b2839", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f8d60e4e-19d2-4b84-8179-137c841cc83f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "918b974e-7de7-4806-b590-e9d6de7b2839"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "34bb4e1e-03ed-4cdc-ab44-9c686dbb041a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f8d60e4e-19d2-4b84-8179-137c841cc83f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b96f7681-3f26-4aa5-ae4c-c108e3919e6b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "a693ac2b-93bb-4d09-b917-171b9d6d2f9e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b96f7681-3f26-4aa5-ae4c-c108e3919e6b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1aae6ec0-3b82-44c9-801a-fc5afc32388b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a693ac2b-93bb-4d09-b917-171b9d6d2f9e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "41f3dffe-6b63-4507-b92b-749492a9b627", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "2bc311e7-78c0-46bb-afd4-0f63180b42a8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "41f3dffe-6b63-4507-b92b-749492a9b627"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a9fb3814-17fc-436f-b483-26bf9c9f5a5f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2bc311e7-78c0-46bb-afd4-0f63180b42a8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9adcf6f1-2a80-4335-bbee-d1d5f8e8df51", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "53cc78c3-f0d4-4397-8c1d-8a02b13b25d9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9adcf6f1-2a80-4335-bbee-d1d5f8e8df51"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "52b75380-111e-43f4-96d2-0f6ce05cd69a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "53cc78c3-f0d4-4397-8c1d-8a02b13b25d9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b0446ccf-d857-4f92-a3e1-49fc6f6256db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9aed3c46-c251-4a7e-bfdd-c8954d8a6232", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b0446ccf-d857-4f92-a3e1-49fc6f6256db"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "21c452b9-da66-458c-92d0-01d8a74e37d5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9aed3c46-c251-4a7e-bfdd-c8954d8a6232"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0e67af87-08be-4fe5-bcdc-6c88afae487a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "2dabc13a-23f2-4a11-9642-3e465b3d3f64", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0e67af87-08be-4fe5-bcdc-6c88afae487a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "48882e23-0a54-414c-a8ad-422f307726d0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2dabc13a-23f2-4a11-9642-3e465b3d3f64"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "15d6b1d0-0bf2-4d88-945b-75c9102d82fc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c43ede87-3513-4b09-82f9-a26a283e6635", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "15d6b1d0-0bf2-4d88-945b-75c9102d82fc"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3f1a8f31-5b29-4966-9ec7-b70893d5231b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c43ede87-3513-4b09-82f9-a26a283e6635"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "246c573e-c6b1-496f-a392-6ae334387b3c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "3c8c42d1-ff12-4a35-8bfa-25edcb7d4f02", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "246c573e-c6b1-496f-a392-6ae334387b3c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b99035ed-0d9d-4338-9cbc-499c3c7068aa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3c8c42d1-ff12-4a35-8bfa-25edcb7d4f02"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "c88484d9-da39-408e-83e5-fdda09909ef4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "45ede2ff-c0fa-46d1-97b5-2f2409787dc0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c88484d9-da39-408e-83e5-fdda09909ef4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e3b682bd-b0dc-44ad-a430-9766e4578e4f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "45ede2ff-c0fa-46d1-97b5-2f2409787dc0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0058b807-3159-4e7c-8e25-6d1651467cea", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f9d12c7a-94ae-4898-aa41-888647f91a32", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0058b807-3159-4e7c-8e25-6d1651467cea"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8f3432b0-4267-40db-8fa4-73e98b130bac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f9d12c7a-94ae-4898-aa41-888647f91a32"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b4fde340-61af-41b0-a2b1-c9262db13a7f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "946d82be-c1d6-4aac-b28b-bde90fe4de4d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b4fde340-61af-41b0-a2b1-c9262db13a7f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5475e224-5a51-4208-8534-a82d5f646c28", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "946d82be-c1d6-4aac-b28b-bde90fe4de4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "68d89567-1ae6-456b-ae4f-ffcc4b028c1d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "a43b89cb-1fad-4ebf-8198-3d6618ff627b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "68d89567-1ae6-456b-ae4f-ffcc4b028c1d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "822aa361-f135-40b7-9988-ca6bb3aebd68", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a43b89cb-1fad-4ebf-8198-3d6618ff627b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0a4fd71d-1cd4-4bb2-ba25-4d33ddb49942", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "32bd399f-77f4-46bc-a780-f88c3a1f2349", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a4fd71d-1cd4-4bb2-ba25-4d33ddb49942"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a43dd302-accf-4dca-950d-c785c8c8c94c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "32bd399f-77f4-46bc-a780-f88c3a1f2349"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "fcee5cd7-017a-4ad9-9f62-ae21b9e6c0ff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f5bb3673-70cf-4177-a100-7e101270179a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fcee5cd7-017a-4ad9-9f62-ae21b9e6c0ff"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "57175144-0751-4f0a-b342-5103073243eb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f5bb3673-70cf-4177-a100-7e101270179a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "ba98f321-1141-43c9-bb7c-a9498132bf0d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "6bbe002d-0c5f-4d0e-a0fb-c90d51c66e2b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ba98f321-1141-43c9-bb7c-a9498132bf0d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d099ea0b-15a3-4305-8f70-ddd616e172d3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6bbe002d-0c5f-4d0e-a0fb-c90d51c66e2b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "e7344133-ba31-466a-ade9-c00611b7a7e9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "1e1fa74d-c3c7-4e95-9697-3ba66093e04f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e7344133-ba31-466a-ade9-c00611b7a7e9"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "050b3938-9723-442c-9589-5cfabd057113", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1e1fa74d-c3c7-4e95-9697-3ba66093e04f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "044e3daa-0164-46b1-8eda-ffb7800496d4", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f4753bb4-3d72-4754-8e4f-6d0ea2f6b7ff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "044e3daa-0164-46b1-8eda-ffb7800496d4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "65f1a010-0508-4f60-abe1-46f11204bece", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f4753bb4-3d72-4754-8e4f-6d0ea2f6b7ff"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "945ec674-ef7b-4742-92ee-61163283d5d0", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "62b9499e-34e1-4d44-8fd0-31c68a4a2c28", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "945ec674-ef7b-4742-92ee-61163283d5d0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2bcc132f-7c57-45e1-bd78-6b6f473c5978", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "62b9499e-34e1-4d44-8fd0-31c68a4a2c28"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b7335ecf-eb1d-496a-9fa1-bfd7ea54477f", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d9350297-3273-430d-a2c0-ecc892f7d01b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b7335ecf-eb1d-496a-9fa1-bfd7ea54477f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "10f3df9d-8fe8-441b-90f5-68f30bc53ac4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d9350297-3273-430d-a2c0-ecc892f7d01b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "fd2ff1a0-2669-48c9-a4a1-98041c05352e", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "7baa672e-f2e1-455e-acc1-7f971376d454", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fd2ff1a0-2669-48c9-a4a1-98041c05352e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "438c5b08-5999-47a7-9b06-9852b567d7a5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7baa672e-f2e1-455e-acc1-7f971376d454"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "bd31e2ab-7281-4916-9ae3-f1dd9d9e4eab", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "63a335f2-bf7e-4c7d-8d33-7ef9ed434b8f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bd31e2ab-7281-4916-9ae3-f1dd9d9e4eab"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "46f43605-0c3b-4614-8cff-ec187439f3a8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "63a335f2-bf7e-4c7d-8d33-7ef9ed434b8f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "cd05b8fe-d823-4f4a-a8a2-ed1143c61fcf", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "39441dd8-bc5d-4649-9ef4-cf7ea1e7f709", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd05b8fe-d823-4f4a-a8a2-ed1143c61fcf"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ed1bedb4-b77c-44ff-b098-ec53ff61966d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "39441dd8-bc5d-4649-9ef4-cf7ea1e7f709"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX II</span></b></p>", "ID": "ac678fec-8757-4c32-8238-110896402eef", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX II</span></b>", "ID": "05a894b5-9644-42a5-8adb-b5fa74e97b94", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ac678fec-8757-4c32-8238-110896402eef"}, {"Element": "<span lang=\"EN-GB\">ANNEX II</span>", "ID": "fd790823-9a33-484b-9672-53aa391762f1", "Styles": "None", "Classes": "None", "Text": "ANNEX II", "ParentId": "05a894b5-9644-42a5-8adb-b5fa74e97b94"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "374c9af7-59dd-4ab8-9cd0-7fef67c079c5", "Styles": "margin-right:70.8pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e86abfd8-8bf8-451b-a236-30fd240a7a86", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "374c9af7-59dd-4ab8-9cd0-7fef67c079c5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER\nRESPONSIBLE FOR BATCH RELEASE</span></b></p>", "ID": "cf07c452-e8c0-43b1-adfb-0fc96d5e0d9c", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER\nRESPONSIBLE FOR BATCH RELEASE</span></b>", "ID": "797b3a2a-5622-4b19-9a75-4558c99f9434", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cf07c452-e8c0-43b1-adfb-0fc96d5e0d9c"}, {"Element": "<span lang=\"EN-GB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER\nRESPONSIBLE FOR BATCH RELEASE</span>", "ID": "c1277294-2611-4943-acbf-16f2f965e937", "Styles": "None", "Classes": "None", "Text": "A.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURER RESPONSIBLE FOR BATCH RELEASE", "ParentId": "797b3a2a-5622-4b19-9a75-4558c99f9434"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "42508ac6-868f-4b2f-8dff-7a3270b04b20", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ca10364c-1aff-4a20-badf-1b307d6f3696", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "42508ac6-868f-4b2f-8dff-7a3270b04b20"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.9pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.45pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS\nOR RESTRICTIONS REGARDING SUPPLY AND USE</span></b></p>", "ID": "4f0259fe-9877-46d5-b5c8-d26c018eadc2", "Styles": "margin-top:0in;margin-right:70.9pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.45pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS\nOR RESTRICTIONS REGARDING SUPPLY AND USE</span></b>", "ID": "32d6b7d6-1a53-4cfe-af4f-8a818925b6d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4f0259fe-9877-46d5-b5c8-d26c018eadc2"}, {"Element": "<span lang=\"EN-GB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS\nOR RESTRICTIONS REGARDING SUPPLY AND USE</span>", "ID": "0e74eb7c-2300-42e0-bc8c-ab3f1861ec83", "Styles": "None", "Classes": "None", "Text": "B.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE", "ParentId": "32d6b7d6-1a53-4cfe-af4f-8a818925b6d2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e88b38e5-149e-4728-aaf0-edcac126d924", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d654f576-be63-497b-9240-7ff96e33b71b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e88b38e5-149e-4728-aaf0-edcac126d924"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:77.95pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.45pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b></p>", "ID": "37a727f5-b88b-4747-a85f-7f535b944989", "Styles": "margin-top:0in;margin-right:77.95pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.45pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></b>", "ID": "0e9e3623-51c6-44fa-9491-418434b72ed6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "37a727f5-b88b-4747-a85f-7f535b944989"}, {"Element": "<span lang=\"EN-GB\">C.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER\nCONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span>", "ID": "2c7e3956-7526-4493-b277-65b06a657fd9", "Styles": "None", "Classes": "None", "Text": "C.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION", "ParentId": "0e9e3623-51c6-44fa-9491-418434b72ed6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:77.9pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "cbea9c38-475c-4b86-9417-eca591549f2c", "Styles": "margin-right:77.9pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "12c22cd1-f559-4da6-98d1-ffa7fc619aff", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cbea9c38-475c-4b86-9417-eca591549f2c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "873aabf7-c52b-4faa-af84-400150732f13", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "12c22cd1-f559-4da6-98d1-ffa7fc619aff"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions or restrictions with regard to the\nsafe and effective use of the medicinal product</span></span></b></p>", "ID": "e3e9fcf5-19dc-4789-bcf3-4fdcb15062c5", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions or restrictions with regard to the\nsafe and effective use of the medicinal product</span></span></b>", "ID": "09a027cd-9ae7-4e98-ad0f-bef6d9e231f7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e3e9fcf5-19dc-4789-bcf3-4fdcb15062c5"}, {"Element": "<span lang=\"EN-GB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <span style=\"text-transform:uppercase\">conditions or restrictions with regard to the\nsafe and effective use of the medicinal product</span></span>", "ID": "8e7fa9ab-ab45-466b-86b7-05827cc91ca6", "Styles": "None", "Classes": "None", "Text": "D.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "09a027cd-9ae7-4e98-ad0f-bef6d9e231f7"}, {"Element": "<span style=\"text-transform:uppercase\">conditions or restrictions with regard to the\nsafe and effective use of the medicinal product</span>", "ID": "185f1c3a-2f6f-4131-9fc9-9be299de9301", "Styles": "text-transform:uppercase", "Classes": "None", "Text": "conditions or restrictions with regard to the safe and effective use of the medicinal product", "ParentId": "8e7fa9ab-ab45-466b-86b7-05827cc91ca6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-right:70.8pt;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "fbed5e72-7dc6-4b5b-b51b-4d97e925ae0f", "Styles": "margin-right:70.8pt;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "21241d47-773c-4065-af4d-33e97deb7daa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fbed5e72-7dc6-4b5b-b51b-4d97e925ae0f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c7d623ed-e8ed-4b2a-877b-3c029cafa7e8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "21241d47-773c-4065-af4d-33e97deb7daa"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\nnormal\"><b><span lang=\"EN-GB\">E.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIFIC\nOBLIGATION TO COMPLETE POST\u2011AUTHORISATION MEASURES FOR THE CONDITIONAL\nMARKETING AUTHORISATION</span></b></p>", "ID": "9dcdb468-9a23-401e-889b-27e3e6f18633", "Styles": "margin-top:0in;margin-right:70.8pt;margin-bottom:\n0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">E.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIFIC\nOBLIGATION TO COMPLETE POST\u2011AUTHORISATION MEASURES FOR THE CONDITIONAL\nMARKETING AUTHORISATION</span></b>", "ID": "8169890c-1973-43f0-82a5-738c3d8d1a38", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9dcdb468-9a23-401e-889b-27e3e6f18633"}, {"Element": "<span lang=\"EN-GB\">E.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIFIC\nOBLIGATION TO COMPLETE POST\u2011AUTHORISATION MEASURES FOR THE CONDITIONAL\nMARKETING AUTHORISATION</span>", "ID": "66c1def9-936b-4de5-aa1a-c17dfe08f2a3", "Styles": "None", "Classes": "None", "Text": "E.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIFIC OBLIGATION TO COMPLETE POST\u2011AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION", "ParentId": "8169890c-1973-43f0-82a5-738c3d8d1a38"}, {"Element": "<b><span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "60c1b9c6-d32c-4747-a273-c9cab3afe84e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "b1fc56d7-3590-4e9b-bce4-f0acea3fec46", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "60c1b9c6-d32c-4747-a273-c9cab3afe84e"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "369855e5-3ab9-4589-9352-3a878b41fba0", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "b1fc56d7-3590-4e9b-bce4-f0acea3fec46"}, {"Element": "<p class=\"TitleB\">A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS RESPONSIBLE FOR\nBATCH RELEASE</p>", "ID": "77497dae-7732-4e39-b822-29f5003f536e", "Styles": "None", "Classes": "['TitleB']", "Text": "A.\u00a0\u00a0\u00a0\u00a0\u00a0 MANUFACTURERS RESPONSIBLE FOR BATCH RELEASE", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e9c13bde-d552-4f1f-9473-9fa991810053", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4a77c019-2ab5-4d59-a85c-afc6af9544b6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e9c13bde-d552-4f1f-9473-9fa991810053"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\">Name and\naddress of the manufacturers responsible for batch release</span></u></p>", "ID": "5571686d-b0a0-4cbe-aee5-fe65f4f3864f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\">Name and\naddress of the manufacturers responsible for batch release</span></u>", "ID": "6a734d2d-199e-4674-9a5e-d911d71c6577", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5571686d-b0a0-4cbe-aee5-fe65f4f3864f"}, {"Element": "<span lang=\"EN-GB\">Name and\naddress of the manufacturers responsible for batch release</span>", "ID": "e4518b97-8a2d-4027-9da4-eac797b90dd9", "Styles": "None", "Classes": "None", "Text": "Name and address of the manufacturers responsible for batch release", "ParentId": "6a734d2d-199e-4674-9a5e-d911d71c6577"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "65b2ba35-1cc8-4781-8300-6047a6f3ebdf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "a0ac95ac-aad1-4850-bca7-b7acfb791a62", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65b2ba35-1cc8-4781-8300-6047a6f3ebdf"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "1d3c90f2-2bb1-49c3-8edf-1517e6f16102", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a0ac95ac-aad1-4850-bca7-b7acfb791a62"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "069fb9eb-489c-4f49-8369-f428dce1d4b3", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "1d3c90f2-2bb1-49c3-8edf-1517e6f16102"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Ireland\nLimited</span></p>", "ID": "796025fc-0f8f-4222-8ca4-2f5de3e0342c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Ireland\nLimited</span>", "ID": "b0e5a129-d43a-46f1-a57b-8c5eb2a29e69", "Styles": "None", "Classes": "None", "Text": "Takeda Ireland Limited", "ParentId": "796025fc-0f8f-4222-8ca4-2f5de3e0342c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grange Castle\nBusiness Park</span></p>", "ID": "cb252dfe-f8f8-46b4-a518-df6995075c97", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Grange Castle\nBusiness Park</span>", "ID": "7bc1c560-8c9d-4db8-a203-efa8ab5e22cf", "Styles": "None", "Classes": "None", "Text": "Grange Castle Business Park", "ParentId": "cb252dfe-f8f8-46b4-a518-df6995075c97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dublin 22</span></p>", "ID": "c6f2ff46-1d7d-41d9-a66d-4f70ef537fe3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Dublin 22</span>", "ID": "46789e6d-e1a2-4f7b-8d58-8bd5864bafc9", "Styles": "None", "Classes": "None", "Text": "Dublin 22", "ParentId": "c6f2ff46-1d7d-41d9-a66d-4f70ef537fe3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">D22 XR57</span></p>", "ID": "0d0985e7-14f7-4cb6-8713-daeb0f29d6da", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">D22 XR57</span>", "ID": "e3c2f81f-9b4c-4186-8bb1-65fa894d42ec", "Styles": "None", "Classes": "None", "Text": "D22 XR57", "ParentId": "0d0985e7-14f7-4cb6-8713-daeb0f29d6da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>", "ID": "443c5709-ea57-4601-911d-ed38979dcb20", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "b84ed856-3b0e-4281-9319-b436a123a234", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "443c5709-ea57-4601-911d-ed38979dcb20"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u></p>", "ID": "d914bfac-7785-4c1c-93e3-1644db768b68", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<u><span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span></u>", "ID": "a322187b-ea77-4dc6-939c-91aa165716a3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d914bfac-7785-4c1c-93e3-1644db768b68"}, {"Element": "<span lang=\"EN-GB\"><span style=\"text-decoration:none\">\u00a0</span></span>", "ID": "1e1f6b2b-c291-4c12-9730-2bd6c0dfc676", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a322187b-ea77-4dc6-939c-91aa165716a3"}, {"Element": "<span style=\"text-decoration:none\">\u00a0</span>", "ID": "ffca3320-0278-412d-a1fa-cce9eadf9a0b", "Styles": "text-decoration:none", "Classes": "None", "Text": "\u00a0", "ParentId": "1e1f6b2b-c291-4c12-9730-2bd6c0dfc676"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda GmbH</span></p>", "ID": "50b784ca-1b87-43de-ab4e-6357ed04a73f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda GmbH</span>", "ID": "e7f938fa-6cce-486c-b242-85aa2eacac40", "Styles": "None", "Classes": "None", "Text": "Takeda GmbH", "ParentId": "50b784ca-1b87-43de-ab4e-6357ed04a73f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Production Site\nSingen</span></p>", "ID": "5066d1a4-73a9-414a-a90e-eeced818ca0f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Production Site\nSingen</span>", "ID": "34ccd65d-124e-4a18-a329-a18cb6496fb8", "Styles": "None", "Classes": "None", "Text": "Production Site Singen", "ParentId": "5066d1a4-73a9-414a-a90e-eeced818ca0f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Robert Bosch\nStrasse 8</span></p>", "ID": "d4889dc9-c933-49ee-889b-d4d30e259df1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Robert Bosch\nStrasse 8</span>", "ID": "59e5dffb-ba65-4ce6-8cac-0793c9e74d37", "Styles": "None", "Classes": "None", "Text": "Robert Bosch Strasse 8", "ParentId": "d4889dc9-c933-49ee-889b-d4d30e259df1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">78224 Singen</span></p>", "ID": "d1021655-fafd-4f21-898e-4c6eeeb13839", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">78224 Singen</span>", "ID": "85fe5550-1a39-4a8f-99db-90e66097a2af", "Styles": "None", "Classes": "None", "Text": "78224 Singen", "ParentId": "d1021655-fafd-4f21-898e-4c6eeeb13839"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Germany</span></p>", "ID": "b0f131a1-930c-4d99-8c96-66b73285e417", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Germany</span>", "ID": "31ca3cb6-9e8c-488f-aa1f-3cddfe6eadb8", "Styles": "None", "Classes": "None", "Text": "Germany", "ParentId": "b0f131a1-930c-4d99-8c96-66b73285e417"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0da859b6-5993-4de3-b60f-c287a4819537", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9587b696-7fd2-4409-9320-9dfd9fecff9e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0da859b6-5993-4de3-b60f-c287a4819537"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S</span></p>", "ID": "6b1d0041-71e0-446b-81e9-07d6e9af8950", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma\nA/S</span>", "ID": "69a853e5-de85-4094-b116-17f834343325", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S", "ParentId": "6b1d0041-71e0-446b-81e9-07d6e9af8950"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dybendal Alle 10</span></p>", "ID": "6311d76c-0f5f-42a5-bbf4-c5c90f015ce5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Dybendal Alle 10</span>", "ID": "71fc031d-e841-4946-8f00-b863010408e6", "Styles": "None", "Classes": "None", "Text": "Dybendal Alle 10", "ParentId": "6311d76c-0f5f-42a5-bbf4-c5c90f015ce5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">2630 Taastrup</span></p>", "ID": "2da4a75d-5633-4fe0-9612-480306ad3a7d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">2630 Taastrup</span>", "ID": "7a67904f-53c5-452f-a502-6b93eb537bd2", "Styles": "None", "Classes": "None", "Text": "2630 Taastrup", "ParentId": "2da4a75d-5633-4fe0-9612-480306ad3a7d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>", "ID": "d9bb8d1e-f0eb-4375-9397-4e4e25e20647", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Denmark</span>", "ID": "0a055786-8062-4aa5-8b9f-d5d5195fa233", "Styles": "None", "Classes": "None", "Text": "Denmark", "ParentId": "d9bb8d1e-f0eb-4375-9397-4e4e25e20647"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9a992a8c-0a24-4343-8102-1895bdceba34", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bc2e9877-5819-4274-820b-b8f686f491c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9a992a8c-0a24-4343-8102-1895bdceba34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The printed\npackage leaflet of the medicinal product must state the name and address of the\nmanufacturer responsible for the release of the concerned batch.</span></p>", "ID": "dd0b26fc-b514-47d1-a6cb-8798ec5aef0d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The printed\npackage leaflet of the medicinal product must state the name and address of the\nmanufacturer responsible for the release of the concerned batch.</span>", "ID": "c6333e5a-e871-48b7-a604-64963daece72", "Styles": "None", "Classes": "None", "Text": "The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.", "ParentId": "dd0b26fc-b514-47d1-a6cb-8798ec5aef0d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a2d807ec-5c74-44f5-96dd-af128d546d4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d05be3d3-8b03-4aaf-960f-dd045c927684", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a2d807ec-5c74-44f5-96dd-af128d546d4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "35cdd2cc-b8a3-4c8d-969c-d4e84f7a7a6d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a5b30a6a-1a42-4620-82b7-e754268e2416", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "35cdd2cc-b8a3-4c8d-969c-d4e84f7a7a6d"}, {"Element": "<p class=\"TitleB\">B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS\nREGARDING SUPPLY AND USE</p>", "ID": "6b52b943-8fff-4008-90b9-e22a79ae63ac", "Styles": "None", "Classes": "['TitleB']", "Text": "B.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "46f18740-be09-429b-92ff-0c42be9179fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df5a41f0-7d23-4d72-903c-7b1335f1bd90", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "46f18740-be09-429b-92ff-0c42be9179fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Medicinal\nproduct subject to restricted medical prescription (see Annex I: Summary of\nProduct Characteristics, section 4.2).</span></p>", "ID": "2ca9b508-729f-420e-8003-065b1f4d874f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Medicinal\nproduct subject to restricted medical prescription (see Annex I: Summary of\nProduct Characteristics, section 4.2).</span>", "ID": "8d32ce25-ce79-4d7d-8496-bc21aacb5536", "Styles": "None", "Classes": "None", "Text": "Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).", "ParentId": "2ca9b508-729f-420e-8003-065b1f4d874f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b87ba4bd-9e0a-40a1-8727-c6e2a1526f39", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9310b053-fe73-4186-9ce7-15edca222a6b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b87ba4bd-9e0a-40a1-8727-c6e2a1526f39"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b4ae8f1e-0e10-47ef-86fd-df335a1eb6ab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5d12554a-5afa-48c3-86b5-41b5ae586fe5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b4ae8f1e-0e10-47ef-86fd-df335a1eb6ab"}, {"Element": "<p class=\"TitleB\">C. \u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS\nOF THE MARKETING AUTHORISATION </p>", "ID": "aae301df-d391-4171-bf42-2aa99e19d4ce", "Styles": "None", "Classes": "['TitleB']", "Text": "C. \u00a0\u00a0\u00a0\u00a0 OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e243047a-f020-4da2-9dad-e3a7010b5dc9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a4dd20e9-89a0-47a0-8c8d-6797167a1f70", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e243047a-f020-4da2-9dad-e3a7010b5dc9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Periodic safety update reports (PSURs)</span></b></p>", "ID": "500a61fb-8dd7-4118-ab92-7a40bf8a31e5", "Styles": "margin-left:0in;text-indent:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a8167a1a-2f44-4957-8808-670497319021", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "500a61fb-8dd7-4118-ab92-7a40bf8a31e5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "932dce8f-db68-46b6-b578-7be625afa50a", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a8167a1a-2f44-4957-8808-670497319021"}, {"Element": "<b><span lang=\"EN-GB\">Periodic safety update reports (PSURs)</span></b>", "ID": "3b734306-3f77-406a-a24a-b42e9efc8928", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "500a61fb-8dd7-4118-ab92-7a40bf8a31e5"}, {"Element": "<span lang=\"EN-GB\">Periodic safety update reports (PSURs)</span>", "ID": "355050e9-6650-4a11-a7ef-571e78aee4c2", "Styles": "None", "Classes": "None", "Text": "Periodic safety update reports (PSURs)", "ParentId": "3b734306-3f77-406a-a24a-b42e9efc8928"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The requirements\nfor submission of PSURs for this medicinal product are set out in the list of\nUnion reference dates (EURD list) </span><span lang=\"EN-GB\">provided for under\nArticle 107c(7) of Directive 2001/83/EC and any subsequent updates published on\nthe European medicines web\u2011portal.</span></p>", "ID": "5304263a-6350-436e-bbd4-43c556b6f097", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The requirements\nfor submission of PSURs for this medicinal product are set out in the list of\nUnion reference dates (EURD list) </span>", "ID": "05e48ca3-0b9b-4ddb-86be-da9a37245c5c", "Styles": "None", "Classes": "None", "Text": "The requirements for submission of PSURs for this medicinal product are set out in the list of Union reference dates (EURD list) ", "ParentId": "5304263a-6350-436e-bbd4-43c556b6f097"}, {"Element": "<span lang=\"EN-GB\">provided for under\nArticle 107c(7) of Directive 2001/83/EC and any subsequent updates published on\nthe European medicines web\u2011portal.</span>", "ID": "cef9f9bc-8cc2-4b6b-8900-f051255fcff7", "Styles": "None", "Classes": "None", "Text": "provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web\u2011portal.", "ParentId": "5304263a-6350-436e-bbd4-43c556b6f097"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7519fa1b-cb71-4201-850b-b58210054710", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d17a5776-808b-4a38-9233-6a17689034c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7519fa1b-cb71-4201-850b-b58210054710"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "10f9f570-5554-429a-b41c-92024ef03c84", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "365937bc-2f72-43d1-bb53-11aef2a54dde", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "10f9f570-5554-429a-b41c-92024ef03c84"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ab7ec490-bba3-4517-bd95-2c1c601dd1b2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "365937bc-2f72-43d1-bb53-11aef2a54dde"}, {"Element": "<p class=\"TitleB\">D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS\nWITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT</p>", "ID": "41c2fcc3-6509-4188-b15d-50abfe1d9f2c", "Styles": "None", "Classes": "['TitleB']", "Text": "D.\u00a0\u00a0\u00a0\u00a0\u00a0 CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5b910653-7eed-46ec-ad38-9692e5da5e3e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "530f2f06-e62f-43c6-bcf4-a3c47cfffd39", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5b910653-7eed-46ec-ad38-9692e5da5e3e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Risk management plan (RMP)</span></b></p>", "ID": "dfa26545-3cfa-4c4b-afe4-33e9262ce93a", "Styles": "margin-left:0in;text-indent:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "765e09ee-364f-4b14-9c3d-d873ad09077d", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "dfa26545-3cfa-4c4b-afe4-33e9262ce93a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d1df91e9-afd2-4ea8-82e6-af63059b3dae", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "765e09ee-364f-4b14-9c3d-d873ad09077d"}, {"Element": "<b><span lang=\"EN-GB\">Risk management plan (RMP)</span></b>", "ID": "c9a8ab64-0cf5-4563-8c19-77191da03e94", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dfa26545-3cfa-4c4b-afe4-33e9262ce93a"}, {"Element": "<span lang=\"EN-GB\">Risk management plan (RMP)</span>", "ID": "d6c9abe5-2e83-4238-8b02-839fbb426ff1", "Styles": "None", "Classes": "None", "Text": "Risk management plan (RMP)", "ParentId": "c9a8ab64-0cf5-4563-8c19-77191da03e94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">The marketing\nauthorisation holder (MAH) shall perform the required pharmacovigilance\nactivities and interventions detailed in the agreed RMP presented in Module\n1.8.2 of the marketing authorisation and any agreed subsequent updates of the\nRMP.</span></p>", "ID": "bf6971a8-4a39-411d-9717-990c0818885b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The marketing\nauthorisation holder (MAH) shall perform the required pharmacovigilance\nactivities and interventions detailed in the agreed RMP presented in Module\n1.8.2 of the marketing authorisation and any agreed subsequent updates of the\nRMP.</span>", "ID": "c3cc3ff4-6348-4dcc-8dcd-aaa3c63203a8", "Styles": "None", "Classes": "None", "Text": "The marketing authorisation holder (MAH) shall perform the required pharmacovigilance activities and interventions detailed in the agreed RMP presented in Module 1.8.2 of the marketing authorisation and any agreed subsequent updates of the RMP.", "ParentId": "bf6971a8-4a39-411d-9717-990c0818885b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f5e58ac2-3d03-4f3c-a99a-4cbf1ca78be0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "53562a58-1169-43f8-9b4c-973821d6f49b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f5e58ac2-3d03-4f3c-a99a-4cbf1ca78be0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">An updated RMP\nshould be submitted:</span></p>", "ID": "f89c1c94-aa04-4f14-8bd8-26455879dc2c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">An updated RMP\nshould be submitted:</span>", "ID": "1603c03d-1e91-46f2-8702-4f72d4889808", "Styles": "None", "Classes": "None", "Text": "An updated RMP should be submitted:", "ParentId": "f89c1c94-aa04-4f14-8bd8-26455879dc2c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">At the request of the European Medicines Agency;</span></p>", "ID": "a355c016-5721-462a-9e29-b2f048a91137", "Styles": "margin-left:0in;text-indent:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "3062dcb0-b6c4-4dd9-bfa5-49d1bdd20fb4", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a355c016-5721-462a-9e29-b2f048a91137"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "756d6be0-caa3-4218-937f-9048afedcddb", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "3062dcb0-b6c4-4dd9-bfa5-49d1bdd20fb4"}, {"Element": "<span lang=\"EN-GB\">At the request of the European Medicines Agency;</span>", "ID": "cef07e0c-fb0c-4108-b397-e66d77d551f9", "Styles": "None", "Classes": "None", "Text": "At the request of the European Medicines Agency;", "ParentId": "a355c016-5721-462a-9e29-b2f048a91137"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Whenever the risk management system is modified,\nespecially as the result of new information being received that may lead to a\nsignificant change to the benefit/risk profile or as the result of an important\n(pharmacovigilance or risk minimisation) milestone being reached. </span></p>", "ID": "0750c5d0-27a4-4e52-a9ed-e6ddc4df3d26", "Styles": "margin-left:0in;text-indent:0in;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "83b89361-7557-4337-aa66-600a7ec30e76", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "0750c5d0-27a4-4e52-a9ed-e6ddc4df3d26"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0a7307d4-b9f6-4db9-834b-e68ed9e87dd6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "83b89361-7557-4337-aa66-600a7ec30e76"}, {"Element": "<span lang=\"EN-GB\">Whenever the risk management system is modified,\nespecially as the result of new information being received that may lead to a\nsignificant change to the benefit/risk profile or as the result of an important\n(pharmacovigilance or risk minimisation) milestone being reached. </span>", "ID": "b7c9b0d5-09dd-4977-ac3c-7b7722c857e0", "Styles": "None", "Classes": "None", "Text": "Whenever the risk management system is modified, especially as the result of new information being received that may lead to a significant change to the benefit/risk profile or as the result of an important (pharmacovigilance or risk minimisation) milestone being reached. ", "ParentId": "0750c5d0-27a4-4e52-a9ed-e6ddc4df3d26"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fc9fb3e1-f4ca-435d-822a-d6df9fc2a77f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "463811d6-99ba-4f33-8253-600c23947147", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fc9fb3e1-f4ca-435d-822a-d6df9fc2a77f"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\npage-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><b><span lang=\"EN-GB\">Obligation to conduct post\u2011authorisation\nmeasures</span></b></p>", "ID": "e2ebc429-6d89-421f-854a-9ac0eb8e9bad", "Styles": "margin-left:0in;text-indent:0in;line-height:normal;\npage-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "7311dde7-33af-489d-9444-b36d7166eae5", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e2ebc429-6d89-421f-854a-9ac0eb8e9bad"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "186d24d5-191e-42d3-b217-49f046ee1a45", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "7311dde7-33af-489d-9444-b36d7166eae5"}, {"Element": "<b><span lang=\"EN-GB\">Obligation to conduct post\u2011authorisation\nmeasures</span></b>", "ID": "a398522c-1a14-487d-8350-e548049507f9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e2ebc429-6d89-421f-854a-9ac0eb8e9bad"}, {"Element": "<span lang=\"EN-GB\">Obligation to conduct post\u2011authorisation\nmeasures</span>", "ID": "b6c39e5d-b3f3-426a-9e8f-7f2ed314bec0", "Styles": "None", "Classes": "None", "Text": "Obligation to conduct post\u2011authorisation measures", "ParentId": "a398522c-1a14-487d-8350-e548049507f9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "aec8c93a-35b6-4275-9372-280dc3c843c7", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5dbc306d-e705-4935-8e10-b0632f5c7dac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "aec8c93a-35b6-4275-9372-280dc3c843c7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">The MAH shall complete, within the stated timeframe, the below\nmeasure:</span></p>", "ID": "3fa0dad8-b372-48ce-a80c-5c9dcbdb661a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The MAH shall complete, within the stated timeframe, the below\nmeasure:</span>", "ID": "9c3efc86-e504-40bc-912e-f0a1830e317d", "Styles": "None", "Classes": "None", "Text": "The MAH shall complete, within the stated timeframe, the below measure:", "ParentId": "3fa0dad8-b372-48ce-a80c-5c9dcbdb661a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4b70b450-5620-4307-9e6a-556d231ae690", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b8e95ca9-1fbd-4189-8da5-17139db37181", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4b70b450-5620-4307-9e6a-556d231ae690"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:1.2pt;border-collapse:collapse\" width=\"629\">\n<tr>\n<td style=\"width:410.15pt;border:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"547\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:61.65pt;border:solid black 1.0pt;\n  border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:410.15pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"547\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Post\u2011authorisation efficacy study (PAES) C16010: To\n  provide an interim report of overall survival at the time of the 3<sup>rd</sup>\n  interim analysis and to provide a final report for the final analysis of OS\n  from the phase 3, randomized, double\u2011blind study C16010 in adult\n  patients with relapsed and/or refractory multiple myeloma.</span></p>\n</td>\n<td style=\"width:61.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">June 2021</span></p>\n</td>\n</tr>\n</table>", "ID": "7d9bdbba-15c1-441c-88ca-d05a7b3ec0d3", "Styles": "margin-left:1.2pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "   ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<tr>\n<td style=\"width:410.15pt;border:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"547\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:61.65pt;border:solid black 1.0pt;\n  border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>\n</td>\n</tr>", "ID": "b5276be5-fe88-4d3e-b5d2-2020776d7c80", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "7d9bdbba-15c1-441c-88ca-d05a7b3ec0d3"}, {"Element": "<td style=\"width:410.15pt;border:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"547\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>", "ID": "9efd9cb3-6624-450b-aad8-acf5c01c381b", "Styles": "width:410.15pt;border:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b5276be5-fe88-4d3e-b5d2-2020776d7c80"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Description</span></b></p>", "ID": "14fb680a-2f2d-4cea-bca8-3956372f021e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9efd9cb3-6624-450b-aad8-acf5c01c381b"}, {"Element": "<b><span lang=\"EN-GB\">Description</span></b>", "ID": "9987347f-532f-41dd-99af-2335d64723cf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "14fb680a-2f2d-4cea-bca8-3956372f021e"}, {"Element": "<span lang=\"EN-GB\">Description</span>", "ID": "f6e4b19d-5c4a-462e-8499-d9fa28ddca5b", "Styles": "None", "Classes": "None", "Text": "Description", "ParentId": "9987347f-532f-41dd-99af-2335d64723cf"}, {"Element": "<td style=\"width:61.65pt;border:solid black 1.0pt;\n  border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>\n</td>", "ID": "80fd844d-9fb1-40fe-8e9b-01bddd198784", "Styles": "width:61.65pt;border:solid black 1.0pt;\n  border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b5276be5-fe88-4d3e-b5d2-2020776d7c80"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>", "ID": "7b29f263-956c-43ea-bc54-3a6d904b7ec4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "80fd844d-9fb1-40fe-8e9b-01bddd198784"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b>", "ID": "bac71096-69c6-4bea-abbb-a3227757c145", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7b29f263-956c-43ea-bc54-3a6d904b7ec4"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Due date</span>", "ID": "72f24a37-ea63-47aa-9ad2-734f4761f8d4", "Styles": "color:black", "Classes": "None", "Text": "Due date", "ParentId": "bac71096-69c6-4bea-abbb-a3227757c145"}, {"Element": "<tr>\n<td style=\"width:410.15pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"547\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Post\u2011authorisation efficacy study (PAES) C16010: To\n  provide an interim report of overall survival at the time of the 3<sup>rd</sup>\n  interim analysis and to provide a final report for the final analysis of OS\n  from the phase 3, randomized, double\u2011blind study C16010 in adult\n  patients with relapsed and/or refractory multiple myeloma.</span></p>\n</td>\n<td style=\"width:61.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">June 2021</span></p>\n</td>\n</tr>", "ID": "e4964f45-cb60-4d83-9d97-4f2b62d948b0", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "7d9bdbba-15c1-441c-88ca-d05a7b3ec0d3"}, {"Element": "<td style=\"width:410.15pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"547\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Post\u2011authorisation efficacy study (PAES) C16010: To\n  provide an interim report of overall survival at the time of the 3<sup>rd</sup>\n  interim analysis and to provide a final report for the final analysis of OS\n  from the phase 3, randomized, double\u2011blind study C16010 in adult\n  patients with relapsed and/or refractory multiple myeloma.</span></p>\n</td>", "ID": "00ecd9a1-4db4-4a07-921e-736174160041", "Styles": "width:410.15pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e4964f45-cb60-4d83-9d97-4f2b62d948b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">Post\u2011authorisation efficacy study (PAES) C16010: To\n  provide an interim report of overall survival at the time of the 3<sup>rd</sup>\n  interim analysis and to provide a final report for the final analysis of OS\n  from the phase 3, randomized, double\u2011blind study C16010 in adult\n  patients with relapsed and/or refractory multiple myeloma.</span></p>", "ID": "aff37cb6-0989-4518-ad39-4d793783094d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "00ecd9a1-4db4-4a07-921e-736174160041"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Post\u2011authorisation efficacy study (PAES) C16010: To\n  provide an interim report of overall survival at the time of the 3<sup>rd</sup>\n  interim analysis and to provide a final report for the final analysis of OS\n  from the phase 3, randomized, double\u2011blind study C16010 in adult\n  patients with relapsed and/or refractory multiple myeloma.</span>", "ID": "86e0faf5-9f4e-47bb-98e5-17da48c7f484", "Styles": "color:black", "Classes": "None", "Text": "Post\u2011authorisation efficacy study (PAES) C16010: To   provide an interim report of overall survival at the time of the 3   interim analysis and to provide a final report for the final analysis of OS   from the phase 3, randomized, double\u2011blind study C16010 in adult   patients with relapsed and/or refractory multiple myeloma.", "ParentId": "aff37cb6-0989-4518-ad39-4d793783094d"}, {"Element": "<sup>rd</sup>", "ID": "1daf698d-936b-4b90-a0e1-79d343d21f64", "Styles": "None", "Classes": "None", "Text": "rd", "ParentId": "86e0faf5-9f4e-47bb-98e5-17da48c7f484"}, {"Element": "<td style=\"width:61.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"82\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">June 2021</span></p>\n</td>", "ID": "18671645-4d1d-4426-97de-46e11973914d", "Styles": "width:61.65pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "e4964f45-cb60-4d83-9d97-4f2b62d948b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">June 2021</span></p>", "ID": "f7efb386-083e-4e66-9e3c-a10091150101", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "18671645-4d1d-4426-97de-46e11973914d"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">June 2021</span>", "ID": "befffe0c-caaf-4cd2-bdda-e8532488d72c", "Styles": "color:black", "Classes": "None", "Text": "June 2021", "ParentId": "f7efb386-083e-4e66-9e3c-a10091150101"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "f024d8e2-0a9f-430f-95b6-65fe528277e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "e1711ef2-bd71-4495-a46e-73db16e4cee6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f024d8e2-0a9f-430f-95b6-65fe528277e5"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b234eb93-ede1-49de-a28b-8af5f0531d5c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e1711ef2-bd71-4495-a46e-73db16e4cee6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "65dea472-510d-4c04-b99d-b06f13616853", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "849e8064-60aa-490a-96b2-0b2ab2105057", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65dea472-510d-4c04-b99d-b06f13616853"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "08d3151b-b648-4c63-8e04-061b1925bcce", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "849e8064-60aa-490a-96b2-0b2ab2105057"}, {"Element": "<p class=\"TitleB\">E.\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIFIC OBLIGATION TO\nCOMPLETE POST\u2011AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING\nAUTHORISATION </p>", "ID": "9ffc9be3-d564-498a-ae1d-07657e6855c5", "Styles": "None", "Classes": "['TitleB']", "Text": "E.\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIFIC OBLIGATION TO COMPLETE POST\u2011AUTHORISATION MEASURES FOR THE CONDITIONAL MARKETING AUTHORISATION ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "41c41401-30a1-4cdd-a1f3-778c23f469a7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "406b07c7-f0ea-4f1f-92ac-23db208182c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "41c41401-30a1-4cdd-a1f3-778c23f469a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">This being a\nconditional marketing authorisation and pursuant to Article 14a(4) of\nRegulation (EC) No\u00a0726/2004, the MAH shall complete, within the stated\ntimeframe, the following measures:</span></p>", "ID": "8cce584a-d067-4906-bb37-d5d6f14cd79f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">This being a\nconditional marketing authorisation and pursuant to Article 14a(4) of\nRegulation (EC) No\u00a0726/2004, the MAH shall complete, within the stated\ntimeframe, the following measures:</span>", "ID": "db242613-4675-4b08-a55b-73897630771d", "Styles": "None", "Classes": "None", "Text": "This being a conditional marketing authorisation and pursuant to Article 14a(4) of Regulation (EC) No\u00a0726/2004, the MAH shall complete, within the stated timeframe, the following measures:", "ParentId": "8cce584a-d067-4906-bb37-d5d6f14cd79f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "87fc15c0-54fb-46da-b351-728cd1c97caa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1c769b72-8d28-47a9-a4be-424a6ccf5328", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "87fc15c0-54fb-46da-b351-728cd1c97caa"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:1.2pt;border-collapse:collapse\" width=\"641\">\n<thead>\n<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n   background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:63.75pt;border:solid black 1.0pt;\n   border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>\n</td>\n</tr>\n</thead>\n<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">C16014: In order to further investigate the efficacy the\n  MAH should conduct a phase 3, randomized, double\u2011blind, multicenter\n  study comparing ixazomib plus lenalidomide and dexamethasone versus placebo\n  plus lenalidomide and dexamethasone in adult patients with newly diagnosed\n  multiple myeloma not eligible for stem cell transplantation (SCT) and provide\n  the final report for primary endpoint PFS.</span></p>\n</td>\n<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">December 2020</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">C16019: In order to further investigate the efficacy the\n  MAH should provide additional OS/PFS2 data when approximately 200 death\n  events have occurred from the Phase 3, randomized, placebo\u2011controlled,\n  double\u2011blind study of ixazomib in maintenance therapy in patients with\n  multiple myeloma following SCT. </span></p>\n</td>\n<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">December 2021</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">NSMM\u20115001: The MAH should conduct a global,\n  prospective, non\u2011interventional, observational study in multiple\n  myeloma patients and provide a report with the final analysis when at least\n  110 PFS events are expected to have occurred in subjects prospectively\n  exposed to ixazomib.</span></p>\n</td>\n<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">July 2022</span></p>\n</td>\n</tr>\n</table>", "ID": "c17932d7-e96d-4385-932b-8e058237676e", "Styles": "margin-left:1.2pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "     ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<thead>\n<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n   background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:63.75pt;border:solid black 1.0pt;\n   border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>\n</td>\n</tr>\n</thead>", "ID": "cf450ded-744c-4d63-8f3f-32b9c1cd47df", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "c17932d7-e96d-4385-932b-8e058237676e"}, {"Element": "<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n   background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>\n<td style=\"width:63.75pt;border:solid black 1.0pt;\n   border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>\n</td>\n</tr>", "ID": "9d720877-6029-46cd-bbdd-25c75bbdf382", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "cf450ded-744c-4d63-8f3f-32b9c1cd47df"}, {"Element": "<td style=\"width:417.25pt;border:solid black 1.0pt;\n   background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Description</span></b></p>\n</td>", "ID": "f8589e9d-dfd2-4326-8474-a35afa66d80c", "Styles": "width:417.25pt;border:solid black 1.0pt;\n   background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9d720877-6029-46cd-bbdd-25c75bbdf382"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Description</span></b></p>", "ID": "aba3d6f1-4a40-4b62-a5a3-6632472fa311", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8589e9d-dfd2-4326-8474-a35afa66d80c"}, {"Element": "<b><span lang=\"EN-GB\">Description</span></b>", "ID": "fb1dd286-3935-4e28-b437-40d3040861ac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aba3d6f1-4a40-4b62-a5a3-6632472fa311"}, {"Element": "<span lang=\"EN-GB\">Description</span>", "ID": "033dacd8-35fb-4ec3-93d1-4aed2629420e", "Styles": "None", "Classes": "None", "Text": "Description", "ParentId": "fb1dd286-3935-4e28-b437-40d3040861ac"}, {"Element": "<td style=\"width:63.75pt;border:solid black 1.0pt;\n   border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>\n</td>", "ID": "5581c78f-5fef-4f1c-a6e8-5a716a1b3a45", "Styles": "width:63.75pt;border:solid black 1.0pt;\n   border-left:none;background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "9d720877-6029-46cd-bbdd-25c75bbdf382"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b></p>", "ID": "6bc0c842-cce7-4707-b05a-51e7fdb6fcfe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5581c78f-5fef-4f1c-a6e8-5a716a1b3a45"}, {"Element": "<b><span lang=\"EN-GB\" style=\"color:black\">Due date</span></b>", "ID": "75e94f20-9e07-4368-8ec9-c5e70e1aa024", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6bc0c842-cce7-4707-b05a-51e7fdb6fcfe"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">Due date</span>", "ID": "3a05c706-ba87-43e6-a31a-2a8bc44bec62", "Styles": "color:black", "Classes": "None", "Text": "Due date", "ParentId": "75e94f20-9e07-4368-8ec9-c5e70e1aa024"}, {"Element": "<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">C16014: In order to further investigate the efficacy the\n  MAH should conduct a phase 3, randomized, double\u2011blind, multicenter\n  study comparing ixazomib plus lenalidomide and dexamethasone versus placebo\n  plus lenalidomide and dexamethasone in adult patients with newly diagnosed\n  multiple myeloma not eligible for stem cell transplantation (SCT) and provide\n  the final report for primary endpoint PFS.</span></p>\n</td>\n<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">December 2020</span></p>\n</td>\n</tr>", "ID": "b7912eee-9bc7-43b3-857e-709853c79123", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "c17932d7-e96d-4385-932b-8e058237676e"}, {"Element": "<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">C16014: In order to further investigate the efficacy the\n  MAH should conduct a phase 3, randomized, double\u2011blind, multicenter\n  study comparing ixazomib plus lenalidomide and dexamethasone versus placebo\n  plus lenalidomide and dexamethasone in adult patients with newly diagnosed\n  multiple myeloma not eligible for stem cell transplantation (SCT) and provide\n  the final report for primary endpoint PFS.</span></p>\n</td>", "ID": "0276fee0-2629-4ce3-bb63-bfdac5d5823a", "Styles": "width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b7912eee-9bc7-43b3-857e-709853c79123"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">C16014: In order to further investigate the efficacy the\n  MAH should conduct a phase 3, randomized, double\u2011blind, multicenter\n  study comparing ixazomib plus lenalidomide and dexamethasone versus placebo\n  plus lenalidomide and dexamethasone in adult patients with newly diagnosed\n  multiple myeloma not eligible for stem cell transplantation (SCT) and provide\n  the final report for primary endpoint PFS.</span></p>", "ID": "4a9e926f-fe28-4c8b-86fa-75a0fd37139f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0276fee0-2629-4ce3-bb63-bfdac5d5823a"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">C16014: In order to further investigate the efficacy the\n  MAH should conduct a phase 3, randomized, double\u2011blind, multicenter\n  study comparing ixazomib plus lenalidomide and dexamethasone versus placebo\n  plus lenalidomide and dexamethasone in adult patients with newly diagnosed\n  multiple myeloma not eligible for stem cell transplantation (SCT) and provide\n  the final report for primary endpoint PFS.</span>", "ID": "58fc5258-fd92-4ef4-bbe0-59f4d92be7c4", "Styles": "color:black", "Classes": "None", "Text": "C16014: In order to further investigate the efficacy the   MAH should conduct a phase 3, randomized, double\u2011blind, multicenter   study comparing ixazomib plus lenalidomide and dexamethasone versus placebo   plus lenalidomide and dexamethasone in adult patients with newly diagnosed   multiple myeloma not eligible for stem cell transplantation (SCT) and provide   the final report for primary endpoint PFS.", "ParentId": "4a9e926f-fe28-4c8b-86fa-75a0fd37139f"}, {"Element": "<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">December 2020</span></p>\n</td>", "ID": "458075ad-f60b-4d37-9098-d5609f66cc05", "Styles": "width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b7912eee-9bc7-43b3-857e-709853c79123"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">December 2020</span></p>", "ID": "8be5c69c-ebdf-4dc3-9f99-2d529322f346", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "458075ad-f60b-4d37-9098-d5609f66cc05"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">December 2020</span>", "ID": "41299c54-4b33-402c-82a1-24e192f722bf", "Styles": "color:black", "Classes": "None", "Text": "December 2020", "ParentId": "8be5c69c-ebdf-4dc3-9f99-2d529322f346"}, {"Element": "<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">C16019: In order to further investigate the efficacy the\n  MAH should provide additional OS/PFS2 data when approximately 200 death\n  events have occurred from the Phase 3, randomized, placebo\u2011controlled,\n  double\u2011blind study of ixazomib in maintenance therapy in patients with\n  multiple myeloma following SCT. </span></p>\n</td>\n<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">December 2021</span></p>\n</td>\n</tr>", "ID": "5d8217cd-816d-4b31-83e5-821d86b706b5", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "c17932d7-e96d-4385-932b-8e058237676e"}, {"Element": "<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">C16019: In order to further investigate the efficacy the\n  MAH should provide additional OS/PFS2 data when approximately 200 death\n  events have occurred from the Phase 3, randomized, placebo\u2011controlled,\n  double\u2011blind study of ixazomib in maintenance therapy in patients with\n  multiple myeloma following SCT. </span></p>\n</td>", "ID": "7dd33c74-2fea-4ab2-9a2a-232a2709d51d", "Styles": "width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5d8217cd-816d-4b31-83e5-821d86b706b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">C16019: In order to further investigate the efficacy the\n  MAH should provide additional OS/PFS2 data when approximately 200 death\n  events have occurred from the Phase 3, randomized, placebo\u2011controlled,\n  double\u2011blind study of ixazomib in maintenance therapy in patients with\n  multiple myeloma following SCT. </span></p>", "ID": "47b397d5-132a-4b8d-b067-1980ece368cb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7dd33c74-2fea-4ab2-9a2a-232a2709d51d"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">C16019: In order to further investigate the efficacy the\n  MAH should provide additional OS/PFS2 data when approximately 200 death\n  events have occurred from the Phase 3, randomized, placebo\u2011controlled,\n  double\u2011blind study of ixazomib in maintenance therapy in patients with\n  multiple myeloma following SCT. </span>", "ID": "3c82205b-1d88-492a-bb3d-f4a8a094cdfa", "Styles": "color:black", "Classes": "None", "Text": "C16019: In order to further investigate the efficacy the   MAH should provide additional OS/PFS2 data when approximately 200 death   events have occurred from the Phase 3, randomized, placebo\u2011controlled,   double\u2011blind study of ixazomib in maintenance therapy in patients with   multiple myeloma following SCT. ", "ParentId": "47b397d5-132a-4b8d-b067-1980ece368cb"}, {"Element": "<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">December 2021</span></p>\n</td>", "ID": "af7a3bf6-c8c1-4353-839f-21be90dfbb70", "Styles": "width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5d8217cd-816d-4b31-83e5-821d86b706b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">December 2021</span></p>", "ID": "3bd118ec-48cd-4384-8df2-ab5234b13f89", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "af7a3bf6-c8c1-4353-839f-21be90dfbb70"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">December 2021</span>", "ID": "f3d3e0ac-7e29-4e21-9822-f2df40e3f64b", "Styles": "color:black", "Classes": "None", "Text": "December 2021", "ParentId": "3bd118ec-48cd-4384-8df2-ab5234b13f89"}, {"Element": "<tr>\n<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">NSMM\u20115001: The MAH should conduct a global,\n  prospective, non\u2011interventional, observational study in multiple\n  myeloma patients and provide a report with the final analysis when at least\n  110 PFS events are expected to have occurred in subjects prospectively\n  exposed to ixazomib.</span></p>\n</td>\n<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">July 2022</span></p>\n</td>\n</tr>", "ID": "8b77e33a-1332-4b80-a052-923207d8394c", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "c17932d7-e96d-4385-932b-8e058237676e"}, {"Element": "<td style=\"width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"556\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">NSMM\u20115001: The MAH should conduct a global,\n  prospective, non\u2011interventional, observational study in multiple\n  myeloma patients and provide a report with the final analysis when at least\n  110 PFS events are expected to have occurred in subjects prospectively\n  exposed to ixazomib.</span></p>\n</td>", "ID": "4dae188d-0284-464f-82d1-3c553ec4ee99", "Styles": "width:417.25pt;border:solid black 1.0pt;\n  border-top:none;background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8b77e33a-1332-4b80-a052-923207d8394c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">NSMM\u20115001: The MAH should conduct a global,\n  prospective, non\u2011interventional, observational study in multiple\n  myeloma patients and provide a report with the final analysis when at least\n  110 PFS events are expected to have occurred in subjects prospectively\n  exposed to ixazomib.</span></p>", "ID": "22bbd938-fd12-41d1-99b5-3415d8bb5ff3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4dae188d-0284-464f-82d1-3c553ec4ee99"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">NSMM\u20115001: The MAH should conduct a global,\n  prospective, non\u2011interventional, observational study in multiple\n  myeloma patients and provide a report with the final analysis when at least\n  110 PFS events are expected to have occurred in subjects prospectively\n  exposed to ixazomib.</span>", "ID": "7e7da30b-4c93-4b5e-b971-4835e577cc56", "Styles": "color:black", "Classes": "None", "Text": "NSMM\u20115001: The MAH should conduct a global,   prospective, non\u2011interventional, observational study in multiple   myeloma patients and provide a report with the final analysis when at least   110 PFS events are expected to have occurred in subjects prospectively   exposed to ixazomib.", "ParentId": "22bbd938-fd12-41d1-99b5-3415d8bb5ff3"}, {"Element": "<td style=\"width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"85\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">July 2022</span></p>\n</td>", "ID": "d793f1f4-1beb-4712-9eba-c89f50f245c1", "Styles": "width:63.75pt;border-top:none;border-left:\n  none;border-bottom:solid black 1.0pt;border-right:solid black 1.0pt;\n  background:white;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "8b77e33a-1332-4b80-a052-923207d8394c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">July 2022</span></p>", "ID": "76379a80-62f6-4c64-9952-e3ae5296e5fc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d793f1f4-1beb-4712-9eba-c89f50f245c1"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">July 2022</span>", "ID": "d854c80a-4cbf-4e1d-b21e-bb9917288c92", "Styles": "color:black", "Classes": "None", "Text": "July 2022", "ParentId": "76379a80-62f6-4c64-9952-e3ae5296e5fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dd27b953-d92d-429f-8fd5-af1f13959cd6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f2ab3e1a-46f0-4f9e-a9c7-201935fa6f79", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dd27b953-d92d-429f-8fd5-af1f13959cd6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2d7dd72f-81ad-4e80-bd11-a5ed4c36929b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9812811e-8d32-450d-a7d2-2c54d8d37480", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2d7dd72f-81ad-4e80-bd11-a5ed4c36929b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "05e09878-8670-4885-a07d-693e3558cd49", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "37f57e1a-d8c5-4538-9d49-beafded229b3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "05e09878-8670-4885-a07d-693e3558cd49"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "67014d63-5399-4f66-9cee-e5ee294faac1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3151b6e7-13fd-4958-9ea1-6fb88a309164", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "67014d63-5399-4f66-9cee-e5ee294faac1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "8d86060c-b837-4e1a-b89b-0f5e7770c616", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "caabc192-6263-4f78-bd15-e5d2fdf59542", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8d86060c-b837-4e1a-b89b-0f5e7770c616"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cf24fb3e-a8e5-4dc1-958e-baa6b96f29a7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "caabc192-6263-4f78-bd15-e5d2fdf59542"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "151c9927-f491-4ddf-8743-1ff3f9fcc614", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "e65ab3c3-38de-454f-bfa7-9fe2f1c722e6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "151c9927-f491-4ddf-8743-1ff3f9fcc614"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "737467fe-a802-43c5-a6d7-d5106c52e518", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e65ab3c3-38de-454f-bfa7-9fe2f1c722e6"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "43390aa0-7d88-452b-a351-61b891f92a17", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "20f05e46-c309-429d-a6b5-a1879a83c1ef", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "43390aa0-7d88-452b-a351-61b891f92a17"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "275fe324-c827-43ce-9452-afc249de9b7b", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "20f05e46-c309-429d-a6b5-a1879a83c1ef"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5ee70a27-ccb2-4558-a6db-01b63a168cd0", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "bb2e6aae-e2cc-487c-85ae-4852f7c66a0a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5ee70a27-ccb2-4558-a6db-01b63a168cd0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2fe0b99b-d7e8-4ad3-a94f-a85f88f968f8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bb2e6aae-e2cc-487c-85ae-4852f7c66a0a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5c0ff70d-1557-43f1-ac82-b27dddd7dfd9", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "94b6a5b5-1b9d-4d98-9dd5-bce346580ff4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5c0ff70d-1557-43f1-ac82-b27dddd7dfd9"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b0c97058-6162-4c42-a482-090325c063b7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "94b6a5b5-1b9d-4d98-9dd5-bce346580ff4"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "d12f1c16-5570-452d-9d6b-cb787ad9a0b6", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9a778e6b-9b0e-4d9d-87d3-0921a4647026", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d12f1c16-5570-452d-9d6b-cb787ad9a0b6"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "954da415-e475-4a20-83eb-343be8fdecc4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9a778e6b-9b0e-4d9d-87d3-0921a4647026"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "6cfaf06c-1087-439e-9b84-36e34f45baa2", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "5e2c0912-3f6c-42ef-bcc7-f483ca634710", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6cfaf06c-1087-439e-9b84-36e34f45baa2"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8a8301d7-ab7f-4206-964b-480377b44940", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5e2c0912-3f6c-42ef-bcc7-f483ca634710"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "233fd6e2-7733-4ec3-ac23-f12b2c5e87cb", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "05e07644-34bb-41bf-b139-ce0afa753d2b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "233fd6e2-7733-4ec3-ac23-f12b2c5e87cb"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a37a8f08-d46b-4f00-85d3-ac58cd430b14", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "05e07644-34bb-41bf-b139-ce0afa753d2b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "46757323-1576-476c-9b4f-e4495e4ae44c", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "a0ff469f-7ccd-41e4-85f7-5a925915a18f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "46757323-1576-476c-9b4f-e4495e4ae44c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e707b95-5cb8-4d29-87e9-b018f0ec4581", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a0ff469f-7ccd-41e4-85f7-5a925915a18f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "69397400-a18d-47ad-9cce-88e393aa20d4", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "533bf473-5d96-4dec-8bf2-44667abad4c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "69397400-a18d-47ad-9cce-88e393aa20d4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e8a1064a-0242-4360-ba24-5d781a1a0071", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "533bf473-5d96-4dec-8bf2-44667abad4c0"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "f5b3763f-ea70-4768-9c24-198c0b61d2ff", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d93b2a67-7de5-435c-a550-e61fa17fbb10", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f5b3763f-ea70-4768-9c24-198c0b61d2ff"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ee5708cf-7f96-4248-b225-5939e7cd23fd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d93b2a67-7de5-435c-a550-e61fa17fbb10"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "65f2ed77-8cfd-413e-9bba-210fa2e1ef0b", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "2c674fb8-35b9-4b68-98e1-4193b5be8e9f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65f2ed77-8cfd-413e-9bba-210fa2e1ef0b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d7bbf13b-c8ab-49c5-add0-941f2f917740", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2c674fb8-35b9-4b68-98e1-4193b5be8e9f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "2f0533b4-d300-4ee1-9815-8b454fd0ec1d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "8638b847-16d0-4ccf-ba7c-9364d496a275", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2f0533b4-d300-4ee1-9815-8b454fd0ec1d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "436819a0-46e8-449a-b1f0-6b3f907c2471", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8638b847-16d0-4ccf-ba7c-9364d496a275"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "ade1960f-0a7c-41af-971b-013ebb96529a", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "76a324ed-8e5d-4a63-af00-65877e2534d0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ade1960f-0a7c-41af-971b-013ebb96529a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9a5cb2ca-b050-48a2-b44b-b75047e45220", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "76a324ed-8e5d-4a63-af00-65877e2534d0"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "7b755625-52d2-482a-a774-e967585a629b", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "72580f97-3128-4ebf-9484-c388c82c0d6d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7b755625-52d2-482a-a774-e967585a629b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f160a759-b419-4233-b0e1-a5554fb7eead", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "72580f97-3128-4ebf-9484-c388c82c0d6d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "29432ff4-dbf3-40b2-a994-f378c4c30af0", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9de2b3be-ef0f-4e0a-9b5c-f89c7ac1cb1d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "29432ff4-dbf3-40b2-a994-f378c4c30af0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "76fb3890-71a3-415d-ae15-1fc94ff6aceb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9de2b3be-ef0f-4e0a-9b5c-f89c7ac1cb1d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "a784f105-bebd-448b-a9ec-976ba19ce402", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "38e21a29-84c9-4157-a713-bf0fec1315d8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a784f105-bebd-448b-a9ec-976ba19ce402"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "43f6ec44-68a1-46e0-b57b-c671f3a1dfde", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "38e21a29-84c9-4157-a713-bf0fec1315d8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "68a29309-0f21-4636-82bc-2f126eec708b", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "e24d32d0-79a4-43e0-97bd-317443bdfa62", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "68a29309-0f21-4636-82bc-2f126eec708b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4620eda-35c0-4d06-bf42-1715c273df15", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e24d32d0-79a4-43e0-97bd-317443bdfa62"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "ced2cd85-c920-4ff5-bf4c-de0edb96cbda", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "eb208d6a-002b-43db-8fa7-a31a2b32c588", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ced2cd85-c920-4ff5-bf4c-de0edb96cbda"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bc9833fc-a4f0-476c-a8f4-f980e7bd84eb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "eb208d6a-002b-43db-8fa7-a31a2b32c588"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "6b45bea0-cff7-4419-8b93-c3ad48dac982", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "3e66d78d-bbdb-4f0c-8c84-ff4ea9f8f390", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b45bea0-cff7-4419-8b93-c3ad48dac982"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "49d6b244-9183-4d00-b0c8-b4ecce00f697", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3e66d78d-bbdb-4f0c-8c84-ff4ea9f8f390"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "2f930014-fcf1-44d2-a4de-c566f3408506", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "75681b13-2bd6-4914-83a4-0a35f1baf226", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2f930014-fcf1-44d2-a4de-c566f3408506"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "530cc07d-7cd4-4038-86ec-b155ac332485", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "75681b13-2bd6-4914-83a4-0a35f1baf226"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "17f116da-8ac8-427a-aad1-6138a95ff326", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c127434e-cb31-4a9f-a5d3-96174248ce45", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "17f116da-8ac8-427a-aad1-6138a95ff326"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cdbd61fe-e1f7-46da-8073-347610cad62d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c127434e-cb31-4a9f-a5d3-96174248ce45"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "588aed60-de57-406e-9988-2411fa36cafd", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "de882a2a-e216-422f-9203-73f72168cec9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "588aed60-de57-406e-9988-2411fa36cafd"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "23af5f26-1a68-4a70-9ff3-df84eaee1822", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "de882a2a-e216-422f-9203-73f72168cec9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "83916fd2-82bf-49fe-82ae-85b912e2d533", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "36076481-2e08-43c8-bdfa-aa7fb776530f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "83916fd2-82bf-49fe-82ae-85b912e2d533"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "951b93d2-1dd0-40eb-aab2-d081900f3dd6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "36076481-2e08-43c8-bdfa-aa7fb776530f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "431fb129-4ba7-43f8-8b7b-d9305b555839", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "906bb7ef-a9b9-4d38-81a0-fb5417f601ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "431fb129-4ba7-43f8-8b7b-d9305b555839"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "909bc9a8-2989-43c1-827e-cb1e03d15a53", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "906bb7ef-a9b9-4d38-81a0-fb5417f601ad"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "06a3d307-4f4d-4b00-9aa4-39260030c7ff", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "8d55df69-6dfd-4874-b552-a4c61c75ef3b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "06a3d307-4f4d-4b00-9aa4-39260030c7ff"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "528108f2-afa5-4042-99b7-7d48457f420b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8d55df69-6dfd-4874-b552-a4c61c75ef3b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">ANNEX III</span></b></p>", "ID": "012ea367-4d62-42f7-b414-e07460144f1b", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">ANNEX III</span></b>", "ID": "1fa04354-9bd3-4a9f-bfa0-f5d8b223b6bb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "012ea367-4d62-42f7-b414-e07460144f1b"}, {"Element": "<span lang=\"EN-GB\">ANNEX III</span>", "ID": "bacdaaf6-8605-459d-b2bd-abfe577c297d", "Styles": "None", "Classes": "None", "Text": "ANNEX III", "ParentId": "1fa04354-9bd3-4a9f-bfa0-f5d8b223b6bb"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "29029cb6-c3b3-4d5b-95d5-1549760817b8", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "b50bfa36-c0ed-45a1-9ddd-2387c43aec10", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "29029cb6-c3b3-4d5b-95d5-1549760817b8"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "51369f66-2da2-4f5f-a064-a8bf58691b94", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b50bfa36-c0ed-45a1-9ddd-2387c43aec10"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b></p>", "ID": "077c47c2-864d-4a25-9cbe-dd88e987bc06", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span></b>", "ID": "5f3c3962-c9a4-4f8b-bb22-4ed23e6cebcd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "077c47c2-864d-4a25-9cbe-dd88e987bc06"}, {"Element": "<span lang=\"EN-GB\">LABELLING AND PACKAGE LEAFLET</span>", "ID": "0e1f23ac-f0fc-4431-a17a-dac226b96c6d", "Styles": "None", "Classes": "None", "Text": "LABELLING AND PACKAGE LEAFLET", "ParentId": "5f3c3962-c9a4-4f8b-bb22-4ed23e6cebcd"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "7a52dde1-2469-4b22-81f2-0da6d972cc18", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c8181fb4-78a7-407c-b7d5-cfac76f28246", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7a52dde1-2469-4b22-81f2-0da6d972cc18"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b98768cf-bbf7-401c-8a6d-b28220b3bfe1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c8181fb4-78a7-407c-b7d5-cfac76f28246"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b7f7672c-d591-421a-9f14-ae96934d0ae0", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "2bbe2906-35c7-4803-8b67-b3d35d87ceed", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b7f7672c-d591-421a-9f14-ae96934d0ae0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "470ddd2e-6b9c-4142-9824-1a1b9e6118d3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2bbe2906-35c7-4803-8b67-b3d35d87ceed"}, {"Element": "<b><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span></b>", "ID": "d91487bb-6a1d-4fa6-a7d5-489ddfe4c213", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "b66d7cfe-deb1-46f6-8d02-1c81d1787c0c", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif;\ncolor:black", "Classes": "None", "Text": " ", "ParentId": "d91487bb-6a1d-4fa6-a7d5-489ddfe4c213"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "8d484fe2-4d46-4837-82fa-8692bcd59378", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "b66d7cfe-deb1-46f6-8d02-1c81d1787c0c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "d3f1916d-ec00-4df6-ac3e-ef0e5c0c350a", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "21922e3a-850f-446b-a600-0a9f2baa1853", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d3f1916d-ec00-4df6-ac3e-ef0e5c0c350a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0059e543-d3e2-4bbe-b6da-30765c11798e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "21922e3a-850f-446b-a600-0a9f2baa1853"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "4507c551-0b04-4948-a896-7afdebf8efce", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "0de83b9d-f7aa-410c-80ec-947f326a33b1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4507c551-0b04-4948-a896-7afdebf8efce"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ff03844e-1cbd-4433-aa50-b27953881938", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0de83b9d-f7aa-410c-80ec-947f326a33b1"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "cd687d4b-b974-4cee-af86-1b1491ebd1b1", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "2651426e-d5cb-484a-83fe-b1d907e26694", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cd687d4b-b974-4cee-af86-1b1491ebd1b1"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cbd14d58-b2cf-4cc2-9f99-f0035b75017f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2651426e-d5cb-484a-83fe-b1d907e26694"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b44d329f-e7bf-464f-857b-90daee8d66f1", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "ff1104aa-f44a-4203-afce-36564c750f3c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b44d329f-e7bf-464f-857b-90daee8d66f1"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a74c722a-7fb3-483d-b210-b4085df63845", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ff1104aa-f44a-4203-afce-36564c750f3c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "8c30dfa7-9813-4507-bba4-ff1bf5a0431b", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "79b5b4c2-3144-4801-a495-5d6cc6fd3cad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8c30dfa7-9813-4507-bba4-ff1bf5a0431b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9f3000c6-df7e-41c6-b93b-ad5555ceb685", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "79b5b4c2-3144-4801-a495-5d6cc6fd3cad"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "d71da0e8-53a5-48de-806d-042c83377164", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "b8774dbd-0bd0-4811-aa19-24de4862d42a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d71da0e8-53a5-48de-806d-042c83377164"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1b6b19b6-6845-46a4-9eb8-267f714839e4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b8774dbd-0bd0-4811-aa19-24de4862d42a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5cb6b2ca-889c-4ce8-8158-ad5cfa913146", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "7daf778c-36f3-46b1-8310-5b7257db4663", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5cb6b2ca-889c-4ce8-8158-ad5cfa913146"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3ba521ee-77cf-4850-b502-0f5bda2979d5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7daf778c-36f3-46b1-8310-5b7257db4663"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "57d60e5d-03ab-491b-98c2-895e834a4045", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "01778509-1b2c-40f7-bf40-77a712eb08e8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "57d60e5d-03ab-491b-98c2-895e834a4045"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f1f319a2-8283-4b21-b6fc-5bdbea94ae62", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "01778509-1b2c-40f7-bf40-77a712eb08e8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "51979c4e-2621-4714-9cbf-f42ac5642031", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "fdd9aefc-b9c6-4745-963d-5ed4aca65da0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "51979c4e-2621-4714-9cbf-f42ac5642031"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "08f79a9a-8504-457b-b3fa-30ce5ba629de", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fdd9aefc-b9c6-4745-963d-5ed4aca65da0"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "f9b5f51e-dc05-4a15-92f3-bd493ed15d8e", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "40029bed-7de0-43ec-abdb-656d20b01458", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f9b5f51e-dc05-4a15-92f3-bd493ed15d8e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "48c0f4b1-866f-4366-8f91-1a8d9a818cb9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "40029bed-7de0-43ec-abdb-656d20b01458"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "38f5ddf6-9b35-4c11-849b-fc73f723b66c", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "e3abd64d-02e7-45da-8658-89a461665e0a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "38f5ddf6-9b35-4c11-849b-fc73f723b66c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "85769b3d-b320-4cb7-9999-3ded0b70ca8c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e3abd64d-02e7-45da-8658-89a461665e0a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "369a789b-da66-413f-84c8-970bf44bb838", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "5288b04f-7078-4543-bc93-6420b4efaee7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "369a789b-da66-413f-84c8-970bf44bb838"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b5d07406-a035-4972-948c-0ff436ed0bc1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5288b04f-7078-4543-bc93-6420b4efaee7"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "7feb1931-bb7c-48b6-bab6-2f3917b09361", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d08fe421-0361-4673-b5ed-cae98b606187", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7feb1931-bb7c-48b6-bab6-2f3917b09361"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d9116268-65e7-4383-a0d3-1c6329e8e397", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d08fe421-0361-4673-b5ed-cae98b606187"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0e970c2e-e42f-463f-b1c6-7a903b1af128", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "7932f84b-5bd0-458f-95d7-a243e8022818", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0e970c2e-e42f-463f-b1c6-7a903b1af128"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a07bfea3-e466-492e-b757-56cc1383fc90", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7932f84b-5bd0-458f-95d7-a243e8022818"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "6b8ee33f-1477-4208-97cc-d211a94636d9", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c8b39335-4211-4cb1-a101-688c836d310b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6b8ee33f-1477-4208-97cc-d211a94636d9"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9c276dde-d9c6-405f-93f4-0e407f0882ec", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c8b39335-4211-4cb1-a101-688c836d310b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "033723a4-5807-4edd-91c0-d0a678f55fb7", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f99d35a3-2bbe-49d1-9292-4f671fa7aaad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "033723a4-5807-4edd-91c0-d0a678f55fb7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f13438c6-91cb-4a03-9c10-120ad06b447a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f99d35a3-2bbe-49d1-9292-4f671fa7aaad"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9ddf4db1-f3b2-4830-a065-9bae68f18af5", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "504e847a-b3b0-454a-b2df-6c707665fa28", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9ddf4db1-f3b2-4830-a065-9bae68f18af5"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1060a04b-04ce-450d-91fd-1804cac171a4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "504e847a-b3b0-454a-b2df-6c707665fa28"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "77ba82e9-83ea-4fc5-b7cf-9c556fd0f70a", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "573e41d2-f98b-486a-9a19-2b97fa04a3d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "77ba82e9-83ea-4fc5-b7cf-9c556fd0f70a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a6b074c5-ab32-4944-ad30-ccdaec2ba181", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "573e41d2-f98b-486a-9a19-2b97fa04a3d2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "b9689335-2629-4c92-80dc-1ca8cb2b40da", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "24f1deba-9b82-4ce0-9b3e-ff3cb5ecf90d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b9689335-2629-4c92-80dc-1ca8cb2b40da"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d05f7cac-a76b-4f6d-9385-66bb4a975dff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "24f1deba-9b82-4ce0-9b3e-ff3cb5ecf90d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "51e5e692-f69f-4a7d-bc1a-3783330f1e22", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "6d93477a-91bf-46e4-b819-299ff816cf48", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "51e5e692-f69f-4a7d-bc1a-3783330f1e22"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0ae4c67e-096e-42e4-bd40-fbdcae337daa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6d93477a-91bf-46e4-b819-299ff816cf48"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "c7dc988c-fdb3-464c-8cd7-aef62e5e5498", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f80eb7c6-a289-4b20-b6bf-31cf355ba644", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c7dc988c-fdb3-464c-8cd7-aef62e5e5498"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b36267ba-897f-45e9-b881-4106af500801", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f80eb7c6-a289-4b20-b6bf-31cf355ba644"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0ee78006-6712-4dc2-9a52-328628cd7551", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "24d1e708-d269-432f-a50f-3f8727fa0a1a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0ee78006-6712-4dc2-9a52-328628cd7551"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a9059163-69b9-42c4-b432-c98bc4506b9b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "24d1e708-d269-432f-a50f-3f8727fa0a1a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "dd3dd270-bcae-44dd-a298-131951d9359d", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9ad8264b-978e-41a2-af0f-aa396099de75", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dd3dd270-bcae-44dd-a298-131951d9359d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5bed50ea-6c69-41c9-ba85-9084df109db7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9ad8264b-978e-41a2-af0f-aa396099de75"}, {"Element": "<p class=\"TitleA\"><span lang=\"EN-GB\">A. LABELLING</span></p>", "ID": "860589e8-3b78-428a-8fb3-7983690977ea", "Styles": "None", "Classes": "['TitleA']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">A. LABELLING</span>", "ID": "85b0b5b6-e057-48d6-8c66-36de689a2ace", "Styles": "None", "Classes": "None", "Text": "A. LABELLING", "ParentId": "860589e8-3b78-428a-8fb3-7983690977ea"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "620326e5-82b3-4a56-b6ab-a9165c2bd283", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d97ac24f-30c1-48dc-81ba-0fa7080bd775", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "620326e5-82b3-4a56-b6ab-a9165c2bd283"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0652eb2b-7204-47c6-8f85-baeffa276f2f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d97ac24f-30c1-48dc-81ba-0fa7080bd775"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "3239b8f9-5b99-447c-ba63-f5d6d88e8d5a", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "c858802d-2ba3-4c36-9899-9d9d6034a282", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3239b8f9-5b99-447c-ba63-f5d6d88e8d5a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7e9c7a37-32c3-4aa4-8345-93de720a4366", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c858802d-2ba3-4c36-9899-9d9d6034a282"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always;\nbackground:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2e8e8eab-7c26-4b10-99f6-9b249da5b15e", "Styles": "line-height:normal;page-break-before:always;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7c3c2010-d5cc-458f-9f6a-e15728357c1a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2e8e8eab-7c26-4b10-99f6-9b249da5b15e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS</span></b></p>\n</div>", "ID": "1e158df1-4c1e-48fb-a8a0-e115d6893446", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>", "ID": "095e4f47-02a0-459f-88a3-77a7d959eeb1", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1e158df1-4c1e-48fb-a8a0-e115d6893446"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b>", "ID": "ad4d1eab-42ff-4b85-85c6-5c9776f50b98", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "095e4f47-02a0-459f-88a3-77a7d959eeb1"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span>", "ID": "d271662e-d283-4d20-906d-d3d32258d638", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING", "ParentId": "ad4d1eab-42ff-4b85-85c6-5c9776f50b98"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "f8df06e1-38d2-419a-bd33-6477f8c6a793", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1e158df1-4c1e-48fb-a8a0-e115d6893446"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "04f5412c-9c7b-4e0f-866c-93e4e8ef3b9a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f8df06e1-38d2-419a-bd33-6477f8c6a793"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "88fb23ff-0092-48bf-b734-a6fb9dc65ae2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "04f5412c-9c7b-4e0f-866c-93e4e8ef3b9a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS</span></b></p>", "ID": "afc08826-a593-4c37-bfe3-88d97aa465f1", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1e158df1-4c1e-48fb-a8a0-e115d6893446"}, {"Element": "<b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS</span></b>", "ID": "3b5cfc7a-58d7-4177-af3a-3733ab7f4352", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "afc08826-a593-4c37-bfe3-88d97aa465f1"}, {"Element": "<span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS</span>", "ID": "54181ef3-b7a8-4519-b018-949a42062256", "Styles": "None", "Classes": "None", "Text": "CARTON CONTAINING WALLET UNIT PACKS", "ParentId": "3b5cfc7a-58d7-4177-af3a-3733ab7f4352"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8d5488b1-e156-484f-8aaf-46451d4cf9b2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "eaeaa302-6233-4eae-b4ad-87446329fea5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8d5488b1-e156-484f-8aaf-46451d4cf9b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6555da72-0c06-4c7f-ba86-7db1bd4b5392", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4faeedb1-56f8-49c8-ba80-fd9fe35576f3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6555da72-0c06-4c7f-ba86-7db1bd4b5392"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "507f125b-7ee1-4f22-9be5-6880bcd2dd4a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "cc9e1fb2-f9c2-4220-aa6a-9aa095f4c516", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "507f125b-7ee1-4f22-9be5-6880bcd2dd4a"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "fd7a5e5b-7f6c-4adc-81a6-7958a25626a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cc9e1fb2-f9c2-4220-aa6a-9aa095f4c516"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "ac94e882-34c6-449d-9b05-4237f24796f8", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "fd7a5e5b-7f6c-4adc-81a6-7958a25626a1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4db60970-624c-4e35-863c-9b4e83fcd7f7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5392a07b-605c-425e-a0d1-04d384e99b34", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4db60970-624c-4e35-863c-9b4e83fcd7f7"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3\u00a0mg\nhard capsules</span></p>", "ID": "b39ea34f-e100-4405-937e-0cd505ee1342", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3\u00a0mg\nhard capsules</span>", "ID": "66744413-34fb-4d63-90f9-8abb25f1ddcb", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 2.3\u00a0mg hard capsules", "ParentId": "b39ea34f-e100-4405-937e-0cd505ee1342"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>", "ID": "3647bbf8-112d-4461-8057-48ca5921fe90", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib </span>", "ID": "03ae0e95-5ff5-425d-9e12-8bd0174fb53f", "Styles": "None", "Classes": "None", "Text": "ixazomib ", "ParentId": "3647bbf8-112d-4461-8057-48ca5921fe90"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1a8a7bc5-2221-47e5-9f12-e13ae00820c1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2294d222-4dbc-46bf-80c6-91dd20782987", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1a8a7bc5-2221-47e5-9f12-e13ae00820c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "300bcfe3-747d-4258-9796-dc1f7cf012b1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e1b82fd4-d495-4450-8c93-98cb37b0cb1b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "300bcfe3-747d-4258-9796-dc1f7cf012b1"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>", "ID": "2081d32b-4393-4cac-9c74-3151d52aa485", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>", "ID": "3234a9e1-3cb2-492c-a9b4-d6768397e8a6", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2081d32b-4393-4cac-9c74-3151d52aa485"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b>", "ID": "74aa5d24-9bcd-4e73-89a4-042367f71701", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3234a9e1-3cb2-492c-a9b4-d6768397e8a6"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span>", "ID": "8df034a0-ef54-4b00-9f7d-f26bc92b653b", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "74aa5d24-9bcd-4e73-89a4-042367f71701"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "26933349-5a9f-4d57-8c32-1f583d6dac1b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "27f8aace-2fc0-4879-a27c-1f236d6ce38d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "26933349-5a9f-4d57-8c32-1f583d6dac1b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 2.3 mg of ixazomib (as 3.3 mg of ixazomib\ncitrate)</span></p>", "ID": "5fa0ea22-7d20-4f60-889c-4c1756ff270a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Each hard capsule contains 2.3 mg of ixazomib (as 3.3 mg of ixazomib\ncitrate)</span>", "ID": "dc0f2c7d-3e94-44ef-a158-15994dc3af8f", "Styles": "None", "Classes": "None", "Text": "Each hard capsule contains 2.3 mg of ixazomib (as 3.3 mg of ixazomib citrate)", "ParentId": "5fa0ea22-7d20-4f60-889c-4c1756ff270a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1f6d90b8-383f-4847-959f-01d792c13dc6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a36ac28f-608a-4f8a-a048-0ef6c9a66c42", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1f6d90b8-383f-4847-959f-01d792c13dc6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "440dc562-e4d9-4d7f-ba66-0cd74a72e6d9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "962bdd54-a4d4-4309-be68-4c51aaf9840f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "440dc562-e4d9-4d7f-ba66-0cd74a72e6d9"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>", "ID": "89431293-6c99-49f4-97c9-e124dbeb22e3", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>", "ID": "0135cd0c-dc37-42e1-8ddd-872c24bf27af", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89431293-6c99-49f4-97c9-e124dbeb22e3"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b>", "ID": "7e4136ce-8805-492f-8007-cdbeeb4d6ca6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0135cd0c-dc37-42e1-8ddd-872c24bf27af"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span>", "ID": "a97f56f3-c69e-4436-b6fe-dd6499cbb086", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "7e4136ce-8805-492f-8007-cdbeeb4d6ca6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "94197365-154b-4134-81e3-80ee09be2865", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e8fdbdc6-b45c-4765-bf54-d3020d3c4dd0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "94197365-154b-4134-81e3-80ee09be2865"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "986d3ba7-4f20-4c76-ba73-bbbdd60b37f5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6099ffcf-736d-445f-9fff-f59dccb43a79", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "986d3ba7-4f20-4c76-ba73-bbbdd60b37f5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>", "ID": "0cb285ee-5a20-4c5e-85ee-d72fbe3b400f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>", "ID": "e8a001c0-f3d7-45ce-85ee-04a84d3b1d1d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0cb285ee-5a20-4c5e-85ee-d72fbe3b400f"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b>", "ID": "1a7bcdac-ce72-469a-a933-90f84516b45f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e8a001c0-f3d7-45ce-85ee-04a84d3b1d1d"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span>", "ID": "66b3302f-2efa-4f69-8131-bdd7690a9953", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "1a7bcdac-ce72-469a-a933-90f84516b45f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9dfa5cd3-18f4-4753-9599-58475a352d8d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c829ba21-c1fb-47d9-baa9-4b649e56e745", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9dfa5cd3-18f4-4753-9599-58475a352d8d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Hard capsule</span></p>", "ID": "8e9b540d-56d7-4b6c-8c6b-88f8751f2fef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">Hard capsule</span>", "ID": "75567b81-87ee-4bfc-a296-ca972f632632", "Styles": "background:silver", "Classes": "None", "Text": "Hard capsule", "ParentId": "8e9b540d-56d7-4b6c-8c6b-88f8751f2fef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "e6d622a8-3b27-4211-b573-5aaa35fd83c9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "56152250-a2c9-427b-8527-4abbefaed5e6", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "e6d622a8-3b27-4211-b573-5aaa35fd83c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3 packs of 1\nhard capsule.</span></p>", "ID": "c18c70b1-7806-4a62-8593-6a6ccb797268", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">3 packs of 1\nhard capsule.</span>", "ID": "5951501a-48e8-446d-8fbc-34ea59d0fb92", "Styles": "None", "Classes": "None", "Text": "3 packs of 1 hard capsule.", "ParentId": "c18c70b1-7806-4a62-8593-6a6ccb797268"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a8cbb0dd-a26b-40ed-9729-faddd33e3bf1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cf4fe54f-3836-47ff-a1db-02abb2041aed", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a8cbb0dd-a26b-40ed-9729-faddd33e3bf1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0124ed7d-1efe-4362-9340-e1505e443f35", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b8a2414f-8064-4f62-89b2-067125e881ee", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0124ed7d-1efe-4362-9340-e1505e443f35"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>", "ID": "ff83d7aa-8321-467c-8715-0da3c2a8d0cc", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>", "ID": "8a89ee91-8401-4a39-99f6-19ed03e23d2a", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ff83d7aa-8321-467c-8715-0da3c2a8d0cc"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b>", "ID": "40f41f6b-5a0f-40c6-9878-bb905b36ffa0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8a89ee91-8401-4a39-99f6-19ed03e23d2a"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span>", "ID": "f46d4c2a-a8be-47a1-875f-f52c998c6591", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "40f41f6b-5a0f-40c6-9878-bb905b36ffa0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "950ebd17-2ab3-41c1-8464-8ea565953726", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b1c2325f-7ff6-4e9f-acd2-2f697192645c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "950ebd17-2ab3-41c1-8464-8ea565953726"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span></p>", "ID": "3af01011-2104-45f7-b267-bd70da55333c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Read the package\nleaflet before use</span>", "ID": "7fd6f6a7-3904-4286-be4b-9f1f853bab92", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use", "ParentId": "3af01011-2104-45f7-b267-bd70da55333c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>", "ID": "b39bc0a2-a4cd-4638-96e7-d93927ec15ed", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Oral use</span>", "ID": "0a347a6d-294d-45e5-bb0b-a5423fd4aa4d", "Styles": "None", "Classes": "None", "Text": "Oral use", "ParentId": "b39bc0a2-a4cd-4638-96e7-d93927ec15ed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a50cc9ca-5dd4-45df-9c29-74c3d324170b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4f3dd9d-8523-4738-a930-12046885fcb1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a50cc9ca-5dd4-45df-9c29-74c3d324170b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fa25745d-1b11-4b0d-bc0c-5c920048620d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "24ddadff-9f0b-4d99-95e6-68744672174a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa25745d-1b11-4b0d-bc0c-5c920048620d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>", "ID": "946c2741-7c51-4c8c-86b0-c311b5259230", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>", "ID": "97261824-f8a7-4ce5-bf7c-2c27222df198", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "946c2741-7c51-4c8c-86b0-c311b5259230"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b>", "ID": "b59434c7-ca12-4bb1-9b7f-12f11ecb4b1a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "97261824-f8a7-4ce5-bf7c-2c27222df198"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span>", "ID": "671d0160-abc9-46a0-abdd-05690b12fdd6", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "b59434c7-ca12-4bb1-9b7f-12f11ecb4b1a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b504058f-87e5-4ab3-94f8-f306ffd35a55", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f63aca73-d64d-4f54-b75f-6e59e3973609", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b504058f-87e5-4ab3-94f8-f306ffd35a55"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>", "ID": "b7ba9583-1104-4ebe-83f7-6b08341b6ad1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span>", "ID": "4916a302-b87f-4deb-a65c-da42f0fe96c7", "Styles": "None", "Classes": "None", "Text": "Keep out of the sight and reach of children", "ParentId": "b7ba9583-1104-4ebe-83f7-6b08341b6ad1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e58525b7-dad8-4309-879e-9c6745a256b3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "840e3a4f-d5a9-4f64-84b4-32a08ab2b6a2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e58525b7-dad8-4309-879e-9c6745a256b3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "520e5a5a-a24d-437d-a1c5-f889be77780f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8a9cf8c0-77bf-406a-807e-f76f1d81c902", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "520e5a5a-a24d-437d-a1c5-f889be77780f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>", "ID": "82335109-b998-4eca-9faa-c3f5758857ac", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>", "ID": "62625cd2-1935-4016-a2a0-d9881289269e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "82335109-b998-4eca-9faa-c3f5758857ac"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b>", "ID": "6219fa18-cbab-4e1b-8a6b-1038bfb62a3d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "62625cd2-1935-4016-a2a0-d9881289269e"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span>", "ID": "84738bae-0e19-4608-bceb-42f6ed4fa8db", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "6219fa18-cbab-4e1b-8a6b-1038bfb62a3d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "198df7f2-187a-40b2-8808-5cb3d6032a98", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e9fd147e-8adb-473e-ac9b-95f15a272a3b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "198df7f2-187a-40b2-8808-5cb3d6032a98"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>", "ID": "952052f9-a14d-49e5-9996-f76977f5b890", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Cytotoxic</span>", "ID": "852b594f-4ae1-4e4e-85d3-e746e9d301b1", "Styles": "None", "Classes": "None", "Text": "Cytotoxic", "ParentId": "952052f9-a14d-49e5-9996-f76977f5b890"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0db9f3a3-107b-4439-9faa-190b71d721de", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7500f616-979c-4c05-97d6-b7aff943c40e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0db9f3a3-107b-4439-9faa-190b71d721de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9c112131-bf28-4597-ad7e-8693dfdae0dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3be5481f-9c64-42ab-aa4b-429e6e3db1da", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9c112131-bf28-4597-ad7e-8693dfdae0dc"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "31a878b6-608f-458f-8ce1-03c51bf433b3", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "ef2b6bd8-8564-48a2-817f-4f444484c583", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "31a878b6-608f-458f-8ce1-03c51bf433b3"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "6c27c7ef-2695-4a9f-b33c-aaa242017157", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ef2b6bd8-8564-48a2-817f-4f444484c583"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "901440b7-850f-492e-abf7-e733b1ee9a55", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "6c27c7ef-2695-4a9f-b33c-aaa242017157"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "51c62a93-2b63-4c66-b764-f00623c7849a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "29564427-5ad4-4788-b97e-db755c6699b9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "51c62a93-2b63-4c66-b764-f00623c7849a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "a85896f2-a907-4912-8133-9116a52aab10", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "b9012d4e-480d-4569-909a-f480a687019a", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "a85896f2-a907-4912-8133-9116a52aab10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f34a3ce3-3f34-4f89-bbdd-de810edf2933", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6fcf1b29-9890-4270-9e35-88e81c05267e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f34a3ce3-3f34-4f89-bbdd-de810edf2933"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f1439efc-2077-4e19-9011-ea2766d7ecc3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d1d70f83-8e66-4703-bc1e-f47a4a62963f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f1439efc-2077-4e19-9011-ea2766d7ecc3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "c7b7ddbb-92ea-4691-829e-86cc5e8a925d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "46749afe-382d-4c25-b3c3-a142474c7780", "Styles": "line-height:normal;page-break-after:avoid;border:\nnone;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c7b7ddbb-92ea-4691-829e-86cc5e8a925d"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "4dc00d7d-0687-4a51-8744-6bfabceeb2b1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "46749afe-382d-4c25-b3c3-a142474c7780"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "c632b21b-3ec6-48c5-a669-0702647938a6", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "4dc00d7d-0687-4a51-8744-6bfabceeb2b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "59e42381-bf0c-45a8-b466-75e7a6d8264f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5c80eaf8-d2a0-46f9-8ea0-896d83bf9c4b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "59e42381-bf0c-45a8-b466-75e7a6d8264f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span></p>", "ID": "d2cd7334-f12d-4fa2-8b52-49cc5144e207", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span>", "ID": "70bfd391-12c5-44ae-aa61-37e011405a03", "Styles": "None", "Classes": "None", "Text": "Do not store above 30\u00baC. Do not freeze. ", "ParentId": "d2cd7334-f12d-4fa2-8b52-49cc5144e207"}, {"Element": "<p class=\"Default\"><span style=\"font-size:11.0pt\">Store in the original package\nin order to protect from moisture.</span></p>", "ID": "b6ffd88a-fe94-4146-8a61-d0675c1cb950", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"font-size:11.0pt\">Store in the original package\nin order to protect from moisture.</span>", "ID": "0c02f801-c432-4fff-9028-b3ce915be9b7", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Store in the original package in order to protect from moisture.", "ParentId": "b6ffd88a-fe94-4146-8a61-d0675c1cb950"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "77fb310d-a751-45b8-84da-254ffc1d5553", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "059d1927-9f98-4242-90ef-f7c873c5cee9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "73ec6fe5-bdb3-401d-8d3e-c70d90b8a619", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "545dc039-4755-43e1-8d3c-b60ffcf749fd", "Styles": "line-height:normal;page-break-after:avoid;border:\nnone;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "73ec6fe5-bdb3-401d-8d3e-c70d90b8a619"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span></b>", "ID": "489fc526-cb86-41cb-80dc-24c5e340fa79", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "545dc039-4755-43e1-8d3c-b60ffcf749fd"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL\nPRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS\nDERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE</span>", "ID": "f985126f-90c2-4433-813f-a08207529c8f", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "489fc526-cb86-41cb-80dc-24c5e340fa79"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "20d8ce7e-9c7c-44b2-be78-8396627c2a0d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ffbc7c9a-c5be-4d4d-b904-5c77b9bdb718", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "20d8ce7e-9c7c-44b2-be78-8396627c2a0d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e133e69b-8ffe-4d1b-a0a0-3f0e25c4e754", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "287cb774-21c9-4091-ad74-5df0839e3348", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e133e69b-8ffe-4d1b-a0a0-3f0e25c4e754"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "b136a9ef-7cf6-452b-ba09-403ea072b08f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "98f70427-149a-4f3c-a891-3422667de79d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b136a9ef-7cf6-452b-ba09-403ea072b08f"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "9fb45bd9-76d7-4c4a-a6f6-9a4270fd37ac", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "98f70427-149a-4f3c-a891-3422667de79d"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "5ed64c24-6342-4a47-9274-216ee3f7ae25", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "9fb45bd9-76d7-4c4a-a6f6-9a4270fd37ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "af273d4b-3fb7-45ab-b88f-5d5b197c5309", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f0702752-9569-44bb-aaf5-d5090a2ecfd0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "af273d4b-3fb7-45ab-b88f-5d5b197c5309"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>", "ID": "ed464134-796b-4e75-9084-af0fecea80da", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma\nA/S </span>", "ID": "7bf85ea0-379d-494d-9646-f466459cac1a", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S ", "ParentId": "ed464134-796b-4e75-9084-af0fecea80da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\">Delta\nPark 45</span><span style=\"border:none windowtext 1.0pt;padding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>", "ID": "82122f3f-d1a1-4bd3-83ba-cc1d0d87efe8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span class=\"readonlyfield1\">Delta\nPark 45</span>", "ID": "ce304b68-e024-43d1-9f17-0343e5c5291e", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "Delta Park 45", "ParentId": "82122f3f-d1a1-4bd3-83ba-cc1d0d87efe8"}, {"Element": "<span style=\"border:none windowtext 1.0pt;padding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span>", "ID": "3c9aa068-d030-41e6-8697-6fbedc48700e", "Styles": "border:none windowtext 1.0pt;padding:0in", "Classes": "None", "Text": " ", "ParentId": "82122f3f-d1a1-4bd3-83ba-cc1d0d87efe8"}, {"Element": "<br/>", "ID": "1ef1141f-ce93-4208-8866-a97a134acdbd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3c9aa068-d030-41e6-8697-6fbedc48700e"}, {"Element": "<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span>", "ID": "de3b6128-6864-4dc6-8d64-32b176da0343", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "2665 Vallensbaek Strand", "ParentId": "3c9aa068-d030-41e6-8697-6fbedc48700e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Denmark</p>", "ID": "7693f13b-50a9-4b57-ba6e-4192eedd447a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Denmark", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "89970dba-9399-4e1c-986b-8464b7d5d566", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "74ec139d-151d-4040-8858-443aec4ce569", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "22b5c2f9-4ff3-438f-bae2-4d5ec9a8e2ed", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "e9ee3b93-44f2-44df-9f48-72e218878372", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "22b5c2f9-4ff3-438f-bae2-4d5ec9a8e2ed"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "6bbde92d-16f7-4ebb-a1f2-692aa88a5a1e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e9ee3b93-44f2-44df-9f48-72e218878372"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "e94296d0-6bf9-4e80-a800-12d42c1233a0", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "6bbde92d-16f7-4ebb-a1f2-692aa88a5a1e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "177aa016-ee81-4b7d-8a2a-0334754c4a8e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1af00aa2-a960-465e-a3ed-fe0dd6162e35", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "177aa016-ee81-4b7d-8a2a-0334754c4a8e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/001</span></p>", "ID": "fe462d01-08cc-47d2-be59-259f553463fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/001</span>", "ID": "a5f17d63-ba4c-4c1b-9589-f8433f73dba2", "Styles": "color:black", "Classes": "None", "Text": "EU/1/16/1094/001", "ParentId": "fe462d01-08cc-47d2-be59-259f553463fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "863fc833-5b01-46f0-99f3-b9ec8fc5f0e0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0f3a80e2-67a7-4be1-97ca-e51813f3d40f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "863fc833-5b01-46f0-99f3-b9ec8fc5f0e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b5af7a4b-b3c6-439e-be34-03fabd04f9a1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "67f2c864-166a-4334-915e-13d1a9640944", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b5af7a4b-b3c6-439e-be34-03fabd04f9a1"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "93d62fe9-22ec-41c9-82af-dfcd58ce0ac7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "3c2def25-8ae2-48d6-a378-add94c101299", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "93d62fe9-22ec-41c9-82af-dfcd58ce0ac7"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "fdf782be-439d-4a23-b167-3ddb4d109935", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3c2def25-8ae2-48d6-a378-add94c101299"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "67564943-253b-41ca-af84-8f6d23406a49", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "fdf782be-439d-4a23-b167-3ddb4d109935"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "8b154b59-6c54-4d44-9f48-9d5a644815dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "6cd528ca-39b3-44d0-9eac-3f9952dbbd5c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8b154b59-6c54-4d44-9f48-9d5a644815dc"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ed0ab381-1016-4579-bd01-54e03eb5a743", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6cd528ca-39b3-44d0-9eac-3f9952dbbd5c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "1c6375f9-e8f9-4203-b3fa-60252b8ed4a8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "cf8ddc49-dbc6-42f1-bea4-a388f187ffb6", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "1c6375f9-e8f9-4203-b3fa-60252b8ed4a8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e3abb7ea-7cb9-49cd-a9e9-010bbc7a9023", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ffc164c4-23a5-48b2-8f67-65861eb3285d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e3abb7ea-7cb9-49cd-a9e9-010bbc7a9023"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1121fdcb-fd96-4e1e-9534-e41112e7591c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c0d25ed7-36a8-4d57-8f3b-369ff119d364", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1121fdcb-fd96-4e1e-9534-e41112e7591c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "3efc62cd-cb14-4e92-9838-44e4842bb34f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "00f40017-71f4-4789-9745-65a4e7803522", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3efc62cd-cb14-4e92-9838-44e4842bb34f"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "d68b2fa3-b943-4a5d-9f20-63352c7cf644", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "00f40017-71f4-4789-9745-65a4e7803522"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "b51fa1f8-a491-4ec8-aa1f-ea939ea9b000", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "d68b2fa3-b943-4a5d-9f20-63352c7cf644"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "900ef84f-3e73-4829-9400-9bcf187811ba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "f821b63e-c588-48f6-b0b8-3bd12f3d6ff0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "900ef84f-3e73-4829-9400-9bcf187811ba"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b255a189-a240-4e92-b09e-72234fc2e1fe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f821b63e-c588-48f6-b0b8-3bd12f3d6ff0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "890319bf-fc82-473c-9e87-a12acae633e4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "180edf74-b7e9-401c-a18b-4ccc75bc3c77", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "890319bf-fc82-473c-9e87-a12acae633e4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "830155c1-af3e-4f1d-b61e-37fd42d85cf6", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "79c74eac-03d0-422b-9024-1d8c96d99796", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "830155c1-af3e-4f1d-b61e-37fd42d85cf6"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "5d04fca0-151c-4702-96c3-84a66eeee202", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "79c74eac-03d0-422b-9024-1d8c96d99796"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "f687268b-76e3-4ba8-8aa6-72e9d2dc9fe3", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "5d04fca0-151c-4702-96c3-84a66eeee202"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9726dc47-c954-4624-b3e1-a0fe7bafb1e0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7ba98722-6416-4248-bead-01cae291b203", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9726dc47-c954-4624-b3e1-a0fe7bafb1e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "db3f450d-ed83-4b19-a5fa-9d76ccdbd38e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "46e41456-757e-4aac-ad4a-89f7a01f6d00", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "db3f450d-ed83-4b19-a5fa-9d76ccdbd38e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "3c1a75c9-023d-461d-b7d7-5349aea4c346", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "90fc2b34-3013-48d4-b3f3-c48c81804bf6", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3c1a75c9-023d-461d-b7d7-5349aea4c346"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "e19095d0-eba7-453d-8910-4f2cf15055e9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "90fc2b34-3013-48d4-b3f3-c48c81804bf6"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "17c7e8a6-b8f6-4127-9e28-613cddce8983", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "e19095d0-eba7-453d-8910-4f2cf15055e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d14446bc-881e-4be4-b98d-02226254d382", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2a46df29-5bd3-4493-96f8-0bc5a07433cf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d14446bc-881e-4be4-b98d-02226254d382"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3\u00a0mg </span></p>", "ID": "6fef527c-c608-4693-9d7c-102d089c9843", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3\u00a0mg </span>", "ID": "d92cc77d-2110-45a0-bba6-0dc367648eec", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 2.3\u00a0mg ", "ParentId": "6fef527c-c608-4693-9d7c-102d089c9843"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "38ab4bfe-0eb7-4b01-b5ee-6df9d675efe2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "a3257838-dc4a-41c0-a915-6567cdabed36", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "38ab4bfe-0eb7-4b01-b5ee-6df9d675efe2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "092f53a1-ad6c-4077-b03c-e946b8ab80ca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "c3618581-632b-4d02-b1b5-a97da090474f", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "092f53a1-ad6c-4077-b03c-e946b8ab80ca"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "94cb45e2-0aad-4c48-9779-189ce4f5129e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "b8fc3dbc-66c3-462f-b2e6-8b8b8d85998c", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94cb45e2-0aad-4c48-9779-189ce4f5129e"}, {"Element": "<b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "446935dd-38c2-47c1-a1a9-0f6ebcac2953", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b8fc3dbc-66c3-462f-b2e6-8b8b8d85998c"}, {"Element": "<span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span>", "ID": "d2deddb3-ece9-40c9-aa13-34c60fc0c8aa", "Styles": "None", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "446935dd-38c2-47c1-a1a9-0f6ebcac2953"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5b07015e-ca39-40e3-bc4d-afe02585ca4c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "397b9682-6fc2-4944-a2e8-895df668c0a0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5b07015e-ca39-40e3-bc4d-afe02585ca4c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">2D barcode carrying the unique identifier included.</span></p>", "ID": "438f4ed0-f021-4a51-87a5-b323d9b9f8af", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">2D barcode carrying the unique identifier included.</span>", "ID": "9b719000-e939-4e6e-83ad-3e6687556718", "Styles": "background:silver", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "438f4ed0-f021-4a51-87a5-b323d9b9f8af"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5ec4caf5-4598-4889-9e02-b1bb18ec8807", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "077eed83-1ec9-4b7b-9e9d-0c8c269648b2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5ec4caf5-4598-4889-9e02-b1bb18ec8807"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d9fae8b5-b026-4fa6-a980-05a50706b3f3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "becf5069-fa4e-44de-bd98-7b60acf1633b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d9fae8b5-b026-4fa6-a980-05a50706b3f3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "d06df70f-8eae-4f8a-8ddb-0af7f9281c17", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>", "ID": "2868b57b-ea64-4e42-9a7d-99ecd6d7464d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d06df70f-8eae-4f8a-8ddb-0af7f9281c17"}, {"Element": "<b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b>", "ID": "f0bde047-842a-42aa-9e93-e6d289695e19", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2868b57b-ea64-4e42-9a7d-99ecd6d7464d"}, {"Element": "<span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span>", "ID": "9568cc23-19de-4414-9be3-d576457feca1", "Styles": "None", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA", "ParentId": "f0bde047-842a-42aa-9e93-e6d289695e19"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "08c4be24-e818-4664-9917-a609df3d1368", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b691e6cc-55df-41c9-82a9-14bc4fd9a93c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "08c4be24-e818-4664-9917-a609df3d1368"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">PC</span></p>", "ID": "1ab557ff-a6c5-40b3-b7b5-a0b1737ec0a4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">PC</span>", "ID": "c95c1870-f4bd-4ae2-9e51-0cd39acb5eaf", "Styles": "None", "Classes": "None", "Text": "PC", "ParentId": "1ab557ff-a6c5-40b3-b7b5-a0b1737ec0a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SN</span></p>", "ID": "5ff23502-3501-4cf2-98da-81ac263a5e53", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">SN</span>", "ID": "436884b6-20a6-4c4c-b3aa-6d1f453e7d43", "Styles": "None", "Classes": "None", "Text": "SN", "ParentId": "5ff23502-3501-4cf2-98da-81ac263a5e53"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NN</span></p>", "ID": "b36abaf8-1f52-4759-9df3-ea62ea688748", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NN</span>", "ID": "24b97dc2-7d5c-48e2-a6d8-10d015f35d64", "Styles": "None", "Classes": "None", "Text": "NN", "ParentId": "b36abaf8-1f52-4759-9df3-ea62ea688748"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "55cec4e9-ebc7-4225-b9aa-f22df977692b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "823d2c6f-14be-42ef-ba67-63be99ebfa1e", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "55cec4e9-ebc7-4225-b9aa-f22df977692b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always;\nbackground:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1be62ac0-afc6-4548-a135-08f297d101dd", "Styles": "line-height:normal;page-break-before:always;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "edb83135-531e-4f3c-b52f-1b82a2811141", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1be62ac0-afc6-4548-a135-08f297d101dd"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT</span></b></p>\n</div>", "ID": "66bdacfd-99b9-4ad3-a97d-660b4b563d3d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>", "ID": "b9ec817d-e75c-4d6a-89bb-5b97626fbe5c", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "66bdacfd-99b9-4ad3-a97d-660b4b563d3d"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b>", "ID": "050d394a-1690-4284-8ed4-f63c07445977", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b9ec817d-e75c-4d6a-89bb-5b97626fbe5c"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span>", "ID": "00eeb003-e5c2-45c3-a823-6c6c11725cfa", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING", "ParentId": "050d394a-1690-4284-8ed4-f63c07445977"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "8f6c1ed2-b2f6-4cf4-9924-769f36076ddc", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "66bdacfd-99b9-4ad3-a97d-660b4b563d3d"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "bbbefd1c-072c-4e4b-9605-7e30e7e23b85", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8f6c1ed2-b2f6-4cf4-9924-769f36076ddc"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "243f43c7-6cb6-4458-b156-b0e80673502e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bbbefd1c-072c-4e4b-9605-7e30e7e23b85"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT</span></b></p>", "ID": "a4053805-6969-4d0b-9623-f72144e01841", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "66bdacfd-99b9-4ad3-a97d-660b4b563d3d"}, {"Element": "<b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT</span></b>", "ID": "6303b0ed-4cfa-4328-ba1a-7517efa7745b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a4053805-6969-4d0b-9623-f72144e01841"}, {"Element": "<span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT</span>", "ID": "c5ac5d7a-05b3-4e46-8c1e-74a882982466", "Styles": "None", "Classes": "None", "Text": "CARTON CONTAINING WALLET UNIT", "ParentId": "6303b0ed-4cfa-4328-ba1a-7517efa7745b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ed17b69c-ca4d-43e3-adbe-d652ca22f2e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d6372ce1-04ad-47e8-8a8e-3ce738f62fc3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ed17b69c-ca4d-43e3-adbe-d652ca22f2e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "738acbbd-cec2-460e-bae3-554a1053c337", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4f0b203e-b4ac-4fb6-9eae-0f43de7fda29", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "738acbbd-cec2-460e-bae3-554a1053c337"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "2a7e9fcb-ce1e-4ad1-b8e0-8ea701669c8d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "b686ee8f-0ae3-46bc-bc4d-2dd627a1d57f", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2a7e9fcb-ce1e-4ad1-b8e0-8ea701669c8d"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "311098dc-63e2-47ce-80f7-6682edc0bbe8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b686ee8f-0ae3-46bc-bc4d-2dd627a1d57f"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "8bb25806-d0f0-43bb-b01b-b01f9ab0a480", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "311098dc-63e2-47ce-80f7-6682edc0bbe8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c63cc47c-b05e-4d0e-9d7d-8f47098470f2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9509a6e2-2454-4858-996b-99d0db074ff6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c63cc47c-b05e-4d0e-9d7d-8f47098470f2"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg hard\ncapsules </span></p>", "ID": "ad256932-1909-4887-9575-06ba2f268394", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg hard\ncapsules </span>", "ID": "7541e6d5-128e-421b-b61a-4a0bc54138a1", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 2.3 mg hard capsules ", "ParentId": "ad256932-1909-4887-9575-06ba2f268394"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>", "ID": "bc1645ca-2773-4b50-8be1-ba80dbd9f956", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib </span>", "ID": "25dad83b-376b-4481-9979-2644bf8b7f17", "Styles": "None", "Classes": "None", "Text": "ixazomib ", "ParentId": "bc1645ca-2773-4b50-8be1-ba80dbd9f956"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "129cecf1-bbd0-47ac-b96c-9faf9da08318", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a7960cc0-68d4-4457-8989-9ea66ec41998", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "129cecf1-bbd0-47ac-b96c-9faf9da08318"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7e519809-cf7d-45b5-a8df-5dc0287b568a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "56e079f6-5cb2-46fe-9861-1ca63c20fbfb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7e519809-cf7d-45b5-a8df-5dc0287b568a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>", "ID": "0615a820-5714-4ba4-b53d-5bb5ba778cfc", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>", "ID": "158a7d9c-902b-45d1-a6b9-906e2775c718", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0615a820-5714-4ba4-b53d-5bb5ba778cfc"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b>", "ID": "eb76ace1-c6a7-4abb-a1e3-bfd682456ef7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "158a7d9c-902b-45d1-a6b9-906e2775c718"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span>", "ID": "4a75223d-f627-4220-a475-0d49aea3d55b", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "eb76ace1-c6a7-4abb-a1e3-bfd682456ef7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "92e267d1-c6ef-44bb-8bee-9e53b6cfa8d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b68006d2-d36c-4358-9890-a505164f508e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "92e267d1-c6ef-44bb-8bee-9e53b6cfa8d0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 2.3 mg of ixazomib (as 3.3 mg of ixazomib\ncitrate)</span></p>", "ID": "74c711df-17f6-4435-8dd6-5b03d3146c8a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Each hard capsule contains 2.3 mg of ixazomib (as 3.3 mg of ixazomib\ncitrate)</span>", "ID": "52f159c1-e371-45e5-b0f3-1c60109b7dd4", "Styles": "None", "Classes": "None", "Text": "Each hard capsule contains 2.3 mg of ixazomib (as 3.3 mg of ixazomib citrate)", "ParentId": "74c711df-17f6-4435-8dd6-5b03d3146c8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "98f37a90-4aa7-4988-a877-4f15ffcdd4ef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "39072f07-5401-4e49-ae4f-3036cf824201", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "98f37a90-4aa7-4988-a877-4f15ffcdd4ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8399495d-0b55-4ccb-90f2-f85a1b916a5c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "357b9c61-2fd8-4f0a-a953-6dc52148cb8f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8399495d-0b55-4ccb-90f2-f85a1b916a5c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>", "ID": "50aa1cee-96a3-4afc-9d8a-b6e2cb726314", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>", "ID": "069042d9-1175-4619-97ce-efad69020158", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "50aa1cee-96a3-4afc-9d8a-b6e2cb726314"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b>", "ID": "de884c78-c7a2-48c5-9676-c2d51864df31", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "069042d9-1175-4619-97ce-efad69020158"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span>", "ID": "54ed7528-7f05-45a7-8360-fff3cede0f2e", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "de884c78-c7a2-48c5-9676-c2d51864df31"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d6a21cea-2a4f-49d3-b3ec-2aa9341a9aed", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "05e5cf8a-1a90-4d64-90f6-bd483adefdb7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d6a21cea-2a4f-49d3-b3ec-2aa9341a9aed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9bdead92-3464-4dbb-8a39-4f16924b3af1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e1bfa273-9383-4902-ac9f-f558db68e186", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9bdead92-3464-4dbb-8a39-4f16924b3af1"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>", "ID": "9f0bb300-e69e-4dcc-9c6e-7e56075439e4", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>", "ID": "d208dcc0-1706-46fb-aba1-7ea7ad333d5e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9f0bb300-e69e-4dcc-9c6e-7e56075439e4"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b>", "ID": "2e2af838-9c7d-4059-bbef-c18adc94c389", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d208dcc0-1706-46fb-aba1-7ea7ad333d5e"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span>", "ID": "26af3e62-bc14-48d4-9589-8b064926ce90", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "2e2af838-9c7d-4059-bbef-c18adc94c389"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c62b0f3f-e064-41c6-84eb-5fd74688e6ce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d7807adb-b396-4ecb-b823-89325c2e2f14", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c62b0f3f-e064-41c6-84eb-5fd74688e6ce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule</span></p>", "ID": "ee23307f-06b9-4301-9fe1-6c89ac34b456", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule</span>", "ID": "f7d329b8-8344-4b7b-9c24-e2a1fd76fae4", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Hard capsule", "ParentId": "ee23307f-06b9-4301-9fe1-6c89ac34b456"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "14ec7018-8b65-4833-8eab-9b0578476487", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "893abab4-c657-495b-a041-9944f97ca55f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "14ec7018-8b65-4833-8eab-9b0578476487"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule.</span></p>", "ID": "901486ec-f725-43c2-8430-a84be343a80f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">1 hard capsule.</span>", "ID": "5dc07d87-212d-4869-8df6-aad02692f2fb", "Styles": "None", "Classes": "None", "Text": "1 hard capsule.", "ParentId": "901486ec-f725-43c2-8430-a84be343a80f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5d05e7b7-c5ca-4f1a-af5d-ec1e8dd7d85d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6294eb04-969d-402c-9ab8-9be6bf0f4573", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5d05e7b7-c5ca-4f1a-af5d-ec1e8dd7d85d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e9776e59-6386-48b6-ae9d-286e2902d7a2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a6210512-4c4c-40e3-a66e-973b38a32726", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e9776e59-6386-48b6-ae9d-286e2902d7a2"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>", "ID": "53a062b8-6de4-4f47-83e5-981fa1efc61b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>", "ID": "030765bd-f8c2-4e50-9d68-8e6eea1e705b", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "53a062b8-6de4-4f47-83e5-981fa1efc61b"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b>", "ID": "7c17e85b-50c4-4880-9f07-245e8b7f16cb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "030765bd-f8c2-4e50-9d68-8e6eea1e705b"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span>", "ID": "0a274320-e85e-4854-98a9-38900a0577ad", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "7c17e85b-50c4-4880-9f07-245e8b7f16cb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dde1a1fd-7539-4ae5-9f75-d150d3cbf5b9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6b5b807b-dfc2-4c26-8523-b58a3b3083f1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dde1a1fd-7539-4ae5-9f75-d150d3cbf5b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span></p>", "ID": "d57e8d18-1569-4fae-bc16-9c9f1dd44992", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Read the package\nleaflet before use</span>", "ID": "a01d96b3-7640-425f-995e-ca6e1d08ae0a", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use", "ParentId": "d57e8d18-1569-4fae-bc16-9c9f1dd44992"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>", "ID": "729de805-dcfd-4776-bdb5-31da5e381c4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Oral use</span>", "ID": "03d28ca6-19ed-49f1-818a-0bccd9141a39", "Styles": "None", "Classes": "None", "Text": "Oral use", "ParentId": "729de805-dcfd-4776-bdb5-31da5e381c4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "81fcbd08-19fc-4a05-9b15-fa5eb1122e8c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0001382b-7743-4678-8363-36eed58a74cd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "81fcbd08-19fc-4a05-9b15-fa5eb1122e8c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "24d89127-ec3e-4ee0-adac-3cecc48073a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "59c76c72-d9c4-42ef-b4f4-ef117e3a0f23", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "24d89127-ec3e-4ee0-adac-3cecc48073a9"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>", "ID": "12735057-7bcf-46de-8684-e48ace10e9a9", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>", "ID": "96353096-785e-4281-ba0a-cc62e3c9018a", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "12735057-7bcf-46de-8684-e48ace10e9a9"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b>", "ID": "08f49ff2-47a0-4520-ad77-a928f314bd54", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "96353096-785e-4281-ba0a-cc62e3c9018a"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span>", "ID": "abb15151-de49-424c-a54f-6341de5ec942", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "08f49ff2-47a0-4520-ad77-a928f314bd54"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2cb41186-1e23-4619-af63-b7420fdd0980", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e248e5a0-6d92-4216-9b08-29863a5bb750", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2cb41186-1e23-4619-af63-b7420fdd0980"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>", "ID": "479381ca-3314-4b77-8417-daec547eb20f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span>", "ID": "81a4e96e-cbdf-41fc-ba94-b41d78a877ac", "Styles": "None", "Classes": "None", "Text": "Keep out of the sight and reach of children", "ParentId": "479381ca-3314-4b77-8417-daec547eb20f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ea162df0-6638-45a1-b8ff-5700c176cd4b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "97a13b1b-68d0-4abb-873a-ae8565d596c3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ea162df0-6638-45a1-b8ff-5700c176cd4b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6d19bb99-67be-4d01-863a-a128304e510f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "22249e9b-bb3e-4018-87ac-5f5e897096ce", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6d19bb99-67be-4d01-863a-a128304e510f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>", "ID": "9c77ea7f-14dd-498b-98a5-d693a112516f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>", "ID": "1cf38061-13af-41f0-ad15-1b537c94ff4e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9c77ea7f-14dd-498b-98a5-d693a112516f"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b>", "ID": "e17d7c8b-9999-4465-92a6-be74d98bd6d2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1cf38061-13af-41f0-ad15-1b537c94ff4e"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span>", "ID": "430b198f-53cb-465e-b185-1b28faf0a495", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "e17d7c8b-9999-4465-92a6-be74d98bd6d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fbbd9c52-ca29-4167-9730-ffbf1da58822", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5ae774ad-5408-4b9e-b1bf-e1330e6fb37a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fbbd9c52-ca29-4167-9730-ffbf1da58822"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>", "ID": "7b80a1d5-f6eb-4273-8161-45bded8d3540", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Cytotoxic</span>", "ID": "5a47f01e-dea4-4296-b3e4-c0b09776ae11", "Styles": "None", "Classes": "None", "Text": "Cytotoxic", "ParentId": "7b80a1d5-f6eb-4273-8161-45bded8d3540"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "36164c24-669f-492e-a573-51709600fe2c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6887f99b-dc09-47ab-aae5-614fa63954fb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "36164c24-669f-492e-a573-51709600fe2c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "589ab1a4-8780-49ec-8348-d670d0e7c476", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ade65b1c-d27d-49db-928f-6898d4e3f916", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "589ab1a4-8780-49ec-8348-d670d0e7c476"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "44dabad6-b680-4a0d-b70b-7ed51231137b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "bdd5f863-d8e1-4092-b0f0-5269dd5be640", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "44dabad6-b680-4a0d-b70b-7ed51231137b"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "dd53d4dc-c99b-4c80-b911-20c3831df9bd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bdd5f863-d8e1-4092-b0f0-5269dd5be640"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "97c16648-6977-4d7e-bc53-120119cccc20", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "dd53d4dc-c99b-4c80-b911-20c3831df9bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "303f6362-6039-4c09-8571-b8cf9eeb05db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8d8fb419-09a9-4625-b02d-afd20a197d25", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "303f6362-6039-4c09-8571-b8cf9eeb05db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "3bb2e030-f038-403e-bf8d-6ce65fde2a6f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "846bfb7f-ce5b-4d76-8407-faa268866069", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "3bb2e030-f038-403e-bf8d-6ce65fde2a6f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a2a90ae5-5354-4ff4-adb1-91663008994c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3f54ada1-0da0-415c-b82d-461b2baa9829", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a2a90ae5-5354-4ff4-adb1-91663008994c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cf7a3c71-0680-4dd4-9f51-2301c1da1d43", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8559a935-2997-45cd-8683-8aad0eb32dde", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cf7a3c71-0680-4dd4-9f51-2301c1da1d43"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "b64ea6a2-6bea-4836-b528-6505f0c02042", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "e8978cfe-34c9-4d2b-b2b7-e9d4dc64aff7", "Styles": "line-height:normal;page-break-after:avoid;border:\nnone;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b64ea6a2-6bea-4836-b528-6505f0c02042"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "f55d3003-1f6e-4784-af3e-262c0ebfc70e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e8978cfe-34c9-4d2b-b2b7-e9d4dc64aff7"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "20828468-a251-43cf-8a27-49c8d220566b", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "f55d3003-1f6e-4784-af3e-262c0ebfc70e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60cb85b5-c3a3-456e-b713-36c4f4210dfb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "25bf6156-3809-42cd-a0d6-fe511f5aa8d7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60cb85b5-c3a3-456e-b713-36c4f4210dfb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span></p>", "ID": "f16b4130-7452-4877-8c51-24b812d85467", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span>", "ID": "89d1e6bd-0b75-4248-a79a-db309284450e", "Styles": "None", "Classes": "None", "Text": "Do not store above 30\u00baC. Do not freeze. ", "ParentId": "f16b4130-7452-4877-8c51-24b812d85467"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Store in the original package in\norder to protect from moisture.</p>", "ID": "217681e3-52a2-451a-b843-e09189a23762", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Store in the original package in order to protect from moisture.", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "9bb0f3c3-6e99-479b-8b6d-8f1a06f39d42", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "60016682-dfaa-45b3-8374-52d3b2936c1f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "666325e1-bdc1-4b11-84d1-e16bbac22711", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "cbf28063-4b2c-4d83-9d41-c91f34528fdd", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "666325e1-bdc1-4b11-84d1-e16bbac22711"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "60db99f2-9403-44cb-856a-0227e4bdbbad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cbf28063-4b2c-4d83-9d41-c91f34528fdd"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "748eb01c-b9e6-4665-ab72-5d0e4472d2d5", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "60db99f2-9403-44cb-856a-0227e4bdbbad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "133dfe03-440c-416b-ba35-864b84927e9b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "232db14d-db7e-4f0d-a191-83ae350732ef", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "133dfe03-440c-416b-ba35-864b84927e9b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "255befaa-99b8-4099-a4b4-334e0fda1d87", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "75f68eec-f643-44ed-be3f-cf9a86ee9a62", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "255befaa-99b8-4099-a4b4-334e0fda1d87"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "d7c61e6d-97a7-4f9c-afee-e18b7d04c3b2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "4d70464e-d2f7-4f83-8d8f-f9bb9b3035e7", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d7c61e6d-97a7-4f9c-afee-e18b7d04c3b2"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "2d7b68e6-b12b-4280-ab5a-32a1056d2263", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4d70464e-d2f7-4f83-8d8f-f9bb9b3035e7"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "3f5a4b77-6021-49a1-bf51-b1203a0373ef", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "2d7b68e6-b12b-4280-ab5a-32a1056d2263"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60eeda6b-62a1-41db-8656-60a94cddf579", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "961a78a0-c8cd-458d-bb4b-c724d4a67bca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60eeda6b-62a1-41db-8656-60a94cddf579"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>", "ID": "4d94b4e9-0e26-4bd9-b76e-4a38571deeaa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma\nA/S </span>", "ID": "5992f2aa-4103-40d6-91e6-d646378bd4a9", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S ", "ParentId": "4d94b4e9-0e26-4bd9-b76e-4a38571deeaa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>", "ID": "e31e4522-2c84-4b71-a1f8-75cd84c61761", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span>", "ID": "95a971c6-1a41-4539-bf85-ca1d40e89aa5", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "", "ParentId": "e31e4522-2c84-4b71-a1f8-75cd84c61761"}, {"Element": "<span lang=\"EN-GB\">Delta Park 45</span>", "ID": "ad07d64d-0601-474b-990d-b15ccd5fb0b7", "Styles": "None", "Classes": "None", "Text": "Delta Park 45", "ParentId": "95a971c6-1a41-4539-bf85-ca1d40e89aa5"}, {"Element": "<span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span>", "ID": "c995476b-9505-42e0-9520-77c59572d936", "Styles": "border:none windowtext 1.0pt;\npadding:0in", "Classes": "None", "Text": " ", "ParentId": "e31e4522-2c84-4b71-a1f8-75cd84c61761"}, {"Element": "<br/>", "ID": "cf131d5c-c9ea-43dc-8c80-71cc7e7e604b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c995476b-9505-42e0-9520-77c59572d936"}, {"Element": "<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span>", "ID": "3d93f10b-1113-4199-8dde-fa3c441090d4", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "2665 Vallensbaek Strand", "ParentId": "c995476b-9505-42e0-9520-77c59572d936"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>", "ID": "5ae74332-e4f6-4aa5-a675-f42d46930713", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Denmark</span>", "ID": "f61de762-f8ba-4729-8be9-619cdce9c603", "Styles": "None", "Classes": "None", "Text": "Denmark", "ParentId": "5ae74332-e4f6-4aa5-a675-f42d46930713"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "45d51f8a-65eb-4652-b2c3-b360e25099a4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3164b68f-b077-47be-8f9d-00faec587507", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "45d51f8a-65eb-4652-b2c3-b360e25099a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "54c6a391-00f2-4504-953c-455b50456892", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "84c94341-e59d-4449-a76b-5dfcf5295ea5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "54c6a391-00f2-4504-953c-455b50456892"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "bd5b49ca-c6f8-441d-8552-4f83545ece10", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "72303771-5f52-485d-814b-884947bd79d3", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bd5b49ca-c6f8-441d-8552-4f83545ece10"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "af95355c-b2fa-452e-a4f7-ad133d9af12c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "72303771-5f52-485d-814b-884947bd79d3"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "66f24762-80c5-423d-884b-545727016da7", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "af95355c-b2fa-452e-a4f7-ad133d9af12c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b7bdbeea-d0ab-4bab-89d1-e55a5f4a2efc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "361b73ac-a64e-4ca8-b23a-a109a2a737ad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b7bdbeea-d0ab-4bab-89d1-e55a5f4a2efc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/001</span></p>", "ID": "90b593bd-ee50-45ce-8bdb-6e7ed54d4c0c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/001</span>", "ID": "0dd6c501-9989-47ad-a71c-63a9bc91aaeb", "Styles": "color:black", "Classes": "None", "Text": "EU/1/16/1094/001", "ParentId": "90b593bd-ee50-45ce-8bdb-6e7ed54d4c0c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c60ddeed-7474-4a1c-b24a-2bfcfaf0654e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4604eb64-1583-47d8-9129-80cda010fb85", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c60ddeed-7474-4a1c-b24a-2bfcfaf0654e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c1760e4e-09b3-42a7-8249-81259b2a614d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "98bcb6b1-15e9-428c-bed2-b3735826a01d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1760e4e-09b3-42a7-8249-81259b2a614d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "20487f72-09b9-4ff6-a7a0-14c61ad4d76b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "0c08769f-ee2d-4ca4-bdfd-4ffab62fe735", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "20487f72-09b9-4ff6-a7a0-14c61ad4d76b"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "7f360ecd-cd55-46b4-82ba-89c3bb638df3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0c08769f-ee2d-4ca4-bdfd-4ffab62fe735"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "aa250f5d-b917-47d1-9daf-c906e035cf85", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "7f360ecd-cd55-46b4-82ba-89c3bb638df3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "2aea9441-e77a-4274-90dd-3c42afa58b14", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "5071b8e5-6621-4c79-baca-3806907fd065", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2aea9441-e77a-4274-90dd-3c42afa58b14"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2189312c-04ec-46ad-b6eb-ad3219c2cf7e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5071b8e5-6621-4c79-baca-3806907fd065"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "c8e2fc06-3867-4511-8991-c000c58cf91e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "4a64666e-6396-4d0d-af9f-5430487fdb94", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "c8e2fc06-3867-4511-8991-c000c58cf91e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "43499fb2-cdc4-4fb2-9d16-ca92f69161db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e15efdf8-364e-40a2-af9e-c20edfdee155", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "43499fb2-cdc4-4fb2-9d16-ca92f69161db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "80ac590d-7a44-475c-a461-2f009dc5df19", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dcb483e4-f89c-4220-9480-254a8348463b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "80ac590d-7a44-475c-a461-2f009dc5df19"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "a76a343b-d57e-478a-a748-08b956c92fe1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "87df0dc1-b503-431b-89da-b5929d662495", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a76a343b-d57e-478a-a748-08b956c92fe1"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "4df05851-55f8-4904-8d7f-c2c2580858d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "87df0dc1-b503-431b-89da-b5929d662495"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "40e39ce3-3d36-4f59-b746-5069cd0cf834", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "4df05851-55f8-4904-8d7f-c2c2580858d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "093a4b1f-4896-4bb2-a315-fe1670ca7925", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "69228acc-6e4e-4429-8441-177f7a661077", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "093a4b1f-4896-4bb2-a315-fe1670ca7925"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c5c03713-8b6a-49dd-8842-0ef4abe69c33", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "69228acc-6e4e-4429-8441-177f7a661077"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "acd3b216-b47e-4c3b-9c59-206652674eb0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "81539c42-c19c-46d9-93cd-8992af4a5888", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "acd3b216-b47e-4c3b-9c59-206652674eb0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "c52230a2-02df-46b7-a97f-4163ede4ef5f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "af1c1cb7-3b56-4904-8cbb-7057b13533ae", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c52230a2-02df-46b7-a97f-4163ede4ef5f"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "444be656-3f85-4fcc-b33b-390399f09995", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "af1c1cb7-3b56-4904-8cbb-7057b13533ae"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "d634bf24-2f3e-4f78-8411-c8589c00f335", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "444be656-3f85-4fcc-b33b-390399f09995"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a4b43ca4-1bd0-4d70-93cb-db49ebc807cf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e1d3e3cf-903f-4529-8caf-450a80567f38", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a4b43ca4-1bd0-4d70-93cb-db49ebc807cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f39b5b87-3f32-43d7-99fe-2c9de70fd61d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7d865328-de7d-4594-9774-9833ec2e2e36", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f39b5b87-3f32-43d7-99fe-2c9de70fd61d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "76b16148-f18f-4615-84f3-d86b1b91c15f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "549a223e-49eb-4824-aac8-06ae4a94adba", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "76b16148-f18f-4615-84f3-d86b1b91c15f"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "ae782642-c0e0-4775-87ca-98e81a6626a4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "549a223e-49eb-4824-aac8-06ae4a94adba"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "fcd87a98-c99e-458c-9ade-7d7dc0353c5a", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "ae782642-c0e0-4775-87ca-98e81a6626a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a572a4e5-801c-4bcb-8f6b-0288ce3c185f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "901418fb-a1d8-44ed-8b1a-bc529cb0220a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a572a4e5-801c-4bcb-8f6b-0288ce3c185f"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg </span></p>", "ID": "0795c43f-dbbe-4770-b28e-0615f63b3e8b", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg </span>", "ID": "f119c9aa-962b-41cd-b564-af0e54265c95", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 2.3 mg ", "ParentId": "0795c43f-dbbe-4770-b28e-0615f63b3e8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0e8ec4c6-aa2f-4236-8e2a-32d45bea88cd", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d557bdee-c1c5-49ff-9142-50100837ea6c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0e8ec4c6-aa2f-4236-8e2a-32d45bea88cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "081a39ac-e770-4cdb-b4e5-83f7429169f6", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4112edf9-8730-4bb0-b3c1-9647debbdc30", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "081a39ac-e770-4cdb-b4e5-83f7429169f6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fa9acd1a-90b7-47c4-878d-613d40cf6e23", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "61933f3d-a6b7-47ad-a713-530042033879", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa9acd1a-90b7-47c4-878d-613d40cf6e23"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "045baa76-99b6-4ff8-a3fc-a1e3819d2c6b", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92e6a1ca-2a18-4b93-b10c-215cf16bbea0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "045baa76-99b6-4ff8-a3fc-a1e3819d2c6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1060e867-93c9-49c1-a304-1aba5672f1df", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "abab503b-8019-4464-bf2c-303f996adb7e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1060e867-93c9-49c1-a304-1aba5672f1df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "caffb57b-97fa-4a7b-9fb8-1ee9d06979e3", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "190e8634-ba31-44a0-89ed-9d1bd0053406", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "caffb57b-97fa-4a7b-9fb8-1ee9d06979e3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "142fe668-aa76-4b7a-a595-e2867210ee6e", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ac98af31-a517-4945-bd44-427e504461af", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "142fe668-aa76-4b7a-a595-e2867210ee6e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c81d938d-80f7-4fb5-a04c-5abc8c7671e0", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "072ab673-2d92-4fb8-ab07-dceafd85bb61", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c81d938d-80f7-4fb5-a04c-5abc8c7671e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "74ef28b4-03af-4c3a-8800-e95e3c74a2ea", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "da0e9043-6f4d-4be2-802d-79613a164abf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "74ef28b4-03af-4c3a-8800-e95e3c74a2ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0f1d56ca-37c2-4b01-83dd-b499f1ec3fae", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "291d9caf-7d1d-4615-ae81-b8fbd26efd25", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0f1d56ca-37c2-4b01-83dd-b499f1ec3fae"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">WALLET</span></b></p>\n</div>", "ID": "f8c40533-f3df-466a-8295-a05e1314d2d9", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>", "ID": "7c74ee92-0109-4cbf-81fd-fd76150630ea", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8c40533-f3df-466a-8295-a05e1314d2d9"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b>", "ID": "8fe40607-8b5d-41a8-9a96-d49cfc09114f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7c74ee92-0109-4cbf-81fd-fd76150630ea"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span>", "ID": "0d8abf43-69ff-40f9-bf47-4cc3e79230a2", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING", "ParentId": "8fe40607-8b5d-41a8-9a96-d49cfc09114f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "02320508-5544-4ea7-b90e-e08ffda22c7d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8c40533-f3df-466a-8295-a05e1314d2d9"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9aac7eef-eea2-464a-84c6-cf83faba2feb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "02320508-5544-4ea7-b90e-e08ffda22c7d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ea1f32b2-fdff-449e-a2ec-54dde5f1ee44", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9aac7eef-eea2-464a-84c6-cf83faba2feb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">WALLET</span></b></p>", "ID": "272a467b-75dd-4377-995d-e225c6225e52", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8c40533-f3df-466a-8295-a05e1314d2d9"}, {"Element": "<b><span lang=\"EN-GB\">WALLET</span></b>", "ID": "9f3ed3a7-5b33-4529-8320-3cfaf7bb4b7b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "272a467b-75dd-4377-995d-e225c6225e52"}, {"Element": "<span lang=\"EN-GB\">WALLET</span>", "ID": "cc792958-d1d5-42cc-a046-10ddd1785587", "Styles": "None", "Classes": "None", "Text": "WALLET", "ParentId": "9f3ed3a7-5b33-4529-8320-3cfaf7bb4b7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f9fa5b07-e409-45e2-9262-ab206c3eacc3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d1742058-bc06-482c-86da-363d913d2625", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f9fa5b07-e409-45e2-9262-ab206c3eacc3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b4eacfce-740c-4d01-a703-5a0c5487f717", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "24ccb060-242a-434d-9ddf-db26db7bd06b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b4eacfce-740c-4d01-a703-5a0c5487f717"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "d8f3878a-af6f-4639-b758-4b3c63ccc0ca", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "8265a544-c881-4706-bb6f-13e669909cc7", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d8f3878a-af6f-4639-b758-4b3c63ccc0ca"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "0bb3fd0c-6e48-4a3a-8538-482901494f61", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8265a544-c881-4706-bb6f-13e669909cc7"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "d14a0163-e20a-460d-8116-6def791052d7", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "0bb3fd0c-6e48-4a3a-8538-482901494f61"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ec666397-4e2d-4548-8023-6d7275e8a19e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "78f5ae66-93e1-4295-842a-a81885b96c98", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ec666397-4e2d-4548-8023-6d7275e8a19e"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg hard\ncapsules </span></p>", "ID": "39bc8707-3997-4d8b-bd49-a5ed95df23de", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg hard\ncapsules </span>", "ID": "72794c00-962d-442c-b78c-5da35629b99f", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 2.3 mg hard capsules ", "ParentId": "39bc8707-3997-4d8b-bd49-a5ed95df23de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>", "ID": "45548b6e-6ba6-4dfc-83a1-ceb49f8d70e5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib </span>", "ID": "bbf4ec79-91c7-4d57-8cec-9de9c62f7b7f", "Styles": "None", "Classes": "None", "Text": "ixazomib ", "ParentId": "45548b6e-6ba6-4dfc-83a1-ceb49f8d70e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3ab6bef1-fea7-4a6e-93fa-2fd1fd946ad3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9975766f-cc9a-45cf-9ecd-715cc3fd3524", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3ab6bef1-fea7-4a6e-93fa-2fd1fd946ad3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "159dfaca-f163-41cf-b909-0b2d49696c3a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a7f9401c-31b4-45ce-99f1-387cb254065e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "159dfaca-f163-41cf-b909-0b2d49696c3a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>", "ID": "07e6b393-4e37-444e-9bdf-6e987d03e02f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>", "ID": "d4a023cd-0c88-41f3-9528-bd69c891414d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "07e6b393-4e37-444e-9bdf-6e987d03e02f"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b>", "ID": "1d601910-c3fb-4507-8fea-7e0b172363e6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d4a023cd-0c88-41f3-9528-bd69c891414d"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span>", "ID": "090d01b4-d0c1-49c8-ac56-f2e98f77b5ec", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "1d601910-c3fb-4507-8fea-7e0b172363e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "282eccef-95b5-412e-a734-d432fe052a1a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "7d1aa237-fd32-46f0-afb3-7a5be5abd979", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "282eccef-95b5-412e-a734-d432fe052a1a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "bd486604-f8af-4a01-8f38-aaa46f1ed52e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "e8a7a528-d6a3-40d8-92a7-01e5a2b65210", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "bd486604-f8af-4a01-8f38-aaa46f1ed52e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>", "ID": "96aad523-26a4-4661-a3f8-b4368772f973", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>", "ID": "3a0c94d4-5a07-4555-9c85-ec481a89f7eb", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "96aad523-26a4-4661-a3f8-b4368772f973"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b>", "ID": "6018253a-ba0c-4eb5-9c5a-a5915d4ff642", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3a0c94d4-5a07-4555-9c85-ec481a89f7eb"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span>", "ID": "ec15ecef-3615-461e-812d-fbd770fe6985", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "6018253a-ba0c-4eb5-9c5a-a5915d4ff642"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "a287a576-642a-4c85-af44-746be29b1151", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "0c55768a-b81a-4ea9-bd51-e9ce414d3fe7", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "a287a576-642a-4c85-af44-746be29b1151"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "d2310d8e-c060-4849-b201-39f39f9a7d89", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "a7960a8e-7375-42b5-a632-4869c3682d8c", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "d2310d8e-c060-4849-b201-39f39f9a7d89"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>", "ID": "e89a806f-34f0-4f8c-85fd-bb4fd361fea5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>", "ID": "1ba1a76b-e306-410a-8d72-cc8789406540", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e89a806f-34f0-4f8c-85fd-bb4fd361fea5"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b>", "ID": "90c14b28-9007-4d96-ab43-ed43578260f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1ba1a76b-e306-410a-8d72-cc8789406540"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span>", "ID": "25e5e8eb-d4f2-44b3-99fa-367fcac62a0b", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "90c14b28-9007-4d96-ab43-ed43578260f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "dbc8bca0-ad13-4287-ae79-82d3fb5b8f01", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "6e19a9a4-507a-4e6e-b0df-0cc0d2d8e73d", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "dbc8bca0-ad13-4287-ae79-82d3fb5b8f01"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Hard capsule </span></p>", "ID": "a204189c-541f-41f6-9b5a-f51d69b4de15", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">Hard capsule </span>", "ID": "7c4b9013-9d28-4ed0-afe1-bf34efde50e4", "Styles": "background:silver", "Classes": "None", "Text": "Hard capsule ", "ParentId": "a204189c-541f-41f6-9b5a-f51d69b4de15"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "d7818ac4-1eb5-40c8-8b16-f86767b58d28", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "a47d75ef-aac8-434c-b78d-b5b3d1200b3f", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "d7818ac4-1eb5-40c8-8b16-f86767b58d28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule</span></p>", "ID": "7c2a50d3-8956-4d57-9735-f9989952ad59", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">1 hard capsule</span>", "ID": "3ce741cd-7677-4970-aa2e-af8829740c1a", "Styles": "None", "Classes": "None", "Text": "1 hard capsule", "ParentId": "7c2a50d3-8956-4d57-9735-f9989952ad59"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "4d2f6809-95d5-4a38-972d-e3031e2072c5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "15d5993f-0750-4730-98bf-a349fa275eeb", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "4d2f6809-95d5-4a38-972d-e3031e2072c5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "2e420aa4-55a5-400f-b1e8-b207d3eb5231", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "dac2567d-0719-4755-83c9-6df86d837829", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "2e420aa4-55a5-400f-b1e8-b207d3eb5231"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>", "ID": "7f7a2bc9-337b-4406-8057-0d84ae663009", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>", "ID": "a9524a61-1485-46d9-8639-8d7178d5f410", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7f7a2bc9-337b-4406-8057-0d84ae663009"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b>", "ID": "0a41ad61-5725-47f0-b72e-98f061d92890", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a9524a61-1485-46d9-8639-8d7178d5f410"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span>", "ID": "6bd83661-45af-4cae-8d7c-b3b24d293b35", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "0a41ad61-5725-47f0-b72e-98f061d92890"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "48e077b8-f772-4744-b8b4-3d781a62b148", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "de588ac0-291f-46bd-a126-fd27e5074ad1", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "48e077b8-f772-4744-b8b4-3d781a62b148"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use.</span></p>", "ID": "b2f53189-14ab-48be-b3e4-b332a9205d25", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Read the package\nleaflet before use.</span>", "ID": "58f224db-c38d-40ad-8ba2-61629c177f24", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "b2f53189-14ab-48be-b3e4-b332a9205d25"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Do not crush, open or chew the capsules. Take each NINLARO capsule\nwhole with water at the same time each week, at least one hour before or no\nsooner than two hours after any food.</span></p>", "ID": "81ba5d0c-2478-4f84-9c28-a108c83dcbbe", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not crush, open or chew the capsules. Take each NINLARO capsule\nwhole with water at the same time each week, at least one hour before or no\nsooner than two hours after any food.</span>", "ID": "d479d78f-7b46-4560-ba9f-c1196d7d3f49", "Styles": "None", "Classes": "None", "Text": "Do not crush, open or chew the capsules. Take each NINLARO capsule whole with water at the same time each week, at least one hour before or no sooner than two hours after any food.", "ParentId": "81ba5d0c-2478-4f84-9c28-a108c83dcbbe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The capsule should not be removed until just prior to dosing.</span></p>", "ID": "3cf68c02-a01c-4431-a6d7-93f5f2e9608d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The capsule should not be removed until just prior to dosing.</span>", "ID": "2435ab54-003a-4100-94d9-96229f6ae5d8", "Styles": "None", "Classes": "None", "Text": "The capsule should not be removed until just prior to dosing.", "ParentId": "3cf68c02-a01c-4431-a6d7-93f5f2e9608d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use </span></p>", "ID": "d2e0ed9c-de6f-4085-8286-aafdb575ce2e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Oral use </span>", "ID": "fc16c0d0-8551-4714-955e-d38794cd337e", "Styles": "None", "Classes": "None", "Text": "Oral use ", "ParentId": "d2e0ed9c-de6f-4085-8286-aafdb575ce2e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "82532a33-a443-4d1a-b6c3-6a4b1e360578", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "de0b9e03-7bf9-4659-b13b-c318352c7843", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "82532a33-a443-4d1a-b6c3-6a4b1e360578"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "fbc9e030-5a26-4ba8-a00b-9191a9caab8a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "164daf81-fe14-4f86-9430-a950c09fb0dd", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "fbc9e030-5a26-4ba8-a00b-9191a9caab8a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>", "ID": "1236fd04-d581-4a81-9084-3fa759dc761c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>", "ID": "e5e034f4-7ced-4437-ae09-3abe9c0f329b", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1236fd04-d581-4a81-9084-3fa759dc761c"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b>", "ID": "269057ff-aaf9-4095-bbe1-9b01c8ab7b44", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e5e034f4-7ced-4437-ae09-3abe9c0f329b"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span>", "ID": "955af83e-df99-4229-9ff0-70ffd98c18c6", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "269057ff-aaf9-4095-bbe1-9b01c8ab7b44"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "c8ab89e4-f8c5-4e27-809a-987f5d2f6e40", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "da528633-1e20-4dc8-8afd-e46ee5bc8be1", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "c8ab89e4-f8c5-4e27-809a-987f5d2f6e40"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "f990d03e-2b55-4e03-9415-9477304c1e76", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "f0bbe6f8-835e-4f3b-b384-55ed7474135d", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "f990d03e-2b55-4e03-9415-9477304c1e76"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>", "ID": "6806278b-491d-4946-931f-09c4e959494b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>", "ID": "1b776a8c-1172-4383-bb63-443dc9168aff", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6806278b-491d-4946-931f-09c4e959494b"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b>", "ID": "6c94ab18-f4e3-481e-9c9e-903456ce2301", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1b776a8c-1172-4383-bb63-443dc9168aff"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span>", "ID": "ce6a6c08-3e41-4226-9879-e973cbce61b6", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "6c94ab18-f4e3-481e-9c9e-903456ce2301"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "65254896-77a9-4238-b4ec-d65db3433b7c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "23dfe989-01e3-40ee-b6fc-1215e8dee073", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "65254896-77a9-4238-b4ec-d65db3433b7c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>", "ID": "ad23c392-2c07-4044-9202-e2692cbe0eff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Cytotoxic</span>", "ID": "3f827f18-3733-410b-bebb-270e4e85bd82", "Styles": "None", "Classes": "None", "Text": "Cytotoxic", "ParentId": "ad23c392-2c07-4044-9202-e2692cbe0eff"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a9b68ac7-960c-484b-9a80-f4cd0ec99075", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "61465a0a-ee37-4d0e-93a0-46a18c9c2881", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a9b68ac7-960c-484b-9a80-f4cd0ec99075"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b4f71c8a-ff02-4476-ab4f-0c5894480f15", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "89083bb9-793a-4694-89f1-430f46c91a97", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b4f71c8a-ff02-4476-ab4f-0c5894480f15"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "1893d47e-e760-45e1-958e-0c892c59fda5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "fddcc565-2693-41e5-a6ec-1b687e98b0c7", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1893d47e-e760-45e1-958e-0c892c59fda5"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "3105972b-2fd5-4e35-a54c-5156c3989940", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fddcc565-2693-41e5-a6ec-1b687e98b0c7"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "870dc841-65af-444b-aa4b-bc8ec41fe67a", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "3105972b-2fd5-4e35-a54c-5156c3989940"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "03d53ac0-8ddd-4911-b73e-fc310835e1c8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c0fd9ca3-365c-4f79-8294-67627b069693", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "03d53ac0-8ddd-4911-b73e-fc310835e1c8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "a89043f2-9b1c-41ac-a056-7a4deec144cc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "27c9a8cf-b589-44ad-a3ed-639d1bb6fa07", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "a89043f2-9b1c-41ac-a056-7a4deec144cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a51e9aff-3283-45a6-88b0-4a7ee29c312a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3faac192-892a-415a-8318-ac59124a355a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a51e9aff-3283-45a6-88b0-4a7ee29c312a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fc60ef7e-e87e-4be2-975b-b1e3cf3529f5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "921c00c8-eb54-4249-8e69-8e1948b58056", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fc60ef7e-e87e-4be2-975b-b1e3cf3529f5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b></p>\n</div>", "ID": "c6c0069d-ea30-4af9-b18f-54f78a4621b8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b></p>", "ID": "25f2a305-3010-47a6-b6fe-b3ce0bea3253", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c6c0069d-ea30-4af9-b18f-54f78a4621b8"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b>", "ID": "a4c22974-0ea7-4974-b48f-9e44820ac995", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "25f2a305-3010-47a6-b6fe-b3ce0bea3253"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span>", "ID": "69d9dc40-986a-4b36-90c8-535f4471286f", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "a4c22974-0ea7-4974-b48f-9e44820ac995"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "2f3fccc9-d66d-45e0-9fb7-707db3869772", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "e722be7d-4779-43cf-9742-d4af46b8d3d6", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "2f3fccc9-d66d-45e0-9fb7-707db3869772"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"background:silver\">\u00a0</span></p>", "ID": "85a0c393-bac2-48d3-b9f4-9af4ef37cb5b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"background:silver\">\u00a0</span>", "ID": "995f0319-1520-4b2f-8777-3588b5a8212b", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "85a0c393-bac2-48d3-b9f4-9af4ef37cb5b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "81b5dc38-6614-47f7-9187-5eddd0d5e497", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "2df82dda-0998-4c8a-9c8d-55e7ddc68ab0", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "81b5dc38-6614-47f7-9187-5eddd0d5e497"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "003702f6-535d-48b0-95c3-2760327d8040", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2df82dda-0998-4c8a-9c8d-55e7ddc68ab0"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "bc4e5f01-c88c-48fe-8cb5-24d25605e60d", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "003702f6-535d-48b0-95c3-2760327d8040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9c24d7d3-5c9c-4ce0-b3ed-0460726bf9f6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "017decd6-c2f5-4c68-b4c9-f96b93493ec7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9c24d7d3-5c9c-4ce0-b3ed-0460726bf9f6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60838a2c-290b-4072-a11f-34e7f7983b92", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f598a01d-87c8-4bf5-97de-123bacda8d54", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60838a2c-290b-4072-a11f-34e7f7983b92"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "defe2415-725d-40b0-a3e8-b0da271f4dc9", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "bf7ff5e1-d183-4235-8588-2f9c63509950", "Styles": "line-height:normal;page-break-after:avoid;border:\nnone;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "defe2415-725d-40b0-a3e8-b0da271f4dc9"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "16727c5d-6429-4e00-be38-615428831320", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bf7ff5e1-d183-4235-8588-2f9c63509950"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "cebc5e91-716b-4f0d-bbf4-4d7cbdf003a0", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "16727c5d-6429-4e00-be38-615428831320"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "de4f68c2-0c0f-492b-bce0-dec135f32f94", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b9ccf8ea-bf80-40bd-8a03-0fc9293ff113", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "de4f68c2-0c0f-492b-bce0-dec135f32f94"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Takeda Pharma A/S </span></p>", "ID": "4ae92ba4-207c-4a42-b2d7-3449f08abfc4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma A/S </span>", "ID": "6422330f-0b86-404a-ab14-5968add76fd1", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S ", "ParentId": "4ae92ba4-207c-4a42-b2d7-3449f08abfc4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "45f0a194-b252-440c-a09e-aa37803e8979", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f4141053-d58f-4413-a48c-1275e3885016", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "45f0a194-b252-440c-a09e-aa37803e8979"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8607655d-1a18-47ed-85aa-549ddc5fffd9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "300acadf-baac-48bd-95c3-0fd77e5c3e06", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8607655d-1a18-47ed-85aa-549ddc5fffd9"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "0ecce0ec-fcfc-447a-8f2e-64bc4717bd54", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "b46f6152-0b5c-45ac-baf1-c4644208bc25", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0ecce0ec-fcfc-447a-8f2e-64bc4717bd54"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "af53073f-c617-44d3-a4bc-8e3a9e4bb702", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b46f6152-0b5c-45ac-baf1-c4644208bc25"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "b5221ae2-29e8-4158-9c3f-7a1d08e9dfcd", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "af53073f-c617-44d3-a4bc-8e3a9e4bb702"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cdfb4ce9-8953-4ef8-beff-bb1e6fe8ac14", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "528d5bbb-7dc2-4c5d-b96d-ce61703348e5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cdfb4ce9-8953-4ef8-beff-bb1e6fe8ac14"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cb207995-b747-4b47-9eb3-124616d3f9c5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "958b291d-d731-4cb3-b1ab-f534eebb4cc4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cb207995-b747-4b47-9eb3-124616d3f9c5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "42a83567-085b-452d-9518-803e03738c47", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "60b3ac9e-7b18-492e-a2f9-81b0bf5753bd", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "42a83567-085b-452d-9518-803e03738c47"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "bb619049-282f-4305-a248-933a18612785", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "60b3ac9e-7b18-492e-a2f9-81b0bf5753bd"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "97d2f980-1a5b-4852-b5f3-6a36838e4dd9", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "bb619049-282f-4305-a248-933a18612785"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "ad625e8c-8444-49e3-bcfe-01b4c12b83fa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "e4e619e9-f197-48cd-aecb-b1be69ce87f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ad625e8c-8444-49e3-bcfe-01b4c12b83fa"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9d97d087-9385-44e0-b0af-03c5665f257c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e4e619e9-f197-48cd-aecb-b1be69ce87f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "ed397794-e546-44c2-8bc5-57300c40643a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "041095d2-f6b5-444f-93c4-0e8dd02bcdf2", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "ed397794-e546-44c2-8bc5-57300c40643a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9d20dc17-8eb0-4bc6-9451-b11a387fdecc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4874cae-ce1b-4dd0-a4e6-d8f719bac77d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9d20dc17-8eb0-4bc6-9451-b11a387fdecc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d5985f66-3844-449a-bb93-4159c2deb099", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "38be04ab-d953-4b72-961f-6e44bb9ecb69", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d5985f66-3844-449a-bb93-4159c2deb099"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "e409b9d6-b5c3-4028-97e5-7a07f7ad9d05", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "85d14630-b431-4131-9708-35a01610634f", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e409b9d6-b5c3-4028-97e5-7a07f7ad9d05"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "190f0e43-c99c-4761-b90f-12fb7d3c653c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "85d14630-b431-4131-9708-35a01610634f"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "c9211fec-4cce-4db2-a5b8-ba929a9496cb", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "190f0e43-c99c-4761-b90f-12fb7d3c653c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b8732538-e896-4a82-aa09-45fcb215b74a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "81566d36-da94-4aa5-9621-61940a9adfa9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b8732538-e896-4a82-aa09-45fcb215b74a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "790fa35b-f3f1-4df2-bcfb-0b3840f86407", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6dfd64a7-6b3d-4e09-9d28-2e1196d46027", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "790fa35b-f3f1-4df2-bcfb-0b3840f86407"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "42db09dd-5d93-48c1-a4fc-5907503eb89d", "Styles": "border:solid windowtext 1.0pt;padding:2.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "6884eb33-a9f1-4b87-adb3-2fa3602718c3", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "42db09dd-5d93-48c1-a4fc-5907503eb89d"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "16bb9825-e416-46e6-8a3d-4cdb5689bc02", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6884eb33-a9f1-4b87-adb3-2fa3602718c3"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "ec267872-b058-430d-88e8-1e98540e02fb", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "16bb9825-e416-46e6-8a3d-4cdb5689bc02"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c002b266-405c-402f-bb51-037a5ea941d2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2134453d-0d5b-46d8-abe0-21a05d3bd18d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c002b266-405c-402f-bb51-037a5ea941d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "226a410a-84cb-4afc-9df5-4bc8a83a4b6e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3dd570b7-320d-47b4-815b-3026d5ff4116", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "226a410a-84cb-4afc-9df5-4bc8a83a4b6e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "bf6420c8-5cc7-4cb7-9e3a-d8ba6fd2982c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "b5a73670-1507-4c61-b169-9802dd840c22", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bf6420c8-5cc7-4cb7-9e3a-d8ba6fd2982c"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "c60b47cb-5db6-434c-ba61-1987a73383d4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b5a73670-1507-4c61-b169-9802dd840c22"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "1e14c161-35bd-4aeb-aaf1-819d6a614efc", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "c60b47cb-5db6-434c-ba61-1987a73383d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fc338ecc-1ecd-4b1e-9b0f-b6845f11ec87", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fe553443-c4e5-4db5-adad-062cefe7db66", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fc338ecc-1ecd-4b1e-9b0f-b6845f11ec87"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f051a2ce-4947-475f-abaf-1e60581ee41f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bbd0ebc0-a7be-4f55-b334-0b32b86dc622", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f051a2ce-4947-475f-abaf-1e60581ee41f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a6d42fc2-dbb8-4d2c-bc47-f173df62511b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "06ebfb55-1318-4a3e-978e-b3f17e7cc6bf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a6d42fc2-dbb8-4d2c-bc47-f173df62511b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "0dc43510-68b2-4928-bf34-9bd59707565a", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9a72f8d2-ab3d-474d-ace8-145ae54c85a1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0dc43510-68b2-4928-bf34-9bd59707565a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e6ef16e-d724-486c-920f-f84ba63d33c2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9a72f8d2-ab3d-474d-ace8-145ae54c85a1"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b></p>\n</div>", "ID": "205acd8a-c132-48ba-b8b0-6ae54165f3a2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>", "ID": "81b786db-fe1f-4ff8-98bd-c55010f1bc50", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "205acd8a-c132-48ba-b8b0-6ae54165f3a2"}, {"Element": "<b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b>", "ID": "49296eff-e1b7-46a7-9bb8-5b1cc5ab683f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "81b786db-fe1f-4ff8-98bd-c55010f1bc50"}, {"Element": "<span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span>", "ID": "eb4d359c-4ee3-4cc7-ae98-f560af8b8107", "Styles": "None", "Classes": "None", "Text": "MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS", "ParentId": "49296eff-e1b7-46a7-9bb8-5b1cc5ab683f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5318dc16-b940-450b-adf5-4a8a1ed72f21", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "205acd8a-c132-48ba-b8b0-6ae54165f3a2"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "22bccc8b-2dd0-404c-b2b8-36c60840b0b9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5318dc16-b940-450b-adf5-4a8a1ed72f21"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7091924a-5dbc-438b-a642-d86f109b7209", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "22bccc8b-2dd0-404c-b2b8-36c60840b0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b></p>", "ID": "b5eed5a2-35a0-4dba-a290-dce0683c07d4", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "205acd8a-c132-48ba-b8b0-6ae54165f3a2"}, {"Element": "<b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b>", "ID": "0c12db87-e3af-4418-a34d-666771c944ef", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b5eed5a2-35a0-4dba-a290-dce0683c07d4"}, {"Element": "<span lang=\"EN-GB\">BLISTER FOR WALLET</span>", "ID": "5572734e-6dbb-4572-85ed-75b0d9250950", "Styles": "None", "Classes": "None", "Text": "BLISTER FOR WALLET", "ParentId": "0c12db87-e3af-4418-a34d-666771c944ef"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "808e7b45-87e0-4cc9-9f88-788e50ab52b0", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "5c43c333-b21e-452f-be32-7538d1b21d62", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "808e7b45-87e0-4cc9-9f88-788e50ab52b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "af4b70bf-fc42-4484-a1dd-aac8cd09f28a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0d0fb5a3-4265-48fb-9ded-beef36bf2eaa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "af4b70bf-fc42-4484-a1dd-aac8cd09f28a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "3f7f64df-5909-4725-a9ff-02ae4070fd7e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "26fe4dce-c785-4651-bacf-2f766d1d8519", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3f7f64df-5909-4725-a9ff-02ae4070fd7e"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "e33a064b-f0e2-4b6f-a25f-096bce3dcdc2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "26fe4dce-c785-4651-bacf-2f766d1d8519"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "3ac84e55-5da7-4fe5-9ee6-20e3b58e97e0", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "e33a064b-f0e2-4b6f-a25f-096bce3dcdc2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "17091bcd-bd2e-44d6-b9de-2efb7ab667c4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "d1f341b4-c0b4-47df-9c26-ba4b3be3caa5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "17091bcd-bd2e-44d6-b9de-2efb7ab667c4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "13531f4d-4e58-4498-8441-5cb2f9eeb8dc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d1f341b4-c0b4-47df-9c26-ba4b3be3caa5"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg</span></p>", "ID": "88012a13-a84f-467e-bdc5-d84dc4c9e9d5", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 2.3 mg</span>", "ID": "38eb0a61-db46-48af-b04c-105217aa105c", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 2.3 mg", "ParentId": "88012a13-a84f-467e-bdc5-d84dc4c9e9d5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib</span></p>", "ID": "6252d7be-aa54-484d-9f54-87228453fff3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib</span>", "ID": "56d70eef-004e-4921-a518-e932203319ef", "Styles": "None", "Classes": "None", "Text": "ixazomib", "ParentId": "6252d7be-aa54-484d-9f54-87228453fff3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c02a9367-71a1-4632-9e1f-b9b9af30aaab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ab5141eb-a80c-4dbf-a8a1-7305564a730d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c02a9367-71a1-4632-9e1f-b9b9af30aaab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d1621b90-a55f-4533-b303-0ef5e1e0999f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1ca013a8-e446-4f34-b726-4503450e5abd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d1621b90-a55f-4533-b303-0ef5e1e0999f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "1aab48af-6e63-4eab-8a99-d5a9256d14b1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "3112f124-4507-4ee0-893d-dbff02b679dc", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1aab48af-6e63-4eab-8a99-d5a9256d14b1"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "742050dd-1041-4b69-900c-e2b1ceafc8c8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3112f124-4507-4ee0-893d-dbff02b679dc"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "7afe9a07-718b-450c-a4df-fd951f0b5d44", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "742050dd-1041-4b69-900c-e2b1ceafc8c8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4d926c3b-4d47-46f8-b980-166904feb446", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9e97742b-31c0-4933-936b-967ef4de7602", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4d926c3b-4d47-46f8-b980-166904feb446"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda</span></p>", "ID": "96be1d33-5a6c-4015-bd2c-6ab3ce474424", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda</span>", "ID": "fed6fe1d-1d58-4669-8c60-2118080ea248", "Styles": "None", "Classes": "None", "Text": "Takeda", "ParentId": "96be1d33-5a6c-4015-bd2c-6ab3ce474424"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c02f9c57-bcaa-4786-9fd3-fe238a5a17da", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "59a587e0-7e8b-4527-8696-1ed9bb470565", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c02f9c57-bcaa-4786-9fd3-fe238a5a17da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bcc35621-31d7-40d4-b8e7-39c8f1fb761f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "277abc7d-f2d7-4a7f-b167-13590ee1d5e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bcc35621-31d7-40d4-b8e7-39c8f1fb761f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "d0eff02b-1a94-4e98-b306-7989f7e2da51", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "fe2a9e9e-fdb3-42ae-bba7-3f85817c3897", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d0eff02b-1a94-4e98-b306-7989f7e2da51"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "0fd6592c-825f-423c-a8fc-f079f9ffcacb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fe2a9e9e-fdb3-42ae-bba7-3f85817c3897"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "f9485e97-f63c-4a23-9c47-35713c26bf89", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "0fd6592c-825f-423c-a8fc-f079f9ffcacb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c14cc865-9d7c-418f-8e18-a3bdf703ce82", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "abb857b5-1dbe-4494-bee3-423d2b81e07b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c14cc865-9d7c-418f-8e18-a3bdf703ce82"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "4d26febb-1a61-4e4a-950f-f0cfd24a9e53", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "6fcab44f-5a39-4c7a-97dd-c584c18f6dfa", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "4d26febb-1a61-4e4a-950f-f0cfd24a9e53"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fe7bd83b-e885-43c7-a43f-8981e74dce1f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b6c44538-eee5-4a5d-abf6-1e97e07a5472", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fe7bd83b-e885-43c7-a43f-8981e74dce1f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0697d335-6d8a-4169-8cba-a8c54ed1f693", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1e0c137d-7a4e-4606-ac6b-7a214886bff5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0697d335-6d8a-4169-8cba-a8c54ed1f693"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "8a48713a-28c8-4041-853a-2e93051dd3e7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "65a9b46f-20c9-41ce-a5c8-fb038b842dbf", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8a48713a-28c8-4041-853a-2e93051dd3e7"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "bce0d34c-6046-4b02-a81f-ace975909f55", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "65a9b46f-20c9-41ce-a5c8-fb038b842dbf"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "af6f6b3a-ec64-4652-a286-b7418da7da9d", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "bce0d34c-6046-4b02-a81f-ace975909f55"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d3480bf7-70f8-4eab-8586-c2f2b2b22e84", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "82da71f9-7054-4e71-96f5-e65499d0ea41", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d3480bf7-70f8-4eab-8586-c2f2b2b22e84"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "6182e05e-62e8-4420-a385-09ae9a7ba719", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "c19172ae-65d1-4168-b522-8ddf20ff2a63", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "6182e05e-62e8-4420-a385-09ae9a7ba719"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e0100896-9c50-48d5-bf7b-919728073921", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e98ada0e-feab-4140-b382-f6e0d9729e5a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e0100896-9c50-48d5-bf7b-919728073921"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "15f52ba9-d0b3-4604-9767-96ecbd53549a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f4524cd1-7dd7-4f82-bba7-1770c869e028", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "15f52ba9-d0b3-4604-9767-96ecbd53549a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</div>", "ID": "d13a0d92-c80d-45d1-890e-02572875f1f9", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>", "ID": "0d717121-d63c-4a30-82d9-1031fce6bbc8", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d13a0d92-c80d-45d1-890e-02572875f1f9"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b>", "ID": "7aca916a-3164-4e3a-a367-dac62e3e129a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0d717121-d63c-4a30-82d9-1031fce6bbc8"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span>", "ID": "a7eec111-c939-40a3-90c9-5204d24e97e9", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER", "ParentId": "7aca916a-3164-4e3a-a367-dac62e3e129a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "19f930e8-e6c7-4550-9581-9aca109fd11e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1ea7ec0f-6e7f-4043-b8d1-eb7903c87c36", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "19f930e8-e6c7-4550-9581-9aca109fd11e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "67c119df-1f1c-4cfe-baba-b5a1119ac439", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "283460de-ce04-4e92-ba62-157d7e5356af", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "67c119df-1f1c-4cfe-baba-b5a1119ac439"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS </span></b></p>\n</div>", "ID": "be35d17d-6f26-4aab-999d-92a9153e294b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>", "ID": "aa215da5-2344-4a01-b899-0fcf90f141a2", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "be35d17d-6f26-4aab-999d-92a9153e294b"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b>", "ID": "22f2c3a9-33f5-450e-8e78-c1827ab3f37e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa215da5-2344-4a01-b899-0fcf90f141a2"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span>", "ID": "9d066d5f-d577-4a6f-8e87-3a685a896545", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING", "ParentId": "22f2c3a9-33f5-450e-8e78-c1827ab3f37e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "6035b26b-cc21-48d2-bf0c-12d955ae6741", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "be35d17d-6f26-4aab-999d-92a9153e294b"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "db4e9c21-26d4-437c-9129-2af939149b55", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6035b26b-cc21-48d2-bf0c-12d955ae6741"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "64b09af0-d801-49fe-9955-97d7183ad1f5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "db4e9c21-26d4-437c-9129-2af939149b55"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS </span></b></p>", "ID": "07f05929-5712-4567-a319-87ec57c4e7fc", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "be35d17d-6f26-4aab-999d-92a9153e294b"}, {"Element": "<b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS </span></b>", "ID": "38ca906b-50a5-4861-880e-99c1b3b093cc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "07f05929-5712-4567-a319-87ec57c4e7fc"}, {"Element": "<span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS </span>", "ID": "ecb5b437-b48c-4300-bea2-99e05c5d27a0", "Styles": "None", "Classes": "None", "Text": "CARTON CONTAINING WALLET UNIT PACKS ", "ParentId": "38ca906b-50a5-4861-880e-99c1b3b093cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cc29311b-ef50-4017-8532-b1a0c951261a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "be93cb2d-1624-4916-97ec-0c82e209c3f5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cc29311b-ef50-4017-8532-b1a0c951261a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7b0e0787-f08a-4d90-b21f-5f48d6cc9631", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d069bc99-c60a-44e5-a520-e5a8867ce5e2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7b0e0787-f08a-4d90-b21f-5f48d6cc9631"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "a3c9cf8d-af01-46f0-a21e-46eb505f17c7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "8ad0396b-c172-470a-b739-4bee4117a1a4", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a3c9cf8d-af01-46f0-a21e-46eb505f17c7"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "5c75e45a-3ea3-4e30-bc56-655d41306e58", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8ad0396b-c172-470a-b739-4bee4117a1a4"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "9bfd1b1d-fde5-48af-be6a-6f394a5a17b0", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "5c75e45a-3ea3-4e30-bc56-655d41306e58"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1156cdc7-ebb6-428c-8d5d-2ec25234a198", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fea2713e-ba89-4995-b22f-5ef44e67b0e5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1156cdc7-ebb6-428c-8d5d-2ec25234a198"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg hard\ncapsules</span></p>", "ID": "0103a037-8556-4571-9b1e-3d1441f5ecea", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg hard\ncapsules</span>", "ID": "7a08aa97-dbf6-42c0-b6e2-b1c84fa15f08", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 3 mg hard capsules", "ParentId": "0103a037-8556-4571-9b1e-3d1441f5ecea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>", "ID": "4080360a-be19-45f6-8e9a-ba0466dc8e22", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib </span>", "ID": "8e43a9bc-dc4a-4fb0-94a2-bfe45bfdf6df", "Styles": "None", "Classes": "None", "Text": "ixazomib ", "ParentId": "4080360a-be19-45f6-8e9a-ba0466dc8e22"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1c31bdce-c2a3-42de-9f54-63039218dd88", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "09fb82d9-7f2a-4727-863f-55d5c1f3eef4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1c31bdce-c2a3-42de-9f54-63039218dd88"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a8f03446-4742-4260-8baa-10ebd45132b5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "53943538-e9c6-49f2-b02c-f82397836539", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a8f03446-4742-4260-8baa-10ebd45132b5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>", "ID": "146f9209-c3bb-446b-8df8-52bf40ad3c4b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>", "ID": "695641f6-5a1e-4f28-9875-ac59b78f780a", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "146f9209-c3bb-446b-8df8-52bf40ad3c4b"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b>", "ID": "c93fdca7-cfb7-4ff0-8d93-52b9fab624c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "695641f6-5a1e-4f28-9875-ac59b78f780a"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span>", "ID": "a3ab41ba-734e-49a6-bc82-ff0df4ba083a", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "c93fdca7-cfb7-4ff0-8d93-52b9fab624c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9a2a9d47-7258-49e4-be98-bedd722cf2ef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0737da9c-48f6-4290-b8c0-619d7cc28d8e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9a2a9d47-7258-49e4-be98-bedd722cf2ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 3 mg of ixazomib (as 4.3 mg of ixazomib\ncitrate) </span></p>", "ID": "e0419914-b21e-4ee2-927c-861e1701a0eb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Each hard capsule contains 3 mg of ixazomib (as 4.3 mg of ixazomib\ncitrate) </span>", "ID": "b1a064b5-12f1-43ec-84d1-5a8df80ac30c", "Styles": "None", "Classes": "None", "Text": "Each hard capsule contains 3 mg of ixazomib (as 4.3 mg of ixazomib citrate) ", "ParentId": "e0419914-b21e-4ee2-927c-861e1701a0eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "90293178-59b0-41b0-8b5e-d99d7daa6376", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8afc52cf-2b35-43fa-b12e-7de6a9fc63c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "90293178-59b0-41b0-8b5e-d99d7daa6376"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2b5d2c76-9f15-402b-ae9a-5ed27495a4a0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3ff44b7f-7878-41c7-9933-e00195e74da9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2b5d2c76-9f15-402b-ae9a-5ed27495a4a0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>", "ID": "24831af4-bc24-411e-b83f-21cba8542002", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>", "ID": "72487574-13ac-40d2-afde-0fee48bc0054", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "24831af4-bc24-411e-b83f-21cba8542002"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b>", "ID": "0d75c228-a777-457c-97ec-f22f10ada834", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "72487574-13ac-40d2-afde-0fee48bc0054"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span>", "ID": "8242e542-35de-489e-9ad7-8f58f6aa2b9c", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "0d75c228-a777-457c-97ec-f22f10ada834"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a0ad11be-9c00-41d5-9aa6-171441ac9912", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "04768a7a-f417-408a-916f-2466f79a1349", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a0ad11be-9c00-41d5-9aa6-171441ac9912"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cfd4a9e4-4f69-44d6-894f-911b20a09df6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "78ac52ce-7440-4c73-a861-316d3f636133", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cfd4a9e4-4f69-44d6-894f-911b20a09df6"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>", "ID": "433f32cc-18fc-461e-ab8e-96fc21afddbc", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>", "ID": "0ec44a54-78c0-43e2-a0f3-023229ab1194", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "433f32cc-18fc-461e-ab8e-96fc21afddbc"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b>", "ID": "5c67a7db-84f9-46c3-840b-4c312c6921b5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0ec44a54-78c0-43e2-a0f3-023229ab1194"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span>", "ID": "9c736445-4c83-48bc-8f45-d177f8250ca3", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "5c67a7db-84f9-46c3-840b-4c312c6921b5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1fe9c316-b41e-4665-af3c-31055eddb12a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "21273d15-65b2-44ac-bb14-da6a076733a9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1fe9c316-b41e-4665-af3c-31055eddb12a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Hard capsule</span><span lang=\"EN-GB\"> </span></p>", "ID": "eb0f5ed5-4889-43e9-ac0f-26368cbb723e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">Hard capsule</span>", "ID": "9ae919a2-ca8f-4c60-9cf0-eefffdc6edc0", "Styles": "background:silver", "Classes": "None", "Text": "Hard capsule", "ParentId": "eb0f5ed5-4889-43e9-ac0f-26368cbb723e"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "236c2092-47c0-4a7d-b769-b167d6c82d9a", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "eb0f5ed5-4889-43e9-ac0f-26368cbb723e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2c3a13ab-a824-44f6-996f-257250c7ca61", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5cdee34a-35b0-4f0b-802b-6698c11267a1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2c3a13ab-a824-44f6-996f-257250c7ca61"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3 packs of 1\nhard capsule.</span></p>", "ID": "54ee3a82-7fd6-4744-90fb-428e30f0a80e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">3 packs of 1\nhard capsule.</span>", "ID": "44328cf8-7ee8-453a-89ac-5d887824680e", "Styles": "None", "Classes": "None", "Text": "3 packs of 1 hard capsule.", "ParentId": "54ee3a82-7fd6-4744-90fb-428e30f0a80e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "37b4db1e-df02-496e-a7d6-0237dd7ec359", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5589d8d9-db1f-4501-b1d6-3b0604ed005a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "37b4db1e-df02-496e-a7d6-0237dd7ec359"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0e289287-4a91-4edb-8d9e-6f0052cfe941", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "32c0fa76-5098-4164-949e-5b34119a92eb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0e289287-4a91-4edb-8d9e-6f0052cfe941"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>", "ID": "647ea3e1-955b-45b7-80e6-bd481dd10b6d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>", "ID": "b2804a93-886d-4f56-bda6-51459bec898e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "647ea3e1-955b-45b7-80e6-bd481dd10b6d"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b>", "ID": "84e460df-1ad3-4b8e-8f50-e6121a4248d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b2804a93-886d-4f56-bda6-51459bec898e"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span>", "ID": "8894c454-8dcd-4308-935c-e8d7153558d7", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "84e460df-1ad3-4b8e-8f50-e6121a4248d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2b10f0a1-8b0c-4cd2-a42c-4fd12c0ead26", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9ec09f79-d73c-4831-8878-af0a2df8b0ff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2b10f0a1-8b0c-4cd2-a42c-4fd12c0ead26"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span></p>", "ID": "9ea09806-6bdf-4567-a7f4-67d3e4067ee9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Read the package\nleaflet before use</span>", "ID": "d7de56be-e057-4408-874d-60b93f0e1a02", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use", "ParentId": "9ea09806-6bdf-4567-a7f4-67d3e4067ee9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c33d7e2d-7695-48aa-a40a-4717ee58bf4b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c4c5e80e-a054-4afe-b2b7-e6378d13b6ac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c33d7e2d-7695-48aa-a40a-4717ee58bf4b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>", "ID": "24aa5032-4d9e-4f56-962e-510a229d0a19", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Oral use</span>", "ID": "7f76bab3-10fc-4186-99eb-13fe2c177250", "Styles": "None", "Classes": "None", "Text": "Oral use", "ParentId": "24aa5032-4d9e-4f56-962e-510a229d0a19"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2cfb5d88-3b0d-4b59-9889-c283e0fea3f3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0f143626-b338-46d8-a13b-74027190e24f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2cfb5d88-3b0d-4b59-9889-c283e0fea3f3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "01174872-f551-4ae1-8ee1-e23efb48db14", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6b602848-5ee4-43e1-973c-a354f1c3885c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "01174872-f551-4ae1-8ee1-e23efb48db14"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>", "ID": "dfeea054-da33-46b1-9e77-6242bf88b122", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>", "ID": "52b17fea-700a-4b47-8663-593289cbcb62", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dfeea054-da33-46b1-9e77-6242bf88b122"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b>", "ID": "3d44c49d-8bce-4fc6-9549-85586b84e3a9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "52b17fea-700a-4b47-8663-593289cbcb62"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span>", "ID": "6080916e-bf92-419f-8e2b-4506a3d0a1c6", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "3d44c49d-8bce-4fc6-9549-85586b84e3a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "33f96f78-2c06-426b-8d67-7cd5a6885ec6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "06cc5f2d-ff5f-4c51-8abf-263e094becb9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "33f96f78-2c06-426b-8d67-7cd5a6885ec6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>", "ID": "ba6c29d0-76bd-4a3a-aa0c-d316f85fa163", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span>", "ID": "0af5a449-b18d-4886-906a-cc391c2c7060", "Styles": "None", "Classes": "None", "Text": "Keep out of the sight and reach of children", "ParentId": "ba6c29d0-76bd-4a3a-aa0c-d316f85fa163"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "be727cca-ebf2-4d3a-914c-05386052c346", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fe679253-d5ab-4513-a938-87daa0dea7b8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "be727cca-ebf2-4d3a-914c-05386052c346"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e01a7783-9287-4df7-a704-652ca2af0595", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a4d3a3cb-350b-4fe6-815e-7cb90405f7ac", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e01a7783-9287-4df7-a704-652ca2af0595"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>", "ID": "cd5f773f-ca44-4383-8ee5-1c12460ec300", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>", "ID": "6451f214-6f7f-479a-ac6e-8de3dc46e767", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cd5f773f-ca44-4383-8ee5-1c12460ec300"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b>", "ID": "cfde9b00-4fff-4dea-97c1-9906b00d4d31", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6451f214-6f7f-479a-ac6e-8de3dc46e767"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span>", "ID": "f7e8a109-9021-4f34-968e-b934e589628d", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "cfde9b00-4fff-4dea-97c1-9906b00d4d31"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4d23d465-49fe-44cd-b8bf-cc3c62bd61e6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e040c44e-5e92-4368-b993-1f9aef746b4c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4d23d465-49fe-44cd-b8bf-cc3c62bd61e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>", "ID": "494c8a4f-cab2-4c90-b843-474b891d5ad3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Cytotoxic</span>", "ID": "4931bc4d-e7f2-4d93-8840-7a5e808ac7bc", "Styles": "None", "Classes": "None", "Text": "Cytotoxic", "ParentId": "494c8a4f-cab2-4c90-b843-474b891d5ad3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "af831116-dc96-405e-a89b-2cf872418270", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4a65c1bb-bf85-4023-9126-06ccf1349f53", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "af831116-dc96-405e-a89b-2cf872418270"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9053570a-234a-4a7a-822a-2e05ed2e9206", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92402935-87d1-460b-871a-9a1c07f1e416", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9053570a-234a-4a7a-822a-2e05ed2e9206"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "bce0d41b-8461-49ec-a4f6-f78a53b01568", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "ab65d396-61a6-41e7-b0ab-5d281c480a09", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bce0d41b-8461-49ec-a4f6-f78a53b01568"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "ef951fb3-29cd-4b7c-bf34-0d2e7807e0d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ab65d396-61a6-41e7-b0ab-5d281c480a09"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "0cd7aac6-b985-49ea-a973-0f3199c81335", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "ef951fb3-29cd-4b7c-bf34-0d2e7807e0d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "15c7af61-17f5-43de-a9e7-69a8fc7724d5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2654630d-0a6b-4f16-a395-c2ff1ac840b4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "15c7af61-17f5-43de-a9e7-69a8fc7724d5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "136889fc-ddeb-4705-9b6d-2ea2bca2ca36", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "8851998b-0e87-4238-bc18-12dc9d6040db", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "136889fc-ddeb-4705-9b6d-2ea2bca2ca36"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b263d053-72f3-46d6-a9de-43a354e1161a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "187b15ec-6775-4823-85ad-33c047f60aad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b263d053-72f3-46d6-a9de-43a354e1161a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "82828e01-7a74-43d2-a899-60afcf5f9983", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ca00c9f8-8445-4d2f-8027-2bde4b71bbf6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "82828e01-7a74-43d2-a899-60afcf5f9983"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "145b62c8-7d45-43fe-97ac-a756d02dfc14", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "2f85d0f0-c8cf-46a2-97a2-c8875a088209", "Styles": "line-height:normal;page-break-after:avoid;border:\nnone;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "145b62c8-7d45-43fe-97ac-a756d02dfc14"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "3e17a85f-5b11-4581-9b23-1673fd9d1752", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2f85d0f0-c8cf-46a2-97a2-c8875a088209"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "7d7d9ee3-e0cf-40db-9b9c-bf6550bd893b", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "3e17a85f-5b11-4581-9b23-1673fd9d1752"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "efb114cb-058b-4b4a-9328-84368374f79e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dd4245fa-c819-4e5b-8fc2-e7eb1f9a8a37", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "efb114cb-058b-4b4a-9328-84368374f79e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span></p>", "ID": "449c60b0-d520-4a48-bad4-89921c15761a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span>", "ID": "3cc84ff1-bf6f-4d9a-b6a1-01b68d643016", "Styles": "None", "Classes": "None", "Text": "Do not store above 30\u00baC. Do not freeze. ", "ParentId": "449c60b0-d520-4a48-bad4-89921c15761a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Store in the original package in\norder to protect from moisture.</p>", "ID": "360e8a1b-8db5-4cfc-928d-82ad601acb18", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Store in the original package in order to protect from moisture.", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "f431c072-c1d0-41df-bb4d-767d1b4c57b8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "3a4e579c-844b-4d5e-845d-201988512f8a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "7e85cc2a-cadc-46b4-913c-57bac1206d3e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "129d1e5d-350a-419a-8bce-3d0e6c7f3b96", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7e85cc2a-cadc-46b4-913c-57bac1206d3e"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "06620b72-c108-49ad-8b44-2686e1eece10", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "129d1e5d-350a-419a-8bce-3d0e6c7f3b96"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "58385f29-05bb-4760-ba33-9c06e5a51b62", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "06620b72-c108-49ad-8b44-2686e1eece10"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "afe4f8a0-cd11-43d3-971d-7880fc33dfc4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e42b1307-dcd4-45af-ad98-6deb318bf0a2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "afe4f8a0-cd11-43d3-971d-7880fc33dfc4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "573cfd59-d6eb-4109-a480-bd9426e2588a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5d113a7c-93cd-4bf9-85ee-cc4485deca2a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "573cfd59-d6eb-4109-a480-bd9426e2588a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "24e8015d-c12a-4bff-8658-299068e8737f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "c6946e03-753f-4d0e-a28f-6eb32bbd87fb", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "24e8015d-c12a-4bff-8658-299068e8737f"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "dec5e6e6-5282-4038-b90c-adddbdf5d017", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c6946e03-753f-4d0e-a28f-6eb32bbd87fb"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "314c310b-a7af-4cf3-8516-8a18158d1eba", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "dec5e6e6-5282-4038-b90c-adddbdf5d017"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "744bb04a-c93a-4f82-9456-7d5b629fd869", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b5c52e24-c731-424c-bce0-268e5b53d4d8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "744bb04a-c93a-4f82-9456-7d5b629fd869"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>", "ID": "21767415-cbf1-4a56-a140-3a7755ca9024", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma\nA/S </span>", "ID": "5a80179c-df33-42be-89e7-7de5d293ce5b", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S ", "ParentId": "21767415-cbf1-4a56-a140-3a7755ca9024"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>", "ID": "3bc5ea80-3959-456d-b5cf-cedcc00b122a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span>", "ID": "a3b436fa-84fe-4c15-a020-0da93f5069c5", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "", "ParentId": "3bc5ea80-3959-456d-b5cf-cedcc00b122a"}, {"Element": "<span lang=\"EN-GB\">Delta Park 45</span>", "ID": "4c66ef22-2584-40aa-b3fc-1ecea3d5eb3e", "Styles": "None", "Classes": "None", "Text": "Delta Park 45", "ParentId": "a3b436fa-84fe-4c15-a020-0da93f5069c5"}, {"Element": "<span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span>", "ID": "cfe0727d-9edf-4996-bbaf-f8b778296175", "Styles": "border:none windowtext 1.0pt;\npadding:0in", "Classes": "None", "Text": " ", "ParentId": "3bc5ea80-3959-456d-b5cf-cedcc00b122a"}, {"Element": "<br/>", "ID": "8337cd9b-fd3c-4f1d-ab0c-c28e6bd9a7c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cfe0727d-9edf-4996-bbaf-f8b778296175"}, {"Element": "<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span>", "ID": "36d3442b-8e65-457b-8a70-e55484bfb511", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "2665 Vallensbaek Strand", "ParentId": "cfe0727d-9edf-4996-bbaf-f8b778296175"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>", "ID": "eadab4b7-5221-4907-8338-9bac2049d59b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Denmark</span>", "ID": "cc10bcd8-db01-413e-b5b7-b1af6f4a2ae8", "Styles": "None", "Classes": "None", "Text": "Denmark", "ParentId": "eadab4b7-5221-4907-8338-9bac2049d59b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0dfac9f7-6bea-43c2-95d8-1260849d60fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b492188a-16ac-4796-9825-bf3a2e4694cd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0dfac9f7-6bea-43c2-95d8-1260849d60fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5b395253-8497-4afa-b263-ac131a160d6a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e15dd54e-ee37-479e-812d-3475b2e9104e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5b395253-8497-4afa-b263-ac131a160d6a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "3cd01a54-07bf-4c05-8ff3-baa2dc9b3c4a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "5fbf198e-3159-4d60-be8b-424cc30a79dc", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3cd01a54-07bf-4c05-8ff3-baa2dc9b3c4a"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "5cbda32a-69d0-4a07-ada7-0d8f60e2b8c6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5fbf198e-3159-4d60-be8b-424cc30a79dc"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "535c568c-d07c-4980-b6aa-c67a84f04482", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "5cbda32a-69d0-4a07-ada7-0d8f60e2b8c6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "60503ffe-c79d-48e7-8f09-7c760ea8f564", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "07e13c83-0cbb-4f7d-bfb8-073e8340b6e3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "60503ffe-c79d-48e7-8f09-7c760ea8f564"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/002</span></p>", "ID": "0c28ffae-7b9b-4c97-a13a-56a03f8a53ae", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/002</span>", "ID": "d4610d35-98d1-4de2-91e9-ebbf6a3b6231", "Styles": "color:black", "Classes": "None", "Text": "EU/1/16/1094/002", "ParentId": "0c28ffae-7b9b-4c97-a13a-56a03f8a53ae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f6ed1280-5859-4b65-8552-564b1c3c8dab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b5c0a60e-16c2-458b-b94a-a8a1de343288", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f6ed1280-5859-4b65-8552-564b1c3c8dab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0d34f723-5202-4f86-8b14-f77b0efb2094", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e3199b9c-419f-462f-8446-4a13e1344c9a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0d34f723-5202-4f86-8b14-f77b0efb2094"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "e354f93b-4e9d-4de1-b8c0-4ee96293493b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "bd2f2213-ef88-40e0-a8d2-cb45be618c8b", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e354f93b-4e9d-4de1-b8c0-4ee96293493b"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "2b7385bf-3c6f-4b2a-ae94-3514e7a37d66", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bd2f2213-ef88-40e0-a8d2-cb45be618c8b"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "17e36aef-a46a-4da0-83d0-9b063a2b35cc", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "2b7385bf-3c6f-4b2a-ae94-3514e7a37d66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "238d88cb-fb48-4da5-a94c-da74f671ba9b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "b378c2b6-a7f8-45e0-b07f-db3f7d7547f2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "238d88cb-fb48-4da5-a94c-da74f671ba9b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2d580e63-b574-4f01-95b0-d6e2fce8f34f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b378c2b6-a7f8-45e0-b07f-db3f7d7547f2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "7601d152-8314-4b34-b90d-82dc7a2b04ad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "b6033e34-4d9a-48b8-98c9-238282590395", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "7601d152-8314-4b34-b90d-82dc7a2b04ad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b06e8ebc-f85e-4ff2-9372-a0aa726bb9d7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "daea0c74-471a-4044-9f24-0effbe7bd104", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b06e8ebc-f85e-4ff2-9372-a0aa726bb9d7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b10d1915-570b-4559-80f1-8660c07d3abe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "27fd1a53-e3c4-4c6a-8182-56b7d8e1aef0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b10d1915-570b-4559-80f1-8660c07d3abe"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "f09e6d2f-426b-42ef-9057-dc31e5de072b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "c2a3228a-5141-4793-9026-cf2e292a49c2", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f09e6d2f-426b-42ef-9057-dc31e5de072b"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "06c120c2-a7cb-4946-a360-30bbe943d7a9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c2a3228a-5141-4793-9026-cf2e292a49c2"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "5fdea7eb-11ea-4d23-9ae9-083ed573b3a0", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "06c120c2-a7cb-4946-a360-30bbe943d7a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "4ff2d150-f768-4d43-88cc-cab8d9d6fd50", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "d2497a6e-19b7-4c49-b773-33d72e7a4e60", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4ff2d150-f768-4d43-88cc-cab8d9d6fd50"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8078914c-9cce-49bc-9350-3765f00319a4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d2497a6e-19b7-4c49-b773-33d72e7a4e60"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "25384ed3-bad1-42e3-bb31-91a6e9526717", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5be4a920-3f36-4de4-85a9-7bd85b26eee5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "25384ed3-bad1-42e3-bb31-91a6e9526717"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "ee22c040-5828-41a7-99d3-805880efa30f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "5cd6f3bf-d9e9-442a-b0f6-fdb79e5eff4a", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ee22c040-5828-41a7-99d3-805880efa30f"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "14064da8-2619-4aaf-9f1e-fd9c81dd7950", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5cd6f3bf-d9e9-442a-b0f6-fdb79e5eff4a"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "36643ecf-2fdd-4724-a839-7234675ea539", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "14064da8-2619-4aaf-9f1e-fd9c81dd7950"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3368a3f2-5017-4fc2-9be2-1f9af731ae23", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c25e25aa-846d-476b-8262-33d076d7f658", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3368a3f2-5017-4fc2-9be2-1f9af731ae23"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1fc13390-1a30-4bd5-a31c-0fb046270afd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5fc139b4-7de3-42ca-8058-390475f9b4ef", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1fc13390-1a30-4bd5-a31c-0fb046270afd"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "877221a2-5973-47bf-8905-6ba4a61fb23d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "f9bab071-201b-40bb-8a87-d256722f87ec", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "877221a2-5973-47bf-8905-6ba4a61fb23d"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "70576b7d-6b9a-47a6-aeba-0ab169d3c05b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f9bab071-201b-40bb-8a87-d256722f87ec"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "f3404bd4-1e79-402e-824c-ad9d65beb2b4", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "70576b7d-6b9a-47a6-aeba-0ab169d3c05b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ab6a8286-e817-45d9-888e-7d3aaf6bb5dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5215bacb-ddde-4c0a-bf00-f8195731d067", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ab6a8286-e817-45d9-888e-7d3aaf6bb5dc"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg </span></p>", "ID": "8f3e1263-bd1e-4a64-9d4a-47ef30c47e99", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg </span>", "ID": "090e805d-fc3d-4a51-8741-273eab544b9d", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 3 mg ", "ParentId": "8f3e1263-bd1e-4a64-9d4a-47ef30c47e99"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "b51704e0-bfaa-4454-b48c-04438ba1242c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "360d0dfc-d740-458d-8288-d57268ace1a5", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "b51704e0-bfaa-4454-b48c-04438ba1242c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "c64e9afc-8ad7-4180-8083-47c6bae5ac8a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "2f0c5403-2952-4a00-b175-94f6b01c00f5", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "c64e9afc-8ad7-4180-8083-47c6bae5ac8a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "04b61f76-72d4-4c82-8b37-c01f479ccb25", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "fb6b0eb5-1ac0-40c0-9705-1b9b429a41e6", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "04b61f76-72d4-4c82-8b37-c01f479ccb25"}, {"Element": "<b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "a3eb0d84-3930-4fd7-ace2-7610e4d7875d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fb6b0eb5-1ac0-40c0-9705-1b9b429a41e6"}, {"Element": "<span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span>", "ID": "de0bb0dc-ab87-4421-b7ec-649971cfc04d", "Styles": "None", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "a3eb0d84-3930-4fd7-ace2-7610e4d7875d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3348da7d-e4cb-484a-8262-414137c29f8b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "edeebb0c-b712-4b5d-9980-89cd875e8fd2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3348da7d-e4cb-484a-8262-414137c29f8b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">2D barcode carrying the unique identifier included.</span></p>", "ID": "e6323dd1-fa59-4cd3-bb45-f39938898906", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">2D barcode carrying the unique identifier included.</span>", "ID": "9c483cf2-bb48-4646-88ef-47f24b27597d", "Styles": "background:silver", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "e6323dd1-fa59-4cd3-bb45-f39938898906"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "14692383-520e-4fc9-a0ad-abbb6d54f71c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "82e286f3-2f27-4bca-a51e-704d0a3e54ef", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "14692383-520e-4fc9-a0ad-abbb6d54f71c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "95af9ba1-46c2-49c3-8ffc-974dcbb56eaf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b400d2a0-4f4c-4e7f-8326-2f9028cd3020", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "95af9ba1-46c2-49c3-8ffc-974dcbb56eaf"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "60e37b95-b772-4c71-9d50-df0125ac619d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>", "ID": "53c05b5d-89cd-4ac5-85ea-96c3399a12cf", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "60e37b95-b772-4c71-9d50-df0125ac619d"}, {"Element": "<b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b>", "ID": "52dd2c6a-97ee-420d-b585-b79e962428cd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "53c05b5d-89cd-4ac5-85ea-96c3399a12cf"}, {"Element": "<span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span>", "ID": "caf1ce8e-36e1-414d-b287-266da8423427", "Styles": "None", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA", "ParentId": "52dd2c6a-97ee-420d-b585-b79e962428cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2945cf7c-20d0-4a1f-9647-bdefb030d271", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "904dc32f-d487-4e1e-b19e-e7c6ebbe428b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2945cf7c-20d0-4a1f-9647-bdefb030d271"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">PC</span></p>", "ID": "73993654-705a-463b-b021-24033d8f7149", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">PC</span>", "ID": "ab837dc6-6920-43e0-afce-ffc060f3a396", "Styles": "None", "Classes": "None", "Text": "PC", "ParentId": "73993654-705a-463b-b021-24033d8f7149"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SN</span></p>", "ID": "e2d46bf9-ef9f-4373-93ca-b9c78af955a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">SN</span>", "ID": "db903262-4916-4817-b627-aeafd9c56163", "Styles": "None", "Classes": "None", "Text": "SN", "ParentId": "e2d46bf9-ef9f-4373-93ca-b9c78af955a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NN</span></p>", "ID": "b9181579-d63c-4088-b7bc-1be2ffdcc39d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NN</span>", "ID": "80812a5d-0d83-4ca4-92c3-9d7eda9be0c4", "Styles": "None", "Classes": "None", "Text": "NN", "ParentId": "b9181579-d63c-4088-b7bc-1be2ffdcc39d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "8c04f1d7-5fab-41e7-8fa2-eb66d05945db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "6df81604-feac-405d-8b99-9a1a0befb58f", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "8c04f1d7-5fab-41e7-8fa2-eb66d05945db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "ab17175c-0a74-46f4-8575-a4f7619d2884", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "ed801bcf-35f9-4168-85f6-c484709b6f54", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "ab17175c-0a74-46f4-8575-a4f7619d2884"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT </span></b></p>\n</div>", "ID": "1b4010c5-d6bd-4655-97a3-cc3e94f99b3b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>", "ID": "f67ad954-348d-4b12-81fe-ebf028200cb6", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1b4010c5-d6bd-4655-97a3-cc3e94f99b3b"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b>", "ID": "3c2cfb33-d04e-4baa-95db-a22206297f62", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f67ad954-348d-4b12-81fe-ebf028200cb6"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span>", "ID": "eaf43d4c-746e-4f01-8888-772743be2479", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING", "ParentId": "3c2cfb33-d04e-4baa-95db-a22206297f62"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "19c8a8d4-a0a5-4286-8244-cbec1d1de8f9", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1b4010c5-d6bd-4655-97a3-cc3e94f99b3b"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "3162f657-6843-4282-9d33-c8ab244e7c7b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "19c8a8d4-a0a5-4286-8244-cbec1d1de8f9"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4373bded-960d-4556-a436-b7b35a66640e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3162f657-6843-4282-9d33-c8ab244e7c7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT </span></b></p>", "ID": "2817fb9e-e372-4550-89ff-5a86ca83f963", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1b4010c5-d6bd-4655-97a3-cc3e94f99b3b"}, {"Element": "<b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT </span></b>", "ID": "e61dcdf0-0926-4b34-91ff-30053969ad8a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2817fb9e-e372-4550-89ff-5a86ca83f963"}, {"Element": "<span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT </span>", "ID": "729ea010-5678-45ea-86fb-c15691d52b4a", "Styles": "None", "Classes": "None", "Text": "CARTON CONTAINING WALLET UNIT ", "ParentId": "e61dcdf0-0926-4b34-91ff-30053969ad8a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "affc02ca-d4eb-49c9-bff6-6959b22ad771", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1c5c5be7-602e-449c-a901-4ffb8fd3269b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "affc02ca-d4eb-49c9-bff6-6959b22ad771"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3b2cf6af-0400-4183-9af1-6045a8d01065", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4c593563-8d72-424f-bade-472b38c61a65", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3b2cf6af-0400-4183-9af1-6045a8d01065"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "f8566fa1-7394-4ef9-a663-fda6792b6f7f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "f164dcc6-8547-417a-9a99-c828712bf73e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8566fa1-7394-4ef9-a663-fda6792b6f7f"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "c2807d10-f036-4c88-bb8e-afa155d14e9a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f164dcc6-8547-417a-9a99-c828712bf73e"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "9320a830-7afc-47a8-bd49-54caae1261ff", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "c2807d10-f036-4c88-bb8e-afa155d14e9a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9d77f3c9-1cc2-468e-8589-c3d0924052fb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cfd483f9-a4e7-4013-adfb-c1fba78dc4d1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9d77f3c9-1cc2-468e-8589-c3d0924052fb"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg hard\ncapsules </span></p>", "ID": "673281a3-b11e-496d-ae27-73e7e552f0ee", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg hard\ncapsules </span>", "ID": "d165e6fe-a93f-4317-9aad-5da37483c1d1", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 3 mg hard capsules ", "ParentId": "673281a3-b11e-496d-ae27-73e7e552f0ee"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>", "ID": "cfa4f80a-f6b8-4b8e-bf41-229ecea35716", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib </span>", "ID": "afd0ca8b-bf7e-44e2-b54b-b5ebefd7be73", "Styles": "None", "Classes": "None", "Text": "ixazomib ", "ParentId": "cfa4f80a-f6b8-4b8e-bf41-229ecea35716"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8540951e-d3ea-4456-98a6-d60c98c0def4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9922e9f6-4819-44a6-b489-cda021835c0c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8540951e-d3ea-4456-98a6-d60c98c0def4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "81934810-d481-498b-bc91-bb5e94380e40", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9be2113b-8540-4da2-91c5-d5a8f888f795", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "81934810-d481-498b-bc91-bb5e94380e40"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>", "ID": "ef689033-57ec-4c40-881c-5c592c7b22ab", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>", "ID": "dd622085-5511-461b-b926-717a9eacfdc4", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ef689033-57ec-4c40-881c-5c592c7b22ab"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b>", "ID": "59669c31-d811-416d-ad8e-705591077ae4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dd622085-5511-461b-b926-717a9eacfdc4"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span>", "ID": "9dfad252-be9e-49a4-bc76-85216b0cb8f1", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "59669c31-d811-416d-ad8e-705591077ae4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e44ed08b-8326-4525-b268-2af24ca37221", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4c1f5f12-ecec-42b6-b325-70dc9add035c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e44ed08b-8326-4525-b268-2af24ca37221"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 3 mg of ixazomib (as 4.3 mg of ixazomib\ncitrate) </span></p>", "ID": "716a2862-70b2-4ae5-b429-932e210fd682", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Each hard capsule contains 3 mg of ixazomib (as 4.3 mg of ixazomib\ncitrate) </span>", "ID": "f927c501-02f5-40f0-9520-bad70bb9d977", "Styles": "None", "Classes": "None", "Text": "Each hard capsule contains 3 mg of ixazomib (as 4.3 mg of ixazomib citrate) ", "ParentId": "716a2862-70b2-4ae5-b429-932e210fd682"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "46e87b8b-2847-4a8f-9194-e63f770ac3e7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3b1ec710-632c-4de7-89c8-a71e63d45625", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "46e87b8b-2847-4a8f-9194-e63f770ac3e7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "23506421-26c4-44db-8156-a68bd7fdfafa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8d861115-cf86-4dba-a7af-3fe01c92d204", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "23506421-26c4-44db-8156-a68bd7fdfafa"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>", "ID": "59928fe6-a343-4177-abc8-9728f0ee245e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>", "ID": "0810fced-2afd-4456-8f10-18a7758b12bc", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "59928fe6-a343-4177-abc8-9728f0ee245e"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b>", "ID": "feab3b5a-3197-4bc2-b376-5637099d9838", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0810fced-2afd-4456-8f10-18a7758b12bc"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span>", "ID": "c982d7b6-0ecb-4b9c-85fe-63a9bbf56206", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "feab3b5a-3197-4bc2-b376-5637099d9838"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c4884299-3823-4aeb-820e-f38b4c667e20", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2f5b1a89-9639-4f39-b7e9-b70c6fff572c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c4884299-3823-4aeb-820e-f38b4c667e20"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8acc9e93-f06c-404c-a394-76883f3424f1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ff7aa2d4-b4d8-4055-b26b-e589a1e8ebcf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8acc9e93-f06c-404c-a394-76883f3424f1"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>", "ID": "19337dc1-e6cd-465a-abc8-8c80f513dd62", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>", "ID": "d423fab1-0cc0-4f39-9d78-614e9aa2c10f", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "19337dc1-e6cd-465a-abc8-8c80f513dd62"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b>", "ID": "496b8b6f-179d-44d9-9e5f-e8e4ab6fc18b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d423fab1-0cc0-4f39-9d78-614e9aa2c10f"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span>", "ID": "09df0c6c-1886-4bcb-946f-467ac8fcf908", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "496b8b6f-179d-44d9-9e5f-e8e4ab6fc18b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "190aface-839a-4174-88aa-dccb4b4fd245", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7e8c7945-4790-40fd-8a3d-7121656e4a98", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "190aface-839a-4174-88aa-dccb4b4fd245"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule</span></p>", "ID": "0b07c764-679b-4a32-b8fe-ed763769fb56", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule</span>", "ID": "20e25dd3-d9a3-44d8-93c2-c12ffad67892", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Hard capsule", "ParentId": "0b07c764-679b-4a32-b8fe-ed763769fb56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0619ed12-9619-4f01-99bf-a703194f0f4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "57b49d31-4986-47e0-94c0-f8bcb749f6c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0619ed12-9619-4f01-99bf-a703194f0f4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule. </span></p>", "ID": "f6946931-b8c2-4011-ad4c-62e2937aa3f7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">1 hard capsule. </span>", "ID": "c7f7cea3-7f08-43cd-a1a0-651bcf7842bf", "Styles": "None", "Classes": "None", "Text": "1 hard capsule. ", "ParentId": "f6946931-b8c2-4011-ad4c-62e2937aa3f7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d570bdcb-d719-48c4-8278-1ce24d86403a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4d95ba99-cb57-4a00-996d-2f6b7f2620ea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d570bdcb-d719-48c4-8278-1ce24d86403a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "54427e20-ab2b-43fe-9142-29f294fb9fa0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "48203b13-e6fa-4ce5-920a-970da4d0083a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "54427e20-ab2b-43fe-9142-29f294fb9fa0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>", "ID": "cc36f414-bbc3-49a8-8024-5f512d9bb8c2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>", "ID": "fba1878d-138c-47e4-92ae-2adcd84f3bc9", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cc36f414-bbc3-49a8-8024-5f512d9bb8c2"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b>", "ID": "b64d104b-c695-42ce-a6bd-a588e725793c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fba1878d-138c-47e4-92ae-2adcd84f3bc9"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span>", "ID": "85abb3f4-cdb8-4dd7-92df-6b03c2b1a1ff", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "b64d104b-c695-42ce-a6bd-a588e725793c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3119ef64-a532-4a9a-858e-4ca650aff417", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "045a099d-af4d-470b-bf52-0ff2d4b6ccfe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3119ef64-a532-4a9a-858e-4ca650aff417"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span></p>", "ID": "7e871424-22a5-4df8-b0d4-5f19b69a99ef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Read the package\nleaflet before use</span>", "ID": "11ae51f6-b754-40b9-9c98-9e9b107863ce", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use", "ParentId": "7e871424-22a5-4df8-b0d4-5f19b69a99ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>", "ID": "c70482b2-c6e3-419e-8a17-b65824bccc09", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Oral use</span>", "ID": "ff1acda2-14b0-42de-abfd-ca454eabac38", "Styles": "None", "Classes": "None", "Text": "Oral use", "ParentId": "c70482b2-c6e3-419e-8a17-b65824bccc09"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "298f8269-2fba-44d9-979b-bbec3bc7f515", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "21a9f1b3-212e-45ad-9d4c-8c292d5f8ac3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "298f8269-2fba-44d9-979b-bbec3bc7f515"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6ec587bf-8fb0-44bb-9f1b-53943a88069c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3130942f-b0f9-43b8-9d0a-968264e59cb9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6ec587bf-8fb0-44bb-9f1b-53943a88069c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>", "ID": "20965ae5-09c5-4533-a851-046b18c4e753", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>", "ID": "c76d68da-e91a-4394-be31-0f89b5457272", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "20965ae5-09c5-4533-a851-046b18c4e753"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b>", "ID": "f55bb4fb-7c11-4a98-bf81-4d08a6f9906b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c76d68da-e91a-4394-be31-0f89b5457272"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span>", "ID": "11c75644-85b7-4d8a-bb7d-d809c9ca0639", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "f55bb4fb-7c11-4a98-bf81-4d08a6f9906b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "00a79036-1fcc-4263-a464-37a36b96cff3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "eacda016-f6ed-455b-94b6-a1ffaf3790a2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "00a79036-1fcc-4263-a464-37a36b96cff3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>", "ID": "f2e8d9b7-c306-4794-988e-e651f15fffe2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span>", "ID": "13274d2f-be30-4d85-a854-c48b108df4cc", "Styles": "None", "Classes": "None", "Text": "Keep out of the sight and reach of children", "ParentId": "f2e8d9b7-c306-4794-988e-e651f15fffe2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b66a8cf0-6d0c-425f-a4ad-02bd81459691", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c765cebb-69f6-49e6-98a4-efde26f0304f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b66a8cf0-6d0c-425f-a4ad-02bd81459691"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "de0bfd4e-113a-4f24-ad58-432b15dcd71d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "efb7451f-8e22-4790-8138-e4ba175293bb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "de0bfd4e-113a-4f24-ad58-432b15dcd71d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>", "ID": "028b3f76-1cea-48a7-a91a-0d01c99b60b8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>", "ID": "96a3bbd2-c178-4a23-b0d8-83e5b20fc3b2", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "028b3f76-1cea-48a7-a91a-0d01c99b60b8"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b>", "ID": "68528495-6e4a-4098-a58c-8ed34a3ceb20", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "96a3bbd2-c178-4a23-b0d8-83e5b20fc3b2"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span>", "ID": "7f23add2-c589-4f5b-90b5-91ef60b77ce0", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "68528495-6e4a-4098-a58c-8ed34a3ceb20"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1e11236c-cffd-4212-aba1-6211e9357e4d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c91c4420-d6d9-492b-a1ea-f33da4c75916", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1e11236c-cffd-4212-aba1-6211e9357e4d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>", "ID": "b7a3cd77-1a49-4f60-af8f-860b5f1f505c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Cytotoxic</span>", "ID": "a13b4ade-b4dc-45ee-b7c4-74697c2ae706", "Styles": "None", "Classes": "None", "Text": "Cytotoxic", "ParentId": "b7a3cd77-1a49-4f60-af8f-860b5f1f505c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "58c3a25c-79f8-40cb-9a38-2b5268ca05e1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "711505b0-c6d9-4062-b150-83daa39c1aea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "58c3a25c-79f8-40cb-9a38-2b5268ca05e1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "507702b9-b3a6-442d-8df9-1e5a4d16bb9a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d43bd224-6b49-4dd5-9ea6-d389e2b09ac2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "507702b9-b3a6-442d-8df9-1e5a4d16bb9a"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "527f45af-e909-4017-9961-6e2b81344dd9", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "03db2675-e426-48e5-a0c5-1dfa54e25d90", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "527f45af-e909-4017-9961-6e2b81344dd9"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "f9b5d7e3-d43a-43ef-92d6-404a87764db8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "03db2675-e426-48e5-a0c5-1dfa54e25d90"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "b5f0c46d-f43c-4701-bf4c-0650062707fe", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "f9b5d7e3-d43a-43ef-92d6-404a87764db8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b25cd69f-bb9c-4b70-9071-64d504bcc255", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d162a53d-9089-4409-8c1e-0f9268d7429b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b25cd69f-bb9c-4b70-9071-64d504bcc255"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "0a39db70-d551-4d52-9b8e-f23e19cb9954", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "70fe85aa-066e-4145-bd66-ef427cd46491", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "0a39db70-d551-4d52-9b8e-f23e19cb9954"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6b8ffd59-580b-441e-a76e-c585892f0992", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a6184a73-5032-4534-9905-0f0c37e48d56", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6b8ffd59-580b-441e-a76e-c585892f0992"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dee8f80b-800b-49fd-ae4f-fee81eb1570c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1fda1fda-cf3f-4ce1-9b51-cdb6559ca73a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dee8f80b-800b-49fd-ae4f-fee81eb1570c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "8669e475-a36e-4de4-930a-0bf43c0b128b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "4119c468-66c7-4c6f-802f-938ea77da9ba", "Styles": "line-height:normal;page-break-after:avoid;border:\nnone;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8669e475-a36e-4de4-930a-0bf43c0b128b"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "4b7c6fae-b718-4ed4-b591-496415f4ce1c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4119c468-66c7-4c6f-802f-938ea77da9ba"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "56412005-ac70-448f-93e2-15914901d49d", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "4b7c6fae-b718-4ed4-b591-496415f4ce1c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ac159f8b-5bca-4a7b-964c-fa5bc81db526", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f07eddc1-fd23-484c-baf5-407219150b41", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ac159f8b-5bca-4a7b-964c-fa5bc81db526"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store above\n30\u00baC. Do not freeze. </span></p>", "ID": "ee1145b7-ab5b-4d77-bfdf-40e7c7917126", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not store above\n30\u00baC. Do not freeze. </span>", "ID": "013e80a8-9697-4ff9-a207-1f4613edad46", "Styles": "None", "Classes": "None", "Text": "Do not store above 30\u00baC. Do not freeze. ", "ParentId": "ee1145b7-ab5b-4d77-bfdf-40e7c7917126"}, {"Element": "<p class=\"Default\"><span style=\"font-size:11.0pt\">Store in the original package\nin order to protect from moisture.</span></p>", "ID": "9f06a3a7-1135-485a-beaa-43c1c83dc8ec", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"font-size:11.0pt\">Store in the original package\nin order to protect from moisture.</span>", "ID": "f81f57d2-e719-457b-b052-123be51c4a04", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Store in the original package in order to protect from moisture.", "ParentId": "9f06a3a7-1135-485a-beaa-43c1c83dc8ec"}, {"Element": "<p class=\"Default\"><span style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "a881d5ef-d919-4724-8df5-ae7babc22471", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"font-size:11.0pt\">\u00a0</span>", "ID": "af377864-4ea3-45e0-86da-17e583d18651", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "a881d5ef-d919-4724-8df5-ae7babc22471"}, {"Element": "<p class=\"Default\"><span style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "8bf0dd53-c8e7-4dc4-9323-85b69de6ed65", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"font-size:11.0pt\">\u00a0</span>", "ID": "081960b7-6379-47b6-9096-1bd7340458f2", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "8bf0dd53-c8e7-4dc4-9323-85b69de6ed65"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "5dae40c1-533c-417d-82df-aa2dbbff7750", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "364ef947-da11-4fe4-b6b5-c56baec91fb4", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5dae40c1-533c-417d-82df-aa2dbbff7750"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "49dba24c-387b-4bdd-92c0-94611a8d5f52", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "364ef947-da11-4fe4-b6b5-c56baec91fb4"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "0e14971e-65a8-489c-a020-ad2878355aa0", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "49dba24c-387b-4bdd-92c0-94611a8d5f52"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "46bfc1af-3726-44ff-a1df-e67f73b46496", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a4bdb971-76d6-4d0b-bb63-cd25213eeead", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "46bfc1af-3726-44ff-a1df-e67f73b46496"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "82925098-3031-42d3-8e4e-fc9bd827788f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3b3b42c0-c8c6-4751-be8e-0f1174ce050e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "82925098-3031-42d3-8e4e-fc9bd827788f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "8c0fd2fb-2511-4bcb-850d-78630697f6bf", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "59e7312d-2f79-44db-97f5-1500aa2e4a76", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8c0fd2fb-2511-4bcb-850d-78630697f6bf"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "7f5feb8f-b3dd-4638-b4c2-f69122f5b3ba", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "59e7312d-2f79-44db-97f5-1500aa2e4a76"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "1ddc349e-cf46-49a4-8c6e-d2d9854b1a89", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "7f5feb8f-b3dd-4638-b4c2-f69122f5b3ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "54faf1da-de9e-4825-9a1b-3c19209f2645", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "383a13e9-adf5-48c7-802e-4d509d223528", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "54faf1da-de9e-4825-9a1b-3c19209f2645"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>", "ID": "3800060e-8f6d-4965-8f86-d87ee1be19ae", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma\nA/S </span>", "ID": "dffd573e-81c3-4ae5-b3a7-ed09ec0088e1", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S ", "ParentId": "3800060e-8f6d-4965-8f86-d87ee1be19ae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>", "ID": "4277d66a-e3ba-4ee8-99f5-9f18000a3d2d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span>", "ID": "695bc0af-9c2e-4b33-8947-f84acd1f9316", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "", "ParentId": "4277d66a-e3ba-4ee8-99f5-9f18000a3d2d"}, {"Element": "<span lang=\"EN-GB\">Delta Park 45</span>", "ID": "8cae46ac-b046-497a-ab80-f9f91c6040a4", "Styles": "None", "Classes": "None", "Text": "Delta Park 45", "ParentId": "695bc0af-9c2e-4b33-8947-f84acd1f9316"}, {"Element": "<span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span>", "ID": "b1f51d51-f088-4917-85ca-83230d2da3fc", "Styles": "border:none windowtext 1.0pt;\npadding:0in", "Classes": "None", "Text": " ", "ParentId": "4277d66a-e3ba-4ee8-99f5-9f18000a3d2d"}, {"Element": "<br/>", "ID": "d2cbe401-813c-4a4b-8730-03dd29609a4b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b1f51d51-f088-4917-85ca-83230d2da3fc"}, {"Element": "<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span>", "ID": "328a5676-9058-40ac-ad24-f52e6127645b", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "2665 Vallensbaek Strand", "ParentId": "b1f51d51-f088-4917-85ca-83230d2da3fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>", "ID": "3d9e6052-8c52-49a4-ba4f-adbbd59e67ef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Denmark</span>", "ID": "3a92491f-73da-4ea7-b05d-7d1fffa54f69", "Styles": "None", "Classes": "None", "Text": "Denmark", "ParentId": "3d9e6052-8c52-49a4-ba4f-adbbd59e67ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b4fde86a-d188-4b85-b7ea-40c027792b58", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "86d49468-33cd-49cc-9e00-c1e534ced9f1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b4fde86a-d188-4b85-b7ea-40c027792b58"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "10437d20-df3b-4034-a6dc-069a94abb026", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6814a279-1a83-4515-a9e0-979a63101484", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "10437d20-df3b-4034-a6dc-069a94abb026"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "d81a199d-261e-48b4-97c3-796ddbfb86ef", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "ee2f9f10-c5b5-4374-b8da-94ab60aceaf2", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d81a199d-261e-48b4-97c3-796ddbfb86ef"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "3057016b-a75d-49f0-9798-7d047a2710b1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ee2f9f10-c5b5-4374-b8da-94ab60aceaf2"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "0acc765c-aa16-4f90-9e62-06423e750e12", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "3057016b-a75d-49f0-9798-7d047a2710b1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "272b8f29-d75f-4702-8a3a-e42f5087350f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0f83c8ee-4756-4166-b2e1-50963b427b1f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "272b8f29-d75f-4702-8a3a-e42f5087350f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/002</span></p>", "ID": "bdd2da43-3516-45a9-afd4-bf79c4e78e44", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/002</span>", "ID": "2f2332ce-37de-401e-a578-e50f94f9a5d5", "Styles": "color:black", "Classes": "None", "Text": "EU/1/16/1094/002", "ParentId": "bdd2da43-3516-45a9-afd4-bf79c4e78e44"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "0cf9c277-23c7-4b05-9b20-704532250332", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "2baf8685-91f1-473a-8e5d-7432d91c3a27", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "0cf9c277-23c7-4b05-9b20-704532250332"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "64ca2e31-04d3-4c4f-a171-be69c7fb7320", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0d12327d-d971-43c6-93b2-f75b05749635", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "64ca2e31-04d3-4c4f-a171-be69c7fb7320"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "258e4047-4cc7-46f6-bc7b-05cecb68f519", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "ee26f488-690d-42b8-94a7-396591b64608", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "258e4047-4cc7-46f6-bc7b-05cecb68f519"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "12d64f5b-ccaa-4871-b105-d49a2e6fcd68", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ee26f488-690d-42b8-94a7-396591b64608"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "2a48be4f-5b52-4020-82c0-e7b83b8b2d87", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "12d64f5b-ccaa-4871-b105-d49a2e6fcd68"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "c70b5729-c5bc-4fab-8ab8-3ce6a9db2f40", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "65b21a77-2976-4d1f-bd98-a640396e887d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c70b5729-c5bc-4fab-8ab8-3ce6a9db2f40"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3856dacb-69e1-4434-92a0-07b1d4c89184", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "65b21a77-2976-4d1f-bd98-a640396e887d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "2224b2d2-4373-4b1b-ab1d-9af28e3a0295", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "fe29e0ac-34a4-4157-bc34-f3c4be43168c", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "2224b2d2-4373-4b1b-ab1d-9af28e3a0295"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b661693a-cc6f-47be-a63e-0d2536a18665", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "735bb24d-7a6c-4d68-bc00-2c42162ae29f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b661693a-cc6f-47be-a63e-0d2536a18665"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c0234004-1210-42af-8259-9759383a514b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d32b7f07-964b-4477-8868-9b2a8ef9725a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c0234004-1210-42af-8259-9759383a514b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "1099154d-b8ca-4840-8381-4e681b2f5ae3", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "10000c00-5edf-4eff-bde7-d99bf11a63d5", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1099154d-b8ca-4840-8381-4e681b2f5ae3"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "5d0ce000-e55c-4011-9966-cce2b1328158", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "10000c00-5edf-4eff-bde7-d99bf11a63d5"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "bc5a72e6-9fb3-49f4-b1bb-215cf48ac0f8", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "5d0ce000-e55c-4011-9966-cce2b1328158"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "1099d871-24b5-4d08-979b-883e795de2ae", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "8a86d253-5b08-4ac8-acb9-4f1972c8fcce", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1099d871-24b5-4d08-979b-883e795de2ae"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d9045cf6-b34f-4a1a-aff0-9a5f3355f676", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8a86d253-5b08-4ac8-acb9-4f1972c8fcce"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3ca2208c-5036-443d-87be-0b55a8250a74", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "38a6f0f4-195c-4e3e-aeb3-5978451ffe57", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3ca2208c-5036-443d-87be-0b55a8250a74"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "492c0693-ce9e-4652-948d-56e8de184641", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "d6bc5c5c-b7c0-46e7-bc3a-2a6a37e8f871", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "492c0693-ce9e-4652-948d-56e8de184641"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "932eba04-7e93-4b91-9e64-edcd2e3340ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d6bc5c5c-b7c0-46e7-bc3a-2a6a37e8f871"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "82041d99-7eac-47d1-a634-5bcacd0db979", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "932eba04-7e93-4b91-9e64-edcd2e3340ad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "573f3ea8-6a35-457f-8e4a-4dddcfeba933", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "55043b00-e35c-454d-9f68-b1231687f10a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "573f3ea8-6a35-457f-8e4a-4dddcfeba933"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9ecef7c4-d534-48ba-ba4b-cf3c7432fd82", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "38cbcac1-845c-48bc-950d-39d02adde61f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9ecef7c4-d534-48ba-ba4b-cf3c7432fd82"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "9da9393b-20e5-4a41-9fb0-2b8260623ad7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "58ca4ca0-2d17-4829-a3f4-0aed76d7a6e7", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9da9393b-20e5-4a41-9fb0-2b8260623ad7"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "01690b5c-a347-4aeb-a0dc-a080f1bb5472", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "58ca4ca0-2d17-4829-a3f4-0aed76d7a6e7"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "362c7a04-e084-4d69-afff-270b7f631556", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "01690b5c-a347-4aeb-a0dc-a080f1bb5472"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9c505e88-836e-4d61-8822-2c753fa33ea5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "88fda0be-7601-42be-b770-9f933c67e4d2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9c505e88-836e-4d61-8822-2c753fa33ea5"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg </span></p>", "ID": "e72afafd-6ede-47d8-a7d5-71dc51a273c0", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg </span>", "ID": "c74ee207-a6ef-4154-9126-5967b04e2d6e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 3 mg ", "ParentId": "e72afafd-6ede-47d8-a7d5-71dc51a273c0"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "cf46a1f8-ab84-4fc4-9e46-2d13d14f4e3b", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "bdc6f800-8c52-485e-b4c7-d324d401a8ae", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "cf46a1f8-ab84-4fc4-9e46-2d13d14f4e3b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "53da03a3-64a1-4c8a-a8cd-d1c6594747f9", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "caa319d8-c95b-43f5-a433-47ebaa59d525", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "53da03a3-64a1-4c8a-a8cd-d1c6594747f9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9da596f8-c526-47c7-bf93-1a259286be25", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0905917b-0ab6-479a-afae-eac9bceb61b7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9da596f8-c526-47c7-bf93-1a259286be25"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">WALLET </span></b></p>\n</div>", "ID": "c59a93ef-59ac-4e3d-be1b-6904ee0a4a80", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>", "ID": "78fa2216-dc25-46bf-844a-436687a65b0f", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c59a93ef-59ac-4e3d-be1b-6904ee0a4a80"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b>", "ID": "4e9c2dc4-b282-4ca7-94ad-febcd8f82fc7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "78fa2216-dc25-46bf-844a-436687a65b0f"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span>", "ID": "ff356449-2bc9-4cbb-a1eb-55a9be5ec023", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING", "ParentId": "4e9c2dc4-b282-4ca7-94ad-febcd8f82fc7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "4d4dd59c-a33b-4919-b182-a90b3d2b7c02", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c59a93ef-59ac-4e3d-be1b-6904ee0a4a80"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f23818bc-e71f-4d66-a9cc-8b8d51376f07", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4d4dd59c-a33b-4919-b182-a90b3d2b7c02"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9bb645be-fde4-4fe5-954a-9f298239524a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f23818bc-e71f-4d66-a9cc-8b8d51376f07"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">WALLET </span></b></p>", "ID": "fed434cc-ac26-4b0f-b5ca-6fb36aa005a8", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c59a93ef-59ac-4e3d-be1b-6904ee0a4a80"}, {"Element": "<b><span lang=\"EN-GB\">WALLET </span></b>", "ID": "cc48f694-98c3-4c4d-93f0-69416f98c576", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fed434cc-ac26-4b0f-b5ca-6fb36aa005a8"}, {"Element": "<span lang=\"EN-GB\">WALLET </span>", "ID": "9e76944c-a8c9-4d6d-873d-38f280f4b395", "Styles": "None", "Classes": "None", "Text": "WALLET ", "ParentId": "cc48f694-98c3-4c4d-93f0-69416f98c576"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fd7a1606-1ad4-450f-aa41-131879d949e8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6e5a6411-8d6f-42e0-ab2e-4f4dd3fb86c2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fd7a1606-1ad4-450f-aa41-131879d949e8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f4f1951c-64a9-47c2-9ac0-dc608131d30f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "20d4a3df-a4f2-40e3-abb2-a1570df9018f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f4f1951c-64a9-47c2-9ac0-dc608131d30f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "24fc969f-75c2-4c9a-8ad8-5813886612d6", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "972e49da-054a-4050-969b-9adb8feefa91", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "24fc969f-75c2-4c9a-8ad8-5813886612d6"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "bd831c4e-8428-4b6f-9cff-2bf08a55d5d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "972e49da-054a-4050-969b-9adb8feefa91"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "233b5ef8-eced-4d95-bf28-30301dfdb121", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "bd831c4e-8428-4b6f-9cff-2bf08a55d5d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "56d0263c-59d7-48a3-b54d-27ea8e14a4a4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a7515df4-62d2-40ca-a382-bce5ee1a1b05", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "56d0263c-59d7-48a3-b54d-27ea8e14a4a4"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg hard\ncapsules </span></p>", "ID": "e411021a-a71c-48da-9caa-611e64f3673a", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 3 mg hard\ncapsules </span>", "ID": "7837b599-2b21-426b-8ded-e519d17997e9", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 3 mg hard capsules ", "ParentId": "e411021a-a71c-48da-9caa-611e64f3673a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>", "ID": "933ea79e-bf01-43b4-9f17-61ebb058d18d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib </span>", "ID": "df326802-196c-490f-a119-28d3ee6728dd", "Styles": "None", "Classes": "None", "Text": "ixazomib ", "ParentId": "933ea79e-bf01-43b4-9f17-61ebb058d18d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cbc84f9c-68bc-49ab-b229-285cf750240e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d5b3c5f5-8948-4769-94bd-5fb688703942", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cbc84f9c-68bc-49ab-b229-285cf750240e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fb3ff222-a3a3-4b39-bbcd-f55e28739e49", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7e4edb85-c0e8-4729-9869-1433d0350402", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fb3ff222-a3a3-4b39-bbcd-f55e28739e49"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>", "ID": "bb878914-20cd-448d-86f4-24a3d48f41f1", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>", "ID": "84794522-d89c-4839-9b0a-a0712f9092d7", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bb878914-20cd-448d-86f4-24a3d48f41f1"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b>", "ID": "1953ffc5-4c02-4c6e-91cf-794b61bd407c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "84794522-d89c-4839-9b0a-a0712f9092d7"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span>", "ID": "9c6e00ac-eba4-4b45-8017-c2ac75533aa9", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "1953ffc5-4c02-4c6e-91cf-794b61bd407c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "f58898dd-e441-4718-9fc2-d15da6c99d9f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "c5b2f378-947c-43ee-815b-82abd8491c51", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "f58898dd-e441-4718-9fc2-d15da6c99d9f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "607cbc14-c774-44b6-8b83-d950bb1aeab1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "bf3d4219-69dd-4298-908c-f06a98d551ab", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "607cbc14-c774-44b6-8b83-d950bb1aeab1"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>", "ID": "06888034-e432-4537-90ee-5f20666e54aa", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>", "ID": "0a78baa5-e7b0-4376-be2a-e638eebf23a4", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "06888034-e432-4537-90ee-5f20666e54aa"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b>", "ID": "c2dcf456-9b87-46ae-af3c-ed4d5f60a64a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a78baa5-e7b0-4376-be2a-e638eebf23a4"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span>", "ID": "d9b74897-fbf7-431d-b1a7-ec05addc7f6f", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "c2dcf456-9b87-46ae-af3c-ed4d5f60a64a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "4629b648-b6c6-4b58-9388-682e6718772a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "9c9615b1-dea8-4778-b96c-13bafcd114bb", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "4629b648-b6c6-4b58-9388-682e6718772a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "150edb54-b59b-44ce-ae4a-11f2ca4e43b7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "b83adda1-4dde-4562-a327-b2dcfd64c877", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "150edb54-b59b-44ce-ae4a-11f2ca4e43b7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>", "ID": "3d7add39-7940-4c01-86e2-082c624eb3fe", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>", "ID": "1ed7fde9-a6c0-44d6-96ee-089af1b9dcb2", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3d7add39-7940-4c01-86e2-082c624eb3fe"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b>", "ID": "b1731323-2e6a-45b2-9297-263cd6ca594a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1ed7fde9-a6c0-44d6-96ee-089af1b9dcb2"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span>", "ID": "954cfb18-7454-4a1b-b717-63d40d94998d", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "b1731323-2e6a-45b2-9297-263cd6ca594a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "359acf77-3189-42a9-9665-adeb7f9ae05c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "348f64cc-1c5b-4688-a8d3-af333eac9dbc", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "359acf77-3189-42a9-9665-adeb7f9ae05c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Hard capsule </span></p>", "ID": "3a5a83fa-2848-4475-97d8-88bf3c829484", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">Hard capsule </span>", "ID": "7f31b402-85eb-4ef1-a6f8-8f5269b162a2", "Styles": "background:silver", "Classes": "None", "Text": "Hard capsule ", "ParentId": "3a5a83fa-2848-4475-97d8-88bf3c829484"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "0d809500-32ec-4c5a-9aef-2b7d14051312", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "94adda8d-48a8-4d5a-9a96-5db232bd1fc8", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "0d809500-32ec-4c5a-9aef-2b7d14051312"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule</span></p>", "ID": "8d13af83-f3e7-4393-9a71-b13e7938fbfd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">1 hard capsule</span>", "ID": "1842fc47-0cac-4524-b572-26a35fd9ef72", "Styles": "None", "Classes": "None", "Text": "1 hard capsule", "ParentId": "8d13af83-f3e7-4393-9a71-b13e7938fbfd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "433d4fff-6827-4696-8e80-52930204224f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "479596d6-35e9-4b47-9eec-a1f5c673c3e8", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "433d4fff-6827-4696-8e80-52930204224f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "2c03f853-fa13-4f8d-a628-8ad0045303b3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "137d6243-9ef1-4185-9254-968f96538f36", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "2c03f853-fa13-4f8d-a628-8ad0045303b3"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>", "ID": "4c1609c5-c802-4718-b67e-c268d8bf6392", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>", "ID": "0188f848-bae9-427c-aee4-0092f18b1226", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4c1609c5-c802-4718-b67e-c268d8bf6392"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b>", "ID": "1c5254ca-eac9-4862-90c3-eb5846541154", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0188f848-bae9-427c-aee4-0092f18b1226"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span>", "ID": "3b864f3f-4982-4da5-98b1-a8df038b8a1b", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "1c5254ca-eac9-4862-90c3-eb5846541154"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "7145a488-baa1-4f74-9031-41ca14439429", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "2dc5ab29-d22f-4877-8700-a3ec9f942579", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "7145a488-baa1-4f74-9031-41ca14439429"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use.</span></p>", "ID": "de6933ed-4858-4a81-a408-cf0a339b0167", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Read the package\nleaflet before use.</span>", "ID": "da90356a-7c49-4ce3-b4eb-0165c44c0e56", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "de6933ed-4858-4a81-a408-cf0a339b0167"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Do not crush, open or chew the capsules. Take each NINLARO capsule\nwhole with water at the same time each week, at least one hour before or no\nsooner than two hours after any food.</span></p>", "ID": "f0f28729-f844-4435-a018-8109f59ce4c8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not crush, open or chew the capsules. Take each NINLARO capsule\nwhole with water at the same time each week, at least one hour before or no\nsooner than two hours after any food.</span>", "ID": "06d653ea-28cf-4f3a-b9dc-987bb76e5cc1", "Styles": "None", "Classes": "None", "Text": "Do not crush, open or chew the capsules. Take each NINLARO capsule whole with water at the same time each week, at least one hour before or no sooner than two hours after any food.", "ParentId": "f0f28729-f844-4435-a018-8109f59ce4c8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The capsule should not be removed until just prior to dosing.</span></p>", "ID": "adf0f434-c741-4d6f-9e0d-7edb4388a91c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The capsule should not be removed until just prior to dosing.</span>", "ID": "81621b23-1946-4a3e-8dc6-8f6779aa9413", "Styles": "None", "Classes": "None", "Text": "The capsule should not be removed until just prior to dosing.", "ParentId": "adf0f434-c741-4d6f-9e0d-7edb4388a91c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use </span></p>", "ID": "c229b551-062a-493c-ace4-1a76d78c9dcc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Oral use </span>", "ID": "11d7311f-7975-4389-a4d3-2ad43af80b47", "Styles": "None", "Classes": "None", "Text": "Oral use ", "ParentId": "c229b551-062a-493c-ace4-1a76d78c9dcc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "226f31fa-52ba-4973-8b65-56753e20b3fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "c1a56d00-8dd2-4d5b-82d5-15b5144924bf", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "226f31fa-52ba-4973-8b65-56753e20b3fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "bd770685-ca99-456f-aa6c-7dc1b915ffd2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "6abc9087-4b70-41da-89eb-7a188e345775", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "bd770685-ca99-456f-aa6c-7dc1b915ffd2"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>", "ID": "aa6dcc2b-a451-4769-abdf-27e7bef63416", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>", "ID": "e73ea711-2130-4849-88a1-19163eddb97f", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aa6dcc2b-a451-4769-abdf-27e7bef63416"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b>", "ID": "15abd3aa-233c-4766-ad64-81380037472b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e73ea711-2130-4849-88a1-19163eddb97f"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span>", "ID": "3581bac1-dc74-49ae-962f-a1dec9a44a42", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "15abd3aa-233c-4766-ad64-81380037472b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "8e42d2b3-f13c-4668-b7ba-c95b85b9b6e0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "c3e18804-d437-468f-8d25-3109b0d61aec", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "8e42d2b3-f13c-4668-b7ba-c95b85b9b6e0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "c0fe8f3d-2dee-4ea3-9c5f-f12b9dc0f5d1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "4fb3db4b-9037-4ee2-9520-2793aab688f7", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "c0fe8f3d-2dee-4ea3-9c5f-f12b9dc0f5d1"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>", "ID": "a8537c86-00d1-4e2c-bbdd-311a07522794", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>", "ID": "d11f7b6d-4348-4c32-a58e-893542a67663", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a8537c86-00d1-4e2c-bbdd-311a07522794"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b>", "ID": "5f8c1fa1-ec58-492f-a8c7-b199d65e6a79", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d11f7b6d-4348-4c32-a58e-893542a67663"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span>", "ID": "0a3fd884-e5ad-482b-8c75-174ecfa9c632", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "5f8c1fa1-ec58-492f-a8c7-b199d65e6a79"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "32267613-985d-470b-868b-da6e866b7c63", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3c664218-32cb-4055-be86-c10e8d728c57", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "32267613-985d-470b-868b-da6e866b7c63"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>", "ID": "89336df2-e67a-4ef0-9084-2d2c0a912db4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Cytotoxic</span>", "ID": "43657b50-8c48-4617-926b-95e35772adee", "Styles": "None", "Classes": "None", "Text": "Cytotoxic", "ParentId": "89336df2-e67a-4ef0-9084-2d2c0a912db4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9a5ed1e0-e9d1-4f26-82f8-30332b20d678", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e1b8a75f-9782-4fe4-a140-4cb74bba6a45", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9a5ed1e0-e9d1-4f26-82f8-30332b20d678"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a6085998-6c87-41a9-a824-7c28a34b77fb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "eb3177ec-a7bc-4bf1-a54b-e6b8f3f23d71", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a6085998-6c87-41a9-a824-7c28a34b77fb"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "2f88e57e-2e02-4fc2-9ea0-c3d083bcd7c0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "337ca5cf-4aa3-40ef-9142-b2908bae2da2", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2f88e57e-2e02-4fc2-9ea0-c3d083bcd7c0"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "db120aea-f738-4b9f-b23d-0c0357904ea3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "337ca5cf-4aa3-40ef-9142-b2908bae2da2"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "2a3c5dc3-fce1-4442-bf97-702fade9a306", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "db120aea-f738-4b9f-b23d-0c0357904ea3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "235c17aa-94ee-453d-b2a3-bf6fbfc969ba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0a110d11-7bd0-4c17-abf2-5d53f6dbb100", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "235c17aa-94ee-453d-b2a3-bf6fbfc969ba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "e70a05b6-2307-4aae-b659-be8cbb03d72f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "78e1a5e8-b348-4e06-a18d-30f864515c89", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "e70a05b6-2307-4aae-b659-be8cbb03d72f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1db3bffa-e33d-467c-990d-b94cc9630517", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d05a4bca-6e4c-483f-bfce-6bc36fb976fa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1db3bffa-e33d-467c-990d-b94cc9630517"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e24ae51d-f12c-4561-845d-703876207028", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c981e560-700b-499b-8b4e-c2c5505c49a1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e24ae51d-f12c-4561-845d-703876207028"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b></p>\n</div>", "ID": "dfefe527-e578-47d3-be74-2793c6300d66", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b></p>", "ID": "2f419267-b84e-4fab-8150-ead5bfd76669", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "dfefe527-e578-47d3-be74-2793c6300d66"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b>", "ID": "d7aab2a6-ce70-47c5-a3dd-86026f5174c7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2f419267-b84e-4fab-8150-ead5bfd76669"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span>", "ID": "858a6358-bfb9-49ea-b404-35aed6a45249", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "d7aab2a6-ce70-47c5-a3dd-86026f5174c7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "79bfa40a-feb6-4cd5-9f3b-7aa673b1b2b2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "22a2ef0f-c018-4120-bbce-2f2a71739248", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "79bfa40a-feb6-4cd5-9f3b-7aa673b1b2b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span style=\"background:silver\">\u00a0</span></p>", "ID": "a9af1288-b4e1-407b-b807-655dafa1bd87", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"background:silver\">\u00a0</span>", "ID": "b9c66322-7022-4e0d-a517-0cb3efc6e8b7", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "a9af1288-b4e1-407b-b807-655dafa1bd87"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "c7fadb01-b71d-4c61-9171-0c373bc93a8a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "57b4df65-f671-42f1-85da-68b286206b5e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c7fadb01-b71d-4c61-9171-0c373bc93a8a"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "c43c3733-baf5-4eff-9951-d286bde0112f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "57b4df65-f671-42f1-85da-68b286206b5e"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "c6517a30-4e8e-4643-8743-1a92ccc6e370", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "c43c3733-baf5-4eff-9951-d286bde0112f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2b18c7a3-9018-47b7-942b-3e27d52e1d65", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9188b1cd-2eb8-4e2c-b931-9fe1073718c4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2b18c7a3-9018-47b7-942b-3e27d52e1d65"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6d64fc67-56f9-42e0-ae64-cdfeded5844b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2e96462e-c22d-4eb6-b60f-c10f2cec844f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6d64fc67-56f9-42e0-ae64-cdfeded5844b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "63b5eb68-537a-4326-9a62-266e4dd3ca0b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "0cf6813b-b753-4b84-83af-a99e376b4ec7", "Styles": "line-height:normal;page-break-after:avoid;border:\nnone;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "63b5eb68-537a-4326-9a62-266e4dd3ca0b"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "56d51c46-50b9-4fea-a8d1-1ff9e2818d97", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0cf6813b-b753-4b84-83af-a99e376b4ec7"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "605e6082-270c-4d0a-8aba-479b68da6e0e", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "56d51c46-50b9-4fea-a8d1-1ff9e2818d97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a219ab04-d597-4e91-bc3b-d7a875f61871", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8d53234b-af0d-49fe-be4f-91142da90417", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a219ab04-d597-4e91-bc3b-d7a875f61871"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Takeda Pharma A/S </span></p>", "ID": "a97f6868-74d1-4aff-a253-41de79c0e7a9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma A/S </span>", "ID": "8b726d4d-29cf-49f7-8796-19cc2327137f", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S ", "ParentId": "a97f6868-74d1-4aff-a253-41de79c0e7a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b738c4d6-3a86-49b0-aedd-edddbf5dc5cf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5369b475-1241-4627-a0b0-7a9c622edae6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b738c4d6-3a86-49b0-aedd-edddbf5dc5cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a4dc5d94-2f45-4469-a229-cc53a87cae6c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "68d21b62-ed03-4f03-bdfb-9bc66304da7d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a4dc5d94-2f45-4469-a229-cc53a87cae6c"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "a0ccf7e4-f699-4488-b8b7-c5bcf3151099", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "156ad88c-de51-4720-87f0-9b359a10a11f", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a0ccf7e4-f699-4488-b8b7-c5bcf3151099"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "a4a5f428-51e4-47ee-a007-b47b1b3228bc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "156ad88c-de51-4720-87f0-9b359a10a11f"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "22e00657-43e7-409e-b4c5-8d921150368f", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "a4a5f428-51e4-47ee-a007-b47b1b3228bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "73568a5f-6733-4a6f-8197-7bbe16a155a0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a292f56a-1cfd-409c-8b49-a67767abd8d1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "73568a5f-6733-4a6f-8197-7bbe16a155a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f225851f-7e82-4872-9d1e-9c8d77ddc4ad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fd70c317-2708-4c9e-a4e2-b741ebbf7d1d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f225851f-7e82-4872-9d1e-9c8d77ddc4ad"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "78fcae2d-183d-45bd-81a7-cba817c33f6a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "7689fba2-aef6-472c-a664-c24cd799fe93", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "78fcae2d-183d-45bd-81a7-cba817c33f6a"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "95b700c5-903d-49c7-a5cd-35c6031b895f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7689fba2-aef6-472c-a664-c24cd799fe93"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "75839a7a-2878-4396-9133-38c1e361ab78", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "95b700c5-903d-49c7-a5cd-35c6031b895f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "ae0cc0e6-679a-4b9a-b6a7-b5f1d13a9242", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "076b82ab-9583-4095-a74d-3aa460798995", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ae0cc0e6-679a-4b9a-b6a7-b5f1d13a9242"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6ce1b82c-f072-4c06-a6ca-a4f6d36f7476", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "076b82ab-9583-4095-a74d-3aa460798995"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "28c67341-94a2-4a70-bfe2-f159868dd60a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "6fa75c6c-bc80-4896-ae23-1c9b1cbda0e7", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "28c67341-94a2-4a70-bfe2-f159868dd60a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1e0149c1-6fe9-45aa-b179-109846054be5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fda92850-42a1-4f42-bb7c-0beb8b5205d9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1e0149c1-6fe9-45aa-b179-109846054be5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c9133dee-c98e-4f20-bd4a-05abd450adc9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c25d5fce-b72a-4af8-8342-9b7cf8dfec22", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c9133dee-c98e-4f20-bd4a-05abd450adc9"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "e45e1bb2-2624-4706-9be4-1110080a0084", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "ed9a4b5e-403f-4f8b-b6ff-1715f5124eb5", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e45e1bb2-2624-4706-9be4-1110080a0084"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "ed233957-ade7-42c1-b083-e0d866e3107f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ed9a4b5e-403f-4f8b-b6ff-1715f5124eb5"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "edf6c271-28b1-43a3-9593-7b535725fedc", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "ed233957-ade7-42c1-b083-e0d866e3107f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "f4051ab4-2d19-4d05-af55-45f7f6bb8f0c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "c169ab4c-57e2-4915-a688-80c406fa3547", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "f4051ab4-2d19-4d05-af55-45f7f6bb8f0c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span></p>", "ID": "b6d55211-3ca0-474f-a101-fd6fc6da70be", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">\u00a0</span>", "ID": "fbbb2a58-9489-44e3-8c48-f54ce888d18d", "Styles": "background:silver", "Classes": "None", "Text": "\u00a0", "ParentId": "b6d55211-3ca0-474f-a101-fd6fc6da70be"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "2e0c713e-8421-4d6b-9edc-7f6d65683306", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "2cac278b-47be-4e08-8380-d6e36bb7ca5c", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2e0c713e-8421-4d6b-9edc-7f6d65683306"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "6f21cf43-436c-4f9a-ba15-f3cad9e6aa70", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2cac278b-47be-4e08-8380-d6e36bb7ca5c"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "e7b843b4-2fc0-4a85-a236-2cd983214e90", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "6f21cf43-436c-4f9a-ba15-f3cad9e6aa70"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c72a2775-8306-439b-be64-3f48a6b3bc88", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "38ce1b9c-1c16-4749-b9c9-08c0f19d81a0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c72a2775-8306-439b-be64-3f48a6b3bc88"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cb02696f-fb7d-4a19-86dc-299e56413f29", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ac8c50ed-6c05-4247-9555-0c496fb40f70", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cb02696f-fb7d-4a19-86dc-299e56413f29"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "486971b4-57b7-4b54-8fa5-9fb472a8110c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "13a48006-0a32-4ca7-b5e4-a83ccf295018", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "486971b4-57b7-4b54-8fa5-9fb472a8110c"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "ea61d35f-9454-4df4-957c-59a313a50c18", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "13a48006-0a32-4ca7-b5e4-a83ccf295018"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "bd7c8288-ed0c-4ff8-b712-fd604db0bf1c", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "ea61d35f-9454-4df4-957c-59a313a50c18"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "1eb12a51-bad9-4c32-8bd5-0f2c7c5db376", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "fa5d7ba9-9d10-4a6c-bf6a-074bf84ac40c", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "1eb12a51-bad9-4c32-8bd5-0f2c7c5db376"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "183bb7fd-da67-4d4d-a9dc-e0b2d6a57f54", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "937ea710-0120-4392-b52b-700da1840182", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "183bb7fd-da67-4d4d-a9dc-e0b2d6a57f54"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "b2bf66c4-bc2a-4cfd-8013-b5e91ea7ba60", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "dabec2df-07ea-46f9-89f2-24ed4b673b5d", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "b2bf66c4-bc2a-4cfd-8013-b5e91ea7ba60"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "47767307-23ca-4058-b8cb-5a4dc4cb31ab", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b17b42b7-715b-47e3-ba1f-3a38cc327313", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "47767307-23ca-4058-b8cb-5a4dc4cb31ab"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "71820b3a-ed69-4fa7-adfc-9a8b27428bab", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "b979d5a7-1643-41d5-8db8-c84f98020953", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "71820b3a-ed69-4fa7-adfc-9a8b27428bab"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "111240cf-89f4-4c5b-827e-d60e1ae24430", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b979d5a7-1643-41d5-8db8-c84f98020953"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b></p>\n</div>", "ID": "4b6a7a2c-6749-4fb3-b3f0-40dfcfa60627", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>", "ID": "e492ea4a-e3f7-4c3c-9762-44d9ee831169", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4b6a7a2c-6749-4fb3-b3f0-40dfcfa60627"}, {"Element": "<b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b>", "ID": "b394bacb-e4eb-499d-9df4-357e57ddd765", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e492ea4a-e3f7-4c3c-9762-44d9ee831169"}, {"Element": "<span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span>", "ID": "69a46f07-0827-48c6-bea2-f7a8ea240af2", "Styles": "None", "Classes": "None", "Text": "MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS", "ParentId": "b394bacb-e4eb-499d-9df4-357e57ddd765"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "209b96b0-567b-4459-a433-cd0f70f1092d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4b6a7a2c-6749-4fb3-b3f0-40dfcfa60627"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "a352b305-168c-4ac5-a9d1-4f4411a3d897", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "209b96b0-567b-4459-a433-cd0f70f1092d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "35bfa20b-562c-42a5-a312-dc2fe9415c81", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a352b305-168c-4ac5-a9d1-4f4411a3d897"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b></p>", "ID": "3cf2b06e-51d8-4b9e-9469-69abaeb89594", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4b6a7a2c-6749-4fb3-b3f0-40dfcfa60627"}, {"Element": "<b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b>", "ID": "d5df821e-f988-40ed-86e5-d10164737c97", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3cf2b06e-51d8-4b9e-9469-69abaeb89594"}, {"Element": "<span lang=\"EN-GB\">BLISTER FOR WALLET</span>", "ID": "43e43868-9efc-4b08-80a4-ddc9f0fd81fb", "Styles": "None", "Classes": "None", "Text": "BLISTER FOR WALLET", "ParentId": "d5df821e-f988-40ed-86e5-d10164737c97"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "527943d5-5eae-4a2f-8d70-3b2e3e409dc9", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "56a21f8e-5944-45ff-b7fc-b5ff33ef06b0", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "527943d5-5eae-4a2f-8d70-3b2e3e409dc9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3ea08a81-09f7-47f8-8be0-95ac77b23924", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a3a4f1d6-b5f3-4f65-b638-2aff174ad28d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3ea08a81-09f7-47f8-8be0-95ac77b23924"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "22b3149d-eed0-4232-9ee1-54bf2de6a1c2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "a254217d-4fec-484d-8500-1687a41ff399", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "22b3149d-eed0-4232-9ee1-54bf2de6a1c2"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "e1b4517c-e237-488d-9dd8-2ee4a09246e2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a254217d-4fec-484d-8500-1687a41ff399"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "2fab27b6-8cc3-41a1-a0ef-39c06b093bd2", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "e1b4517c-e237-488d-9dd8-2ee4a09246e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "73149630-6219-48a6-b228-867ff0778db9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "11d525ca-2629-4920-b031-6152bb16223a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "73149630-6219-48a6-b228-867ff0778db9"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "41355395-cbb1-4713-b512-f5e8112c7307", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "11d525ca-2629-4920-b031-6152bb16223a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO 3 mg</span></p>", "ID": "6054b999-7fb2-455a-9d59-5a55a1e4ab2c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO 3 mg</span>", "ID": "5a91332f-b560-479e-a565-3b38267e4491", "Styles": "None", "Classes": "None", "Text": "NINLARO 3 mg", "ParentId": "6054b999-7fb2-455a-9d59-5a55a1e4ab2c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib</span></p>", "ID": "35ec770c-be65-4473-ad9d-eb35f6f554b4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib</span>", "ID": "2f31f726-f6fc-4260-adc8-1021f1d137b9", "Styles": "None", "Classes": "None", "Text": "ixazomib", "ParentId": "35ec770c-be65-4473-ad9d-eb35f6f554b4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4a329aac-b19a-484a-ba4b-a3fef0f54a4e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7313c22-c5da-433d-b5a9-f90f63b6a961", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4a329aac-b19a-484a-ba4b-a3fef0f54a4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4ce2ff27-e684-4568-8598-2b341563ac53", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6a41453c-907f-411a-b031-a268c4379ecd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4ce2ff27-e684-4568-8598-2b341563ac53"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "49bbb48d-37ea-4f8e-b735-564056b431d4", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "4d7530fd-a77d-4850-95af-57a56076d192", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "49bbb48d-37ea-4f8e-b735-564056b431d4"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "501c39b8-8cb1-4269-97f7-c1f10d026dbd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4d7530fd-a77d-4850-95af-57a56076d192"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "7b63973d-a47a-4a0d-ad2c-9234c0b7cfe2", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "501c39b8-8cb1-4269-97f7-c1f10d026dbd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bb39f8d5-fd19-4986-af6b-d922a2ca590e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "922e9040-1a12-4378-8291-eda7316c8c64", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bb39f8d5-fd19-4986-af6b-d922a2ca590e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda </span></p>", "ID": "be260bd8-629f-47a5-b12b-3e029a38c1fc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda </span>", "ID": "6bb4be07-f773-440a-be8a-9093bb436379", "Styles": "None", "Classes": "None", "Text": "Takeda ", "ParentId": "be260bd8-629f-47a5-b12b-3e029a38c1fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "98c3ba2c-9a6b-4d49-8329-b9d76dbbafe7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "424a720c-4fe6-4ba5-bc70-783a280089cd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "98c3ba2c-9a6b-4d49-8329-b9d76dbbafe7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "768fa586-d20f-4ff1-8543-be7d2e8fc432", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "89868913-eaed-40e2-a8a4-977f625dc347", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "768fa586-d20f-4ff1-8543-be7d2e8fc432"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "de8b013d-861e-446b-979f-71a953fca315", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "bdbc7298-0b5b-41e3-9610-684594abbdb9", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "de8b013d-861e-446b-979f-71a953fca315"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "52e39456-c28a-4460-adc5-f17d80e6b73a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bdbc7298-0b5b-41e3-9610-684594abbdb9"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "5624824d-603e-41cc-bfcf-41a8b164a39d", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "52e39456-c28a-4460-adc5-f17d80e6b73a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d17bfaa2-f39c-4777-b2fe-30246fdadb1d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "024db647-5a9c-4b07-b54a-045257f2d925", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d17bfaa2-f39c-4777-b2fe-30246fdadb1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "f96818de-01b7-4d26-8b94-48224b50dece", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "e0267301-0c65-4007-b2ca-765047b7833b", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "f96818de-01b7-4d26-8b94-48224b50dece"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7866d486-69a1-4303-a05a-d331ae44f9b0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fb1cf640-f463-4b71-9933-9bacecdfe18e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7866d486-69a1-4303-a05a-d331ae44f9b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d116b56a-78b2-45f4-a853-54fb7eec7983", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "58b22dff-de7e-4fba-a8f0-0818ac0bc95a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d116b56a-78b2-45f4-a853-54fb7eec7983"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER </span></b></p>\n</div>", "ID": "1337ff8f-f39c-48d1-9c42-c397ff3a934e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER </span></b></p>", "ID": "6a20f902-f955-4ae3-bb37-3551d95cadb3", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1337ff8f-f39c-48d1-9c42-c397ff3a934e"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER </span></b>", "ID": "7add6608-8497-43e5-8c21-9f15745ee29e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6a20f902-f955-4ae3-bb37-3551d95cadb3"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER </span>", "ID": "e8ae0ade-f019-4d9f-b1ef-8e65d4ef3122", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER ", "ParentId": "7add6608-8497-43e5-8c21-9f15745ee29e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ecc1f384-ab93-44ca-b1ca-61caca40a44a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92bf3fd8-1413-4993-a395-9df89a183d0a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ecc1f384-ab93-44ca-b1ca-61caca40a44a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "31c1c1b7-fed7-4ab5-89df-ab122f9d6990", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "2c486b43-8b11-4e8a-b0e0-5607af7da237", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "31c1c1b7-fed7-4ab5-89df-ab122f9d6990"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b49e3d7a-054a-4ba8-b878-f2e2524b6518", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5c4acf3e-5d02-43f5-ac81-2f95667d2b75", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b49e3d7a-054a-4ba8-b878-f2e2524b6518"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b66d6dde-3807-4cff-904b-125c4507ec94", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "93993d83-0d0d-423c-9b5a-60606ec22a83", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b66d6dde-3807-4cff-904b-125c4507ec94"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</div>", "ID": "00dbe7ae-4234-49f5-9c9d-4727888e5b8a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>", "ID": "8d620ce4-0d35-4f9f-ab83-056102129e9a", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "00dbe7ae-4234-49f5-9c9d-4727888e5b8a"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b>", "ID": "1e3e5f6a-8148-4d03-a535-a2c3a89f71d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8d620ce4-0d35-4f9f-ab83-056102129e9a"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span>", "ID": "997d4bf7-abd5-4ded-b02d-6914881206ef", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER", "ParentId": "1e3e5f6a-8148-4d03-a535-a2c3a89f71d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3cbd7b65-0859-4295-b4fa-9278bd9303ac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b95ccea4-4e5b-4b25-a4a6-b3709c6e4d4b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3cbd7b65-0859-4295-b4fa-9278bd9303ac"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a697b88b-7da1-4c3c-942c-37046a8cc6bc", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "00f5aa09-24f5-4fb3-ba10-3fd3ab2fe483", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a697b88b-7da1-4c3c-942c-37046a8cc6bc"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS </span></b></p>\n</div>", "ID": "9b2cbf16-96db-41f1-8eb2-79a0158c75b4", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b></p>", "ID": "54b5ad4d-147d-455d-a056-97c71ce5e072", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9b2cbf16-96db-41f1-8eb2-79a0158c75b4"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span></b>", "ID": "fa13b162-c47d-43f2-a4f9-b8bbac91e403", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "54b5ad4d-147d-455d-a056-97c71ce5e072"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE OUTER PACKAGING</span>", "ID": "318d4152-af00-45bc-a042-b8657cfaff15", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE OUTER PACKAGING", "ParentId": "fa13b162-c47d-43f2-a4f9-b8bbac91e403"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "faa595d1-6a22-47ae-907c-faed7bbf40c0", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9b2cbf16-96db-41f1-8eb2-79a0158c75b4"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "17d563e3-7674-4c50-94fa-cd43ab31ae52", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "faa595d1-6a22-47ae-907c-faed7bbf40c0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d5a0d361-e7e8-4d8d-b006-192009d240a0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "17d563e3-7674-4c50-94fa-cd43ab31ae52"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS </span></b></p>", "ID": "442b193a-568e-4330-8594-1c66b2cff905", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9b2cbf16-96db-41f1-8eb2-79a0158c75b4"}, {"Element": "<b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS </span></b>", "ID": "abf45210-464c-4d39-9b45-ad6bae43f4cb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "442b193a-568e-4330-8594-1c66b2cff905"}, {"Element": "<span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT PACKS </span>", "ID": "2979f8a3-39bb-4f92-8983-bbb047306c82", "Styles": "None", "Classes": "None", "Text": "CARTON CONTAINING WALLET UNIT PACKS ", "ParentId": "abf45210-464c-4d39-9b45-ad6bae43f4cb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "75e27897-016b-4521-9a5d-f04f65e6d117", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fee0acfe-dee9-4323-8a38-03b966a581de", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "75e27897-016b-4521-9a5d-f04f65e6d117"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "19a86918-0750-4633-ac36-a9bc7a41484d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3db29e29-6e34-498f-a5c3-82d5cd01cc1b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "19a86918-0750-4633-ac36-a9bc7a41484d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "6ba9fa29-34df-4c03-98b3-e39395f35caa", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "b3970c3d-9d6d-44a8-aac5-783c25036b78", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ba9fa29-34df-4c03-98b3-e39395f35caa"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "d7262f99-f728-4c39-ba78-b33ca0101538", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b3970c3d-9d6d-44a8-aac5-783c25036b78"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "14d08c2a-37ea-4d6a-b478-d6401ba96ec3", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "d7262f99-f728-4c39-ba78-b33ca0101538"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "26d06acb-cf3c-442c-859d-e1372fb33bac", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "def99b9f-471f-48f6-a2c8-2c8aacc0b4f8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "26d06acb-cf3c-442c-859d-e1372fb33bac"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg hard\ncapsules</span></p>", "ID": "ee75cf56-9bda-4783-8d4c-ae7a01a99244", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg hard\ncapsules</span>", "ID": "abdfbd88-d689-4c9f-9c7f-0bc06773a1e2", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 4 mg hard capsules", "ParentId": "ee75cf56-9bda-4783-8d4c-ae7a01a99244"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>", "ID": "272b35c8-90b0-4a48-b287-bfc4de1d9bd0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib </span>", "ID": "b17d9574-c563-444b-b45b-f59b83da0448", "Styles": "None", "Classes": "None", "Text": "ixazomib ", "ParentId": "272b35c8-90b0-4a48-b287-bfc4de1d9bd0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c3bb25d5-12c0-4402-a3d7-3f1a6b0dfacf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "184acbee-14fb-4fad-a90c-3663817b0e38", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c3bb25d5-12c0-4402-a3d7-3f1a6b0dfacf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5ff20619-8399-489e-b8ea-2c68c285d42e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f71295b3-b618-48f7-9ed7-53826838a400", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5ff20619-8399-489e-b8ea-2c68c285d42e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>", "ID": "d0e1df5e-57ca-4cab-b99d-d07bacc3a3c5", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>", "ID": "02e094fe-f8c4-4fa8-b7b7-9a2e49812ba5", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d0e1df5e-57ca-4cab-b99d-d07bacc3a3c5"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b>", "ID": "ad43b245-b986-428c-8b2f-5bb3758111f9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "02e094fe-f8c4-4fa8-b7b7-9a2e49812ba5"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span>", "ID": "2d3d769f-ac13-4169-a5f4-b0fcb5c488d2", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "ad43b245-b986-428c-8b2f-5bb3758111f9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dba55074-c16d-48cb-a184-7db53d3b4963", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6c5d05e6-2d6f-4c8b-ba47-97a5557551f4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dba55074-c16d-48cb-a184-7db53d3b4963"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 4 mg of ixazomib (as 5.7 mg of ixazomib\ncitrate).</span></p>", "ID": "650e5790-e231-44d2-b04b-f6d39afbb5f9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Each hard capsule contains 4 mg of ixazomib (as 5.7 mg of ixazomib\ncitrate).</span>", "ID": "8a7302ce-00d0-4844-b4a7-4e5d06e21464", "Styles": "None", "Classes": "None", "Text": "Each hard capsule contains 4 mg of ixazomib (as 5.7 mg of ixazomib citrate).", "ParentId": "650e5790-e231-44d2-b04b-f6d39afbb5f9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c1783e31-aee1-45b5-8c84-0f95a2e837bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e4a24c62-99f0-42e5-aeea-b35eac022150", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1783e31-aee1-45b5-8c84-0f95a2e837bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bff758a9-8298-4d32-9e7a-c9c1751917f5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "630c79b6-0ff8-4c1e-848f-514c1451a678", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bff758a9-8298-4d32-9e7a-c9c1751917f5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>", "ID": "293e4c47-a5a4-4820-9f19-80bf5d47447f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>", "ID": "1116dafd-9ddf-456f-8d5f-f38eb0cde6d9", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "293e4c47-a5a4-4820-9f19-80bf5d47447f"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b>", "ID": "719e8948-110a-43da-be8b-a9db5140e3a3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1116dafd-9ddf-456f-8d5f-f38eb0cde6d9"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span>", "ID": "e4d91f07-3184-4716-bc68-0e6121dd3bdc", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "719e8948-110a-43da-be8b-a9db5140e3a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f97983e4-3c20-47b2-b0e0-a5e08688a91b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3b2f6e94-6373-4491-abd9-e1c3df878c65", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f97983e4-3c20-47b2-b0e0-a5e08688a91b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "caa33a50-5fe5-4cd4-9f8b-4a62348882ef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "efbb7779-d23a-4359-994a-c1976f539ead", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "caa33a50-5fe5-4cd4-9f8b-4a62348882ef"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>", "ID": "88e495c8-48df-4540-87c9-8803dc58139f", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>", "ID": "3b2f5483-2290-45e4-8956-a2efb2868d62", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "88e495c8-48df-4540-87c9-8803dc58139f"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b>", "ID": "82364df1-6d3e-4dc3-b9a0-48340076810e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3b2f5483-2290-45e4-8956-a2efb2868d62"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span>", "ID": "e6a826b3-31cf-4e13-9506-c8b41e91b79f", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "82364df1-6d3e-4dc3-b9a0-48340076810e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "13b8d661-14c7-40f5-88ff-48764b2c391a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92eb3c5c-2e66-4ea4-9460-ee2c377d86c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "13b8d661-14c7-40f5-88ff-48764b2c391a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Hard capsule</span></p>", "ID": "16f8e16a-5cc4-429e-9ba5-92e091f9185a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">Hard capsule</span>", "ID": "c83ddd2a-5c2b-42b3-b5bb-fe01525427c7", "Styles": "background:silver", "Classes": "None", "Text": "Hard capsule", "ParentId": "16f8e16a-5cc4-429e-9ba5-92e091f9185a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2776f823-1c9f-4fb6-b560-ec32125d32a9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92c7feca-7097-477f-ae01-0351abb5e01a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2776f823-1c9f-4fb6-b560-ec32125d32a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3 packs of 1\nhard capsule.</span></p>", "ID": "d29b47d3-c0b5-4243-8f5e-a0b8a1df8a1b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">3 packs of 1\nhard capsule.</span>", "ID": "bad00d51-a64a-4d45-8622-f9e1512ad8ab", "Styles": "None", "Classes": "None", "Text": "3 packs of 1 hard capsule.", "ParentId": "d29b47d3-c0b5-4243-8f5e-a0b8a1df8a1b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "98dcca50-58f6-4f1c-bb87-428811bd5e3b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1254c39c-281a-4cbf-b34b-e20d31124776", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "98dcca50-58f6-4f1c-bb87-428811bd5e3b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4d5399a3-1fac-40e2-8510-ef8d9ed82817", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "596c08dc-632c-45da-aaf6-2cda4a8c1f33", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4d5399a3-1fac-40e2-8510-ef8d9ed82817"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>", "ID": "46bf8c9a-939c-4aaf-81f5-1eb569cec969", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>", "ID": "e43bfaec-85d7-4d66-86fc-24ebe069d651", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "46bf8c9a-939c-4aaf-81f5-1eb569cec969"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b>", "ID": "abd1e0da-35b8-4171-bbcf-5eba7d51d1d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e43bfaec-85d7-4d66-86fc-24ebe069d651"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span>", "ID": "5349ab7a-7a47-4dad-b45a-18767effd133", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "abd1e0da-35b8-4171-bbcf-5eba7d51d1d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5b646b2a-77ad-4a2b-8c9b-083c85925d5b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "03724ea9-81a9-4ad2-a988-0f448b106017", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5b646b2a-77ad-4a2b-8c9b-083c85925d5b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span><span lang=\"EN-GB\"> </span></p>", "ID": "91a40377-2921-4784-a916-ef4da8f9a06e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Read the package\nleaflet before use</span>", "ID": "5adf6338-5dc2-440a-8fb8-0bc83b092d19", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use", "ParentId": "91a40377-2921-4784-a916-ef4da8f9a06e"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "2dcc47ef-6d8c-4afe-9214-2f5fea918c27", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "91a40377-2921-4784-a916-ef4da8f9a06e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>", "ID": "c42ebaa7-1e84-4b36-9be7-6a7c4c8cc38a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Oral use</span>", "ID": "f97a2a18-8e79-4ed7-956b-e42d2594f567", "Styles": "None", "Classes": "None", "Text": "Oral use", "ParentId": "c42ebaa7-1e84-4b36-9be7-6a7c4c8cc38a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9793ab9a-9fd9-4e5a-bd55-2a855dc4d8c7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "15686610-8ba6-4dd9-bcc8-0079f8853bc2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9793ab9a-9fd9-4e5a-bd55-2a855dc4d8c7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fded42f9-0339-4640-a347-7c657dd94704", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8f510d9e-890f-46ee-9585-19746299a540", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fded42f9-0339-4640-a347-7c657dd94704"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>", "ID": "c425d821-1c98-44d1-aa03-b4b66a2c5ba3", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>", "ID": "b6ab75f9-00ec-44c6-b026-fb42202ee8fa", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c425d821-1c98-44d1-aa03-b4b66a2c5ba3"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b>", "ID": "f0ad78f9-2656-4449-a28d-02b09012be4c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b6ab75f9-00ec-44c6-b026-fb42202ee8fa"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span>", "ID": "67fdbd13-9aca-4286-8c33-178280362942", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "f0ad78f9-2656-4449-a28d-02b09012be4c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f18c8776-eeaa-40c6-85f5-c249932973f7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5e18dfd5-0714-4474-a507-9af7cb70e520", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f18c8776-eeaa-40c6-85f5-c249932973f7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>", "ID": "e45539b2-256e-4a63-9c7b-27fe55efe971", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span>", "ID": "614f5968-633c-4c4b-ad28-a902cd4284ed", "Styles": "None", "Classes": "None", "Text": "Keep out of the sight and reach of children", "ParentId": "e45539b2-256e-4a63-9c7b-27fe55efe971"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "73b418c4-4750-4e75-9779-480c57f18664", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6e614c72-bbb5-49fb-88af-c2b7b7c55556", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "73b418c4-4750-4e75-9779-480c57f18664"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b1130259-bec4-4e15-8ed2-3f7876cc1ccf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bf7f967c-bd0f-434f-9962-d2de99205a64", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b1130259-bec4-4e15-8ed2-3f7876cc1ccf"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>", "ID": "a8fe9598-7ac8-4827-a760-daa4b3c313bf", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>", "ID": "0e143436-4e27-42fd-bf2c-9857b5fa8a18", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a8fe9598-7ac8-4827-a760-daa4b3c313bf"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b>", "ID": "147715f9-6f22-4e4d-af4d-e2abcb973c04", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0e143436-4e27-42fd-bf2c-9857b5fa8a18"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span>", "ID": "13d5d8bd-4a28-4cce-a605-898cb2d19e5f", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "147715f9-6f22-4e4d-af4d-e2abcb973c04"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "26ba8c19-ab02-4eff-a008-c85bb2f6c155", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0d3e837e-40bd-4b8b-9e8c-96234cd1030a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "26ba8c19-ab02-4eff-a008-c85bb2f6c155"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>", "ID": "567fe3b6-cd9e-4287-a528-287f077907fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Cytotoxic</span>", "ID": "26ba5aa8-9cfc-4891-bdc1-78b0be4d09bd", "Styles": "None", "Classes": "None", "Text": "Cytotoxic", "ParentId": "567fe3b6-cd9e-4287-a528-287f077907fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fa49684b-e8dd-4ad7-a6eb-983264f6a473", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7a573153-5669-416c-acec-21a826a136c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fa49684b-e8dd-4ad7-a6eb-983264f6a473"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cfceb567-5e2e-4191-bb44-1246be9d5775", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "035f86c4-21f6-4ff7-9e10-e3fc19dc2bb6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cfceb567-5e2e-4191-bb44-1246be9d5775"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "06dcb909-69da-4927-ba31-f73ce9f9b9f3", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "f9bcfda5-6de9-4a38-af03-b0e732e1bd21", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "06dcb909-69da-4927-ba31-f73ce9f9b9f3"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "94cd67ef-bb24-4627-bf9a-88e1fd95b4c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f9bcfda5-6de9-4a38-af03-b0e732e1bd21"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "ffaf7263-b240-4fb3-8ab6-49839c892232", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "94cd67ef-bb24-4627-bf9a-88e1fd95b4c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1c2ec37b-123a-4cb0-9738-5304a8de9f64", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "02f05b01-fb7e-48f5-9fc7-6228c0dba95b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1c2ec37b-123a-4cb0-9738-5304a8de9f64"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "6a8f02c7-13f4-4ee4-a8c4-ccf0bddb1ca4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "0aa9f46a-7ee0-40cd-a9d7-1c9152782803", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "6a8f02c7-13f4-4ee4-a8c4-ccf0bddb1ca4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "00ff6d64-435b-40d7-8f06-14cde75bab1d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4349ab0c-fc07-46f9-b996-74a1966a566b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "00ff6d64-435b-40d7-8f06-14cde75bab1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "719b6ef2-b994-4836-a072-84f8b76a484b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bc80d99e-8286-47d7-8e3c-3d1ddd3177dc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "719b6ef2-b994-4836-a072-84f8b76a484b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "eb64b6e6-f8ad-4c55-800a-89b41374bdf8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "1dc811e5-82d6-4035-b039-a581e5380b4b", "Styles": "line-height:normal;page-break-after:avoid;border:\nnone;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "eb64b6e6-f8ad-4c55-800a-89b41374bdf8"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "6a2cab63-4833-47cd-ae71-316b304f1df8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1dc811e5-82d6-4035-b039-a581e5380b4b"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "fd1fc4ad-bee9-4012-978b-fb4dae1f87c9", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "6a2cab63-4833-47cd-ae71-316b304f1df8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8adb0114-9102-4e27-8854-7b7e5d300f2d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "148cbd1c-a235-45c0-a1a1-ecee898cf7c0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8adb0114-9102-4e27-8854-7b7e5d300f2d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span></p>", "ID": "d1de3763-f8aa-49c9-b92c-2524cbe1ed28", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not store\nabove 30\u00baC. Do not freeze. </span>", "ID": "431605c4-5ef8-460e-96e0-d46ae2c58e14", "Styles": "None", "Classes": "None", "Text": "Do not store above 30\u00baC. Do not freeze. ", "ParentId": "d1de3763-f8aa-49c9-b92c-2524cbe1ed28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">Store in the original package in\norder to protect from moisture.</p>", "ID": "1abfd9f7-1fed-47bc-ab2d-66e0eac33dd7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "Store in the original package in order to protect from moisture.", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "ca0c38a5-3f8b-492b-a5da-dece37d0e487", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "2915df05-3789-4f68-aad5-aed3f530416e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "8e69f172-52e9-43c9-93c1-ba1e05d550e2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "3de0dd67-7099-40ee-8bd2-f5db85303401", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8e69f172-52e9-43c9-93c1-ba1e05d550e2"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "65893691-31cd-4bc1-9e35-038e84868b85", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3de0dd67-7099-40ee-8bd2-f5db85303401"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "26b05b12-b614-4428-a578-a586f3e1098e", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "65893691-31cd-4bc1-9e35-038e84868b85"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "516b314a-f9d6-48ef-a808-768f47eda41c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "43a49dc9-c982-4e84-aeb1-b5cefbc743ca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "516b314a-f9d6-48ef-a808-768f47eda41c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "525eeed4-4271-4c0e-a558-7ef67cb28527", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2976bbf0-f9a2-4338-b087-5f3bbaf9c185", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "525eeed4-4271-4c0e-a558-7ef67cb28527"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "a6f9c58e-1824-4961-931b-ee3082263d68", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "468473e8-1aa9-4de5-abbb-177a3674945c", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a6f9c58e-1824-4961-931b-ee3082263d68"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "ea41ee2a-c45e-4ff9-88ae-e7f621744b97", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "468473e8-1aa9-4de5-abbb-177a3674945c"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "d152f758-d76b-46a7-8627-b7919a640f0e", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "ea41ee2a-c45e-4ff9-88ae-e7f621744b97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9f8af9ee-dfe3-430d-ac1b-7a98eed17dbf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5d640014-b6aa-4c55-974c-5d3fba893c61", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9f8af9ee-dfe3-430d-ac1b-7a98eed17dbf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>", "ID": "07f35d84-f7c5-4425-8188-e18c9ee0aca1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma\nA/S </span>", "ID": "d22bf218-b920-454f-8f6c-a3f9bfda4c74", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S ", "ParentId": "07f35d84-f7c5-4425-8188-e18c9ee0aca1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>", "ID": "4aee1dbf-f942-484e-abe9-72d0550df676", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span>", "ID": "ca8de13d-6731-4536-a336-a7c4bfa9b448", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "", "ParentId": "4aee1dbf-f942-484e-abe9-72d0550df676"}, {"Element": "<span lang=\"EN-GB\">Delta Park 45</span>", "ID": "cdf02008-d0f5-4bfe-922a-a07a1ca3dc97", "Styles": "None", "Classes": "None", "Text": "Delta Park 45", "ParentId": "ca8de13d-6731-4536-a336-a7c4bfa9b448"}, {"Element": "<span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span>", "ID": "313dd9fe-7ed0-45a5-8b28-1525763af19c", "Styles": "border:none windowtext 1.0pt;\npadding:0in", "Classes": "None", "Text": " ", "ParentId": "4aee1dbf-f942-484e-abe9-72d0550df676"}, {"Element": "<br/>", "ID": "3d306520-52a1-4f5e-89a0-55f280140f80", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "313dd9fe-7ed0-45a5-8b28-1525763af19c"}, {"Element": "<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span>", "ID": "f6694829-0e53-456c-8ec4-c9069b03884a", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "2665 Vallensbaek Strand", "ParentId": "313dd9fe-7ed0-45a5-8b28-1525763af19c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>", "ID": "51aa1980-0fcb-417c-8657-31cc404c9867", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Denmark</span>", "ID": "c579be93-8f38-45b3-8742-2ae4af86cb26", "Styles": "None", "Classes": "None", "Text": "Denmark", "ParentId": "51aa1980-0fcb-417c-8657-31cc404c9867"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "189e930c-a8b7-475b-b2d2-ab4632c27ed9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c0ff574d-79eb-417d-8ef6-ffa92ff6553a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "189e930c-a8b7-475b-b2d2-ab4632c27ed9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1a3abc2a-a9f0-4d6a-beb4-a469b898e330", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "93d55572-44bc-41fe-88ad-d58d084d1fca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1a3abc2a-a9f0-4d6a-beb4-a469b898e330"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "2852d40e-53d6-402c-844a-7c21a5b751df", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "665614c0-408e-44e6-a951-3dc74af2c3a3", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2852d40e-53d6-402c-844a-7c21a5b751df"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "97d3d692-e373-4e8d-8d7c-07a45acd44f6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "665614c0-408e-44e6-a951-3dc74af2c3a3"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "f37c021c-5455-4823-9fca-14305a40a38e", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "97d3d692-e373-4e8d-8d7c-07a45acd44f6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b6b4f2a6-8d51-400b-8f54-cf1261aea7f6", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4b267b45-1114-4e34-a149-e71deac21e25", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b6b4f2a6-8d51-400b-8f54-cf1261aea7f6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/003</span></p>", "ID": "ce3746c4-bb1e-4574-805b-b4f33c4fa861", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/003</span>", "ID": "49e02a36-0b0e-4400-aa9a-9ea88ba93d9e", "Styles": "color:black", "Classes": "None", "Text": "EU/1/16/1094/003", "ParentId": "ce3746c4-bb1e-4574-805b-b4f33c4fa861"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f10cb05b-6593-468f-9108-803310269eca", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9c62a939-0ca1-4dfd-b6f3-1bcd0d3f88c3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f10cb05b-6593-468f-9108-803310269eca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3c115eff-694e-4c6f-ae41-4a82f1c0088d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d63ad5d8-d255-445a-b79f-ae510bd6b657", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3c115eff-694e-4c6f-ae41-4a82f1c0088d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "c3ee6ac9-3521-4623-b65b-729fb959ea38", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "d871cd99-d4b3-4a0c-bb55-e5ff83f099e6", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c3ee6ac9-3521-4623-b65b-729fb959ea38"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "11f43156-08ed-43cb-832c-ddf37ea2d76a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d871cd99-d4b3-4a0c-bb55-e5ff83f099e6"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "b16c53c7-cca9-452c-9796-3c737eb2ee22", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "11f43156-08ed-43cb-832c-ddf37ea2d76a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "5c8e2048-359d-496b-a16f-18c82253c366", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "41b4e1d4-e952-4cc4-8f2e-9320d6a1c912", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5c8e2048-359d-496b-a16f-18c82253c366"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e7aec22-7423-4a7f-8bd2-e44b837950bf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "41b4e1d4-e952-4cc4-8f2e-9320d6a1c912"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "697346eb-b7b9-40f0-bc94-8cd102413437", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "3474647b-ee78-489c-8a42-f5a1bb897a8e", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "697346eb-b7b9-40f0-bc94-8cd102413437"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8d9f19e6-23ee-44bb-a1e0-772069f6673f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a0aea2e5-fe35-448b-8dc3-55ad61699c96", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8d9f19e6-23ee-44bb-a1e0-772069f6673f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "67cd6b13-1bc0-4012-837e-83d90ae44038", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8540ec05-45c6-4b7c-a50b-8a8cd0863c23", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "67cd6b13-1bc0-4012-837e-83d90ae44038"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "efc5a870-5bbe-49b7-a3ca-da4130ffd4ec", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "c27b97a6-7960-4484-9a0f-6f6439c40212", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "efc5a870-5bbe-49b7-a3ca-da4130ffd4ec"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "3497b257-3f96-4802-8918-0d6f64c7810c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c27b97a6-7960-4484-9a0f-6f6439c40212"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "89bd7dad-ccb3-4908-afee-734aa6703041", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "3497b257-3f96-4802-8918-0d6f64c7810c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a10f5fb0-573c-4531-9c9f-84b3e4451444", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "61e129d6-3d4e-4c2c-a00b-122752407f91", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a10f5fb0-573c-4531-9c9f-84b3e4451444"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "afa5afd6-010a-4719-8c8f-724974946d73", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "21ae365e-198e-40ae-b655-b33514517f94", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "afa5afd6-010a-4719-8c8f-724974946d73"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "2178ba00-5e3b-4964-b6a4-7bc74be69f4a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "97f8e8c8-0fbd-491c-a2dd-a415158c2875", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2178ba00-5e3b-4964-b6a4-7bc74be69f4a"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "8a524461-4968-48d7-8421-57096ddcc533", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "97f8e8c8-0fbd-491c-a2dd-a415158c2875"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "8c479ba7-fd46-4f50-932c-ddc4c3fbf395", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "8a524461-4968-48d7-8421-57096ddcc533"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "84855459-4e92-4a07-b28f-fa09fa46488c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4de3e539-75f1-4ca7-9585-c9dfc1cab2ef", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "84855459-4e92-4a07-b28f-fa09fa46488c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "65d26272-9752-4d7b-bc50-01ae9bc5bb24", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6c2d0737-d6b5-4f03-9aa2-e4b939f03308", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "65d26272-9752-4d7b-bc50-01ae9bc5bb24"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "488f5aca-2779-4458-ac18-c5c82768c304", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "076be3b1-0363-497b-84aa-ee4f19dcb843", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "488f5aca-2779-4458-ac18-c5c82768c304"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "41e2ff5f-3488-498f-be6a-59c19f50ec50", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "076be3b1-0363-497b-84aa-ee4f19dcb843"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "66151da6-90eb-4688-9729-004fdb2c74c0", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "41e2ff5f-3488-498f-be6a-59c19f50ec50"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "41600bcd-5862-489c-a0a1-b1b5fd8fb37b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "044be9d6-f841-4204-85d5-2b84def74e7a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "41600bcd-5862-489c-a0a1-b1b5fd8fb37b"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg </span></p>", "ID": "441084bb-47a1-4e9b-b7fe-998e936a6989", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg </span>", "ID": "335bcb00-b1bc-4175-bff0-54777cfb5182", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 4 mg ", "ParentId": "441084bb-47a1-4e9b-b7fe-998e936a6989"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "d9cf9d11-0aac-49c4-80f5-6402dd4479c6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "15a8ff99-83fc-42e0-880f-81885697c60b", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "d9cf9d11-0aac-49c4-80f5-6402dd4479c6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "3fb41848-e137-4fe6-aa52-dfcb559247cb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "aea07434-cd24-4666-a8f2-72ca8e52e553", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "3fb41848-e137-4fe6-aa52-dfcb559247cb"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b></p>\n</div>", "ID": "b70925ee-01b6-443f-ab2a-d8d9d84806f3", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b></p>", "ID": "68a0721f-dab1-4e9b-8d14-f12bea8e3372", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b70925ee-01b6-443f-ab2a-d8d9d84806f3"}, {"Element": "<b><span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span></b>", "ID": "85678591-02b7-4102-a92a-9290d73bfbf1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "68a0721f-dab1-4e9b-8d14-f12bea8e3372"}, {"Element": "<span lang=\"EN-GB\">17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE</span>", "ID": "b770c922-b15d-495e-b039-cf8a09ab281f", "Styles": "None", "Classes": "None", "Text": "17.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER \u2013 2D BARCODE", "ParentId": "85678591-02b7-4102-a92a-9290d73bfbf1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "724fed7f-f8f6-45f2-98fa-5beb0ec4c6ed", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6b25e186-7197-43ce-91bf-00bc077e6712", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "724fed7f-f8f6-45f2-98fa-5beb0ec4c6ed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">2D barcode carrying the unique identifier included.</span></p>", "ID": "6fa54853-d700-4d05-8780-157885b3b16e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">2D barcode carrying the unique identifier included.</span>", "ID": "07c9f532-616a-4a06-93da-1fe931b0be68", "Styles": "background:silver", "Classes": "None", "Text": "2D barcode carrying the unique identifier included.", "ParentId": "6fa54853-d700-4d05-8780-157885b3b16e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9db3889d-5c28-475d-9aa3-288474876b18", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ca0e6895-e0ea-4350-b0c7-34fb3b15305d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9db3889d-5c28-475d-9aa3-288474876b18"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "667070f1-9391-4c97-89b0-c6e4c7c6fd28", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9251dec2-cc9e-46ea-ad4a-ee4958afa267", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "667070f1-9391-4c97-89b0-c6e4c7c6fd28"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>\n</div>", "ID": "9d007ba9-d898-471d-b0ae-3610a65a6146", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b></p>", "ID": "e7903452-56ab-41f6-a56e-9756adb307e4", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9d007ba9-d898-471d-b0ae-3610a65a6146"}, {"Element": "<b><span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span></b>", "ID": "b26f33e9-3275-4774-885f-0fb117f73902", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e7903452-56ab-41f6-a56e-9756adb307e4"}, {"Element": "<span lang=\"EN-GB\">18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA</span>", "ID": "7398066a-841e-4632-9cd5-6ae7b56757ed", "Styles": "None", "Classes": "None", "Text": "18.\u00a0\u00a0\u00a0\u00a0 UNIQUE IDENTIFIER - HUMAN READABLE DATA", "ParentId": "b26f33e9-3275-4774-885f-0fb117f73902"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5625d232-dcd0-48b4-a44f-554915a5b21c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "695b7135-a235-411b-ba24-6754d7d3f4a0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5625d232-dcd0-48b4-a44f-554915a5b21c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">PC</span></p>", "ID": "639a5dbf-cc76-4ccf-8160-6c56026de98e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">PC</span>", "ID": "aa2d50be-f22c-4f88-b385-c61fb15d354f", "Styles": "None", "Classes": "None", "Text": "PC", "ParentId": "639a5dbf-cc76-4ccf-8160-6c56026de98e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">SN</span></p>", "ID": "494fe694-7ec6-47ac-91c2-677e6a0fa2dc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">SN</span>", "ID": "af725b1e-bdfe-4a8d-9483-c05bbfc47779", "Styles": "None", "Classes": "None", "Text": "SN", "ParentId": "494fe694-7ec6-47ac-91c2-677e6a0fa2dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NN</span></p>", "ID": "8b24f9a1-6a1c-4c8a-b5f0-02147250acad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NN</span>", "ID": "05696658-4271-44e4-994b-98eda415ae2b", "Styles": "None", "Classes": "None", "Text": "NN", "ParentId": "8b24f9a1-6a1c-4c8a-b5f0-02147250acad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "b03eabcd-5395-45ef-91b9-436ab20c94bf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "0c5c3e7f-fb75-422b-b510-bc0304f3ceae", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "b03eabcd-5395-45ef-91b9-436ab20c94bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always;\nbackground:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9391c841-8d74-4c5d-a86f-2d28bf1d7186", "Styles": "line-height:normal;page-break-before:always;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "01124af8-1f8b-479a-910b-604501df0fad", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9391c841-8d74-4c5d-a86f-2d28bf1d7186"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT </span></b></p>\n</div>", "ID": "9ab6e3ee-65a6-4f63-86c8-cbafc88e626a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>", "ID": "352d52a1-e4f9-4e7c-bcea-6a3298412e27", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9ab6e3ee-65a6-4f63-86c8-cbafc88e626a"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b>", "ID": "6bd849d7-5087-4ecf-b0ab-942a8800e62c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "352d52a1-e4f9-4e7c-bcea-6a3298412e27"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span>", "ID": "f458e9c7-724c-41a3-821a-3debfdd7c7b7", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING", "ParentId": "6bd849d7-5087-4ecf-b0ab-942a8800e62c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "e3c31010-6147-4c89-a867-cfccde004162", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9ab6e3ee-65a6-4f63-86c8-cbafc88e626a"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "8cffeb60-f448-45f6-ba91-d7866260fd88", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e3c31010-6147-4c89-a867-cfccde004162"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6f93e7ed-bd07-43c1-a035-2ccd10721e0c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8cffeb60-f448-45f6-ba91-d7866260fd88"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT </span></b></p>", "ID": "1937cae5-aa9c-49e3-9f76-9e897e368a91", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9ab6e3ee-65a6-4f63-86c8-cbafc88e626a"}, {"Element": "<b><span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT </span></b>", "ID": "7af5aea1-ddc2-4db4-9f3f-2bdfacd587f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1937cae5-aa9c-49e3-9f76-9e897e368a91"}, {"Element": "<span lang=\"EN-GB\">CARTON CONTAINING WALLET UNIT </span>", "ID": "0247f2de-407a-42b0-b334-42e04282a589", "Styles": "None", "Classes": "None", "Text": "CARTON CONTAINING WALLET UNIT ", "ParentId": "7af5aea1-ddc2-4db4-9f3f-2bdfacd587f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4dafb9b9-7b72-4849-856f-b171d8927d4b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "39a00fc0-44a5-4f6d-b191-48f5cd383a62", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4dafb9b9-7b72-4849-856f-b171d8927d4b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a4d78545-721b-4d90-addd-92f56a42f294", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "91b9c755-6ade-4bf3-a043-f3550e29af6a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a4d78545-721b-4d90-addd-92f56a42f294"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "ed51b115-e553-439a-bd35-1345adcbba38", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "0b276f3d-b31f-4374-b5da-c8573b65cd1a", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ed51b115-e553-439a-bd35-1345adcbba38"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "95144953-552d-4a6b-8846-1f80bc70ec1d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0b276f3d-b31f-4374-b5da-c8573b65cd1a"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "f79abae2-f02d-460b-881b-25030b392ea3", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "95144953-552d-4a6b-8846-1f80bc70ec1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "df70f182-c48c-46a8-b262-d271725c62d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "921a8667-bcdd-4da5-a220-a2f435e2a3ab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "df70f182-c48c-46a8-b262-d271725c62d0"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg hard\ncapsules </span></p>", "ID": "69200556-d9d1-4ec9-b66c-c84a546671dc", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg hard\ncapsules </span>", "ID": "e850ccb4-eac2-47b8-b647-d436e6711153", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 4 mg hard capsules ", "ParentId": "69200556-d9d1-4ec9-b66c-c84a546671dc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>", "ID": "12204ee1-ecf8-4eec-9a29-3caad153a5c2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib </span>", "ID": "56ee9084-b3da-483a-b8bc-749e95ae518d", "Styles": "None", "Classes": "None", "Text": "ixazomib ", "ParentId": "12204ee1-ecf8-4eec-9a29-3caad153a5c2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e0c49cbb-a056-47e2-930b-256620f5938b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e03ea5b3-547a-42c4-ae20-372df7f05044", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e0c49cbb-a056-47e2-930b-256620f5938b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "734ee33c-774c-49d5-87db-f229acef5769", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "406f2323-d0e9-4463-b636-3ee09e26224f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "734ee33c-774c-49d5-87db-f229acef5769"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>", "ID": "38b1e7ef-1775-47cd-b4df-c79dbcac0c8d", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>", "ID": "9635cc29-0318-4ee2-a500-4d70942ef1ae", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "38b1e7ef-1775-47cd-b4df-c79dbcac0c8d"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b>", "ID": "cb1b64f6-c3a8-4f67-b8a9-d5d387b2e28d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9635cc29-0318-4ee2-a500-4d70942ef1ae"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span>", "ID": "afe38a7f-e492-4857-ab4b-430850cb6202", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "cb1b64f6-c3a8-4f67-b8a9-d5d387b2e28d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ac27a91f-974b-4dd6-8eb2-72e5c9168259", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8cd2473e-d9cd-4f43-9beb-740b630a45a8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ac27a91f-974b-4dd6-8eb2-72e5c9168259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Each hard capsule contains 4 mg of ixazomib (as 5.7 mg of ixazomib\ncitrate).</span></p>", "ID": "f819ca6b-76f4-4adb-a166-d3e4474b803f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Each hard capsule contains 4 mg of ixazomib (as 5.7 mg of ixazomib\ncitrate).</span>", "ID": "5c1e4575-9eaa-4084-a5f3-07b4ee9ead36", "Styles": "None", "Classes": "None", "Text": "Each hard capsule contains 4 mg of ixazomib (as 5.7 mg of ixazomib citrate).", "ParentId": "f819ca6b-76f4-4adb-a166-d3e4474b803f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0a884881-aa1b-4458-88de-b0171ae23a59", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1826cc71-174b-4ad0-a16f-94d3005a8528", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0a884881-aa1b-4458-88de-b0171ae23a59"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a3adb253-9d35-41e0-95bc-930ab30dfdeb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e326960e-c6ef-459f-bfe3-427c48f595bd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a3adb253-9d35-41e0-95bc-930ab30dfdeb"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>", "ID": "c2beb550-5f98-4b59-8ee3-4e999abd7f3a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>", "ID": "3ecb8be7-4d02-4c61-99d9-20eaa216ea4d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c2beb550-5f98-4b59-8ee3-4e999abd7f3a"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b>", "ID": "2a11e97d-5251-464f-86a5-45d3d24e099f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3ecb8be7-4d02-4c61-99d9-20eaa216ea4d"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span>", "ID": "35fd2551-b839-4032-a167-90675b0e8b28", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "2a11e97d-5251-464f-86a5-45d3d24e099f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6cc05aa6-09ea-4ff9-8270-8d7fd9fe0051", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "908e2314-788b-4a77-bb4f-123f9263fa06", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6cc05aa6-09ea-4ff9-8270-8d7fd9fe0051"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "abc8611f-bc13-4df0-b8ec-3d9bd9ad2ffe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a2379794-d4a0-470f-9581-3a8cded29562", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "abc8611f-bc13-4df0-b8ec-3d9bd9ad2ffe"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>", "ID": "c49159bc-07f6-4ad3-a915-bb10d7dcefbd", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>", "ID": "710e517e-8879-42f8-8900-44072ed637c6", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c49159bc-07f6-4ad3-a915-bb10d7dcefbd"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b>", "ID": "bd0806cd-bb9e-49d6-86c0-c4634dcc7beb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "710e517e-8879-42f8-8900-44072ed637c6"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span>", "ID": "9ab925aa-1024-49d0-84b4-946c7dbc2b54", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "bd0806cd-bb9e-49d6-86c0-c4634dcc7beb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "83896792-5d55-4012-8bd8-2d112bd54c97", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d22c745c-7272-4be7-b73c-69c615165a4b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "83896792-5d55-4012-8bd8-2d112bd54c97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule</span></p>", "ID": "1d59aad1-bd68-4ae4-8f60-7470b1b28309", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule</span>", "ID": "3eda5032-8402-4f0d-9f9d-f94cb2e0f4ad", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Hard capsule", "ParentId": "1d59aad1-bd68-4ae4-8f60-7470b1b28309"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "69d7d4b0-227f-46ee-a74e-a3c8716d55ad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d2ecedb9-130b-457f-afa8-61fa8f554201", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "69d7d4b0-227f-46ee-a74e-a3c8716d55ad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule. </span></p>", "ID": "a16adbfd-2be7-4758-85c6-ee78a6ccf349", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">1 hard capsule. </span>", "ID": "ff3165e3-a2f6-468e-82b8-c6ff86d77ffb", "Styles": "None", "Classes": "None", "Text": "1 hard capsule. ", "ParentId": "a16adbfd-2be7-4758-85c6-ee78a6ccf349"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0d3c7518-58ff-4ac7-b8e7-6f01307bdbfa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "136e6545-6370-410c-b097-2f02488c179b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0d3c7518-58ff-4ac7-b8e7-6f01307bdbfa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6784ed71-ab5c-4691-baa1-728c38cd517d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0dcb75a9-c904-4747-874c-73e3e651a558", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6784ed71-ab5c-4691-baa1-728c38cd517d"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>", "ID": "255a7110-51c2-4a90-8a51-3ba1d0e46d98", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>", "ID": "203fcdbd-e6b3-44a4-b2fa-b70e20c8b04f", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "255a7110-51c2-4a90-8a51-3ba1d0e46d98"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b>", "ID": "1fc7a387-e98f-4daf-9bde-d53aa708f442", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "203fcdbd-e6b3-44a4-b2fa-b70e20c8b04f"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span>", "ID": "8678001f-b83a-483a-8455-f4d21a7e92b9", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "1fc7a387-e98f-4daf-9bde-d53aa708f442"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4c62cc8a-c996-4595-b554-3c48deff1668", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a94ddab8-7ca8-4532-abc0-c805b017dc5c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4c62cc8a-c996-4595-b554-3c48deff1668"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use</span></p>", "ID": "a3045260-5156-4803-ac5c-382a872942b6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Read the package\nleaflet before use</span>", "ID": "2b9ef39b-e056-4dee-a016-ffab92e02118", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use", "ParentId": "a3045260-5156-4803-ac5c-382a872942b6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "86c7ee43-906f-4d49-9a2c-e601a5b0f1de", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1afe7f42-804a-498a-a262-7de751bcc1b5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "86c7ee43-906f-4d49-9a2c-e601a5b0f1de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use</span></p>", "ID": "096f9cf8-58ee-46ba-8fd1-b5f0ad51f509", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Oral use</span>", "ID": "3e416ac5-f7a1-4d6b-90d4-a0b7499a537b", "Styles": "None", "Classes": "None", "Text": "Oral use", "ParentId": "096f9cf8-58ee-46ba-8fd1-b5f0ad51f509"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ec08f6f0-6f4f-47a3-b871-a8abaafed48b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92c7ff01-e98f-4969-9d5a-c9a362eb4bc4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ec08f6f0-6f4f-47a3-b871-a8abaafed48b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "28213e05-0bca-4578-8f4e-3628316a0791", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7a2e483-432e-478c-85b9-1181f8389f6c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "28213e05-0bca-4578-8f4e-3628316a0791"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>", "ID": "6d438435-8c0b-4655-b2cb-118e0fdb59e8", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>", "ID": "3d55d526-e0f4-4f7a-8ab4-8540eb2e2447", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6d438435-8c0b-4655-b2cb-118e0fdb59e8"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b>", "ID": "8108f6f9-37a1-4f26-8597-dacf2194ed16", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d55d526-e0f4-4f7a-8ab4-8540eb2e2447"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span>", "ID": "52e03e5c-9959-4917-9305-e8f165683ec7", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "8108f6f9-37a1-4f26-8597-dacf2194ed16"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "00d49bd9-c04f-4258-b943-eeee7a8a53e2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f9026804-70f9-41a5-beb3-7e11fe3b14cd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "00d49bd9-c04f-4258-b943-eeee7a8a53e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span></p>", "ID": "6b3b79f6-94e5-495a-b15c-78afaaff2de5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Keep out of the\nsight and reach of children</span>", "ID": "a4ebf2a2-039c-4f62-af97-069f67bd2248", "Styles": "None", "Classes": "None", "Text": "Keep out of the sight and reach of children", "ParentId": "6b3b79f6-94e5-495a-b15c-78afaaff2de5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "26432d3e-b518-4301-bd83-f928b477fd4c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3b13a993-50a1-404c-9da8-38231ab13372", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "26432d3e-b518-4301-bd83-f928b477fd4c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4ece346c-42ae-4e6c-9e75-753d8d9cf98b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "82acf31a-dae9-4183-a7c8-742adf2d02dd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4ece346c-42ae-4e6c-9e75-753d8d9cf98b"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>", "ID": "b90bdcd4-3fbe-43e0-8b62-e9b84bf3843b", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>", "ID": "036ea933-e929-40a9-8aed-01647a4d968b", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b90bdcd4-3fbe-43e0-8b62-e9b84bf3843b"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b>", "ID": "5257441f-1ea3-4ac5-bdfe-1689e29b6abf", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "036ea933-e929-40a9-8aed-01647a4d968b"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span>", "ID": "c5ee3855-47ec-4567-a219-0f170f610ef9", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "5257441f-1ea3-4ac5-bdfe-1689e29b6abf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a398e89c-ab01-49b8-a29d-817a9d84b322", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "82f85bb1-752f-4ab5-b958-2bf09993b12e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a398e89c-ab01-49b8-a29d-817a9d84b322"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>", "ID": "fc7f461a-6cde-4710-aaf2-f797e5f28236", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Cytotoxic</span>", "ID": "65ff695a-85c6-4630-bd48-46e782182065", "Styles": "None", "Classes": "None", "Text": "Cytotoxic", "ParentId": "fc7f461a-6cde-4710-aaf2-f797e5f28236"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "13c9cfce-dc0d-4cfa-a390-18602f291045", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f7b33688-c474-434c-928b-6f9b5531f70c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "13c9cfce-dc0d-4cfa-a390-18602f291045"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "057450ce-0346-4926-afe6-36ee0f722f82", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d2c65096-e39a-4b33-8c9a-99d10a25f23e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "057450ce-0346-4926-afe6-36ee0f722f82"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "28c027fd-26f9-45b9-8ee0-9f4df566f283", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "011f66f6-9f2d-4f9b-90ad-40d1673ccae4", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "28c027fd-26f9-45b9-8ee0-9f4df566f283"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "f37e6879-aafe-4fdb-a68d-418459bc82ec", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "011f66f6-9f2d-4f9b-90ad-40d1673ccae4"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "607cb4a7-8954-45a5-9c4c-cb9ec90e71b7", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "f37e6879-aafe-4fdb-a68d-418459bc82ec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b5d1dd2f-9a6f-4de9-aed2-a50ff41bf045", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4ba82a18-49e5-4502-8caa-b2ea06f175b3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b5d1dd2f-9a6f-4de9-aed2-a50ff41bf045"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP:</span></p>", "ID": "f07227f4-092a-4e34-a449-ee377ccd32e7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP:</span>", "ID": "b03430b1-c86b-44fa-9e20-009d60a5a9fb", "Styles": "None", "Classes": "None", "Text": "EXP:", "ParentId": "f07227f4-092a-4e34-a449-ee377ccd32e7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "155a27bd-e64d-405e-b3d1-0dd39fd7d687", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "563dc600-4e3b-427a-a19e-aa6786d9c9d6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "155a27bd-e64d-405e-b3d1-0dd39fd7d687"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2407266f-5874-40ca-aea2-845e85110b20", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c20961d0-0d70-4208-b8e6-ee9bc603c8f1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2407266f-5874-40ca-aea2-845e85110b20"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>\n</div>", "ID": "1e3718e6-6b6e-4254-ac88-b9d2464563ea", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b></p>", "ID": "d49577ea-b9af-4ff7-9dfe-6d711f48a5d9", "Styles": "line-height:normal;page-break-after:avoid;border:\nnone;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1e3718e6-6b6e-4254-ac88-b9d2464563ea"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span></b>", "ID": "1f98b3b5-7427-4413-b14f-246899b27399", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d49577ea-b9af-4ff7-9dfe-6d711f48a5d9"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL\nSTORAGE CONDITIONS</span>", "ID": "70b0cd73-5e06-4079-8bbc-52dc977f746c", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "1f98b3b5-7427-4413-b14f-246899b27399"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dce270cb-5e06-4818-b32f-785b33d91e68", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "142f0089-769d-4da0-af1b-19d0d9d73ea5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dce270cb-5e06-4818-b32f-785b33d91e68"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Do not store above 30\u00baC. Do not freeze. </span></p>", "ID": "34fbb1c5-ac0c-4f76-b4d7-7cb325bd868b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not store above 30\u00baC. Do not freeze. </span>", "ID": "d8f60c0e-0e22-4c6c-8192-3a84b678f713", "Styles": "None", "Classes": "None", "Text": "Do not store above 30\u00baC. Do not freeze. ", "ParentId": "34fbb1c5-ac0c-4f76-b4d7-7cb325bd868b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "95da14a8-52cc-4989-bd1e-646fd3121c2d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3598dcc7-c041-4182-8521-403061fae142", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "95da14a8-52cc-4989-bd1e-646fd3121c2d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\">Store in\nthe original package in order to protect from moisture.</p>", "ID": "9e24cc65-4826-4391-8053-14e1df643311", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "Store in the original package in order to protect from moisture.", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "b699c0ef-1534-4dda-94e9-fdf3426596a4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "7466c482-2b53-48aa-92b5-10f4451bf974", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "2aba690a-961c-47af-957e-952cb9ffc863", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "e93ae664-976c-4578-ba7f-b2c4e8c237f1", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2aba690a-961c-47af-957e-952cb9ffc863"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "8724dce0-357c-47b8-95ba-8d5c5427d9c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e93ae664-976c-4578-ba7f-b2c4e8c237f1"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "ce8cf3da-39d3-4ee3-8039-a059cf1c0921", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "8724dce0-357c-47b8-95ba-8d5c5427d9c1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9bf59ef0-2e04-436a-bb75-793ba4424dba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "11a617c5-a400-4150-b162-33c03b53fafc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9bf59ef0-2e04-436a-bb75-793ba4424dba"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ac5d428a-7d8d-4b4d-9c7f-53107a922245", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4983a7c0-4236-4b7e-a277-31ba838f0f23", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ac5d428a-7d8d-4b4d-9c7f-53107a922245"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "ad5a1679-ce74-46b3-bd52-d907437f0c2e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "1169a0be-bfda-41f7-b7a5-1c0bfe9e2c91", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ad5a1679-ce74-46b3-bd52-d907437f0c2e"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "b7ef42dc-b3c9-4f9c-883b-968576963df1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1169a0be-bfda-41f7-b7a5-1c0bfe9e2c91"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "cf84e02e-e368-485b-8284-52eeb7d83799", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "b7ef42dc-b3c9-4f9c-883b-968576963df1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "899d8b9e-eda0-4469-811d-ca2f9f1fdf33", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "70a5ca28-ae52-4b46-afc0-b2782f9608c0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "899d8b9e-eda0-4469-811d-ca2f9f1fdf33"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S </span></p>", "ID": "7c0fb20e-d0f6-4e9d-9d6b-3e8610577e01", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma\nA/S </span>", "ID": "33011fad-6e34-4c45-8ebf-68913c4376b8", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S ", "ParentId": "7c0fb20e-d0f6-4e9d-9d6b-3e8610577e01"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>", "ID": "1d5f91d0-386a-45ed-9656-ed5d5dde5f94", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span>", "ID": "3ae357ab-39dd-4446-9b6c-006219e24b21", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "", "ParentId": "1d5f91d0-386a-45ed-9656-ed5d5dde5f94"}, {"Element": "<span lang=\"EN-GB\">Delta Park 45</span>", "ID": "9a189e1f-2170-46f4-975a-044cb855d939", "Styles": "None", "Classes": "None", "Text": "Delta Park 45", "ParentId": "3ae357ab-39dd-4446-9b6c-006219e24b21"}, {"Element": "<span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span>", "ID": "c16a8138-ff63-446e-a733-8193446dbea4", "Styles": "border:none windowtext 1.0pt;\npadding:0in", "Classes": "None", "Text": " ", "ParentId": "1d5f91d0-386a-45ed-9656-ed5d5dde5f94"}, {"Element": "<br/>", "ID": "c23797d6-4544-42cd-8a48-75c05fb1d3b5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c16a8138-ff63-446e-a733-8193446dbea4"}, {"Element": "<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span>", "ID": "5fedb975-5502-43e5-a592-3703e60aedbb", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "2665 Vallensbaek Strand", "ParentId": "c16a8138-ff63-446e-a733-8193446dbea4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>", "ID": "de487bbe-3b2d-4325-b6e6-c9fffcf0c5c3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Denmark</span>", "ID": "24d05b5a-5fb9-46eb-a2fe-433e9960d485", "Styles": "None", "Classes": "None", "Text": "Denmark", "ParentId": "de487bbe-3b2d-4325-b6e6-c9fffcf0c5c3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "68fa6e1f-6238-42e6-b33e-e0312090e61c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5cd450e4-84b6-424b-84da-61ef3db16010", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "68fa6e1f-6238-42e6-b33e-e0312090e61c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0c886c93-73f4-48ef-a6e8-3bc7015e7d0e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6d4c871d-5d10-45a1-9062-75263196a231", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0c886c93-73f4-48ef-a6e8-3bc7015e7d0e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "71bdd35c-15b2-4034-a3f2-06813e4c1d64", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "b0c178a5-488f-49d1-8884-fc3778eb8e97", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "71bdd35c-15b2-4034-a3f2-06813e4c1d64"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "14fcd3b8-904a-404c-b290-d054aba4997d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b0c178a5-488f-49d1-8884-fc3778eb8e97"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "749cb862-aa41-4a34-987b-9125ef6199a1", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "14fcd3b8-904a-404c-b290-d054aba4997d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ab011aa8-3d21-40b6-a7a1-1225ac15caae", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df578b15-47c4-47d5-8aba-f38c9c8cda8d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ab011aa8-3d21-40b6-a7a1-1225ac15caae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/003</span></p>", "ID": "f1a530b1-d93e-44fc-9bc4-62e9a1c5d7a7", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black\">EU/1/16/1094/003</span>", "ID": "0c0b67d2-aad3-4761-a1cf-e47da6abfd59", "Styles": "color:black", "Classes": "None", "Text": "EU/1/16/1094/003", "ParentId": "f1a530b1-d93e-44fc-9bc4-62e9a1c5d7a7"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "95f068f3-bb01-4ca4-8e11-1381e53c3d24", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "abd9eedb-2fbe-470f-beae-d00a15cedc65", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "95f068f3-bb01-4ca4-8e11-1381e53c3d24"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bda46977-1a93-48a0-8f0f-ad7ba3b1529f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5fb1a157-550a-4c20-8040-4f9342fde7dd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bda46977-1a93-48a0-8f0f-ad7ba3b1529f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "6e78e814-abbe-4ea6-bb40-8fc8777a8642", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "f40d3184-cf26-4ab9-82e2-892843899bd4", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6e78e814-abbe-4ea6-bb40-8fc8777a8642"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "ac4dba7e-ec1a-4492-bdb1-9423927903df", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f40d3184-cf26-4ab9-82e2-892843899bd4"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "a5ae9447-84a5-4edf-854c-6c7a5247efc4", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "ac4dba7e-ec1a-4492-bdb1-9423927903df"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "23380488-c0d5-4b9b-aa5b-7a2ba22978ce", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "fb0e8049-0711-4724-9051-3adc693ad15c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "23380488-c0d5-4b9b-aa5b-7a2ba22978ce"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "79539ead-9ee7-41c0-b97c-b6b85a42b2aa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fb0e8049-0711-4724-9051-3adc693ad15c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "7a08f883-9221-4759-aa20-36dd3955f5fd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "62193b27-3ad4-4b44-b3fd-973b6c9a8851", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "7a08f883-9221-4759-aa20-36dd3955f5fd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "351fe6e7-2699-4d8e-bcb2-c399f646a2bf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e7ddf8c9-f70e-4868-8302-419b57e4d4b2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "351fe6e7-2699-4d8e-bcb2-c399f646a2bf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "61e5117f-65dc-406f-bf95-4334cad7b30e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0ad7c073-8e26-473a-8eee-0808f7b41f0c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "61e5117f-65dc-406f-bf95-4334cad7b30e"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "484faad3-4653-40da-99a6-dad43e23da18", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "415030cc-c783-40f5-91a2-fe385ce86872", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "484faad3-4653-40da-99a6-dad43e23da18"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "c5f12e69-c028-4cf4-a104-acb79103f5de", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "415030cc-c783-40f5-91a2-fe385ce86872"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "a586caff-77cc-4393-9c8b-310b19bc683e", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "c5f12e69-c028-4cf4-a104-acb79103f5de"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "65d9835a-7b81-4d3e-97aa-ea46bf2a833a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f759c46a-b412-4006-aac0-bd2c2627fe3f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "65d9835a-7b81-4d3e-97aa-ea46bf2a833a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8f9d97bc-0fc1-46fe-b7ce-8f6313b96e45", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "58df51c1-80e0-4fa7-a736-29cd885d3c32", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8f9d97bc-0fc1-46fe-b7ce-8f6313b96e45"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "1ad760d9-26ea-4efe-8e51-03332db8cfb0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "0e853583-603b-4f24-a4c6-db39a789c7cc", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1ad760d9-26ea-4efe-8e51-03332db8cfb0"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "cb24c319-02f3-4994-8a02-dff2d34a954d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0e853583-603b-4f24-a4c6-db39a789c7cc"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "4cb3bc36-99c3-4d7f-9268-a56d57d3ca14", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "cb24c319-02f3-4994-8a02-dff2d34a954d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9b44b52d-c504-42c7-9496-adcd88a214ef", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "df88057f-8024-4875-83fd-73036677971c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9b44b52d-c504-42c7-9496-adcd88a214ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ac6427e2-5123-4c62-ba7b-3ae841645cd6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "35e033fc-cd6c-47f7-a1ee-e72e64209799", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ac6427e2-5123-4c62-ba7b-3ae841645cd6"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "d547f5d8-761e-47bd-ab86-8dda289b45f6", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "c1936980-b003-4eea-a4bb-92087c827a27", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d547f5d8-761e-47bd-ab86-8dda289b45f6"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "a3f5238a-3ce4-4e83-87f3-cf5ff7d9d1d4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c1936980-b003-4eea-a4bb-92087c827a27"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "06f4e974-c1ae-461d-9919-a962d5ec4d30", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "a3f5238a-3ce4-4e83-87f3-cf5ff7d9d1d4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4e26e0a8-d72a-44d2-8c34-dd7180233f8f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ccc7a209-8eae-47ac-91a1-19b1e5290148", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4e26e0a8-d72a-44d2-8c34-dd7180233f8f"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg </span></p>", "ID": "198976cc-579c-41a9-aa32-74bbad9e6276", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg </span>", "ID": "70b22562-6b09-4c2f-86e5-7b8c44160e30", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 4 mg ", "ParentId": "198976cc-579c-41a9-aa32-74bbad9e6276"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "f9c86ea1-a06d-4c7e-82ef-a79b1f391b48", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "1d775f30-c8d9-49b5-9541-8f1622fac8b5", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "f9c86ea1-a06d-4c7e-82ef-a79b1f391b48"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "b1abf80c-ff0a-4b86-8f14-17867ddc6bcf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "45267f7d-96b6-42b7-86c8-6b01dfd7ca67", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "b1abf80c-ff0a-4b86-8f14-17867ddc6bcf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;background:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "47e32493-cd81-48ff-af42-71b80b4a3963", "Styles": "line-height:normal;background:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4d42eba3-473b-42a8-aa98-7db43b5788c8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "47e32493-cd81-48ff-af42-71b80b4a3963"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f2cb2e0d-2853-4355-a2f3-98366db791e1", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "da88d0d2-923a-4189-84f4-f84d359f2f8b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f2cb2e0d-2853-4355-a2f3-98366db791e1"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">WALLET </span></b></p>\n</div>", "ID": "51230e37-0b1f-4cfe-99c8-30d0d29778b2", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b></p>", "ID": "87730518-11f5-4bd4-8a7a-7b304808a15c", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "51230e37-0b1f-4cfe-99c8-30d0d29778b2"}, {"Element": "<b><span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span></b>", "ID": "6a61fc03-79e1-4362-b910-d9e6f0c2ab20", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "87730518-11f5-4bd4-8a7a-7b304808a15c"}, {"Element": "<span lang=\"EN-GB\">PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING</span>", "ID": "b6082467-708d-4107-90bb-e1e4fc51ab07", "Styles": "None", "Classes": "None", "Text": "PARTICULARS TO APPEAR ON THE INTERMEDIATE PACKAGING", "ParentId": "6a61fc03-79e1-4362-b910-d9e6f0c2ab20"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "a7d28fbc-f138-4992-9914-3fde8cf5f7a4", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "51230e37-0b1f-4cfe-99c8-30d0d29778b2"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "adc21315-71e9-4088-a107-fff2e1ae88a5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a7d28fbc-f138-4992-9914-3fde8cf5f7a4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "261f3784-c0dc-45be-8824-c94ec943f9ee", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "adc21315-71e9-4088-a107-fff2e1ae88a5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">WALLET </span></b></p>", "ID": "273fc792-ffa0-486a-91cf-a7fde066976d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "51230e37-0b1f-4cfe-99c8-30d0d29778b2"}, {"Element": "<b><span lang=\"EN-GB\">WALLET </span></b>", "ID": "9b9e681b-a94a-494a-8a65-850b03fe5bd1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "273fc792-ffa0-486a-91cf-a7fde066976d"}, {"Element": "<span lang=\"EN-GB\">WALLET </span>", "ID": "93cd0517-a743-4e8c-a0c3-ecbff8fb4010", "Styles": "None", "Classes": "None", "Text": "WALLET ", "ParentId": "9b9e681b-a94a-494a-8a65-850b03fe5bd1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d33e7c91-e6dc-4232-a869-2eb8f8431f74", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dcb430fb-bc79-46d0-93c7-c7695241e77a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d33e7c91-e6dc-4232-a869-2eb8f8431f74"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b138017a-97bc-4e41-8f57-33a9ccedbb52", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e7c6e683-021c-42d4-b607-313391f171e2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b138017a-97bc-4e41-8f57-33a9ccedbb52"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "61b949c0-2432-47bd-a1cf-0620a514e92a", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "8794fda7-de71-4364-8ef0-ad7866400af2", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "61b949c0-2432-47bd-a1cf-0620a514e92a"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "e2ccc90b-111b-4ce9-b413-462187a45659", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8794fda7-de71-4364-8ef0-ad7866400af2"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "7800efc7-1f79-400c-a05e-2d36e42168cc", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "e2ccc90b-111b-4ce9-b413-462187a45659"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0778090f-2192-495c-a342-fd6cc913d5ba", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "64510c14-e64f-4f06-9bba-0621ee7ac559", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0778090f-2192-495c-a342-fd6cc913d5ba"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg hard\ncapsules </span></p>", "ID": "30af0f9f-481c-40f2-9101-ea27d1cd9c31", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg hard\ncapsules </span>", "ID": "a655b0fa-bcd0-4337-b5b5-7c744fbdec4b", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 4 mg hard capsules ", "ParentId": "30af0f9f-481c-40f2-9101-ea27d1cd9c31"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib </span></p>", "ID": "28600e18-b364-4e2b-be8f-744f1a3d7ba5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib </span>", "ID": "0ec2b5aa-49e4-465b-a484-0e85cd93dc27", "Styles": "None", "Classes": "None", "Text": "ixazomib ", "ParentId": "28600e18-b364-4e2b-be8f-744f1a3d7ba5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ce1b7c1d-82dc-407c-bb65-f2da805a4812", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "93412852-33e0-4e9e-80e9-793bc2ff8239", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ce1b7c1d-82dc-407c-bb65-f2da805a4812"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "56c56f32-7960-4b3a-9e92-74ed3234d3b4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aeedf12a-b1c7-41d2-892d-5bf969d80faa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "56c56f32-7960-4b3a-9e92-74ed3234d3b4"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>\n</div>", "ID": "6ba16ca5-7a8d-4f12-be51-b6b53ce40ded", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b></p>", "ID": "3272d3e3-bade-4b17-a5c9-af3f1d5f90d8", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ba16ca5-7a8d-4f12-be51-b6b53ce40ded"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span></b>", "ID": "37bace19-82e6-4bde-8e51-0502fd2d55cd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3272d3e3-bade-4b17-a5c9-af3f1d5f90d8"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE\nSUBSTANCE(S)</span>", "ID": "53ae1a52-18f8-4719-b2a6-479ea5176eca", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 STATEMENT OF ACTIVE SUBSTANCE(S)", "ParentId": "37bace19-82e6-4bde-8e51-0502fd2d55cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9e681575-5793-48b7-958e-ffa62aff7827", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4d3cc578-e323-4fec-a8d4-9b20be69ed6d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9e681575-5793-48b7-958e-ffa62aff7827"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8490410f-ecaf-48df-896a-e47ceac3d58f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e50baad3-0d69-484b-8e33-4d932c707685", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8490410f-ecaf-48df-896a-e47ceac3d58f"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>\n</div>", "ID": "0418fddc-6ecb-4fee-a0a7-fab740191e37", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b></p>", "ID": "f7c495e0-f9b9-44bd-a6d2-0857171bb0f9", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0418fddc-6ecb-4fee-a0a7-fab740191e37"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span></b>", "ID": "0ef09f5f-9e89-4fe6-b74c-bc03bf403843", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f7c495e0-f9b9-44bd-a6d2-0857171bb0f9"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS</span>", "ID": "eda26e89-74fd-457b-8410-c46f835cab85", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 LIST OF EXCIPIENTS", "ParentId": "0ef09f5f-9e89-4fe6-b74c-bc03bf403843"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b0709ebe-a783-47db-b6fa-b288e557ab80", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "92320145-6c40-4210-bf70-b578f80b5e04", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b0709ebe-a783-47db-b6fa-b288e557ab80"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f6b40e0b-ec50-457a-ba8e-dc905de740a7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c9e15318-b4d2-435c-adc8-a4b9e2aa98b6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f6b40e0b-ec50-457a-ba8e-dc905de740a7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>\n</div>", "ID": "3ee05b3a-6466-4919-bb2a-3ed0663f9133", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b></p>", "ID": "a64428de-f5fe-4bab-b441-28d97cfc4b91", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3ee05b3a-6466-4919-bb2a-3ed0663f9133"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span></b>", "ID": "c7247d05-da30-466c-9347-5cb497509d3a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a64428de-f5fe-4bab-b441-28d97cfc4b91"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND\nCONTENTS</span>", "ID": "a9554e9c-7c1e-49a6-8ff5-59b04cde1e96", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 PHARMACEUTICAL FORM AND CONTENTS", "ParentId": "c7247d05-da30-466c-9347-5cb497509d3a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fc8a7132-54b4-4a34-90ef-06b4bb03e30c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f5fd6911-3f50-46eb-8b94-516cc18f8911", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fc8a7132-54b4-4a34-90ef-06b4bb03e30c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule </span></p>", "ID": "fbe9998e-f2c3-4786-9779-31a720f19f02", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"color:black;background:#D9D9D9\">Hard capsule </span>", "ID": "fb2a947d-c841-4185-967f-fd86f1b5bed7", "Styles": "color:black;background:#D9D9D9", "Classes": "None", "Text": "Hard capsule ", "ParentId": "fbe9998e-f2c3-4786-9779-31a720f19f02"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span></p>", "ID": "ed129aa2-f215-4684-8389-810d96706484", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span>", "ID": "1167ab3d-aecd-4cfa-8b4d-5d355b6450bf", "Styles": "background:#D9D9D9", "Classes": "None", "Text": "\u00a0", "ParentId": "ed129aa2-f215-4684-8389-810d96706484"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1 hard capsule</span></p>", "ID": "ea6904b7-9f26-4df5-8f61-22a2eef5d149", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">1 hard capsule</span>", "ID": "1e15ec4f-99a8-4195-bf17-4f31ba57c3b6", "Styles": "None", "Classes": "None", "Text": "1 hard capsule", "ParentId": "ea6904b7-9f26-4df5-8f61-22a2eef5d149"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span></p>", "ID": "476844b5-e991-494f-bdb6-53b304f7a58b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#D9D9D9\">\u00a0</span>", "ID": "ee146420-775b-4fbe-8cc2-9a5be7ecf989", "Styles": "background:#D9D9D9", "Classes": "None", "Text": "\u00a0", "ParentId": "476844b5-e991-494f-bdb6-53b304f7a58b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4cb6ad93-a27b-466a-b5a2-1f7dbc442a51", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fbf7e7ac-ca1a-40db-8b23-be414f57370e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4cb6ad93-a27b-466a-b5a2-1f7dbc442a51"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>\n</div>", "ID": "1a51bdca-7715-465f-8cef-6b8b97625074", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b></p>", "ID": "3d568a7b-bb18-454f-bc14-d7cae59c750a", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1a51bdca-7715-465f-8cef-6b8b97625074"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span></b>", "ID": "43076f8b-0df4-4914-b0b9-0d27cbd4f827", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3d568a7b-bb18-454f-bc14-d7cae59c750a"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF\nADMINISTRATION</span>", "ID": "dce05dd9-1ecb-4ba1-bfeb-fa447dab5b6f", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METHOD AND ROUTE(S) OF ADMINISTRATION", "ParentId": "43076f8b-0df4-4914-b0b9-0d27cbd4f827"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ef2be0cd-c014-43b0-8379-5afbc6adc1a7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e9f00f55-9aa6-4c19-aca5-b0881fb4d8fa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ef2be0cd-c014-43b0-8379-5afbc6adc1a7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Read the package\nleaflet before use.</span></p>", "ID": "79db4a43-9621-4d8d-96ec-2dc96f83473e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Read the package\nleaflet before use.</span>", "ID": "88252209-f0bc-44ab-9e3d-cf31be5a31d6", "Styles": "None", "Classes": "None", "Text": "Read the package leaflet before use.", "ParentId": "79db4a43-9621-4d8d-96ec-2dc96f83473e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Do not crush, open or chew the capsules. Take each NINLARO capsule\nwhole with water at the same time each week, at least one hour before or no\nsooner than two hours after any food.</span></p>", "ID": "2a1372bd-fea3-4164-8483-f3831b1a3463", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not crush, open or chew the capsules. Take each NINLARO capsule\nwhole with water at the same time each week, at least one hour before or no\nsooner than two hours after any food.</span>", "ID": "dc8c669f-0612-40f6-be17-da47232b1fd7", "Styles": "None", "Classes": "None", "Text": "Do not crush, open or chew the capsules. Take each NINLARO capsule whole with water at the same time each week, at least one hour before or no sooner than two hours after any food.", "ParentId": "2a1372bd-fea3-4164-8483-f3831b1a3463"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The capsule should not be removed until just prior to dosing.</span></p>", "ID": "ba6f7e5b-aff4-42b2-86f6-46a9e73e37cf", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The capsule should not be removed until just prior to dosing.</span>", "ID": "6d58af6b-fe1d-49fa-9801-9377dec771ee", "Styles": "None", "Classes": "None", "Text": "The capsule should not be removed until just prior to dosing.", "ParentId": "ba6f7e5b-aff4-42b2-86f6-46a9e73e37cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Oral use </span></p>", "ID": "3e93f7b1-463c-42e6-bad5-9134e00e7ba6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Oral use </span>", "ID": "8164c544-d455-4c22-8818-8a3c57487c7f", "Styles": "None", "Classes": "None", "Text": "Oral use ", "ParentId": "3e93f7b1-463c-42e6-bad5-9134e00e7ba6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f1e93683-da08-49a3-8577-290708dbeb3b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a395e2af-f2ab-4506-bba3-7efa76614307", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f1e93683-da08-49a3-8577-290708dbeb3b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ea484c90-6e0e-4ecc-88a7-bbfd1a790a18", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "224c3a2a-f965-4a6b-b897-3bcea40792c8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ea484c90-6e0e-4ecc-88a7-bbfd1a790a18"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>\n</div>", "ID": "500be3e3-092d-429b-a17b-70d827ce63fc", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>", "ID": "0f995903-dd18-4281-a866-d3a228b028ef", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "500be3e3-092d-429b-a17b-70d827ce63fc"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b>", "ID": "853e1bfa-cc68-4f1d-9f99-0cea556df039", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0f995903-dd18-4281-a866-d3a228b028ef"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE\nMEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span>", "ID": "2ab79866-66de-4c87-b176-72c6630142dc", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN", "ParentId": "853e1bfa-cc68-4f1d-9f99-0cea556df039"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e1a074b6-9668-4130-8c20-7f66d73ebe63", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "67ab70c3-eb4b-4f36-a338-9461e2b57795", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e1a074b6-9668-4130-8c20-7f66d73ebe63"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "34d57a61-0630-4e4e-9306-cdf6b349cb34", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "03e5b44a-00b6-49f8-b045-78595a4de6fe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "34d57a61-0630-4e4e-9306-cdf6b349cb34"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>\n</div>", "ID": "977ee11c-f032-4418-8cff-25d0f17ffcd0", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b></p>", "ID": "b7f5892e-2510-43ef-995e-dcc83746e981", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "977ee11c-f032-4418-8cff-25d0f17ffcd0"}, {"Element": "<b><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span></b>", "ID": "0cbd9975-1663-4470-abff-821643c3e529", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b7f5892e-2510-43ef-995e-dcc83746e981"}, {"Element": "<span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF\nNECESSARY</span>", "ID": "0476587e-d13c-40ce-8281-51341ee3415b", "Styles": "None", "Classes": "None", "Text": "7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER SPECIAL WARNING(S), IF NECESSARY", "ParentId": "0cbd9975-1663-4470-abff-821643c3e529"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e8eba85c-1d48-491d-9aae-0a0bab4f37c7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e1c0b74e-dc83-4c66-af89-dc882d22a4aa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e8eba85c-1d48-491d-9aae-0a0bab4f37c7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Cytotoxic</span></p>", "ID": "41d89da4-e901-41e7-b008-a2486c6198a0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Cytotoxic</span>", "ID": "41d6ca61-cb94-4235-b19d-f8bf55bdd2e2", "Styles": "None", "Classes": "None", "Text": "Cytotoxic", "ParentId": "41d89da4-e901-41e7-b008-a2486c6198a0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fdb79d6e-4875-4af3-ae82-ceb5a01aba83", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6fc1b2b6-9635-420e-ac86-dcea04ae759b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fdb79d6e-4875-4af3-ae82-ceb5a01aba83"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4ea33474-ac07-45e4-a353-c69f5f47def5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "14883111-27f7-4fc8-8aa0-eb4940fe7598", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4ea33474-ac07-45e4-a353-c69f5f47def5"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "e896390c-8572-4673-8e52-81c1abbcad36", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "92f7ace1-d34a-42f4-b47f-bd96428eabbe", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e896390c-8572-4673-8e52-81c1abbcad36"}, {"Element": "<b><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "0f5bba54-196e-4224-b4af-fcae9e952e33", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "92f7ace1-d34a-42f4-b47f-bd96428eabbe"}, {"Element": "<span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "803b3808-6d13-46cd-8417-bda371d5552d", "Styles": "None", "Classes": "None", "Text": "8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "0f5bba54-196e-4224-b4af-fcae9e952e33"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3ec97194-4ac4-40d4-a270-5be9613d0d1d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ac38448d-dbef-4265-a38a-9a87bc455a78", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3ec97194-4ac4-40d4-a270-5be9613d0d1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "fdfc2bb9-f5a0-4a5c-a4ce-7d78e180c06f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "cd42231c-9e7d-4aac-b1c2-df184c8a048c", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "fdfc2bb9-f5a0-4a5c-a4ce-7d78e180c06f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7b646413-28eb-480d-92b2-a7e1e3a516fc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "32033e09-8f83-4c61-9fae-ba3d3b36bad0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7b646413-28eb-480d-92b2-a7e1e3a516fc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "50c108dd-6bc2-42c3-9190-63e9a32733d2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "78388010-3ad9-4aca-8d54-a2c15fa14584", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "50c108dd-6bc2-42c3-9190-63e9a32733d2"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b></p>\n</div>", "ID": "a0c40b42-af73-4ce7-beab-7007376efb91", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b></p>", "ID": "fe13ac52-5048-47f8-bf80-ce837027a3cc", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a0c40b42-af73-4ce7-beab-7007376efb91"}, {"Element": "<b><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span></b>", "ID": "ad956516-accb-48ce-b626-6b203c56357b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fe13ac52-5048-47f8-bf80-ce837027a3cc"}, {"Element": "<span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS</span>", "ID": "dd628128-ca82-4838-912a-7b1b841205d1", "Styles": "None", "Classes": "None", "Text": "9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 SPECIAL STORAGE CONDITIONS", "ParentId": "ad956516-accb-48ce-b626-6b203c56357b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b10b6e73-1f8e-42ba-bcf8-454b08dc3e6a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9835da5b-8990-49f5-93af-da71863c400e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b10b6e73-1f8e-42ba-bcf8-454b08dc3e6a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\">\u00a0</p>", "ID": "a1d81e91-5901-436a-add2-a93c008f11f5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "\u00a0", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>\n</div>", "ID": "ec5ad0ab-2b4d-4c32-b827-aa876b20a067", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b></p>", "ID": "7e92b682-6bef-4d7e-94a4-aee6642bb32c", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ec5ad0ab-2b4d-4c32-b827-aa876b20a067"}, {"Element": "<b><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span></b>", "ID": "21d74e38-e430-4487-9eeb-d7fffadce438", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7e92b682-6bef-4d7e-94a4-aee6642bb32c"}, {"Element": "<span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF\nUNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL\nPRODUCTS, IF APPROPRIATE</span>", "ID": "a99c5e3c-ac8a-4d4a-b47c-2812b32a10ed", "Styles": "None", "Classes": "None", "Text": "10.\u00a0\u00a0\u00a0\u00a0 SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE", "ParentId": "21d74e38-e430-4487-9eeb-d7fffadce438"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4f10aeab-4347-4413-9a50-dfa71249f076", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9245b49e-0502-4c07-a449-0c80212ae612", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4f10aeab-4347-4413-9a50-dfa71249f076"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7ce64321-4551-471f-9d3c-bf94e4753257", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9aea3ac2-ebc8-4cc2-8e23-afc20d650cf0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7ce64321-4551-471f-9d3c-bf94e4753257"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "f0ecb94f-d420-47d0-890d-8cdd899f78fe", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;border:\nnone;padding:0in\"><b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b></p>", "ID": "bc19516e-4292-42b8-922a-b52bb8498b9c", "Styles": "line-height:normal;page-break-after:avoid;border:\nnone;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f0ecb94f-d420-47d0-890d-8cdd899f78fe"}, {"Element": "<b><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span></b>", "ID": "78a8971e-9c4f-43e1-8a8d-579c200fcbd1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bc19516e-4292-42b8-922a-b52bb8498b9c"}, {"Element": "<span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0\u00a0 NAME AND\nADDRESS OF THE MARKETING AUTHORISATION HOLDER</span>", "ID": "e63d025b-4466-4814-85ab-aa21e22b90cd", "Styles": "None", "Classes": "None", "Text": "11.\u00a0\u00a0\u00a0\u00a0 NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "78a8971e-9c4f-43e1-8a8d-579c200fcbd1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8256f8b1-2012-45d3-9153-48ce3c33446e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1005db47-f6ed-40da-9a31-4ac37010ae0d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8256f8b1-2012-45d3-9153-48ce3c33446e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Takeda Pharma A/S </span></p>", "ID": "124fd5f5-6a5d-46a0-9b23-4f5f2df91ea1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma A/S </span>", "ID": "2e5d7a44-1064-4892-a782-fd58ffae381a", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S ", "ParentId": "124fd5f5-6a5d-46a0-9b23-4f5f2df91ea1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bfbede3d-7b96-4277-b1cc-67e1e9694319", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "94b59092-ab3d-49b0-a084-e30427070432", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bfbede3d-7b96-4277-b1cc-67e1e9694319"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7080f863-ff6a-45df-91f0-17b59a083e67", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "78ce7f69-7f41-4956-9e01-e97ed2ccf692", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7080f863-ff6a-45df-91f0-17b59a083e67"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>\n</div>", "ID": "632d7a47-f55c-4a4f-9344-2a5b54b61f51", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b></p>", "ID": "c4bb07fa-603c-4fdb-944e-36ac55b21cd8", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "632d7a47-f55c-4a4f-9344-2a5b54b61f51"}, {"Element": "<b><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span></b>", "ID": "f80b2a84-c60f-4c13-b425-31dd6834cd32", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c4bb07fa-603c-4fdb-944e-36ac55b21cd8"}, {"Element": "<span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) </span>", "ID": "d620b7c6-6bab-4435-8037-b50040803bff", "Styles": "None", "Classes": "None", "Text": "12.\u00a0\u00a0\u00a0\u00a0 MARKETING AUTHORISATION NUMBER(S) ", "ParentId": "f80b2a84-c60f-4c13-b425-31dd6834cd32"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fe60e5f6-e859-4ed9-8c06-3757120a2739", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3c02399c-6fc1-4683-99b8-492d7bb425de", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fe60e5f6-e859-4ed9-8c06-3757120a2739"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "44bb4210-20e5-4336-adb2-0cd952666756", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "faeaa507-ec3e-4d07-a709-1643ed7b2695", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "44bb4210-20e5-4336-adb2-0cd952666756"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "aca4bf78-82cb-4f02-b446-805ad676b414", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "a734ac7c-f1ba-4f9b-815e-4935cfbb35d2", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "aca4bf78-82cb-4f02-b446-805ad676b414"}, {"Element": "<b><span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "9d30b05a-0b33-438d-9d31-a10b6eca0068", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a734ac7c-f1ba-4f9b-815e-4935cfbb35d2"}, {"Element": "<span lang=\"EN-GB\">13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "dbbb5f63-62e7-43c8-8d2f-d545474d5490", "Styles": "None", "Classes": "None", "Text": "13.\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "9d30b05a-0b33-438d-9d31-a10b6eca0068"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "fbac5c58-c3a2-4fb9-8649-58ae3824a89c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "0adf6f92-7639-4570-94e6-445a7f12246a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fbac5c58-c3a2-4fb9-8649-58ae3824a89c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ad948494-55cf-45db-89c8-b4f3e8f3a93c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0adf6f92-7639-4570-94e6-445a7f12246a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "b7e67af2-6021-47a4-b586-ffd8a11c8b9b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "3c9c78f9-8ea7-46ab-917b-bbf6f1215e46", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "b7e67af2-6021-47a4-b586-ffd8a11c8b9b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c53f2a2e-5aa2-475f-92ea-3c21023750c8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9ab6ad3f-ed8a-4ae9-bd74-fdb897989d17", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c53f2a2e-5aa2-475f-92ea-3c21023750c8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c1f7b213-49f3-4833-81c2-c3fa6e798102", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b82e9e00-bcff-4ac8-9777-90ea09c501eb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1f7b213-49f3-4833-81c2-c3fa6e798102"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>\n</div>", "ID": "8b0c708b-c0cb-4e3d-bcde-8e4dea21dc72", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>", "ID": "5af9d7e9-53c8-479a-9d3e-6ae11da97fe7", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8b0c708b-c0cb-4e3d-bcde-8e4dea21dc72"}, {"Element": "<b><span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span></b>", "ID": "7227e57d-ca80-4b18-8d6e-89988b98c270", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5af9d7e9-53c8-479a-9d3e-6ae11da97fe7"}, {"Element": "<span lang=\"EN-GB\">14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY</span>", "ID": "ca40e483-e98f-4775-b66c-f983ac2e8292", "Styles": "None", "Classes": "None", "Text": "14.\u00a0\u00a0\u00a0\u00a0 GENERAL CLASSIFICATION FOR SUPPLY", "ParentId": "7227e57d-ca80-4b18-8d6e-89988b98c270"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "af4f3bca-a33c-49af-ac5a-adc183644623", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "132aae62-134c-4e02-a3c3-f23a701d3be9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "af4f3bca-a33c-49af-ac5a-adc183644623"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2207c91a-2a84-4c0d-8bee-6b305dbdc442", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2e95cf7f-c929-4ca3-a919-605d849e8a9a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2207c91a-2a84-4c0d-8bee-6b305dbdc442"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>\n</div>", "ID": "70d2e3c8-4c4f-431d-bc5f-2a947dea8120", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b></p>", "ID": "3e3ee97b-2956-4f5f-b602-a17c60c8a819", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "70d2e3c8-4c4f-431d-bc5f-2a947dea8120"}, {"Element": "<b><span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span></b>", "ID": "2246c416-7951-4d29-87e8-dce19468b96f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3e3ee97b-2956-4f5f-b602-a17c60c8a819"}, {"Element": "<span lang=\"EN-GB\">15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE</span>", "ID": "562e0e3f-a378-4c7a-921e-b8fc4fa6a731", "Styles": "None", "Classes": "None", "Text": "15.\u00a0\u00a0\u00a0\u00a0 INSTRUCTIONS ON USE", "ParentId": "2246c416-7951-4d29-87e8-dce19468b96f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "cd36d23b-8d0f-4a0e-b1c0-850c2c2430d3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c65e9e99-a97e-479f-86f4-701244542fa3", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "cd36d23b-8d0f-4a0e-b1c0-850c2c2430d3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "12205625-5685-4660-854b-dc33f88122b9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "aa079883-5bec-4af3-a793-e6d67fc573a5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "12205625-5685-4660-854b-dc33f88122b9"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>\n</div>", "ID": "d11cad71-8aa6-4cb7-afbf-cb65ed834d66", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 0in 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b></p>", "ID": "0362919d-68ef-42fc-9624-28b0b21e45db", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d11cad71-8aa6-4cb7-afbf-cb65ed834d66"}, {"Element": "<b><span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span></b>", "ID": "76dd6293-3ee3-497d-8500-c55d32ac085b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0362919d-68ef-42fc-9624-28b0b21e45db"}, {"Element": "<span lang=\"EN-GB\">16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE</span>", "ID": "6fc73f7b-2ab3-472d-b45c-a11084de603a", "Styles": "None", "Classes": "None", "Text": "16.\u00a0\u00a0\u00a0\u00a0 INFORMATION IN BRAILLE", "ParentId": "76dd6293-3ee3-497d-8500-c55d32ac085b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2bc3ef5b-6b83-4e8b-8adc-e3e1094514db", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3452833f-797a-4f84-8dae-2773083b8535", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2bc3ef5b-6b83-4e8b-8adc-e3e1094514db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span></p>", "ID": "570b7f3a-dc72-4e7c-945d-3e35d05970c0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:#CCCCCC\">\u00a0</span>", "ID": "4655498d-7049-46ed-b03e-ff0b1720ecf3", "Styles": "background:#CCCCCC", "Classes": "None", "Text": "\u00a0", "ParentId": "570b7f3a-dc72-4e7c-945d-3e35d05970c0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "fdd4e4df-e96a-45c1-afd7-b88e561a5063", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8bd5c005-6dcb-4bd3-9cc9-5191e6387b99", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fdd4e4df-e96a-45c1-afd7-b88e561a5063"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-before:always\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "58260236-52bd-4b1d-b310-d2245f752a54", "Styles": "line-height:normal;page-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "54f55574-766e-4244-94f2-deae4324ea91", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "58260236-52bd-4b1d-b310-d2245f752a54"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "17f4b75b-e03f-4584-bab3-8734ee5970e8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "54f55574-766e-4244-94f2-deae4324ea91"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b></p>\n</div>", "ID": "da946f17-ad1d-4fe1-9190-08a3843220d6", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "    ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b></p>", "ID": "56c6b837-43a6-40cc-8933-d73887ac4fc9", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "da946f17-ad1d-4fe1-9190-08a3843220d6"}, {"Element": "<b><span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span></b>", "ID": "e52f0cd0-dacf-4242-93bc-7201cdc2353b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "56c6b837-43a6-40cc-8933-d73887ac4fc9"}, {"Element": "<span lang=\"EN-GB\">MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS</span>", "ID": "aaa1cc67-4aa2-4805-a287-3dd618991cb8", "Styles": "None", "Classes": "None", "Text": "MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS", "ParentId": "e52f0cd0-dacf-4242-93bc-7201cdc2353b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "793f7d6c-dd9c-4c88-b925-0c740473a99b", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "da946f17-ad1d-4fe1-9190-08a3843220d6"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "722b7f8a-0a15-4931-9404-a25722b4972c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "793f7d6c-dd9c-4c88-b925-0c740473a99b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e29c248c-db16-4403-9bf8-5382e978a869", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "722b7f8a-0a15-4931-9404-a25722b4972c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b></p>", "ID": "1f40602d-bf86-441a-8630-4ddbb4d90f5d", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "da946f17-ad1d-4fe1-9190-08a3843220d6"}, {"Element": "<b><span lang=\"EN-GB\">BLISTER FOR WALLET</span></b>", "ID": "32b682a1-7602-498b-a6c5-4b2c23c8dc67", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1f40602d-bf86-441a-8630-4ddbb4d90f5d"}, {"Element": "<span lang=\"EN-GB\">BLISTER FOR WALLET</span>", "ID": "dae736f1-6ae6-4aa1-aa9d-900c35ea41b4", "Styles": "None", "Classes": "None", "Text": "BLISTER FOR WALLET", "ParentId": "32b682a1-7602-498b-a6c5-4b2c23c8dc67"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span></p>", "ID": "f75eb9fb-efe5-4a68-83ea-e07b3fcc6751", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">\u00a0</span>", "ID": "253df8d7-0b1a-47be-b086-ec5a44cd2cc8", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "\u00a0", "ParentId": "f75eb9fb-efe5-4a68-83ea-e07b3fcc6751"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>\n</div>", "ID": "6cfdc786-0c79-4e81-83e1-93a504d16cea", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b></p>", "ID": "d0a76261-9c92-44d1-accc-933b289cdb19", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6cfdc786-0c79-4e81-83e1-93a504d16cea"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span></b>", "ID": "972cbc99-3815-4e3e-8896-73e3542009d1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d0a76261-9c92-44d1-accc-933b289cdb19"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT</span>", "ID": "a0fd814e-d3fd-4f16-826e-2b5539c8e0d1", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MEDICINAL PRODUCT", "ParentId": "972cbc99-3815-4e3e-8896-73e3542009d1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "6ace8873-7a8d-43bf-98b1-3e5226d52dc0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "0cbb5126-f339-4031-84e0-9515dddae242", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6ace8873-7a8d-43bf-98b1-3e5226d52dc0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "eb4c5eba-8437-475c-98de-31f10edbb970", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0cbb5126-f339-4031-84e0-9515dddae242"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg</span></p>", "ID": "4aba9fb1-5395-4464-a4da-6d3c08c2d2bd", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">NINLARO 4 mg</span>", "ID": "97f29f0e-b0af-44df-865f-c63156c7648f", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "NINLARO 4 mg", "ParentId": "4aba9fb1-5395-4464-a4da-6d3c08c2d2bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">ixazomib</span></p>", "ID": "468a8c5b-c788-4148-b5ed-a20c89c6c407", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib</span>", "ID": "1d35fae3-1120-4cfa-983c-42003b43f60d", "Styles": "None", "Classes": "None", "Text": "ixazomib", "ParentId": "468a8c5b-c788-4148-b5ed-a20c89c6c407"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "09ee8f42-aa7b-4d34-8469-89391a912975", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f0c4209c-f06d-4184-b722-5a9bfd1335e8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "09ee8f42-aa7b-4d34-8469-89391a912975"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "04ed936c-8307-4455-bd42-e19afbff4084", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9b67bb22-62b1-48b6-b848-e051641fa9a1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "04ed936c-8307-4455-bd42-e19afbff4084"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>\n</div>", "ID": "37646a9a-be5e-408c-8d78-5d12f9edbcf7", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b></p>", "ID": "74789b27-ef1d-45c0-9f66-f5b270f565b9", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "37646a9a-be5e-408c-8d78-5d12f9edbcf7"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span></b>", "ID": "f90586b2-15f6-402e-9fde-d1b2db237834", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "74789b27-ef1d-45c0-9f66-f5b270f565b9"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING\nAUTHORISATION HOLDER</span>", "ID": "7978465b-8d60-4ee2-8a16-5e2b6043057f", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 NAME OF THE MARKETING AUTHORISATION HOLDER", "ParentId": "f90586b2-15f6-402e-9fde-d1b2db237834"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2c2347dd-cc70-4b74-a5aa-1ab820c2d347", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "48d509fa-d0f0-44d7-a532-337b664caa82", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2c2347dd-cc70-4b74-a5aa-1ab820c2d347"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda </span></p>", "ID": "8f55e2e2-d988-4ae2-a05b-93e52f7733a3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda </span>", "ID": "0ad72a3b-5602-40c3-8ec2-907b9cd1174c", "Styles": "None", "Classes": "None", "Text": "Takeda ", "ParentId": "8f55e2e2-d988-4ae2-a05b-93e52f7733a3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a1b48bd3-3663-435a-9bdd-3537a369a92c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "67632e61-7f6d-47d9-b0f3-80a560d7ee5d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a1b48bd3-3663-435a-9bdd-3537a369a92c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b03dd6af-0e8a-46e2-adfd-9c69a999db08", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0119eaa7-29cd-4004-851a-aa5be512cfdb", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b03dd6af-0e8a-46e2-adfd-9c69a999db08"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>\n</div>", "ID": "51a48e8a-ddf7-4e30-aaec-672e1dec4396", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 2.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b></p>", "ID": "15d316f5-c7d3-423c-8a77-c42895bb9e0e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "51a48e8a-ddf7-4e30-aaec-672e1dec4396"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span></b>", "ID": "64f261ec-3816-41bf-9566-54c968dba551", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "15d316f5-c7d3-423c-8a77-c42895bb9e0e"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE</span>", "ID": "5d27b87f-498e-4482-8592-0493e91b685a", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EXPIRY DATE", "ParentId": "64f261ec-3816-41bf-9566-54c968dba551"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b278f7bc-bfcf-44c1-be4d-ea0139f91f61", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f9aee9d1-69b4-481a-8a2b-9b07d964b75d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b278f7bc-bfcf-44c1-be4d-ea0139f91f61"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">EXP</span></p>", "ID": "034c6f94-514b-4ebe-b677-82cc0cf7b18b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">EXP</span>", "ID": "e2589c94-efde-4772-838d-e89b140e92f4", "Styles": "None", "Classes": "None", "Text": "EXP", "ParentId": "034c6f94-514b-4ebe-b677-82cc0cf7b18b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f171ef4f-cb95-43b6-91eb-22cc26ad9595", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c9e0fa78-a620-437d-9bc7-b004edb221b5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f171ef4f-cb95-43b6-91eb-22cc26ad9595"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "32401bdf-8c08-4e1c-b81e-971bb82b3255", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "79655063-b38a-46d2-aaa2-32945a2822a6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "32401bdf-8c08-4e1c-b81e-971bb82b3255"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>\n</div>", "ID": "6905f7c0-d6cf-446c-939e-c6032c9a218c", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b></p>", "ID": "ca47068b-2c7a-42e2-b7c0-76388ef7e816", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6905f7c0-d6cf-446c-939e-c6032c9a218c"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span></b>", "ID": "b8452023-09dc-4a6f-a810-f596053dc50d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ca47068b-2c7a-42e2-b7c0-76388ef7e816"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER</span>", "ID": "ddb3207d-b617-428c-9ccb-eed9aa4cf361", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BATCH NUMBER", "ParentId": "b8452023-09dc-4a6f-a810-f596053dc50d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "afa7016c-4063-4f07-8045-02b36f5db2eb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "96844f80-fa2f-41cf-b30b-6d47c3883d71", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "afa7016c-4063-4f07-8045-02b36f5db2eb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Lot</span></p>", "ID": "b98029af-45e3-4be4-93ad-ea0024c84f1f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Lot</span>", "ID": "765be2ab-5282-4c60-8597-7ac87183ccd6", "Styles": "None", "Classes": "None", "Text": "Lot", "ParentId": "b98029af-45e3-4be4-93ad-ea0024c84f1f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "7f647c77-2dda-4bae-a813-96884e2a6b6e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ac4314d2-b064-44fd-930e-4d98900b0ace", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "7f647c77-2dda-4bae-a813-96884e2a6b6e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9b6d6973-05de-4126-a548-b787c08449d0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1dfd0225-99bc-45de-a212-af2487596ae6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9b6d6973-05de-4126-a548-b787c08449d0"}, {"Element": "<div style=\"border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt\">\n<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>\n</div>", "ID": "5ded05f5-c597-42a7-8dec-91620de65e6e", "Styles": "border:solid windowtext 1.0pt;padding:1.0pt 4.0pt 1.0pt 4.0pt", "Classes": "None", "Text": "  ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;border:none;padding:0in\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b></p>", "ID": "30f178ac-f6ce-45a2-a45e-caa3630c2a0e", "Styles": "line-height:normal;border:none;padding:0in", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5ded05f5-c597-42a7-8dec-91620de65e6e"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span></b>", "ID": "74d94b25-82fe-40d3-9ab5-57f8a2e6ab17", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "30f178ac-f6ce-45a2-a45e-caa3630c2a0e"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER</span>", "ID": "7753f123-5123-4640-977a-d70fa7f6a81c", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OTHER", "ParentId": "74d94b25-82fe-40d3-9ab5-57f8a2e6ab17"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "44f0f3be-a1bb-4190-87b9-567e44bffd2e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "78194b4e-6a9f-4dd3-9335-17473f889dea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "44f0f3be-a1bb-4190-87b9-567e44bffd2e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\npage-break-before:always\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "91f16bf0-aaf7-47be-8f09-48513135b301", "Styles": "text-align:center;line-height:normal;\npage-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "17d8eb62-3909-4eb8-bcc1-1a110e05ebe8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "91f16bf0-aaf7-47be-8f09-48513135b301"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "6176c026-49ea-49a2-8909-0439c21aa27b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "17d8eb62-3909-4eb8-bcc1-1a110e05ebe8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "33f7f68d-ac9e-4a7a-a318-241eea212c6d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "58adb2d7-7530-434b-a3a6-c3b3886631e8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "33f7f68d-ac9e-4a7a-a318-241eea212c6d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9341f1e9-e1e6-42a3-b589-a8bfe8b77326", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "58adb2d7-7530-434b-a3a6-c3b3886631e8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "79daa901-b3d3-4ae7-87c6-762978b9ea8b", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "11d5d192-111d-4899-bf09-a7301f66ad2e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "79daa901-b3d3-4ae7-87c6-762978b9ea8b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "9b742c4f-505b-4e68-841b-4a86dfbf58cf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "11d5d192-111d-4899-bf09-a7301f66ad2e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "34e81382-128c-485c-867f-dd76a110a98a", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9eeeaf40-154a-409b-bad4-4ebc0e37ea94", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "34e81382-128c-485c-867f-dd76a110a98a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3cb061a1-6d5f-4ecb-a748-df08d2f5a746", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9eeeaf40-154a-409b-bad4-4ebc0e37ea94"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "44ce416e-5204-4149-8b68-18a7834e8a7d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "66d41807-3477-4bf9-939d-3147036fae4f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "44ce416e-5204-4149-8b68-18a7834e8a7d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b4300899-8c13-47c4-98ab-124125a12314", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "66d41807-3477-4bf9-939d-3147036fae4f"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5db85b8e-4410-4a0b-bead-258ecfaddf80", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "d0fe8833-d986-402e-86ed-2427229fa2f0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5db85b8e-4410-4a0b-bead-258ecfaddf80"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a3fa156a-2b1e-4812-ab75-306cfa5994ce", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d0fe8833-d986-402e-86ed-2427229fa2f0"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "ffca17c7-8208-4e60-9491-cb1e6a31c46c", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "0560ef78-1c3e-41d3-ab0b-71ca722c4ec9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ffca17c7-8208-4e60-9491-cb1e6a31c46c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f4a56dbf-1fa3-4f25-a208-4b1cc172f912", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0560ef78-1c3e-41d3-ab0b-71ca722c4ec9"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5adf8864-f915-4c0f-8ec4-e94dd05d5b9b", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "dc13edd4-c144-4340-950a-4b672f36646c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5adf8864-f915-4c0f-8ec4-e94dd05d5b9b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "06a8a9c3-d162-41fb-80f3-6f1ad1910b1e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dc13edd4-c144-4340-950a-4b672f36646c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "d98e5775-20a8-4a47-b047-8351ea87d4f4", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9756ca4f-58bf-4c98-8666-d759b9811424", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d98e5775-20a8-4a47-b047-8351ea87d4f4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b23cec2a-2234-4973-b245-9d0f3fb2108d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9756ca4f-58bf-4c98-8666-d759b9811424"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "d46ecd8a-e5fc-4e77-89d9-854aba8f6e17", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "000a5dbd-18d9-4b17-bab8-e3df2b1cac44", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d46ecd8a-e5fc-4e77-89d9-854aba8f6e17"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "dae24129-5615-4892-975d-d37db3888af2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "000a5dbd-18d9-4b17-bab8-e3df2b1cac44"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "9034c2f6-fb03-4e25-9dc5-13219d1d9b64", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "ed6f769f-6044-421b-ba92-29bf57342496", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9034c2f6-fb03-4e25-9dc5-13219d1d9b64"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "215c99fc-a5f3-4f25-b29f-7fa061419757", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ed6f769f-6044-421b-ba92-29bf57342496"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "6c97ffb0-fafd-4d81-a845-150ef1f3a14a", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "9310dbcb-094b-4dde-8938-07665f7c0c7d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6c97ffb0-fafd-4d81-a845-150ef1f3a14a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a3dc35c6-1171-48c1-a9ea-b5dc9338f260", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9310dbcb-094b-4dde-8938-07665f7c0c7d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "26648cb7-6492-46ff-ba35-f836c34cab12", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "a4c5db06-faca-44ac-805b-23c631cce228", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "26648cb7-6492-46ff-ba35-f836c34cab12"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "eefdaf05-f329-46fd-a0bf-d5c3c73f4fb4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a4c5db06-faca-44ac-805b-23c631cce228"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "4b2e6247-1ba3-4d54-89d4-638ac6f7d659", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "203317d8-7096-4fb8-b4c6-6cfd7e1e0924", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4b2e6247-1ba3-4d54-89d4-638ac6f7d659"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0ad3ecc4-f52b-4e98-96aa-8f11b3c2d20d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "203317d8-7096-4fb8-b4c6-6cfd7e1e0924"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "4aec9e67-433c-4b5d-b95f-ad2af2572fe2", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "469ca6e1-c1d4-483e-a8e7-97e980398af6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4aec9e67-433c-4b5d-b95f-ad2af2572fe2"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c9b5ce6f-57de-4e49-8944-47b4bf2c2cbe", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "469ca6e1-c1d4-483e-a8e7-97e980398af6"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "bd343b52-5827-457a-8cd6-ea4611d3d6b5", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "06fe9c37-db37-4f22-9b69-3365e6ad104b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bd343b52-5827-457a-8cd6-ea4611d3d6b5"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "de7e7acd-282f-4070-9907-ba57f2990635", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "06fe9c37-db37-4f22-9b69-3365e6ad104b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "7ad4b689-85ae-4de0-a0c9-a3cb040c3617", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "3df110e7-6979-4523-9ea4-611a59409703", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7ad4b689-85ae-4de0-a0c9-a3cb040c3617"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fd447daa-6127-4270-be3d-cab5c39f56e5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3df110e7-6979-4523-9ea4-611a59409703"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "5fa17823-2816-4954-9f28-225b7d378a68", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "1a8b494d-fb62-4024-b6f7-56d12c84f9aa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5fa17823-2816-4954-9f28-225b7d378a68"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "85b73fc8-b30a-4efe-8f85-fabe02357b11", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1a8b494d-fb62-4024-b6f7-56d12c84f9aa"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "10cf5c88-f8c4-4ce7-974f-629e05518db1", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "0003f2dc-4f46-443f-8626-2957eb8cfbb8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "10cf5c88-f8c4-4ce7-974f-629e05518db1"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3b8a985d-d2d4-440b-8328-d82d4494d5e2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0003f2dc-4f46-443f-8626-2957eb8cfbb8"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "d52d5f5d-72f7-4285-951e-59d8ac64573a", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "880ff568-361a-43b0-8a4a-b6dc6966fffa", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d52d5f5d-72f7-4285-951e-59d8ac64573a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ac928a0b-726e-4e57-981f-5ec84746a6d5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "880ff568-361a-43b0-8a4a-b6dc6966fffa"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "98c312ae-ee21-4977-a0f6-83d9967d413a", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "47b90456-68ed-4584-b9c9-aacca981fd06", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "98c312ae-ee21-4977-a0f6-83d9967d413a"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e4ded9e-25cd-4e00-9928-13113172a62e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "47b90456-68ed-4584-b9c9-aacca981fd06"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "eee37d98-f252-4403-a1e2-db9d93923f7f", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "50db0c98-d819-469b-a7a7-d1510f8c068a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eee37d98-f252-4403-a1e2-db9d93923f7f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ef264917-6ea0-483a-86eb-3d3f9db95823", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "50db0c98-d819-469b-a7a7-d1510f8c068a"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "a7e1aa26-4197-4ac9-a782-b3e02c7e727f", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "68572a7c-b282-4dfc-8d86-6cea3b40529f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a7e1aa26-4197-4ac9-a782-b3e02c7e727f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "401d2356-4520-434f-82fa-bcc47c3bbc59", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "68572a7c-b282-4dfc-8d86-6cea3b40529f"}, {"Element": "<p class=\"TitleA\"><span lang=\"EN-GB\">B. PACKAGE LEAFLET</span></p>", "ID": "26c3eece-029a-49df-a92d-2fefb9520653", "Styles": "None", "Classes": "['TitleA']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">B. PACKAGE LEAFLET</span>", "ID": "940494ef-0b59-4272-badd-9393d731bdbe", "Styles": "None", "Classes": "None", "Text": "B. PACKAGE LEAFLET", "ParentId": "26c3eece-029a-49df-a92d-2fefb9520653"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "7de5c153-7bfc-45b5-95b2-4751e61c40dc", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "688c6ba2-cbca-4953-88a8-301d070ea97c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7de5c153-7bfc-45b5-95b2-4751e61c40dc"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "10dd931d-d401-43d8-9125-a4da68ee79b5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "688c6ba2-cbca-4953-88a8-301d070ea97c"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\npage-break-before:always\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3fe2923b-a156-4f5d-9c5f-48bc30c1304e", "Styles": "text-align:center;line-height:normal;\npage-break-before:always", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d1c6faf9-a718-47a0-97b7-088bba97426d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3fe2923b-a156-4f5d-9c5f-48bc30c1304e"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1c528e67-7e17-4156-810f-a1c034540082", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "47b8ac55-9028-4133-9604-5936ce1f63b5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1c528e67-7e17-4156-810f-a1c034540082"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">Package leaflet: Information for the patient</span></b></p>", "ID": "ced656fd-4b4c-46ed-b81b-4d1bb7a17187", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Package leaflet: Information for the patient</span></b>", "ID": "47f29c1f-951a-4fa3-a5fa-6024499d1e6d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ced656fd-4b4c-46ed-b81b-4d1bb7a17187"}, {"Element": "<span lang=\"EN-GB\">Package leaflet: Information for the patient</span>", "ID": "df2c9ee9-6e3c-4dff-a2ae-4639eb7a3035", "Styles": "None", "Classes": "None", "Text": "Package leaflet: Information for the patient", "ParentId": "47f29c1f-951a-4fa3-a5fa-6024499d1e6d"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal;\nbackground:white\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4f307043-d15a-4d02-859d-9715e3316d4b", "Styles": "text-align:center;line-height:normal;\nbackground:white", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ffd967f4-e06f-4553-bffb-f19e0bf3b0ff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4f307043-d15a-4d02-859d-9715e3316d4b"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg hard capsules</span></b></p>", "ID": "493c728b-4eb2-4aca-86bf-622ecfc7c0d9", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">NINLARO 2.3\u00a0mg hard capsules</span></b>", "ID": "6fb7ae39-7d60-4841-b183-7a6d0ed3e9a2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "493c728b-4eb2-4aca-86bf-622ecfc7c0d9"}, {"Element": "<span lang=\"EN-GB\">NINLARO 2.3\u00a0mg hard capsules</span>", "ID": "f459e16d-ed2f-4316-badd-6c6426470ccc", "Styles": "None", "Classes": "None", "Text": "NINLARO 2.3\u00a0mg hard capsules", "ParentId": "6fb7ae39-7d60-4841-b183-7a6d0ed3e9a2"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsules</span></b></p>", "ID": "7161d1f0-be80-4310-b370-3551e450157d", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsules</span></b>", "ID": "86c1db84-5111-4744-b85c-09fc35eee2d6", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7161d1f0-be80-4310-b370-3551e450157d"}, {"Element": "<span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsules</span>", "ID": "06692a4d-eae1-4102-97f8-2714c6af809d", "Styles": "None", "Classes": "None", "Text": "NINLARO 3\u00a0mg hard capsules", "ParentId": "86c1db84-5111-4744-b85c-09fc35eee2d6"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><b><span lang=\"EN-GB\">NINLARO 4\u00a0mg hard capsules</span></b></p>", "ID": "5199860a-312c-4606-beb7-bdab187222f3", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">NINLARO 4\u00a0mg hard capsules</span></b>", "ID": "36029b0d-7f73-4b2e-a0a9-6768a0134005", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5199860a-312c-4606-beb7-bdab187222f3"}, {"Element": "<span lang=\"EN-GB\">NINLARO 4\u00a0mg hard capsules</span>", "ID": "ca417707-a097-4ef8-a81e-8481820e9f9f", "Styles": "None", "Classes": "None", "Text": "NINLARO 4\u00a0mg hard capsules", "ParentId": "36029b0d-7f73-4b2e-a0a9-6768a0134005"}, {"Element": "<p align=\"center\" class=\"MsoNormal\" style=\"text-align:center;line-height:normal\"><span lang=\"EN-GB\">ixazomib</span></p>", "ID": "2e0509cc-2893-4c57-8dfc-a924b14da049", "Styles": "text-align:center;line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">ixazomib</span>", "ID": "ecba8d4c-eb6f-40b3-a4fd-baadbdb043d3", "Styles": "None", "Classes": "None", "Text": "ixazomib", "ParentId": "2e0509cc-2893-4c57-8dfc-a924b14da049"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c20ff80b-4722-4c80-ae49-3c6a62e69f38", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d1f6bab5-936c-4632-8d01-7427947f1468", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c20ff80b-4722-4c80-ae49-3c6a62e69f38"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Immagine 3\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image001.gif\" width=\"22\"/></span><span lang=\"EN-GB\">This medicine is subject to additional monitoring. This will allow\nquick identification of new safety information. You can help by reporting any\nside effects you may get. See the end of section\u00a04 for how to report side\neffects.</span><span lang=\"EN-GB\"> </span></p>", "ID": "deb9b6a6-a1a5-4871-870c-2f7cf33ec4cf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\"><img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Immagine 3\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image001.gif\" width=\"22\"/></span>", "ID": "2bb3b9f6-217b-4a97-b0ad-d6613fa7c865", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "deb9b6a6-a1a5-4871-870c-2f7cf33ec4cf"}, {"Element": "<img alt=\"BT_1000x858px\" border=\"0\" height=\"18\" id=\"Immagine 3\" src=\"Ninlaro%20II-25%20EN%20PI%20clea_files/image001.gif\" width=\"22\"/>", "ID": "8ed54692-ac5c-46d0-9876-e96613d98d6d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2bb3b9f6-217b-4a97-b0ad-d6613fa7c865"}, {"Element": "<span lang=\"EN-GB\">This medicine is subject to additional monitoring. This will allow\nquick identification of new safety information. You can help by reporting any\nside effects you may get. See the end of section\u00a04 for how to report side\neffects.</span>", "ID": "ba7c5348-d96a-4f9b-9587-3d0db33c0140", "Styles": "None", "Classes": "None", "Text": "This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section\u00a04 for how to report side effects.", "ParentId": "deb9b6a6-a1a5-4871-870c-2f7cf33ec4cf"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "72606479-0e60-4b1b-8b65-e0045daeaf46", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "deb9b6a6-a1a5-4871-870c-2f7cf33ec4cf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6366a164-6518-47b5-878d-eb40a7b87c72", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5bc37b83-081a-48ba-9883-e13a9ae6549e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6366a164-6518-47b5-878d-eb40a7b87c72"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Read all of this leaflet carefully before you start taking this\nmedicine because it contains </span></b></p>", "ID": "4362d18d-29c2-40e9-ad59-c1d02e9099fe", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Read all of this leaflet carefully before you start taking this\nmedicine because it contains </span></b>", "ID": "37d9456a-4431-415d-9226-4548eaf2f530", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4362d18d-29c2-40e9-ad59-c1d02e9099fe"}, {"Element": "<span lang=\"EN-GB\">Read all of this leaflet carefully before you start taking this\nmedicine because it contains </span>", "ID": "136c085c-be0b-41ca-9c53-8d5284e6e782", "Styles": "None", "Classes": "None", "Text": "Read all of this leaflet carefully before you start taking this medicine because it contains ", "ParentId": "37d9456a-4431-415d-9226-4548eaf2f530"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">important information for you.</span></b></p>", "ID": "846ca983-6b9d-49e5-8463-e8092ce47249", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">important information for you.</span></b>", "ID": "fe139c7a-3f81-4eab-b4ef-589bda31a565", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "846ca983-6b9d-49e5-8463-e8092ce47249"}, {"Element": "<span lang=\"EN-GB\">important information for you.</span>", "ID": "bd7b6767-89f5-4058-ae9f-b99c049b1114", "Styles": "None", "Classes": "None", "Text": "important information for you.", "ParentId": "fe139c7a-3f81-4eab-b4ef-589bda31a565"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Keep this leaflet. You may need to read it\nagain. </span></p>", "ID": "15a00ced-fa0e-43ba-adf7-1e421e1e6636", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "0bcff78a-59d0-4cda-90d9-6638ff945247", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "15a00ced-fa0e-43ba-adf7-1e421e1e6636"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "306217a6-f5b7-4cd8-a9c3-6aec418a9016", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "0bcff78a-59d0-4cda-90d9-6638ff945247"}, {"Element": "<span lang=\"EN-GB\">Keep this leaflet. You may need to read it\nagain. </span>", "ID": "e9b457b2-9b58-4e22-b22d-35189df608e9", "Styles": "None", "Classes": "None", "Text": "Keep this leaflet. You may need to read it again. ", "ParentId": "15a00ced-fa0e-43ba-adf7-1e421e1e6636"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you have any further questions, ask your\ndoctor, pharmacist or nurse.</span></p>", "ID": "4a61e940-aab5-44e9-b0b8-1f7d078ab1a7", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b5bd582b-0b71-46cb-8f41-97c71ec1c2b3", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "4a61e940-aab5-44e9-b0b8-1f7d078ab1a7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c484a7bd-57be-42b7-9b46-910095615250", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b5bd582b-0b71-46cb-8f41-97c71ec1c2b3"}, {"Element": "<span lang=\"EN-GB\">If you have any further questions, ask your\ndoctor, pharmacist or nurse.</span>", "ID": "caf976ae-5747-4c63-9881-29e25abb5f7a", "Styles": "None", "Classes": "None", "Text": "If you have any further questions, ask your doctor, pharmacist or nurse.", "ParentId": "4a61e940-aab5-44e9-b0b8-1f7d078ab1a7"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This\nmedicine has been prescribed for you only. Do not pass it on to others. It may\nharm them, even if their signs of illness are the same as yours.</span></p>", "ID": "53c19796-c40b-4684-9f22-5de0434c1b87", "Styles": "margin-top:0in;margin-right:-.1pt;margin-bottom:0in;\nmargin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This\nmedicine has been prescribed for you only. Do not pass it on to others. It may\nharm them, even if their signs of illness are the same as yours.</span>", "ID": "52945655-40b9-45ff-984c-8652ad876a12", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.", "ParentId": "53c19796-c40b-4684-9f22-5de0434c1b87"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">If you get any side effects, talk to your doctor,\npharmacist or nurse. This includes any possible side effects not listed in this\nleaflet. See section\u00a04.</span></p>", "ID": "b15b71e7-47ce-4f3d-a407-3432c6b68c5c", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6ec16c8a-2e4e-40b7-805e-c8390370be5c", "Styles": "None", "Classes": "None", "Text": "-", "ParentId": "b15b71e7-47ce-4f3d-a407-3432c6b68c5c"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4e25273a-0318-42b1-8922-70fa70ec7e5b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6ec16c8a-2e4e-40b7-805e-c8390370be5c"}, {"Element": "<span lang=\"EN-GB\">If you get any side effects, talk to your doctor,\npharmacist or nurse. This includes any possible side effects not listed in this\nleaflet. See section\u00a04.</span>", "ID": "f0a18fff-1199-4e46-9c97-ea38386e982e", "Styles": "None", "Classes": "None", "Text": "If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section\u00a04.", "ParentId": "b15b71e7-47ce-4f3d-a407-3432c6b68c5c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2b7a79fa-7fe8-4d25-8511-6ee98231958a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cb4f361c-f500-4991-be20-d664b86fed56", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2b7a79fa-7fe8-4d25-8511-6ee98231958a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What is in this leaflet</span></b></p>", "ID": "86341e4e-c3a0-4c40-9d0b-a6639b6dcfec", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">What is in this leaflet</span></b>", "ID": "24e0b39c-a245-4244-89a2-3097285188e9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "86341e4e-c3a0-4c40-9d0b-a6639b6dcfec"}, {"Element": "<span lang=\"EN-GB\">What is in this leaflet</span>", "ID": "2a3bbe7a-bece-440e-8435-901e694ae4ba", "Styles": "None", "Classes": "None", "Text": "What is in this leaflet", "ParentId": "24e0b39c-a245-4244-89a2-3097285188e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0 What\nNINLARO is and what it is used for</span></p>", "ID": "0dbca897-2464-472d-99c9-5151c953636a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0 What\nNINLARO is and what it is used for</span>", "ID": "7c352408-1f03-440f-b7fa-bde7a4fe89d6", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0 What NINLARO is and what it is used for", "ParentId": "0dbca897-2464-472d-99c9-5151c953636a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0 What\nyou need to know before you take NINLARO</span></p>", "ID": "5c5617a8-cbf8-491f-96f5-de650ba3d84c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0 What\nyou need to know before you take NINLARO</span>", "ID": "2af3f9d2-9692-4dac-a89a-4dc43ee309e0", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0 What you need to know before you take NINLARO", "ParentId": "5c5617a8-cbf8-491f-96f5-de650ba3d84c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0 How\nto take NINLARO</span></p>", "ID": "aa6d1b90-72bb-4e41-a272-93be7aec37da", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0 How\nto take NINLARO</span>", "ID": "ba9dc16f-6f9b-4ca8-934a-dcc301ea0971", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0 How to take NINLARO", "ParentId": "aa6d1b90-72bb-4e41-a272-93be7aec37da"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0 Possible\nside effects</span></p>", "ID": "af44ba6d-c0e4-4c07-aec3-f08fdc1494cd", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0 Possible\nside effects</span>", "ID": "476ca768-6d7f-4acb-82ac-f37a030801f0", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0 Possible side effects", "ParentId": "af44ba6d-c0e4-4c07-aec3-f08fdc1494cd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0 How\nto store NINLARO</span></p>", "ID": "bc98ac66-9d92-484d-8256-b6f7d0b0c35f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0 How\nto store NINLARO</span>", "ID": "5eb3650a-5c35-405d-97e0-e8705c3e7a86", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0 How to store NINLARO", "ParentId": "bc98ac66-9d92-484d-8256-b6f7d0b0c35f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0 Contents\nof the pack and other information</span></p>", "ID": "7a22d2d1-95be-44ee-8d87-d2e405536125", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0 Contents\nof the pack and other information</span>", "ID": "c11cb3d7-6788-4696-a4f9-56dc6fb5ed15", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0 Contents of the pack and other information", "ParentId": "7a22d2d1-95be-44ee-8d87-d2e405536125"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c4dbcdf1-d2a3-4965-b36d-8afcf60781f1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5a7744cd-ba98-42a9-b221-c4dafd83855f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c4dbcdf1-d2a3-4965-b36d-8afcf60781f1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "098ee8cd-05f7-4a57-89e9-37b619172cd0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4897b6cb-2e16-4700-8846-3f34c390a1c9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "098ee8cd-05f7-4a57-89e9-37b619172cd0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What NINLARO is and what it\nis used for</span></b></p>", "ID": "002e4b9f-2f3d-46f5-bb39-2a63a58af68e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What NINLARO is and what it\nis used for</span></b>", "ID": "4765fe78-bedd-4681-ba66-e7be2360b11e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "002e4b9f-2f3d-46f5-bb39-2a63a58af68e"}, {"Element": "<span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What NINLARO is and what it\nis used for</span>", "ID": "6dccd789-afbe-44ec-8edf-c3271141311e", "Styles": "None", "Classes": "None", "Text": "1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What NINLARO is and what it is used for", "ParentId": "4765fe78-bedd-4681-ba66-e7be2360b11e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6da829ed-fd5d-4d0a-9581-c96f91dfd74a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "875111d9-6e89-414f-bbfa-b59b51774142", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6da829ed-fd5d-4d0a-9581-c96f91dfd74a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What NINLARO is</span></b></p>", "ID": "7fa0f1f6-460f-41ed-8b06-8322d983948b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">What NINLARO is</span></b>", "ID": "8f3206a5-cdc6-4911-8aa7-4520d8c3f5db", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7fa0f1f6-460f-41ed-8b06-8322d983948b"}, {"Element": "<span lang=\"EN-GB\">What NINLARO is</span>", "ID": "bc287d2c-d7e4-482a-92bd-fc2c2e102c6e", "Styles": "None", "Classes": "None", "Text": "What NINLARO is", "ParentId": "8f3206a5-cdc6-4911-8aa7-4520d8c3f5db"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO is a\ncancer medicine that contains ixazomib, a \u2018proteasome inhibitor\u2019.</span></p>", "ID": "a6780093-fcd9-4327-ac50-6a578fee6940", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO is a\ncancer medicine that contains ixazomib, a \u2018proteasome inhibitor\u2019.</span>", "ID": "5e34c35d-cbec-40dc-80f5-d7849a65bfe1", "Styles": "None", "Classes": "None", "Text": "NINLARO is a cancer medicine that contains ixazomib, a \u2018proteasome inhibitor\u2019.", "ParentId": "a6780093-fcd9-4327-ac50-6a578fee6940"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "82748775-e69b-4462-ade8-c3c9b0698baf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b9f03e11-6055-4c86-babd-9d8eeba20692", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "82748775-e69b-4462-ade8-c3c9b0698baf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO is used\nto treat a cancer of the bone marrow called multiple myeloma. Its active\nsubstance ixazomib works by blocking the action of proteasomes. These are\nstructures inside the cell that digest proteins and are important for cell\nsurvival. Because myeloma cells produce a lot of proteins, blocking the action\nof proteasomes can kill the cancerous cells.</span></p>", "ID": "eb887ad5-7704-4121-be81-2435da0ab14b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO is used\nto treat a cancer of the bone marrow called multiple myeloma. Its active\nsubstance ixazomib works by blocking the action of proteasomes. These are\nstructures inside the cell that digest proteins and are important for cell\nsurvival. Because myeloma cells produce a lot of proteins, blocking the action\nof proteasomes can kill the cancerous cells.</span>", "ID": "618fbc48-9e3b-4330-83cb-d80982b91036", "Styles": "None", "Classes": "None", "Text": "NINLARO is used to treat a cancer of the bone marrow called multiple myeloma. Its active substance ixazomib works by blocking the action of proteasomes. These are structures inside the cell that digest proteins and are important for cell survival. Because myeloma cells produce a lot of proteins, blocking the action of proteasomes can kill the cancerous cells.", "ParentId": "eb887ad5-7704-4121-be81-2435da0ab14b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "36aaf4a8-32cc-4121-b971-3c6c14e81963", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1a0e735b-076c-4889-9dde-889acc480fb2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "36aaf4a8-32cc-4121-b971-3c6c14e81963"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What NINLARO is used for</span></b></p>", "ID": "eb3107f1-e10a-41e2-b005-de76373c4074", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">What NINLARO is used for</span></b>", "ID": "d4ca15d0-31a2-41eb-894a-6ca9aa0b83e5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "eb3107f1-e10a-41e2-b005-de76373c4074"}, {"Element": "<span lang=\"EN-GB\">What NINLARO is used for</span>", "ID": "c3721782-5a08-40ca-810c-d76426f2542b", "Styles": "None", "Classes": "None", "Text": "What NINLARO is used for", "ParentId": "d4ca15d0-31a2-41eb-894a-6ca9aa0b83e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO is used\nto treat adults with multiple myeloma.</span><span lang=\"EN-GB\"> NINLARO will be\ngiven to you together with lenalidomide and dexamethasone, which are other\nmedicines used to treat multiple myeloma.</span></p>", "ID": "0d6dd2a3-23dd-4d3a-a7bf-72e9bb1dd9b3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO is used\nto treat adults with multiple myeloma.</span>", "ID": "201f5f3f-9ecc-433b-85b3-d7467b3816eb", "Styles": "None", "Classes": "None", "Text": "NINLARO is used to treat adults with multiple myeloma.", "ParentId": "0d6dd2a3-23dd-4d3a-a7bf-72e9bb1dd9b3"}, {"Element": "<span lang=\"EN-GB\"> NINLARO will be\ngiven to you together with lenalidomide and dexamethasone, which are other\nmedicines used to treat multiple myeloma.</span>", "ID": "09678a12-639f-468c-a878-a5253ea038fe", "Styles": "None", "Classes": "None", "Text": " NINLARO will be given to you together with lenalidomide and dexamethasone, which are other medicines used to treat multiple myeloma.", "ParentId": "0d6dd2a3-23dd-4d3a-a7bf-72e9bb1dd9b3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b110664a-afc7-4c88-a050-08215a312b7e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "28d5e064-999e-428c-96c7-8691ed908002", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b110664a-afc7-4c88-a050-08215a312b7e"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">What multiple myeloma is </span></b></p>", "ID": "b0da0d62-370c-4b57-97f7-ec10311c7bb9", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">What multiple myeloma is </span></b>", "ID": "408b1d3e-e954-49fa-9c30-8ef5db23d77e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b0da0d62-370c-4b57-97f7-ec10311c7bb9"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">What multiple myeloma is </span>", "ID": "7844a7bc-9006-40e7-b951-8bb801ea7f7b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "What multiple myeloma is ", "ParentId": "408b1d3e-e954-49fa-9c30-8ef5db23d77e"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Multiple\nmyeloma is a cancer of the blood</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> which affects a type of cell, called the plasma cell</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">. A plasma cell is a blood\ncell that normally produces proteins to fight infections. People with multiple\nmyeloma have cancerous plasma cells, also called </span><span lang=\"EN-GB\" style=\"font-size:11.0pt\"><a href=\"javascript:void(0);\" title=\"(my-uh-LOW-muh) Cancerous plasma cells.\"><span style=\"color:windowtext;\ntext-decoration:none\">myeloma cells</span></a></span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">, which can damage the bones. Protein\nproduced by myeloma cells can damage the kidneys. Treatment for multiple\nmyeloma involves killing myeloma cells and reducing the symptoms of the\ndisease. </span></p>", "ID": "65524aa2-86a8-4157-b8ae-811bb4159d5f", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Multiple\nmyeloma is a cancer of the blood</span>", "ID": "6d40d9dc-03da-4c61-9f46-a0c250c47aac", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Multiple myeloma is a cancer of the blood", "ParentId": "65524aa2-86a8-4157-b8ae-811bb4159d5f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> which affects a type of cell, called the plasma cell</span>", "ID": "61382821-65d3-4c75-b440-8ee229e3a325", "Styles": "font-size:11.0pt;\ncolor:windowtext", "Classes": "None", "Text": " which affects a type of cell, called the plasma cell", "ParentId": "65524aa2-86a8-4157-b8ae-811bb4159d5f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">. A plasma cell is a blood\ncell that normally produces proteins to fight infections. People with multiple\nmyeloma have cancerous plasma cells, also called </span>", "ID": "fde7210a-ac69-42c8-8f8a-ee5a3a6c4d96", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": ". A plasma cell is a blood cell that normally produces proteins to fight infections. People with multiple myeloma have cancerous plasma cells, also called ", "ParentId": "65524aa2-86a8-4157-b8ae-811bb4159d5f"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\"><a href=\"javascript:void(0);\" title=\"(my-uh-LOW-muh) Cancerous plasma cells.\"><span style=\"color:windowtext;\ntext-decoration:none\">myeloma cells</span></a></span>", "ID": "3f4673e8-663c-4a65-bdf2-d76cb1fb8fa4", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "", "ParentId": "65524aa2-86a8-4157-b8ae-811bb4159d5f"}, {"Element": "<a href=\"javascript:void(0);\" title=\"(my-uh-LOW-muh) Cancerous plasma cells.\"><span style=\"color:windowtext;\ntext-decoration:none\">myeloma cells</span></a>", "ID": "592a3350-324e-4f3b-960b-0315f77f570e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3f4673e8-663c-4a65-bdf2-d76cb1fb8fa4"}, {"Element": "<span style=\"color:windowtext;\ntext-decoration:none\">myeloma cells</span>", "ID": "53448910-62b1-4c61-91b8-9a9857c213b4", "Styles": "color:windowtext;\ntext-decoration:none", "Classes": "None", "Text": "myeloma cells", "ParentId": "592a3350-324e-4f3b-960b-0315f77f570e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">, which can damage the bones. Protein\nproduced by myeloma cells can damage the kidneys. Treatment for multiple\nmyeloma involves killing myeloma cells and reducing the symptoms of the\ndisease. </span>", "ID": "963e2e44-2032-458c-98e2-92ebd0265619", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": ", which can damage the bones. Protein produced by myeloma cells can damage the kidneys. Treatment for multiple myeloma involves killing myeloma cells and reducing the symptoms of the disease. ", "ParentId": "65524aa2-86a8-4157-b8ae-811bb4159d5f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c2a329d3-eaee-4afc-8cda-ab74b2ff18b0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b37acd00-3f08-44bd-9cb0-5d4dd230e418", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c2a329d3-eaee-4afc-8cda-ab74b2ff18b0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e7973262-d30e-418f-ad08-a0799a57024a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f5f00c17-e5f7-4bf6-b6fa-b5ed7dd23a8c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e7973262-d30e-418f-ad08-a0799a57024a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before\nyou take NINLARO</span></b></p>", "ID": "c892a303-f7b9-4e0d-a6d3-29a172420421", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before\nyou take NINLARO</span></b>", "ID": "2462ceea-59c0-4bab-8d14-d83481318c60", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c892a303-f7b9-4e0d-a6d3-29a172420421"}, {"Element": "<span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before\nyou take NINLARO</span>", "ID": "6532bc7a-bca2-47ca-b83a-37a6bf0374dd", "Styles": "None", "Classes": "None", "Text": "2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 What you need to know before you take NINLARO", "ParentId": "2462ceea-59c0-4bab-8d14-d83481318c60"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><i><span lang=\"EN-GB\">\u00a0</span></i></p>", "ID": "8044e7e7-49e7-4cb4-bf8b-e7666a36051f", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<i><span lang=\"EN-GB\">\u00a0</span></i>", "ID": "403bc3c2-4e20-47f0-bc73-9561f231d4c9", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8044e7e7-49e7-4cb4-bf8b-e7666a36051f"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "79aae2a8-e0ff-415c-9458-6e95c331a476", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "403bc3c2-4e20-47f0-bc73-9561f231d4c9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Do not take NINLARO</span></b></p>", "ID": "615e4e85-e47a-4856-83cb-4f2909cbd79a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Do not take NINLARO</span></b>", "ID": "03f0ff7f-1c87-45e7-aa80-fc803753ae3d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "615e4e85-e47a-4856-83cb-4f2909cbd79a"}, {"Element": "<span lang=\"EN-GB\">Do not take NINLARO</span>", "ID": "35a1e237-0072-491c-b563-4a0486fe02fc", "Styles": "None", "Classes": "None", "Text": "Do not take NINLARO", "ParentId": "03f0ff7f-1c87-45e7-aa80-fc803753ae3d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal\"><span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 if you are\nallergic to ixazomib or to any of the other any of the other ingredients of\nthis medicine (listed in section\u00a06).</span></p>", "ID": "bbdb93a0-7a0d-443c-a5ba-d4a8458657d7", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 if you are\nallergic to ixazomib or to any of the other any of the other ingredients of\nthis medicine (listed in section\u00a06).</span>", "ID": "22c02c62-f507-4dd3-9feb-d565781eff90", "Styles": "None", "Classes": "None", "Text": "-\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 if you are allergic to ixazomib or to any of the other any of the other ingredients of this medicine (listed in section\u00a06).", "ParentId": "bbdb93a0-7a0d-443c-a5ba-d4a8458657d7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2b22c29a-5599-4de2-b775-0574b7b8a9ec", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7b06435a-0806-41b3-a861-59ee8c1c0eff", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2b22c29a-5599-4de2-b775-0574b7b8a9ec"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">If you are\nuncertain whether the condition above applies to you, talk to your doctor,\npharmacist or nurse before taking NINLARO.</span></p>", "ID": "66792a76-bfc2-46bc-b00d-284cae2aadb1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">If you are\nuncertain whether the condition above applies to you, talk to your doctor,\npharmacist or nurse before taking NINLARO.</span>", "ID": "ea8d3f03-eef9-424c-b14a-2e38192d4861", "Styles": "None", "Classes": "None", "Text": "If you are uncertain whether the condition above applies to you, talk to your doctor, pharmacist or nurse before taking NINLARO.", "ParentId": "66792a76-bfc2-46bc-b00d-284cae2aadb1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "805cca93-8b2d-4201-bb06-eac9ca5f6bf7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f3f92622-ace1-44e6-acd7-6c25e2a04a8e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "805cca93-8b2d-4201-bb06-eac9ca5f6bf7"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Warnings and precautions</span></b></p>", "ID": "a8b589c4-8cca-48ee-a84d-9602ce4e88a9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Warnings and precautions</span></b>", "ID": "4d6fb0b3-e1ca-4517-9333-e997fecd8565", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a8b589c4-8cca-48ee-a84d-9602ce4e88a9"}, {"Element": "<span lang=\"EN-GB\">Warnings and precautions</span>", "ID": "788dbf28-cb3a-474f-8eb2-105da994f9c9", "Styles": "None", "Classes": "None", "Text": "Warnings and precautions", "ParentId": "4d6fb0b3-e1ca-4517-9333-e997fecd8565"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">Talk to your doctor, pharmacist or nurse before taking or during\ntreatment with NINLARO if:</span></p>", "ID": "54ceff4e-382b-4a7d-8694-f3ceebb02bb3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Talk to your doctor, pharmacist or nurse before taking or during\ntreatment with NINLARO if:</span>", "ID": "1dcf5c0d-a889-4e28-bce6-ded488a8f28d", "Styles": "None", "Classes": "None", "Text": "Talk to your doctor, pharmacist or nurse before taking or during treatment with NINLARO if:", "ParentId": "54ceff4e-382b-4a7d-8694-f3ceebb02bb3"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">you have a history of bleeding</span></p>", "ID": "e34f6397-eea5-4aaf-bd8c-afaa6ba7a1f2", "Styles": "margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "5cb60d45-888b-4c3d-8e5d-3417f984dcf2", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "e34f6397-eea5-4aaf-bd8c-afaa6ba7a1f2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "fc8417ad-1532-4d76-9e80-730336fe9c54", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "5cb60d45-888b-4c3d-8e5d-3417f984dcf2"}, {"Element": "<span lang=\"EN-GB\">you have a history of bleeding</span>", "ID": "daa59663-3720-44dc-8b8d-1f738dc6645d", "Styles": "None", "Classes": "None", "Text": "you have a history of bleeding", "ParentId": "e34f6397-eea5-4aaf-bd8c-afaa6ba7a1f2"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">you have persistent nausea, vomiting or diarrhoea</span></p>", "ID": "f50e8d1a-af0a-4ee8-ba14-e81c1837c74a", "Styles": "margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f7450396-0268-43f7-8f55-a6658c0c4a9f", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f50e8d1a-af0a-4ee8-ba14-e81c1837c74a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "dbeead91-9649-49a0-87cb-bd9744dbd1e8", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f7450396-0268-43f7-8f55-a6658c0c4a9f"}, {"Element": "<span lang=\"EN-GB\">you have persistent nausea, vomiting or diarrhoea</span>", "ID": "2a5f0f31-aff2-4c44-a320-de7548da6f26", "Styles": "None", "Classes": "None", "Text": "you have persistent nausea, vomiting or diarrhoea", "ParentId": "f50e8d1a-af0a-4ee8-ba14-e81c1837c74a"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>you\nhave a history of nerve problems, to include tingling and numbness</span></p>", "ID": "feb947bf-4219-481d-b1a7-ff7607fbfd27", "Styles": "margin:0in;text-indent:0in;line-height:normal;\ntext-autospace:none", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "93059f33-4566-482d-918f-6bb1a0972ac6", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "feb947bf-4219-481d-b1a7-ff7607fbfd27"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "15516fa7-7482-49b6-adeb-df3333cd5fcf", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "93059f33-4566-482d-918f-6bb1a0972ac6"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>you\nhave a history of nerve problems, to include tingling and numbness</span>", "ID": "ebc2a1f7-21a8-4c7b-8384-ae2810f4340b", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "you have a history of nerve problems, to include tingling and numbness", "ParentId": "feb947bf-4219-481d-b1a7-ff7607fbfd27"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>you\nhave a history of swelling</span></p>", "ID": "3478cd40-7685-468d-8c4c-40c42d27d1c2", "Styles": "margin:0in;text-indent:0in;line-height:normal;\ntext-autospace:none", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "733491f6-001d-4c3a-a1d8-14c17628d3b7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "3478cd40-7685-468d-8c4c-40c42d27d1c2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "73a3090c-60b1-4a01-9c7a-13ebc55d1b95", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "733491f6-001d-4c3a-a1d8-14c17628d3b7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>you\nhave a history of swelling</span>", "ID": "535529a1-b626-4ab1-9516-ae6b48a695f4", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "you have a history of swelling", "ParentId": "3478cd40-7685-468d-8c4c-40c42d27d1c2"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>you\nhave a persistent rash</span></p>", "ID": "23189119-bdad-4704-98e6-a8268ab47373", "Styles": "margin:0in;text-indent:0in;line-height:normal;\ntext-autospace:none", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b8fe1594-342a-46c0-9fbd-4d6efb89bff3", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "23189119-bdad-4704-98e6-a8268ab47373"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "2993bcd1-b458-49f0-89c7-a7c81f73842b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b8fe1594-342a-46c0-9fbd-4d6efb89bff3"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>you\nhave a persistent rash</span>", "ID": "02a818b7-fd4c-4c0a-8201-751b6e369322", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "you have a persistent rash", "ParentId": "23189119-bdad-4704-98e6-a8268ab47373"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">you have or have had liver or kidney problems as\nyour dose may have to be adjusted</span></p>", "ID": "ab17413f-a787-4ee9-aa59-d492b3eac4d0", "Styles": "margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "b888a0ce-3517-494d-983e-0419a7f26c33", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "ab17413f-a787-4ee9-aa59-d492b3eac4d0"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ba25486a-de5d-45fc-88c4-ce7370f3374e", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "b888a0ce-3517-494d-983e-0419a7f26c33"}, {"Element": "<span lang=\"EN-GB\">you have or have had liver or kidney problems as\nyour dose may have to be adjusted</span>", "ID": "899d90af-509a-46a5-93f2-ca6777bceb6d", "Styles": "None", "Classes": "None", "Text": "you have or have had liver or kidney problems as your dose may have to be adjusted", "ParentId": "ab17413f-a787-4ee9-aa59-d492b3eac4d0"}, {"Element": "<p class=\"MsoListParagraph\" style=\"margin-bottom:0in;text-indent:-.5in;\nline-height:normal;text-autospace:none\"><span style=\"font-family:Symbol;\ncolor:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span style='font-family:\"Times New Roman\",serif;color:black'>you\nhave or have had damage to the smallest blood vessels known as thrombotic\nmicroangiopathy or thrombotic thrombocytopenic purpura. Tell your doctor if you\ndevelop fatigue, fever, bruising, bleeding, decreased urination, swelling,\nconfusion, vision loss, and seizures.</span></p>", "ID": "fdc0f471-0c80-4416-87c4-6c89d72b3b9b", "Styles": "margin-bottom:0in;text-indent:-.5in;\nline-height:normal;text-autospace:none", "Classes": "['MsoListParagraph']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style=\"font-family:Symbol;\ncolor:black\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "685bcc4c-11b6-4418-9452-f8b0b75031c8", "Styles": "font-family:Symbol;\ncolor:black", "Classes": "None", "Text": "\u00b7", "ParentId": "fdc0f471-0c80-4416-87c4-6c89d72b3b9b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "30f39b3b-82b8-4e10-b15e-520f42ca1398", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "685bcc4c-11b6-4418-9452-f8b0b75031c8"}, {"Element": "<span style='font-family:\"Times New Roman\",serif;color:black'>you\nhave or have had damage to the smallest blood vessels known as thrombotic\nmicroangiopathy or thrombotic thrombocytopenic purpura. Tell your doctor if you\ndevelop fatigue, fever, bruising, bleeding, decreased urination, swelling,\nconfusion, vision loss, and seizures.</span>", "ID": "42e06bbf-92e4-41b5-943e-c5dac01511ac", "Styles": "font-family:\"Times New Roman\",serif;color:black", "Classes": "None", "Text": "you have or have had damage to the smallest blood vessels known as thrombotic microangiopathy or thrombotic thrombocytopenic purpura. Tell your doctor if you develop fatigue, fever, bruising, bleeding, decreased urination, swelling, confusion, vision loss, and seizures.", "ParentId": "fdc0f471-0c80-4416-87c4-6c89d72b3b9b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "068052e7-dce2-4bbd-8c35-432d7484c703", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "277a1c29-8573-4e43-9169-39f11ccbfd84", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "068052e7-dce2-4bbd-8c35-432d7484c703"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Your doctor will\nexamine you and you will be monitored closely during treatment. Before starting\nNINLARO and during treatment, you will have blood tests to check that you have\nenough blood cells.</span></p>", "ID": "5153b942-e94e-4ee4-a099-1d0d896e0614", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Your doctor will\nexamine you and you will be monitored closely during treatment. Before starting\nNINLARO and during treatment, you will have blood tests to check that you have\nenough blood cells.</span>", "ID": "b561e9cd-34ef-4a6d-a2e2-76a543157b1d", "Styles": "None", "Classes": "None", "Text": "Your doctor will examine you and you will be monitored closely during treatment. Before starting NINLARO and during treatment, you will have blood tests to check that you have enough blood cells.", "ParentId": "5153b942-e94e-4ee4-a099-1d0d896e0614"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6ccad912-9b99-4d38-a3de-aae375e5bdc9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e7275de7-a23e-41cc-90b7-6110cda9d30c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6ccad912-9b99-4d38-a3de-aae375e5bdc9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Children and adolescents</span></b></p>", "ID": "0a1ddcf5-f547-47bf-90a7-55c6c257dd44", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Children and adolescents</span></b>", "ID": "ae6c3e02-7521-4bcc-b235-30ad2b8b3cae", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0a1ddcf5-f547-47bf-90a7-55c6c257dd44"}, {"Element": "<span lang=\"EN-GB\">Children and adolescents</span>", "ID": "f8e91b07-830e-46a3-a8ef-0716983b135a", "Styles": "None", "Classes": "None", "Text": "Children and adolescents", "ParentId": "ae6c3e02-7521-4bcc-b235-30ad2b8b3cae"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO is not\nrecommended for use in children and adolescents aged under 18\u00a0years.</span></p>", "ID": "98cd15a3-6789-4b29-a0cd-b0f33266205a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO is not\nrecommended for use in children and adolescents aged under 18\u00a0years.</span>", "ID": "5ea29e1a-4b2f-4e5d-a8d8-fa540db68699", "Styles": "None", "Classes": "None", "Text": "NINLARO is not recommended for use in children and adolescents aged under 18\u00a0years.", "ParentId": "98cd15a3-6789-4b29-a0cd-b0f33266205a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "688f061a-843e-49dd-ac2f-280310b6a43b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "b1aa6df5-8fa7-421f-88d3-aef84c47bdd8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "688f061a-843e-49dd-ac2f-280310b6a43b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "60364f03-1591-4d9d-b8d8-343f6b40a321", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b1aa6df5-8fa7-421f-88d3-aef84c47bdd8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other medicines and NINLARO</span></b></p>", "ID": "0672cd62-3b4f-4a0c-8c11-1cc383b161d3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Other medicines and NINLARO</span></b>", "ID": "18be8030-fd74-4285-ba5a-e3a735216ad7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0672cd62-3b4f-4a0c-8c11-1cc383b161d3"}, {"Element": "<span lang=\"EN-GB\">Other medicines and NINLARO</span>", "ID": "c7e89450-1799-415c-992d-81d42110d50e", "Styles": "None", "Classes": "None", "Text": "Other medicines and NINLARO", "ParentId": "18be8030-fd74-4285-ba5a-e3a735216ad7"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tell\nyour doctor, pharmacist or nurse if you are taking, have recently taken or\nmight take any other medicines. This includes any medicines obtained without a\nprescription, such as vitamins or herbal remedies. This is because other\nmedicines can affect the way NINLARO works. In particular, tell your doctor,\npharmacist or nurse if you are taking any of the following medicines:\ncarbamazepine, phenytoin, rifampicin and St. John\u2019s wort (<i>Hypericum </i><i>perforatum</i>).\nThese medicines should be avoided as they may reduce the effectiveness of\nNINLARO.</span></p>", "ID": "754fc79e-8fd0-4867-b3c2-bcd07f1c7f07", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tell\nyour doctor, pharmacist or nurse if you are taking, have recently taken or\nmight take any other medicines. This includes any medicines obtained without a\nprescription, such as vitamins or herbal remedies. This is because other\nmedicines can affect the way NINLARO works. In particular, tell your doctor,\npharmacist or nurse if you are taking any of the following medicines:\ncarbamazepine, phenytoin, rifampicin and St. John\u2019s wort (<i>Hypericum </i><i>perforatum</i>).\nThese medicines should be avoided as they may reduce the effectiveness of\nNINLARO.</span>", "ID": "daf39e9e-2d0d-4bcf-850b-ea928162a441", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines. This includes any medicines obtained without a prescription, such as vitamins or herbal remedies. This is because other medicines can affect the way NINLARO works. In particular, tell your doctor, pharmacist or nurse if you are taking any of the following medicines: carbamazepine, phenytoin, rifampicin and St. John\u2019s wort (). These medicines should be avoided as they may reduce the effectiveness of NINLARO.", "ParentId": "754fc79e-8fd0-4867-b3c2-bcd07f1c7f07"}, {"Element": "<i>Hypericum </i>", "ID": "b30b8203-f7e6-4e4f-a6e3-b28e5af6ff23", "Styles": "None", "Classes": "None", "Text": "Hypericum ", "ParentId": "daf39e9e-2d0d-4bcf-850b-ea928162a441"}, {"Element": "<i>perforatum</i>", "ID": "745a817f-c9fb-4911-9148-4d01b6337902", "Styles": "None", "Classes": "None", "Text": "perforatum", "ParentId": "daf39e9e-2d0d-4bcf-850b-ea928162a441"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "44bcd65d-11eb-4bab-ad60-1673e61e1daf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "002dc646-be78-47ca-9ab6-44378bf9bd1e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "44bcd65d-11eb-4bab-ad60-1673e61e1daf"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Pregnancy and breast\u2011feeding</span></b></p>", "ID": "d0e4e55c-1492-4031-bed0-2917a4977a87", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Pregnancy and breast\u2011feeding</span></b>", "ID": "0a9569fa-3204-45c3-a1d5-e4a259404a28", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "d0e4e55c-1492-4031-bed0-2917a4977a87"}, {"Element": "<span lang=\"EN-GB\">Pregnancy and breast\u2011feeding</span>", "ID": "0969f85d-1b0e-4b45-b4f3-5fb3f7aab613", "Styles": "None", "Classes": "None", "Text": "Pregnancy and breast\u2011feeding", "ParentId": "0a9569fa-3204-45c3-a1d5-e4a259404a28"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO is not\nrecommended during pregnancy as it may harm your unborn baby. Breast\u2011feeding\nshould be stopped when taking NINLARO.</span></p>", "ID": "084fb587-71c4-4458-afa1-170deb37204f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO is not\nrecommended during pregnancy as it may harm your unborn baby. Breast\u2011feeding\nshould be stopped when taking NINLARO.</span>", "ID": "a2b32ba8-c418-4601-a2a6-6740e0f5b7e7", "Styles": "None", "Classes": "None", "Text": "NINLARO is not recommended during pregnancy as it may harm your unborn baby. Breast\u2011feeding should be stopped when taking NINLARO.", "ParentId": "084fb587-71c4-4458-afa1-170deb37204f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "761bf66c-d073-4b4e-9146-11d7e16fce9f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4db42f07-9991-42f2-8d79-74377c73d275", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "761bf66c-d073-4b4e-9146-11d7e16fce9f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Avoid becoming\npregnant or breast\u2011feeding while being treated with NINLARO. If you are\npregnant or breast\u2011feeding, think you may be pregnant or are planning to\nhave a baby, ask your doctor or pharmacist for advice before taking this\nmedicine. </span></p>", "ID": "4c10c0da-2173-469e-b54b-8bac455bdf69", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Avoid becoming\npregnant or breast\u2011feeding while being treated with NINLARO. If you are\npregnant or breast\u2011feeding, think you may be pregnant or are planning to\nhave a baby, ask your doctor or pharmacist for advice before taking this\nmedicine. </span>", "ID": "1ac840b7-cf97-496a-a76d-10ebd29b6913", "Styles": "None", "Classes": "None", "Text": "Avoid becoming pregnant or breast\u2011feeding while being treated with NINLARO. If you are pregnant or breast\u2011feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. ", "ParentId": "4c10c0da-2173-469e-b54b-8bac455bdf69"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1284c521-adba-457f-8492-d6daac2b1897", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e22a4475-8622-4422-a7ef-d64217b78eb6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1284c521-adba-457f-8492-d6daac2b1897"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">If you are a woman of childbearing potential or a man who can father\na child, you </span><span lang=\"EN-GB\">must use effective contraception during\nand for 90\u00a0days after treatment. </span><span lang=\"EN-GB\">Women using\nhormonal contraceptives should additionally use a barrier method of\ncontraception. </span><span lang=\"EN-GB\">Tell doctor right away if you or your\npartner becomes pregnant while receiving NINLARO.</span></p>", "ID": "6da9c869-a992-4098-9ff0-a3416f83b460", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">If you are a woman of childbearing potential or a man who can father\na child, you </span>", "ID": "9b9c8750-7aab-4b4f-95bd-60d0b7e090cf", "Styles": "None", "Classes": "None", "Text": "If you are a woman of childbearing potential or a man who can father a child, you ", "ParentId": "6da9c869-a992-4098-9ff0-a3416f83b460"}, {"Element": "<span lang=\"EN-GB\">must use effective contraception during\nand for 90\u00a0days after treatment. </span>", "ID": "73083a7e-0b8a-4bb3-a596-f3c30a95080d", "Styles": "None", "Classes": "None", "Text": "must use effective contraception during and for 90\u00a0days after treatment. ", "ParentId": "6da9c869-a992-4098-9ff0-a3416f83b460"}, {"Element": "<span lang=\"EN-GB\">Women using\nhormonal contraceptives should additionally use a barrier method of\ncontraception. </span>", "ID": "d5c41742-f0bb-41bc-afb3-ce0f88318550", "Styles": "None", "Classes": "None", "Text": "Women using hormonal contraceptives should additionally use a barrier method of contraception. ", "ParentId": "6da9c869-a992-4098-9ff0-a3416f83b460"}, {"Element": "<span lang=\"EN-GB\">Tell doctor right away if you or your\npartner becomes pregnant while receiving NINLARO.</span>", "ID": "6369edca-50a7-4809-9327-a81f617eefca", "Styles": "None", "Classes": "None", "Text": "Tell doctor right away if you or your partner becomes pregnant while receiving NINLARO.", "ParentId": "6da9c869-a992-4098-9ff0-a3416f83b460"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">As NINLARO is given in combination with lenalidomide, </span><span lang=\"EN-GB\">you should adhere to the pregnancy prevention programme of\nlenalidomide</span><span lang=\"EN-GB\"> because lenalidomide can be harmful to the\nunborn child.</span></p>", "ID": "bd0993a3-264e-4395-bd74-aeeb4aa604b2", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">As NINLARO is given in combination with lenalidomide, </span>", "ID": "a55b50a2-697e-4be2-b118-fe620a3b1d14", "Styles": "None", "Classes": "None", "Text": "As NINLARO is given in combination with lenalidomide, ", "ParentId": "bd0993a3-264e-4395-bd74-aeeb4aa604b2"}, {"Element": "<span lang=\"EN-GB\">you should adhere to the pregnancy prevention programme of\nlenalidomide</span>", "ID": "7f42649d-02de-45a2-95e9-294d61d3ec2a", "Styles": "None", "Classes": "None", "Text": "you should adhere to the pregnancy prevention programme of lenalidomide", "ParentId": "bd0993a3-264e-4395-bd74-aeeb4aa604b2"}, {"Element": "<span lang=\"EN-GB\"> because lenalidomide can be harmful to the\nunborn child.</span>", "ID": "115f1132-5471-4207-865c-6f3372ba0d6b", "Styles": "None", "Classes": "None", "Text": " because lenalidomide can be harmful to the unborn child.", "ParentId": "bd0993a3-264e-4395-bd74-aeeb4aa604b2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1f058934-8770-44a3-90b6-c79274c305ea", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "2dfdc2e9-f87a-40d1-9d80-5b177066337c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1f058934-8770-44a3-90b6-c79274c305ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">See the package leaflets for lenalidomide and dexamethasone for additional\ninformation on pregnancy and breast\u2011feeding</span></p>", "ID": "3cbaf444-5e90-41d9-89ac-8eb2891ff9a8", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">See the package leaflets for lenalidomide and dexamethasone for additional\ninformation on pregnancy and breast\u2011feeding</span>", "ID": "3c6254e9-acb9-4568-ab66-2193be00a425", "Styles": "None", "Classes": "None", "Text": "See the package leaflets for lenalidomide and dexamethasone for additional information on pregnancy and breast\u2011feeding", "ParentId": "3cbaf444-5e90-41d9-89ac-8eb2891ff9a8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "65203329-2d43-4c22-9aaf-60290f2f0b27", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3bff12ea-3ade-4a87-a672-b2fe27c5dcbc", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "65203329-2d43-4c22-9aaf-60290f2f0b27"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Driving and using machines</span></b></p>", "ID": "86edd128-f6ca-47ed-ab5f-481809111d0e", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Driving and using machines</span></b>", "ID": "f24a8043-18a8-4b6d-b488-ac54f1a14000", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "86edd128-f6ca-47ed-ab5f-481809111d0e"}, {"Element": "<span lang=\"EN-GB\">Driving and using machines</span>", "ID": "5e2d46d0-c213-4e8f-9bd6-249f1ab7e985", "Styles": "None", "Classes": "None", "Text": "Driving and using machines", "ParentId": "f24a8043-18a8-4b6d-b488-ac54f1a14000"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO may\naffect your ability to drive or use machines. You may feel tired and dizzy while\ntaking NINLARO. Do not drive or operate machines if you have these side effects.</span></p>", "ID": "8867aa21-03fd-4fc0-98c1-9cc26735d423", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO may\naffect your ability to drive or use machines. You may feel tired and dizzy while\ntaking NINLARO. Do not drive or operate machines if you have these side effects.</span>", "ID": "d22d0930-54f2-4975-b4e3-567c192ce1cb", "Styles": "None", "Classes": "None", "Text": "NINLARO may affect your ability to drive or use machines. You may feel tired and dizzy while taking NINLARO. Do not drive or operate machines if you have these side effects.", "ParentId": "8867aa21-03fd-4fc0-98c1-9cc26735d423"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "10b4182b-481f-49bf-81a6-64d1ee15b1d6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c6684c6b-57e9-4957-a43b-bbe0a0c59054", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "10b4182b-481f-49bf-81a6-64d1ee15b1d6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b43b4f60-5304-450f-901e-531546d8482b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "3f190f34-5c5d-41f7-8cd9-4d105cfd6d4f", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b43b4f60-5304-450f-901e-531546d8482b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take NINLARO</span></b></p>", "ID": "cde076fa-29da-410f-aaaa-2c53c12e62eb", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take NINLARO</span></b>", "ID": "417af5a8-83c3-4961-8143-dcbed425824b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cde076fa-29da-410f-aaaa-2c53c12e62eb"}, {"Element": "<span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take NINLARO</span>", "ID": "c54d8560-4925-472f-a108-b4adde40b79e", "Styles": "None", "Classes": "None", "Text": "3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to take NINLARO", "ParentId": "417af5a8-83c3-4961-8143-dcbed425824b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f8aa6bbf-35e5-462d-8327-d0371803a114", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "bb8f6d96-3496-4bd8-86f2-4a5b6f9616a8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f8aa6bbf-35e5-462d-8327-d0371803a114"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO must be\nprescribed to you by a doctor with experience of treating multiple myeloma.\nAlways take this medicine exactly as your doctor or pharmacist has told you. </span></p>", "ID": "871bea06-d24b-4144-92ca-121d37165a7b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO must be\nprescribed to you by a doctor with experience of treating multiple myeloma.\nAlways take this medicine exactly as your doctor or pharmacist has told you. </span>", "ID": "eb63dd7f-45ab-4159-b5fa-e5b64b6d9da0", "Styles": "None", "Classes": "None", "Text": "NINLARO must be prescribed to you by a doctor with experience of treating multiple myeloma. Always take this medicine exactly as your doctor or pharmacist has told you. ", "ParentId": "871bea06-d24b-4144-92ca-121d37165a7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9fdb4c11-2116-4743-8200-84ff246ea41d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ad4fc889-1f26-4442-a32d-9cc48071ffc8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9fdb4c11-2116-4743-8200-84ff246ea41d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO</span><span lang=\"EN-GB\"> is used with lenalidomide (a medicine which affects how your immune\nsystem works) and dexamethasone (an anti\u2011inflammatory medicine).</span></p>", "ID": "506ae4d1-000b-4d1e-84f4-1db09e4bb555", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO</span>", "ID": "c9d8a18e-e377-49d8-a2d3-2fc26789d3eb", "Styles": "None", "Classes": "None", "Text": "NINLARO", "ParentId": "506ae4d1-000b-4d1e-84f4-1db09e4bb555"}, {"Element": "<span lang=\"EN-GB\"> is used with lenalidomide (a medicine which affects how your immune\nsystem works) and dexamethasone (an anti\u2011inflammatory medicine).</span>", "ID": "39a92ffa-efff-4668-8b34-261e2a66948e", "Styles": "None", "Classes": "None", "Text": " is used with lenalidomide (a medicine which affects how your immune system works) and dexamethasone (an anti\u2011inflammatory medicine).", "ParentId": "506ae4d1-000b-4d1e-84f4-1db09e4bb555"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "f0f15a60-f466-422a-bfd4-03c7840608b6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "59b35571-b464-445a-99ab-e5b036463fdd", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f0f15a60-f466-422a-bfd4-03c7840608b6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">NINLARO,\nlenalidomide and dexamethasone are taken in 4\u2011week treatment cycles. NINLARO\nis taken once a week (on the same day of the week) for the first 3\u00a0weeks\nof this cycle. The recommended dose is one 4\u00a0mg capsule taken by mouth.</span></p>", "ID": "3d4d621c-2018-49ae-9f8e-a3fd9c1abebc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO,\nlenalidomide and dexamethasone are taken in 4\u2011week treatment cycles. NINLARO\nis taken once a week (on the same day of the week) for the first 3\u00a0weeks\nof this cycle. The recommended dose is one 4\u00a0mg capsule taken by mouth.</span>", "ID": "5d7a2e6c-d04f-4578-b14b-5f68d7c76b5f", "Styles": "None", "Classes": "None", "Text": "NINLARO, lenalidomide and dexamethasone are taken in 4\u2011week treatment cycles. NINLARO is taken once a week (on the same day of the week) for the first 3\u00a0weeks of this cycle. The recommended dose is one 4\u00a0mg capsule taken by mouth.", "ParentId": "3d4d621c-2018-49ae-9f8e-a3fd9c1abebc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c58b0650-5e25-4bfe-a7fe-582ace05d519", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8c2c9163-f999-4b94-af60-644115718262", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c58b0650-5e25-4bfe-a7fe-582ace05d519"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">The recommended dose of lenalidomide is 25\u00a0mg taken every day\nfor the first 3\u00a0weeks of the cycle. The recommended dose of dexamethasone\nis 40\u00a0mg taken once a week on the same day for all 4\u00a0weeks of the\ncycle. </span></p>", "ID": "14f87a1c-f3da-4abd-8e27-fe1d978c3a9b", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">The recommended dose of lenalidomide is 25\u00a0mg taken every day\nfor the first 3\u00a0weeks of the cycle. The recommended dose of dexamethasone\nis 40\u00a0mg taken once a week on the same day for all 4\u00a0weeks of the\ncycle. </span>", "ID": "e71df6c6-f1a3-4ef3-95d7-ee20aacfb297", "Styles": "None", "Classes": "None", "Text": "The recommended dose of lenalidomide is 25\u00a0mg taken every day for the first 3\u00a0weeks of the cycle. The recommended dose of dexamethasone is 40\u00a0mg taken once a week on the same day for all 4\u00a0weeks of the cycle. ", "ParentId": "14f87a1c-f3da-4abd-8e27-fe1d978c3a9b"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "f7a2efcf-6418-423e-82dd-d33b3d681b50", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "7e0931f1-f3ab-47b2-a699-3cebb4b5cd95", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "f7a2efcf-6418-423e-82dd-d33b3d681b50"}, {"Element": "<table align=\"left\" border=\"1\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"border-collapse:collapse;border:none;margin-left:6.75pt;margin-right:\n 6.75pt\">\n<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Dosing schedule: NINLARO taken with lenalidomide\n  and dexamethasone</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:.5in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Take medicine</span></p>\n</td>\n</tr>\n<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:92.3pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 1</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 2</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 3</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.35pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 4</span></b></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 1</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">2 to 7</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 8</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">9 to 14</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 15</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">16 to 21</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 22</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days 23 to 28</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">NINLARO</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Lenalidomide</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Dexamethasone</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n</table>", "ID": "e1eff435-f71e-4f64-8eee-0d74b2527062", "Styles": "border-collapse:collapse;border:none;margin-left:6.75pt;margin-right:\n 6.75pt", "Classes": "['MsoNormalTable']", "Text": "        ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Dosing schedule: NINLARO taken with lenalidomide\n  and dexamethasone</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:.5in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Take medicine</span></p>\n</td>\n</tr>", "ID": "09a88362-86fe-4a4a-b5d9-b5d70033a7d3", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e1eff435-f71e-4f64-8eee-0d74b2527062"}, {"Element": "<td colspan=\"9\" style=\"width:466.1pt;border:none;\n  border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Dosing schedule: NINLARO taken with lenalidomide\n  and dexamethasone</span></b></p>\n<p class=\"MsoNormal\" style=\"margin-left:.5in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Take medicine</span></p>\n</td>", "ID": "6ff3ac41-1e18-46fc-abf7-fd8358d45d31", "Styles": "width:466.1pt;border:none;\n  border-bottom:solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "09a88362-86fe-4a4a-b5d9-b5d70033a7d3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;\n  text-autospace:none\"><b><span lang=\"EN-GB\">Dosing schedule: NINLARO taken with lenalidomide\n  and dexamethasone</span></b></p>", "ID": "10b91c8b-7d16-48fd-926b-a174b0858d18", "Styles": "line-height:normal;page-break-after:avoid;\n  text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ff3ac41-1e18-46fc-abf7-fd8358d45d31"}, {"Element": "<b><span lang=\"EN-GB\">Dosing schedule: NINLARO taken with lenalidomide\n  and dexamethasone</span></b>", "ID": "66d871f5-a054-4c8b-879f-0753dd553759", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "10b91c8b-7d16-48fd-926b-a174b0858d18"}, {"Element": "<span lang=\"EN-GB\">Dosing schedule: NINLARO taken with lenalidomide\n  and dexamethasone</span>", "ID": "7d7d17a1-b402-4855-ba50-d061a80d48ed", "Styles": "None", "Classes": "None", "Text": "Dosing schedule: NINLARO taken with lenalidomide   and dexamethasone", "ParentId": "66d871f5-a054-4c8b-879f-0753dd553759"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:.5in;line-height:normal;page-break-after:\n  avoid;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Take medicine</span></p>", "ID": "840b40ae-898c-4863-bbed-19399ce6b2b2", "Styles": "margin-left:.5in;line-height:normal;page-break-after:\n  avoid;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6ff3ac41-1e18-46fc-abf7-fd8358d45d31"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "2cf6592e-92f5-4e66-8164-f457ff2b6a6c", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "840b40ae-898c-4863-bbed-19399ce6b2b2"}, {"Element": "<span lang=\"EN-GB\">Take medicine</span>", "ID": "139695b5-4e55-423e-b737-a8e00689e7f8", "Styles": "None", "Classes": "None", "Text": "Take medicine", "ParentId": "840b40ae-898c-4863-bbed-19399ce6b2b2"}, {"Element": "<tr>\n<td colspan=\"9\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b></p>\n</td>\n</tr>", "ID": "653ec199-83d2-4d02-a738-0b298a47e4c8", "Styles": "None", "Classes": "None", "Text": "  ", "ParentId": "e1eff435-f71e-4f64-8eee-0d74b2527062"}, {"Element": "<td colspan=\"9\" style=\"width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"621\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b></p>\n</td>", "ID": "5bd04adc-442e-4afc-b993-1634942e68cc", "Styles": "width:466.1pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "653ec199-83d2-4d02-a738-0b298a47e4c8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b></p>", "ID": "aa8efeee-491d-4f41-a034-17da4c1e165e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5bd04adc-442e-4afc-b993-1634942e68cc"}, {"Element": "<b><span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span></b>", "ID": "d04c0e6e-d575-4403-ab0c-41dff7a04a51", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "aa8efeee-491d-4f41-a034-17da4c1e165e"}, {"Element": "<span lang=\"EN-GB\">28\u2011day cycle (a 4\u2011week cycle)</span>", "ID": "34fba794-4a24-43e6-8332-a856cc41b20a", "Styles": "None", "Classes": "None", "Text": "28\u2011day cycle (a 4\u2011week cycle)", "ParentId": "d04c0e6e-d575-4403-ab0c-41dff7a04a51"}, {"Element": "<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td colspan=\"2\" style=\"width:92.3pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 1</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 2</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 3</span></b></p>\n</td>\n<td colspan=\"2\" style=\"width:92.35pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 4</span></b></p>\n</td>\n</tr>", "ID": "5d44e0a6-d69f-46e8-ac7e-545cf97aec2a", "Styles": "None", "Classes": "None", "Text": "      ", "ParentId": "e1eff435-f71e-4f64-8eee-0d74b2527062"}, {"Element": "<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "78d5b8fa-6ea3-48ae-ad71-6e8942b0e6b3", "Styles": "width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5d44e0a6-d69f-46e8-ac7e-545cf97aec2a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3ec7d9ca-b8f6-4afd-815a-8884c27fa4d4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "78d5b8fa-6ea3-48ae-ad71-6e8942b0e6b3"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "210b29f7-4ce5-4500-9ea5-52d9ac4f5f81", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3ec7d9ca-b8f6-4afd-815a-8884c27fa4d4"}, {"Element": "<td colspan=\"2\" style=\"width:92.3pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 1</span></b></p>\n</td>", "ID": "0038e8dd-534c-4871-98cd-46b2bc1f41b3", "Styles": "width:92.3pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5d44e0a6-d69f-46e8-ac7e-545cf97aec2a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 1</span></b></p>", "ID": "102faadc-a1db-4667-9b74-d9f482923e6d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0038e8dd-534c-4871-98cd-46b2bc1f41b3"}, {"Element": "<b><span lang=\"EN-GB\">Week 1</span></b>", "ID": "bc47de1c-b84f-4731-99d3-8dc2dfa077f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "102faadc-a1db-4667-9b74-d9f482923e6d"}, {"Element": "<span lang=\"EN-GB\">Week 1</span>", "ID": "fb771843-0c08-4bdb-b670-1010bfee6228", "Styles": "None", "Classes": "None", "Text": "Week 1", "ParentId": "bc47de1c-b84f-4731-99d3-8dc2dfa077f8"}, {"Element": "<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 2</span></b></p>\n</td>", "ID": "db55827a-5cda-4ce3-a2c8-4a99be4f8a8a", "Styles": "width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5d44e0a6-d69f-46e8-ac7e-545cf97aec2a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 2</span></b></p>", "ID": "43da4d65-16db-4f5a-96f3-8a31a3579570", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "db55827a-5cda-4ce3-a2c8-4a99be4f8a8a"}, {"Element": "<b><span lang=\"EN-GB\">Week 2</span></b>", "ID": "9dc5c38e-9935-42e0-a5b7-419490e73163", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "43da4d65-16db-4f5a-96f3-8a31a3579570"}, {"Element": "<span lang=\"EN-GB\">Week 2</span>", "ID": "5b297af5-6f52-4ad6-bcca-82636791aab6", "Styles": "None", "Classes": "None", "Text": "Week 2", "ParentId": "9dc5c38e-9935-42e0-a5b7-419490e73163"}, {"Element": "<td colspan=\"2\" style=\"width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 3</span></b></p>\n</td>", "ID": "85a688bb-1052-4a8f-9dc8-8db163188300", "Styles": "width:92.4pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5d44e0a6-d69f-46e8-ac7e-545cf97aec2a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 3</span></b></p>", "ID": "fe91cde8-084f-49d1-813b-a827fe64d84e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "85a688bb-1052-4a8f-9dc8-8db163188300"}, {"Element": "<b><span lang=\"EN-GB\">Week 3</span></b>", "ID": "168b6206-efb7-43ca-9005-313af53df00e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fe91cde8-084f-49d1-813b-a827fe64d84e"}, {"Element": "<span lang=\"EN-GB\">Week 3</span>", "ID": "52f67b3d-fdaa-4739-b6c6-a203cbb5f42e", "Styles": "None", "Classes": "None", "Text": "Week 3", "ParentId": "168b6206-efb7-43ca-9005-313af53df00e"}, {"Element": "<td colspan=\"2\" style=\"width:92.35pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"123\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 4</span></b></p>\n</td>", "ID": "c29f6c31-bb7e-4214-941c-4ec0bc33a69c", "Styles": "width:92.35pt;border-top:none;\n  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "5d44e0a6-d69f-46e8-ac7e-545cf97aec2a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Week 4</span></b></p>", "ID": "c06850d4-fa9f-4d2a-b9fb-42c700aaf94e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c29f6c31-bb7e-4214-941c-4ec0bc33a69c"}, {"Element": "<b><span lang=\"EN-GB\">Week 4</span></b>", "ID": "f0a9867c-6de9-456e-936f-985b63ea2544", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c06850d4-fa9f-4d2a-b9fb-42c700aaf94e"}, {"Element": "<span lang=\"EN-GB\">Week 4</span>", "ID": "bff191ec-d802-40eb-bed6-5131971435a3", "Styles": "None", "Classes": "None", "Text": "Week 4", "ParentId": "f0a9867c-6de9-456e-936f-985b63ea2544"}, {"Element": "<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 1</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">2 to 7</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 8</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">9 to 14</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 15</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">16 to 21</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 22</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days 23 to 28</span></p>\n</td>\n</tr>", "ID": "47ae3dd9-4e67-4d89-a646-3a847eea04e5", "Styles": "None", "Classes": "None", "Text": "          ", "ParentId": "e1eff435-f71e-4f64-8eee-0d74b2527062"}, {"Element": "<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "ffcb8c56-4592-45ab-bc7c-21a3a478ca2c", "Styles": "width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47ae3dd9-4e67-4d89-a646-3a847eea04e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c174d2cd-3bd4-4f2f-9070-44f33a9b8fef", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ffcb8c56-4592-45ab-bc7c-21a3a478ca2c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "99aeba56-60a9-4d60-929c-9c4449eb0f94", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c174d2cd-3bd4-4f2f-9070-44f33a9b8fef"}, {"Element": "<td style=\"width:40.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 1</span></p>\n</td>", "ID": "7b4c3a24-7b14-4e0e-8b2f-6264cce55f74", "Styles": "width:40.35pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47ae3dd9-4e67-4d89-a646-3a847eea04e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 1</span></p>", "ID": "c17eae06-095f-494c-a774-505cb900d064", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7b4c3a24-7b14-4e0e-8b2f-6264cce55f74"}, {"Element": "<span lang=\"EN-GB\">Day 1</span>", "ID": "d8fe34fb-654b-4888-b579-44d3536502cd", "Styles": "None", "Classes": "None", "Text": "Day 1", "ParentId": "c17eae06-095f-494c-a774-505cb900d064"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">2 to 7</span></p>\n</td>", "ID": "a7899273-c8c8-48e0-88d9-6df85e6ff23f", "Styles": "width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "47ae3dd9-4e67-4d89-a646-3a847eea04e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>", "ID": "071592c2-6389-4b69-83a9-132516321f04", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a7899273-c8c8-48e0-88d9-6df85e6ff23f"}, {"Element": "<span lang=\"EN-GB\">Days </span>", "ID": "8d083e58-78e3-4247-b6e7-f230715a3597", "Styles": "None", "Classes": "None", "Text": "Days ", "ParentId": "071592c2-6389-4b69-83a9-132516321f04"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">2 to 7</span></p>", "ID": "861fe9e8-89f6-4017-8b3b-e44f80421452", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a7899273-c8c8-48e0-88d9-6df85e6ff23f"}, {"Element": "<span lang=\"EN-GB\">2 to 7</span>", "ID": "2dd7b16b-11e5-4786-bb9e-8f93079912a7", "Styles": "None", "Classes": "None", "Text": "2 to 7", "ParentId": "861fe9e8-89f6-4017-8b3b-e44f80421452"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 8</span></p>\n</td>", "ID": "89ce1db9-b66a-41e2-81c0-d97685df3695", "Styles": "width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47ae3dd9-4e67-4d89-a646-3a847eea04e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 8</span></p>", "ID": "c4fe7d97-9838-45ca-9694-42fbf5746732", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "89ce1db9-b66a-41e2-81c0-d97685df3695"}, {"Element": "<span lang=\"EN-GB\">Day 8</span>", "ID": "021055ee-8712-4205-a1f2-542799fa6737", "Styles": "None", "Classes": "None", "Text": "Day 8", "ParentId": "c4fe7d97-9838-45ca-9694-42fbf5746732"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">9 to 14</span></p>\n</td>", "ID": "533ab58b-c3bf-4d3a-bbf2-e7e45b777766", "Styles": "width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "47ae3dd9-4e67-4d89-a646-3a847eea04e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>", "ID": "34dc79c5-0572-4211-a704-1d8370cd8f1d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "533ab58b-c3bf-4d3a-bbf2-e7e45b777766"}, {"Element": "<span lang=\"EN-GB\">Days </span>", "ID": "68e10e47-c0c1-44ad-b09a-907198426fbd", "Styles": "None", "Classes": "None", "Text": "Days ", "ParentId": "34dc79c5-0572-4211-a704-1d8370cd8f1d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">9 to 14</span></p>", "ID": "6ac89edc-a914-4838-8893-460075ff489f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "533ab58b-c3bf-4d3a-bbf2-e7e45b777766"}, {"Element": "<span lang=\"EN-GB\">9 to 14</span>", "ID": "92f7817e-528c-440a-95d6-21ca02e872df", "Styles": "None", "Classes": "None", "Text": "9 to 14", "ParentId": "6ac89edc-a914-4838-8893-460075ff489f"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 15</span></p>\n</td>", "ID": "a2b1ce3a-b17e-476c-991e-792658e2127f", "Styles": "width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47ae3dd9-4e67-4d89-a646-3a847eea04e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 15</span></p>", "ID": "24e4bf00-42de-4040-a30b-fc6b0dc0c460", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "a2b1ce3a-b17e-476c-991e-792658e2127f"}, {"Element": "<span lang=\"EN-GB\">Day 15</span>", "ID": "253dd92d-ac99-4380-8330-97cf9a99b3b0", "Styles": "None", "Classes": "None", "Text": "Day 15", "ParentId": "24e4bf00-42de-4040-a30b-fc6b0dc0c460"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">16 to 21</span></p>\n</td>", "ID": "3a058afe-0f65-443b-ad4e-6c245b1ba950", "Styles": "width:51.95pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "   ", "ParentId": "47ae3dd9-4e67-4d89-a646-3a847eea04e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days </span></p>", "ID": "a670118d-3a4a-4a40-9c33-ed288f8ffd8c", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a058afe-0f65-443b-ad4e-6c245b1ba950"}, {"Element": "<span lang=\"EN-GB\">Days </span>", "ID": "654e466f-ee15-4222-9f84-ba9197eb107a", "Styles": "None", "Classes": "None", "Text": "Days ", "ParentId": "a670118d-3a4a-4a40-9c33-ed288f8ffd8c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">16 to 21</span></p>", "ID": "0dbdd820-05f4-4fd5-bf8d-321f49c5f10d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3a058afe-0f65-443b-ad4e-6c245b1ba950"}, {"Element": "<span lang=\"EN-GB\">16 to 21</span>", "ID": "528f7db2-95ce-4bfd-928d-ca136aa16aa5", "Styles": "None", "Classes": "None", "Text": "16 to 21", "ParentId": "0dbdd820-05f4-4fd5-bf8d-321f49c5f10d"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 22</span></p>\n</td>", "ID": "09006d9b-8265-43b7-8326-8cc6925cac2a", "Styles": "width:40.45pt;border-top:none;border-left:\n  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47ae3dd9-4e67-4d89-a646-3a847eea04e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Day 22</span></p>", "ID": "22fc4f95-887c-46ea-943e-2af0a1a54df0", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "09006d9b-8265-43b7-8326-8cc6925cac2a"}, {"Element": "<span lang=\"EN-GB\">Day 22</span>", "ID": "b3f018be-c233-4c27-accd-ff4795db9849", "Styles": "None", "Classes": "None", "Text": "Day 22", "ParentId": "22fc4f95-887c-46ea-943e-2af0a1a54df0"}, {"Element": "<td style=\"width:51.9pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days 23 to 28</span></p>\n</td>", "ID": "7073be77-483c-4bad-b888-71ada0d114bd", "Styles": "width:51.9pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "47ae3dd9-4e67-4d89-a646-3a847eea04e5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Days 23 to 28</span></p>", "ID": "e4e709d9-7e57-483b-aafb-e03356937c99", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7073be77-483c-4bad-b888-71ada0d114bd"}, {"Element": "<span lang=\"EN-GB\">Days 23 to 28</span>", "ID": "575bb0c7-4a00-4628-9ef2-1bf91f7c5616", "Styles": "None", "Classes": "None", "Text": "Days 23 to 28", "ParentId": "e4e709d9-7e57-483b-aafb-e03356937c99"}, {"Element": "<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">NINLARO</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "c0435f36-3279-4a7d-a14f-ae333ae52259", "Styles": "None", "Classes": "None", "Text": "          ", "ParentId": "e1eff435-f71e-4f64-8eee-0d74b2527062"}, {"Element": "<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">NINLARO</span></p>\n</td>", "ID": "773b1eec-4069-40fc-918b-3a940809c9b8", "Styles": "width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c0435f36-3279-4a7d-a14f-ae333ae52259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">NINLARO</span></p>", "ID": "ebe9516e-3202-4059-b63d-3cc5807cc7d4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "773b1eec-4069-40fc-918b-3a940809c9b8"}, {"Element": "<span lang=\"EN-GB\">NINLARO</span>", "ID": "75a11608-1723-4208-b765-c597b61fbac7", "Styles": "None", "Classes": "None", "Text": "NINLARO", "ParentId": "ebe9516e-3202-4059-b63d-3cc5807cc7d4"}, {"Element": "<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "fcac5e4f-23ae-4842-af9c-94fab73d5d55", "Styles": "width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c0435f36-3279-4a7d-a14f-ae333ae52259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "523f3ae1-f9f4-4790-b676-8228c86532e5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fcac5e4f-23ae-4842-af9c-94fab73d5d55"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "760b31f8-f2af-402a-86a7-cd1e0e8832f7", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "523f3ae1-f9f4-4790-b676-8228c86532e5"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "0c590ee4-a3d7-4d28-985a-c8fe016ec96b", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c0435f36-3279-4a7d-a14f-ae333ae52259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c1100a1f-5b19-4361-9390-c0401b90e10a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0c590ee4-a3d7-4d28-985a-c8fe016ec96b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e62bfb06-3669-40e9-a351-cc9f5166e62b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c1100a1f-5b19-4361-9390-c0401b90e10a"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "05995337-5a8f-45e6-b34b-26850fc94ea8", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c0435f36-3279-4a7d-a14f-ae333ae52259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "0099d2f3-e440-443a-a09c-aad54bd25c81", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "05995337-5a8f-45e6-b34b-26850fc94ea8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "b75b9be7-71a2-41e9-aa13-671dd2509582", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "0099d2f3-e440-443a-a09c-aad54bd25c81"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "2e37e502-34d7-49e7-97a2-d6e32adfca86", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c0435f36-3279-4a7d-a14f-ae333ae52259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5343a140-45a0-42d6-84eb-5df87373da87", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "2e37e502-34d7-49e7-97a2-d6e32adfca86"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d7bcacca-ec48-4b00-9de3-9e13c0cd9a59", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5343a140-45a0-42d6-84eb-5df87373da87"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "06fe831d-1ea9-4cc5-a81d-6e282a4b4fe7", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c0435f36-3279-4a7d-a14f-ae333ae52259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "33bd3d45-9593-4c68-b3e0-6e1d133d76f2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "06fe831d-1ea9-4cc5-a81d-6e282a4b4fe7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "f3cce722-185e-4c4f-aa6f-a91f140a83f5", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "33bd3d45-9593-4c68-b3e0-6e1d133d76f2"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "5276f264-1d06-4a38-9460-fefc0a3ff291", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c0435f36-3279-4a7d-a14f-ae333ae52259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "1a67fab7-83a8-43af-8e50-53d8b3d4e996", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5276f264-1d06-4a38-9460-fefc0a3ff291"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "deee909f-c7ed-4e1d-930c-08b1481040ca", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1a67fab7-83a8-43af-8e50-53d8b3d4e996"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "c6006022-3721-4bb7-b561-bce41689c45e", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c0435f36-3279-4a7d-a14f-ae333ae52259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "67860227-c102-4c5d-986b-c2e85c7819d5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c6006022-3721-4bb7-b561-bce41689c45e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "47962f43-6815-43c3-b5cb-4a773f5a92af", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "67860227-c102-4c5d-986b-c2e85c7819d5"}, {"Element": "<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "c466482a-901c-403c-ae74-a7d518145aec", "Styles": "width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c0435f36-3279-4a7d-a14f-ae333ae52259"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "42fa57c9-5e04-4f44-aefd-98deef1a6228", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "c466482a-901c-403c-ae74-a7d518145aec"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "76b0d109-3e35-45dd-a3b0-e0c383771a16", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "42fa57c9-5e04-4f44-aefd-98deef1a6228"}, {"Element": "<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Lenalidomide</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "b2c5fafb-f11c-4145-a0f3-2e195cbb471f", "Styles": "None", "Classes": "None", "Text": "          ", "ParentId": "e1eff435-f71e-4f64-8eee-0d74b2527062"}, {"Element": "<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Lenalidomide</span></p>\n</td>", "ID": "3feef81f-2fe7-4e6b-a028-a23cc1bb6bd4", "Styles": "width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b2c5fafb-f11c-4145-a0f3-2e195cbb471f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Lenalidomide</span></p>", "ID": "cbbf9c14-1db5-4910-b82d-85fa6bd330fb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3feef81f-2fe7-4e6b-a028-a23cc1bb6bd4"}, {"Element": "<span lang=\"EN-GB\">Lenalidomide</span>", "ID": "afbeeb12-3f86-45b1-81d2-4da6793c4f60", "Styles": "None", "Classes": "None", "Text": "Lenalidomide", "ParentId": "cbbf9c14-1db5-4910-b82d-85fa6bd330fb"}, {"Element": "<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "ccfe4c22-c058-40a4-9581-493ce0425466", "Styles": "width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b2c5fafb-f11c-4145-a0f3-2e195cbb471f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "ac4b3092-384f-4b79-9240-005811b3c69a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ccfe4c22-c058-40a4-9581-493ce0425466"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "e69f4fe8-b4b0-43df-aca7-44a491b5d551", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "ac4b3092-384f-4b79-9240-005811b3c69a"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>", "ID": "623c1a11-c19e-4327-9829-d908fc39ab09", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b2c5fafb-f11c-4145-a0f3-2e195cbb471f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>", "ID": "368206dd-428f-4a1a-87e4-09fe4a99deef", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "623c1a11-c19e-4327-9829-d908fc39ab09"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "abceabf7-a58e-40c7-8d6f-8b791d81f471", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "368206dd-428f-4a1a-87e4-09fe4a99deef"}, {"Element": "<span lang=\"EN-GB\">Daily</span>", "ID": "a6c5a811-c852-4b55-9455-79e70ce3494b", "Styles": "None", "Classes": "None", "Text": "Daily", "ParentId": "368206dd-428f-4a1a-87e4-09fe4a99deef"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "f7272ccc-0385-400b-a72c-31410fde00fb", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b2c5fafb-f11c-4145-a0f3-2e195cbb471f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "eacf8cce-944b-4a52-a505-2be683338ada", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f7272ccc-0385-400b-a72c-31410fde00fb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "b933517c-cb99-4b11-802d-69a6122c8e8d", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "eacf8cce-944b-4a52-a505-2be683338ada"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>", "ID": "e5513f5c-9887-49ce-9c2d-9a563c145d67", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b2c5fafb-f11c-4145-a0f3-2e195cbb471f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>", "ID": "f1d3e747-3528-4de9-a3c9-c78e373ec0c2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e5513f5c-9887-49ce-9c2d-9a563c145d67"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "031ee3f5-a158-41ee-baaf-75dbe15de4d3", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "f1d3e747-3528-4de9-a3c9-c78e373ec0c2"}, {"Element": "<span lang=\"EN-GB\">Daily</span>", "ID": "bb84c9ac-c7ec-4d5d-a46c-f16a79364ddb", "Styles": "None", "Classes": "None", "Text": "Daily", "ParentId": "f1d3e747-3528-4de9-a3c9-c78e373ec0c2"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "603fac3b-d303-4828-9690-5e9b32908ec6", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b2c5fafb-f11c-4145-a0f3-2e195cbb471f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "52bafaa4-b691-4aa4-83dd-750cfc8653c5", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "603fac3b-d303-4828-9690-5e9b32908ec6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "25829931-9a2d-43a7-850c-cb383a095f99", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "52bafaa4-b691-4aa4-83dd-750cfc8653c5"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>\n</td>", "ID": "766c1054-df86-408d-8938-c4283c521ccb", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b2c5fafb-f11c-4145-a0f3-2e195cbb471f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span><span lang=\"EN-GB\">Daily</span></p>", "ID": "3f6eb6a0-abe2-4ea7-a03f-77ca1186dddb", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "766c1054-df86-408d-8938-c4283c521ccb"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "5652ed30-f28a-48ba-b54b-68cfbea24b90", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "3f6eb6a0-abe2-4ea7-a03f-77ca1186dddb"}, {"Element": "<span lang=\"EN-GB\">Daily</span>", "ID": "4888fa91-ca42-4312-8806-d4d98fa39066", "Styles": "None", "Classes": "None", "Text": "Daily", "ParentId": "3f6eb6a0-abe2-4ea7-a03f-77ca1186dddb"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "8e5e252e-f297-4109-9ea8-f2978584f7e2", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b2c5fafb-f11c-4145-a0f3-2e195cbb471f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a473fb51-f834-4c7d-bbe9-63b18b5d15d1", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8e5e252e-f297-4109-9ea8-f2978584f7e2"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e90c5578-6258-40f7-8112-616182080eb8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a473fb51-f834-4c7d-bbe9-63b18b5d15d1"}, {"Element": "<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "d21ad50d-9e94-404b-abd6-64515d3fff11", "Styles": "width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "b2c5fafb-f11c-4145-a0f3-2e195cbb471f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c2c251e7-40a0-4b02-ad47-c4ea8344034e", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d21ad50d-9e94-404b-abd6-64515d3fff11"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "629a4cb0-a565-4182-b451-14b924d6cec1", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c2c251e7-40a0-4b02-ad47-c4ea8344034e"}, {"Element": "<tr>\n<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Dexamethasone</span></p>\n</td>\n<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>\n<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "c777433c-d37b-490b-b86c-48264fcde0b9", "Styles": "None", "Classes": "None", "Text": "          ", "ParentId": "e1eff435-f71e-4f64-8eee-0d74b2527062"}, {"Element": "<td style=\"width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"129\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Dexamethasone</span></p>\n</td>", "ID": "b2ae4666-0fe9-458b-8b7d-eb3c3a3983af", "Styles": "width:96.65pt;border:solid windowtext 1.0pt;\n  border-top:none;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c777433c-d37b-490b-b86c-48264fcde0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">Dexamethasone</span></p>", "ID": "b981b641-927b-4158-a7b9-5acf6f0d643f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b2ae4666-0fe9-458b-8b7d-eb3c3a3983af"}, {"Element": "<span lang=\"EN-GB\">Dexamethasone</span>", "ID": "bc60c0f3-b562-4742-af4a-dc6ada8fef77", "Styles": "None", "Classes": "None", "Text": "Dexamethasone", "ParentId": "b981b641-927b-4158-a7b9-5acf6f0d643f"}, {"Element": "<td style=\"width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "fe9439f6-4b3e-41e3-8a29-3c74979fefc0", "Styles": "width:40.35pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c777433c-d37b-490b-b86c-48264fcde0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "37350db0-ee47-41e3-99c1-cf71a32d0d21", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fe9439f6-4b3e-41e3-8a29-3c74979fefc0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "c2ad2a4e-c7ec-4f98-b0ed-0ffbe7bc044e", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "37350db0-ee47-41e3-99c1-cf71a32d0d21"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "35391b26-b9d2-4806-84e2-49e2b1ffadd5", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c777433c-d37b-490b-b86c-48264fcde0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "34e9f89f-4f63-4579-9275-4c9d6b6def2a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "35391b26-b9d2-4806-84e2-49e2b1ffadd5"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ed66830f-cb3c-4b27-951f-aa64be37a747", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "34e9f89f-4f63-4579-9275-4c9d6b6def2a"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "4f822b5d-d84e-4342-b48b-e7253d5b48ac", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c777433c-d37b-490b-b86c-48264fcde0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "ce5654d9-13bc-4b20-a5f1-09ee81f03b3d", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4f822b5d-d84e-4342-b48b-e7253d5b48ac"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "e7220e3c-883e-46fb-a11a-5d17f7b4d120", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "ce5654d9-13bc-4b20-a5f1-09ee81f03b3d"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "d663a859-7935-4bae-801a-ace79734ea9e", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c777433c-d37b-490b-b86c-48264fcde0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4627bee0-e807-4aa7-8c43-f4820b370d01", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d663a859-7935-4bae-801a-ace79734ea9e"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "13f8f039-67c8-4abb-aefb-ce968860bd4e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4627bee0-e807-4aa7-8c43-f4820b370d01"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "490c17a2-04be-45b5-9a29-4ff061a0e2fa", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c777433c-d37b-490b-b86c-48264fcde0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "c733ffab-fca2-4fba-8dd5-16555176ccbe", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "490c17a2-04be-45b5-9a29-4ff061a0e2fa"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "f9883381-d17c-47a7-86b6-1357487d2b0f", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "c733ffab-fca2-4fba-8dd5-16555176ccbe"}, {"Element": "<td style=\"width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "5b3edec0-5aea-4548-8b6e-82b2a67fddf4", "Styles": "width:51.95pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  background:#BFBFBF;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c777433c-d37b-490b-b86c-48264fcde0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5ae3d6dc-1c5f-4b2a-8c1b-4033863b0c97", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5b3edec0-5aea-4548-8b6e-82b2a67fddf4"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "01cbdb72-2620-4613-8a77-8d9a203185d8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5ae3d6dc-1c5f-4b2a-8c1b-4033863b0c97"}, {"Element": "<td style=\"width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"54\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>\n</td>", "ID": "d8391404-e89e-4d6e-a1fb-b1b05b746f77", "Styles": "width:40.45pt;border-top:none;border-left:none;\n  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c777433c-d37b-490b-b86c-48264fcde0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span></p>", "ID": "2d699e77-7bc4-4cf7-a990-9730dfe49180", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d8391404-e89e-4d6e-a1fb-b1b05b746f77"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Webdings\">a</span>", "ID": "188dc919-23b4-49f4-a334-72c1e61f5a8c", "Styles": "font-family:Webdings", "Classes": "None", "Text": "a", "ParentId": "2d699e77-7bc4-4cf7-a990-9730dfe49180"}, {"Element": "<td style=\"width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt\" width=\"69\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "3e2bd29c-06de-498e-85ba-19a2575a7778", "Styles": "width:51.9pt;border-top:none;border-left:none;border-bottom:\n  solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;background:#BFBFBF;\n  padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "  ", "ParentId": "c777433c-d37b-490b-b86c-48264fcde0b9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "9429aa47-8c27-44c3-a52e-8902f87c50d2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3e2bd29c-06de-498e-85ba-19a2575a7778"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fb00b740-f99e-4ddd-9a1c-0a85bbdbf097", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "9429aa47-8c27-44c3-a52e-8902f87c50d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "bef8ce59-a484-4816-8ccb-928b93449ad4", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1c072aa6-e837-411a-a49f-83c707a6beb2", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "bef8ce59-a484-4816-8ccb-928b93449ad4"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">You\nshould read the Package Leaflets of these other medicines for further\ninformation on their use and effects. </span></p>", "ID": "1d74e35c-b60f-423b-aaba-4b788a9b7040", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">You\nshould read the Package Leaflets of these other medicines for further\ninformation on their use and effects. </span>", "ID": "452d0772-080d-405e-a195-b4f6b8ac97b1", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "You should read the Package Leaflets of these other medicines for further information on their use and effects. ", "ParentId": "1d74e35c-b60f-423b-aaba-4b788a9b7040"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "dfebb758-5e18-4899-81ad-0a9022da84e3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "22a5f155-aba8-43a4-94ad-94bd5e853737", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "dfebb758-5e18-4899-81ad-0a9022da84e3"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If\nyou have liver or kidney problems, your doctor may prescribe NINLARO capsules\ncontaining 3\u00a0mg. If you have side effects, your doctor may prescribe\nNINLARO capsules containing 3\u00a0mg or 2.3\u00a0mg. The doctor may also\nadjust the doses of the other medicines.</span></p>", "ID": "b5d8d543-7e95-4dda-886f-9c110ace8bc5", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If\nyou have liver or kidney problems, your doctor may prescribe NINLARO capsules\ncontaining 3\u00a0mg. If you have side effects, your doctor may prescribe\nNINLARO capsules containing 3\u00a0mg or 2.3\u00a0mg. The doctor may also\nadjust the doses of the other medicines.</span>", "ID": "51d78091-7172-4ff4-a57c-cdc7f4926b1b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "If you have liver or kidney problems, your doctor may prescribe NINLARO capsules containing 3\u00a0mg. If you have side effects, your doctor may prescribe NINLARO capsules containing 3\u00a0mg or 2.3\u00a0mg. The doctor may also adjust the doses of the other medicines.", "ParentId": "b5d8d543-7e95-4dda-886f-9c110ace8bc5"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "f3c40654-9144-4314-8d0f-009083dff626", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "ce4518f9-bf64-45c5-9c5a-d2bc6bbdda54", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "f3c40654-9144-4314-8d0f-009083dff626"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">How and when to take NINLARO </span></b></p>", "ID": "0e90737b-2306-4e51-be18-211baafddb12", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">How and when to take NINLARO </span></b>", "ID": "0691efb1-263a-4a00-a01d-4a1fc493ae9b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0e90737b-2306-4e51-be18-211baafddb12"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">How and when to take NINLARO </span>", "ID": "40370f8d-8333-4a85-9c05-f1111cb96024", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "How and when to take NINLARO ", "ParentId": "0691efb1-263a-4a00-a01d-4a1fc493ae9b"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Take NINLARO at least one hour before or at\nleast two hours after food. </span></p>", "ID": "81cb1337-bb60-415c-9f37-5bc6fc24a85a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "4726dee1-29b4-41df-b203-98a100794049", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "81cb1337-bb60-415c-9f37-5bc6fc24a85a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "dafbf81e-d740-4cf2-a244-526aadad5129", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "4726dee1-29b4-41df-b203-98a100794049"}, {"Element": "<span lang=\"EN-GB\">Take NINLARO at least one hour before or at\nleast two hours after food. </span>", "ID": "6567ed59-362d-46a8-95fa-c5302d871248", "Styles": "None", "Classes": "None", "Text": "Take NINLARO at least one hour before or at least two hours after food. ", "ParentId": "81cb1337-bb60-415c-9f37-5bc6fc24a85a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Swallow the capsule whole with water. Do not crush,\nchew or open the capsule. </span></p>", "ID": "9666bc34-f226-414b-ba07-d549e25e3b27", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "da2235fc-3d72-40d4-9145-58cb881a3b71", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "9666bc34-f226-414b-ba07-d549e25e3b27"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8f447c26-80e3-4529-ba35-1b2870dd11b1", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "da2235fc-3d72-40d4-9145-58cb881a3b71"}, {"Element": "<span lang=\"EN-GB\">Swallow the capsule whole with water. Do not crush,\nchew or open the capsule. </span>", "ID": "916bd640-545d-430f-8e87-c3bf6e767a5e", "Styles": "None", "Classes": "None", "Text": "Swallow the capsule whole with water. Do not crush, chew or open the capsule. ", "ParentId": "9666bc34-f226-414b-ba07-d549e25e3b27"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">Do not let the contents of the capsule come into\ncontact with your skin. If the powder accidentally comes into contact with your\nskin, wash it off thoroughly with soap and water. If the capsule breaks, clean\nup the powder, taking care that it does not cause dust in the air. </span></p>", "ID": "908396f9-d321-4ef6-9d66-ebb2b393b4f7", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a5743103-2c50-41af-be1f-932ad41032b5", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "908396f9-d321-4ef6-9d66-ebb2b393b4f7"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "bf430a7a-59aa-4e0a-973e-f89dcb6b0b36", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a5743103-2c50-41af-be1f-932ad41032b5"}, {"Element": "<span lang=\"EN-GB\">Do not let the contents of the capsule come into\ncontact with your skin. If the powder accidentally comes into contact with your\nskin, wash it off thoroughly with soap and water. If the capsule breaks, clean\nup the powder, taking care that it does not cause dust in the air. </span>", "ID": "aa7310a6-b02e-4f9c-9bc3-31a03bf6f5a6", "Styles": "None", "Classes": "None", "Text": "Do not let the contents of the capsule come into contact with your skin. If the powder accidentally comes into contact with your skin, wash it off thoroughly with soap and water. If the capsule breaks, clean up the powder, taking care that it does not cause dust in the air. ", "ParentId": "908396f9-d321-4ef6-9d66-ebb2b393b4f7"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "54b534b2-5cbc-4f73-ac3b-483b952d41ca", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "14fb89fc-9ef4-4a24-900e-8f443a01b0ef", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "54b534b2-5cbc-4f73-ac3b-483b952d41ca"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you take more NINLARO than you\nshould </span></b></p>", "ID": "b0d72ac5-2c76-4513-80c9-2e014d305353", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you take more NINLARO than you\nshould </span></b>", "ID": "1f8f3b1a-a9f0-4e06-b43a-461b6d1ef9c3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b0d72ac5-2c76-4513-80c9-2e014d305353"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you take more NINLARO than you\nshould </span>", "ID": "3f511539-328a-4240-90a0-a9122c4bae60", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "If you take more NINLARO than you should ", "ParentId": "1f8f3b1a-a9f0-4e06-b43a-461b6d1ef9c3"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Accidental overdose\ncan cause serious side effects.</span><span lang=\"EN-GB\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you take more NINLARO\nthan you should, talk to a doctor immediately or go to a hospital straight\naway. Take the medicine pack with you.</span></p>", "ID": "be4e7a8e-14bc-418f-a6bc-b2c34d3d2e64", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Accidental overdose\ncan cause serious side effects.</span>", "ID": "2dadbc92-ecd5-4948-9f3e-3b8105d3d7aa", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Accidental overdose can cause serious side effects.", "ParentId": "be4e7a8e-14bc-418f-a6bc-b2c34d3d2e64"}, {"Element": "<span lang=\"EN-GB\"> </span>", "ID": "a179a8bf-dec7-474c-8e68-b47357169673", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "be4e7a8e-14bc-418f-a6bc-b2c34d3d2e64"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you take more NINLARO\nthan you should, talk to a doctor immediately or go to a hospital straight\naway. Take the medicine pack with you.</span>", "ID": "611f2476-a090-4669-85d3-b80285e6297d", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "If you take more NINLARO than you should, talk to a doctor immediately or go to a hospital straight away. Take the medicine pack with you.", "ParentId": "be4e7a8e-14bc-418f-a6bc-b2c34d3d2e64"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "b9ec9668-2307-422a-bfe5-b46399fc5643", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "5c23267e-efe1-4f06-ac28-c62d75765f1b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "b9ec9668-2307-422a-bfe5-b46399fc5643"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Duration of the treatment with\nNINLARO </span></b></p>", "ID": "7fa7ea5a-da95-4f7c-b214-00b9d8048976", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Duration of the treatment with\nNINLARO </span></b>", "ID": "2ba4157d-cb1f-47fb-a141-03063159d77f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7fa7ea5a-da95-4f7c-b214-00b9d8048976"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Duration of the treatment with\nNINLARO </span>", "ID": "ee908d84-efcd-431e-b002-df143ff2cf90", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Duration of the treatment with NINLARO ", "ParentId": "2ba4157d-cb1f-47fb-a141-03063159d77f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">You should\ncontinue treatment until your doctor tells you to stop. </span></p>", "ID": "dd580eb2-e0c1-4395-8342-cc4c3727d1e9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">You should\ncontinue treatment until your doctor tells you to stop. </span>", "ID": "264f7346-f0e2-4bcc-a16d-5f045cc281cf", "Styles": "None", "Classes": "None", "Text": "You should continue treatment until your doctor tells you to stop. ", "ParentId": "dd580eb2-e0c1-4395-8342-cc4c3727d1e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "85118029-9ad0-48a8-8bb8-8be9d9f2979c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "25137545-fc1d-40b1-b368-2db72928201c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "85118029-9ad0-48a8-8bb8-8be9d9f2979c"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you forget to take NINLARO </span></b></p>", "ID": "5d529288-1903-462c-9280-05b589f1374b", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you forget to take NINLARO </span></b>", "ID": "db5f4fb5-ca5d-4751-9a84-235f3ac5f594", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "5d529288-1903-462c-9280-05b589f1374b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If you forget to take NINLARO </span>", "ID": "ea2f1df8-98d3-4ac2-9a98-15d5736fa56f", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "If you forget to take NINLARO ", "ParentId": "db5f4fb5-ca5d-4751-9a84-235f3ac5f594"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><span lang=\"EN-GB\">If a dose is missed or delayed, you should take the dose\nas long as the next scheduled dose is more than 3 days or 72\u00a0hours away. </span><span lang=\"EN-GB\">Do not take a missed dose if it is within 3\u00a0days or 72\u00a0hours\nof your next scheduled dose.</span></p>", "ID": "ffd7d7ca-dfd4-459d-9e4a-70b75d004999", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">If a dose is missed or delayed, you should take the dose\nas long as the next scheduled dose is more than 3 days or 72\u00a0hours away. </span>", "ID": "0f7ac8d8-e1d5-47ba-abc2-b2bc3592258f", "Styles": "None", "Classes": "None", "Text": "If a dose is missed or delayed, you should take the dose as long as the next scheduled dose is more than 3 days or 72\u00a0hours away. ", "ParentId": "ffd7d7ca-dfd4-459d-9e4a-70b75d004999"}, {"Element": "<span lang=\"EN-GB\">Do not take a missed dose if it is within 3\u00a0days or 72\u00a0hours\nof your next scheduled dose.</span>", "ID": "538ed829-4758-4324-ba79-a1255c59cda8", "Styles": "None", "Classes": "None", "Text": "Do not take a missed dose if it is within 3\u00a0days or 72\u00a0hours of your next scheduled dose.", "ParentId": "ffd7d7ca-dfd4-459d-9e4a-70b75d004999"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "325f914a-ee8e-4359-911f-62892f4496ed", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "d217a241-e07c-40fc-9b61-261ab8bda743", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "325f914a-ee8e-4359-911f-62892f4496ed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">If you vomit after taking a dose, do not take an extra dose. Take\nthe next dose, as normal, when it is due. </span></p>", "ID": "e95a6f17-01ac-442d-9aea-95ce69775e11", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">If you vomit after taking a dose, do not take an extra dose. Take\nthe next dose, as normal, when it is due. </span>", "ID": "a4f3ef4e-4a22-44de-8427-b8c195c9ffc5", "Styles": "None", "Classes": "None", "Text": "If you vomit after taking a dose, do not take an extra dose. Take the next dose, as normal, when it is due. ", "ParentId": "e95a6f17-01ac-442d-9aea-95ce69775e11"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "f2d0e83b-eda6-4a3b-965a-1d1a1bed6573", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "371db9d8-3384-4efe-84a8-21cf5af5078c", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "f2d0e83b-eda6-4a3b-965a-1d1a1bed6573"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If\nyou have any further questions on the use of this medicine, ask your doctor or\npharmacist.</span></p>", "ID": "447d38c8-a8d7-4041-a9ef-508a9815310a", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">If\nyou have any further questions on the use of this medicine, ask your doctor or\npharmacist.</span>", "ID": "5f66b131-d7ec-4538-b46b-daf84438def4", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "If you have any further questions on the use of this medicine, ask your doctor or pharmacist.", "ParentId": "447d38c8-a8d7-4041-a9ef-508a9815310a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "38f6ed9c-93e0-474f-a62f-920ffa6793ad", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b7671068-c099-4c45-b00e-07a8e9d9069b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "38f6ed9c-93e0-474f-a62f-920ffa6793ad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ec05e20b-c9cc-4df9-bfd9-9ad786cf1d40", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cfe77109-5f39-424c-866f-4dd456aa3de6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ec05e20b-c9cc-4df9-bfd9-9ad786cf1d40"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></b></p>", "ID": "e6d8b8d0-bdd8-426d-b842-24330041eee4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span></b>", "ID": "757fd6bd-b293-41d4-a749-105d5f43df0f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e6d8b8d0-bdd8-426d-b842-24330041eee4"}, {"Element": "<span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side\neffects</span>", "ID": "28588e48-1f7f-40ad-848f-98fd4e5e2546", "Styles": "None", "Classes": "None", "Text": "4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Possible side effects", "ParentId": "757fd6bd-b293-41d4-a749-105d5f43df0f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5dd27c4a-25d5-437e-9df9-b365c4c33c74", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "fafe5778-25d7-4028-a6dc-a7b701f40fb7", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5dd27c4a-25d5-437e-9df9-b365c4c33c74"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Like all\nmedicines, this medicine can cause side effects, although not everybody gets\nthem.</span></p>", "ID": "c0ae0a73-c289-4cc0-84c1-d9f4414b6605", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Like all\nmedicines, this medicine can cause side effects, although not everybody gets\nthem.</span>", "ID": "04d46e36-13ba-428e-8b05-827b96638624", "Styles": "None", "Classes": "None", "Text": "Like all medicines, this medicine can cause side effects, although not everybody gets them.", "ParentId": "c0ae0a73-c289-4cc0-84c1-d9f4414b6605"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "02a1d0ab-aefd-45dd-83b9-3718e1040921", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "39504175-365c-4368-ad59-a09a3d467423", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "02a1d0ab-aefd-45dd-83b9-3718e1040921"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Tell your doctor or pharmacist straight away if you\nnotice any of these following very common serious side effects which may affect\nmore than 1 in 10 people:</span></b></p>", "ID": "1a52d702-d1be-4104-b44e-ea87307f214d", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Tell your doctor or pharmacist straight away if you\nnotice any of these following very common serious side effects which may affect\nmore than 1 in 10 people:</span></b>", "ID": "79ede5b0-d915-4b95-b5d5-9c9d6261419c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1a52d702-d1be-4104-b44e-ea87307f214d"}, {"Element": "<span lang=\"EN-GB\">Tell your doctor or pharmacist straight away if you\nnotice any of these following very common serious side effects which may affect\nmore than 1 in 10 people:</span>", "ID": "c35ff384-4a62-4f51-ab25-2c5178b6ad07", "Styles": "None", "Classes": "None", "Text": "Tell your doctor or pharmacist straight away if you notice any of these following very common serious side effects which may affect more than 1 in 10 people:", "ParentId": "79ede5b0-d915-4b95-b5d5-9c9d6261419c"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">low platelet counts (thrombocytopenia) which may\nincrease the risk of nose bleeds and you may easily bruise </span></p>", "ID": "b9c650eb-5bfa-415d-bc5c-297f73e9e3d5", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "3db16a7d-a80c-4b70-bccb-70955232d918", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b9c650eb-5bfa-415d-bc5c-297f73e9e3d5"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6e9fc411-fb17-4571-91f2-9f16a1069195", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "3db16a7d-a80c-4b70-bccb-70955232d918"}, {"Element": "<span lang=\"EN-GB\">low platelet counts (thrombocytopenia) which may\nincrease the risk of nose bleeds and you may easily bruise </span>", "ID": "ecb8a07b-8840-4900-8fab-3638b7cf41b4", "Styles": "None", "Classes": "None", "Text": "low platelet counts (thrombocytopenia) which may increase the risk of nose bleeds and you may easily bruise ", "ParentId": "b9c650eb-5bfa-415d-bc5c-297f73e9e3d5"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">nausea, vomiting and diarrhoea</span></p>", "ID": "b2e6cccd-4ae8-40d3-8836-33d318d4d615", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "686a8b07-900e-4475-a398-65e9119c74d7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b2e6cccd-4ae8-40d3-8836-33d318d4d615"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0eab7636-284f-4a53-be05-3142a50349ac", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "686a8b07-900e-4475-a398-65e9119c74d7"}, {"Element": "<span lang=\"EN-GB\">nausea, vomiting and diarrhoea</span>", "ID": "e3c392cb-064c-49b9-b0cc-a7c8455d82de", "Styles": "None", "Classes": "None", "Text": "nausea, vomiting and diarrhoea", "ParentId": "b2e6cccd-4ae8-40d3-8836-33d318d4d615"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">numbness, tingling or burning of the hands or\nfeet (peripheral neuropathy)</span></p>", "ID": "5d0131b6-d27a-449c-b3ab-9408cb0fe812", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f5fee7ac-33cf-46f8-8abc-4646432dc0b8", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "5d0131b6-d27a-449c-b3ab-9408cb0fe812"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "f4f08eb6-d93c-4c55-adc7-0fd539ec947b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f5fee7ac-33cf-46f8-8abc-4646432dc0b8"}, {"Element": "<span lang=\"EN-GB\">numbness, tingling or burning of the hands or\nfeet (peripheral neuropathy)</span>", "ID": "5e4aab19-df87-4114-9d8d-a56e5e4c6063", "Styles": "None", "Classes": "None", "Text": "numbness, tingling or burning of the hands or feet (peripheral neuropathy)", "ParentId": "5d0131b6-d27a-449c-b3ab-9408cb0fe812"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">swelling of the legs or feet (peripheral oedema)</span></p>", "ID": "7b9ba0e8-feb5-4104-827c-df48dd91e280", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "0d2ef8d0-ec24-4d1e-8670-23ddc788a1e7", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7b9ba0e8-feb5-4104-827c-df48dd91e280"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4120ba39-4395-4b43-96ed-b9ff3be683c7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "0d2ef8d0-ec24-4d1e-8670-23ddc788a1e7"}, {"Element": "<span lang=\"EN-GB\">swelling of the legs or feet (peripheral oedema)</span>", "ID": "60d52d3d-da23-4ab5-a429-bab4d7202b16", "Styles": "None", "Classes": "None", "Text": "swelling of the legs or feet (peripheral oedema)", "ParentId": "7b9ba0e8-feb5-4104-827c-df48dd91e280"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">skin rash that may be itchy and in a few areas\nor all over the body </span></p>", "ID": "cd3c0079-fb53-452d-87c7-999f13668f5b", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "22ac908a-ccd0-4c10-b4fc-9170b2a3bf7f", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "cd3c0079-fb53-452d-87c7-999f13668f5b"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "a3476917-1b9e-42d3-a85c-74283c68b6f7", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "22ac908a-ccd0-4c10-b4fc-9170b2a3bf7f"}, {"Element": "<span lang=\"EN-GB\">skin rash that may be itchy and in a few areas\nor all over the body </span>", "ID": "a2f96e7a-90c5-4551-83c9-ab5bf00246d1", "Styles": "None", "Classes": "None", "Text": "skin rash that may be itchy and in a few areas or all over the body ", "ParentId": "cd3c0079-fb53-452d-87c7-999f13668f5b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5d98fdad-3b12-4973-91d4-fb7bb67a945f", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8508a4f1-d23a-4312-a1ff-38b6338abd5c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5d98fdad-3b12-4973-91d4-fb7bb67a945f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">Additionally, tell a doctor immediately if you notice any of these\nfollowing </span></b><b><span lang=\"EN-GB\">rare side effects which may affect up\nto 1 in 1,000 people: </span></b></p>", "ID": "b9445a6b-fd18-4c83-b75e-833ae21b8842", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Additionally, tell a doctor immediately if you notice any of these\nfollowing </span></b>", "ID": "69d20278-17f4-4f69-bc20-b80fef000dc7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b9445a6b-fd18-4c83-b75e-833ae21b8842"}, {"Element": "<span lang=\"EN-GB\">Additionally, tell a doctor immediately if you notice any of these\nfollowing </span>", "ID": "8812ef27-8493-4f1d-bef2-2f93c6050971", "Styles": "None", "Classes": "None", "Text": "Additionally, tell a doctor immediately if you notice any of these following ", "ParentId": "69d20278-17f4-4f69-bc20-b80fef000dc7"}, {"Element": "<b><span lang=\"EN-GB\">rare side effects which may affect up\nto 1 in 1,000 people: </span></b>", "ID": "e5e34ace-0ff7-4314-960e-2d3c2b9cee00", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b9445a6b-fd18-4c83-b75e-833ae21b8842"}, {"Element": "<span lang=\"EN-GB\">rare side effects which may affect up\nto 1 in 1,000 people: </span>", "ID": "db9eb567-e483-46fc-9a45-f5bb7130bda3", "Styles": "None", "Classes": "None", "Text": "rare side effects which may affect up to 1 in 1,000 people: ", "ParentId": "e5e34ace-0ff7-4314-960e-2d3c2b9cee00"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">severe skin rashes such as red to purple bumps\n(Sweet\u2019s syndrome) or rash with skin peeling and mouth sores (Stevens\u2011Johnson\nsyndrome)</span></p>", "ID": "b92253a2-fd2e-4be0-b609-ea8afe37c86e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "98b9a840-c250-4b38-94e9-ff25aae4e928", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b92253a2-fd2e-4be0-b609-ea8afe37c86e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "9160978a-e2ef-46d8-a39a-1087dffea6e8", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "98b9a840-c250-4b38-94e9-ff25aae4e928"}, {"Element": "<span lang=\"EN-GB\">severe skin rashes such as red to purple bumps\n(Sweet\u2019s syndrome) or rash with skin peeling and mouth sores (Stevens\u2011Johnson\nsyndrome)</span>", "ID": "9f4f0529-9300-4c7e-a05b-32319a58156e", "Styles": "None", "Classes": "None", "Text": "severe skin rashes such as red to purple bumps (Sweet\u2019s syndrome) or rash with skin peeling and mouth sores (Stevens\u2011Johnson syndrome)", "ParentId": "b92253a2-fd2e-4be0-b609-ea8afe37c86e"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">muscle weakness, loss of feelings of the toes\nand feet or loss of leg movement (transverse myelitis)</span></p>", "ID": "7f02b10c-4ae0-4274-9a04-97b32df85119", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "e19e9505-f656-407d-b58b-d6644cf78273", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7f02b10c-4ae0-4274-9a04-97b32df85119"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6f535529-3863-4054-9662-15fbd8a567df", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "e19e9505-f656-407d-b58b-d6644cf78273"}, {"Element": "<span lang=\"EN-GB\">muscle weakness, loss of feelings of the toes\nand feet or loss of leg movement (transverse myelitis)</span>", "ID": "d6884a0e-faa0-42e9-8881-54148bf51192", "Styles": "None", "Classes": "None", "Text": "muscle weakness, loss of feelings of the toes and feet or loss of leg movement (transverse myelitis)", "ParentId": "7f02b10c-4ae0-4274-9a04-97b32df85119"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">changes in vision, changes in mental status, or\nseizures (posterior reversible encephalopathy syndrome)</span></p>", "ID": "fcd41789-dc43-4f15-9ff8-94d24258df99", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "aa6d3732-13bb-4cf7-830d-2139cbb53202", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "fcd41789-dc43-4f15-9ff8-94d24258df99"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4f80d0b4-b30f-4fee-ad05-09988d7b2e17", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "aa6d3732-13bb-4cf7-830d-2139cbb53202"}, {"Element": "<span lang=\"EN-GB\">changes in vision, changes in mental status, or\nseizures (posterior reversible encephalopathy syndrome)</span>", "ID": "7cf29456-7be2-4ad4-afc0-87eab40de010", "Styles": "None", "Classes": "None", "Text": "changes in vision, changes in mental status, or seizures (posterior reversible encephalopathy syndrome)", "ParentId": "fcd41789-dc43-4f15-9ff8-94d24258df99"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">rapid death of cancer cells that may cause\ndizziness, decreased urination, confusion, vomiting, nausea, swelling,\nshortness of breath, or heart rhythm disturbances (tumour lysis syndrome)</span></p>", "ID": "7eca280a-1ad0-4718-b8ee-4fd438d7c5f4", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d4435f6f-fd60-4476-8f26-00f1cb010031", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "7eca280a-1ad0-4718-b8ee-4fd438d7c5f4"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "0390444b-0eff-46e7-b876-329471c16a0a", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d4435f6f-fd60-4476-8f26-00f1cb010031"}, {"Element": "<span lang=\"EN-GB\">rapid death of cancer cells that may cause\ndizziness, decreased urination, confusion, vomiting, nausea, swelling,\nshortness of breath, or heart rhythm disturbances (tumour lysis syndrome)</span>", "ID": "92c9d4d5-4796-420d-a3fa-92aace03294f", "Styles": "None", "Classes": "None", "Text": "rapid death of cancer cells that may cause dizziness, decreased urination, confusion, vomiting, nausea, swelling, shortness of breath, or heart rhythm disturbances (tumour lysis syndrome)", "ParentId": "7eca280a-1ad0-4718-b8ee-4fd438d7c5f4"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">rare blood condition resulting from blood clots that\nmay cause fatigue, fever, bruising, bleeding e.g. nose bleeds, decreased\nurination, swelling, confusion, vision loss, and seizures (thrombotic\nmicroangiopathy, thrombotic thrombocytopenic purpura)</span></p>", "ID": "878454eb-eacb-49fd-9406-2a646acd2d4e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "91d62028-7bf0-4907-84fb-95b6337a4b8c", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "878454eb-eacb-49fd-9406-2a646acd2d4e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "30bc99a6-0ce1-4bba-92c5-134f0c303800", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "91d62028-7bf0-4907-84fb-95b6337a4b8c"}, {"Element": "<span lang=\"EN-GB\">rare blood condition resulting from blood clots that\nmay cause fatigue, fever, bruising, bleeding e.g. nose bleeds, decreased\nurination, swelling, confusion, vision loss, and seizures (thrombotic\nmicroangiopathy, thrombotic thrombocytopenic purpura)</span>", "ID": "9ee9e117-ef3b-408c-acd2-d519fdc3d83d", "Styles": "None", "Classes": "None", "Text": "rare blood condition resulting from blood clots that may cause fatigue, fever, bruising, bleeding e.g. nose bleeds, decreased urination, swelling, confusion, vision loss, and seizures (thrombotic microangiopathy, thrombotic thrombocytopenic purpura)", "ParentId": "878454eb-eacb-49fd-9406-2a646acd2d4e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0e54df4e-2a9b-42cb-a7e0-82ba1ef56917", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ba21771f-d7cc-4515-8bec-96f4925be74c", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0e54df4e-2a9b-42cb-a7e0-82ba1ef56917"}, {"Element": "<p class=\"Default\"><b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Other possible\nside effects </span></b></p>", "ID": "fffeb55a-ac28-4fcf-8b86-441868feb1a0", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Other possible\nside effects </span></b>", "ID": "4f946c12-3da4-4f8d-a508-8d91d21e5d2d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fffeb55a-ac28-4fcf-8b86-441868feb1a0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Other possible\nside effects </span>", "ID": "be73674f-5494-4eae-aebe-af046a537b69", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Other possible side effects ", "ParentId": "4f946c12-3da4-4f8d-a508-8d91d21e5d2d"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><span style='font-family:\n\"Times New Roman\",serif'>Tell your doctor or pharmacist if any of the side\neffects below become severe. </span></p>", "ID": "aa9b7d5f-11cc-48b1-9240-d0e69a2f5901", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style='font-family:\n\"Times New Roman\",serif'>Tell your doctor or pharmacist if any of the side\neffects below become severe. </span>", "ID": "80960186-4bd5-403d-8311-c015afae32de", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "Tell your doctor or pharmacist if any of the side effects below become severe. ", "ParentId": "aa9b7d5f-11cc-48b1-9240-d0e69a2f5901"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><span style='font-family:\n\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "a5a687b3-c815-4373-b22b-c63192d77c59", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span style='font-family:\n\"Times New Roman\",serif'>\u00a0</span>", "ID": "f634dd06-3a80-4320-a7ae-c5288800457b", "Styles": "font-family:\n\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "a5a687b3-c815-4373-b22b-c63192d77c59"}, {"Element": "<p class=\"MsoNoSpacing\" style=\"page-break-after:avoid\"><b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very common side effects may affect\nmore than 1 in 10 people:</span></b></p>", "ID": "66f007e6-4412-475c-bcf0-1f1de7152e9f", "Styles": "page-break-after:avoid", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very common side effects may affect\nmore than 1 in 10 people:</span></b>", "ID": "6aca1c61-09d7-4195-9926-d0647ed40cb1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "66f007e6-4412-475c-bcf0-1f1de7152e9f"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Very common side effects may affect\nmore than 1 in 10 people:</span>", "ID": "23c969e4-ec87-4ad9-bd61-5c45d85a2294", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Very common side effects may affect more than 1 in 10 people:", "ParentId": "6aca1c61-09d7-4195-9926-d0647ed40cb1"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">constipation</span></p>", "ID": "8ccf94ac-cbf7-4cd2-85c6-7a106ab71f66", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "3ce6e3a3-271c-4e84-bdee-219935aa0b63", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "8ccf94ac-cbf7-4cd2-85c6-7a106ab71f66"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "4aa65dc6-78d2-4891-8f15-420cb8f9f160", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "3ce6e3a3-271c-4e84-bdee-219935aa0b63"}, {"Element": "<span lang=\"EN-GB\">constipation</span>", "ID": "a70888e4-ac5a-4b84-aeeb-a1bf526a9dd8", "Styles": "None", "Classes": "None", "Text": "constipation", "ParentId": "8ccf94ac-cbf7-4cd2-85c6-7a106ab71f66"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">back pain</span></p>", "ID": "c2985355-6c8a-4aff-a06c-4f7fcb0fc7df", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6adba638-8647-4aee-a722-915bea048bb8", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "c2985355-6c8a-4aff-a06c-4f7fcb0fc7df"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "41706a64-6323-4dcc-b105-d954ea510b17", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6adba638-8647-4aee-a722-915bea048bb8"}, {"Element": "<span lang=\"EN-GB\">back pain</span>", "ID": "06dc3653-1a6e-49d7-abac-8facb6cfab68", "Styles": "None", "Classes": "None", "Text": "back pain", "ParentId": "c2985355-6c8a-4aff-a06c-4f7fcb0fc7df"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">cold\u2011like symptoms (upper respiratory\ntract infection)</span></p>", "ID": "f0062a6c-de88-47ff-b158-b13e7c83baa9", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1e7b096e-fb5d-4acb-8227-51206fe2cd70", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f0062a6c-de88-47ff-b158-b13e7c83baa9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d55f021b-602d-42bf-81d8-fd3510c67b01", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1e7b096e-fb5d-4acb-8227-51206fe2cd70"}, {"Element": "<span lang=\"EN-GB\">cold\u2011like symptoms (upper respiratory\ntract infection)</span>", "ID": "e83e0a50-98d1-4f01-a127-cc642996a288", "Styles": "None", "Classes": "None", "Text": "cold\u2011like symptoms (upper respiratory tract infection)", "ParentId": "f0062a6c-de88-47ff-b158-b13e7c83baa9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">feeling tired or weak (fatigue)</span></p>", "ID": "addf0197-1258-4382-932e-45ff464e8df9", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "703e6fad-24bd-4686-9591-7c29f681c6a0", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "addf0197-1258-4382-932e-45ff464e8df9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "87c20785-a652-4620-bf59-ff513f25db21", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "703e6fad-24bd-4686-9591-7c29f681c6a0"}, {"Element": "<span lang=\"EN-GB\">feeling tired or weak (fatigue)</span>", "ID": "f38d302e-35dd-4768-8c36-46d89ef74a60", "Styles": "None", "Classes": "None", "Text": "feeling tired or weak (fatigue)", "ParentId": "addf0197-1258-4382-932e-45ff464e8df9"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">lowered white blood cells called neutrophils (neutropenia)\nthat may increase the risk of infection </span></p>", "ID": "06b8a265-cd17-4a78-b498-2dbba35379da", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d5de4382-f400-42c3-9f19-508d7c0815fb", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "06b8a265-cd17-4a78-b498-2dbba35379da"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "43cc2490-c872-4e3e-a70a-63314446f201", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d5de4382-f400-42c3-9f19-508d7c0815fb"}, {"Element": "<span lang=\"EN-GB\">lowered white blood cells called neutrophils (neutropenia)\nthat may increase the risk of infection </span>", "ID": "ed672679-3304-4933-8268-e262d29b2833", "Styles": "None", "Classes": "None", "Text": "lowered white blood cells called neutrophils (neutropenia) that may increase the risk of infection ", "ParentId": "06b8a265-cd17-4a78-b498-2dbba35379da"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">not feeling like eating (decreased appetite)</span></p>", "ID": "92265e89-aa3c-4dac-aea5-746e625e52c8", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "434f8ec9-da27-41db-8eaa-dbc6b9034b61", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "92265e89-aa3c-4dac-aea5-746e625e52c8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "c304ac22-7373-4a6d-91a6-a652abb587d9", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "434f8ec9-da27-41db-8eaa-dbc6b9034b61"}, {"Element": "<span lang=\"EN-GB\">not feeling like eating (decreased appetite)</span>", "ID": "aff41f64-50e5-49fe-a99a-404b9bf3b668", "Styles": "None", "Classes": "None", "Text": "not feeling like eating (decreased appetite)", "ParentId": "92265e89-aa3c-4dac-aea5-746e625e52c8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">irregular heart rate (arrhythmia)</span></p>", "ID": "ebb8d3c6-9ba7-4736-b26d-e1e231931f59", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1f5c24d0-b7dd-428b-abe6-d84a6e1dd9e1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "ebb8d3c6-9ba7-4736-b26d-e1e231931f59"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8e6954a5-d139-43fe-81df-14c4b04e5a11", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1f5c24d0-b7dd-428b-abe6-d84a6e1dd9e1"}, {"Element": "<span lang=\"EN-GB\">irregular heart rate (arrhythmia)</span>", "ID": "7930fefb-3619-4749-8932-efd5ddab22a6", "Styles": "None", "Classes": "None", "Text": "irregular heart rate (arrhythmia)", "ParentId": "ebb8d3c6-9ba7-4736-b26d-e1e231931f59"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">vision conditions including blurred vision, dry\neye and pink eye (conjunctivitis)</span></p>", "ID": "377916dd-f66a-4c3d-925e-2f9321b0b70e", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "23f40cd9-ab01-486f-8b98-3b770834afb4", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "377916dd-f66a-4c3d-925e-2f9321b0b70e"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "67dd2074-3de5-44be-8bf0-a420a8521905", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "23f40cd9-ab01-486f-8b98-3b770834afb4"}, {"Element": "<span lang=\"EN-GB\">vision conditions including blurred vision, dry\neye and pink eye (conjunctivitis)</span>", "ID": "7975846f-0f2c-448d-886c-55ceadae43c5", "Styles": "None", "Classes": "None", "Text": "vision conditions including blurred vision, dry eye and pink eye (conjunctivitis)", "ParentId": "377916dd-f66a-4c3d-925e-2f9321b0b70e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "982d42ee-9e54-41a3-8d46-b007b34d9128", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7a5a62cc-aabd-47b8-8def-ce9a5cacd3c9", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "982d42ee-9e54-41a3-8d46-b007b34d9128"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid;text-autospace:\nnone\"><b><span lang=\"EN-GB\">Common side effects may affect up to 1 in 10 people:</span></b></p>", "ID": "4dffc784-4a6d-4639-9aef-63f496a346df", "Styles": "line-height:normal;page-break-after:avoid;text-autospace:\nnone", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Common side effects may affect up to 1 in 10 people:</span></b>", "ID": "7ef624fe-94be-4508-b008-b62154521133", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4dffc784-4a6d-4639-9aef-63f496a346df"}, {"Element": "<span lang=\"EN-GB\">Common side effects may affect up to 1 in 10 people:</span>", "ID": "d1c2508d-6680-4065-b07e-0ed28f418954", "Styles": "None", "Classes": "None", "Text": "Common side effects may affect up to 1 in 10 people:", "ParentId": "7ef624fe-94be-4508-b008-b62154521133"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">reactivation of the chicken pox virus (shingles)\nthat can cause a skin rash and pain (herpes zoster)</span></p>", "ID": "bc589f9a-c441-4d62-b3d2-5dc967a40f82", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "eb5b52f9-9ffa-4e14-8249-480e0f4fe3b3", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "bc589f9a-c441-4d62-b3d2-5dc967a40f82"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "006e3078-8424-4a1b-92ae-192f4f6d4371", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "eb5b52f9-9ffa-4e14-8249-480e0f4fe3b3"}, {"Element": "<span lang=\"EN-GB\">reactivation of the chicken pox virus (shingles)\nthat can cause a skin rash and pain (herpes zoster)</span>", "ID": "3a6edf8f-5ee8-4dba-90d9-0cfbe5e21de6", "Styles": "None", "Classes": "None", "Text": "reactivation of the chicken pox virus (shingles) that can cause a skin rash and pain (herpes zoster)", "ParentId": "bc589f9a-c441-4d62-b3d2-5dc967a40f82"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">lowered blood pressure (hypotension)</span></p>", "ID": "3608f74c-228b-42d2-8fe2-dcd92f47c8a6", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "305729c3-abba-42db-802e-22de14ff8fa1", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "3608f74c-228b-42d2-8fe2-dcd92f47c8a6"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6d962f42-638c-4854-9c64-ba4eb5c4f5ef", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "305729c3-abba-42db-802e-22de14ff8fa1"}, {"Element": "<span lang=\"EN-GB\">lowered blood pressure (hypotension)</span>", "ID": "2db88513-cfd4-4905-b347-f270c3197cc1", "Styles": "None", "Classes": "None", "Text": "lowered blood pressure (hypotension)", "ParentId": "3608f74c-228b-42d2-8fe2-dcd92f47c8a6"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">shortness of breath or persistent coughing or\nwheezing (heart failure)</span></p>", "ID": "8c71ae9e-bf23-42a1-a660-aafb4d1c3756", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "c158340d-a463-494e-9d18-96e0a14f60ca", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "8c71ae9e-bf23-42a1-a660-aafb4d1c3756"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "b1b31afd-61a9-4859-953a-a5bd7906721c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "c158340d-a463-494e-9d18-96e0a14f60ca"}, {"Element": "<span lang=\"EN-GB\">shortness of breath or persistent coughing or\nwheezing (heart failure)</span>", "ID": "d0f3516f-5bf7-4d20-a96e-736fcf444e9b", "Styles": "None", "Classes": "None", "Text": "shortness of breath or persistent coughing or wheezing (heart failure)", "ParentId": "8c71ae9e-bf23-42a1-a660-aafb4d1c3756"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">yellow discoloration of eyes and skin (jaundice which\ncould be a symptom of liver  impairment)</span></p>", "ID": "871da7cd-104f-4592-a185-3b1d269c611a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "cc6703d6-423d-436f-97af-e3580ffe8b0a", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "871da7cd-104f-4592-a185-3b1d269c611a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "3ccc0970-4e57-4e6c-b07f-18a7a5f7486c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "cc6703d6-423d-436f-97af-e3580ffe8b0a"}, {"Element": "<span lang=\"EN-GB\">yellow discoloration of eyes and skin (jaundice which\ncould be a symptom of liver  impairment)</span>", "ID": "719231d2-5c52-4018-9722-cab53da9d38f", "Styles": "None", "Classes": "None", "Text": "yellow discoloration of eyes and skin (jaundice which could be a symptom of liver  impairment)", "ParentId": "871da7cd-104f-4592-a185-3b1d269c611a"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">low levels of potassium in the blood\n(hypokalaemia)</span></p>", "ID": "16f62792-a71f-41ab-bca9-e6bb94da8c5a", "Styles": "margin-left:28.35pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "bb551aab-158e-483d-9fbb-5b4a0c734e47", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "16f62792-a71f-41ab-bca9-e6bb94da8c5a"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "7c1e6dda-69c8-461a-b363-3378867fd52e", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "bb551aab-158e-483d-9fbb-5b4a0c734e47"}, {"Element": "<span lang=\"EN-GB\">low levels of potassium in the blood\n(hypokalaemia)</span>", "ID": "85fe4320-53b3-4bc9-94d2-66ef5e1a2953", "Styles": "None", "Classes": "None", "Text": "low levels of potassium in the blood (hypokalaemia)", "ParentId": "16f62792-a71f-41ab-bca9-e6bb94da8c5a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e618dce5-d446-4ebc-a6ba-ea9522bb65d2", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f58d0538-94e0-4943-bee1-857638a48366", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e618dce5-d446-4ebc-a6ba-ea9522bb65d2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Reporting of side effects</span></b></p>", "ID": "ccc9f390-bc6e-4456-a83c-fab2559d29a4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Reporting of side effects</span></b>", "ID": "99e152a9-15bd-4f12-b3b4-b0e35e0ce42b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ccc9f390-bc6e-4456-a83c-fab2559d29a4"}, {"Element": "<span lang=\"EN-GB\">Reporting of side effects</span>", "ID": "63cc48a9-1fbc-48ee-8048-9050c9ad64f4", "Styles": "None", "Classes": "None", "Text": "Reporting of side effects", "ParentId": "99e152a9-15bd-4f12-b3b4-b0e35e0ce42b"}, {"Element": "<p class=\"BodytextAgency\" style=\"margin-bottom:0in;line-height:normal\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>If you\nget any side effects, talk to your doctor, pharmacist or nurse. This includes\nany possible side effects not listed in this leaflet. You can also report side\neffects directly via <span style=\"background:silver\">the national reporting\nsystem listed in </span><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:silver\">Appendix\u00a0V</span></a>. By reporting side effects\nyou can help provide more information on the safety of this medicine.</span></p>", "ID": "669f49f7-d29a-477a-9d5e-e6fcc0c9d9a4", "Styles": "margin-bottom:0in;line-height:normal", "Classes": "['BodytextAgency']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'>If you\nget any side effects, talk to your doctor, pharmacist or nurse. This includes\nany possible side effects not listed in this leaflet. You can also report side\neffects directly via <span style=\"background:silver\">the national reporting\nsystem listed in </span><a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:silver\">Appendix\u00a0V</span></a>. By reporting side effects\nyou can help provide more information on the safety of this medicine.</span>", "ID": "4f10c241-98c4-4bae-b2cb-b4597b357312", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via . By reporting side effects you can help provide more information on the safety of this medicine.", "ParentId": "669f49f7-d29a-477a-9d5e-e6fcc0c9d9a4"}, {"Element": "<span style=\"background:silver\">the national reporting\nsystem listed in </span>", "ID": "a093f28f-25c4-4e81-8f41-37eadd20d080", "Styles": "background:silver", "Classes": "None", "Text": "the national reporting system listed in ", "ParentId": "4f10c241-98c4-4bae-b2cb-b4597b357312"}, {"Element": "<a href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc\"><span style=\"background:silver\">Appendix\u00a0V</span></a>", "ID": "3edc7ce5-a92b-4667-9e49-281a928e2a52", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4f10c241-98c4-4bae-b2cb-b4597b357312"}, {"Element": "<span style=\"background:silver\">Appendix\u00a0V</span>", "ID": "941d0b3d-5ca1-4c68-825c-1e22734faf08", "Styles": "background:silver", "Classes": "None", "Text": "Appendix\u00a0V", "ParentId": "3edc7ce5-a92b-4667-9e49-281a928e2a52"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5a72a09e-ba65-470f-9b6a-0723d50927e9", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4df36bca-d558-4509-994e-6f044250dc5e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5a72a09e-ba65-470f-9b6a-0723d50927e9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "11e99b53-4d88-4443-afe0-2726b88c51af", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "20632c93-19b7-4450-bb5b-9fe01c139d9e", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "11e99b53-4d88-4443-afe0-2726b88c51af"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nNINLARO</span></b></p>", "ID": "f5f086f0-cb80-4881-94bc-7b47e79708b9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nNINLARO</span></b>", "ID": "efb00ea0-c8de-425a-a3ee-dc43fe1c77cc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f5f086f0-cb80-4881-94bc-7b47e79708b9"}, {"Element": "<span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store\nNINLARO</span>", "ID": "50fbab76-e819-4976-94e5-ddcf339b4580", "Styles": "None", "Classes": "None", "Text": "5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 How to store NINLARO", "ParentId": "efb00ea0-c8de-425a-a3ee-dc43fe1c77cc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "d170aa1f-a284-4f7c-b8a2-ab542f9c33e3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "73dc5584-db29-48f6-a6ab-9ec6ac5b0032", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "d170aa1f-a284-4f7c-b8a2-ab542f9c33e3"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Keep this\nmedicine out of the sight and reach of children.</span></p>", "ID": "f99779c2-c42b-4204-b851-a563419e9d6c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Keep this\nmedicine out of the sight and reach of children.</span>", "ID": "a77ea36b-33f5-44b7-8bae-3d7042c4a4f8", "Styles": "None", "Classes": "None", "Text": "Keep this medicine out of the sight and reach of children.", "ParentId": "f99779c2-c42b-4204-b851-a563419e9d6c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "63704d04-3787-44a8-8627-dbeeef7bdb79", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0e3d3579-82b1-4d9c-8439-b605fb5263c5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "63704d04-3787-44a8-8627-dbeeef7bdb79"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not use this\nmedicine after the expiry date which is stated on the blister, wallet and\ncarton after EXP. The expiry date refers to the last day of that month.</span></p>", "ID": "60f22232-e747-496d-9f4c-c4289d15452e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not use this\nmedicine after the expiry date which is stated on the blister, wallet and\ncarton after EXP. The expiry date refers to the last day of that month.</span>", "ID": "123b9b2f-5b43-4e00-b4bb-7465345730cc", "Styles": "None", "Classes": "None", "Text": "Do not use this medicine after the expiry date which is stated on the blister, wallet and carton after EXP. The expiry date refers to the last day of that month.", "ParentId": "60f22232-e747-496d-9f4c-c4289d15452e"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2ad6dce0-017e-4bdd-98b3-c4ee157f2d08", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "0cd10f01-b50e-4bc4-84ab-7fec84e9f4af", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2ad6dce0-017e-4bdd-98b3-c4ee157f2d08"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Do\nnot store above 30\u00a0\u00b0C. Do not freeze. </span></p>", "ID": "061ce519-7d2c-42e9-8372-35f7da97c2f4", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Do\nnot store above 30\u00a0\u00b0C. Do not freeze. </span>", "ID": "bee835fb-99aa-40c5-a3e9-1888d1ce0929", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Do not store above 30\u00a0\u00b0C. Do not freeze. ", "ParentId": "061ce519-7d2c-42e9-8372-35f7da97c2f4"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "5f8d8278-3ef7-471b-bfdd-f8435a38f5a7", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "22cc7a0a-c0fb-4648-b03f-17b25a8cff3b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "5f8d8278-3ef7-471b-bfdd-f8435a38f5a7"}, {"Element": "<p class=\"MsoNoSpacing\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Store\nin the original package in order to protect from moisture.</span></p>", "ID": "8991d5ca-b640-408a-8cce-a0fbd4954af7", "Styles": "None", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Store\nin the original package in order to protect from moisture.</span>", "ID": "91a6220a-5787-44ce-bb8b-af69a7a136c5", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Store in the original package in order to protect from moisture.", "ParentId": "8991d5ca-b640-408a-8cce-a0fbd4954af7"}, {"Element": "<p class=\"MsoNoSpacing\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span></p>", "ID": "f443d795-2894-496d-a6c2-ac8dc6c60354", "Styles": "None", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>\u00a0</span>", "ID": "de21a3d3-e9ff-419d-a55f-5ba0a4fb0b21", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "\u00a0", "ParentId": "f443d795-2894-496d-a6c2-ac8dc6c60354"}, {"Element": "<p class=\"MsoNoSpacing\"><span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do\nnot remove the capsule until you need to take a dose.</span></p>", "ID": "f5f10598-c531-4f78-a2c3-0e5b56abb2ca", "Styles": "None", "Classes": "['MsoNoSpacing']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style='font-family:\"Times New Roman\",serif'>Do\nnot remove the capsule until you need to take a dose.</span>", "ID": "47cefad9-ec12-48c0-94a2-a6370c9acfe1", "Styles": "font-family:\"Times New Roman\",serif", "Classes": "None", "Text": "Do not remove the capsule until you need to take a dose.", "ParentId": "f5f10598-c531-4f78-a2c3-0e5b56abb2ca"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "74831536-9dbd-4e25-a8bf-891670109304", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1d539744-ff38-44f7-99f2-7a76a9194baa", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "74831536-9dbd-4e25-a8bf-891670109304"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not use this\nmedicine if you notice any damage or signs of tampering to medicine packaging.</span></p>", "ID": "6a0401f3-4606-4981-9a7b-72ede665cf37", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not use this\nmedicine if you notice any damage or signs of tampering to medicine packaging.</span>", "ID": "216f18c7-e112-4ca6-ad38-e25840452708", "Styles": "None", "Classes": "None", "Text": "Do not use this medicine if you notice any damage or signs of tampering to medicine packaging.", "ParentId": "6a0401f3-4606-4981-9a7b-72ede665cf37"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e513d8f7-0eba-44a7-be96-30a04d348a6a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "cfee5eae-da5a-4b89-88bc-547bd560f3c8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e513d8f7-0eba-44a7-be96-30a04d348a6a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Do not throw\naway any medicines via wastewater or household waste. Ask your pharmacist how\nto throw away medicines you no longer use. These measures will help protect the\nenvironment.</span></p>", "ID": "1ca67107-8d7d-463d-b04f-fc17fe5d8c13", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Do not throw\naway any medicines via wastewater or household waste. Ask your pharmacist how\nto throw away medicines you no longer use. These measures will help protect the\nenvironment.</span>", "ID": "43a17f7a-4167-44d5-ac6c-ce572aa21a94", "Styles": "None", "Classes": "None", "Text": "Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.", "ParentId": "1ca67107-8d7d-463d-b04f-fc17fe5d8c13"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "0e0fb968-51f8-48f9-972f-219e79cde7bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "ba0258b6-91ad-409f-80ab-b33d1ca1b107", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "0e0fb968-51f8-48f9-972f-219e79cde7bc"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c4993048-80c8-437a-94a2-bb2af6e7c7a4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e9b4ed20-5253-481a-a631-e792bd43aa7a", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c4993048-80c8-437a-94a2-bb2af6e7c7a4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and\nother information</span></b></p>", "ID": "c58d0323-fab2-4764-ba7a-3476a1c46f96", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and\nother information</span></b>", "ID": "49093ce3-42b5-4bc7-bfc5-aeeabc55aef0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c58d0323-fab2-4764-ba7a-3476a1c46f96"}, {"Element": "<span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and\nother information</span>", "ID": "e68f8287-f5af-4b7a-a5fc-3eda4df96ba7", "Styles": "None", "Classes": "None", "Text": "6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Contents of the pack and other information", "ParentId": "49093ce3-42b5-4bc7-bfc5-aeeabc55aef0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "8772bd68-3ac4-4190-bc64-764baa2f2d82", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "414d1741-d63e-415b-9f2d-1e2a11c4715d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8772bd68-3ac4-4190-bc64-764baa2f2d82"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "04c41441-07d8-47c5-afff-1d20af6f4dd6", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "414d1741-d63e-415b-9f2d-1e2a11c4715d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What NINLARO contains </span></b></p>", "ID": "b8ec35cb-b373-42b7-b65e-86fd7b27f45b", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">What NINLARO contains </span></b>", "ID": "08431b0f-d4cc-46f3-9eb6-9bed483b3f3e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b8ec35cb-b373-42b7-b65e-86fd7b27f45b"}, {"Element": "<span lang=\"EN-GB\">What NINLARO contains </span>", "ID": "8dfc8fd1-182a-47a2-a073-a72de68884ff", "Styles": "None", "Classes": "None", "Text": "What NINLARO contains ", "ParentId": "08431b0f-d4cc-46f3-9eb6-9bed483b3f3e"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO\n2.3\u00a0mg hard capsule: </span></p>", "ID": "1556273d-2819-4ec0-8426-fda2c546c1ae", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO\n2.3\u00a0mg hard capsule: </span>", "ID": "94da18da-0aea-4506-bc30-8d7ccd2ccf43", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "NINLARO 2.3\u00a0mg hard capsule: ", "ParentId": "1556273d-2819-4ec0-8426-fda2c546c1ae"}, {"Element": "<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The active substance is\nixazomib. Each capsule contains 2.3\u00a0mg of ixazomib (as 3.3\u00a0mg of\nixazomib citrate).</span></p>", "ID": "0bd7e7b9-5fdb-4ade-995b-4ac7ec348925", "Styles": "margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "79afdc20-428b-41cc-9083-c6020bfe18ac", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "0bd7e7b9-5fdb-4ade-995b-4ac7ec348925"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "6300259f-b4f8-41ad-9434-1dda494a5cfa", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "79afdc20-428b-41cc-9083-c6020bfe18ac"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The active substance is\nixazomib. Each capsule contains 2.3\u00a0mg of ixazomib (as 3.3\u00a0mg of\nixazomib citrate).</span>", "ID": "2501d039-ac10-4d2f-97a2-a4e7684b1ef9", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The active substance is ixazomib. Each capsule contains 2.3\u00a0mg of ixazomib (as 3.3\u00a0mg of ixazomib citrate).", "ParentId": "0bd7e7b9-5fdb-4ade-995b-4ac7ec348925"}, {"Element": "<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The other ingredients are:</span></p>", "ID": "a323b741-195a-4105-8ce3-1a38124558e0", "Styles": "margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "bedb20c2-c70e-4ad1-be3c-9c8d00d60c1a", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "a323b741-195a-4105-8ce3-1a38124558e0"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "7bcedb19-bd81-482d-b003-c5cb27551e4b", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "bedb20c2-c70e-4ad1-be3c-9c8d00d60c1a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The other ingredients are:</span>", "ID": "a2060a40-348f-4c0b-927f-540405790682", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The other ingredients are:", "ParentId": "a323b741-195a-4105-8ce3-1a38124558e0"}, {"Element": "<p class=\"Default\" style=\"margin-left:0in;text-indent:0in\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">In the capsule: microcrystalline\ncellulose, magnesium stearate and talc.</span></p>", "ID": "d50d160f-4ace-48f2-a284-94780fdfbfae", "Styles": "margin-left:0in;text-indent:0in", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "d29e6ffa-b49f-4de4-902b-fc743ddca6ef", "Styles": "font-size:11.0pt;font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "d50d160f-4ace-48f2-a284-94780fdfbfae"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d7736294-cdda-431d-ab0a-d6c384783e9c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "d29e6ffa-b49f-4de4-902b-fc743ddca6ef"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">In the capsule: microcrystalline\ncellulose, magnesium stearate and talc.</span>", "ID": "99060bde-5c47-49a2-a7ca-6a43e562929a", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "In the capsule: microcrystalline cellulose, magnesium stearate and talc.", "ParentId": "d50d160f-4ace-48f2-a284-94780fdfbfae"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The capsule shell contains: gelatin, titanium\ndioxide (E171) and red iron oxide (E172) </span></p>", "ID": "f6ca4d2b-0ba7-47a5-9845-c1268bf692d8", "Styles": "margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a365db66-ccd7-44e4-ae4f-e45debd3ce71", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "f6ca4d2b-0ba7-47a5-9845-c1268bf692d8"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "1a246d05-98aa-478b-8197-de754da838ab", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a365db66-ccd7-44e4-ae4f-e45debd3ce71"}, {"Element": "<span lang=\"EN-GB\">The capsule shell contains: gelatin, titanium\ndioxide (E171) and red iron oxide (E172) </span>", "ID": "827ba822-3b9c-41bc-b7e1-14656def98b1", "Styles": "None", "Classes": "None", "Text": "The capsule shell contains: gelatin, titanium dioxide (E171) and red iron oxide (E172) ", "ParentId": "f6ca4d2b-0ba7-47a5-9845-c1268bf692d8"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The printing ink contains: shellac, propylene\nglycol, potassium hydroxide, and black iron  oxide (E172).</span></p>", "ID": "b3d7b04c-aa5b-4fc4-89c4-24c19a23d42f", "Styles": "margin-left:0in;text-indent:0in;line-height:normal;\ntext-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "ebeabf29-2e9d-4d1f-8e25-fa6d13a5de27", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "b3d7b04c-aa5b-4fc4-89c4-24c19a23d42f"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "8bd825ac-e32f-45da-bfc5-3107b5007225", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "ebeabf29-2e9d-4d1f-8e25-fa6d13a5de27"}, {"Element": "<span lang=\"EN-GB\">The printing ink contains: shellac, propylene\nglycol, potassium hydroxide, and black iron  oxide (E172).</span>", "ID": "46ba579f-014b-4366-8945-5ae7b568d27f", "Styles": "None", "Classes": "None", "Text": "The printing ink contains: shellac, propylene glycol, potassium hydroxide, and black iron  oxide (E172).", "ParentId": "b3d7b04c-aa5b-4fc4-89c4-24c19a23d42f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "976e0aa1-d803-404e-bea7-283c29a38225", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "a572cfe2-3f69-462a-a0a0-615a5a8d7767", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "976e0aa1-d803-404e-bea7-283c29a38225"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "01d4f91e-45d9-40a8-b45f-6bf7dea13194", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a572cfe2-3f69-462a-a0a0-615a5a8d7767"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsule: </span></p>", "ID": "3368a6ce-622d-4c17-ba64-2bfbb2e31553", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">NINLARO 3\u00a0mg hard capsule: </span>", "ID": "b45aeaef-64f4-402c-a13d-c20a01828f68", "Styles": "None", "Classes": "None", "Text": "NINLARO 3\u00a0mg hard capsule: ", "ParentId": "3368a6ce-622d-4c17-ba64-2bfbb2e31553"}, {"Element": "<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The active substance is\nixazomib. Each capsule contains 3\u00a0mg of ixazomib (as 4.3\u00a0mg of\nixazomib citrate). </span></p>", "ID": "9b11a06d-f6b0-4aea-ad34-2b9d34aeab9d", "Styles": "margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "6744e7e7-ef64-46e8-b16c-9363a9c53ba6", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "9b11a06d-f6b0-4aea-ad34-2b9d34aeab9d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "9044f1ee-0357-48ca-829e-b4e4a1e23a4d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "6744e7e7-ef64-46e8-b16c-9363a9c53ba6"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The active substance is\nixazomib. Each capsule contains 3\u00a0mg of ixazomib (as 4.3\u00a0mg of\nixazomib citrate). </span>", "ID": "bdc0546d-ef64-41fc-a782-b66e57e45fe5", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The active substance is ixazomib. Each capsule contains 3\u00a0mg of ixazomib (as 4.3\u00a0mg of ixazomib citrate). ", "ParentId": "9b11a06d-f6b0-4aea-ad34-2b9d34aeab9d"}, {"Element": "<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The other ingredients are:</span></p>", "ID": "41708818-c603-43cb-af8e-159ae21e1a34", "Styles": "margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "2c04a02e-8888-48fc-b751-6d02b3dc25b0", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "41708818-c603-43cb-af8e-159ae21e1a34"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "79aa1b90-0efd-4a48-80a4-be6e13bdbfc6", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "2c04a02e-8888-48fc-b751-6d02b3dc25b0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The other ingredients are:</span>", "ID": "bc848f04-d037-4dbf-a4d0-37ed8d319b3f", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The other ingredients are:", "ParentId": "41708818-c603-43cb-af8e-159ae21e1a34"}, {"Element": "<p class=\"Default\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">In the capsule: microcrystalline\ncellulose, magnesium stearate and talc.</span></p>", "ID": "53a2470d-d0ce-4399-ab5a-9980e8df85cd", "Styles": "margin-left:56.7pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "00fa3127-ec9d-4f61-92d9-a2a01468e5e4", "Styles": "font-size:11.0pt;font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "53a2470d-d0ce-4399-ab5a-9980e8df85cd"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "28fb1394-17be-4a32-a054-3f92d9f19a3d", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "00fa3127-ec9d-4f61-92d9-a2a01468e5e4"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">In the capsule: microcrystalline\ncellulose, magnesium stearate and talc.</span>", "ID": "670ca826-0796-4852-ad12-9abe85e71a30", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "In the capsule: microcrystalline cellulose, magnesium stearate and talc.", "ParentId": "53a2470d-d0ce-4399-ab5a-9980e8df85cd"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The capsule shell contains: gelatin, titanium\ndioxide (E171) and black iron oxide (E172) </span></p>", "ID": "60bce16a-aaf8-4107-87c4-2190e0b8623d", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "1332ca48-ef85-407a-83e8-d346efbf4d00", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "60bce16a-aaf8-4107-87c4-2190e0b8623d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "ae664703-e8a8-4dfc-bea1-1b85329a546c", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "1332ca48-ef85-407a-83e8-d346efbf4d00"}, {"Element": "<span lang=\"EN-GB\">The capsule shell contains: gelatin, titanium\ndioxide (E171) and black iron oxide (E172) </span>", "ID": "68719277-088c-463d-9ff9-9f4b727e84a6", "Styles": "None", "Classes": "None", "Text": "The capsule shell contains: gelatin, titanium dioxide (E171) and black iron oxide (E172) ", "ParentId": "60bce16a-aaf8-4107-87c4-2190e0b8623d"}, {"Element": "<p class=\"MsoNormal\" style=\"margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none\"><span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\">The printing ink contains: shellac, propylene\nglycol, potassium hydroxide, and black iron oxide (E172).</span></p>", "ID": "1ec34ad9-6589-4d4e-99f5-4dd5c93bf58d", "Styles": "margin-left:56.7pt;text-indent:-28.35pt;line-height:\nnormal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "f29a8df1-09a2-48e4-8927-b77dc1d106e9", "Styles": "font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "1ec34ad9-6589-4d4e-99f5-4dd5c93bf58d"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "d0d83840-d5bc-4d26-8644-065bf40be850", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "f29a8df1-09a2-48e4-8927-b77dc1d106e9"}, {"Element": "<span lang=\"EN-GB\">The printing ink contains: shellac, propylene\nglycol, potassium hydroxide, and black iron oxide (E172).</span>", "ID": "03e5594e-098c-4bfc-97f2-cabf359a7b18", "Styles": "None", "Classes": "None", "Text": "The printing ink contains: shellac, propylene glycol, potassium hydroxide, and black iron oxide (E172).", "ParentId": "1ec34ad9-6589-4d4e-99f5-4dd5c93bf58d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "ba396ddf-dede-437e-8364-161b398c3b20", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "728ef386-4b17-4b09-9e75-e1b95b81d983", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ba396ddf-dede-437e-8364-161b398c3b20"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO 4\u00a0mg hard capsule: </span></p>", "ID": "fc9678f0-b2e5-460f-b2d6-856f4eff3767", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO 4\u00a0mg hard capsule: </span>", "ID": "d465418b-6ed9-4bbd-a3cb-74e21096eb66", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "NINLARO 4\u00a0mg hard capsule: ", "ParentId": "fc9678f0-b2e5-460f-b2d6-856f4eff3767"}, {"Element": "<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The active substance is\nixazomib. Each capsule contains 4\u00a0mg of ixazomib (as 5.7\u00a0mg of\nixazomib citrate). </span></p>", "ID": "0113abb3-2bd1-40cb-a1e6-6364f5ad7ffc", "Styles": "margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "a86c3a27-7a73-4bab-93fa-be9895c0736b", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "0113abb3-2bd1-40cb-a1e6-6364f5ad7ffc"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "9b7651f5-41b3-4b46-81b4-4519c1cfbf4a", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "a86c3a27-7a73-4bab-93fa-be9895c0736b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The active substance is\nixazomib. Each capsule contains 4\u00a0mg of ixazomib (as 5.7\u00a0mg of\nixazomib citrate). </span>", "ID": "e38ccad9-138e-475e-b9fe-37704f48dcb6", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The active substance is ixazomib. Each capsule contains 4\u00a0mg of ixazomib (as 5.7\u00a0mg of ixazomib citrate). ", "ParentId": "0113abb3-2bd1-40cb-a1e6-6364f5ad7ffc"}, {"Element": "<p class=\"Default\" style=\"margin-left:28.35pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The other ingredients are</span></p>", "ID": "a5f17b48-4eef-4071-a9c0-94e9ea2b10ff", "Styles": "margin-left:28.35pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">-<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "62d01d50-7c31-4a81-931f-70c8b6c96f7e", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "-", "ParentId": "a5f17b48-4eef-4071-a9c0-94e9ea2b10ff"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "fa4ef427-6f3a-44a4-861b-9d1915ae772f", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "62d01d50-7c31-4a81-931f-70c8b6c96f7e"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The other ingredients are</span>", "ID": "7fd4a594-375a-40fb-ab37-2a384e0ddbbe", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The other ingredients are", "ParentId": "a5f17b48-4eef-4071-a9c0-94e9ea2b10ff"}, {"Element": "<p class=\"Default\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">In the capsule: microcrystalline\ncellulose, magnesium stearate and talc.</span></p>", "ID": "cfcbf8df-28e4-48ca-bfb9-ff2776564da9", "Styles": "margin-left:56.7pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "5f5d718d-edac-4bf0-b9c2-396a0e39b779", "Styles": "font-size:11.0pt;font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "cfcbf8df-28e4-48ca-bfb9-ff2776564da9"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "52ed0fa1-565f-4ead-9157-0595b03b80f1", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "5f5d718d-edac-4bf0-b9c2-396a0e39b779"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">In the capsule: microcrystalline\ncellulose, magnesium stearate and talc.</span>", "ID": "937a81ab-3185-45b4-a81a-0088948ba796", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "In the capsule: microcrystalline cellulose, magnesium stearate and talc.", "ParentId": "cfcbf8df-28e4-48ca-bfb9-ff2776564da9"}, {"Element": "<p class=\"Default\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The capsule shell\ncontains: gelatin, titanium dioxide (E171), yellow iron oxide (E172) and red\niron oxide (E172) </span></p>", "ID": "a405369a-9382-457b-93d2-e80fad8c7346", "Styles": "margin-left:56.7pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "380bae36-7305-494a-b69c-ff6bc9d4d298", "Styles": "font-size:11.0pt;font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "a405369a-9382-457b-93d2-e80fad8c7346"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "31f17fc8-ed2a-49dc-9255-0e718d4fed91", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "380bae36-7305-494a-b69c-ff6bc9d4d298"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The capsule shell\ncontains: gelatin, titanium dioxide (E171), yellow iron oxide (E172) and red\niron oxide (E172) </span>", "ID": "b6f18c3e-7bd4-435e-9ac9-7657c47d990a", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The capsule shell contains: gelatin, titanium dioxide (E171), yellow iron oxide (E172) and red iron oxide (E172) ", "ParentId": "a405369a-9382-457b-93d2-e80fad8c7346"}, {"Element": "<p class=\"Default\" style=\"margin-left:56.7pt;text-indent:-28.35pt\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span><span lang=\"EN-GB\" style=\"font-size:11.0pt\">The printing ink\ncontains: shellac, propylene glycol, potassium hydroxide, and black iron oxide\n(E172).</span></p>", "ID": "15d68ba6-2c59-416e-a8d9-6b1ff12ebdc2", "Styles": "margin-left:56.7pt;text-indent:-28.35pt", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;font-family:Symbol\">\u00b7<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span></span>", "ID": "73ae396c-923f-4f9e-abef-591fc5b59891", "Styles": "font-size:11.0pt;font-family:Symbol", "Classes": "None", "Text": "\u00b7", "ParentId": "15d68ba6-2c59-416e-a8d9-6b1ff12ebdc2"}, {"Element": "<span style='font:7.0pt \"Times New Roman\"'>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\n</span>", "ID": "67c91810-4c76-4977-96e5-e1eaa1a20a89", "Styles": "font:7.0pt \"Times New Roman\"", "Classes": "None", "Text": "\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ", "ParentId": "73ae396c-923f-4f9e-abef-591fc5b59891"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">The printing ink\ncontains: shellac, propylene glycol, potassium hydroxide, and black iron oxide\n(E172).</span>", "ID": "75f6e81c-47f4-4653-8468-555212d98a03", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "The printing ink contains: shellac, propylene glycol, potassium hydroxide, and black iron oxide (E172).", "ParentId": "15d68ba6-2c59-416e-a8d9-6b1ff12ebdc2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "3dd5344b-dfc7-464f-aba2-21be469aafbe", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "e819b652-9622-47c2-95d5-94addfda1caf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "3dd5344b-dfc7-464f-aba2-21be469aafbe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "3aae9a31-41d6-49ed-a88d-6b4e1478c195", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "f2c889db-25a4-4c16-98aa-c7d2e460a436", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3aae9a31-41d6-49ed-a88d-6b4e1478c195"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "43172ad7-4220-44ce-b08a-4d1700537c69", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "f2c889db-25a4-4c16-98aa-c7d2e460a436"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">What NINLARO looks like and contents of the pack</span></b></p>", "ID": "a0af5b69-fd78-4af8-bea1-847b5d942ba3", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">What NINLARO looks like and contents of the pack</span></b>", "ID": "7b9339db-1d3d-4fd9-90c3-74ee4804a73d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a0af5b69-fd78-4af8-bea1-847b5d942ba3"}, {"Element": "<span lang=\"EN-GB\">What NINLARO looks like and contents of the pack</span>", "ID": "de614ec3-8397-4a0f-b2e1-48329b7f6504", "Styles": "None", "Classes": "None", "Text": "What NINLARO looks like and contents of the pack", "ParentId": "7b9339db-1d3d-4fd9-90c3-74ee4804a73d"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO 2.3\u00a0mg hard capsule: Light\npink, size 4, marked \u201cTakeda\u201d on the cap and \u201c2.3\u00a0mg\u201d\non the body with black ink.</span></p>", "ID": "d889b0a4-0ceb-4413-81aa-c59982b9fb8a", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO 2.3\u00a0mg hard capsule: Light\npink, size 4, marked \u201cTakeda\u201d on the cap and \u201c2.3\u00a0mg\u201d\non the body with black ink.</span>", "ID": "c6b1d0b9-00e7-471b-85d7-49546b33aa26", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "NINLARO 2.3\u00a0mg hard capsule: Light pink, size 4, marked \u201cTakeda\u201d on the cap and \u201c2.3\u00a0mg\u201d on the body with black ink.", "ParentId": "d889b0a4-0ceb-4413-81aa-c59982b9fb8a"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "ae25fa0e-55cd-4caf-b521-ab700fbf9d23", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "42d27f43-d8d5-4188-b49d-4cc4fa32ed22", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "ae25fa0e-55cd-4caf-b521-ab700fbf9d23"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO\n3\u00a0mg hard capsule:</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Light\ngrey, size 4, marked \u201cTakeda\u201d on the cap and\n\u201c3\u00a0mg\u201d on the body with black ink.</span></p>", "ID": "00f1fbcc-bc97-4b03-8adc-f19b9fc5def1", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO\n3\u00a0mg hard capsule:</span>", "ID": "b19b31a8-00fd-41ef-a2e3-fbc326861be1", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "NINLARO 3\u00a0mg hard capsule:", "ParentId": "00f1fbcc-bc97-4b03-8adc-f19b9fc5def1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> </span>", "ID": "0fe1cafe-db58-46c0-9086-013e2f13e1b0", "Styles": "font-size:11.0pt;\ncolor:windowtext", "Classes": "None", "Text": " ", "ParentId": "00f1fbcc-bc97-4b03-8adc-f19b9fc5def1"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Light\ngrey, size 4, marked \u201cTakeda\u201d on the cap and\n\u201c3\u00a0mg\u201d on the body with black ink.</span>", "ID": "71426608-dadf-431f-923e-80e35db43a77", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Light grey, size 4, marked \u201cTakeda\u201d on the cap and \u201c3\u00a0mg\u201d on the body with black ink.", "ParentId": "00f1fbcc-bc97-4b03-8adc-f19b9fc5def1"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "8aba3aeb-6e56-4a30-b6f9-bdff8e73a0c1", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "81d36fd4-c773-4abb-8cb7-71fecedea846", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "8aba3aeb-6e56-4a30-b6f9-bdff8e73a0c1"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO\n4\u00a0mg hard capsule:</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Light\norange, size 3, marked \u201cTakeda\u201d on the cap and\n\u201c4\u00a0mg\u201d on the body with black ink.</span></p>", "ID": "b6e4ee05-5845-4189-ac91-d14cbe02c8f5", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">NINLARO\n4\u00a0mg hard capsule:</span>", "ID": "00b73847-f4f1-40a4-98a4-231a8d0d5b33", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "NINLARO 4\u00a0mg hard capsule:", "ParentId": "b6e4ee05-5845-4189-ac91-d14cbe02c8f5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;\ncolor:windowtext\"> </span>", "ID": "3b6e8694-c3cb-43f5-a2be-797c295baed6", "Styles": "font-size:11.0pt;\ncolor:windowtext", "Classes": "None", "Text": " ", "ParentId": "b6e4ee05-5845-4189-ac91-d14cbe02c8f5"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Light\norange, size 3, marked \u201cTakeda\u201d on the cap and\n\u201c4\u00a0mg\u201d on the body with black ink.</span>", "ID": "efded214-360c-4988-9c80-6137df0515c2", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Light orange, size 3, marked \u201cTakeda\u201d on the cap and \u201c4\u00a0mg\u201d on the body with black ink.", "ParentId": "b6e4ee05-5845-4189-ac91-d14cbe02c8f5"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "fc93e3fe-fcc5-428c-9c21-c483f09830ea", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "519b0afb-c2ae-49f2-a48f-7de2b85778e0", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "fc93e3fe-fcc5-428c-9c21-c483f09830ea"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Each pack\ncontains 3\u00a0hard capsules (three single cartons, each containing a blister\nsealed inside a wallet. Each blister contains one capsule).</span></p>", "ID": "a9c4ad65-d98b-4c77-a4dd-d0dadeae0d56", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Each pack\ncontains 3\u00a0hard capsules (three single cartons, each containing a blister\nsealed inside a wallet. Each blister contains one capsule).</span>", "ID": "b17478c6-5934-4ba4-8911-cc6ef0fb8af5", "Styles": "None", "Classes": "None", "Text": "Each pack contains 3\u00a0hard capsules (three single cartons, each containing a blister sealed inside a wallet. Each blister contains one capsule).", "ParentId": "a9c4ad65-d98b-4c77-a4dd-d0dadeae0d56"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "c78f30d2-dc49-431e-b05b-aa4efae2e412", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f79bf7ff-b40f-4888-8b2e-e6c0f2c5c810", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "c78f30d2-dc49-431e-b05b-aa4efae2e412"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Marketing Authorisation Holder </span></b></p>", "ID": "41c5d5e0-8da9-47f5-b401-c5e6d7d74aca", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Marketing Authorisation Holder </span></b>", "ID": "9ea28261-7bb0-4e08-ad37-ac7a827d148c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "41c5d5e0-8da9-47f5-b401-c5e6d7d74aca"}, {"Element": "<span lang=\"EN-GB\">Marketing Authorisation Holder </span>", "ID": "c9cacf44-0232-4c28-b9f1-d5c079ca39f1", "Styles": "None", "Classes": "None", "Text": "Marketing Authorisation Holder ", "ParentId": "9ea28261-7bb0-4e08-ad37-ac7a827d148c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Pharma\nA/S</span></p>", "ID": "fb3f1f9e-1c9a-4a3b-bf02-241df308c48a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Pharma\nA/S</span>", "ID": "4088ba3f-f133-4005-b03e-b1a7c7279619", "Styles": "None", "Classes": "None", "Text": "Takeda Pharma A/S", "ParentId": "fb3f1f9e-1c9a-4a3b-bf02-241df308c48a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span><span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span></p>", "ID": "d25c62b8-230d-4ff9-871f-63e821066e6e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span class=\"readonlyfield1\"><span lang=\"EN-GB\">Delta Park 45</span></span>", "ID": "a19d5f85-a6ad-42dc-b806-0678aedec6a0", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "", "ParentId": "d25c62b8-230d-4ff9-871f-63e821066e6e"}, {"Element": "<span lang=\"EN-GB\">Delta Park 45</span>", "ID": "ac44f8a0-2a5f-4247-a228-5c87b68df11b", "Styles": "None", "Classes": "None", "Text": "Delta Park 45", "ParentId": "a19d5f85-a6ad-42dc-b806-0678aedec6a0"}, {"Element": "<span lang=\"EN-GB\" style=\"border:none windowtext 1.0pt;\npadding:0in\"><br/>\n<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span></span>", "ID": "2cdce33d-e38b-400a-97d1-0948445148ef", "Styles": "border:none windowtext 1.0pt;\npadding:0in", "Classes": "None", "Text": " ", "ParentId": "d25c62b8-230d-4ff9-871f-63e821066e6e"}, {"Element": "<br/>", "ID": "9e1d20e1-7fcd-48bd-8241-410f362917ad", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2cdce33d-e38b-400a-97d1-0948445148ef"}, {"Element": "<span class=\"readonlyfield1\">2665 Vallensbaek Strand</span>", "ID": "00b956b0-c110-43cb-98d1-b12705da6e52", "Styles": "None", "Classes": "['readonlyfield1']", "Text": "2665 Vallensbaek Strand", "ParentId": "2cdce33d-e38b-400a-97d1-0948445148ef"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Denmark</span></p>", "ID": "fe2b96f9-963f-4ebf-8f19-326d070aca40", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Denmark</span>", "ID": "af38396b-03eb-4f7d-befd-cd2d6a5d6d24", "Styles": "None", "Classes": "None", "Text": "Denmark", "ParentId": "fe2b96f9-963f-4ebf-8f19-326d070aca40"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "74a789ea-e162-448c-b38b-bc13ed532d7d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8dfd6ece-3642-4883-a471-4a27081c3a4d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "74a789ea-e162-448c-b38b-bc13ed532d7d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Manufacturer</span></b></p>", "ID": "b1d326da-0240-45a3-b040-c5759225f97d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Manufacturer</span></b>", "ID": "ad6fe171-b254-4020-89f3-5c693de6a1f8", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b1d326da-0240-45a3-b040-c5759225f97d"}, {"Element": "<span lang=\"EN-GB\">Manufacturer</span>", "ID": "8a64ba4c-dfd1-4428-aab8-3e27b35601f0", "Styles": "None", "Classes": "None", "Text": "Manufacturer", "ParentId": "ad6fe171-b254-4020-89f3-5c693de6a1f8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Takeda Ireland\nLimited</span></p>", "ID": "c7f14bda-1524-4f80-94ca-36b32b8fac76", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Takeda Ireland\nLimited</span>", "ID": "ef0dbbfe-4c22-4754-8b29-61079193b506", "Styles": "None", "Classes": "None", "Text": "Takeda Ireland Limited", "ParentId": "c7f14bda-1524-4f80-94ca-36b32b8fac76"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Grange Castle\nBusiness Park</span></p>", "ID": "f4652c8f-b4c5-43ad-8bc6-272468bb5d3d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Grange Castle\nBusiness Park</span>", "ID": "d2fa58df-0cb4-4b31-9fcc-2ce37e46047e", "Styles": "None", "Classes": "None", "Text": "Grange Castle Business Park", "ParentId": "f4652c8f-b4c5-43ad-8bc6-272468bb5d3d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Dublin 22</span></p>", "ID": "0c52dd1d-0f2c-4837-98c1-45a721f00d47", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Dublin 22</span>", "ID": "6d4f1a68-3d01-41d0-b463-ed38bd3630ca", "Styles": "None", "Classes": "None", "Text": "Dublin 22", "ParentId": "0c52dd1d-0f2c-4837-98c1-45a721f00d47"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">D22 XR57</span></p>", "ID": "675e52ee-b0e2-4a9b-8277-4d331d209982", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">D22 XR57</span>", "ID": "011ecacf-942c-494b-9a58-589cb6b820e5", "Styles": "None", "Classes": "None", "Text": "D22 XR57", "ParentId": "675e52ee-b0e2-4a9b-8277-4d331d209982"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Ireland</span></p>", "ID": "b911b684-fd32-4085-b9b9-323f2f762fde", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "a5c67c37-55a2-47af-8143-843597b764ab", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "b911b684-fd32-4085-b9b9-323f2f762fde"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "a895707f-4747-46d8-9951-08605f67ae3c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a482d196-f85b-4ca3-9781-3b6e31c88d70", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a895707f-4747-46d8-9951-08605f67ae3c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Takeda Pharma A/S</span></p>", "ID": "2956baac-d6e7-4fd0-b444-73e93d8f5502", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">Takeda Pharma A/S</span>", "ID": "d9f57c85-6a59-4dc7-b231-9f95fdf1dd70", "Styles": "background:silver", "Classes": "None", "Text": "Takeda Pharma A/S", "ParentId": "2956baac-d6e7-4fd0-b444-73e93d8f5502"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Dybendal Alle 10</span></p>", "ID": "6ed684e5-36b0-4899-b82b-e58344887f58", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">Dybendal Alle 10</span>", "ID": "2b88818d-3d7c-40f4-919b-138805f0f4e6", "Styles": "background:silver", "Classes": "None", "Text": "Dybendal Alle 10", "ParentId": "6ed684e5-36b0-4899-b82b-e58344887f58"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">2630 Taastrup</span></p>", "ID": "71f9b674-e3bb-43ae-9592-f7200659bbf5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">2630 Taastrup</span>", "ID": "161b63b8-ca6b-4e25-bc66-08b2d555dcd5", "Styles": "background:silver", "Classes": "None", "Text": "2630 Taastrup", "ParentId": "71f9b674-e3bb-43ae-9592-f7200659bbf5"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Denmark</span></p>", "ID": "5ea4c374-3895-4517-8b3a-6e9cc9536961", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">Denmark</span>", "ID": "44714848-af9e-4592-b036-596d907ff680", "Styles": "background:silver", "Classes": "None", "Text": "Denmark", "ParentId": "5ea4c374-3895-4517-8b3a-6e9cc9536961"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "5121e839-a482-4ee6-b764-50fc9fcf99f9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b19d70fb-eece-4982-93ed-c291ed95b6d8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5121e839-a482-4ee6-b764-50fc9fcf99f9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Takeda GmbH</span></p>", "ID": "d72c9889-fd61-4e8a-b234-873c28e613e2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">Takeda GmbH</span>", "ID": "958324c4-4b60-4be4-9ce1-4abb978ff20d", "Styles": "background:silver", "Classes": "None", "Text": "Takeda GmbH", "ParentId": "d72c9889-fd61-4e8a-b234-873c28e613e2"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\" style=\"background:\nsilver\">Takeda (Werk Singen)</span></p>", "ID": "8dfde51d-904b-49e7-8b7e-248582f27035", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"DE\" style=\"background:\nsilver\">Takeda (Werk Singen)</span>", "ID": "ed119e8c-6983-4e27-8807-5d64c433b6f3", "Styles": "background:\nsilver", "Classes": "None", "Text": "Takeda (Werk Singen)", "ParentId": "8dfde51d-904b-49e7-8b7e-248582f27035"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\" style=\"background:\nsilver\">Robert Bosch Stra\u00dfe 8</span></p>", "ID": "5630c78e-8387-444c-8703-e42a628aeec8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"DE\" style=\"background:\nsilver\">Robert Bosch Stra\u00dfe 8</span>", "ID": "908bee88-4a89-476a-abcb-ca31d7d81b46", "Styles": "background:\nsilver", "Classes": "None", "Text": "Robert Bosch Stra\u00dfe 8", "ParentId": "5630c78e-8387-444c-8703-e42a628aeec8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">78224 Singen</span></p>", "ID": "569b8315-510c-4016-88a9-dfdd698b2a2a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">78224 Singen</span>", "ID": "b4df3a16-8c46-4401-b58b-229355a86d5f", "Styles": "background:silver", "Classes": "None", "Text": "78224 Singen", "ParentId": "569b8315-510c-4016-88a9-dfdd698b2a2a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\" style=\"background:silver\">Germany</span></p>", "ID": "62583900-15bd-49fb-8f91-2948197499aa", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\" style=\"background:silver\">Germany</span>", "ID": "bb7a2f31-c069-4f07-b7e1-cafa246068b8", "Styles": "background:silver", "Classes": "None", "Text": "Germany", "ParentId": "62583900-15bd-49fb-8f91-2948197499aa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6163765f-6abe-48c2-b87d-579f9e6ab638", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "f93c9f94-2495-4b4a-b1f3-289fd7577bcf", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6163765f-6abe-48c2-b87d-579f9e6ab638"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">For any\ninformation about this medicine, please contact the local representative of the\nMarketing Authorisation Holder:</span></p>", "ID": "3e44c0b9-4aa8-4c3b-a820-03705dfbdbc1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">For any\ninformation about this medicine, please contact the local representative of the\nMarketing Authorisation Holder:</span>", "ID": "9508faf8-558d-44c5-b921-ad7cd2294f38", "Styles": "None", "Classes": "None", "Text": "For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:", "ParentId": "3e44c0b9-4aa8-4c3b-a820-03705dfbdbc1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e29ca0ce-f289-47eb-8be6-5ae12a2f8d30", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c73e1a49-abc0-445d-a1c1-db949afbc139", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e29ca0ce-f289-47eb-8be6-5ae12a2f8d30"}, {"Element": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"MsoNormalTable\" style=\"margin-left:-1.7pt;border-collapse:collapse\" width=\"624\">\n<tr style=\"height:67.3pt\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.3pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">takeda-belgium@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.3pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"FI\">Lietuva</span></b></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda,\n  UAB </span></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +370 521 09 070 </span></p>\n<p class=\"Default\"><span lang=\"FI\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0430\u043a\u0435\u0434\u0430\n  \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0435\u043b.:\n  + 359 2 958 27 36</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">takeda-belgium@takeda.com\n  </span></p>\n</td>\n</tr>\n<tr style=\"height:67.75pt\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.75pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Czech\n  Republic s.r.o. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  + 420 234 722 722 </span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.75pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Kft. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +361\n  2707030 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma A/S </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +45 46 77 11 11 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FI\">Malta</span></b></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 06\n  502601 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +49 (0) 800 825 3325</span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt\">medinfoEMEA@takeda.com</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Nederland</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Nederland bv </span></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +31 23 56 68 777 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">nl.medical.info@takeda.com\n  </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"PT-BR\">Eesti</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda Pharma AS </span></p>\n<p class=\"Default\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +372 6177 669 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-NYN\">Norge</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  AS </span></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +47 6676 3030 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">infonorge@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">TAKEDA\n  </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395\u039b\u039b\u0391\u03a3</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0391</span><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">.</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">T\u03b7\u03bb</span><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">: +30 210 6387800</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">gr.info@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">\u00d6sterreich</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Ges.m.b.H. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +43 (0)\n  800-20 80 50 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Espa\u00f1a</span></b></p>\n<p class=\"Default\"><span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00e9utica Espa\u00f1a S.A </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +34 917 90 42 22</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">spain@takeda.com</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PL\">Polska</span></b></p>\n<p class=\"Default\"><span lang=\"PL\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma sp. z o.o</span></p>\n<p class=\"Default\"><span lang=\"PL\" style=\"font-size:11.0pt\">Tel.: + 48 22 608 13\n  00 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\">France</span></b></p>\n<p class=\"Default\"><span lang=\"FR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  France SAS</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">T\u00e9l:</span><span lang=\"FR\"> </span><span lang=\"FR\">+ 33 1 40 67 33 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">medinfoEMEA@takeda.com</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Portugal</span></b></p>\n<p class=\"Default\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00eauticos Portugal, Lda. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 351 21\n  120 1457 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Croatia d.o.o. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +385 1 377 88 96 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Products Ireland Limited </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +353 (0) 1 6420021 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals SRL </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +40 21\n  335 03 91 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-NYN\">Slovenija</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH Podru\u017enica Slovenija </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">Tel.+ 386 (0)\n  59 082 480 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vistor hf. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi</span><span lang=\"EN-GB\">: +354 535 7000 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">vistor@vistor.is\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Slovakia s.r.o. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +421 (2)\n  20 602 600 </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Italia</span></b></p>\n<p class=\"Default\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 06\n  502601 </span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Suomi/Finland</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Oy</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Puh/Tel:</span><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\"> +358 20 746 5000 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">\u00a0</span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"Default\"><span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">A. Potamitis Medicare\n  Ltd</span></p>\n<p class=\"Default\"><span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">T</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u03b7\u03bb</span><span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">: </span><span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">+357 22583333</span></p>\n<p class=\"Default\"><span lang=\"ES\" style=\"font-size:11.0pt\">info@potamitismedicare.com</span><span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Sverige</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma AB </span></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +46 8 731 28 00 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">infosweden@takeda.com\n  </span></p>\n</td>\n</tr>\n<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">Latvija</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda Latvia SIA </span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Tel: +371 67840082 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">United Kingdom</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda UK Ltd </span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel: +44 (0)1628 537 900 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>\n</table>", "ID": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f", "Styles": "margin-left:-1.7pt;border-collapse:collapse", "Classes": "['MsoNormalTable']", "Text": "               ", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<tr style=\"height:67.3pt\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.3pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">takeda-belgium@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.3pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"FI\">Lietuva</span></b></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda,\n  UAB </span></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +370 521 09 070 </span></p>\n<p class=\"Default\"><span lang=\"FI\">\u00a0</span></p>\n</td>\n</tr>", "ID": "23032af7-64cd-4433-961b-cce5a388035d", "Styles": "height:67.3pt", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.3pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">takeda-belgium@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "0490018a-f5b1-4fde-b7ff-bcf51bd7ef26", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.3pt", "Classes": "None", "Text": "      ", "ParentId": "23032af7-64cd-4433-961b-cce5a388035d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien</span></b></p>", "ID": "b9ee3fce-889f-4828-ba1f-8914d89914d3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0490018a-f5b1-4fde-b7ff-bcf51bd7ef26"}, {"Element": "<b><span lang=\"DE\">Belgi\u00eb/Belgique/Belgien</span></b>", "ID": "e8b471df-7c20-4631-ac66-661165412e1f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b9ee3fce-889f-4828-ba1f-8914d89914d3"}, {"Element": "<span lang=\"DE\">Belgi\u00eb/Belgique/Belgien</span>", "ID": "b08989b4-3fad-40ac-b3d6-56e4e34d0ab7", "Styles": "None", "Classes": "None", "Text": "Belgi\u00eb/Belgique/Belgien", "ParentId": "e8b471df-7c20-4631-ac66-661165412e1f"}, {"Element": "<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span></p>", "ID": "c6f06563-34b9-4d31-97df-10981da5da68", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "0490018a-f5b1-4fde-b7ff-bcf51bd7ef26"}, {"Element": "<span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span>", "ID": "7bd4ff14-6df2-4cb8-9770-f0602f477a0a", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Belgium ", "ParentId": "c6f06563-34b9-4d31-97df-10981da5da68"}, {"Element": "<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span></p>", "ID": "e2b8a510-0477-40e6-abf3-370609909736", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "0490018a-f5b1-4fde-b7ff-bcf51bd7ef26"}, {"Element": "<span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span>", "ID": "5bf92a7e-82cf-476a-9b55-0d7af65895af", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel/T\u00e9l:   +32 2 464 06 11 ", "ParentId": "e2b8a510-0477-40e6-abf3-370609909736"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">takeda-belgium@takeda.com\n  </span></p>", "ID": "8a19dbe8-588b-4160-ad57-f9e2935e5836", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "0490018a-f5b1-4fde-b7ff-bcf51bd7ef26"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">takeda-belgium@takeda.com\n  </span>", "ID": "c1c39024-f82b-4561-ab1b-64c0ebde1872", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "takeda-belgium@takeda.com   ", "ParentId": "8a19dbe8-588b-4160-ad57-f9e2935e5836"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "e46d5e00-0d6c-4c6a-9c7f-9cdef68cc9cf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "0490018a-f5b1-4fde-b7ff-bcf51bd7ef26"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "7ba00c89-025a-48d2-b1d5-a7810586f05d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e46d5e00-0d6c-4c6a-9c7f-9cdef68cc9cf"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.3pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"FI\">Lietuva</span></b></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda,\n  UAB </span></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +370 521 09 070 </span></p>\n<p class=\"Default\"><span lang=\"FI\">\u00a0</span></p>\n</td>", "ID": "bba86af4-8903-4aa0-a8a7-39dcd6a77759", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.3pt", "Classes": "None", "Text": "     ", "ParentId": "23032af7-64cd-4433-961b-cce5a388035d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"FI\">Lietuva</span></b></p>", "ID": "bfd93985-a6e8-4118-8db1-ca558b76ec0a", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bba86af4-8903-4aa0-a8a7-39dcd6a77759"}, {"Element": "<b><span lang=\"FI\">Lietuva</span></b>", "ID": "cef9b12b-8506-42e8-99a4-e88178c66926", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bfd93985-a6e8-4118-8db1-ca558b76ec0a"}, {"Element": "<span lang=\"FI\">Lietuva</span>", "ID": "c2c37aec-c0b8-4d99-af77-2525b735ae0c", "Styles": "None", "Classes": "None", "Text": "Lietuva", "ParentId": "cef9b12b-8506-42e8-99a4-e88178c66926"}, {"Element": "<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda,\n  UAB </span></p>", "ID": "f1857bfb-f592-4596-b2e7-b256a72810a2", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bba86af4-8903-4aa0-a8a7-39dcd6a77759"}, {"Element": "<span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda,\n  UAB </span>", "ID": "303efe0f-b1b0-485d-976c-8f2c8eef4391", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda,   UAB ", "ParentId": "f1857bfb-f592-4596-b2e7-b256a72810a2"}, {"Element": "<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +370 521 09 070 </span></p>", "ID": "77805186-b2ea-446a-96bc-f76f1b252c93", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bba86af4-8903-4aa0-a8a7-39dcd6a77759"}, {"Element": "<span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +370 521 09 070 </span>", "ID": "3038cebd-31aa-4357-b2fd-b5d77a22249b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel:   +370 521 09 070 ", "ParentId": "77805186-b2ea-446a-96bc-f76f1b252c93"}, {"Element": "<p class=\"Default\"><span lang=\"FI\">\u00a0</span></p>", "ID": "852ca311-3385-4e68-ac57-a37e12876dc6", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "bba86af4-8903-4aa0-a8a7-39dcd6a77759"}, {"Element": "<span lang=\"FI\">\u00a0</span>", "ID": "f6670cd4-6913-4f2d-96a1-09aaeb2ff635", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "852ca311-3385-4e68-ac57-a37e12876dc6"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0430\u043a\u0435\u0434\u0430\n  \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0435\u043b.:\n  + 359 2 958 27 36</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">takeda-belgium@takeda.com\n  </span></p>\n</td>\n</tr>", "ID": "f63e7aab-0711-4c50-bc22-b5284e0a8cb0", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0430\u043a\u0435\u0434\u0430\n  \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0435\u043b.:\n  + 359 2 958 27 36</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "3ec533bd-ad1e-44d3-aaca-bf8f904c0d0c", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "f63e7aab-0711-4c50-bc22-b5284e0a8cb0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;text-autospace:none\"><b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b></p>", "ID": "909389f2-4c85-4a65-82b1-814d0ee4a2ff", "Styles": "line-height:normal;text-autospace:none", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3ec533bd-ad1e-44d3-aaca-bf8f904c0d0c"}, {"Element": "<b><span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span></b>", "ID": "a7846dfc-e53b-4962-b323-b4b34290d0dc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "909389f2-4c85-4a65-82b1-814d0ee4a2ff"}, {"Element": "<span lang=\"EN-GB\">\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f</span>", "ID": "6051edb4-6a7d-4e41-ad0b-0b11aed468c5", "Styles": "None", "Classes": "None", "Text": "\u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f", "ParentId": "a7846dfc-e53b-4962-b323-b4b34290d0dc"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0430\u043a\u0435\u0434\u0430\n  \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f </span></p>", "ID": "862cd91d-c38b-4851-9389-35114642201b", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "3ec533bd-ad1e-44d3-aaca-bf8f904c0d0c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0430\u043a\u0435\u0434\u0430\n  \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f </span>", "ID": "ae9709f7-7edb-4e74-8392-a4176727c9ac", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u0422\u0430\u043a\u0435\u0434\u0430   \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f ", "ParentId": "862cd91d-c38b-4851-9389-35114642201b"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0435\u043b.:\n  + 359 2 958 27 36</span></p>", "ID": "e16283e3-bf78-4387-8160-8fe939eca644", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "3ec533bd-ad1e-44d3-aaca-bf8f904c0d0c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0422\u0435\u043b.:\n  + 359 2 958 27 36</span>", "ID": "84187431-52d6-4e07-841e-1271129ae4cc", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u0422\u0435\u043b.:   + 359 2 958 27 36", "ParentId": "e16283e3-bf78-4387-8160-8fe939eca644"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span></p>", "ID": "08f8da11-0c44-4e74-844c-aeebabb332a9", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "3ec533bd-ad1e-44d3-aaca-bf8f904c0d0c"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u00a0</span>", "ID": "1164898d-44d7-4f20-8260-73f3a53986dd", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u00a0", "ParentId": "08f8da11-0c44-4e74-844c-aeebabb332a9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "4fe271cd-d408-4486-8577-73cb843b219d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3ec533bd-ad1e-44d3-aaca-bf8f904c0d0c"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "c4fec05e-b48e-4184-b356-46e3746a2299", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4fe271cd-d408-4486-8577-73cb843b219d"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Luxembourg/Luxemburg</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">takeda-belgium@takeda.com\n  </span></p>\n</td>", "ID": "59a01fae-845e-4aae-a314-2a0664011525", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "f63e7aab-0711-4c50-bc22-b5284e0a8cb0"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Luxembourg/Luxemburg</span></b></p>", "ID": "b3589086-b0f3-47d7-b757-271c08b355bb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "59a01fae-845e-4aae-a314-2a0664011525"}, {"Element": "<b><span lang=\"DE\">Luxembourg/Luxemburg</span></b>", "ID": "55ecb78b-88e1-4074-874b-112a943c70e0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b3589086-b0f3-47d7-b757-271c08b355bb"}, {"Element": "<span lang=\"DE\">Luxembourg/Luxemburg</span>", "ID": "2e3bf450-2c93-42ca-89da-b5abaef0e9d0", "Styles": "None", "Classes": "None", "Text": "Luxembourg/Luxemburg", "ParentId": "55ecb78b-88e1-4074-874b-112a943c70e0"}, {"Element": "<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span></p>", "ID": "1dc308a5-21cf-496b-94ed-113d8ed41637", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "59a01fae-845e-4aae-a314-2a0664011525"}, {"Element": "<span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Belgium </span>", "ID": "bd729ade-9802-4583-a898-55e84e28f6c3", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Belgium ", "ParentId": "1dc308a5-21cf-496b-94ed-113d8ed41637"}, {"Element": "<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span></p>", "ID": "6944bf26-a5d4-43fb-859d-08b61fcfde93", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "59a01fae-845e-4aae-a314-2a0664011525"}, {"Element": "<span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel/T\u00e9l:\n  +32 2 464 06 11 </span>", "ID": "2dd0de3a-0399-4fb0-8603-ccdbf3ae7a00", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel/T\u00e9l:   +32 2 464 06 11 ", "ParentId": "6944bf26-a5d4-43fb-859d-08b61fcfde93"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">takeda-belgium@takeda.com\n  </span></p>", "ID": "b5e0c263-51fe-433b-9fd8-22948637f62d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "59a01fae-845e-4aae-a314-2a0664011525"}, {"Element": "<span lang=\"EN-GB\">takeda-belgium@takeda.com\n  </span>", "ID": "9adab492-f9a5-41c6-9d5d-fb646543afcc", "Styles": "None", "Classes": "None", "Text": "takeda-belgium@takeda.com   ", "ParentId": "b5e0c263-51fe-433b-9fd8-22948637f62d"}, {"Element": "<tr style=\"height:67.75pt\">\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.75pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Czech\n  Republic s.r.o. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  + 420 234 722 722 </span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.75pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Kft. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +361\n  2707030 </span></p>\n</td>\n</tr>", "ID": "b7e6aba4-08d7-4718-be45-0b564c599550", "Styles": "height:67.75pt", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.75pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Czech\n  Republic s.r.o. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  + 420 234 722 722 </span></p>\n</td>", "ID": "f8095617-cdaa-4e1e-ace1-b7c7294da240", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.75pt", "Classes": "None", "Text": "     ", "ParentId": "b7e6aba4-08d7-4718-be45-0b564c599550"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b></p>", "ID": "fdad85cd-0bfb-45a8-8ada-70d7e6dd4f7f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f8095617-cdaa-4e1e-ace1-b7c7294da240"}, {"Element": "<b><span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span></b>", "ID": "370c2766-32d8-4cdf-a65e-d85e3ed26de4", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "fdad85cd-0bfb-45a8-8ada-70d7e6dd4f7f"}, {"Element": "<span lang=\"EN-GB\">\u010cesk\u00e1\n  republika</span>", "ID": "9c11007a-e3d2-484d-87d1-b5a5c9797efd", "Styles": "None", "Classes": "None", "Text": "\u010cesk\u00e1   republika", "ParentId": "370c2766-32d8-4cdf-a65e-d85e3ed26de4"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals </span></p>", "ID": "455f2d7c-2926-466f-a2b3-55aefe2240f6", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "f8095617-cdaa-4e1e-ace1-b7c7294da240"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals </span>", "ID": "b9794327-d194-4d09-92f7-10e73876e6e2", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Pharmaceuticals ", "ParentId": "455f2d7c-2926-466f-a2b3-55aefe2240f6"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Czech\n  Republic s.r.o. </span></p>", "ID": "0ddb64eb-7f94-4b29-9fe4-7bd15bbd8386", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "f8095617-cdaa-4e1e-ace1-b7c7294da240"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Czech\n  Republic s.r.o. </span>", "ID": "5fa90e86-4967-4c63-9dfe-35e7a4fbd6ad", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Czech   Republic s.r.o. ", "ParentId": "0ddb64eb-7f94-4b29-9fe4-7bd15bbd8386"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  + 420 234 722 722 </span></p>", "ID": "435133ad-c867-465a-8f29-28da1142d4b0", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "f8095617-cdaa-4e1e-ace1-b7c7294da240"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  + 420 234 722 722 </span>", "ID": "12478bcf-b79d-431e-aa8a-90bda6a4adb8", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel:   + 420 234 722 722 ", "ParentId": "435133ad-c867-465a-8f29-28da1142d4b0"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.75pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Kft. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +361\n  2707030 </span></p>\n</td>", "ID": "b924f347-1fd5-4cf9-ab46-6d0ef4016a59", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt;\n  height:67.75pt", "Classes": "None", "Text": "    ", "ParentId": "b7e6aba4-08d7-4718-be45-0b564c599550"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b></p>", "ID": "3f92d319-214f-4107-8099-8755bf13f0ff", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b924f347-1fd5-4cf9-ab46-6d0ef4016a59"}, {"Element": "<b><span lang=\"EN-GB\">Magyarorsz\u00e1g</span></b>", "ID": "0ac301b1-d8d0-47cd-94b9-48605a3e6c5d", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "3f92d319-214f-4107-8099-8755bf13f0ff"}, {"Element": "<span lang=\"EN-GB\">Magyarorsz\u00e1g</span>", "ID": "d1750883-66ae-4578-8964-d4d5d5fa211d", "Styles": "None", "Classes": "None", "Text": "Magyarorsz\u00e1g", "ParentId": "0ac301b1-d8d0-47cd-94b9-48605a3e6c5d"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Kft. </span></p>", "ID": "db9a3f59-78db-4c76-b9d7-b18e5599b98d", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "b924f347-1fd5-4cf9-ab46-6d0ef4016a59"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Kft. </span>", "ID": "a5d1d100-4ee9-45ba-87de-d180156610a3", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Pharma Kft. ", "ParentId": "db9a3f59-78db-4c76-b9d7-b18e5599b98d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +361\n  2707030 </span></p>", "ID": "6cd75a2f-610b-4bf8-aa5a-ac25e85b6185", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b924f347-1fd5-4cf9-ab46-6d0ef4016a59"}, {"Element": "<span lang=\"EN-GB\">Tel: +361\n  2707030 </span>", "ID": "37befca3-bbec-4097-b1a4-d153d39f51f3", "Styles": "None", "Classes": "None", "Text": "Tel: +361   2707030 ", "ParentId": "6cd75a2f-610b-4bf8-aa5a-ac25e85b6185"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma A/S </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +45 46 77 11 11 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FI\">Malta</span></b></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 06\n  502601 </span></p>\n</td>\n</tr>", "ID": "8ca7f1fd-09c6-470b-acfe-3bca2a81e0f9", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Danmark</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma A/S </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +45 46 77 11 11 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "8f02d56e-f18a-4464-86f0-08b83056db74", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "8ca7f1fd-09c6-470b-acfe-3bca2a81e0f9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Danmark</span></b></p>", "ID": "cdf3965c-6d89-4045-b098-a77ec379ae6d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8f02d56e-f18a-4464-86f0-08b83056db74"}, {"Element": "<b><span lang=\"EN-GB\">Danmark</span></b>", "ID": "a2136cfe-b4be-4cc2-ab6c-dede36a91644", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "cdf3965c-6d89-4045-b098-a77ec379ae6d"}, {"Element": "<span lang=\"EN-GB\">Danmark</span>", "ID": "cf4d341f-c08a-4a03-bbf7-803402d2ffc3", "Styles": "None", "Classes": "None", "Text": "Danmark", "ParentId": "a2136cfe-b4be-4cc2-ab6c-dede36a91644"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma A/S </span></p>", "ID": "3b3ae3c8-9d07-468e-ac3f-246e28d065f9", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "8f02d56e-f18a-4464-86f0-08b83056db74"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma A/S </span>", "ID": "760c7a46-274d-45bc-910c-ca9f3ce65599", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Pharma A/S ", "ParentId": "3b3ae3c8-9d07-468e-ac3f-246e28d065f9"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +45 46 77 11 11 </span></p>", "ID": "e7e59c5e-101a-43a9-9ae3-b757bf938e27", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "8f02d56e-f18a-4464-86f0-08b83056db74"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +45 46 77 11 11 </span>", "ID": "8bb6552b-7b96-4643-a89f-ea70a2a6a16e", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tlf:   +45 46 77 11 11 ", "ParentId": "e7e59c5e-101a-43a9-9ae3-b757bf938e27"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "75ef3789-b03d-4621-b667-411bb110d3c6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "8f02d56e-f18a-4464-86f0-08b83056db74"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8e14834c-c33e-4b4f-9dd4-73254058f639", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "75ef3789-b03d-4621-b667-411bb110d3c6"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FI\">Malta</span></b></p>\n<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 06\n  502601 </span></p>\n</td>", "ID": "ab49ee91-064a-4d41-93b4-b43db348e4bb", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "8ca7f1fd-09c6-470b-acfe-3bca2a81e0f9"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FI\">Malta</span></b></p>", "ID": "48687f20-2ac6-4f8f-8d9b-195afc3dc724", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab49ee91-064a-4d41-93b4-b43db348e4bb"}, {"Element": "<b><span lang=\"FI\">Malta</span></b>", "ID": "6d774db0-b68b-42d7-b97e-880abf4ac9a2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "48687f20-2ac6-4f8f-8d9b-195afc3dc724"}, {"Element": "<span lang=\"FI\">Malta</span>", "ID": "02c8430f-28aa-47f4-ad11-8ea6e5e99035", "Styles": "None", "Classes": "None", "Text": "Malta", "ParentId": "6d774db0-b68b-42d7-b97e-880abf4ac9a2"}, {"Element": "<p class=\"Default\"><span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span></p>", "ID": "a4f66b28-ea84-45cf-b98a-0c08d4812a6b", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ab49ee91-064a-4d41-93b4-b43db348e4bb"}, {"Element": "<span lang=\"FI\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span>", "ID": "7fa68674-42c6-4d6c-9c33-3a3ab711f026", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Italia S.p.A. ", "ParentId": "a4f66b28-ea84-45cf-b98a-0c08d4812a6b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 06\n  502601 </span></p>", "ID": "2ebe5c54-a420-443c-9b2d-cc0e7736cdb0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ab49ee91-064a-4d41-93b4-b43db348e4bb"}, {"Element": "<span lang=\"EN-GB\">Tel: +39 06\n  502601 </span>", "ID": "96912393-8054-4a0d-a7b8-ee0d2853d669", "Styles": "None", "Classes": "None", "Text": "Tel: +39 06   502601 ", "ParentId": "2ebe5c54-a420-443c-9b2d-cc0e7736cdb0"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +49 (0) 800 825 3325</span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt\">medinfoEMEA@takeda.com</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Nederland</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Nederland bv </span></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +31 23 56 68 777 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">nl.medical.info@takeda.com\n  </span></p>\n</td>\n</tr>", "ID": "f020eaa1-2249-4647-bcad-4c86d61cbf9c", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH </span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +49 (0) 800 825 3325</span></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt\">medinfoEMEA@takeda.com</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>\n</td>", "ID": "fd24c6eb-97f4-4bc8-ad7a-6b03d4dab4a9", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "f020eaa1-2249-4647-bcad-4c86d61cbf9c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">Deutschland</span></b></p>", "ID": "b6af08d8-d72d-4042-abc6-6ee64b755b0e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd24c6eb-97f4-4bc8-ad7a-6b03d4dab4a9"}, {"Element": "<b><span lang=\"DE\">Deutschland</span></b>", "ID": "5427b105-3dcd-4b4b-9b95-5f75b377cd14", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "b6af08d8-d72d-4042-abc6-6ee64b755b0e"}, {"Element": "<span lang=\"DE\">Deutschland</span>", "ID": "10a3429d-a9ab-441e-a61f-7e2fbfd1f904", "Styles": "None", "Classes": "None", "Text": "Deutschland", "ParentId": "5427b105-3dcd-4b4b-9b95-5f75b377cd14"}, {"Element": "<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH </span></p>", "ID": "691e7499-a209-41e7-8db6-057454d1366b", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "fd24c6eb-97f4-4bc8-ad7a-6b03d4dab4a9"}, {"Element": "<span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH </span>", "ID": "267f6cd4-5065-4194-8928-1b05abe5dd2d", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   GmbH ", "ParentId": "691e7499-a209-41e7-8db6-057454d1366b"}, {"Element": "<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +49 (0) 800 825 3325</span></p>", "ID": "078e8992-5417-4adf-b395-51baa3142fbf", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "fd24c6eb-97f4-4bc8-ad7a-6b03d4dab4a9"}, {"Element": "<span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +49 (0) 800 825 3325</span>", "ID": "b08fc5b1-caf6-4c01-8269-a4df27832180", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel:   +49 (0) 800 825 3325", "ParentId": "078e8992-5417-4adf-b395-51baa3142fbf"}, {"Element": "<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt\">medinfoEMEA@takeda.com</span></p>", "ID": "d9859243-18a3-404b-9c93-b701e1d05638", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "fd24c6eb-97f4-4bc8-ad7a-6b03d4dab4a9"}, {"Element": "<span lang=\"DE\" style=\"font-size:11.0pt\">medinfoEMEA@takeda.com</span>", "ID": "7c40d416-f372-47f9-b268-500ac9a5c554", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "medinfoEMEA@takeda.com", "ParentId": "d9859243-18a3-404b-9c93-b701e1d05638"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"DE\">\u00a0</span></p>", "ID": "fdec1d92-b593-4609-94dc-6686573b3f68", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "fd24c6eb-97f4-4bc8-ad7a-6b03d4dab4a9"}, {"Element": "<span lang=\"DE\">\u00a0</span>", "ID": "9bf83436-862f-448c-82d3-4f3e932cf062", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fdec1d92-b593-4609-94dc-6686573b3f68"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Nederland</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Nederland bv </span></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +31 23 56 68 777 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">nl.medical.info@takeda.com\n  </span></p>\n</td>", "ID": "cc0faa43-dcd8-4ae8-985d-60edfbaf0459", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "f020eaa1-2249-4647-bcad-4c86d61cbf9c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Nederland</span></b></p>", "ID": "132112c4-9ce2-457d-b0c8-1c208fa412d9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cc0faa43-dcd8-4ae8-985d-60edfbaf0459"}, {"Element": "<b><span lang=\"SV\">Nederland</span></b>", "ID": "2479e3dc-10cd-4523-983f-2e10809073c3", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "132112c4-9ce2-457d-b0c8-1c208fa412d9"}, {"Element": "<span lang=\"SV\">Nederland</span>", "ID": "5e66d564-9e3b-4e39-a484-2bba2f973429", "Styles": "None", "Classes": "None", "Text": "Nederland", "ParentId": "2479e3dc-10cd-4523-983f-2e10809073c3"}, {"Element": "<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Nederland bv </span></p>", "ID": "13ec1230-56d2-415a-b49c-c6dc3b060dcc", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "cc0faa43-dcd8-4ae8-985d-60edfbaf0459"}, {"Element": "<span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Nederland bv </span>", "ID": "e92ee374-558e-471c-ae42-e438dac7af43", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Nederland bv ", "ParentId": "13ec1230-56d2-415a-b49c-c6dc3b060dcc"}, {"Element": "<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +31 23 56 68 777 </span></p>", "ID": "2852db84-ad30-4813-ba65-ea66f1916e66", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "cc0faa43-dcd8-4ae8-985d-60edfbaf0459"}, {"Element": "<span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +31 23 56 68 777 </span>", "ID": "0c4dc210-90ee-445d-bce6-fa4f5521d535", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel:   +31 23 56 68 777 ", "ParentId": "2852db84-ad30-4813-ba65-ea66f1916e66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">nl.medical.info@takeda.com\n  </span></p>", "ID": "a27918ef-b7b3-4c89-813c-0ac4cee9e56e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "cc0faa43-dcd8-4ae8-985d-60edfbaf0459"}, {"Element": "<span lang=\"SV\">nl.medical.info@takeda.com\n  </span>", "ID": "2ad1d234-cac2-488e-bc20-3a72e68cc0cf", "Styles": "None", "Classes": "None", "Text": "nl.medical.info@takeda.com   ", "ParentId": "a27918ef-b7b3-4c89-813c-0ac4cee9e56e"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"PT-BR\">Eesti</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda Pharma AS </span></p>\n<p class=\"Default\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +372 6177 669 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-NYN\">Norge</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  AS </span></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +47 6676 3030 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">infonorge@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">\u00a0</span></p>\n</td>\n</tr>", "ID": "2c3babac-c870-47d1-b830-f2c661e19dad", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"PT-BR\">Eesti</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda Pharma AS </span></p>\n<p class=\"Default\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +372 6177 669 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">\u00a0</span></p>\n</td>", "ID": "e42c10c7-b9b1-43f1-b265-6bf8cc35d20c", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "2c3babac-c870-47d1-b830-f2c661e19dad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"PT-BR\">Eesti</span></b></p>", "ID": "07543631-67ae-4c4f-8102-5a6cc4993619", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e42c10c7-b9b1-43f1-b265-6bf8cc35d20c"}, {"Element": "<b><span lang=\"PT-BR\">Eesti</span></b>", "ID": "60274ce6-ce37-4d4b-9ee3-c4d8325b31c1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "07543631-67ae-4c4f-8102-5a6cc4993619"}, {"Element": "<span lang=\"PT-BR\">Eesti</span>", "ID": "e2b4489f-9566-4461-bae2-fa422b47c5b6", "Styles": "None", "Classes": "None", "Text": "Eesti", "ParentId": "60274ce6-ce37-4d4b-9ee3-c4d8325b31c1"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda Pharma AS </span></p>", "ID": "263a877f-8f7b-4f43-8858-b7a25d2b59d4", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "e42c10c7-b9b1-43f1-b265-6bf8cc35d20c"}, {"Element": "<span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda Pharma AS </span>", "ID": "dba4b958-c0ce-44b1-96e1-3efe60bc810d", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda Pharma AS ", "ParentId": "263a877f-8f7b-4f43-8858-b7a25d2b59d4"}, {"Element": "<p class=\"Default\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +372 6177 669 </span></p>", "ID": "2c71b626-a278-4e74-9e86-0c7b41b624fa", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "e42c10c7-b9b1-43f1-b265-6bf8cc35d20c"}, {"Element": "<span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +372 6177 669 </span>", "ID": "615b68ad-ff5f-43da-abaf-c8b047479339", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel:   +372 6177 669 ", "ParentId": "2c71b626-a278-4e74-9e86-0c7b41b624fa"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"PT-BR\">\u00a0</span></p>", "ID": "fc1da90a-7bcd-4a23-91df-6d0c418e7fbf", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "e42c10c7-b9b1-43f1-b265-6bf8cc35d20c"}, {"Element": "<span lang=\"PT-BR\">\u00a0</span>", "ID": "f7b273e9-849d-44c7-9af5-ceac6569a1c8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "fc1da90a-7bcd-4a23-91df-6d0c418e7fbf"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-NYN\">Norge</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  AS </span></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +47 6676 3030 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">infonorge@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">\u00a0</span></p>\n</td>", "ID": "94501dd6-aecd-4853-835e-a5fb7badfa28", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "2c3babac-c870-47d1-b830-f2c661e19dad"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-NYN\">Norge</span></b></p>", "ID": "e35c131a-7748-45a8-99a9-cbf03482fe8a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94501dd6-aecd-4853-835e-a5fb7badfa28"}, {"Element": "<b><span lang=\"NO-NYN\">Norge</span></b>", "ID": "af2cd44b-79b4-4344-888c-a167654fa747", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "e35c131a-7748-45a8-99a9-cbf03482fe8a"}, {"Element": "<span lang=\"NO-NYN\">Norge</span>", "ID": "008fb0c8-9efc-4591-807e-93f4e59daf47", "Styles": "None", "Classes": "None", "Text": "Norge", "ParentId": "af2cd44b-79b4-4344-888c-a167654fa747"}, {"Element": "<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  AS </span></p>", "ID": "2d17139b-dff7-449d-956d-8488d6b8926a", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "94501dd6-aecd-4853-835e-a5fb7badfa28"}, {"Element": "<span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  AS </span>", "ID": "9d1e0de5-6194-4394-9f4a-67033891742f", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   AS ", "ParentId": "2d17139b-dff7-449d-956d-8488d6b8926a"}, {"Element": "<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +47 6676 3030 </span></p>", "ID": "b6ebfba8-8943-44ef-91a9-5eda6b08f205", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "94501dd6-aecd-4853-835e-a5fb7badfa28"}, {"Element": "<span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Tlf:\n  +47 6676 3030 </span>", "ID": "470ef3ea-16e5-4e19-aca2-d8dba8c454a3", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tlf:   +47 6676 3030 ", "ParentId": "b6ebfba8-8943-44ef-91a9-5eda6b08f205"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">infonorge@takeda.com\n  </span></p>", "ID": "b95082e1-036c-4cd1-a17f-6e5d999fe4cb", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94501dd6-aecd-4853-835e-a5fb7badfa28"}, {"Element": "<span lang=\"NO-NYN\">infonorge@takeda.com\n  </span>", "ID": "14ffb789-3536-445e-beef-8a8ea10ad35a", "Styles": "None", "Classes": "None", "Text": "infonorge@takeda.com   ", "ParentId": "b95082e1-036c-4cd1-a17f-6e5d999fe4cb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">\u00a0</span></p>", "ID": "e8c12acf-7142-492e-9f28-17a1d0228e2d", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "94501dd6-aecd-4853-835e-a5fb7badfa28"}, {"Element": "<span lang=\"NO-NYN\">\u00a0</span>", "ID": "855bd37b-5a68-4802-b904-0371a1953fef", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e8c12acf-7142-492e-9f28-17a1d0228e2d"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">TAKEDA\n  </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395\u039b\u039b\u0391\u03a3</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0391</span><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">.</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">T\u03b7\u03bb</span><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">: +30 210 6387800</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">gr.info@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">\u00d6sterreich</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Ges.m.b.H. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +43 (0)\n  800-20 80 50 </span></p>\n</td>\n</tr>", "ID": "f39bb17d-defb-454a-8f2b-e3fab073498a", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">TAKEDA\n  </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395\u039b\u039b\u0391\u03a3</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0391</span><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">.</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">T\u03b7\u03bb</span><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">: +30 210 6387800</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">gr.info@takeda.com\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "5e66f1c9-d7ff-48c0-90dc-d25d36fc2a1b", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "f39bb17d-defb-454a-8f2b-e3fab073498a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b></p>", "ID": "a1aed941-0755-4fbb-9b63-cf6d644512c5", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5e66f1c9-d7ff-48c0-90dc-d25d36fc2a1b"}, {"Element": "<b><span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span></b>", "ID": "c8df83a5-5ad0-472d-a92b-e8d8310fd4e5", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a1aed941-0755-4fbb-9b63-cf6d644512c5"}, {"Element": "<span lang=\"EN-GB\">\u0395\u03bb\u03bb\u03ac\u03b4\u03b1</span>", "ID": "654e3287-9249-4819-9719-16eb38a43e45", "Styles": "None", "Classes": "None", "Text": "\u0395\u03bb\u03bb\u03ac\u03b4\u03b1", "ParentId": "c8df83a5-5ad0-472d-a92b-e8d8310fd4e5"}, {"Element": "<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">TAKEDA\n  </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395\u039b\u039b\u0391\u03a3</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0391</span><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">.</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span></p>", "ID": "229b49cf-641f-4877-86d7-1d0e34fa9a55", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "5e66f1c9-d7ff-48c0-90dc-d25d36fc2a1b"}, {"Element": "<span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">TAKEDA\n  </span>", "ID": "958006d9-a636-41e6-9823-8bb30dea62dd", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "TAKEDA   ", "ParentId": "229b49cf-641f-4877-86d7-1d0e34fa9a55"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395\u039b\u039b\u0391\u03a3</span>", "ID": "8536aa19-7b1e-45c6-89d4-f132d1e31034", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u0395\u039b\u039b\u0391\u03a3", "ParentId": "229b49cf-641f-4877-86d7-1d0e34fa9a55"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span>", "ID": "f0de9fdd-7239-4b94-a9af-7e8c6b144bec", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": " ", "ParentId": "229b49cf-641f-4877-86d7-1d0e34fa9a55"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0391</span>", "ID": "e152a242-6025-42f4-9503-b065874b4e46", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u0391", "ParentId": "229b49cf-641f-4877-86d7-1d0e34fa9a55"}, {"Element": "<span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">.</span>", "ID": "3326c926-0ee1-438c-a181-dd10ba8446ce", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": ".", "ParentId": "229b49cf-641f-4877-86d7-1d0e34fa9a55"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u0395</span>", "ID": "bf2a48e7-d67f-4bfa-927e-bdce44973f57", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u0395", "ParentId": "229b49cf-641f-4877-86d7-1d0e34fa9a55"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\"> </span>", "ID": "59ac43b9-a8cd-4d1c-b3bd-a242b710cbc6", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": " ", "ParentId": "229b49cf-641f-4877-86d7-1d0e34fa9a55"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">T\u03b7\u03bb</span><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">: +30 210 6387800</span></p>", "ID": "66d3cb2e-7ff8-4fa8-89bc-b3dee450d198", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "5e66f1c9-d7ff-48c0-90dc-d25d36fc2a1b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">T\u03b7\u03bb</span>", "ID": "0aae1c22-c964-466b-805b-b4317dcfcf5b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "T\u03b7\u03bb", "ParentId": "66d3cb2e-7ff8-4fa8-89bc-b3dee450d198"}, {"Element": "<span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">: +30 210 6387800</span>", "ID": "8744bfe8-e3bf-4072-bd7b-de12d46b0099", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": ": +30 210 6387800", "ParentId": "66d3cb2e-7ff8-4fa8-89bc-b3dee450d198"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">gr.info@takeda.com\n  </span></p>", "ID": "d6b998ee-c900-4ae4-b2e4-924b96642bb6", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "5e66f1c9-d7ff-48c0-90dc-d25d36fc2a1b"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">gr.info@takeda.com\n  </span>", "ID": "9f270e53-54be-4ca5-9ad1-8433414d98a1", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "gr.info@takeda.com   ", "ParentId": "d6b998ee-c900-4ae4-b2e4-924b96642bb6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "755819cc-e4a5-4d0b-b4c9-f6bc52db437b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "5e66f1c9-d7ff-48c0-90dc-d25d36fc2a1b"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "1d987ade-0cd6-4b6d-8131-fd7c1fe729ea", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "755819cc-e4a5-4d0b-b4c9-f6bc52db437b"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">\u00d6sterreich</span></b></p>\n<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Ges.m.b.H. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +43 (0)\n  800-20 80 50 </span></p>\n</td>", "ID": "af9c8cd9-8b07-4677-804a-b3db7f16c01c", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "f39bb17d-defb-454a-8f2b-e3fab073498a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"DE\">\u00d6sterreich</span></b></p>", "ID": "6e86212c-8f37-40a2-bd5a-3e7c7f0638bc", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "af9c8cd9-8b07-4677-804a-b3db7f16c01c"}, {"Element": "<b><span lang=\"DE\">\u00d6sterreich</span></b>", "ID": "0cfcb21f-7f87-4e96-81a7-0fb313c7f47f", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6e86212c-8f37-40a2-bd5a-3e7c7f0638bc"}, {"Element": "<span lang=\"DE\">\u00d6sterreich</span>", "ID": "38cfd666-ebf4-43c0-9f00-d11f9113bab2", "Styles": "None", "Classes": "None", "Text": "\u00d6sterreich", "ParentId": "0cfcb21f-7f87-4e96-81a7-0fb313c7f47f"}, {"Element": "<p class=\"Default\"><span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Ges.m.b.H. </span></p>", "ID": "89b14a54-48b7-4ee0-9830-593bafddba18", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "af9c8cd9-8b07-4677-804a-b3db7f16c01c"}, {"Element": "<span lang=\"DE\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma Ges.m.b.H. </span>", "ID": "4f2b564f-6109-4399-ad40-6e96dc77cffe", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Pharma Ges.m.b.H. ", "ParentId": "89b14a54-48b7-4ee0-9830-593bafddba18"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +43 (0)\n  800-20 80 50 </span></p>", "ID": "201ba722-2850-4195-ac98-75f24f2fa2e7", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "af9c8cd9-8b07-4677-804a-b3db7f16c01c"}, {"Element": "<span lang=\"EN-GB\">Tel: +43 (0)\n  800-20 80 50 </span>", "ID": "0a5666f8-3728-4f02-86c3-f855749baa49", "Styles": "None", "Classes": "None", "Text": "Tel: +43 (0)   800-20 80 50 ", "ParentId": "201ba722-2850-4195-ac98-75f24f2fa2e7"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Espa\u00f1a</span></b></p>\n<p class=\"Default\"><span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00e9utica Espa\u00f1a S.A </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +34 917 90 42 22</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">spain@takeda.com</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PL\">Polska</span></b></p>\n<p class=\"Default\"><span lang=\"PL\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma sp. z o.o</span></p>\n<p class=\"Default\"><span lang=\"PL\" style=\"font-size:11.0pt\">Tel.: + 48 22 608 13\n  00 </span></p>\n</td>\n</tr>", "ID": "0c4786d3-61e3-4423-b051-5c8644690ea4", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Espa\u00f1a</span></b></p>\n<p class=\"Default\"><span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00e9utica Espa\u00f1a S.A </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +34 917 90 42 22</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">spain@takeda.com</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "b2c7a96a-829b-4231-ad67-5895170b153d", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "0c4786d3-61e3-4423-b051-5c8644690ea4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">Espa\u00f1a</span></b></p>", "ID": "674cd488-b846-4de3-b478-6c19e6e2e5a8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b2c7a96a-829b-4231-ad67-5895170b153d"}, {"Element": "<b><span lang=\"ES\">Espa\u00f1a</span></b>", "ID": "f493a9a3-ab93-43fe-b4bc-42797b70c7ed", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "674cd488-b846-4de3-b478-6c19e6e2e5a8"}, {"Element": "<span lang=\"ES\">Espa\u00f1a</span>", "ID": "00b63bab-cc9a-4117-9328-14441b840eaf", "Styles": "None", "Classes": "None", "Text": "Espa\u00f1a", "ParentId": "f493a9a3-ab93-43fe-b4bc-42797b70c7ed"}, {"Element": "<p class=\"Default\"><span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00e9utica Espa\u00f1a S.A </span></p>", "ID": "3c8c392a-7aaf-446d-86ee-968b39ed96d5", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "b2c7a96a-829b-4231-ad67-5895170b153d"}, {"Element": "<span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00e9utica Espa\u00f1a S.A </span>", "ID": "912d90f5-68ec-4068-9edc-d8a45d93cc62", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Farmac\u00e9utica Espa\u00f1a S.A ", "ParentId": "3c8c392a-7aaf-446d-86ee-968b39ed96d5"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +34 917 90 42 22</span></p>", "ID": "1a2c5240-147f-4a91-94b4-f6e42842b3c6", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "b2c7a96a-829b-4231-ad67-5895170b153d"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +34 917 90 42 22</span>", "ID": "efff00c6-1831-4843-bfd8-6c23d1019ffd", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel:   +34 917 90 42 22", "ParentId": "1a2c5240-147f-4a91-94b4-f6e42842b3c6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">spain@takeda.com</span></p>", "ID": "292f1da0-a01a-4ad5-8a36-ad7bb4d7c3fe", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b2c7a96a-829b-4231-ad67-5895170b153d"}, {"Element": "<span lang=\"EN-GB\">spain@takeda.com</span>", "ID": "6d28590c-e30d-401e-b054-3e847b8d23c7", "Styles": "None", "Classes": "None", "Text": "spain@takeda.com", "ParentId": "292f1da0-a01a-4ad5-8a36-ad7bb4d7c3fe"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b08282df-159e-4600-a8bd-54ec7acd5a3b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b2c7a96a-829b-4231-ad67-5895170b153d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "4bda017b-c2a6-4070-9560-9d9380908b9b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b08282df-159e-4600-a8bd-54ec7acd5a3b"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PL\">Polska</span></b></p>\n<p class=\"Default\"><span lang=\"PL\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma sp. z o.o</span></p>\n<p class=\"Default\"><span lang=\"PL\" style=\"font-size:11.0pt\">Tel.: + 48 22 608 13\n  00 </span></p>\n</td>", "ID": "860db9bb-2651-4f6d-9bfb-34a57adf906f", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "0c4786d3-61e3-4423-b051-5c8644690ea4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PL\">Polska</span></b></p>", "ID": "bb8ba222-523f-4ed8-93d4-efcfdb925c92", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "860db9bb-2651-4f6d-9bfb-34a57adf906f"}, {"Element": "<b><span lang=\"PL\">Polska</span></b>", "ID": "71df1edc-b905-425a-9fa8-f7c93db7af3b", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bb8ba222-523f-4ed8-93d4-efcfdb925c92"}, {"Element": "<span lang=\"PL\">Polska</span>", "ID": "0bff95b7-48b0-40b3-8464-e3d26bd09fdb", "Styles": "None", "Classes": "None", "Text": "Polska", "ParentId": "71df1edc-b905-425a-9fa8-f7c93db7af3b"}, {"Element": "<p class=\"Default\"><span lang=\"PL\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma sp. z o.o</span></p>", "ID": "1189a582-06eb-4c75-9d26-9ed012eb03a4", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "860db9bb-2651-4f6d-9bfb-34a57adf906f"}, {"Element": "<span lang=\"PL\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma sp. z o.o</span>", "ID": "25d87c9b-1547-4a56-964f-b4935db431ed", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Pharma sp. z o.o", "ParentId": "1189a582-06eb-4c75-9d26-9ed012eb03a4"}, {"Element": "<p class=\"Default\"><span lang=\"PL\" style=\"font-size:11.0pt\">Tel.: + 48 22 608 13\n  00 </span></p>", "ID": "780c50e0-5fa4-4b8c-8e4f-a8436519b639", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "860db9bb-2651-4f6d-9bfb-34a57adf906f"}, {"Element": "<span lang=\"PL\" style=\"font-size:11.0pt\">Tel.: + 48 22 608 13\n  00 </span>", "ID": "aebdbfef-11fa-498e-aec5-c66e28418179", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Tel.: + 48 22 608 13   00 ", "ParentId": "780c50e0-5fa4-4b8c-8e4f-a8436519b639"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\">France</span></b></p>\n<p class=\"Default\"><span lang=\"FR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  France SAS</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">T\u00e9l:</span><span lang=\"FR\"> </span><span lang=\"FR\">+ 33 1 40 67 33 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">medinfoEMEA@takeda.com</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Portugal</span></b></p>\n<p class=\"Default\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00eauticos Portugal, Lda. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 351 21\n  120 1457 </span></p>\n</td>\n</tr>", "ID": "f41a34d0-8736-4654-b9c3-5f22497bfa16", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\">France</span></b></p>\n<p class=\"Default\"><span lang=\"FR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  France SAS</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">T\u00e9l:</span><span lang=\"FR\"> </span><span lang=\"FR\">+ 33 1 40 67 33 00</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">medinfoEMEA@takeda.com</span></p>\n</td>", "ID": "d0a7f791-e9d6-454f-af5b-c74d11bac09a", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "f41a34d0-8736-4654-b9c3-5f22497bfa16"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"FR\">France</span></b></p>", "ID": "a92c65f1-65ad-4bf8-9752-ff5fd53a8693", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d0a7f791-e9d6-454f-af5b-c74d11bac09a"}, {"Element": "<b><span lang=\"FR\">France</span></b>", "ID": "19454ea5-8b03-4dce-a3a0-83fae5225cd1", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a92c65f1-65ad-4bf8-9752-ff5fd53a8693"}, {"Element": "<span lang=\"FR\">France</span>", "ID": "b09a9063-724f-49c4-8279-761787ebfda5", "Styles": "None", "Classes": "None", "Text": "France", "ParentId": "19454ea5-8b03-4dce-a3a0-83fae5225cd1"}, {"Element": "<p class=\"Default\"><span lang=\"FR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  France SAS</span></p>", "ID": "834e8edd-ac7c-4031-9513-d7370fea170f", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "d0a7f791-e9d6-454f-af5b-c74d11bac09a"}, {"Element": "<span lang=\"FR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  France SAS</span>", "ID": "55df1752-d6df-4bf7-8863-8245b7dd89ee", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   France SAS", "ParentId": "834e8edd-ac7c-4031-9513-d7370fea170f"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">T\u00e9l:</span><span lang=\"FR\"> </span><span lang=\"FR\">+ 33 1 40 67 33 00</span></p>", "ID": "5ed8a83d-7788-4fac-804f-7c882fcdf95b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d0a7f791-e9d6-454f-af5b-c74d11bac09a"}, {"Element": "<span lang=\"FR\">T\u00e9l:</span>", "ID": "9e71cec1-ac0d-4a9f-a3ad-a2ee59087ac4", "Styles": "None", "Classes": "None", "Text": "T\u00e9l:", "ParentId": "5ed8a83d-7788-4fac-804f-7c882fcdf95b"}, {"Element": "<span lang=\"FR\"> </span>", "ID": "4e637818-de39-4037-8beb-efc0c25e103a", "Styles": "None", "Classes": "None", "Text": " ", "ParentId": "5ed8a83d-7788-4fac-804f-7c882fcdf95b"}, {"Element": "<span lang=\"FR\">+ 33 1 40 67 33 00</span>", "ID": "b23f83e0-26c2-4a1e-823f-a64e3faed704", "Styles": "None", "Classes": "None", "Text": "+ 33 1 40 67 33 00", "ParentId": "5ed8a83d-7788-4fac-804f-7c882fcdf95b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"FR\">medinfoEMEA@takeda.com</span></p>", "ID": "c9144127-344c-4b66-be23-56bf8efeaf5b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "d0a7f791-e9d6-454f-af5b-c74d11bac09a"}, {"Element": "<span lang=\"FR\">medinfoEMEA@takeda.com</span>", "ID": "a8afec50-2459-42da-a39c-4e615a0f581c", "Styles": "None", "Classes": "None", "Text": "medinfoEMEA@takeda.com", "ParentId": "c9144127-344c-4b66-be23-56bf8efeaf5b"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Portugal</span></b></p>\n<p class=\"Default\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00eauticos Portugal, Lda. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 351 21\n  120 1457 </span></p>\n</td>", "ID": "4a3ab107-f41f-4565-91de-d585e068c325", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "f41a34d0-8736-4654-b9c3-5f22497bfa16"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"PT-BR\">Portugal</span></b></p>", "ID": "6a359e17-7fac-483b-a9ba-e89431f4634c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4a3ab107-f41f-4565-91de-d585e068c325"}, {"Element": "<b><span lang=\"PT-BR\">Portugal</span></b>", "ID": "c3b8f5ed-d1ed-4ed2-b98d-fcabd9639c70", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6a359e17-7fac-483b-a9ba-e89431f4634c"}, {"Element": "<span lang=\"PT-BR\">Portugal</span>", "ID": "fefd4519-874d-4527-867d-b3c1676bea80", "Styles": "None", "Classes": "None", "Text": "Portugal", "ParentId": "c3b8f5ed-d1ed-4ed2-b98d-fcabd9639c70"}, {"Element": "<p class=\"Default\"><span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00eauticos Portugal, Lda. </span></p>", "ID": "57f4ef7f-9f35-4140-9145-246cb9b48571", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "4a3ab107-f41f-4565-91de-d585e068c325"}, {"Element": "<span lang=\"PT-BR\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Farmac\u00eauticos Portugal, Lda. </span>", "ID": "527c910a-8df1-4f46-8b2f-b081cca24f19", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Farmac\u00eauticos Portugal, Lda. ", "ParentId": "57f4ef7f-9f35-4140-9145-246cb9b48571"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: + 351 21\n  120 1457 </span></p>", "ID": "c344641d-af36-475f-b268-ea079fbb7188", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "4a3ab107-f41f-4565-91de-d585e068c325"}, {"Element": "<span lang=\"EN-GB\">Tel: + 351 21\n  120 1457 </span>", "ID": "26ff1a28-8ab9-458f-9c30-88d983efca5c", "Styles": "None", "Classes": "None", "Text": "Tel: + 351 21   120 1457 ", "ParentId": "c344641d-af36-475f-b268-ea079fbb7188"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Croatia d.o.o. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +385 1 377 88 96 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Products Ireland Limited </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +353 (0) 1 6420021 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals SRL </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +40 21\n  335 03 91 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-NYN\">Slovenija</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH Podru\u017enica Slovenija </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">Tel.+ 386 (0)\n  59 082 480 </span></p>\n</td>\n</tr>", "ID": "d567abe6-fa7d-463c-bbc3-1bc50525030d", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\"><span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Croatia d.o.o. </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +385 1 377 88 96 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Products Ireland Limited </span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +353 (0) 1 6420021 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "ebd8915b-f17d-4feb-9bd0-9235093e36be", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "          ", "ParentId": "d567abe6-fa7d-463c-bbc3-1bc50525030d"}, {"Element": "<span lang=\"EN-GB\" style='font-size:11.0pt;font-family:\"Times New Roman\",serif'><br clear=\"all\" style=\"page-break-before:always\"/>\n</span>", "ID": "5eefc7d6-eb9c-4411-b6f1-296fee99a68a", "Styles": "font-size:11.0pt;font-family:\"Times New Roman\",serif", "Classes": "None", "Text": " ", "ParentId": "ebd8915b-f17d-4feb-9bd0-9235093e36be"}, {"Element": "<br clear=\"all\" style=\"page-break-before:always\"/>", "ID": "31a329ef-40a3-4a7a-9ae6-aba2f47a2579", "Styles": "page-break-before:always", "Classes": "None", "Text": "", "ParentId": "5eefc7d6-eb9c-4411-b6f1-296fee99a68a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "2114665c-053b-4f02-b4bb-700d831d5b01", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebd8915b-f17d-4feb-9bd0-9235093e36be"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "90ebe8b1-7a97-4a61-8b5d-c99f78eddd14", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "2114665c-053b-4f02-b4bb-700d831d5b01"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Hrvatska</span></b></p>", "ID": "a189cef5-400e-473c-9cae-0cb085a2c78a", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebd8915b-f17d-4feb-9bd0-9235093e36be"}, {"Element": "<b><span lang=\"EN-GB\">Hrvatska</span></b>", "ID": "2f34afdb-e050-465f-b2b1-d2f97cea213e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "a189cef5-400e-473c-9cae-0cb085a2c78a"}, {"Element": "<span lang=\"EN-GB\">Hrvatska</span>", "ID": "a91dde74-9592-4887-a457-2c6e06143422", "Styles": "None", "Classes": "None", "Text": "Hrvatska", "ParentId": "2f34afdb-e050-465f-b2b1-d2f97cea213e"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Croatia d.o.o. </span></p>", "ID": "7e03782a-1a44-4bff-9946-847bd526b144", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebd8915b-f17d-4feb-9bd0-9235093e36be"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Croatia d.o.o. </span>", "ID": "80d55120-a49d-4c8f-a020-9b3d2bd4533e", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Pharmaceuticals Croatia d.o.o. ", "ParentId": "7e03782a-1a44-4bff-9946-847bd526b144"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +385 1 377 88 96 </span></p>", "ID": "f70e54e8-2a8d-48c9-99ed-ea78b20eb191", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebd8915b-f17d-4feb-9bd0-9235093e36be"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +385 1 377 88 96 </span>", "ID": "d75130d5-73f5-4bfd-9f6a-f5bcf0e89dc9", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel:   +385 1 377 88 96 ", "ParentId": "f70e54e8-2a8d-48c9-99ed-ea78b20eb191"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "8f306085-d156-45c2-988e-5e51bc650ae8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebd8915b-f17d-4feb-9bd0-9235093e36be"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "5441af85-f470-45c3-a349-55a3db73e0ec", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "8f306085-d156-45c2-988e-5e51bc650ae8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Ireland</span></b></p>", "ID": "1a9ea4a9-d441-4d7a-a578-49d0b1a383f1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebd8915b-f17d-4feb-9bd0-9235093e36be"}, {"Element": "<b><span lang=\"EN-GB\">Ireland</span></b>", "ID": "bb580a20-5325-4266-8949-1b73f1bc8730", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "1a9ea4a9-d441-4d7a-a578-49d0b1a383f1"}, {"Element": "<span lang=\"EN-GB\">Ireland</span>", "ID": "544c83ac-41dc-4741-a0b4-5226db297fd3", "Styles": "None", "Classes": "None", "Text": "Ireland", "ParentId": "bb580a20-5325-4266-8949-1b73f1bc8730"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Products Ireland Limited </span></p>", "ID": "69a126db-b092-4b41-91ad-a170104b58b4", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebd8915b-f17d-4feb-9bd0-9235093e36be"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Products Ireland Limited </span>", "ID": "4c57cd44-65e4-452c-a59e-82dfdb9d86cf", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Products Ireland Limited ", "ParentId": "69a126db-b092-4b41-91ad-a170104b58b4"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +353 (0) 1 6420021 </span></p>", "ID": "4677f690-5682-45fb-ac8c-0cbd6f62ab66", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "ebd8915b-f17d-4feb-9bd0-9235093e36be"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +353 (0) 1 6420021 </span>", "ID": "21d11d04-4321-439f-8c22-ac24a2e7c312", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel:   +353 (0) 1 6420021 ", "ParentId": "4677f690-5682-45fb-ac8c-0cbd6f62ab66"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "6096f2ff-7e57-4273-b644-e0ab12f51ca3", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "ebd8915b-f17d-4feb-9bd0-9235093e36be"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "80ec39cc-b3e2-468c-9d4d-68b2705b912d", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "6096f2ff-7e57-4273-b644-e0ab12f51ca3"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals SRL </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +40 21\n  335 03 91 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-NYN\">Slovenija</span></b></p>\n<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH Podru\u017enica Slovenija </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">Tel.+ 386 (0)\n  59 082 480 </span></p>\n</td>", "ID": "34452f0b-73e5-4034-a61f-3bb4ce2245ba", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "         ", "ParentId": "d567abe6-fa7d-463c-bbc3-1bc50525030d"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "05a7c3d8-5fc9-43d7-8c9e-4e2e7994b051", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34452f0b-73e5-4034-a61f-3bb4ce2245ba"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "4286e19e-ec51-485c-bfd6-f1082d490053", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "05a7c3d8-5fc9-43d7-8c9e-4e2e7994b051"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "becf1d5b-d550-4e59-abd8-64b88cac323b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "4286e19e-ec51-485c-bfd6-f1082d490053"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Rom\u00e2nia</span></b></p>", "ID": "9fb0256d-0759-4d2f-8cdf-256f6d257f3c", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34452f0b-73e5-4034-a61f-3bb4ce2245ba"}, {"Element": "<b><span lang=\"EN-GB\">Rom\u00e2nia</span></b>", "ID": "62bda610-253b-43b1-b07f-55f07b59902e", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9fb0256d-0759-4d2f-8cdf-256f6d257f3c"}, {"Element": "<span lang=\"EN-GB\">Rom\u00e2nia</span>", "ID": "2b8a849c-a975-4238-804f-d7cd0b974f28", "Styles": "None", "Classes": "None", "Text": "Rom\u00e2nia", "ParentId": "62bda610-253b-43b1-b07f-55f07b59902e"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals SRL </span></p>", "ID": "c68f7a43-2a83-46b1-a3a7-50ae8972b152", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "34452f0b-73e5-4034-a61f-3bb4ce2245ba"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals SRL </span>", "ID": "2dce3641-b657-4fdd-960e-bb4c5397500b", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Pharmaceuticals SRL ", "ParentId": "c68f7a43-2a83-46b1-a3a7-50ae8972b152"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +40 21\n  335 03 91 </span></p>", "ID": "3e9c19c1-1cca-47dc-aa40-c7fdf7fc5e14", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34452f0b-73e5-4034-a61f-3bb4ce2245ba"}, {"Element": "<span lang=\"EN-GB\">Tel: +40 21\n  335 03 91 </span>", "ID": "ef1381da-4a10-4a4b-ace5-2e1df260e12a", "Styles": "None", "Classes": "None", "Text": "Tel: +40 21   335 03 91 ", "ParentId": "3e9c19c1-1cca-47dc-aa40-c7fdf7fc5e14"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "80388bab-687e-4d2d-b216-b414013cb7c2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34452f0b-73e5-4034-a61f-3bb4ce2245ba"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "a0ac4d13-9190-4ddd-8755-715d5e4135ed", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "80388bab-687e-4d2d-b216-b414013cb7c2"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "20b67f05-782c-4755-b21e-114202ddcad4", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "a0ac4d13-9190-4ddd-8755-715d5e4135ed"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"NO-NYN\">Slovenija</span></b></p>", "ID": "94642f04-4a63-40ce-9cf5-4dd9821e8628", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34452f0b-73e5-4034-a61f-3bb4ce2245ba"}, {"Element": "<b><span lang=\"NO-NYN\">Slovenija</span></b>", "ID": "c7b2b899-4fb2-46d2-92ad-bc81161d04c0", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "94642f04-4a63-40ce-9cf5-4dd9821e8628"}, {"Element": "<span lang=\"NO-NYN\">Slovenija</span>", "ID": "99db0904-0f3a-4a39-a55c-1ba142d06a52", "Styles": "None", "Classes": "None", "Text": "Slovenija", "ParentId": "c7b2b899-4fb2-46d2-92ad-bc81161d04c0"}, {"Element": "<p class=\"Default\"><span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH Podru\u017enica Slovenija </span></p>", "ID": "b8e7fecc-8b8e-480e-8fae-c005ae458ef1", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "34452f0b-73e5-4034-a61f-3bb4ce2245ba"}, {"Element": "<span lang=\"NO-NYN\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  GmbH Podru\u017enica Slovenija </span>", "ID": "2507f34f-e7d3-40f1-9663-db8db862df40", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   GmbH Podru\u017enica Slovenija ", "ParentId": "b8e7fecc-8b8e-480e-8fae-c005ae458ef1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"NO-NYN\">Tel.+ 386 (0)\n  59 082 480 </span></p>", "ID": "17ed7ce1-6046-4e57-a183-e2de34dfdb60", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "34452f0b-73e5-4034-a61f-3bb4ce2245ba"}, {"Element": "<span lang=\"NO-NYN\">Tel.+ 386 (0)\n  59 082 480 </span>", "ID": "9afceb3b-2ced-427b-ae42-ec0dbda80003", "Styles": "None", "Classes": "None", "Text": "Tel.+ 386 (0)   59 082 480 ", "ParentId": "17ed7ce1-6046-4e57-a183-e2de34dfdb60"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vistor hf. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi</span><span lang=\"EN-GB\">: +354 535 7000 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">vistor@vistor.is\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Slovakia s.r.o. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +421 (2)\n  20 602 600 </span></p>\n</td>\n</tr>", "ID": "e4c686c3-127d-4475-b6b8-6cb9b088ab4a", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vistor hf. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi</span><span lang=\"EN-GB\">: +354 535 7000 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">vistor@vistor.is\n  </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "6de8b31a-3c71-4993-8638-bf5f0a92650d", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "e4c686c3-127d-4475-b6b8-6cb9b088ab4a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00cdsland</span></b></p>", "ID": "2937e3b9-85f0-4b1e-bdf2-ee2f71a681c0", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6de8b31a-3c71-4993-8638-bf5f0a92650d"}, {"Element": "<b><span lang=\"EN-GB\">\u00cdsland</span></b>", "ID": "f9f4de28-2a8f-4701-bb50-c0bea777dbfb", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2937e3b9-85f0-4b1e-bdf2-ee2f71a681c0"}, {"Element": "<span lang=\"EN-GB\">\u00cdsland</span>", "ID": "790e3af9-0b71-47cf-b795-96135b52baa8", "Styles": "None", "Classes": "None", "Text": "\u00cdsland", "ParentId": "f9f4de28-2a8f-4701-bb50-c0bea777dbfb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Vistor hf. </span></p>", "ID": "71264a2c-6d55-45ed-93e3-d5a0eb830cc1", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6de8b31a-3c71-4993-8638-bf5f0a92650d"}, {"Element": "<span lang=\"EN-GB\">Vistor hf. </span>", "ID": "45b6958e-ae10-4d5c-97ab-b6d0c45eca08", "Styles": "None", "Classes": "None", "Text": "Vistor hf. ", "ParentId": "71264a2c-6d55-45ed-93e3-d5a0eb830cc1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">S\u00edmi</span><span lang=\"EN-GB\">: +354 535 7000 </span></p>", "ID": "e50c2490-0955-4bb6-886e-f85c49726189", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6de8b31a-3c71-4993-8638-bf5f0a92650d"}, {"Element": "<span lang=\"EN-GB\">S\u00edmi</span>", "ID": "85b034e2-af52-459b-b639-b859bba58bbb", "Styles": "None", "Classes": "None", "Text": "S\u00edmi", "ParentId": "e50c2490-0955-4bb6-886e-f85c49726189"}, {"Element": "<span lang=\"EN-GB\">: +354 535 7000 </span>", "ID": "7ff97f11-959c-4c12-9e55-49bf342c6063", "Styles": "None", "Classes": "None", "Text": ": +354 535 7000 ", "ParentId": "e50c2490-0955-4bb6-886e-f85c49726189"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">vistor@vistor.is\n  </span></p>", "ID": "d73cdb24-3ed9-4d17-9684-7ce52fbf91e6", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6de8b31a-3c71-4993-8638-bf5f0a92650d"}, {"Element": "<span lang=\"EN-GB\">vistor@vistor.is\n  </span>", "ID": "da7e39f2-b1ee-45f0-8de8-a10520019245", "Styles": "None", "Classes": "None", "Text": "vistor@vistor.is   ", "ParentId": "d73cdb24-3ed9-4d17-9684-7ce52fbf91e6"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "89673b65-c8c4-4caf-a38f-08026f5abe45", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "6de8b31a-3c71-4993-8638-bf5f0a92650d"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "277576aa-0bf0-438c-a087-c26860e12dc0", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "89673b65-c8c4-4caf-a38f-08026f5abe45"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Slovakia s.r.o. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +421 (2)\n  20 602 600 </span></p>\n</td>", "ID": "3db19756-5898-4fdb-8fbf-f00fa3d3566a", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "e4c686c3-127d-4475-b6b8-6cb9b088ab4a"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b></p>", "ID": "f7c00f42-3175-4edd-87d0-e9b46387e571", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3db19756-5898-4fdb-8fbf-f00fa3d3566a"}, {"Element": "<b><span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span></b>", "ID": "749fa79a-4cdf-4c26-85aa-258c2076ebc7", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "f7c00f42-3175-4edd-87d0-e9b46387e571"}, {"Element": "<span lang=\"EN-GB\">Slovensk\u00e1\n  republika</span>", "ID": "14bd45ff-91d2-4471-a77f-c4c512e6feb4", "Styles": "None", "Classes": "None", "Text": "Slovensk\u00e1   republika", "ParentId": "749fa79a-4cdf-4c26-85aa-258c2076ebc7"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Slovakia s.r.o. </span></p>", "ID": "747526ff-2916-47de-a75e-360139f98f34", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "3db19756-5898-4fdb-8fbf-f00fa3d3566a"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharmaceuticals Slovakia s.r.o. </span>", "ID": "5d6f649d-d4e2-4b04-a2c5-e1b1028893a7", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Pharmaceuticals Slovakia s.r.o. ", "ParentId": "747526ff-2916-47de-a75e-360139f98f34"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +421 (2)\n  20 602 600 </span></p>", "ID": "55aae0a9-0109-49c9-839f-d8b2ca1cf67b", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "3db19756-5898-4fdb-8fbf-f00fa3d3566a"}, {"Element": "<span lang=\"EN-GB\">Tel: +421 (2)\n  20 602 600 </span>", "ID": "0b2b6adb-64c7-45af-bb04-feb6fe355c99", "Styles": "None", "Classes": "None", "Text": "Tel: +421 (2)   20 602 600 ", "ParentId": "55aae0a9-0109-49c9-839f-d8b2ca1cf67b"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Italia</span></b></p>\n<p class=\"Default\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 06\n  502601 </span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Suomi/Finland</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Oy</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Puh/Tel:</span><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\"> +358 20 746 5000 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">\u00a0</span></p>\n</td>\n</tr>", "ID": "e6c8bc9b-6d51-4827-b6bb-e20b233f6097", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Italia</span></b></p>\n<p class=\"Default\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 06\n  502601 </span></p>\n</td>", "ID": "7e14cc4e-a143-4628-9fb8-0945fd5a2a2c", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "    ", "ParentId": "e6c8bc9b-6d51-4827-b6bb-e20b233f6097"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"IT\">Italia</span></b></p>", "ID": "9a819d64-f295-4644-8c9b-716463033ede", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7e14cc4e-a143-4628-9fb8-0945fd5a2a2c"}, {"Element": "<b><span lang=\"IT\">Italia</span></b>", "ID": "f838b3d5-a621-44dc-b086-caf397e3cf0a", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "9a819d64-f295-4644-8c9b-716463033ede"}, {"Element": "<span lang=\"IT\">Italia</span>", "ID": "a7e9028b-39b1-4f10-b63a-357cf6bdda99", "Styles": "None", "Classes": "None", "Text": "Italia", "ParentId": "f838b3d5-a621-44dc-b086-caf397e3cf0a"}, {"Element": "<p class=\"Default\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span></p>", "ID": "98193d58-2f93-4f65-87bb-447f22b07deb", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "7e14cc4e-a143-4628-9fb8-0945fd5a2a2c"}, {"Element": "<span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Italia S.p.A. </span>", "ID": "b9efdd75-74db-439b-b5a7-67c4622ace24", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Italia S.p.A. ", "ParentId": "98193d58-2f93-4f65-87bb-447f22b07deb"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Tel: +39 06\n  502601 </span></p>", "ID": "7dd3d9d1-1f84-4a76-a274-388b49cac883", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "7e14cc4e-a143-4628-9fb8-0945fd5a2a2c"}, {"Element": "<span lang=\"EN-GB\">Tel: +39 06\n  502601 </span>", "ID": "0298a724-9ef7-4aae-aea5-a1964aebeea6", "Styles": "None", "Classes": "None", "Text": "Tel: +39 06   502601 ", "ParentId": "7dd3d9d1-1f84-4a76-a274-388b49cac883"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Suomi/Finland</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Oy</span></p>\n<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Puh/Tel:</span><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\"> +358 20 746 5000 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">\u00a0</span></p>\n</td>", "ID": "f37e8549-c9db-4cc0-a7f6-a0c9d21106bf", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "e6c8bc9b-6d51-4827-b6bb-e20b233f6097"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Suomi/Finland</span></b></p>", "ID": "155b4220-7f53-410e-a400-f5548d4a4b2f", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f37e8549-c9db-4cc0-a7f6-a0c9d21106bf"}, {"Element": "<b><span lang=\"SV\">Suomi/Finland</span></b>", "ID": "30661873-dd3a-4d65-8ac2-3607f0cd61be", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "155b4220-7f53-410e-a400-f5548d4a4b2f"}, {"Element": "<span lang=\"SV\">Suomi/Finland</span>", "ID": "13c54956-20db-4213-a01f-40e7657600b0", "Styles": "None", "Classes": "None", "Text": "Suomi/Finland", "ParentId": "30661873-dd3a-4d65-8ac2-3607f0cd61be"}, {"Element": "<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Oy</span></p>", "ID": "c6b31c0e-3f22-4f56-ab29-835583e77622", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "f37e8549-c9db-4cc0-a7f6-a0c9d21106bf"}, {"Element": "<span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Oy</span>", "ID": "8f50552b-ef76-4cd5-8926-5926d1057889", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Oy", "ParentId": "c6b31c0e-3f22-4f56-ab29-835583e77622"}, {"Element": "<p class=\"Default\"><span lang=\"EN-GB\" style=\"font-size:11.0pt\">Puh/Tel:</span><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\"> +358 20 746 5000 </span></p>", "ID": "b4c01d74-1424-48e2-aaf7-c2f2645f631b", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "f37e8549-c9db-4cc0-a7f6-a0c9d21106bf"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt\">Puh/Tel:</span>", "ID": "a523aa72-c910-4df1-929d-b7f1283e8e3d", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "Puh/Tel:", "ParentId": "b4c01d74-1424-48e2-aaf7-c2f2645f631b"}, {"Element": "<span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\"> +358 20 746 5000 </span>", "ID": "09844a9a-e8f6-4766-bda1-fa504d51757a", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": " +358 20 746 5000 ", "ParentId": "b4c01d74-1424-48e2-aaf7-c2f2645f631b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"SV\">\u00a0</span></p>", "ID": "5064a1a7-eadb-45ed-a763-a31f58e2396e", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "f37e8549-c9db-4cc0-a7f6-a0c9d21106bf"}, {"Element": "<span lang=\"SV\">\u00a0</span>", "ID": "62c67a44-9489-413b-a196-69e3c0daa83b", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "5064a1a7-eadb-45ed-a763-a31f58e2396e"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"Default\"><span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">A. Potamitis Medicare\n  Ltd</span></p>\n<p class=\"Default\"><span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">T</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u03b7\u03bb</span><span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">: </span><span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">+357 22583333</span></p>\n<p class=\"Default\"><span lang=\"ES\" style=\"font-size:11.0pt\">info@potamitismedicare.com</span><span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">\u00a0</span></b></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Sverige</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma AB </span></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +46 8 731 28 00 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">infosweden@takeda.com\n  </span></p>\n</td>\n</tr>", "ID": "7d308349-ef0d-43c8-97bb-2485fb8b1c97", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>\n<p class=\"Default\"><span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">A. Potamitis Medicare\n  Ltd</span></p>\n<p class=\"Default\"><span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">T</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u03b7\u03bb</span><span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">: </span><span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">+357 22583333</span></p>\n<p class=\"Default\"><span lang=\"ES\" style=\"font-size:11.0pt\">info@potamitismedicare.com</span><span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\"> </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">\u00a0</span></b></p>\n</td>", "ID": "1f1d393c-aec3-4f1d-acb3-93104cff8a59", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "7d308349-ef0d-43c8-97bb-2485fb8b1c97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b></p>", "ID": "4960e883-ac50-4921-89a4-6205243ac0f9", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1f1d393c-aec3-4f1d-acb3-93104cff8a59"}, {"Element": "<b><span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span></b>", "ID": "60972b46-320c-4c0f-b9e1-b9f20c507b17", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4960e883-ac50-4921-89a4-6205243ac0f9"}, {"Element": "<span lang=\"EN-GB\">\u039a\u03cd\u03c0\u03c1\u03bf\u03c2</span>", "ID": "fa25b4f2-8051-4e3d-83e3-1b6e8b5608ee", "Styles": "None", "Classes": "None", "Text": "\u039a\u03cd\u03c0\u03c1\u03bf\u03c2", "ParentId": "60972b46-320c-4c0f-b9e1-b9f20c507b17"}, {"Element": "<p class=\"Default\"><span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">A. Potamitis Medicare\n  Ltd</span></p>", "ID": "0216001d-55f3-4199-88e6-3c0c9f62bcec", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "1f1d393c-aec3-4f1d-acb3-93104cff8a59"}, {"Element": "<span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">A. Potamitis Medicare\n  Ltd</span>", "ID": "2fbcc854-e826-43ba-871d-847efa621fdd", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "A. Potamitis Medicare   Ltd", "ParentId": "0216001d-55f3-4199-88e6-3c0c9f62bcec"}, {"Element": "<p class=\"Default\"><span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">T</span><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u03b7\u03bb</span><span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">: </span><span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">+357 22583333</span></p>", "ID": "60d59263-7f3b-44e8-b6fd-19091bdf0fe8", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "1f1d393c-aec3-4f1d-acb3-93104cff8a59"}, {"Element": "<span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">T</span>", "ID": "4a6f91ae-e5d0-4363-9cca-8cd3c3d7a927", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "T", "ParentId": "60d59263-7f3b-44e8-b6fd-19091bdf0fe8"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">\u03b7\u03bb</span>", "ID": "fad9097b-d606-4fe7-8938-44dd03a6bea5", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "\u03b7\u03bb", "ParentId": "60d59263-7f3b-44e8-b6fd-19091bdf0fe8"}, {"Element": "<span lang=\"ES-TRAD\" style=\"font-size:11.0pt;color:windowtext\">: </span>", "ID": "540203da-100b-46e0-9550-33df62e82c2d", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": ": ", "ParentId": "60d59263-7f3b-44e8-b6fd-19091bdf0fe8"}, {"Element": "<span lang=\"ES-TRAD\" style=\"font-size:11.0pt\">+357 22583333</span>", "ID": "79dd1f35-1ad8-4419-8342-f2c59bfb5f2f", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "+357 22583333", "ParentId": "60d59263-7f3b-44e8-b6fd-19091bdf0fe8"}, {"Element": "<p class=\"Default\"><span lang=\"ES\" style=\"font-size:11.0pt\">info@potamitismedicare.com</span><span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\"> </span></p>", "ID": "210071cb-b5cc-4510-aaaf-f43314ce9347", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "1f1d393c-aec3-4f1d-acb3-93104cff8a59"}, {"Element": "<span lang=\"ES\" style=\"font-size:11.0pt\">info@potamitismedicare.com</span>", "ID": "9f83c6ba-8fe3-4c23-a133-fa4091aca93c", "Styles": "font-size:11.0pt", "Classes": "None", "Text": "info@potamitismedicare.com", "ParentId": "210071cb-b5cc-4510-aaaf-f43314ce9347"}, {"Element": "<span lang=\"ES\" style=\"font-size:11.0pt;color:windowtext\"> </span>", "ID": "db5d031c-9118-4b40-9a84-13ec76b2b9d4", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": " ", "ParentId": "210071cb-b5cc-4510-aaaf-f43314ce9347"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"ES\">\u00a0</span></b></p>", "ID": "6d076afb-4294-40a6-94f6-94902c193ac2", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "1f1d393c-aec3-4f1d-acb3-93104cff8a59"}, {"Element": "<b><span lang=\"ES\">\u00a0</span></b>", "ID": "741acddc-68b9-4077-9069-6f4659dbeadc", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "6d076afb-4294-40a6-94f6-94902c193ac2"}, {"Element": "<span lang=\"ES\">\u00a0</span>", "ID": "6d839808-7f5e-40f3-a710-af236447b945", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "741acddc-68b9-4077-9069-6f4659dbeadc"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Sverige</span></b></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma AB </span></p>\n<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +46 8 731 28 00 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">infosweden@takeda.com\n  </span></p>\n</td>", "ID": "b3d77804-53b0-4102-aec6-afa0c9520d55", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "     ", "ParentId": "7d308349-ef0d-43c8-97bb-2485fb8b1c97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"SV\">Sverige</span></b></p>", "ID": "c217b034-284d-4b92-86a9-7669a040f917", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b3d77804-53b0-4102-aec6-afa0c9520d55"}, {"Element": "<b><span lang=\"SV\">Sverige</span></b>", "ID": "3ccaf673-887c-479b-9f60-d273d81d87f2", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "c217b034-284d-4b92-86a9-7669a040f917"}, {"Element": "<span lang=\"SV\">Sverige</span>", "ID": "c19a0a8a-1690-4ef9-b465-7ace1dbdfcd0", "Styles": "None", "Classes": "None", "Text": "Sverige", "ParentId": "3ccaf673-887c-479b-9f60-d273d81d87f2"}, {"Element": "<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma AB </span></p>", "ID": "981f23cd-6e4c-4fb8-8ee2-5f767a257876", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "b3d77804-53b0-4102-aec6-afa0c9520d55"}, {"Element": "<span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Takeda\n  Pharma AB </span>", "ID": "6beb6c9f-4de4-4043-a436-1699a56574eb", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda   Pharma AB ", "ParentId": "981f23cd-6e4c-4fb8-8ee2-5f767a257876"}, {"Element": "<p class=\"Default\"><span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +46 8 731 28 00 </span></p>", "ID": "3b04f627-d749-40fa-9d23-690bc5aa6b7b", "Styles": "None", "Classes": "['Default']", "Text": "", "ParentId": "b3d77804-53b0-4102-aec6-afa0c9520d55"}, {"Element": "<span lang=\"SV\" style=\"font-size:11.0pt;color:windowtext\">Tel:\n  +46 8 731 28 00 </span>", "ID": "9c5a4ebd-a101-4a4a-87c3-eaf7198da7bb", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel:   +46 8 731 28 00 ", "ParentId": "3b04f627-d749-40fa-9d23-690bc5aa6b7b"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">infosweden@takeda.com\n  </span></p>", "ID": "19918872-4869-4259-a328-7c515379c9e4", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "b3d77804-53b0-4102-aec6-afa0c9520d55"}, {"Element": "<span lang=\"EN-GB\">infosweden@takeda.com\n  </span>", "ID": "13285b12-ae88-4534-9e1c-a1516b482c73", "Styles": "None", "Classes": "None", "Text": "infosweden@takeda.com   ", "ParentId": "19918872-4869-4259-a328-7c515379c9e4"}, {"Element": "<tr>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">Latvija</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda Latvia SIA </span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Tel: +371 67840082 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT\">\u00a0</span></p>\n</td>\n<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">United Kingdom</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda UK Ltd </span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel: +44 (0)1628 537 900 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>\n</tr>", "ID": "c14ed110-eb1d-4e8d-b31d-055a81be8c06", "Styles": "None", "Classes": "None", "Text": "   ", "ParentId": "d2f4f618-0e81-4b26-aa9c-4d9e5250fd7f"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">Latvija</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda Latvia SIA </span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Tel: +371 67840082 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT\">\u00a0</span></p>\n</td>", "ID": "9c0af8e3-a62d-4194-af33-2ead39da615f", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "c14ed110-eb1d-4e8d-b31d-055a81be8c06"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">\u00a0</span></b></p>", "ID": "0fd27920-d8c5-47ca-82ca-810cf7752cf0", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9c0af8e3-a62d-4194-af33-2ead39da615f"}, {"Element": "<b><span lang=\"IT\">\u00a0</span></b>", "ID": "e2039583-e7e5-4de5-9687-b6f168da917c", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "0fd27920-d8c5-47ca-82ca-810cf7752cf0"}, {"Element": "<span lang=\"IT\">\u00a0</span>", "ID": "cd653374-6281-4885-842f-c058f5a375d5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "e2039583-e7e5-4de5-9687-b6f168da917c"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">Latvija</span></b></p>", "ID": "dcc79795-a85f-47c3-91fc-a46b89ab046d", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9c0af8e3-a62d-4194-af33-2ead39da615f"}, {"Element": "<b><span lang=\"IT\">Latvija</span></b>", "ID": "f7f55277-2843-486c-923d-5e0d3ba3ce99", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "dcc79795-a85f-47c3-91fc-a46b89ab046d"}, {"Element": "<span lang=\"IT\">Latvija</span>", "ID": "cfe58d29-af50-4d42-8a38-85ca2fbb426a", "Styles": "None", "Classes": "None", "Text": "Latvija", "ParentId": "f7f55277-2843-486c-923d-5e0d3ba3ce99"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda Latvia SIA </span></p>", "ID": "98f128f0-c821-43fb-98cc-aa73aeabc5ad", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "9c0af8e3-a62d-4194-af33-2ead39da615f"}, {"Element": "<span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Takeda Latvia SIA </span>", "ID": "aab88fbd-0fd8-442a-af8d-4829d703c525", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda Latvia SIA ", "ParentId": "98f128f0-c821-43fb-98cc-aa73aeabc5ad"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Tel: +371 67840082 </span></p>", "ID": "3652934e-5bad-4049-80d6-e14e9db094c8", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "9c0af8e3-a62d-4194-af33-2ead39da615f"}, {"Element": "<span lang=\"IT\" style=\"font-size:11.0pt;color:windowtext\">Tel: +371 67840082 </span>", "ID": "584991ac-1263-4841-8660-488d83a9ad26", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel: +371 67840082 ", "ParentId": "3652934e-5bad-4049-80d6-e14e9db094c8"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"IT\">\u00a0</span></p>", "ID": "1e35f741-27a9-4bfa-91da-91e45efd2ef9", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "9c0af8e3-a62d-4194-af33-2ead39da615f"}, {"Element": "<span lang=\"IT\">\u00a0</span>", "ID": "38bcf527-e71a-4d1b-92c4-69cfc2b12f93", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "1e35f741-27a9-4bfa-91da-91e45efd2ef9"}, {"Element": "<td style=\"width:233.9pt;padding:0in 5.4pt 0in 5.4pt\" valign=\"top\" width=\"312\">\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">\u00a0</span></b></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">United Kingdom</span></b></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda UK Ltd </span></p>\n<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel: +44 (0)1628 537 900 </span></p>\n<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>\n</td>", "ID": "885693a9-8b46-469f-9f3e-88c6aec45ce0", "Styles": "width:233.9pt;padding:0in 5.4pt 0in 5.4pt", "Classes": "None", "Text": "      ", "ParentId": "c14ed110-eb1d-4e8d-b31d-055a81be8c06"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"IT\">\u00a0</span></b></p>", "ID": "4387b578-bc1b-41ba-8011-b53246a385ae", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "885693a9-8b46-469f-9f3e-88c6aec45ce0"}, {"Element": "<b><span lang=\"IT\">\u00a0</span></b>", "ID": "ce215ba6-bca1-44f9-9729-a71687157106", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "4387b578-bc1b-41ba-8011-b53246a385ae"}, {"Element": "<span lang=\"IT\">\u00a0</span>", "ID": "3485b12f-68cd-4a9e-ac22-2af10db9ab99", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "ce215ba6-bca1-44f9-9729-a71687157106"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">United Kingdom</span></b></p>", "ID": "7c394774-82c7-43fe-af88-1ab5d4e34e7a", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "885693a9-8b46-469f-9f3e-88c6aec45ce0"}, {"Element": "<b><span lang=\"EN-GB\">United Kingdom</span></b>", "ID": "cd1e15ec-2064-4943-a052-7656722a2c71", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "7c394774-82c7-43fe-af88-1ab5d4e34e7a"}, {"Element": "<span lang=\"EN-GB\">United Kingdom</span>", "ID": "942476b3-bb73-48c9-840b-0ef144a21898", "Styles": "None", "Classes": "None", "Text": "United Kingdom", "ParentId": "cd1e15ec-2064-4943-a052-7656722a2c71"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda UK Ltd </span></p>", "ID": "6b8f7163-a7ef-4f57-8703-5609bd3d5fea", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "885693a9-8b46-469f-9f3e-88c6aec45ce0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Takeda UK Ltd </span>", "ID": "1d5bceaf-fb4f-430d-8055-7aa117220287", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Takeda UK Ltd ", "ParentId": "6b8f7163-a7ef-4f57-8703-5609bd3d5fea"}, {"Element": "<p class=\"Default\" style=\"page-break-after:avoid\"><span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel: +44 (0)1628 537 900 </span></p>", "ID": "a5bc1538-a125-4ccf-a97e-dbbd88475661", "Styles": "page-break-after:avoid", "Classes": "['Default']", "Text": "", "ParentId": "885693a9-8b46-469f-9f3e-88c6aec45ce0"}, {"Element": "<span lang=\"EN-GB\" style=\"font-size:11.0pt;color:windowtext\">Tel: +44 (0)1628 537 900 </span>", "ID": "b9f3cd21-24b4-42bf-b999-a5e82474bf40", "Styles": "font-size:11.0pt;color:windowtext", "Classes": "None", "Text": "Tel: +44 (0)1628 537 900 ", "ParentId": "a5bc1538-a125-4ccf-a97e-dbbd88475661"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "62121b6b-50c2-4cdc-9ad0-f57d9c82c9c4", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "885693a9-8b46-469f-9f3e-88c6aec45ce0"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "30b7a86e-fec2-475c-8239-37e5b71886ab", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "62121b6b-50c2-4cdc-9ad0-f57d9c82c9c4"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><b><span lang=\"EN-GB\">\u00a0</span></b></p>", "ID": "bfecdcfa-c439-4c21-9d44-751ed5f56ed8", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">\u00a0</span></b>", "ID": "905e962b-865b-4a87-872b-e58325907a97", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "bfecdcfa-c439-4c21-9d44-751ed5f56ed8"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "a8197824-47c5-4302-9b9b-18f5d9f77d44", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "905e962b-865b-4a87-872b-e58325907a97"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">This leaflet was last revised in </span></b></p>", "ID": "8630e8b4-902e-49bc-995c-bba2c7b21762", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">This leaflet was last revised in </span></b>", "ID": "91719809-32f1-4b12-b10f-a40762e015bd", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "8630e8b4-902e-49bc-995c-bba2c7b21762"}, {"Element": "<span lang=\"EN-GB\">This leaflet was last revised in </span>", "ID": "d7280e0b-397c-4327-af34-6d5fb3d2c977", "Styles": "None", "Classes": "None", "Text": "This leaflet was last revised in ", "ParentId": "91719809-32f1-4b12-b10f-a40762e015bd"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "83afcf9d-62b6-49f7-8de1-2c60587dcea1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "8eb2d057-7636-49be-af50-4dedb38b72d8", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "83afcf9d-62b6-49f7-8de1-2c60587dcea1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><b><span lang=\"EN-GB\">Other sources of information</span></b></p>", "ID": "2d103345-5499-4fa5-80fb-304d9ecd0786", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<b><span lang=\"EN-GB\">Other sources of information</span></b>", "ID": "6396c858-1e97-4480-9d1c-97f299276111", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "2d103345-5499-4fa5-80fb-304d9ecd0786"}, {"Element": "<span lang=\"EN-GB\">Other sources of information</span>", "ID": "efb10aac-a5f8-48cd-828b-788586fc7278", "Styles": "None", "Classes": "None", "Text": "Other sources of information", "ParentId": "6396c858-1e97-4480-9d1c-97f299276111"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal;page-break-after:avoid\"><span lang=\"EN-GB\">\u00a0</span></p>", "ID": "b47a1eab-1774-43cb-b59a-422c98abfed1", "Styles": "line-height:normal;page-break-after:avoid", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">\u00a0</span>", "ID": "b202dd49-f0f0-40be-bf32-b7dbf87ec1d5", "Styles": "None", "Classes": "None", "Text": "\u00a0", "ParentId": "b47a1eab-1774-43cb-b59a-422c98abfed1"}, {"Element": "<p class=\"MsoNormal\" style=\"line-height:normal\"><span lang=\"EN-GB\">Detailed\ninformation on this medicine is available on the European Medicines Agency web\nsite: <a href=\"http://www.ema.europa.eu/\">http://www.ema.europa.eu</a>.<a name=\"_GoBack\"></a></span></p>", "ID": "f9e8ba3b-b878-4033-baf1-51d6e2efb055", "Styles": "line-height:normal", "Classes": "['MsoNormal']", "Text": "", "ParentId": "bac005d4-97c7-423a-a704-2189366a81b7"}, {"Element": "<span lang=\"EN-GB\">Detailed\ninformation on this medicine is available on the European Medicines Agency web\nsite: <a href=\"http://www.ema.europa.eu/\">http://www.ema.europa.eu</a>.<a name=\"_GoBack\"></a></span>", "ID": "ca3b031a-fbdd-4a3e-b48d-b36fcef34107", "Styles": "None", "Classes": "None", "Text": "Detailed information on this medicine is available on the European Medicines Agency web site: .", "ParentId": "f9e8ba3b-b878-4033-baf1-51d6e2efb055"}, {"Element": "<a href=\"http://www.ema.europa.eu/\">http://www.ema.europa.eu</a>", "ID": "bb8077a7-4c95-4766-ac82-dfa4266aa124", "Styles": "None", "Classes": "None", "Text": "http://www.ema.europa.eu", "ParentId": "ca3b031a-fbdd-4a3e-b48d-b36fcef34107"}, {"Element": "<a name=\"_GoBack\"></a>", "ID": "efd4df76-50b3-4c04-ad10-0ed2cdca8c80", "Styles": "None", "Classes": "None", "Text": "", "ParentId": "ca3b031a-fbdd-4a3e-b48d-b36fcef34107"}]}